
<html lang="en"     class="pb-page"  data-request-id="70aa1bbd-c9af-4e4e-98e6-10d30a463500"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.5b00386;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-19;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women’s Health" /></meta><meta name="dc.Creator" content="Mark P.  Thomas" /></meta><meta name="dc.Creator" content="Barry V. L.  Potter" /></meta><meta name="dc.Description" content="In 1994, following work from this laboratory, it was reported that estrone-3-O-sulfamate irreversibly inhibits a new potential hormone-dependent cancer target steroid sulfatase (STS). Subsequent dr..." /></meta><meta name="Description" content="In 1994, following work from this laboratory, it was reported that estrone-3-O-sulfamate irreversibly inhibits a new potential hormone-dependent cancer target steroid sulfatase (STS). Subsequent dr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 12, 2015" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00386" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00386" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00386" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00386" /></link>
        
    
    

<title>Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women’s Health | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00386" /></meta><meta property="og:title" content="Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women’s Health" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0033.jpeg" /></meta><meta property="og:description" content="In 1994, following work from this laboratory, it was reported that estrone-3-O-sulfamate irreversibly inhibits a new potential hormone-dependent cancer target steroid sulfatase (STS). Subsequent drug discovery projects were initiated to develop the core aryl O-sulfamate pharmacophore that, over some 20 years, have led to steroidal and nonsteroidal drugs in numerous preclinical and clinical trials, with promising results in oncology and women’s health, including endometriosis. Drugs have been designed to inhibit STS, e.g., Irosustat, as innovative dual-targeting aromatase-steroid sulfatase inhibitors (DASIs) and as multitargeting agents for hormone-independent tumors, such as the steroidal STX140 and nonsteroidal counterparts, acting inter alia through microtubule disruption. The aryl sulfamate pharmacophore is highly versatile, operating via three distinct mechanisms of action, and imbues attractive pharmaceutical properties. This Perspective gives a personal view of the work leading both to the therapeutic concepts and these drugs, their current status, and how they might develop in the future." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00386"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00386">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00386&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00386&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00386&amp;href=/doi/10.1021/acs.jmedchem.5b00386" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 7634-7658</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00229" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.5b01220" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Development of the Aryl <i>O</i>-Sulfamate Pharmacophore for Oncology and Women’s Health</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+P.++Thomas">Mark P. Thomas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barry+V.+L.++Potter">Barry V. L. Potter</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, United Kingdom</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Wolfson Laboratory of Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>Phone: +44 (0)1865 271850. Fax: +44 (0)1865 271853. E-mail: <a href="/cdn-cgi/l/email-protection#385a594a4a411648574c4c5d4a784850594a5516574016595b164d53"><span class="__cf_email__" data-cfemail="4c2e2d3e3e35623c233838293e0c3c242d3e21622334622d2f623927">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00386&amp;href=/doi/10.1021%2Facs.jmedchem.5b00386" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 7634–7658</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 20, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 March 2015</li><li><span class="item_label"><b>Published</b> online</span>12 June 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 October 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00386" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00386</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7634%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMark%2BP.%2BThomas%252C%2BBarry%2BV.%2BL.%2BPotter%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D19%26contentID%3Dacs.jmedchem.5b00386%26title%3DDiscovery%2Band%2BDevelopment%2Bof%2Bthe%2BAryl%2BO-Sulfamate%2BPharmacophore%2Bfor%2BOncology%2Band%2BWomen%25E2%2580%2599s%2BHealth%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7658%26publicationDate%3DOctober%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00386"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2263</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">50</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00386" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women’s Health&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;P. Thomas&quot;},{&quot;first_name&quot;:&quot;Barry&quot;,&quot;last_name&quot;:&quot;V. L. Potter&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;7634-7658&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00386&quot;},&quot;abstract&quot;:&quot;In 1994, following work from this laboratory, it was reported that estrone-3-O-sulfamate irreversibly inhibits a new potential hormone-dependent cancer target steroid sulfatase (STS). Subsequent drug discovery projects were initiated to develop the core aryl O-sulfamate pharmacophore that, over some 20 years, have led to steroidal and nonsteroidal drugs in numerous preclinical and clinical trials, with promising results in oncology and women’s health, including endometriosis. Drugs have been designed to inhibit STS, e.g., Irosustat, as innovative dual-targeting aromatase-steroid sulfatase inhibitors (DASIs) and as multitargeting agents for hormone-independent tumors, such as the steroidal STX140 and nonsteroidal counterparts, acting inter alia through microtubule disruption. The aryl sulfamate pharmacophore is highly versatile, operating via three distinct mechanisms of action, and imbues attractive pharmaceutical properties. This Perspective gives a personal view of the work leading both to the therapeutic c&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00386&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00386" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00386&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00386" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00386&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00386" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00386&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00386&amp;href=/doi/10.1021/acs.jmedchem.5b00386" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00386" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00386" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00386%26sid%3Dliteratum%253Aachs%26pmid%3D25992880%26genre%3Darticle%26aulast%3DThomas%26date%3D2015%26atitle%3DDiscovery%2Band%2BDevelopment%2Bof%2Bthe%2BAryl%2BO-Sulfamate%2BPharmacophore%2Bfor%2BOncology%2Band%2BWomen%25E2%2580%2599s%2BHealth%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D19%26spage%3D7634%26epage%3D7658%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292243" title="Scanning tunneling spectroscopy">Scanning tunneling spectroscopy</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/jmcmar.2015.58.issue-19/20151008/jmcmar.2015.58.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0033.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00386&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In 1994, following work from this laboratory, it was reported that estrone-3-<i>O</i>-sulfamate irreversibly inhibits a new potential hormone-dependent cancer target steroid sulfatase (STS). Subsequent drug discovery projects were initiated to develop the core aryl <i>O</i>-sulfamate pharmacophore that, over some 20 years, have led to steroidal and nonsteroidal drugs in numerous preclinical and clinical trials, with promising results in oncology and women’s health, including endometriosis. Drugs have been designed to inhibit STS, e.g., Irosustat, as innovative dual-targeting aromatase-steroid sulfatase inhibitors (DASIs) and as multitargeting agents for hormone-independent tumors, such as the steroidal STX140 and nonsteroidal counterparts, acting inter alia through microtubule disruption. The aryl sulfamate pharmacophore is highly versatile, operating via three distinct mechanisms of action, and imbues attractive pharmaceutical properties. This Perspective gives a personal view of the work leading both to the therapeutic concepts and these drugs, their current status, and how they might develop in the future.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Many cancers are hormone-dependent, with tumor growth stimulated by estrogens and androgens. This is particularly true in female breast cancer, where the majority of sufferers are postmenopausal and about three-quarters of the cancers are hormone-dependent.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Such tumors are categorized as hormone responsive if there is expression of either estrogen receptors (ER+), progesterone receptors, or both. In the adult human, there are three main A-ring aromatic estrogens, estrone (E1), estradiol (E2), and estriol (E3). The nonaromatic androgen androstenediol also has estrogenic effects but is about 100-fold weaker than estradiol, albeit produced in relatively large amounts in the postmenopausal setting.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Androstenediol potently stimulates the growth of MCF-7 breast cancer cells in vitro and mammary tumors in rats. One approach to preventing the action of estrogens that stems from the success of the antiestrogen tamoxifen, which for decades has been considered the first-line therapy for hormone-responsive breast cancer, is to block the estrogen receptor with a selective estrogen receptor modulator (SERM) or down-regulator (SERD), e.g., raloxifene, ospemifene, fulvestrant, etc.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> A second approach is to prevent the production of estrogen by inhibiting the biosynthetic enzymes involved in estrogen production, and the mainstay of this approach has been the development of aromatase inhibitors (AIs). Clinical trials have found AIs to be superior to tamoxifen both in terms of disease-free survival and adverse side effects, although ultimately tumor progression will occur.</div><div class="NLM_p">The estrogens are synthesized from androgen precursors, estradiol from testosterone and estrone from androstenedione (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). In both cases, the enzyme catalyzing the reaction is aromatase, which is the only enzyme able to catalyze the aromatization of the A-ring and, therefore, the only enzyme capable of synthesizing estrogens. If aromatase is inhibited in the postmenopausal setting, where most ovarian estrogen production has ceased, by, e.g., the clinically successful so-called third-generation aromatase inhibitors anastrozole (Arimidex), letrozole (Femara), or exemestane (Aromasin), then the production of estrogens should be stopped. In postmenopausal women, peripheral conversion through aromatase is the major source of estrogen, and AIs have been found to reduce systemic estrogen levels by as much as 98%. In postmenopausal women, however, levels of estrone sulfate (E1S), formed by the action of a sulfotransferase, are much higher than those of E1 and the half-life of E1S in plasma is long. Thus, this large circulatory pool of E1S may act as a reservoir of E1.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Because the body is able to store estrogens peripherally in the form of E1S, steroid sulfatase (STS) can convert E1S in situ in tumor cells to estrone which can then be converted to estradiol by 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1),<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> thus producing the hormone in an intracrine fashion. In cancerous breast tissue, this may be the main route of estrogen production, as the levels of STS and 17β-HSD1 are reported to be higher here than in normal tissues.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10">(7-10)</a> The importance of intracrinology as a concept has been recently reviewed<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and its key role in breast cancer in particular.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0028.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Origin of estrogenic steroids in postmenopausal women with hormone-dependent breast cancer. Also shown is the steroid ring labeling and atom numbering system. Cyp<sub>450</sub>, cytochrome P<sub>450</sub>; ER, estrogen receptor; 3β-HSDI, 3β-hydroxysteroid dehydrogenase C5,C4-isomerase; 17β-HSD, 17β-hydroxysteroid dehydrogenase, the numeral after the HSD denotes the α-subtype of this enzyme.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00386&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">STS mRNA expression is significantly higher in breast cancer tissue than in nonmalignant breast tissue<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and is also a predictor of recurrence.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> High levels are thus a significant predictor of reduced relapse-free survival. Using immunohistochemistry and a specific STS antibody, STS was located in the cytoplasm of malignant breast tissue cells and therefore may play a significant role in regulating estrone or estrogen levels within the tumor.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> While mRNA for the sulfotransferase was found to be localized in both carcinoma and intratumoral stromal cells, that of STS was detected only in carcinoma cells and STS immunoreactivity was significantly correlated with tumor size.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Therefore, STS inhibitors might be particularly beneficial for tumors expressing high levels of STS and this would in principle also allow desirable patient stratification by means of a diagnostic test for STS.</div><div class="NLM_p">Circulating E1S entering tumor cells via organic anion transporters can be hydrolyzed in situ to E1 by STS and then converted to E2 to drive tumor cell proliferation. This process will clearly be unaffected by aromatase inhibition. Also, because aromatase has no role to play in the synthesis of the androgen androstenediol, inhibition of aromatase should have no influence on the estrogenic effects of androstenediol.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Nevertheless, aromatase inhibitors have proven to be highly effective treatments for many postmenopausal breast cancers.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Indeed, a very recent study, the IBIS-II trial, investigated the use of anastrozole for prevention of breast cancer in healthy postmenopausal women at high risk of the disease and showed that it significantly reduced the risk of invasive ER+ cancer developing.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> By contrast, androstenediol is formed from androstenediol sulfate, itself derived from dehydroepiandrosterone sulfate (DHEAS) and both of these are substrates for STS. STS was found to hydrolyze readily both DHEAS and estrone sulfate, thus indicating that only one sulfatase exists for both estrogen and androgen pathways.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> This suggests that inhibition of STS should not only affect the in situ generation of E1, in an intracrine fashion as above, but also should block the other pathway of estrogenic stimulation via androstenediol, both aromatase-independent pathways. It was thus reasoned that additional blockade of the sulfatase-dependent pathways may improve the therapeutic response to endocrine therapy, either alone or in combination.</div><div class="NLM_p">The structural biology and enzymology of the enzymes of estrogen metabolism have been recently reviewed,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and there are multiple reviews that cover various aspects of the biology and chemistry of aromatase and STS and their inhibitors<a onclick="showRef(event, 'ref21 ref22 ref23 ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24 ref25 ref26 ref27">(21-27)</a> as well as the intellectual property status of the STS field.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This Perspective illustrates the development of series of inhibitors that have been, or could be still further, developed into drugs to treat cancer. All are based around the aryl sulfamate pharmacophore, the chemistry and therapeutic potential of which have been the subject of several extensive reviews.<a onclick="showRef(event, 'ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32 ref33">(29-33)</a></div><div class="NLM_p"><i>N</i>-Sulfamate derivatives such as cyclamate, and including aryl <i>N</i>-sulfamate derivatives, are long known as sweeteners.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Also, <i>O</i>-sulfamates when attached to nucleosides, as esters of sulfamic acid, have found roles in the inhibition of bacterial aminoacyl-tRNA synthetases,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and as antivirals, antibiotics, and antitrypanosomals, e.g., nucleosidin (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and, when attached to a modified monosaccharide, the anticonvulsant fructopyranose derivative, topiramate (Topomax, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) as a treatment for epilepsy<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> as well as the related analogue RWJ-37497,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> both carbonic anhydrase inhibitors. Intriguingly and most recently, the sulfamate-based nucleoside analogue MLN4924<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) is a first-in-class selective inhibitor of the proximal regulator of the NEDD8-activating enzyme (NAE), a protein homeostatic pathway essential for cancer cell growth and survival<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and is currently in clinical trials for the treatment of cancer. It is a mechanism-based inhibitor of NAE and creates a covalent adduct with NEDD8 catalyzed by the enzyme.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">At the inception of our work in the early 1990s, although earlier patents had been filed on dialkyl aryl sulfamate esters and some work in the anticonvulsant field claimed aryl sulfamates, we were aware of little, if any, formal work with polycyclic aryl <i>O</i>-sulfamate esters as drug candidates; the surprisingly very clean patent landscape then in this regard verified this and enabled an initial 1991 priority filing and subsequent grant of very broad composition-of-matter patent coverage around this pharmacophore.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Around this time also the first work on imidazolylphenyl sulfamate-based aryl <i>O</i>-sulfamates as potential topical antiglaucoma agents was published.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Later, the <i>N</i>-substituted aryl sulfamate ester derivative Avasimibe (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), a selective acyl-coenzyme A:cholesterol <i>O</i>-acyltransferase inhibitory lipid-regulating agent reaching phase III trials but later withdrawn, was under development by Pfizer up to 2004 for the potential treatment of hyperlipidemia and atherosclerosis.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0029.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Some sulfamate-based drugs and drug candidates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00386&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Estrone 3-<i>O</i>-Sulfamate (EMATE)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62020" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62020" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The isoxazole derivative of 17-α-ethinyltestosterone, danazol, was the first compound shown to inhibit STS<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a>, and a small human study later concluded that it had in vivo effects on steroid sulfatase but was weak.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Initial work in our group to develop highly potent inhibitors of STS was published in 1993 with the development of structural analogues of estrone sulfate (E1S). This work was based upon exploring structural surrogates of the sulfate group and led to reversible inhibitors. An early success was the synthesis of the diastereoisomeric estrone 3-methylthiophosphonate, <b>1</b> (and other 3-<i>O</i>-phosphonate and thiophosphonate analogues), that was a good inhibitor of STS in MCF-7 breast cancer cells (96% inhibition at 10 μM) and in placental microsomes (IC<sub>50</sub> = 43 μM), with the S<sub>P</sub>-isomer being the more potent diastereoisomer.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45, 46)</a> The following year, the inhibitory activities of a different set of E1S analogues, <b>2</b>–<b>4</b>, were reported, the most potent of which was estrone 3-<i>O</i>-sulfamate, <b>2</b> (EMATE).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> In MCF-7 breast cancer cells, <b>2</b> inhibited STS activity by more than 99% at 0.1 μM, with the level of inhibition declining with increasing methylation of the amino group, and in placental microsomes, the IC<sub>50</sub> for STS inhibition by <b>2</b> was 80 nM. By treating MCF-7 cells with <b>2</b>, <b>3</b>, and <b>4</b>, washing the cells, and then assaying the STS activity, <b>2</b> was characterized as a time- and concentration-dependent irreversible active-site directed inhibitor. Cells treated with <b>3</b> and <b>4</b> by contrast recovered 50% and 80% of their STS activity, respectively.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The hydrolysis of both E1S and DHEAS by human placental STS expressed in COS-1 cells was also effectively inhibited by <b>2</b>, it not making any difference whether the cells were intact or broken.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Kinetic studies showed that <b>2</b> inactivates STS in a time-, dose-, and pH-dependent manner.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0034.gif" alt="" id="fx1" /></img></div><div class="NLM_p">The in vivo inhibition of E1S and DHEAS hydrolysis in the liver was tested by subcutaneous (sc) injection of rats for 7 days with 10 mg/kg <b>2</b>.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Both activities were almost completely abolished. A dose–response study found no effect of 0.01 mg/kg <b>2</b> on liver STS activity but 87% inhibition at 0.1 mg/kg and almost complete inhibition at 1 and 10 mg/kg when <b>2</b> was administered by sc injection.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> A single dose of <b>2</b> (10 mg/kg, sc) was sufficient to abolish STS activity for 3 days, with a 10–15% recovery of activity after 7 days in liver, uterine, and brain tissues but still no activity in ovarian or adrenal tissues. Treatment for 10 days (10 mg/kg/day, sc) resulted in inhibition for 10 days after the last dose, with up to 30% recovery after 15 days.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> The growth of mammary tumors was significantly reduced in animals receiving <b>2</b>.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Although clearly inactive in vitro as an irreversible STS inhibitor, the dimethyl analogue of <b>2</b> was nevertheless orally active and highly potent in vivo in inhibiting NMU-induced mammary tumor growth,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> demonstrating that this compound, <b>4</b>, is likely demethylated in vivo to <b>2</b>.</div><div class="NLM_p">Also in 1996 the development of a self-emulsifying formulation of <b>2</b> suitable for oral administration<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a> and the results of a pharmacokinetics study<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> were reported. A dose–response study with oral administration to rats produced results almost identical to those obtained following sc injection.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a><b>2</b> was rapidly absorbed and readily detected in rat plasma after oral administration, with plasma concentrations correlating with the size of the administered dose over the 10–40 mg/kg range. Rat liver STS was almost completely inhibited within 30 min of oral or intravenous (iv) administration of <b>2</b>. The following year, the development of an assay of STS activity in white blood cells (WBC) was reported.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> This was necessary because, if patients with breast cancer were to be treated, a simple method to monitor the extent and duration of STS inhibition is essential. Two hours after the oral administration of 10, 20, or 40 mg/kg <b>2</b> to rats, no difference in STS activity between samples taken from the liver and WBC was observed, both being inhibited by over 98% at all doses. Plasma concentrations of <b>2</b> after a single oral dose of 0.5 mg/kg to two human male volunteers peaked at 12.3 nmol/L after 4 h in one, and at 10.9 nmol/L after 6 h in the other: in both cases <b>2</b> appeared to be rapidly absorbed. It was not possible to measure E1 or E1S concentrations in these volunteers, but 12 hours after administration of <b>2</b> dehydroepiandrosterone (DHEA) levels had fallen by 41% and 72% and remained below pretreatment levels for more than 72 h. In keeping with <b>2</b> inhibiting STS, the levels of DHEAS increased, by 50% and 34% after 24 h, with this increase being maintained for at least 72 h.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p">Several analogues of <b>2</b> at the sulfamate group were synthesized to try to illuminate the mechanism of STS inhibition.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> None of the compounds <b>5</b>–<b>8</b> was a good inhibitor, the best of them, <b>5</b>, achieving 53% inhibition at 50 μM (compared with >99% inhibition at 1 μM for <b>2</b>), with <b>6</b> inhibiting by 12% at 50 μM, <b>7</b> failing to inhibit at 100 μM, and <b>8</b> inhibiting by 19% and 45% at 60 and 300 μM, respectively. Both <b>5</b> and <b>6</b> failed to show irreversible time-dependent inhibition of the enzyme, suggesting that the bridging oxygen in the sulfamate moiety of <b>2</b> is essential for irreversible inhibition. The X-ray crystal structure of <b>2</b> was also determined.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> On the basis of these results, two possible mechanisms of action for inhibition by <b>2</b> were proposed, one via an electrophilic aminosulphene intermediate and another via a nucleophilic attack by an amino acid residue in the active site<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> (vide infra).</div><div class="NLM_p last">Additional analogues of <b>2</b> were synthesized to determine the structure–activity relationship (SAR), with modifications of the sulfamate (<b>9</b>–<b>21</b>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The <i>N</i>-acylated derivatives (<b>14</b>, <b>15</b>, <b>18</b>) were highly potent.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Despite the initial promising findings, however, <b>2</b> was not chosen for clinical development at this stage as an STS inhibitor in oncology as the estradiol sulfamate version (E2MATE, <b>22</b>) was surprisingly found to be a highly potent estrogen in rats, with increased systemic, but reduced hepatic, estrogenicity upon oral administration<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> despite (like E1S) not binding to the estrogen receptor.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> This results from its sequestration and transport through the liver within red blood cells where it is bound to carbonic anhydrase. A uterine weight gain assay in ovariectomized rats showed that a dose of only 2 μg of <b>22</b> was required to double the weight of the uterus, compared with 10 μg of ethinyl estradiol and 200 μg of estradiol.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Thus, <b>22</b> is approximately five times more potent than ethinyl estradiol, which is widely used in HRT and oral contraception. This surprising finding led to the clinical evaluation of the estradiol version of <b>2</b> (<b>22</b>, also known as STX68 and J995) under license as a prodrug for hormone replacement therapy applications.<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a> In later work, we showed that STS is able to hydrolyze estrogen sulfamates as a result of its mechanism of irreversible inhibition and that, therefore, <b>2</b> is indeed a prodrug for estrone<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> or, in principle, <b>22</b> for estradiol. In vitro studies, using [<sup>3</sup>H]estrone sulfamate, revealed that its uptake (95.9 ± 2.4%) by red blood cells is much higher than that for the nonsulphamoylated estrogen. Results from these studies demonstrated convincingly that STS is the enzyme responsible for the removal of the sulphamoyl group and it therefore has a crucial role in regulating the estrogenicity associated with this class of drug. To date, the pro-drug approach for <b>22</b> has been investigated clinically up to phase II and some limited clinical data are available in the public domain.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0001.gif" alt="" id="fx2" /></img></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">COUMATEs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34306" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34306" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Because the estrogenicity of <b>2</b> precluded its originally anticipated application in oncology, a search for an orally active, nonsteroidal, nonestrogenic, Lipinski-compliant STS inhibitor was undertaken, primarily based upon steroidal A/B ring surrogates. One of the first compounds developed was 4-methylcoumarin-7-<i>O</i>-sulfamate (<b>23</b>, COUMATE), which inhibits STS irreversibly in a time- and concentration-dependent manner, has an IC<sub>50</sub> of 380 nM in MCF-7 cells, and in rats has no estrogenic activity.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Oral dosing of rats for 7 days (10 mg/kg/day) inhibited liver STS activity by 85%, with enzyme activity returning to normal over 7 days.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> An initial series of derivatives of <b>23</b> was synthesized, of which the most potent was 3,4-dimethylcoumarin-7-<i>O</i>-sulfamate (<b>24</b>), which inhibited STS in MCF-7 cells with IC<sub>50</sub> = 30 nM.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> This suggested that there was room for larger moieties at the coumarin 3- and 4-positions, so a series of tricyclic compounds was synthesized (<b>25</b>–<b>34</b>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">1</a>) that proved more potent.<a onclick="showRef(event, 'ref67 ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref67 ref68 ref69 ref70">(67-70)</a> The most potent of these compounds were <b>29</b> and <b>30</b>, but it was <b>27</b>, known as Irosustat (also known as 667 COUMATE, STX64, and subsequently BN83495),<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> that was selected for extensive in vivo studies because it was thought that the lower hydrophobicity of the smaller ring size would result in the compound having better pharmacokinetic and pharmacodynamic properties.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Note that tricyclic <b>34</b>, with a ring size of 15, although significantly weaker in vitro, was the most potent in vivo. The greater activity of these nonsteroidal compounds relative to <b>2</b> was attributed to the enhanced “sulfamoyl transfer potential” as a result of the lower phenolic p<i>K</i><sub>a</sub> of the parent.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> This class of nonsteroidal compound importantly was also shown to inhibit STS irreversibly. Single or multiple doses of <b>27</b> inhibited rat liver STS by >90%, and oral or subcutaneous doses prevented the growth of nitrosomethylurea-induced mammary tumors in rats.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The synthetic route to <b>27</b> and its congeners is very straightforward, comprising only two steps, a Pechmann reaction between resorcinol and the corresponding cyclic β-ketoester, and a sulfamoylation,<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> making them attractive candidates for industrial scale-up.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Activities of Tricyclic Coumarin Sulfamates against STS in Human Placental Microsomes</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0002.gif" alt="" id="GRAPHIC-d3059e696-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="center">200</td><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="center">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="center">70</td><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="center">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="center">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="center">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="center">2.4</td><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="center">370</td></tr></tbody></table></div></div><div class="NLM_p">An investigation of the pharmacokinetics of <b>27</b> following a single po or iv dose (10 mg/kg) revealed a bioavailability of 95% and detectable levels in plasma for 8 h.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> In plasma ex vivo, <b>27</b> is rapidly degraded, but in vivo degradation is prevented by sequestration inside red blood cells where it binds to (and inhibits) carbonic anhydrase II (CAII, IC<sub>50</sub> = 22 nM), a feature, also, of <b>2</b> (IC<sub>50</sub> = 23 nM) and its derivatives.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The X-ray crystal structures of both <b>2</b><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> and <b>27</b><a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> in complex with CAII were determined. The ability of red blood cells to prevent metabolic degradation and facilitate transport to tissues may account for the high bioavailability of <b>27</b>.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Moreover, this sequestration allows the drug to evade first-pass metabolism.<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75, 76)</a></div><div class="NLM_p">The structure of one of the COUMATE class, <b>29</b>, is shown below drawn in a folded fashion to show how it could potentially mimic a steroid structure in binding to STS. When one also notes that sulfamate esters, like sulphonamides, are weak acids with the first p<i>K</i><sub>a</sub> in the 7–9 region, depending upon solvent, it becomes clear that there will be a significant amount present in the anionic form as drawn, at physiological pH, thus making the analogue (and indeed <b>2</b> itself) a good mimic of the normal STS substrate. Added to this is the fact that the sulfamate ester can also be substantially present as the neutral form which will aid permeability, tissue penetration, and presumably sequestration in red blood cells.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0003.gif" alt="" id="fx3" /></img></div><div class="NLM_p">The working hypothesis adopted for the mechanism of action of aryl sulfamates in inactivation of STS is generally that the sulfamoyl group is likely transferred to the protein active site in some fashion and several mechanisms have been postulated, although none is conclusively proven as yet.<a onclick="showRef(event, 'ref48 ref55 ref67'); return false;" href="javascript:void(0);" class="ref ref48 ref55 ref67">(48, 55, 67)</a> In eukaryotic sulfatases, a critical formylglycine (FGly) residue is generated by post-translational modification of an active site cysteine residue. This FGly, in its hydrated form as a <i>gem</i>-diol, is thought to be generally involved in the catalytic mechanism of all sulfatases and is a potential target for irreversible modification by sulfamate-based inhibitors.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> In 2003, an X-ray crystal structure of human STS became available, illustrating its “mushroom-like” structure,<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> and structural aspects of sulfatases have been reviewed.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Using the STS crystal structure, docking experiments indicated the likely correct positioning of the sulfamate group of <b>27</b> in the active site is opposite the crucial hydrated FGly residue,<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> suggesting that the sulfamate group, as a good steric and electronic sulfate mimic, might be transferred to this residue during inhibition. The idea that inhibition of STS by sulfamate esters is facilitated by some kind of sulfamoyl group transfer to the active site of STS is intrinsic to the ideas presented in this review and is the currently accepted mode of action for such drugs, even if the precise mechanism is as yet unknown. Further ideas on this subject have been recently discussed<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> but are beyond the scope of the present review.</div><div class="NLM_p"><b>27</b> was the first STS inhibitor to enter phase I clinical trials in postmenopausal women with estrogen receptor-positive breast cancer who had failed on other treatment regimens.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> An initial oral dose of either 5 or 20 mg was followed a week later by three fortnightly cycles, each comprising 5 days dosing and 9 days off treatment. Systemic uptake after oral administration was monitored using the WBC assay.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> At the end of the dosing period, STS activity in biopsied breast tumor tissue was inhibited by 99% and serum concentrations of estrone, estradiol, androstenediol, and DHEA had, as expected, fallen significantly from pretreatment levels. Unexpectedly, the levels of the aromatase substrates testosterone and androstenedione also fell significantly, implying that these were also linked to STS-active precursor cleavage, at least in part. This could in principle augment STS inhibitor effectiveness as a monotherapy, and androstenedione is of course a substrate for aromatase. The drug was well-tolerated with only minor adverse effects recorded. Four patients who had previously progressed on aromatase inhibitors showed stable disease for up to seven months;<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> some of these patients continued to receive compassionate dosing after the end of the trial. Results of the first trial have been summarized.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> A subsequent phase I dose escalation study determined the optimal dose of <b>27</b> as 40 mg/day. In phase I/II trials, clinical observation of stable disease was observed in a cohort of 35 estrogen receptor-positive metastatic breast cancer patients at this dose (one patient stable for 13 months, one for 8 months, one for 7 months, and 3 for ca. six months). Biopsy-validated erythematous skin infiltration in one patient was no longer visible after one month of treatment. Virtually complete inhibition of STS was observed with all doses between 5 and 80 mg/day, achieving ≥95% STS inhibition, and the maximum tolerated dose was not reached.<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82, 83)</a> Excellent safety and tolerability was observed. However, for unknown reasons, relative bioavailability decreases with increasing dose.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Clinical progress has been reviewed.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Thus, the well tolerated treatment showed STS inhibition associated with a significant reduction in the levels of some circulating steroid hormones and, within some patients, prolonged clinical partial responses, demonstrating the clinical interest of STS inhibition and importantly validating the underpinning scientific concepts. Further trials in breast cancer are ongoing vide infra.</div><div class="NLM_p">Endometrial cancer, developing from the inner uterine lining, is the most common cancer found in the female reproductive system, and there is a strong medical need for new agents. Of ca. 40000 new cases of endometrial cancer diagnosed during 2008 in the U.S., ca. 7500 women died from this disease. A multicenter phase II study of <b>27</b> as a treatment for estrogen receptor-positive endometrial cancer in women with recurrent or advanced disease was undertaken against the current standard of care (megestrol acetate) with, as primary end point, the proportion of patients who neither progressed nor died after 6 months of treatment. Progression-free survival, clinical benefits, overall survival, and safety were evaluated as secondary end points. Although the primary end point was not reached, the study found clinical benefit from <b>27</b>, with 47.2% of patients having stable disease, 36.1% alive without progression at six months, and 11.1% having a complete or partial response.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Again, the treatment was well tolerated and STS inhibition was associated with a significant reduction in the levels of some circulating steroid hormones and, in some patients, prolonged clinical partial responses.</div><div class="NLM_p">Male patients suffering from prostate cancer often undergo castration to reduce hormone levels, with a further period of remission following adrenalectomy.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> This is probably because the adrenal production of androgens (DHEA and DHEAS) is stopped. In the prostate, these androgens can be converted to testosterone and dihydrotestosterone that drive tumor growth, analogous to the in situ cleavage of E1S in breast tumor cells. Significant STS activity has been detected in prostate tissue and in LNCaP prostate cancer cells, suggesting that here also STS could facilitate the intracrine production of hormones to stimulate tumor growth. Organic anion transporting polypeptides can transport DHEAS into human prostate cancer cells<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> to be converted via endogenous STS action into DHEA and then into testosterone by hydroxysteroid dehydrogenases and into DHT via 5α reductase. Knockdown of the transporter reduced DHEAS-stimulated cell growth as did the administration of <b>27</b>.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> The effect of <b>27</b> on hormone levels in male patients suffering from castration-resistant prostate cancer was studied in a further U.S. clinical trial,<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> and a phase I dose escalation study of <b>27</b> was conducted in chemo-naïve, castration-resistant prostate cancer patients showing evidence of disease progression. Aims were to evaluate the safety, tolerability, pharmacokinetic, and endocrine parameters (DHEA, androstenediol, and testosterone) consequent upon STS inhibition resulting from 28 days of oral drug administration. In all the patients, the concentration of testosterone, androstenediol, DHEA, and DHEAS fell. <b>27</b> demonstrated nearly complete STS inhibition and was well tolerated, with dry skin as the most common related adverse event. Pharmacodynamic proof of concept was thus demonstrated, leading to an increase in DHEAS level and significant suppression of relevant nonsulfated androgens. The DHEA:DHEAS ratio was decreased by 338%.</div><div class="NLM_p">Further development of <b>27</b> in monotherapy for the above hormone-dependent cancers is not currently ongoing, substantially based on the observation that <b>27</b> is not superior to megesterol acetate, the current standard of care, in a phase II trial of endometrial cancer. However, on the basis of the excellent STS inhibition observed, the phase I/II results obtained in the metastatic prostate and breast cancer trials, the good clinical safety profiles noted, associated with the reduction of hormonal parameters and the potentially encouraging clinical efficacy seen, the development focus is currently moving toward exploration of <b>27</b> in combination with other hormonal therapies. Thus, two further UK clinical trials with <b>27</b> were initiated in 2012 in breast cancer; these trials aim to explore the benefit of combination dosing with the aromatase inhibitor anastrozole (the IRIS trial)<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90, 91)</a> and also to examine the effects of <b>27</b> in breast cancer patients using PET scanning (the IPET Trial).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></div><div class="NLM_p">The ectopic growth of endometrial tissue outside the uterus is a characteristic of endometriosis, a nonmalignant gynecological disease leading to chronic pelvic pain and infertility. In addition to production of estrogens in the ovaries, there is compelling evidence that local synthesis of estrogens in endometriotic lesions promotes progression of the disease and resistance to endocrine therapy. The disease is rarer in postmenopausal women, suggesting that it is estrogen-dependent. With an estimated 80 million patients worldwide, the disease is still poorly understood, most treatments have unpleasant side effects, and current therapies are grossly inadequate. Aromatase and STS activity have been detected in both eutopic and ectopic endometrial tissue with the level of STS activity, but not aromatase activity, correlating with the severity of the disease.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a><b>27</b> almost completely blocked STS activity in homogenized endometrial tissue, suggesting that STS inhibition may be a useful treatment for endometriosis.<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93, 94)</a> Positive in vivo preclinical data using our original STS inhibitor <b>22</b> were also reported independently. In induced endometriotic lesions, <b>22</b> inhibited STS in vivo, with no effect on the number of lesions, although the lesions were smaller than those in untreated animals.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Clinical trials have taken place in endometriosis using <b>22</b> (also known as PGL2001).<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a><b>22</b> entered phase I clinical trials in Germany in 2008 as an STS inhibitor in healthy premenopausal women to advance this compound toward a novel, once-a-week, oral medication. In this randomized, double-blind, placebo-controlled phase I study of <b>22</b>, either alone or in combination with an inhibitor of ovarian estrogen production, 24 healthy women of reproductive age were treated for 4 weeks.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a><b>22</b> reduced endometrial STS activity by 91%, and both drugs together reduced activity by 96%; in both cases, the activity levels remained low for at least a month after cessation of treatment.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The drug continues in clinical trials against endometriosis, and multicenter phase IIa studies to investigate its efficacy, safety, pharmacokinetics, and pharmacodynamics started in Hungary, Poland, and Romania in 2012.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div><div class="NLM_p"><b>27</b> undergoes desulfamoylation to yield the sufamoyl-free derivative, 667-coumarin.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Metabolism by hepatocytes and liver microsomes was extensive, and in vitro studies showed similar metabolic profiles in rats, dogs, monkeys, and both human sexes. The main metabolites were sulfated and glucuronidated derivatives of 667-coumarin and some of its monohydroxylated analogues.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> CYP1A2 was competitively inhibited by 667-coumarin with a <i>K</i><sub>i</sub> of 0.77 μM, but CYP2A6, CYB2B6, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4/5, and several UDP-glucuronosyltransferases were not inhibited.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> However, in the in vivo setting where the drug is sequestered inside red blood cells, the significance of any such CYP inhibition may be significantly reduced.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0004.gif" alt="" id="fx4" /></img></div><div class="NLM_p">The topical application of <b>27</b> or its <i>N</i>,<i>N</i>-dimethyl analogue (STX289, <b>35</b>) to the dorsal neck region of nude mice resulted in the inhibition of skin and liver STS.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Desulfamoylation of <b>27</b> occurred in both the presence and absence of cells, but <i>N</i>,<i>N</i>-demethylation of <b>35</b> did not occur in the absence of cells, suggesting that <b>35</b> may be suitable for development as a topically applied STS inhibitor.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><div class="NLM_p last">A number of potent steroid sulfatase inhibitors have been developed, originally and subsequently in women’s health and also in oncology for the treatment of hormone sensitive diseases such as breast cancer, extending to endometrial cancer, prostate cancer, and endometriosis. STS inhibition was also earlier shown to have potential in immune modulation. Thus, DHEA and DHEAS have an immunostimulatory role in vivo.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> However, <b>2</b> blocked the ability of DHEAS, but not DHEA, to act as an immunostimulant. Because conditions such as rheumatoid arthritis may result from an inappropriate immune response and increased production of Th1 cytokines STS inhibition could be of therapeutic benefit. <b>2</b> markedly altered progression using a model of arthritis,<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> in dermatology,<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> and in memory and cognitive function. <b>2</b> was administered alone and in combination with DHEAS to rats, which were then tested for the reversal of scopolamine-induced amnesia. <b>2</b> enhanced the reversal of amnesia by DHEAS, suggesting that STS inhibition can potentiate the memory-enhancing properties of DHEAS and that so increasing the levels of endogenous sulfated neurosteroids may enhance learning and/or memory function.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Interestingly, a recent report details that pharmacological modulation of the STS axis using <b>23</b> results in enhanced response control in models of attention deficit hyperactivity disorder (ADHD) comparable to that with commonly used ADHD therapeutics such as methylphenidate and atomoxetine.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> More recently, there are indications of STS involvement<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> and therapeutic potential in ovarian cancer,<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> lung cancer,<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> colon cancer,<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> and bladder cancer.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> STS occurs in bone, but little is known about its role in bone function. STS is present in human preosteoblastic bone cells and can influence bone cell growth via conversion of sulfated steroids. Preosteoblastic MG-63 cells and microsomes both possess STS activity that was blocked by <b>2</b> and <b>27</b>; <b>27</b> inhibited cell growth.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Such wider topics are outside the scope of this review and the earlier work has been more widely discussed<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> but demonstrate that the scope for application of the concept of STS inhibition and the inhibitors developed is very wide and still substantially unexplored. The broadly positive results observed in the initial clinical trials serve to validate the original scientific concepts put forward. Whether the future lies in monotherapy or combination therapy, however, still remains to be established.</div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Steroid Sulfamate Derivatives, Leading to Microtubule Disruptors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alongside the development of <b>23</b> and <b>27</b>, and given the powerful estrogenicity of <b>22</b>, a program was initiated to develop a nonestrogenic derivative of <b>2</b> based on the steroidal core. A first series of compounds involved modification of the A ring (<b>36</b>–<b>38</b>) alongside, for some of the structures, converting the estrone core to estradiol (<b>39</b>, <b>40</b>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">2</a>).<a onclick="showRef(event, 'ref112 ref113 ref114 ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref112 ref113 ref114 ref115 ref116">(112-116)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Activities of A-Ring-Modified Derivatives of <b>2</b> and <b>22</b> against STS Using Placental Microsomes (PM) and MCF-7 Cells<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0005.gif" alt="" id="GRAPHIC-d3059e1131-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub><b>1</b></sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char=".">sulfatase IC<sub>50</sub> (nM) in PM</th><th class="colsep0 rowsep0" align="center" char=".">MCF-7 GI<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Core Structure A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">199</td><td class="colsep0 rowsep0" align="char" char=".">22.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char=".">1200</td><td class="colsep0 rowsep0" align="char" char=".">0.042</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="6" align="center">Core Structure B</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">2.35</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Data taken from refs <a onclick="showRef(event, 'ref112 ref113 ref114 ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref112 ref113 ref114 ref115 ref116">112−116</a>. Data for many other compounds with different substituents at R<sub>1</sub>, R<sub>2</sub>, and R<sub>3</sub> are not shown.</p></div></div></div><div class="NLM_p">In placental microsomes, <b>2</b> inhibits STS with IC<sub>50</sub> = 199 nM.<a onclick="showRef(event, 'ref112 ref113 ref114 ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref112 ref113 ref114 ref115 ref116">(-112-116)</a> The 2-methoxy derivative <b>36</b> inhibits STS with IC<sub>50</sub> = 30 nM.<a onclick="showRef(event, 'ref112 ref113 ref114 ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref112 ref113 ref114 ref115 ref116">(112-116)</a> Converting the estrone core of <b>2</b> to an estradiol core yields <b>22</b>. In placental microsomes, <b>22</b> inhibits STS with IC<sub>50</sub> = 16 nM.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a><b>22</b> is also able to inhibit STS in vitro in human endometrial tissue and in vivo in murine liver, leukocytes, and uterine tissue.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Note also the activity of <b>22</b> in models of endometriosis vide supra.</div><div class="NLM_p">KW-2581, 17-diisopropylcarbamoyl-1,3,5(10),16-estratetraen-3-yl sulfamate (<b>41</b>), a potent and nonestrogenic steroidal STS inhibitor based on <b>2</b>, was evaluated in a range of in vivo tumor models. <b>41</b>, given daily orally at 1 mg/kg, inhibited the growth of human breast cancer ZR-75-1 xenografts stimulated with E1S,<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117, 118)</a> and further work demonstrated the inhibitory effect of <b>41</b> in E1S-stimulated growth of NMU-induced rat mammary tumors.<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117, 118)</a> These studies importantly also demonstrated that tumors with an elevated STS activity had a greater final tumor volume as also noted earlier.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> A more recent development is ESE-16, <b>42</b>, which has been shown to cause both apoptotic and autophagic cell death.<a onclick="showRef(event, 'ref120 ref121'); return false;" href="javascript:void(0);" class="ref ref120 ref121">(120, 121)</a><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0006.gif" alt="" id="fx5" /></img></div><div class="NLM_p">A development of the 17-position-reduced version of <b>36</b>, but also sulfamoylated on the D ring (<b>43</b>, known as STX140), inhibited MCF-7 cell proliferation and in vivo STS activity.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Both <b>43</b> and <b>44</b> (STX243), the 2-ethyl variant of <b>43</b>, inhibited the proliferation of MCF-7 cells and doxorubicin- and mitoxantrone-resistant variants, causing arrest in the G<sub>2</sub>/M phase of the cell cycle.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Treatment of adult human fibroblasts with 0.1 μM <b>43</b> caused a reversible change in cell morphology and induced G<sub>2</sub>/M arrest but not apoptosis.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> The same treatment when applied to human umbilical vein endothelial cells (HUVECs) had no effect until the coadministration of TNF-α which induced apoptosis.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> CAL51 cells are resistant to TRAIL-induced apoptosis, but <b>43</b> is able to stimulate the activation of caspases downstream of TRAIL and thus overcome the TRAIL resistance.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> When tested for their ability to inhibit the proliferation of estrogen receptor positive (MCF-7) and negative (MDA-MB-231) cells, <b>43</b> inhibited the growth of both cell lines (IC<sub>50</sub> = 0.25 and 0.29 μM, respectively) as did the 17-cyanomethyl derivative (STX641) <b>45</b> (IC<sub>50</sub> = 0.07 and 0.08 μM, respectively).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> SAR studies looking at the effects of a range of alkyl and alkoxy substituents at the 2-position in combination with various substituents (sulfamates and their derivatives, acetates, and amides) at the 17-position yielded a large amount of data pertaining to both in vitro and in vivo activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">3</a>, compounds <b>40</b> and <b>43</b>–<b>45</b>).<a onclick="showRef(event, 'ref126 ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref126 ref127 ref128">(126-128)</a> Although derived from considerations linked to a desire to decrease the estrogenicity of <b>2</b>, it was also realized that <b>43</b> is in effect a derivative of 2-methoxyestradiol (2MeOE2, Panzem), a natural endogenous metabolite of estradiol that binds poorly to the estradiol receptor. 2MeOE2 is a microtubule inhibitor, antiproliferative, antiangiogenic, and induces apoptosis in some cancer cell lines;<a onclick="showRef(event, 'ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref129 ref130">(129, 130)</a> it inhibits tubulin polymerization by interacting at the colchicine site.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> While several phase I/II cancer clinical trials have been undertaken with this compound, progress was hindered by its very poor bioavailability and its extensive metabolism in vivo. Indeed, one such trial was terminated due to the complete absence of 2MeOE2 detected in patient plasma despite patients being dosed with 3 g per day.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Extensive efforts have been made to synthesize analogues of this agent,<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> and <b>43</b> in particular is a promising derivative and clinical trial candidate vide infra.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory and Antiproliferative Activities of 2-Substituted Estradiol Derivatives<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0007.gif" alt="" id="GRAPHIC-d3059e1495-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">GI<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center" char=".">sulfatase IC<sub>50</sub> (nM) in PM</th><th class="colsep0 rowsep0" align="center" char=".">MCF-7</th><th class="colsep0 rowsep0" align="center" char=".">MDA-MB-231</th><th class="colsep0 rowsep0" align="center" char=".">DU145</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">2.35</td><td class="colsep0 rowsep0" align="char" char=".">0.94</td><td class="colsep0 rowsep0" align="char" char=".">1.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CN</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.071</td><td class="colsep0 rowsep0" align="char" char=".">0.062</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">1000</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">PM, placental microsomes. Data taken from refs <a onclick="showRef(event, 'ref126 ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref126 ref127 ref128">126−128</a>. Data for many other compounds with different substituents at R<sub>1</sub>, R<sub>2</sub>, and R<sub>3</sub> are not shown.</p></div></div></div><div class="NLM_p">2-Methoxy-EMATE (<b>36</b>), at a concentration of 1 μM, inhibited the growth of MCF-7 breast cancer cells by 52% by inducing apoptosis: the cells arrested in the G<sub>2</sub>/M phase.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> This was not totally unexpected, as 2MeOE2 (<b>40</b>) inhibits tubulin polymerization,<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> cell adhesion, migration, and motility,<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> induces cells to undergo mitotic arrest and apoptosis,<a onclick="showRef(event, 'ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref135 ref136">(-135, 136)</a> and has antiangiogenic and antitumor properties.<a onclick="showRef(event, 'ref130 ref135 ref137'); return false;" href="javascript:void(0);" class="ref ref130 ref135 ref137">(130, 135, 137)</a> Over an 11-day period, <b>36</b> induced the in vivo regression of two out of three tumors in rats when given orally at a dosage of 20 mg/kg/day.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a><b>36</b> and its close analogue <b>37</b> (2-ethyl-EMATE) function as antimicrotubule agents, inhibiting the ability of paclitaxel to promote tubulin assembly in vitro,<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> a finding that is a possible explanation for the marked effect on the morphology of MDA-MB-231 cells and breast tumor-derived fibroblasts which adopt a more rounded shape than usual.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> The same two compounds were tested for their ability to inhibit the growth of two prostate cell lines, LNCaP (androgen receptor positive) and PC3 (androgen receptor negative), and an ovarian cell line (A2780) and adriamycin- and cisplatin-resistant derivatives of it (A2780cis and A2780adr).<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Both <b>36</b> and <b>37</b> inhibited the growth of all five cell lines with IC<sub>50</sub> values between 1.3 μM and less than 0.1 μM. Several of the compounds of this class were tested against the NCI 55 cell panel, and <b>37</b> was found to be consistently the most potent inhibitor of cell growth.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Furthermore, <b>37</b> was also an effective inhibitor of angiogenesis.<a onclick="showRef(event, 'ref115 ref141'); return false;" href="javascript:void(0);" class="ref ref115 ref141">(115, 141)</a></div><div class="NLM_p">Nude mice were inoculated with MCF-7 cells and tumor growth was stimulated using subcutaneously implanted estradiol pellets before oral administration of 20 mg/kg of <b>43</b> or <b>45</b> for 5 days a week. After 3 weeks, tumor volumes had decreased by 52% (<b>43</b>) and 22% (<b>45</b>).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Similarly, <b>38</b> caused tumor regression or a dramatic reduction in tumor growth at three different dosing regimens, with the effects being sustained after cessation of treatment.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> A pharmacokinetic study of <b>40</b> and its bis-sulfamoylated analogue <b>43</b> found that in mice after a single oral dose of 10 mg/kg the bioavailability of <b>43</b> was 85%, with significant amounts being detectable after 24 h; there were insignificant amounts of metabolites of <b>43</b>, and no <b>40</b> was detectable.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> In nude mice, the growth of xenografts (derived from MDA-MB-435 (estrogen receptor negative) melanoma cancer cells) was almost totally inhibited by <b>43</b> given orally for 28 days at a dosage of 20 mg/kg/day, with inhibition of tumor growth being maintained for 28 days after cessation of dosing; <b>40</b>, at the same dose, had no effect on tumor growth.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> The action of <b>43</b> was assessed in a P-glycoprotein-overexpressing tumor cell line both in vitro and in vivo and efficacy determined in xenograft models. <b>43</b> showed excellent efficacy in both wild-type and resistant breast cancer xenograft models, in contrast to taxol and 2-methoxyestradiol. Its potential was further highlighted by its efficacy in xenografts from docetaxel-resistant and metastatic triple-negative tumors, derived from patients who had failed on taxane therapy.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a><b>43</b> also proved to be synergistic when dosed in vivo in MCF-7 (breast) and LNCaP (prostate) xenograft models with the metabolic inhibitor 2-deoxyglucose (2DG). The idea was to combine the antiangiogenic–microtubule disruptor <b>43</b>, with an inhibitor of glycolysis. Glycolysis is inhibited by 2DG. Angiogenesis inhibition by <b>43</b> may increase hypoxia and make a solid tumor even more reliant on glycolysis, in theory sensitizing it to 2DG. In this first study showing the benefit of combining a microtubule disruptor with 2DG in the two most common solid tumors, daily oral administration of <b>43</b> resulted in a 46% reduction of tumor volume, while the combination of <b>43</b> and 2DG reduced tumor volume by 76%.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> 2DG alone had no significant effect on tumor growth.</div><div class="NLM_p">Despite paclitaxel’s clinical success in hormone-refractory breast cancer, it has a poor pharmacological profile, characterized by a low therapeutic index (TIX) and severe dose limiting toxicities such as neutropenia and peripheral neuropathy. <b>43</b> was compared to paclitaxel in vivo and the TIX and pharmacological profile determined in three breast cancer models.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> In a murine metastatic 4T1 orthotopic model, <b>43</b> significantly inhibited primary tumor growth and lung metastases. While paclitaxel induced significant peripheral neuropathy and neutropenia, no <b>43</b>-induced neuropathies were observed in MF-1 female nude mice. C3(1)/SV40 T/t-antigen transgenic mice develop hormone-independent breast cancer; this animal model closely mimics the human condition. An oral dose of <b>43</b> at 20 mg/kg/day for 15 weeks starting at age 12 weeks significantly attenuated the growth of mammary tumors; all control animals developed palpable mammary tumors by age 23 weeks, but 47% of treated animals remained tumor free throughout the study.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> A late intervention study, with treatment (20 mg/kg/day, po for 8 weeks) commencing when tumor volume reached 100–300 mm<sup>3</sup> resulted, after 3 weeks of dosing, in an 80.4% reduction in tumor growth compared to controls and, after 7 weeks, in a 35% reduction, with treated animals surviving 1–2 weeks longer than control animals.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Mice bearing MDA-MB-231 xenografts were treated with oral doses of <b>43</b> of 10–80 mg/kg/day. Doses from 25 mg/kg/day upward induced tumor regression but also an initial weight loss. The lowest dose to cause mortality was 30 mg/kg/day. A thrice weekly dose of 80 mg/kg induced tumor regression. Daily dosing established the therapeutic index (LD<sub>50</sub> (30 mg/kg)/ED<sub>50</sub> (10 mg/kg)) as 3, with that for intermittent dosing (LD<sub>50</sub> = 80 mg/kg, ED<sub>50</sub> = 20 mg/kg) as 4. No plasma accumulation of <b>43</b> was observed.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Thus, <b>43</b> has a greater anticancer efficacy, TIX, and reduced neurotoxicity compared to paclitaxel and may be of significant benefit to patients with breast cancer.</div><div class="NLM_p">Both <b>43</b> and <b>44</b> compete with colchicine for tubulin binding and disrupt interphase microtubules, leading to cell cycle arrest and apoptosis in vitro and in vivo,<a onclick="showRef(event, 'ref140 ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref140 ref146 ref147">(140, 146, 147)</a> and both inhibit angiogenesis in vitro and in vivo.<a onclick="showRef(event, 'ref141 ref142'); return false;" href="javascript:void(0);" class="ref ref141 ref142">(141, 142)</a> It has been proposed that the antiangiogenic activities of microtubule disruptors are mediated by the inhibition of hypoxia inducible factor 1 (Hif-1).<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> This protein is a transcription factor which under hypoxic conditions, activates the transcription of about 60 target genes, and which, in an O<sub>2</sub>-independent manner, is regulated through the phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) signaling pathways.<a onclick="showRef(event, 'ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref149 ref150">(149, 150)</a> Intratumoral hypoxia results in increased levels of Hif-1. These higher levels result in increased expression of carbonic anhydrase IX (CAIX).<a onclick="showRef(event, 'ref151 ref152'); return false;" href="javascript:void(0);" class="ref ref151 ref152">(151, 152)</a> CAIX helps regulate intracellular pH in the more extreme than normal environment found under hypoxic conditions, stimulates cancer cell migratory pathways, and is associated with tumor aggressiveness and invasiveness. We found that under hypoxic conditions in vitro, both <b>43</b> and <b>44</b> inhibit Hif-1 accumulation in the nucleus but in vivo, of the five genes examined, the expression of only CAIX is down-regulated (Stengel, Potter et al., unpublished data). This suggests that the antitumor activity of these two compounds is probably independent of Hif-1 and may be mediated by a more direct inhibition of CAIX expression and/or activity. Sulfamates and their bioisosteres (sulfonamides and sulfamides) are known carbonic anhydrase inhibitors.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a><b>44</b> inhibits carbonic anhydrase II (CAII) with <i>K</i><sub>i</sub> = 232 nM, and we have reported the cocrystal structure of the CAII–<b>44</b> complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2X7T">2X7T</a>), as well as with other steroid sulfamates.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> As with <b>27</b>, the binding of <b>44</b> to CAII inside red blood cells may contribute to the pharmacokinetic properties of the compound. This study also uncovered the presence of a second binding site on CAII. Given the high structural similarity between CAII and CAIX,<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a><b>44</b> would be expected to bind to and inhibit CAIX. Nonsteroidal sulfamates have been shown to inhibit CAIX<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> and to inhibit metastasis, and using the recently published crystal structure of the CAIX catalytic domain<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> and computational docking, we have shown that <b>43</b> and <b>44</b> can dock effectively into the CAIX substrate binding site (Stengel, Potter et al., unpublished data).</div><div class="NLM_p">Building on the observation of the potency of <b>45</b>, the SAR of C-17 cyano-substituted estratrienes was explored (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">4</a>, compounds <b>46</b>–<b>51</b>).<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Compounds <b>45</b>, <b>46</b>, and <b>47</b> had potent antiproliferative effects against human cancer cells in vitro, with the SAR suggesting that a sterically unhindered hydrogen bond acceptor attached to C-17 may be responsible for the enhanced activity of these compounds. The sulfamate derivatives inhibited STS, and <b>47</b> was shown to act as a microtubule disruptor and to have significant in vitro antiangiogenic activity. The in vivo effects of compounds <b>45</b> and <b>46</b> on the growth of MDA-MB-231 xenografts in female nude athymic mice following oral dosing for 28 days at 40 and 80 mg/kg (<b>45</b>) and 120 mg/kg (<b>46</b>) were studied. Both inhibited tumor growth with no observable toxic effects.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Compounds <b>48</b> and <b>49</b> achieved greater than 50% growth inhibition in a majority of eight cancer cell lines at concentrations below 10 nM: <b>50</b> and <b>51</b> were poorer inhibitors (mean growth inhibition ∼3 μM).<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Antiproliferative Activities of 2-Substituted Estradiol Derivatives<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0008.gif" alt="" id="GRAPHIC-d3059e2010-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">GI<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">MCF-7</th><th class="colsep0 rowsep0" align="center">MDA-MB-231</th><th class="colsep0 rowsep0" align="center">DU145</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="center">Core Structure ‘C’</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CN</td><td class="colsep0 rowsep0" align="center">0.3</td><td class="colsep0 rowsep0" align="center">0.117</td><td class="colsep0 rowsep0" align="center">0.485</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CN</td><td class="colsep0 rowsep0" align="center">0.07</td><td class="colsep0 rowsep0" align="center">0.071</td><td class="colsep0 rowsep0" align="center">0.062</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CN</td><td class="colsep0 rowsep0" align="center">0.06</td><td class="colsep0 rowsep0" align="center">0.141</td><td class="colsep0 rowsep0" align="center">0.054</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH(CN)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">0.33</td><td class="colsep0 rowsep0" align="center">0.249</td><td class="colsep0 rowsep0" align="center">0.159</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">CHMeCN</td><td class="colsep0 rowsep0" align="center">29.1</td><td class="colsep0 rowsep0" align="center">7.5</td><td class="colsep0 rowsep0" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="center">0.324</td><td class="colsep0 rowsep0" align="center">0.342</td><td class="colsep0 rowsep0" align="center"><0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="7" align="center">Core Structure ‘E’</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">75.4</td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Data taken from ref <a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">158</a>. Data for many other compounds with different substituents at R<sub>1</sub>, R<sub>2</sub>, and R<sub>3</sub> are not shown.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">D-Ring Modified Estrogen Derivatives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A third approach adopted to find a nonestrogenic derivative of <b>2</b> was to retain the A-, B-, and C-rings of the estrogen core but replace the D ring with an <i>N</i>-substituted piperidinedione moiety to create a series of 16,17-<i>seco</i>-estra-1,3,5(10)-triene-16,17-imide derivatives (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">5</a>, compounds <b>52</b>–<b>64</b>).<a onclick="showRef(event, 'ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref159 ref160">(159, 160)</a> The most potent of these, inhibiting STS in placental microsomes with IC<sub>50</sub> = 1 nM, were <b>55</b> and <b>61</b>.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Both compounds, when given to ovariectomized rats for 5 days at 10 mg/kg/day, inhibited liver STS activity by 99% and had no effect on uterine growth, so are not estrogenic.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Inhibitory Activities of D-ring <i>seco</i> Estradiol Derivatives<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0009.gif" alt="" id="GRAPHIC-d3059e2275-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0031.gif" alt="" id="fx20" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>Table a</sup><p class="last">PM, placental microsomes. Data taken from ref <a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">159</a>.</p></div></div><div></div></div><div class="NLM_p">The in vivo activity of <b>55</b>, also known as STX213, has been compared with that of <b>27</b>.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> MCF-7 cells stably expressing STS (MCF-7<sub>STS</sub>) were generated and, along with wild-type MCF-7 cells (MCF-7<sub>WT</sub>), were implanted into ovariectomized female nude mice receiving estradiol sulfate (E2S) sc injections. <b>55</b> or <b>27</b> were given orally for 49 days followed by a 35 day recovery period, during which the mice received only E2S. After 49 days, tumor size in control mice receiving only E2S had increased 5.5-fold (MCF-7<sub>WT</sub>) and 3.8-fold (MCF-7<sub>STS</sub>). <b>55</b> (10 mg/kg) reduced MCF-7<sub>WT</sub> tumor growth by 56% over the dosing period, with growth during the recovery period being significantly retarded. <b>27</b> (20 mg/kg) reduced MCF-7<sub>WT</sub> tumor growth by 39% over the dosing period but during the recovery period did not significantly affect tumor growth. The MCF-7<sub>STS</sub> tumors responded even better: <b>55</b> (10 mg/kg) caused a 39% regression of tumor growth with no significant growth during the recovery period, and <b>27</b> (20 mg/kg) inhibited growth by 79%. Both compounds completely inhibited liver and tumor STS activity.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div><div class="NLM_p last">If the <i>N</i>-propyl group of <b>55</b> is replaced with an <i>N</i>-3,3,3-trifluoropropyl group, designed to block a potential site of metabolism, the resultant compound, <b>65</b> (STX1938), is 5-fold more potent in vitro, inhibiting STS with IC<sub>50</sub> = 35 pM, and is nonestrogenic.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> After a single oral dose of 0.5 mg/kg, <b>65</b> completely inhibits rat liver STS and, compared with <b>55</b>, has a significantly longer duration of inhibition.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> We have attributed the greater potency of <b>65</b> (compared to <b>55</b>) to the increased lipophilicity imparted by the trifluoropropyl moiety and the ability of the fluorine atoms to participate in C–F·····H–O and C–F·····H–N interactions in the STS binding site. An in vivo study found that administration of both <b>55</b> and <b>65</b> at a once weekly dose of 1 mg/kg to rats carrying MCF-7 cells stably expressing STS significantly inhibited tumor growth, completely inhibited liver and tumor STS activity and significantly reduced plasma E2 levels.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0010.gif" alt="" id="fx6" /></img></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">NONFUSED-RING Sulfatase Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63777" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63777" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All of the compounds mentioned so far have had fused ring cores. To attempt to break away from this constraint, diethylstilbestrol-bis-sulfamate (<b>66</b>) was synthesized.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0011.gif" alt="" id="fx7" /></img></div><div class="NLM_p">This inhibited STS in MCF-7 cells with IC<sub>50</sub> = 10 nM.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> However, this compound is likely to be desulfamoylated to yield the estrogenic diethylstilbestrol so was not developed further, but it did show that a fused ring system is not necessary for inhibition of STS. Consequently, we developed a series of benzophenone-based STS inhibitors (<b>67</b>–<b>86</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">6</a>).<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> From Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">6</a> it can be seen that <b>67</b> is a potent inhibitor: in vivo evaluation in rats showed liver STS activity to be inhibited by 84% and 93% 24 h after a single oral dose of 1 or 10 mg/kg, respectively.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Inhibition of STS Activity<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0012.gif" alt="" id="GRAPHIC-d3059e2420-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">sulfatase % inhibition in MCF-7 cells 0.1 μM</th><th class="colsep0 rowsep0" align="center">sulfatase % inhibition in PM 10 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">71.4</td><td class="colsep0 rowsep0" align="center">98.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>N═CHNMe<sub>2</sub></td><td class="colsep0 rowsep0" align="center">46.3</td><td class="colsep0 rowsep0" align="center">85.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center">34.8</td><td class="colsep0 rowsep0" align="center">62.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">C═O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center"><10</td><td class="colsep0 rowsep0" align="center">76.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center"><10</td><td class="colsep0 rowsep0" align="center">65.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">67.2</td><td class="colsep0 rowsep0" align="center">65.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center">26.6</td><td class="colsep0 rowsep0" align="center">33.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">22.2</td><td class="colsep0 rowsep0" align="center">22.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center"><10</td><td class="colsep0 rowsep0" align="center">11.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">C(OH)C<sub>6</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center"><10</td><td class="colsep0 rowsep0" align="center"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"><10</td><td class="colsep0 rowsep0" align="center">47.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"><10</td><td class="colsep0 rowsep0" align="center">71.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">21.3</td><td class="colsep0 rowsep0" align="center">28.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">93.1</td><td class="colsep0 rowsep0" align="center">91.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center">99.3</td><td class="colsep0 rowsep0" align="center">86.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>82</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">46.6</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>83</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">16.1</td><td class="colsep0 rowsep0" align="center">31.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>84</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center"><10</td><td class="colsep0 rowsep0" align="center"><10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>85</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">75.3</td><td class="colsep0 rowsep0" align="center">51.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="center"><10</td><td class="colsep0 rowsep0" align="center">18.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">PM, placental microsomes; ND, not determined. Data taken from ref <a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">164</a>.</p></div></div></div><div class="NLM_p last">Other polycyclic sulfamates that inhibit STS include chromenone-based compounds (<b>87</b>) with potencies of up to 0.34 nM<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> and 2-phenylindole-based compounds (<b>88</b>) with potencies of up to 2 nM.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Reversible STS inhibitors are also known: these do not contain a sulfamate moiety and are not cleaved as part of the inhibition mechanism.<a onclick="showRef(event, 'ref167 ref168'); return false;" href="javascript:void(0);" class="ref ref167 ref168">(167, 168)</a><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0013.gif" alt="" id="fx8" /></img></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Nonsteroidal Tubulin Polymerization Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As described above, <b>36</b> and <b>43</b> inhibit the growth of cancer cells, at least in part, by inhibiting tubulin polymerization. Having established the SAR for antiproliferative activity in the steroidal series the translation of the key elements of the steroidal three-point pharmacophore, namely the 2-methoxy group, 17-position H bond acceptor and the 3-<i>O</i>-sulfamate motif, into alternate nonsteroidal series was envisaged. The expectation was to engineer in better pharmaceutical properties and promote more chemical diversity, to develop new series of microtubule disruptors optimized hopefully to surpass, in many respects, the steroidal template from which their design was inspired. The tetrahydroisoquinoline (THIQ) template appeared ideal for this purpose (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Thus, the two key substituents of the steroidal A-ring were incorporated into a heterocyclic mimic of the A,B-ring system and then projected, through attachment at <i>N</i>-2, onto a hydrogen bond acceptor into the appropriate area of space to address the third interaction. The <i>N</i>-2 nitrogen offers an achiral site of attachment and allows for a convergent approach with a good degree of synthetic flexibility.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0030.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Three-point pharmacophore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00386&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We also applied this template to the generation of a chimeric microtubule disruptor class. Colchicine (<b>89</b>) is a potent and well-established natural product microtubule disruptor, of which its trimethoxyaryl motif is an important part of the active pharmacophore. In a nonsteroidal chimeric tubulin polymerization inhibitor the aryl sulfamate pharmacophore was combined with the trimethoxyaryl motif in a THIQ-based structure (<b>90</b>, STX2484): this compound inhibited the growth of DU-145 and MDA-MB-231 cells with GI<sub>50</sub> values of 0.297 and 0.329 μM, respectively.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Consequently, over 200 compounds were synthesized based on core compound <b>91</b> with a range of substituents at various positions to determine the SAR.<a onclick="showRef(event, 'ref103 ref104 ref105 ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref103 ref104 ref105 ref106 ref107">(103-107)</a> Antiproliferative results for some of the more potent compounds (<b>92</b>–<b>101</b>) are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">7</a>.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0014.gif" alt="" id="fx9" /></img></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Antiproliferative Activities of THIQ Derivatives (Based on <b>91</b>)<a class="ref internalNav" href="#tbl8-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">GI<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">R3</th><th class="colsep0 rowsep0" align="center">R4</th><th class="colsep0 rowsep0" align="center">R5</th><th class="colsep0 rowsep0" align="center">R6</th><th class="colsep0 rowsep0" align="center">R7</th><th class="colsep0 rowsep0" align="center">R8</th><th class="colsep0 rowsep0" align="center" char=".">DU-145</th><th class="colsep0 rowsep0" align="center" char=".">MDA-MB-231</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>90</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.297</td><td class="colsep0 rowsep0" align="char" char=".">0.329</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>92</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.041</td><td class="colsep0 rowsep0" align="char" char=".">0.052</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>93</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.222</td><td class="colsep0 rowsep0" align="char" char=".">0.234</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>94</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.286</td><td class="colsep0 rowsep0" align="char" char=".">0.281</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>95</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.299</td><td class="colsep0 rowsep0" align="char" char=".">0.269</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>96</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.189</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>97</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>98</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>99</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>100</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>101</b></td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="left">OEt</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl8-fn1"><div class="footnote" id="tbl8-fn1"><sup>a</sup><p class="last">In all cases R<sub>1</sub> = OSO<sub>2</sub>NH<sub>2</sub>, X = CH<sub>2</sub>, and R<sub>9</sub> = H. Data taken from refs <a onclick="showRef(event, 'ref169 ref171 ref172 ref173 ref174'); return false;" href="javascript:void(0);" class="ref ref169 ref171 ref172 ref173 ref174">169,171−174</a>. Data for many other compounds with different substituents at R<sub>2</sub>, R<sub>3</sub>, R<sub>4</sub>, R<sub>5</sub>, R<sub>6</sub>, R<sub>7</sub>, and R<sub>8</sub> are not shown.</p></div></div></div><div class="NLM_p">Experiments to determine the mode of action of this novel class revealed that <b>90</b> is a tubulin disruptor which induces p53 expression, Bcl2 phosphorylation, caspase-3 cleavage, cell cycle arrest, and apoptosis.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> It is also a potent antiangiogenic agent, both in vitro and in vivo. In breast cancer xenografts in mice <b>90</b>, when dosed orally at 20 mg/kg/day for 35 days, suppressed tumor growth by 84%, with limited toxicity.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Similarly, <b>92</b> (20 mg/kg po) greatly inhibited the growth of MDA-MB-231 xenografts in athymic female nude mice.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Crucially, and in stark contrast to paclitaxel, the efficacy of <b>90</b> was unchanged in two clinically relevant drug-resistant models.</div><div class="NLM_p">One compound (<b>93</b>) inhibited the growth of DU-145 and MDA MB-231 cells with GI<sub>50</sub> = 0.222 and 0.234 μM, respectively, and in mice displayed good in vivo activity against RPMI-8226 multiple myeloma xenografts at a dosage of 40 mg/kg/day for 28 days.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0015.gif" alt="" id="fx10" /></img></div><div class="NLM_p">Not surprisingly, this general class of nonsteroidal sulfamate-substituted compounds also behaves as STS inhibitors (Potter et al., unpublished data), similarly to their steroidal counterparts. Even though the sulfamate group in all of these multitargeting microtubule disruptors, designed to target hormone-independent tumors, is acting not to engender STS inhibition but as a structural component to enhance the overall recognition pharmacophore, it is possible that the additional property of irreversible STS inhibition might confer further advantages. Others have taken our sulfamoylated THIQ core in modified form (e.g., <b>102</b>), confirmed that it inhibits STS (IC<sub>50</sub> = 0.3 μM), and shown that both <b>102</b> and the desulfamoylated product of the STS inhibition reaction (<b>103</b>) function as SERMs binding to human ERα with IC<sub>50</sub> = 3.1 μM (<b>102</b>) and IC<sub>50</sub> = 24.6 μM (<b>103</b>).<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0016.gif" alt="" id="fx11" /></img></div><div class="NLM_p last">Our focus on THIQ-based compounds was also extended to their dihydroisoquinolinone-based equivalents, <b>104</b>.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> Many of the compounds with linkers other than a carbonyl were inactive, but the most potent, <b>105</b> (surprisingly with a hydroxyl group rather than a sulfamate), inhibited the growth of DU-145 and MDA-MB-231 cells with GI<sub>50</sub> values of 51 and 71 nM, respectively.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> The sulfamate derivatives of <b>105</b> and <b>106</b> still possessed submicromolar activity and both exhibited antiangiogenic activity.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> Moreover, both also inhibited tubulin polymerization as well as colchicine binding with potencies comparable to the clinically used microtubule disruptor combretastatin A4.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> An X-ray structure of one analogue with X = C═O showed how steric and electronic factors can in principle produce a conformation to mimic a steroid.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0017.gif" alt="" id="fx12" /></img></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Multitargeting Agents, including Dual Aromatase–Sulfatase Inhibitors (DASIs)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As stated in the Introduction, the major route of estrogen production is by the aromatization of the A-ring of androgens, a reaction catalyzed by aromatase. Inhibition of aromatase lowers estrogen levels and has resulted in an effective endocrine therapy for many breast cancers.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> It is to be expected that chronic treatment with an aromatase inhibitor will lead to the development of compensatory mechanisms to increase estradiol levels; indeed, a recent paper showed that the administration of an aromatase inhibitor to breast cancer patients increased levels of both STS and 17β-HSD1 leading to increased estradiol levels.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> The administration of an STS inhibitor alongside an aromatase inhibitor should, in a multitargeting fashion, lower estrogen levels further but, importantly, should also address the in situ production of estrogen (including androstenediol) from the sulfate in tumor cells by STS in an intracrine fashion. Trials are currently ongoing to explore the effects of coadministration of aromatase inhibitors and <b>27</b>.<a onclick="showRef(event, 'ref90 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref90 ref91 ref92">(-90-92)</a> An alternative to administering two drugs, one to inhibit each enzyme, is to develop a single agent that inhibits both aromatase and STS, i.e., a <i>D</i>ual <i>A</i>romatase–<i>S</i>ulfatase <i>I</i>nhibitor (DASI). Pharmaceutical arguments in favor of using single molecule multitargeted agents have been advanced,<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> and there are numerous reports of approaches now emerging using dual- and even triple-targeted agents, particularly to address the development of resistance. For example, cancer cells that have acquired resistance to single-target EGFR inhibitors through upregulation of AXL or loss of E-cadherin remain sensitive to the triple-targeted single molecule agent CUDC-101, now in clinical trials, suggesting that coupling HDAC and HER2 inhibitory activities to an EGFR inhibitor is effective in overcoming drug resistance and preventing cancer cell migration.<a onclick="showRef(event, 'ref179 ref180'); return false;" href="javascript:void(0);" class="ref ref179 ref180">(179, 180)</a></div><div class="NLM_p">One attractive approach to achieve a DASI prototype was to take advanced or clinically used aromatase inhibitors and to build in the aryl sulfamate pharmacophore to imbue potential dual activity. The molecule 4-[(4-bromobenzyl)(4-cyanophenyl)amino]-4<i>H</i>-1,2,4-triazole, <b>107</b>, known as YM511, is an inhibitor of aromatase with IC<sub>50</sub> = 0.12 nM in human placental microsomes.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> This was transformed into a prototype DASI by replacing the bromobenzyl moiety with an aryl sulfamate, yielding an initial series of potent dual activity compounds (<b>108</b>, <b>109</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">8</a>).<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> To validate the concept in vivo, female Wistar rats were given a single oral dose (10 mg/kg) of either <b>107</b> or <b>108</b> (IC<sub>50</sub> = 227 nM<sub>(STS)</sub>, 100 nM<sub>(aromatase)</sub>) 3 days after hormonal stimulation of estradiol production. Three hours after the drug dosing, plasma estradiol levels in the <b>107</b>-treated rats were reduced by 70% compared to controls, and in the <b>108</b>-treated rats, the level was down by 39%, implying that aromatase was being inhibited. <b>107</b> itself had no significant effect on liver STS inhibition, as expected, but <b>108</b> showed almost complete inhibition (≥98%). This demonstrated that the DASI concept is viable.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. In Vitro Inhibition of Aromatase and STS in JEG-3 Cells<a class="ref internalNav" href="#tbl9-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0018.gif" alt="" id="GRAPHIC-d3059e3367-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">aromatase IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">sulfatase IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>107</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>108</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">227</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>109</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.82</td><td class="colsep0 rowsep0" align="center">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>110</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.77</td><td class="colsep0 rowsep0" align="center">590</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl9-fn1"><div class="footnote" id="tbl9-fn1"><sup>a</sup><p class="last">ND, not determined. Data taken from refs <a onclick="showRef(event, 'ref182 ref183 ref184'); return false;" href="javascript:void(0);" class="ref ref182 ref183 ref184">182−184</a>. Data for many other compounds with different substituents at R<sub>1</sub>, R<sub>2</sub>, R<sub>3</sub>, R<sub>4</sub>, and R<sub>5</sub> are not shown.</p></div></div></div><div class="NLM_p">A significant attraction of this overall approach is that irreversible targeting through low nM potency STS inhibition is combined with reversible low nM potency aromatase inhibition. Lead compounds have already been developed that possess IC<sub>50</sub> values for aromatase inhibition that are at least comparable to or often even better than those clinical aromatase inhibitors in widespread use vide infra. Thus, in a clinical setting, for a DASI there will only effectively be the need to titrate the dose required for aromatase inhibition because STS will be rapidly and irreversibly inhibited. This is likely to be the case even with dual agents potentially with weaker STS inhibitory potency; inhibition will still be targeted and irreversible, but slightly less rapid.</div><div class="NLM_p">The initial series of compounds was extended with further variants to establish the SAR (<b>110</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">8</a>).<a onclick="showRef(event, 'ref183 ref184'); return false;" href="javascript:void(0);" class="ref ref183 ref184">(-183, 184)</a> This showed that moving the sulfamate group from the <i>para</i>- to the <i>meta</i>-position of the aryl ring generally improves the aromatase inhibitory activity but weakens the STS inhibitory activity. We evaluated compounds <b>109</b> (IC<sub>50</sub> = 39 nM<sub>(STS)</sub>, 0.82 nM<sub>(aromatase)</sub>) and <b>110</b> in vivo in the same manner as <b>108</b> (described above). Three hours after dosing with <b>109</b>, there was almost complete inhibition of both aromatase and STS; after 24 h, the percentage inhibition of aromatase and STS had fallen to 85% and 72%, respectively. Compound <b>110</b> was initially as successful as <b>109</b> in inhibiting STS, but the level of inhibition fell to only 33% after 24 h. However, the aromatase inhibition was much worse than <b>109</b>, achieving 82% inhibition after 3 h and falling to only 20% after 24 h.</div><div class="NLM_p">The activities of <b>27</b> (a STS inhibitor), Letrozole (<b>111</b>, an aromatase inhibitor), and <b>109</b>, a DASI,<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> were compared. MCF-7 cells stably expressing either aromatase (MCF-7<sub>aromatase</sub>) or STS (MCF-7<sub>STS</sub>) were implanted into MF-1 ovariectomized female nude mice receiving both hormonal injections to stimulate tumor growth and one of the three drugs for 28 days. <b>111</b> inhibited the growth of MCF-7<sub>aromatase</sub> tumors but not MCF-7<sub>STS</sub> tumors; the inhibition pattern of <b>27</b> was the reverse of this. However, <b>109</b> completely inhibited the growth of both tumor types, completely inhibited both aromatase and STS activity, and caused a significant reduction in plasma estradiol levels.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a></div><div class="NLM_p">A further 53 compounds based around core structure <b>112</b> with various combinations of X, R<sub>1</sub>, and R<sub>2</sub> moieties were synthesized, and evaluated; some of these are exemplified (<b>113</b>–<b>119</b>), and the activity data for these compounds are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">9</a>.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> All 53 compounds have the 4-(4<i>H</i>-1,2,4-triazol-4-ylamino)benzonitrile moiety for aromatase inhibition, and most have the aryl sulfamate moiety for STS inhibition, those that do not are the phenolic DASI precursors, the crystal structures of two of which (<b>113</b> and <b>119</b><a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a>) have been solved as has the crystal structure of the DASI <b>118</b>.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> Most of the compounds are better aromatase inhibitors than <b>109</b> but worse STS inhibitors. With IC<sub>50</sub> = 0.26 nM, <b>114</b> is the best aromatase inhibitor, and the best DASI is <b>116</b> with aromatase IC<sub>50</sub> = 0.45 nM and STS IC<sub>50</sub> = 1200 nM.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> The SAR of these compounds shows that those containing a thioether or alkylene linker are more potent aromatase inhibitors than those containing an ether, sulfone, or sulphonamide linker and that beyond linkers of two atoms the length of the linker has a limited effect on aromatase inhibition. Compounds <b>115</b>–<b>117</b> were administered to female Wistar rats at a dose of 10 mg/kg. <b>116</b> was the most potent, reducing aromatase activity by 92% and STS activity by 98%.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a></div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. In Vitro Inhibition of Aromatase and STS in JEG-3 Cells<a class="ref internalNav" href="#tbl10-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0019.gif" alt="" id="GRAPHIC-d3059e3699-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">aromatase IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">sulfatase IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">aromatase IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">sulfatase IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>108</b></td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">227</td><td class="colsep0 rowsep0" align="left"><b>116</b></td><td class="colsep0 rowsep0" align="center">0.45</td><td class="colsep0 rowsep0" align="center">1200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>113</b></td><td class="colsep0 rowsep0" align="center">0.28</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="left"><b>117</b></td><td class="colsep0 rowsep0" align="center">0.51</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>114</b></td><td class="colsep0 rowsep0" align="center">0.26</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="left"><b>118</b></td><td class="colsep0 rowsep0" align="center">0.73</td><td class="colsep0 rowsep0" align="center">1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>115</b></td><td class="colsep0 rowsep0" align="center">0.42</td><td class="colsep0 rowsep0" align="center">3100</td><td class="colsep0 rowsep0" align="left"><b>119</b></td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl10-fn1"><div class="footnote" id="tbl10-fn1"><sup>a</sup><p class="last">ND, not determined. Data taken from refs <a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">186</a>. Data for many other compounds with different substituents at R<sub>1</sub>, R<sub>2</sub>, and X are not shown.</p></div></div></div><div class="NLM_p">In a further series of compounds, the single ring aryl sulfamate was replaced with a bicyclic aryl sulfamate, seven examples of which are exemplified, <b>120</b>–<b>126</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">10</a>).<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> All displayed good aromatase inhibition in vitro, but STS inhibition was variable. The most potent DASI was <b>122</b> with a substituted naphthalene ring. In female Wistar rats an oral dose of 10 mg/kg resulted, after 3 h, in 93% inhibition of both aromatase and STS.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a></div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. In Vitro Inhibition of Aromatase and STS in JEG-3 Cells<a class="ref internalNav" href="#tbl11-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0020.gif" alt="" id="GRAPHIC-d3059e3833-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">aromatase IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">sulfatase IC<sub>50</sub> (nM) or % inhibition at 10 μM</th><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">aromatase IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">sulfatase IC<sub>50</sub> (nM) or % inhibition at 10 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>120</b></td><td class="colsep0 rowsep0" align="center">5.2</td><td class="colsep0 rowsep0" align="center">42.6%</td><td class="colsep0 rowsep0" align="left"><b>124</b></td><td class="colsep0 rowsep0" align="center">2.7</td><td class="colsep0 rowsep0" align="center"><10%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>121</b></td><td class="colsep0 rowsep0" align="center">31</td><td class="colsep0 rowsep0" align="center">367</td><td class="colsep0 rowsep0" align="left"><b>125</b></td><td class="colsep0 rowsep0" align="center">2.3</td><td class="colsep0 rowsep0" align="center">4%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>122</b></td><td class="colsep0 rowsep0" align="center">2.1</td><td class="colsep0 rowsep0" align="center">26</td><td class="colsep0 rowsep0" align="left"><b>126</b></td><td class="colsep0 rowsep0" align="center">4.0</td><td class="colsep0 rowsep0" align="center">44.9%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>123</b></td><td class="colsep0 rowsep0" align="center">0.25</td><td class="colsep0 rowsep0" align="center">205</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl11-fn1"><div class="footnote" id="tbl11-fn1"><sup>a</sup><p class="last">Data taken from ref <a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">187</a>.</p></div></div></div><div class="NLM_p">With a DASI successfully based on the <b>107</b> core, a series of DASIs based around the Anastrozole (<b>127</b>), Letrozole (<b>111</b>), and Vorozole (<b>128</b>) core structures was synthesized; all of the precursor compounds are potent aromatase inhibitors with IC<sub>50</sub> values of 1.5, 0.89, and 29 nM, respectively.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0021.gif" alt="" id="fx13" /></img></div><div class="NLM_p"><b>127</b> was modified by replacing one of the 2-cyanopropyl moieties with aryl sulfamate derivatives connected to the core by a variety of linkers (<b>130</b>–<b>139</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">11</a>).<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Two control compounds were also synthesized, one lacking the triazole moiety necessary for aromatase inhibition (<b>130</b>) and the other lacking the sulfamate moiety necessary for STS inhibition (<b>131</b>). With IC<sub>50</sub> = 3.5 nM, <b>132</b> was the most potent aromatase inhibitor but, in common with all the compounds of this class, had little activity against STS in vitro. However, when tested in vivo, <b>132</b> reduced aromatase activity by 70% and, surprisingly, STS activity by 83%.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> This difference between in vitro and in vivo activities may possibly be related to drug metabolism and pharmacokinetic (DMPK) factors. It is also possible that even a weak in vitro sulfamate-based STS inhibitor could still induce time-dependent irreversible STS inhibition in vivo, albeit more slowly. Thus, while a reasonable target profile was low nM inhibition in vitro for both activities, this is most critical for the aromatase inhibitory component but may not be essential for the STS inhibitory component.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. In Vitro Inhibition of Aromatase and STS in JEG-3 Cells<a class="ref internalNav" href="#tbl12-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0022.gif" alt="" id="GRAPHIC-d3059e3992-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0032.gif" alt="" id="fx26" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl12-fn1"><div class="footnote" id="tbl12-fn1"><sup>Table a</sup><p class="last">Data taken from ref <a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">188</a>.</p></div></div><div></div></div><div class="NLM_p">Derivatives of <b>111</b> and <b>128</b> were synthesized. The first compound, <b>140</b>, in vitro inhibited aromatase with IC<sub>50</sub> = 3044 nM and STS with IC<sub>50</sub> >10000 nM.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> However, in vivo, it reduced aromatase activity by 60% and STS activity by 88%. This demonstrated that using <b>111</b> as a DASI template could also work. A series of compounds based on the <b>111</b> core (<b>140</b>, <b>141</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">12</a>)<a onclick="showRef(event, 'ref190 ref191'); return false;" href="javascript:void(0);" class="ref ref190 ref191">(190, 191)</a> was thus developed, along with two compounds based on the <b>128</b> core (<b>142</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">12</a>).<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> The sulfamates are likely to be substantially desulfamoylated in vivo, so the phenolic parent compounds were also tested for their ability to inhibit aromatase. Note that compound <b>141</b> is a racemate. Of the DASIs, the most potent aromatase inhibitor was <b>141</b>. When the separate enantiomers of this compound were synthesized, the <i>R</i>-enantiomer proved to be the more potent aromatase inhibitor and the <i>S</i>-enantiomer the more potent STS inhibitor. Desulfamoylation resulted in greater inhibition of aromatase. The <b>128</b>-based sulfamate, <b>142</b>, had very poor activity against STS, so this core structure was not developed any further.</div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. In Vitro Inhibition of Aromatase and STS in JEG-3 Cells<a class="ref internalNav" href="#tbl13-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0023.gif" alt="" id="GRAPHIC-d3059e4078-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">aromatase IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">sulfatase IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>111</b> (Letrozole)</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">0.89</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>140</b></td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">3044</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>141</b></td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">3.0</td><td class="colsep0 rowsep0" align="center">2600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>141a</b> <i>R</i>-(+)</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">3.2</td><td class="colsep0 rowsep0" align="center">4633</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>141b</b> <i>S</i>-(−)</td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="center">14.3</td><td class="colsep0 rowsep0" align="center">553</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>128</b> (Vorozole)</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" colspan="2" align="center">–N═N–N(Me)–</td><td class="colsep0 rowsep0" align="center">29</td><td class="colsep0 rowsep0" align="center">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>142</b></td><td class="colsep0 rowsep0" align="left">OSO<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" colspan="2" align="center">–N═N–N(Me)–</td><td class="colsep0 rowsep0" align="center">29</td><td class="colsep0 rowsep0" align="center">>10000</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl13-fn1"><div class="footnote" id="tbl13-fn1"><sup>a</sup><p class="last">Data taken from refs <a onclick="showRef(event, 'ref189 ref190 ref191'); return false;" href="javascript:void(0);" class="ref ref189 ref190 ref191">189−191</a>.</p></div></div></div><div class="NLM_p">It was also attractive to develop a new series of aromatase inhibitors with the structural potential to be converted into a DASI. Thus, compounds were synthesized by employing Suzuki chemistry based around a biphenyl core (<b>143</b>) with a triazole to interact with the iron in the aromatase heme group and a variety of other substituents designed.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> These compounds inhibited aromatase in JEG-3 cells with IC<sub>50</sub> values as low as 0.12 nM. They were then further developed by modification of one of the phenyl groups to imbue STS inhibitory activity, thus incorporating the aryl sulfamate pharmacophore.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> Almost 50 compounds were synthesized based around this core, the most potent of which as a dual inhibitor was <b>144</b> with aromatase IC<sub>50</sub> = 0.5 nM and STS IC<sub>50</sub> = 5.5 nM in JEG-3 cells; the nonsulfamoylated equivalent inhibited aromatase with IC<sub>50</sub> = 0.15 nM. Compound <b>144</b> also inhibits CAII (IC<sub>50</sub> = 86 nM), is nonestrogenic, and in rats, following an oral dose of 1 mg/kg, inhibits aromatase activity by 60% and STS activity by 92%.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0024.gif" alt="" id="fx14" /></img></div><div class="NLM_p">Examination of the docked poses of aromatase and STS inhibitors suggested there was space in both enzyme substrate binding sites to further develop this pharmacophore. Consequently, several hybrid compounds were synthesized based around core structure <b>145</b>.<a onclick="showRef(event, 'ref193 ref194'); return false;" href="javascript:void(0);" class="ref ref193 ref194">(-193, 194)</a> These represented a combination of the most successful biphenyl-based structures coupled with the proven aryl triazole motif from other series and linked to the substituted biphenyl moiety through nitrogen. Impressively, the most potent of these inhibited both enzymes in JEG-3 cells with IC<sub>50</sub> values in the low picomolar range (Table <a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">13</a>), making such compounds currently the best in class, worthy of further development and in vivo studies.</div><div class="NLM_table-wrap" id="tbl14"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. In Vitro Inhibition in JEG-3 Cells of Aromatase and STS Activity<a class="ref internalNav" href="#tbl14-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0025.gif" alt="" id="GRAPHIC-d3059e4338-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">aromatase IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">STS IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">aromatase IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">STS IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>146</b></td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="center">2900</td><td class="colsep0 rowsep0" align="left"><b>151</b></td><td class="colsep0 rowsep0" align="char" char=".">0.018</td><td class="colsep0 rowsep0" align="center">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>147</b></td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="center">2900</td><td class="colsep0 rowsep0" align="left"><b>152</b></td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="center">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>148</b></td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="left"><b>153</b></td><td class="colsep0 rowsep0" align="char" char=".">0.47</td><td class="colsep0 rowsep0" align="center">55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>149</b></td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="center">2.3</td><td class="colsep0 rowsep0" align="left"><b>154</b></td><td class="colsep0 rowsep0" align="char" char=".">0.75</td><td class="colsep0 rowsep0" align="center">240</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>150</b></td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="center">0.83</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl14-fn1"><div class="footnote" id="tbl14-fn1"><sup>a</sup><p class="last">Data taken from refs <a onclick="showRef(event, 'ref193 ref194'); return false;" href="javascript:void(0);" class="ref ref193 ref194">193,194</a>.</p></div></div></div><div class="NLM_p last">Another attempt at designing a dual-targeting drug using steroid sulfamate-based technology, and based upon the idea behind our original pro-drug work on <b>22</b>, has led to a molecule possessing both antiestrogenic and STS inhibitory components.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> Thus, SR16157 (<b>155</b>) was designed as an STS inhibitor that should also release a selective estrogen receptor modulator (SERM) SR16137 (<b>156</b>) upon sulfamate cleavage.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a><b>155</b> is not itself a SERM: it inhibits E1S-stimulated MCF-7 cell proliferation and displays a 10-fold higher antiestrogenic potency than other SERMs such as tamoxifen. <b>155</b> is active in vivo and shows low toxicity with a good pharmacokinetic profile.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> As yet, no clinical studies appear to be planned. See also the recent extension of this idea to the nonsteroidal realm, as discussed above.<a onclick="showRef(event, 'ref175 ref197'); return false;" href="javascript:void(0);" class="ref ref175 ref197">(175, 197)</a> This approach is different from the DASI approach outlined above, where the sulfamate-based STS inhibitor is also itself an aromatase inhibitor without any necessary metabolism. Moreover, in many cases, the sulfamate-cleaved phenolic moiety is also itself a potent aromatase inhibitor. What limits the “pro-drug” approach, as already discussed here,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> as elsewhere, is that enzymatic cleavage is accompanied by irreversible inhibition of STS, the cleavage facilitator. The effectiveness of the dual STS-SERM approach in vivo will thus be dictated both by the extent of STS-mediated cleavage achievable as well as overall pharmacodynamic properties.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0026.gif" alt="" id="fx15" /></img></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There are compelling reasons to explore potential new mechanisms for endocrine therapy working via biosynthetic principles and renewed interest in doing so. These are reinforced by the clinical success of the now very well established aromatase inhibitors as an endocrine therapy in cancer together with their recently demonstrated potential as preventative agents<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and the more recent and still ongoing success story exemplified by the 17α-hydroxy lyase/C17,20 lyase inhibitor abiraterone (Zytiga) as a hormone therapy in prostate cancer.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a></div><div class="NLM_p">The past 20 years or so has seen a greater appreciation of the mechanisms of “intracrinology”,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> whereby, e.g., circulating DHEAS can be converted peripherally to sex steroids. Also, in this intracrine fashion, stimulation of cell growth can still occur via mechanisms thought to involve import of E1S locally into tumors via organic anion transporters<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> followed by further in situ enzymatic transformations, although the relevant transporters have yet to be conclusively identified. Of the various enzymes implicated in intracrine processes, the STS-mediated pathway has emerged as a significant player not only in breast cancer<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> but in multiple other hormone-dependent disease states, and the therapeutic value of pharmacological intervention at STS is worthy of clinical exploration. It is also clear that measurement of tumor STS expression can be a biomarker for progression-free and overall survival and could be used for patient stratification.</div><div class="NLM_p">The discovery of aryl-<i>O</i>-sulfamates as the first potent and irreversible inhibitors of STS has stimulated the generation of a large body of preclinical and clinical work through “first-in-class” drugs <b>22</b> and <b>27</b> (Irosustat) that has substantially validated the scientific and therapeutic concepts originally proposed. These irreversible sulfamate-based drugs have cemented their value as the leading agents to block STS and have not been surpassed in terms of potency. Indeed, the reversible derivatives so far developed have not progressed beyond early in vitro preclinical studies. Only one sulfamate derivative, <b>27</b>, has been explored clinically in three types of hormone-dependent cancer to date, but there are still emerging targets becoming available, ovarian cancer is a good example,<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> and very recently there are interesting preliminary implications for bladder cancer.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Interestingly also, <b>22</b> was originally developed as an estradiol prodrug for HRT and reached phase II trials but is now being actively developed as a STS inhibitor for treating endometriosis.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div><div class="NLM_p">The aryl-<i>O</i>-sulfamate pharmacophore has proven to be highly versatile and in active compounds features in three different roles: as a prodrug cleavable by STS, as a moiety that is most likely actively transferred in some fashion to a residue in the STS active site when employed as an STS inhibitor, and finally, simply as a structural augmentation enhancing potency in the steroidal and nonsteroidal multitargeting microtubule disruptors. It seems clear that the sulfamate group not only offers versatility and high potency but also, by virtue of such substituted compounds being sequestered in red blood cells, also confers in vivo stabilization, resistance to metabolism, and excellent pharmacokinetic and bioavailability properties. This could possibly be more widely exploited in drug design.</div><div class="NLM_p">So far, no aryl sulfamate derivative targeting hormone-dependent disease has reached phase III clinical trials. It remains to be seen whether this will be achieved in some indication as monotherapy or whether it might better be achieved via a combination approach, e.g., with an aromatase inhibitor, as is currently being pursued for breast cancer. In terms of such multitargeting, it seems clear that the DASI approach offers great potential in cases where there is expected to be a synergy between STS and aromatase inhibition and that such an approach could address acquired resistance mechanisms. Additionally, compounds such as <b>43</b> or their nonsteroidal counterparts offer huge potential as multitargeting agents for either hormone-independent tumors, where the preclinical potential is strongly proven, or perhaps even as a still highly potent STS inhibitor with added cytotoxic/antiangiogenic activity in a hormone-dependent setting. Compared with the parent endogenous 2-methoxyestradiol that is very poorly bioavailable and extensively metabolized, the bis-sulfamate derivative is highly bioavailable and strongly protected against metabolism while maintaining or even enhancing the core activities of the parent. This is a model that could be exploited elsewhere.</div><div class="NLM_p">Interestingly, there have been reports focusing upon the design of <sup>11</sup>C-labeled radiopharmaceuticals both for <b>43</b> to study angiogenesis<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> and related to the DASI concept to study aromatase and STS expression using PET.<a onclick="showRef(event, 'ref202 ref203'); return false;" href="javascript:void(0);" class="ref ref202 ref203">(202, 203)</a> These will be of particular utility once these other classes of compound enter formal clinical trials.</div><div class="NLM_p last">Thus, after some 20 years of research and development, it is clear that aryl-<i>O</i>-sulfamates offer considerable promise and to date have still perhaps not yet demonstrated their full potential. The therapeutic value of STS inhibition is, however, now firmly established clinically, but the optimal setting for an STS inhibitor still needs to be found, both in terms of clinical pathology and whether as monotherapy, classical combination therapy, or (even in certain relevant applications) using a single molecule dual agent such as a DASI. Additionally, and like aromatase inhibitors,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> STS inhibition alone or in combination may also have clinical potential in a preventative oncology setting.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00386" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40722" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40722" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barry V. L. Potter</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a9cbc8dbdbd087d9c6ddddccdbe9d9c1c8dbc487c6d187c8ca87dcc2"><span class="__cf_email__" data-cfemail="abc9cad9d9d285dbc4dfdfced9ebdbc3cad9c685c4d385cac885dec0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark P. Thomas</span> - <span class="hlFld-Affiliation affiliation">Wolfson
Laboratory of Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath BA2
7AY, United Kingdom</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Mark P. Thomas</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00386&amp;id=BIO-d3059e4565-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mark P. Thomas</b> has a B.Sc. degree (biochemistry, 1989, Wales), a Ph.D. degree (protein chemistry and enzymology, 1992, London), and a M.Sc. degree (computer science, 2000, Bristol). He has academic experience in protein chemistry and enzymology (cysteine proteinases, HIV integrase) and crystallization and crystallography (restriction endonucleases), and both academic and industrial experience in computational drug discovery, design, and development (kinases, steroid-metabolizing enzymes, proteins involved in calcium signaling, and opioid receptors). He is a named author on thirty-eight published papers and five patents.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Barry V. L. Potter</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00386&amp;id=BIO-d3059e4570-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Barry V. L. Potter</b> studied Chemistry at Oxford, completing a DPhil and a DSc. After postdocs in Oxford and at the Max-Planck-Institute for Experimentelle Medizin, he became a Lecturer at Leicester and a Lister Institute Fellow, moving to the chair of Medicinal Chemistry at Bath and in 2015 to Oxford. Research interests are in signal transduction and anticancer drug discovery. He was CSO of Sterix, acquired by major pharma. He has published over 500 papers and is inventor of 45 granted U.S. patents. He has won four RSC medals, the GlaxoSmithKline International Achievement Award, the RSC-BMCS Medicinal Chemistry Lectureship, and was “Investigator of the Year” at the 2012 European Life Science Awards. He is a Wellcome Trust Senior Investigator and a Fellow of the UK Academy of Medical Sciences.</p></figure></div><div class="ack" id="ACK-d3059e4575-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">More than 20 years of numerous chemical and interdisciplinary collaborators have been involved in this work. Their names are acknowledged as coauthors on many of the papers cited. B.V.L.P. is a Wellcome Trust Senior Investigator (grant 101010).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i27" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i27"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> Abbreviations Used</h2><tr><td class="NLM_term">3β-HSDI</td><td class="NLM_def"><p class="first last">3β-hydroxysteroid dehydrogenase C5,C4-isomerase</p></td></tr><tr><td class="NLM_term">17β-HSD</td><td class="NLM_def"><p class="first last">17β-hydroxysteroid dehydrogenase</p></td></tr><tr><td class="NLM_term">CAII</td><td class="NLM_def"><p class="first last">carbonic anhydrase II</p></td></tr><tr><td class="NLM_term">CAIX</td><td class="NLM_def"><p class="first last">carbonic anhydrase IX</p></td></tr><tr><td class="NLM_term">Cyp<sub>450</sub></td><td class="NLM_def"><p class="first last">cytochrome P<sub>450</sub></p></td></tr><tr><td class="NLM_term">DASI</td><td class="NLM_def"><p class="first last">dual aromatase-sulfatase inhibitor</p></td></tr><tr><td class="NLM_term">DHEA</td><td class="NLM_def"><p class="first last">dehydroepiandrosterone</p></td></tr><tr><td class="NLM_term">DHEAS</td><td class="NLM_def"><p class="first last">dehydroepiandrosterone-3-<i>O</i>-sulfate</p></td></tr><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism and pharmacokinetics</p></td></tr><tr><td class="NLM_term">E1</td><td class="NLM_def"><p class="first last">estrone</p></td></tr><tr><td class="NLM_term">E2</td><td class="NLM_def"><p class="first last">estradiol</p></td></tr><tr><td class="NLM_term">E3</td><td class="NLM_def"><p class="first last">estriol</p></td></tr><tr><td class="NLM_term">E1S</td><td class="NLM_def"><p class="first last">estrone-3-<i>O</i>-sulfate</p></td></tr><tr><td class="NLM_term">E2S</td><td class="NLM_def"><p class="first last">estradiol-3-<i>O</i>-sulfate</p></td></tr><tr><td class="NLM_term">EMATE</td><td class="NLM_def"><p class="first last">estrone 3-<i>O</i>-sulfamate</p></td></tr><tr><td class="NLM_term">E2MATE</td><td class="NLM_def"><p class="first last">estradiol-3-<i>O</i>-sulfamate</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">estrogen receptor</p></td></tr><tr><td class="NLM_term">Hif-1</td><td class="NLM_def"><p class="first last">hypoxia inducible factor 1</p></td></tr><tr><td class="NLM_term">HRT</td><td class="NLM_def"><p class="first last">hormone replacement therapy</p></td></tr><tr><td class="NLM_term">HUVEC</td><td class="NLM_def"><p class="first last">human umbilical vein endothelial cell</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">NAE</td><td class="NLM_def"><p class="first last">NEDD8-activating enzyme</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3-kinase</p></td></tr><tr><td class="NLM_term">PM</td><td class="NLM_def"><p class="first last">placental microsomes</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">by mouth</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SERD</td><td class="NLM_def"><p class="first last">selective estrogen receptor down-regulator</p></td></tr><tr><td class="NLM_term">SERM</td><td class="NLM_def"><p class="first last">selective estrogen receptor modulator</p></td></tr><tr><td class="NLM_term">STS</td><td class="NLM_def"><p class="first last">steroid sulfatase</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor-α</p></td></tr><tr><td class="NLM_term">WBC</td><td class="NLM_def"><p class="first last">white blood cells</p></td></tr><tr><td class="NLM_term">2MeOE2</td><td class="NLM_def"><p class="first last">2-methoxyestradiol</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 203 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sandoval, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forte, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein-Geltink, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, H.</span><span> </span><span class="NLM_article-title">Indicator measures ER/PR and HER2 testing among women with invasive breast cancer</span> <span class="citation_source-journal">Curr. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23443917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A280%3ADC%252BC3svhslCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=62-63&author=C.+Sandovalauthor=R.+Rahalauthor=T.+Forteauthor=J.+Klein-Geltinkauthor=D.+Heauthor=H.+Bryant&title=Indicator+measures+ER%2FPR+and+HER2+testing+among+women+with+invasive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Indicator measures er/pr and her2 testing among women with invasive breast cancer</span></div><div class="casAuthors">Sandoval C; Rahal R; Forte T; Klein-Geltink J; He D; Bryant H</div><div class="citationInfo"><span class="NLM_cas:title">Current oncology (Toronto, Ont.)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-3</span>
        ISSN:<span class="NLM_cas:issn">1198-0052</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTO7KaYO6iGv3jf77P2BG3fW6udTcc2eYHQYZCA3LTqrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svhslCqtA%253D%253D&md5=33adb477c94acfffecf8fb55927c392d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandoval%26aufirst%3DC.%26aulast%3DRahal%26aufirst%3DR.%26aulast%3DForte%26aufirst%3DT.%26aulast%3DKlein-Geltink%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DD.%26aulast%3DBryant%26aufirst%3DH.%26atitle%3DIndicator%2520measures%2520ER%252FPR%2520and%2520HER2%2520testing%2520among%2520women%2520with%2520invasive%2520breast%2520cancer%26jtitle%3DCurr.%2520Oncol.%26date%3D2013%26volume%3D20%26spage%3D62%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Spinola, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferand, L.</span><span> </span><span class="NLM_article-title">Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2FBF01807337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=2954599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaL2sXltV2ls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1986&pages=241-248&author=P.+G.+Spinolaauthor=B.+Marchettiauthor=L.+Ferand&title=Adrenal+steroids+stimulate+growth+and+progesterone+receptor+levels+in+rat+uterus+and+DMBA-induced+mammary+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors</span></div><div class="casAuthors">Spinola, Paulo G.; Marchetti, Bianca; Labrie, Fernand</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">241-8</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    </div><div class="casAbstract">The effects of treatment with the adrenal steroids androst-5-ene-3β,17β-diol (Δ5-diol) and dehydroepiandrosterone (DHEA) on the growth and progesterone receptor levels of dimethylbenz[a]anthracene (DMBA)-induced mammary tumors and uteri in the rat were studied.  Although the total no. of tumors in ovariectomized animals was 0.60 tumor per rat after 24 days, it increased to 2.54 and 1.42 in the Δ5-diol- and DHEA (2 mg, twice daily)-treated animals, resp.  Very few new tumors developed during a 24-day period in ovariectomized animals (0.07/rat), but an av. of 0.47 new tumor per animal appeared in intact rats.  In ovariectomized animals treated with Δ5-diol or DHEA, the nos. of new tumors were 0.77 and 0.42, resp.  An even more striking effect was obsd. on av. total tumor area, which decreased from 4.70 cm2 in intact animals to 0.75 cm2 following ovariectomy.  Values of 9.79 and 3.93 cm2 were found in the Δ5-diol- and DHEA-treated ovariectomized animals, resp.  Treatment of ovariectomized animals with Δ5-diol and DHEA increased progesterone receptor levels in both the uteri and DMBA-induced mammary tumors.  Uterine wt. was also increased by treatment with the 2 adrenal steroids.  Thus, 2 adrenal C19-Δ5 steroids, Δ5-diol and DHEA, possess stimulatory effects analogous to those of estrogens on DMBA-induced mammary tumor growth and progesterone receptor levels in the rat, which supports the suggestion of an important role of these adrenal steroids in breast cancer and other estrogen-sensitive diseases in the human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zH3xH1E6LbVg90H21EOLACvtfcHk0ljpoAw5Pfx4tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXltV2ls7g%253D&md5=fa34d6fe9a090224c667bff47daa07a1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2FBF01807337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01807337%26sid%3Dliteratum%253Aachs%26aulast%3DSpinola%26aufirst%3DP.%2BG.%26aulast%3DMarchetti%26aufirst%3DB.%26aulast%3DFerand%26aufirst%3DL.%26atitle%3DAdrenal%2520steroids%2520stimulate%2520growth%2520and%2520progesterone%2520receptor%2520levels%2520in%2520rat%2520uterus%2520and%2520DMBA-induced%2520mammary%2520tumors%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1986%26volume%3D8%26spage%3D241%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Komm, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirkin, S.</span><span> </span><span class="NLM_article-title">An overview of current and emerging SERMs</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2014.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=24667357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVaksrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=207-222&author=B.+S.+Kommauthor=S.+Mirkin&title=An+overview+of+current+and+emerging+SERMs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of current and emerging SERMs</span></div><div class="casAuthors">Komm, Barry S.; Mirkin, Sebastian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">207-222</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Selective estrogen receptor modulators (SERMs) are compds. that exhibit tissue-specific estrogen receptor (ER) agonist or antagonist activity, and are used for various indications, including treatment of breast cancer, osteoporosis, and menopausal symptoms.  Endometrial safety has been a key differentiator between SERMs in clin. practice.  For example, tamoxifen exhibits ER agonist activity in the uterus, resulting in an increased risk of endometrial hyperplasia and malignancy, whereas raloxifene and bazedoxifene have neutral effects on the uterus.  Based on their efficacy and long-term safety, SERMs are increasingly being prescribed for women who cannot tolerate other treatment options and for younger women at an increased risk of fracture who may remain on therapy for long periods of time.  Continuing advances in the understanding of SERM mechanisms of action and structural interactions with the ER may lead to the development of new agents and combinations of agents to provide optimal treatments to meet the varying needs of postmenopausal women.  One such example is the tissue selective estrogen complex, which partners a SERM with 1 or more estrogens, with the aim of blending the desired estrogen-receptor agonist activities of estrogens on vasomotor symptoms, vulvar-vaginal atrophy, and loss of bone mass with the tissue selectivity of a SERM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOCA6pLjN2GrVg90H21EOLACvtfcHk0ljpoAw5Pfx4tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVaksrjK&md5=18074eedb314d30864441d3f57cc4880</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2014.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2014.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DKomm%26aufirst%3DB.%2BS.%26aulast%3DMirkin%26aufirst%3DS.%26atitle%3DAn%2520overview%2520of%2520current%2520and%2520emerging%2520SERMs%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D143%26spage%3D207%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Santner, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feil, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span> </span><span class="NLM_article-title">In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1210%2Fjcem-59-1-29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=6725522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaL2cXks1Khtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1984&pages=29-33&author=S.+J.+Santnerauthor=P.+D.+Feilauthor=R.+J.+Santen&title=In+situ+estrogen+production+via+the+estrone+sulfatase+pathway+in+breast+tumors%3A+relative+importance+versus+the+aromatase+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">In situ estrogen production via the estrone sulfatase pathway in breast tumors:  relative importance versus the aromatase pathway</span></div><div class="casAuthors">Santner, S. J.; Feil, P. D.; Santen, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-33</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">Breast tumor estrogen prodn. via the estrone sulfate  [481-97-0] to estrone  [53-16-7] (i.e., estrone sulfatase  [59298-96-3]) pathway was evaluated and compared with the androstenedione  [63-05-8] to estrone (aromatase  [9039-48-9]) system in human and rodent mammary tumors.  Estrone prodn. from estrone sulfate was related linearly with time and tissue concns., exhibited an apparent Km of 20 μM, and produced a linear Eadie-Hofstee kinetic plot consistent with a single class of enzymic sites.  Measurement of sulfatase in 35 human breast tumors using enzyme satg. conditions revealed estrone prodn. ranging 0.8-125 μmol/g protein·h.  The corresponding range in host mammary tumors was 3.5-7.1 μmol/g protein·h.  In human breast tumors, sulfatase activity did not correlate with the levels of estrogen receptor or progesterone receptor.  Comparison of sulfatase with aromatase activity in human tumors at physiol. levels of substrate revealed estrone formation via sulfatase of 2.8 pmol estrone produced/g protein·h, whereas aromatase produced only 0.27 pmol/g protein·h.  In rat mammary tumors, sulfatase activity was similar to that in human tumors, whereas aromatase activity was not detected.  Thus, estrone sulfatase appears to be the enzyme primarily responsible for intratissue estrone prodn. in hormone-dependent breast carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOaFBTVgqU8bVg90H21EOLACvtfcHk0lgb3S9y_e8Mqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1Khtrk%253D&md5=53b9e2be2e2892cc16de570f826dc443</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1210%2Fjcem-59-1-29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-59-1-29%26sid%3Dliteratum%253Aachs%26aulast%3DSantner%26aufirst%3DS.%2BJ.%26aulast%3DFeil%26aufirst%3DP.%2BD.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26atitle%3DIn%2520situ%2520estrogen%2520production%2520via%2520the%2520estrone%2520sulfatase%2520pathway%2520in%2520breast%2520tumors%253A%2520relative%2520importance%2520versus%2520the%2520aromatase%2520pathway%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1984%26volume%3D59%26spage%3D29%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">van Landeghem, A. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poortman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabuurs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thijssen, J. H. H.</span><span> </span><span class="NLM_article-title">Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2907</span><span class="NLM_x">–</span> <span class="NLM_lpage">2912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=2907-2912&author=A.+A.+J.+van+Landeghemauthor=J.+Poortmanauthor=M.+Nabuursauthor=J.+H.+H.+Thijssen&title=Endogenous+concentration+and+subcellular+distribution+of+androgens+in+normal+and+malignant+human+breast+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BLandeghem%26aufirst%3DA.%2BA.%2BJ.%26aulast%3DPoortman%26aufirst%3DJ.%26aulast%3DNabuurs%26aufirst%3DM.%26aulast%3DThijssen%26aufirst%3DJ.%2BH.%2BH.%26atitle%3DEndogenous%2520concentration%2520and%2520subcellular%2520distribution%2520of%2520androgens%2520in%2520normal%2520and%2520malignant%2520human%2520breast%2520tissue%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26spage%3D2907%26epage%3D2912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pasqualini, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chetrite, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blacker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delalonde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloche, C.</span><span> </span><span class="NLM_article-title">Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1460</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1210%2Fjc.81.4.1460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8636351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28Xit1OnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1996&pages=1460-1464&author=J.+R.+Pasqualiniauthor=G.+Chetriteauthor=C.+Blackerauthor=M.+C.+Feinsteinauthor=L.+Delalondeauthor=M.+Talbiauthor=C.+Maloche&title=Concentrations+of+estrone%2C+estradiol%2C+and+estrone+sulfate+and+evaluation+of+sulfatase+and+aromatase+activities+in+pre-+and+postmenopausal+breast+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients</span></div><div class="casAuthors">Pasqualini, J. R.; Chetrite, G.; Blacker, C.; Feinstein, M.-C.; Delalonde, L.; Talbi, M.; Maloche, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1460-4</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">This report concerns the evaluation of various estrogens, estrone (E1), estradiol (E2), and estrone (E1S), as well as E1S-sulfatase and aromatase activities in pre- and postmenopausal women with breast cancer.  The levels (in picomoles per g; mean ± SEM) of the various estrogens in the breast tissue from premenopausal patients (n = 11) are:  E1, 1.4 ± 0.5; E2, 1.2 ± 0.6; and E2S, 1.2 ± 0.3.  In postmenopausal patients (n = 23), the values are, resp., 1.0 ± 0.4, 1.4 ± 0.7, and 3.3 ± 1.9.  These concns. of estrogens in the tumors of postmenopausal patients are significantly higher than those found in plasma.  The activity of E1S-sulfatase in both pre- and postmenopausal patients was 50-200 times higher than that of aromatase.  E1S-sulfatase and aromatase activities are significantly higher in post-menopausal than in cycling patients.  It is concluded that despite the low levels of circulating estrogens in postmenopausal patients, the tissue concns. of these steroids are several-fold higher than those in plasma, suggesting tumor accumulation of these estrogens.  The physiopathol. and clincal significance of these high levels of the various estrogens (E1, E2, and E1S) as well as sulfatase and aromatase activities in postmenopausal patients with breast cancer is yet to be explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6nga1SVOv8rVg90H21EOLACvtfcHk0lgb3S9y_e8Mqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xit1OnsLs%253D&md5=1a694ce52708f818b8f13bc29ee20592</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1210%2Fjc.81.4.1460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.81.4.1460%26sid%3Dliteratum%253Aachs%26aulast%3DPasqualini%26aufirst%3DJ.%2BR.%26aulast%3DChetrite%26aufirst%3DG.%26aulast%3DBlacker%26aufirst%3DC.%26aulast%3DFeinstein%26aufirst%3DM.%2BC.%26aulast%3DDelalonde%26aufirst%3DL.%26aulast%3DTalbi%26aufirst%3DM.%26aulast%3DMaloche%26aufirst%3DC.%26atitle%3DConcentrations%2520of%2520estrone%252C%2520estradiol%252C%2520and%2520estrone%2520sulfate%2520and%2520evaluation%2520of%2520sulfatase%2520and%2520aromatase%2520activities%2520in%2520pre-%2520and%2520postmenopausal%2520breast%2520cancer%2520patients%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1996%26volume%3D81%26spage%3D1460%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gunnarsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stål, O.</span><span> </span><span class="NLM_article-title">and Members of the Southeast Sweden Breast Cancer Group. Abnormal expression of 17-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">8448</span><span class="NLM_x">–</span> <span class="NLM_lpage">8451</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=8448-8451&author=C.+Gunnarssonauthor=B.+M.+Olssonauthor=O.+St%C3%A5l&title=and+Members+of+the+Southeast+Sweden+Breast+Cancer+Group.+Abnormal+expression+of+17-hydroxysteroid+dehydrogenases+in+breast+cancer+predicts+late+recurrence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGunnarsson%26aufirst%3DC.%26aulast%3DOlsson%26aufirst%3DB.%2BM.%26aulast%3DSt%25C3%25A5l%26aufirst%3DO.%26atitle%3Dand%2520Members%2520of%2520the%2520Southeast%2520Sweden%2520Breast%2520Cancer%2520Group.%2520Abnormal%2520expression%2520of%252017-hydroxysteroid%2520dehydrogenases%2520in%2520breast%2520cancer%2520predicts%2520late%2520recurrence%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D8448%26epage%3D8451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Pasqualini, J. R.</span><span> </span><span class="NLM_article-title">The selective estrogen enzyme modulators in breast cancer: a review</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1654</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1654&publication_year=2004&pages=123-143&author=J.+R.+Pasqualini&title=The+selective+estrogen+enzyme+modulators+in+breast+cancer%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasqualini%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520selective%2520estrogen%2520enzyme%2520modulators%2520in%2520breast%2520cancer%253A%2520a%2520review%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2004%26volume%3D1654%26spage%3D123%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Vihko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Härkönen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isomaa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaija, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurkela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulkka, A.</span><span> </span><span class="NLM_article-title">Control of cell proliferation of steroids: the role of 17HSDs</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.mce.2005.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=16406264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Wgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=2006&pages=141-148&author=P.+Vihkoauthor=A.+Herralaauthor=P.+H%C3%A4rk%C3%B6nenauthor=V.+Isomaaauthor=H.+Kaijaauthor=R.+Kurkelaauthor=A.+Pulkka&title=Control+of+cell+proliferation+of+steroids%3A+the+role+of+17HSDs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Control of cell proliferation by steroids: The role of 17HSDs</span></div><div class="casAuthors">Vihko, P.; Herrala, A.; Haerkoenen, P.; Isomaa, V.; Kaija, H.; Kurkela, R.; Pulkka, A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">141-148</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sex steroid hormone signaling regulates the development, growth, and functioning of the breast and the prostate and plays a role in the development and progression of cancer in these organs.  The intracellular concn. of active sex steroid hormones in target tissues is regulated by several enzymes, including 17β-hydroxysteroid dehydrogenases (17HSDs).  Changes in the expression patterns of these enzymes may play a pathophysiol. role in malignant transformation.  We recently analyzed the mRNA expressions of the 17HSD type 1, 2, and 5 enzymes in about 800 breast carcinoma specimens.  Both 17HSD type 1 and 2 mRNAs were detected in normal breast tissue from premenopausal women but not in specimens from postmenopausal women.  The patients with tumors expressing 17HSD type 1 mRNA or protein had significantly shorter overall and disease-free survival than the other patients.  The expression of 17HSD type 5 was significantly higher in breast tumor specimens than in normal tissue.  Cox multivariate analyses showed that 17HSD type 1, tumor size, and estrogen receptor alpha (ERα) had independent prognostic significance.  We developed, using a LNCaP prostate cancer cell line, a model to study the malignant transformation of prostate cancer and showed that androgen-sensitive LNCaP cells are transformed into neuroendocrine-like cells when cultured without androgens and, eventually into highly proliferating androgen-independent cells.  We conducted Northern hybridizations and microarrays to analyze the gene expression during these processes.  Substantial changes in the expressions of steroid metabolizing enzymes occurred during the transformation process.  The variations in steroid-metabolizing enzymes during cancer progression may be crucial in the regulation of the growth and function of organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj00uWp8UAurVg90H21EOLACvtfcHk0lgGpsl27aWfsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Wgtbg%253D&md5=d48719dd79f7bb9ecd218490b979f237</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2005.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2005.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DVihko%26aufirst%3DP.%26aulast%3DHerrala%26aufirst%3DA.%26aulast%3DH%25C3%25A4rk%25C3%25B6nen%26aufirst%3DP.%26aulast%3DIsomaa%26aufirst%3DV.%26aulast%3DKaija%26aufirst%3DH.%26aulast%3DKurkela%26aufirst%3DR.%26aulast%3DPulkka%26aufirst%3DA.%26atitle%3DControl%2520of%2520cell%2520proliferation%2520of%2520steroids%253A%2520the%2520role%2520of%252017HSDs%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2006%26volume%3D248%26spage%3D141%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Simpson, E. R.</span><span> </span><span class="NLM_article-title">Sources of estrogen and their importance</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2803%2900360-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=14623515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVemsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2003&pages=225-230&author=E.+R.+Simpson&title=Sources+of+estrogen+and+their+importance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Sources of estrogen and their importance</span></div><div class="casAuthors">Simpson, E. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3-5</span>),
    <span class="NLM_cas:pages">225-230</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">: Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  In premenopausal women, the ovaries are the principle source of estradiol, which functions as a circulating hormone to act on distal target tissues.  However, in postmenopausal women when the ovaries cease to produce estrogen, and in men, this is no longer the case, because estradiol is no longer solely an endocrine factor.  Instead, it is produced in a no. of extra-gonadal sites and acts locally at these sites as a paracrine or even intracrine factor.  These sites include the mesenchymal cells of adipose tissue including that of the breast, osteoblasts and chondrocytes of bone, the vascular endothelium and aortic smooth muscle cells, and numerous sites in the brain.  Thus, circulating levels of estrogens in postmenopausal women and in men are not the drivers of estrogen action, they are reactive rather than proactive.  This is because in these cases circulating estrogen originates in the extra-gonadal sites where it acts locally, and if it escapes local metab. then it enters the circulation.  Therefore, circulating levels reflect rather than direct estrogen action in postmenopausal women and in men.  Tissue-specific regulation of CYP19 expression is achieved through the use of distinct promoters, each of which is regulated by different hormonal factors and second messenger signaling pathways.  Thus, in the ovary, CYP19 expression is regulated by FSH which acts through cAMP via the proximal promoter II, whereas in placenta the distal promoter I.1 regulates CYP19 expression in response to retinoids.  In adipose tissue and bone by contrast, another distal promoter-promoter I.4-drives CYP19 expression under the control of glucocorticoids, class 1 cytokines and TNFα.  The importance of this unique aspect of the tissue-specific regulation of aromatase expression lies in the fact that the low circulating levels of estrogens which are obsd. in postmenopausal women have little bearing on the concns. of estrogen in, for example, a breast tumor, which can reach levels at least one order of magnitude greater than those present in the circulation, due to local synthesis within the breast.  Thus, the estrogen which is responsible for breast cancer development, for the maintenance of bone mineralization and for the maintenance of cognitive function is not circulating estrogen but rather that which is produced locally at these specific sites within the breast, bone and brain.  In breast adipose of breast cancer patients, aromatase activity and CYP19 expression are elevated.  This occurs in response to tumor-derived factors such as prostaglandin E2 produced by breast tumor fibroblasts and epithelium as well as infiltrating macrophages.  This increased CYP19 expression is assocd. with a switch in promoter usage from the normal adipose-specific promoter I.4 to the cAMP responsive promoter, promoter II.  Since these two promoters are regulated by different cohorts of transcription factors and coactivators, it follows that the differential regulation of CYP19 expression via alternative promoters in disease-free and cancerous breast adipose tissue may permit the development of selective aromatase modulators (SAMs) that target the aberrant overexpression of aromatase in cancerous breast, while sparing estrogen synthesis in other sites such as normal adipose tissue, bone and brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXkuXyHF9aebVg90H21EOLACvtfcHk0lgGpsl27aWfsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVemsr4%253D&md5=c1624c91faeee8db6aec04c2be84b3a2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900360-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900360-1%26sid%3Dliteratum%253Aachs%26aulast%3DSimpson%26aufirst%3DE.%2BR.%26atitle%3DSources%2520of%2520estrogen%2520and%2520their%2520importance%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D86%26spage%3D225%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Labrie, F.</span><span> </span><span class="NLM_article-title">All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2014.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=24923731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFWltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2015&pages=133-138&author=F.+Labrie&title=All+sex+steroids+are+made+intracellularly+in+peripheral+tissues+by+the+mechanisms+of+intracrinology+after+menopause"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause</span></div><div class="casAuthors">Labrie, Fernand</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133-138</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Following the arrest of estradiol secretion by the ovaries at menopause, all estrogens and all androgens in postmenopausal women are made locally in peripheral target tissues according to the physiol. mechanisms of intracrinol.  The locally made sex steroids exert their action and are inactivated intracellularly without biol. significant release of the active sex steroids in the circulation.  The level of expression of the steroid-forming and steroid-inactivating enzymes is specific to each cell type in each tissue, thus permitting to each cell/tissue to synthesize a small amt. of androgens and/or estrogens in order to meet the local physiol. needs without affecting the other tissues of the organism.  Achieved after 500 million years of evolution, combination of the arrest of ovarian estrogen secretion, the availability of high circulating levels of DHEA and the expression of the peripheral sex steroid-forming enzymes have permitted the appearance of menopause with a continuing access to intratissular sex steroids for the individual cells/tissues without systemic exposure to circulating estradiol.  In fact, one essential condition of menopause is to maintain serum estradiol at biol. inactive (substhreshold) concns., thus avoiding stimulation of the endometrium and risk of endometrial cancer.  Measurement of the low levels of serum estrogens and androgens in postmenopausal women absolutely requires the use of MS/MS-based technol. in order to obtain reliable accurate, specific and precise assays.While the activity of the series of steroidogenic enzymes can vary, the serum levels of DHEA show large individual variations going from barely detectable to practically normal "premenopausal" values, thus explaining the absence of menopausal symptoms in about 25% of women.  It should be added that the intracrine system has no feedback elements to adjust the serum levels of DHEA, thus meaning that women with low DHEA activity will not be improved without external supplementation.  Exogenous DHEA, however, follows the same intracrine rules as described for endogenous DHEA, thus maintaining serum estrogen levels at substhreshold or biol. inactive concns.  Such blood concns. are not different from those obsd. in normal postmenopausal women having high serum DHEA concns.  Androgens, on the other hand, are practically all made intracellularly from DHEA by the mechanisms of intracrinol. and are always maintained at very low levels in the blood in both pre- and postmenopausal women.  Proof of the importance of intracrinol. is also provided, among others, by the well-recognized benefits of aromatase inhibitors and antiestrogens used successfully for the treatment of breast cancer in postmenopausal women where all estrogens are made locally.  Each medical indication for the use of DHEA, however, requires clin. trials performed according to the FDA guidelines and the best rules of clin. medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh8ztXVFD0f7Vg90H21EOLACvtfcHk0lgGpsl27aWfsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFWltLw%253D&md5=9cd148db461f2b020210f06f0a6e8585</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2014.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2014.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DLabrie%26aufirst%3DF.%26atitle%3DAll%2520sex%2520steroids%2520are%2520made%2520intracellularly%2520in%2520peripheral%2520tissues%2520by%2520the%2520mechanisms%2520of%2520intracrinology%2520after%2520menopause%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D145%26spage%3D133%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">McNamara, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasano, H.</span><span> </span><span class="NLM_article-title">The intracrinology of breast cancer</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2014.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=24751707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslGntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2015&pages=172-178&author=K.+M.+McNamaraauthor=H.+Sasano&title=The+intracrinology+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The intracrinology of breast cancer</span></div><div class="casAuthors">McNamara, Keely May; Sasano, Hironobu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">172-178</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The importance of intracrinol., or in situ prodn. of steroids from circulating precursors, in breast cancer has been firmly established in estrogen actions on postmenopausal patients.  Expression levels of various steroid synthesizing and/or metabolizing enzymes have been examd. in human breast cancer tissues by a no. of groups.  The enzymes examd. include those capable of converting circulating DHEA-S to sex steroids (STS and 3βHSDΔ4-5 isomerase), the group of enzymes that modulate the strength of both androgens and estrogens (17βHSD family) as well as the androgenic 5αR enzymes and the estrogenic aromatase enzyme.  In addn. to these DHEA-related metab. pathways, other intracrine pathways involving progesterone and cholesterol have also been examd.  Some risk factors of breast cancer development, including obesity, have also been postulated to interact with steroid metabolising pathways.  In this review, we aimed to summarise the current state of knowledge regarding intracrine metab. including expression levels of various enzymes and receptors, focusing particularly upon the importance of the prodn. of biol. potent steroids from circulating sulfated precursors such as DHEA-S.  In addn., we attempted to summarise the factors, both steroidal and non-steroidal, involved in the regulation of these enzymes and propose future directions for research in this particular field.  The concept of intracrinol. was first proposed over 20 years ago but there still remain many unanswered questions which could open new horizons for the understanding of intracrine metab. in the breast.This article is part of a Special Issue entitled 'Essential role of DHEA'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPUqPBD8ilp7Vg90H21EOLACvtfcHk0lgGpsl27aWfsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslGntL8%253D&md5=4ef9d4e5963930edc03b70053c95ef0c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2014.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2014.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamara%26aufirst%3DK.%2BM.%26aulast%3DSasano%26aufirst%3DH.%26atitle%3DThe%2520intracrinology%2520of%2520breast%2520cancer%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D145%26spage%3D172%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Utsumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, N.</span><span> </span><span class="NLM_article-title">Elevated steroid sulfatase expression in breast cancers</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2800%2900060-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10925213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvVCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2000&pages=141-145&author=T.+Utsumiauthor=N.+Yoshimuraauthor=S.+Takeuchiauthor=M.+Marutaauthor=K.+Maedaauthor=N.+Harada&title=Elevated+steroid+sulfatase+expression+in+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated steroid sulfatase expression in breast cancers</span></div><div class="casAuthors">Utsumi, Toshiaki; Yoshimura, Noriko; Takeuchi, Shinji; Maruta, Morito; Maeda, Kotaro; Harada, Nobuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">141-145</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">In situ estrogen synthesis makes an important contribution to the high estrogen concn. found in breast cancer tissues.  Steroid sulfatase which hydrolyzes several sulfated steroids such as estrone sulfate, dehydroepiandrosterone sulfate, and cholesterol sulfate may be involved.  In the present study, the authors therefore, assessed steroid sulfatase mRNA levels in breast malignancies and background tissues from 38 patients by reverse transcription and polymerase chain reaction.  The levels in breast cancer tissues were significantly increased at 1458.4 amol/mg RNA (mean) as compared with 535.6 amol/mg RNA for non-malignant tissues.  Thus, increased steroid sulfatase expression may be partly responsible for local overprodn. of estrogen and provide a growth advantage for tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBshQnCaEe-bVg90H21EOLACvtfcHk0ljDMYIpbpTArg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvVCgtb4%253D&md5=6343f061e266720d9624efb7e9ae4003</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2800%2900060-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252800%252900060-1%26sid%3Dliteratum%253Aachs%26aulast%3DUtsumi%26aufirst%3DT.%26aulast%3DYoshimura%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DS.%26aulast%3DMaruta%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DN.%26atitle%3DElevated%2520steroid%2520sulfatase%2520expression%2520in%2520breast%2520cancers%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D73%26spage%3D141%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Utsumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, N.</span><span> </span><span class="NLM_article-title">Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=377-381&author=T.+Utsumiauthor=N.+Yoshimuraauthor=S.+Takeuchiauthor=J.+Andoauthor=M.+Marutaauthor=K.+Maedaauthor=N.+Harada&title=Steroid+sulfatase+expression+is+an+independent+predictor+of+recurrence+in+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUtsumi%26aufirst%3DT.%26aulast%3DYoshimura%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DJ.%26aulast%3DMaruta%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DN.%26atitle%3DSteroid%2520sulfatase%2520expression%2520is%2520an%2520independent%2520predictor%2520of%2520recurrence%2520in%2520human%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D377%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasano, H.</span><span> </span><span class="NLM_article-title">Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">2762</span><span class="NLM_x">–</span> <span class="NLM_lpage">2770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2762-2770&author=T.+Suzukiauthor=T.+Nakataauthor=Y.+Mikiauthor=C.+Kanekoauthor=T.+Moriyaauthor=T.+Ishidaauthor=S.+Akinagaauthor=H.+Hirakawaauthor=M.+Kimuraauthor=H.+Sasano&title=Estrogen+sulfotransferase+and+steroid+sulfatase+in+human+breast+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DNakata%26aufirst%3DT.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DKaneko%26aufirst%3DC.%26aulast%3DMoriya%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DT.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DHirakawa%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DSasano%26aufirst%3DH.%26atitle%3DEstrogen%2520sulfotransferase%2520and%2520steroid%2520sulfatase%2520in%2520human%2520breast%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D2762%26epage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussbaumer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehr, P.</span><span> </span><span class="NLM_article-title">Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2800%2900077-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=11070351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFWnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2000&pages=225-235&author=A.+Billichauthor=P.+Nussbaumerauthor=P.+Lehr&title=Stimulation+of+MCF-7+breast+cancer+cell+proliferation+by+estrone+sulfate+and+dehydroepiandrosterone+sulfate%3A+inhibition+by+novel+non-steroidal+steroid+sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors</span></div><div class="casAuthors">Billich, Andreas; Nussbaumer, Peter; Lehr, Philipp</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">225-235</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Steroid sulfatase (STS) regulates the formation of active steroids from systemic precursors, such as estrone sulfate and dehydroepiandrosterone sulfate (DHEAS).  In breast tissues, this pathway is a source for local prodn. of estrogens, which support the growth of endocrine-dependent tumors.  Therefore, inhibitors of STS could have therapeutic potential.  In this study, the authors report on substituted chromenone sulfamates as a novel class of non-steroidal irreversible inhibitors of STS.  The compds. are substantially more potent (6- to 80-fold) than previously described types of non-steroidal inhibitors when tested against purified STS.  In MCF-7 breast cancer cells, they inhibit STS activity with IC50 below 100 pM.  Importantly, the compds. also potently block estrone sulfate-stimulated growth of MCF-7 cells, again with IC50 below 100 pM.  For one compd., the authors also obsd. a lack of any estrogenic effect at high concns. (1 μM).  The authors also demonstrate for the first time that STS inhibitors can block the DHEAS-stimulated growth of MCF-7 cells.  Interestingly, this cannot be achieved with specific inhibitors of the aromatase, suggesting that stimulation of MCF-7 cell growth by DHEAS follows an aromatase-independent pathway.  This gives further justification to consider steroid sulfatase inhibitors as potential drugs in the therapy of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGony8N4_gmv6LVg90H21EOLACvtfcHk0ljDMYIpbpTArg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFWnsrk%253D&md5=bc48d55d2638440308400788df0cf026</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2800%2900077-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252800%252900077-7%26sid%3Dliteratum%253Aachs%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DNussbaumer%26aufirst%3DP.%26aulast%3DLehr%26aufirst%3DP.%26atitle%3DStimulation%2520of%2520MCF-7%2520breast%2520cancer%2520cell%2520proliferation%2520by%2520estrone%2520sulfate%2520and%2520dehydroepiandrosterone%2520sulfate%253A%2520inhibition%2520by%2520novel%2520non-steroidal%2520steroid%2520sulfatase%2520inhibitors%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D73%26spage%3D225%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Obiorah, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, V. C.</span><span> </span><span class="NLM_article-title">Progress in endocrine approaches to the treatment and prevention of breast cancer</span> <span class="citation_source-journal">Maturitas</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=315-321&author=I.+Obiorahauthor=V.+C.+Jordan&title=Progress+in+endocrine+approaches+to+the+treatment+and+prevention+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObiorah%26aufirst%3DI.%26aulast%3DJordan%26aufirst%3DV.%2BC.%26atitle%3DProgress%2520in%2520endocrine%2520approaches%2520to%2520the%2520treatment%2520and%2520prevention%2520of%2520breast%2520cancer%26jtitle%3DMaturitas%26date%3D2011%26volume%3D70%26spage%3D315%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Cuzick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sestak, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawthorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansel, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Minckwitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, A.</span><span> </span><span class="NLM_article-title">IBIS-II investigators. Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">383</span><span class="NLM_x">, </span> <span class="NLM_fpage">1041</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2014&pages=1041-1048&author=J.+Cuzickauthor=I.+Sestakauthor=J.+F.+Forbesauthor=M.+Dowsettauthor=J.+Knoxauthor=S.+Cawthornauthor=C.+Saundersauthor=N.+Rocheauthor=R.+E.+Manselauthor=G.+von+Minckwitzauthor=B.+Bonanniauthor=T.+Palvaauthor=A.+Howell&title=IBIS-II+investigators.+Anastrozole+for+prevention+of+breast+cancer+in+high-risk+postmenopausal+women+%28IBIS-II%29%3A+an+international%2C+double-blind%2C+randomised+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuzick%26aufirst%3DJ.%26aulast%3DSestak%26aufirst%3DI.%26aulast%3DForbes%26aufirst%3DJ.%2BF.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DKnox%26aufirst%3DJ.%26aulast%3DCawthorn%26aufirst%3DS.%26aulast%3DSaunders%26aufirst%3DC.%26aulast%3DRoche%26aufirst%3DN.%26aulast%3DMansel%26aufirst%3DR.%2BE.%26aulast%3Dvon%2BMinckwitz%26aufirst%3DG.%26aulast%3DBonanni%26aufirst%3DB.%26aulast%3DPalva%26aufirst%3DT.%26aulast%3DHowell%26aufirst%3DA.%26atitle%3DIBIS-II%2520investigators.%2520Anastrozole%2520for%2520prevention%2520of%2520breast%2520cancer%2520in%2520high-risk%2520postmenopausal%2520women%2520%2528IBIS-II%2529%253A%2520an%2520international%252C%2520double-blind%252C%2520randomised%2520placebo-controlled%2520trial%26jtitle%3DLancet%26date%3D2014%26volume%3D383%26spage%3D1041%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauvois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The hydrolysis of estrone sulphate and dehydroepiandrosterone sulphate by human sulfatase expressed in transfected COS-1 cells</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2F0960-0760%2894%2990177-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8049127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK2cXlt1GmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=101-104&author=A.+Purohitauthor=S.+Dauvoisauthor=M.+G.+Parkerauthor=B.+V.+L.+Potterauthor=G.+J.+Williamsauthor=M.+J.+Reed&title=The+hydrolysis+of+estrone+sulphate+and+dehydroepiandrosterone+sulphate+by+human+sulfatase+expressed+in+transfected+COS-1+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by human steroid sulfatase expressed in transfected COS-1 cells</span></div><div class="casAuthors">Purohit, A.; Dauvois, Sophie; Parker, M. G.; Potter, B. V. L.; Williams, G. J.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">101-4</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">Whether the same or distinct steroid sulfatases (STS) are involved in the hydrolysis of alkyl and aryl steroid sulfates remains controversial.  The authors have examd. the ability of a placental steroid sulfatase to hydrolyze estrone sulfate and/or dehydroepiandrosterone sulfate (DHA-S) by expressing the enzyme in COS-1 cells.  Using either intact cells or broken cell prepns., the expressed sulfatase was found to hydrolyze both estrone sulfate and DHA-S.  The catalysis of estrone sulfate and DHA-S by the expressed sulfatase was almost completely abolished by the steroid sulfatase inhibitor, estrone-3-O-sulfamate.  It is concluded that both alkyl and aryl steroid sulfates can be hydrolyzed by the same steroid sulfatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqvHhWUBDjKLVg90H21EOLACvtfcHk0lhBGXxAPl3MoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlt1GmtLo%253D&md5=f534aee5fecd4be2c90f0bd0d9c8090d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2894%2990177-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252894%252990177-5%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DDauvois%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DM.%2BG.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520hydrolysis%2520of%2520estrone%2520sulphate%2520and%2520dehydroepiandrosterone%2520sulphate%2520by%2520human%2520sulfatase%2520expressed%2520in%2520transfected%2520COS-1%2520cells%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1994%26volume%3D50%26spage%3D101%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">The structural biology of oestrogen metabolism</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2012.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23291110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2013&pages=27-49&author=M.+P.+Thomasauthor=B.+V.+L.+Potter&title=The+structural+biology+of+oestrogen+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The structural biology of oestrogen metabolism</span></div><div class="casAuthors">Thomas, Mark P.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-49</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Many enzymes catalyze reactions that have an estrogen as a substrate and/or a product.  The reactions catalyzed include aromatization, oxidn., redn., sulfonation, desulfonation, hydroxylation and methoxylation.  The enzymes that catalyze these reactions must all recognize and bind estrogen but, despite this, they have diverse structures.  This review looks at each of these enzymes in turn, describing the structure and discussing the mechanism of the catalyzed reaction.  Since estrogen has a role in many disease states inhibition of the enzymes of estrogen metab. may have an impact on the state or progression of the disease and inhibitors of these enzymes are briefly discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozRHAveD8_NrVg90H21EOLACvtfcHk0lhEAHd5yMGlZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCnsL8%253D&md5=5c005e36a520fbe3e30fc7777c084a3f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2012.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2012.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DThe%2520structural%2520biology%2520of%2520oestrogen%2520metabolism%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D137%26spage%3D27%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lønning, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eikesdal, H. P.</span><span> </span><span class="NLM_article-title">Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">R183</span><span class="NLM_x">–</span> <span class="NLM_lpage">R201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=R183-R201&author=P.+E.+L%C3%B8nningauthor=H.+P.+Eikesdal&title=Aromatase+inhibition+2013%3A+clinical+state+of+the+art+and+questions+that+remain+to+be+solved"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B8nning%26aufirst%3DP.%2BE.%26aulast%3DEikesdal%26aufirst%3DH.%2BP.%26atitle%3DAromatase%2520inhibition%25202013%253A%2520clinical%2520state%2520of%2520the%2520art%2520and%2520questions%2520that%2520remain%2520to%2520be%2520solved%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2013%26volume%3D20%26spage%3DR183%26epage%3DR201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroid sulphatase inhibitors: a new endocrine therapy</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1994&pages=673-680&author=M.+J.+Reedauthor=A.+Purohitauthor=N.+M.+Howarthauthor=B.+V.+L.+Potter&title=Steroid+sulphatase+inhibitors%3A+a+new+endocrine+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroid%2520sulphatase%2520inhibitors%253A%2520a%2520new%2520endocrine%2520therapy%26jtitle%3DDrugs%2520Future%26date%3D1994%26volume%3D19%26spage%3D673%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hanson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Best, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.-H.</span><span> </span><span class="NLM_article-title">Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">5736</span><span class="NLM_x">–</span> <span class="NLM_lpage">5763</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=5736-5763&author=S.+R.+Hansonauthor=M.+D.+Bestauthor=C.-H.+Wong&title=Sulfatases%3A+structure%2C+mechanism%2C+biological+activity%2C+inhibition%2C+and+synthetic+utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DS.%2BR.%26aulast%3DBest%26aufirst%3DM.%2BD.%26aulast%3DWong%26aufirst%3DC.-H.%26atitle%3DSulfatases%253A%2520structure%252C%2520mechanism%252C%2520biological%2520activity%252C%2520inhibition%252C%2520and%2520synthetic%2520utility%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D5736%26epage%3D5763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroid sulfatase: molecular biology, regulation, and inhibition</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1210%2Fer.2004-0003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15561802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslGjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=171-202&author=M.+J.+Reedauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=S.+P.+Newmanauthor=B.+V.+L.+Potter&title=Steroid+sulfatase%3A+molecular+biology%2C+regulation%2C+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid sulfatase: Molecular biology, regulation, and inhibition</span></div><div class="casAuthors">Reed, M. J.; Purohit, A.; Woo, L. W. L.; Newman, S. P.; Potter, B. V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-202</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Steroid sulfatase (STS) is responsible for the hydrolysis of aryl and alkyl steroid sulfates and therefore has a pivotal role in regulating the formation of biol. active steroids.  STS is widely distributed throughout the body, and its action is implicated in physiol. processes and pathol. conditions.  The crystal structure of STS has been resolved, but relatively little is known about what regulates its expression or activity.  Research into the control and inhibition of this enzyme has been stimulated by its important role in supporting the growth of hormone-dependent tumors of the breast and prostate.  STS is responsible for the hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate to estrone and dehydroepiandrosterone, resp., both of which can be converted to steroids with estrogenic properties (i.e., estradiol and androstenediol) that can stimulate tumor growth.  STS expression is increased in breast tumors and has prognostic significance.  The role of STS in supporting tumor growth prompted the development of potent STS inhibitors.  Several steroidal and nonsteroidal STS inhibitors are now available, with the irreversible type of inhibitor having a phenol sulfamate ester as its active pharmacophore.  One such inhibitor, 667 COUMATE, has now entered a phase I trial in postmenopausal women with breast cancer.  The skin is also an important site of STS activity, and deficiency of this enzyme is assocd. with X-linked ichthyosis.  STS may also be involved in regulating part of the immune response and some aspects of cognitive function.  The development of potent STS inhibitors will allow investigation of the role of this enzyme in physiol. and pathol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvDkv9jdOyZ7Vg90H21EOLACvtfcHk0lhEAHd5yMGlZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslGjtr4%253D&md5=5ea6cff3a5f23b3f31d08506c724df06</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1210%2Fer.2004-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2004-0003%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroid%2520sulfatase%253A%2520molecular%2520biology%252C%2520regulation%252C%2520and%2520inhibition%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26spage%3D171%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Maltais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, D.</span><span> </span><span class="NLM_article-title">Steroid sulfatase inhibitors: A review covering the promising 2000–2010 decade</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=929-948&author=R.+Maltaisauthor=D.+Poirier&title=Steroid+sulfatase+inhibitors%3A+A+review+covering+the+promising+2000%E2%80%932010+decade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaltais%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DD.%26atitle%3DSteroid%2520sulfatase%2520inhibitors%253A%2520A%2520review%2520covering%2520the%2520promising%25202000%25E2%2580%25932010%2520decade%26jtitle%3DSteroids%26date%3D2011%26volume%3D76%26spage%3D929%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Development of sulfatase inhibitors</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.mce.2010.12.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=21238537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFyrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2011&pages=175-185&author=L.+W.+L.+Wooauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Development+of+sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Development of steroid sulfatase inhibitors</span></div><div class="casAuthors">Woo, L. W. Lawrence; Purohit, Atul; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-185</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Hydrolysis of biol. inactive steroid sulfates to unconjugated steroids by steroid sulfatase (STS) is strongly implicated in rendering estrogenic stimulation to hormone-dependent cancers such as those of the breast.  Considerable progress has been made in the past two decades with regard to the discovery, design and development of STS inhibitors.  We outline historical aspects of their development, cumulating in the discovery of the first clin. trial candidate STX64 (BN83495, Irosustat) and other sulfamate-based inhibitors.  The development of reversible STS inhibitors and the design of dual inhibitors of both aromatase and STS is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVFcnJi-qZY7Vg90H21EOLACvtfcHk0liSNVqTCPNNsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFyrtLc%253D&md5=51d494bcb6a02d6b64dddfcb29bfdb06</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2010.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2010.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DDevelopment%2520of%2520sulfatase%2520inhibitors%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2011%26volume%3D340%26spage%3D175%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Secky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svoboda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klameth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeillinger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jäger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thalhammer, T.</span><span> </span><span class="NLM_article-title">The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors</span> <span class="citation_source-journal">J. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">957605</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=957605&author=L.+Seckyauthor=M.+Svobodaauthor=L.+Klamethauthor=E.+Bajnaauthor=G.+Hamiltonauthor=R.+Zeillingerauthor=W.+J%C3%A4gerauthor=T.+Thalhammer&title=The+sulfatase+pathway+for+estrogen+formation%3A+targets+for+the+treatment+and+diagnosis+of+hormone-associated+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSecky%26aufirst%3DL.%26aulast%3DSvoboda%26aufirst%3DM.%26aulast%3DKlameth%26aufirst%3DL.%26aulast%3DBajna%26aufirst%3DE.%26aulast%3DHamilton%26aufirst%3DG.%26aulast%3DZeillinger%26aufirst%3DR.%26aulast%3DJ%25C3%25A4ger%26aufirst%3DW.%26aulast%3DThalhammer%26aufirst%3DT.%26atitle%3DThe%2520sulfatase%2520pathway%2520for%2520estrogen%2520formation%253A%2520targets%2520for%2520the%2520treatment%2520and%2520diagnosis%2520of%2520hormone-associated%2520tumors%26jtitle%3DJ.%2520Drug%2520Delivery%26date%3D2013%26spage%3D957605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Williams, S. J.</span><span> </span><span class="NLM_article-title">Sulfatase inhibitors: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1517%2F13543776.2013.736965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23136854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCksr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=79-98&author=S.+J.+Williams&title=Sulfatase+inhibitors%3A+a+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfatase inhibitors: a patent review</span></div><div class="casAuthors">Williams, Spencer J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-98</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Steroid sulfatase (STS) converts sulfated hormones to free hormones of importance in hormone-dependent diseases such as breast cancer and endometriosis.  Carbohydrate sulfatases degrade complex carbohydrates as part of normal cellular turnover; certain lysosomal storage disorders (LSDs) involve defective processing of sulfated glycosaminoglycans by mutant sulfatases.Areas covered: Aryl sulfamates have been developed as STS inhibitors, and STX64 and PGL2001 are under evaluation in Phase I and II clin. trials for treatment of endometrial and metastatic breast and prostate cancers and endometriosis.  Dual-acting compds. have emerged that are aromatase inhibitors (AIs), selective estrogen receptor antagonists, or inhibitors of microtubule polymn.  Sulfamidase inhibitors as pharmacol. chaperones to assist maturation of folding-defective mutants for the treatment of Sanfilippo type A disease are under investigation.  Coverage: The patent literature after the mid-1990s.Expert opinion: The failure of STX64 in a Phase II monotherapy clin. trial should not dissuade further investigations in multidrug regimens, particularly in combination with AIs.  The recent development of dual-acting compds. may enhance the potential for success in the clinic.  Further investigations into aryl sulfamates are required to clarify the mol. mechanism of action; addnl., new reversible sulfatase inhibition concepts are needed for the development of pharmacol. chaperones for sulfatase LSDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZuermyRH1ibVg90H21EOLACvtfcHk0liSNVqTCPNNsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCksr3F&md5=bc07e9358b004543cb4ac5c85f578f30</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.736965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.736965%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BJ.%26atitle%3DSulfatase%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D79%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Audrieth, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sveda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisler, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, M. J.</span><span> </span><span class="NLM_article-title">Sulfamic acid, sulfamide, and related aquo-ammonosulfuric acids</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1940</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr60083a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1940&pages=49-94&author=L.+F.+Audriethauthor=M.+Svedaauthor=H.+H.+Sislerauthor=M.+J.+Butler&title=Sulfamic+acid%2C+sulfamide%2C+and+related+aquo-ammonosulfuric+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcr60083a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60083a003%26sid%3Dliteratum%253Aachs%26aulast%3DAudrieth%26aufirst%3DL.%2BF.%26aulast%3DSveda%26aufirst%3DM.%26aulast%3DSisler%26aufirst%3DH.%2BH.%26aulast%3DButler%26aufirst%3DM.%2BJ.%26atitle%3DSulfamic%2520acid%252C%2520sulfamide%252C%2520and%2520related%2520aquo-ammonosulfuric%2520acids%26jtitle%3DChem.%2520Rev.%26date%3D1940%26volume%3D26%26spage%3D49%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Benson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillane, W. J.</span><span> </span><span class="NLM_article-title">Sulfamic acid and its <i>N</i>-substituted derivatives</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr60324a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1980&pages=151-186&author=G.+A.+Bensonauthor=W.+J.+Spillane&title=Sulfamic+acid+and+its+N-substituted+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcr60324a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60324a002%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DG.%2BA.%26aulast%3DSpillane%26aufirst%3DW.%2BJ.%26atitle%3DSulfamic%2520acid%2520and%2520its%2520N-substituted%2520derivatives%26jtitle%3DChem.%2520Rev.%26date%3D1980%26volume%3D80%26spage%3D151%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Benson, G. A.; Spillane, W. J.</span><span> </span><span class="NLM_article-title">Sulfamic acid and derivatives</span>. In  <span class="citation_source-book">The Chemistry of Sulfonic Acids, Esters and their Derivatives</span>; <span class="NLM_contrib-group">Patai, S.; Rappoport, Z.</span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1991</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">947</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2F0470034394.ch22" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1991&pages=947-1036&author=G.+A.+Benson&author=W.+J.+Spillaneauthor=S.+Patai&author=Z.+Rappoport&title=The+Chemistry+of+Sulfonic+Acids%2C+Esters+and+their+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2F0470034394.ch22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0470034394.ch22%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DG.%2BA.%26atitle%3DSulfamic%2520acid%2520and%2520derivatives%26btitle%3DThe%2520Chemistry%2520of%2520Sulfonic%2520Acids%252C%2520Esters%2520and%2520their%2520Derivatives%26aulast%3DPatai%26aufirst%3DS.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D1991%26spage%3D947%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Spillane, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaubier, J.-B.</span><span> </span><span class="NLM_article-title">Sulfamic acid and its <i>N</i>- and <i>O</i>-substituted derivatives</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">2507</span><span class="NLM_x">–</span> <span class="NLM_lpage">2586</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr400230c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFeqtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=2507-2586&author=W.+Spillaneauthor=J.-B.+Malaubier&title=Sulfamic+acid+and+its+N-+and+O-substituted+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamic Acid and Its N- and O-Substituted Derivatives</span></div><div class="casAuthors">Spillane, William; Malaubier, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2507-2586</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Sulfamic acid and its N- and O- substituted derivs. is reviewed.  In the present review, the 21 yr period from 1991 to the end of 2011 is covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfdqd-0CdcP7Vg90H21EOLACvtfcHk0lgxuAbPw8j-ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFeqtrrJ&md5=6e9dbf02dbb2985b70133d9f766f09a2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcr400230c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400230c%26sid%3Dliteratum%253Aachs%26aulast%3DSpillane%26aufirst%3DW.%26aulast%3DMalaubier%26aufirst%3DJ.-B.%26atitle%3DSulfamic%2520acid%2520and%2520its%2520N-%2520and%2520O-substituted%2520derivatives%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D2507%26epage%3D2586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Winum, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, J.-l.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Sulfamates and their therapeutic potential</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2Fmed.20021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15478125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlWhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=186-228&author=J.-Y.+Winumauthor=A.+Scozzafavaauthor=J.-l.+Monteroauthor=C.+T.+Supuran&title=Sulfamates+and+their+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamates and their therapeutic potential</span></div><div class="casAuthors">Winum, Jean-Yves; Scozzafava, Andrea; Montero, Jean-Louis; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">186-228</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Starting from the very simple mol. sulfamic acid, O-substituted-, N-substituted-, or di-/tri-substituted sulfamates may be obtained, which show specific biol. activities which were or started to be exploited for the design of many types of therapeutic agents.  Among them, sulfamate inhibitors of aminoacyl-tRNA synthetases (aaRSs) were recently reported, constituting completely new classes of antibiotics, useful in the fight of drug-resistant infections.  Anti-viral agents incorporating sulfamate moieties have also been obtained, with at least two types of such derivs. investigated: the nucleoside/nucleotide human immunodeficiency virus (HIV) reverse transcriptase inhibitors, and the HIV protease inhibitors (PIs).  In the increasing armamentarium of anti-cancer drugs, the sulfamates occupy a special position, with at least two important targets evidenced so far: the steroid sulfatases (STSs) and the carbonic anhydrases (CAs).  An impressing no. of inhibitors of STSs of the sulfamate type have been reported in the last years, with several compds., such as 667 COUMATE among others, progressing to clin. trials for the treatment of hormone-dependent tumors (breast and prostate cancers).  This field is rapidly evolving, with many types of new inhibitors being constantly reported and designed in such a way as to increase their anti-tumor properties, and decrease undesired features (for example, estrogenicity, a problem encountered with the first generation such inhibitors, such as EMATE).  Among the many isoenzymes of CAs, at least two, CA IX and CA XII, are highly overexpressed in tumors, being generally absent in the normal tissues.  Inhibition of tumor-assocd. CAs was hypothesized to lead to novel therapeutic approaches for the treatment of cancer.  Many sulfamates act as very potent (low nanomolar) CA inhibitors.  The x-ray crystal structure of the best-studied isoenzyme, CA II, with three sulfamates (sulfamic acid, topiramate, and EMATE) has recently been reported, which allowed for a rationale drug design of new inhibitors.  Indeed, low nanomolar CA IX inhibitors of the sulfamate type have been reported, although such compds. also act as efficient inhibitors of isoenzymes CA I and II, which are not assocd. with tumors.  A large no. of anti-convulsant sulfamates have been described, with one such compd., topiramate, being widely used clin. as anti-epileptic drug.  By taking into consideration a side effect of topiramate, an anti-epileptic drug leading to wt. loss in some patients, it has recently been proposed to use this drug and related sulfamates for the treatment of obesity.  The rationale of this use is based on the inhibition of the mitochondrial CA isoenzyme, CA V, involved in lipogenesis.  Some sulfamates were also shown to possess potent inhibitory activity against acyl CoA:cholesterol acyltransferase, an enzyme involved in cholesterol metab.  One such agent, avasimibe, is in advanced clin. trials for the treatment of hyperlipidemia and atherosclerosis.  Thus, the sulfamate moiety offers very attractive possibilities for the drug design of various pharmacol. agents, which are on one hand due to the relative ease with which such compds. are synthesized, and on the other one, due to the fact that biol. activity of most of them is impressive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIqLDcmtZep7Vg90H21EOLACvtfcHk0lgxuAbPw8j-ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlWhsL4%253D&md5=d9d2f31b7cdf47a11d204227813c0f2a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fmed.20021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20021%26sid%3Dliteratum%253Aachs%26aulast%3DWinum%26aufirst%3DJ.-Y.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DJ.-l.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DSulfamates%2520and%2520their%2520therapeutic%2520potential%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2005%26volume%3D25%26spage%3D186%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Spillane, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concagh, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, S. N.</span><span> </span><span class="NLM_article-title">Sulfamate sweeteners</span> <span class="citation_source-journal">Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1996&pages=255-261&author=W.+J.+Spillaneauthor=C.+A.+Ryderauthor=M.+R.+Walshauthor=P.+J.+Curranauthor=D.+G.+Concaghauthor=S.+N.+Wall&title=Sulfamate+sweeteners"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpillane%26aufirst%3DW.%2BJ.%26aulast%3DRyder%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DM.%2BR.%26aulast%3DCurran%26aufirst%3DP.%2BJ.%26aulast%3DConcagh%26aufirst%3DD.%2BG.%26aulast%3DWall%26aufirst%3DS.%2BN.%26atitle%3DSulfamate%2520sweeteners%26jtitle%3DFood%2520Chem.%26date%3D1996%26volume%3D56%26spage%3D255%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Florini, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, P. H.</span><span> </span><span class="NLM_article-title">Inhibition of protein synthesis in vitro and in vivo by nucleocidin, an antitrypanosomal antibiotic</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">241</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1098</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=1966&pages=1091-1098&author=J.+R.+Floriniauthor=H.+H.+Birdauthor=P.+H.+Bell&title=Inhibition+of+protein+synthesis+in+vitro+and+in+vivo+by+nucleocidin%2C+an+antitrypanosomal+antibiotic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlorini%26aufirst%3DJ.%2BR.%26aulast%3DBird%26aufirst%3DH.%2BH.%26aulast%3DBell%26aufirst%3DP.%2BH.%26atitle%3DInhibition%2520of%2520protein%2520synthesis%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520nucleocidin%252C%2520an%2520antitrypanosomal%2520antibiotic%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1966%26volume%3D241%26spage%3D1091%26epage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Rosenfeld, W. E.</span><span> </span><span class="NLM_article-title">Topiramate: a review of preclinical, pharmacokinetic, and clinical data</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1294</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0149-2918%2897%2980006-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=9444441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK1cXjslGgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1997&pages=1294-1308&author=W.+E.+Rosenfeld&title=Topiramate%3A+a+review+of+preclinical%2C+pharmacokinetic%2C+and+clinical+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Topiramate: a review of preclinical, pharmacokinetic, and clinical data</span></div><div class="casAuthors">Rosenfeld, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1294-1308</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica</span>)
        </div><div class="casAbstract">A review with 35 refs. The antiepileptic drug (AED) topiramate is a monosaccharide deriv. with a sulfamate functionality.  It modulates voltage-dependent sodium conductance, potentiates GABA-evoked currents, and blocks the kainate/AMPA (α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) subtype of the glutamate receptor.  Topiramate is rapidly absorbed and has linear, proportional, steady-state pharmacokinetics.  It has no known clin. significant effect on plasma levels of carbamazepine, valproic acid, or phenobarbital, although it may increase plasma concns. of phenytoin in some patients.  When topiramate is used with hepatic enzyme-inducing AEDs, its plasma concns. are approx. 50% lower than when it is administered alone.  The efficacy of topiramate administered at 200-1000 mg/day in 2 divided doses as adjunctive therapy for partial-onset seizures has been investigated in 5 double-masked, placebo-controlled trials.  The median percentage redn. in av. monthly seizure frequency from basal values was 12% for placebo, compared with 30% for the 200-mg/day group and 48% for the 400-mg/day group.  At a dosage of 400 mg/day, a seizure redn. of ≥75% was seen in 22% of topiramate patients, compared with 7% of those receiving placebo; ≤9% of topiramate patients, compared with none of those receiving placebo, became seizure free.  Although little addnl. efficacy was seen at dosages of 600, 800, and 1000 mg/day, doses should be individualized, because some patients may respond to higher dosages.  When topiramate is combined with other AEDs, the most common side effects at dosages of 200-400 mg/day are somnolence, dizziness, ataxia, psychomotor slowing, hesitant speech, and word-finding difficulties.  Most patients who experienced adverse events during the 1st 8 wk of the trials no longer experienced them by their last visit.  Although there was a 1.5% incidence of renal stones that may be assocd. with carbonic anhydrase inhibition, >75% of the patients experiencing a stone continued on therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6U15oCfnJUbVg90H21EOLACvtfcHk0lgM00tc-gdX3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslGgsw%253D%253D&md5=ac886f9be8493e4debd214e1a2d24576</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2897%2980006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252897%252980006-9%26sid%3Dliteratum%253Aachs%26aulast%3DRosenfeld%26aufirst%3DW.%2BE.%26atitle%3DTopiramate%253A%2520a%2520review%2520of%2520preclinical%252C%2520pharmacokinetic%252C%2520and%2520clinical%2520data%26jtitle%3DClin.%2520Ther.%26date%3D1997%26volume%3D19%26spage%3D1294%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Recacha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, D.</span><span> </span><span class="NLM_article-title">Crystal structure of human carbonic anhydrase II complexed with an anti-convulsant sugar sulfamate</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2002&pages=437-441&author=R.+Recachaauthor=M.+J.+Costanzoauthor=B.+E.+Maryanoffauthor=D.+Chattopadhyay&title=Crystal+structure+of+human+carbonic+anhydrase+II+complexed+with+an+anti-convulsant+sugar+sulfamate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRecacha%26aufirst%3DR.%26aulast%3DCostanzo%26aufirst%3DM.%2BJ.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DChattopadhyay%26aufirst%3DD.%26atitle%3DCrystal%2520structure%2520of%2520human%2520carbonic%2520anhydrase%2520II%2520complexed%2520with%2520an%2520anti-convulsant%2520sugar%2520sulfamate%26jtitle%3DBiochem.%2520J.%26date%3D2002%26volume%3D361%26spage%3D437%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Bedford, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownell, J. E.</span><span> </span><span class="NLM_article-title">Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=29-46&author=L.+Bedfordauthor=J.+Loweauthor=L.+R.+Dickauthor=R.+J.+Mayerauthor=J.+E.+Brownell&title=Ubiquitin-like+protein+conjugation+and+the+ubiquitin%E2%80%93proteasome+system+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBedford%26aufirst%3DL.%26aulast%3DLowe%26aufirst%3DJ.%26aulast%3DDick%26aufirst%3DL.%2BR.%26aulast%3DMayer%26aufirst%3DR.%2BJ.%26aulast%3DBrownell%26aufirst%3DJ.%2BE.%26atitle%3DUbiquitin-like%2520protein%2520conjugation%2520and%2520the%2520ubiquitin%25E2%2580%2593proteasome%2520system%2520as%2520drug%2520targets%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D29%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Brownell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzese, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bump, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soucy, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhollen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhardt, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loke, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingaraj, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamman, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spelman, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langston, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyskocil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sells, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallender, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visiers, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L. R.</span><span> </span><span class="NLM_article-title">Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=102-111&author=J.+E.+Brownellauthor=M.+D.+Sintchakauthor=J.+M.+Gavinauthor=H.+Liaoauthor=F.+J.+Bruzzeseauthor=N.+J.+Bumpauthor=T.+A.+Soucyauthor=M.+A.+Milhollenauthor=X.+Yangauthor=A.+L.+Burkhardtauthor=J.+Maauthor=H.-K.+Lokeauthor=T.+Lingarajauthor=D.+Wuauthor=K.+B.+Hammanauthor=J.+J.+Spelmanauthor=C.+A.+Cullisauthor=S.+P.+Langstonauthor=S.+Vyskocilauthor=T.+B.+Sellsauthor=W.+D.+Mallenderauthor=I.+Visiersauthor=P.+Liauthor=C.+F.+Claiborneauthor=M.+Rolfeauthor=J.+B.+Bolenauthor=L.+R.+Dick&title=Substrate-assisted+inhibition+of+ubiquitin-like+protein-activating+enzymes%3A+the+NEDD8+E1+inhibitor+MLN4924+forms+a+NEDD8-AMP+mimetic+in+situ"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrownell%26aufirst%3DJ.%2BE.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DGavin%26aufirst%3DJ.%2BM.%26aulast%3DLiao%26aufirst%3DH.%26aulast%3DBruzzese%26aufirst%3DF.%2BJ.%26aulast%3DBump%26aufirst%3DN.%2BJ.%26aulast%3DSoucy%26aufirst%3DT.%2BA.%26aulast%3DMilhollen%26aufirst%3DM.%2BA.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DBurkhardt%26aufirst%3DA.%2BL.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DLoke%26aufirst%3DH.-K.%26aulast%3DLingaraj%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DHamman%26aufirst%3DK.%2BB.%26aulast%3DSpelman%26aufirst%3DJ.%2BJ.%26aulast%3DCullis%26aufirst%3DC.%2BA.%26aulast%3DLangston%26aufirst%3DS.%2BP.%26aulast%3DVyskocil%26aufirst%3DS.%26aulast%3DSells%26aufirst%3DT.%2BB.%26aulast%3DMallender%26aufirst%3DW.%2BD.%26aulast%3DVisiers%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DClaiborne%26aufirst%3DC.%2BF.%26aulast%3DRolfe%26aufirst%3DM.%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DDick%26aufirst%3DL.%2BR.%26atitle%3DSubstrate-assisted%2520inhibition%2520of%2520ubiquitin-like%2520protein-activating%2520enzymes%253A%2520the%2520NEDD8%2520E1%2520inhibitor%2520MLN4924%2520forms%2520a%2520NEDD8-AMP%2520mimetic%2520in%2520situ%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D37%26spage%3D102%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Reed, M. J.; Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroid sulphatase inhibitors</span>. United States Patent 5,616,574,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=M.+J.+Reed&author=B.+V.+L.+Potter&title=Steroid+sulphatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DSteroid%2520sulphatase%2520inhibitors%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Lo, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maren, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welstead, W. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gripshover, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shamblee, D. A.</span><span> </span><span class="NLM_article-title">Synthesis and physicochemical properties of sulfamate derivatives as topical antiglaucoma agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">4790</span><span class="NLM_x">–</span> <span class="NLM_lpage">4794</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00104a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=4790-4794&author=Y.+S.+Loauthor=J.+C.+Nolanauthor=T.+H.+Marenauthor=W.+J.+Welsteadauthor=D.+F.+Gripshoverauthor=D.+A.+Shamblee&title=Synthesis+and+physicochemical+properties+of+sulfamate+derivatives+as+topical+antiglaucoma+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm00104a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00104a003%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DY.%2BS.%26aulast%3DNolan%26aufirst%3DJ.%2BC.%26aulast%3DMaren%26aufirst%3DT.%2BH.%26aulast%3DWelstead%26aufirst%3DW.%2BJ.%26aulast%3DGripshover%26aufirst%3DD.%2BF.%26aulast%3DShamblee%26aufirst%3DD.%2BA.%26atitle%3DSynthesis%2520and%2520physicochemical%2520properties%2520of%2520sulfamate%2520derivatives%2520as%2520topical%2520antiglaucoma%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D4790%26epage%3D4794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Llaverías, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laguna, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alegret, M.</span><span> </span><span class="NLM_article-title">Pharmacology of the ACAT inhibitor Avasimibe (CI-1011)</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=33-50&author=G.+Llaver%C3%ADasauthor=J.+C.+Lagunaauthor=M.+Alegret&title=Pharmacology+of+the+ACAT+inhibitor+Avasimibe+%28CI-1011%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlaver%25C3%25ADas%26aufirst%3DG.%26aulast%3DLaguna%26aufirst%3DJ.%2BC.%26aulast%3DAlegret%26aufirst%3DM.%26atitle%3DPharmacology%2520of%2520the%2520ACAT%2520inhibitor%2520Avasimibe%2520%2528CI-1011%2529%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2003%26volume%3D21%26spage%3D33%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Carlström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Döberl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pousette, Å.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rannevik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilking, N.</span><span> </span><span class="NLM_article-title">Inhibition of steroid sulfatase activity by danazol</span> <span class="citation_source-journal">Acta Obstet. Gynecol. Scand</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 123</span><span class="NLM_x">) </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.3109%2F00016348409156994" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1984&pages=107-111&issue=Suppl+123&author=K.+Carlstr%C3%B6mauthor=A.+D%C3%B6berlauthor=%C3%85.+Pousetteauthor=G.+Rannevikauthor=N.+Wilking&title=Inhibition+of+steroid+sulfatase+activity+by+danazol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3109%2F00016348409156994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00016348409156994%26sid%3Dliteratum%253Aachs%26aulast%3DCarlstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DD%25C3%25B6berl%26aufirst%3DA.%26aulast%3DPousette%26aufirst%3D%25C3%2585.%26aulast%3DRannevik%26aufirst%3DG.%26aulast%3DWilking%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520steroid%2520sulfatase%2520activity%2520by%2520danazol%26jtitle%3DActa%2520Obstet.%2520Gynecol.%2520Scand%26date%3D1984%26volume%3D63%26issue%3DSuppl%2520123%26spage%3D107%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riaz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilchik, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The origin of oestrone sulphate in normal and malignant breast tissues in postmenopausal women</span> <span class="citation_source-journal">Horm. Metab. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">532</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1055%2Fs-2007-1003382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1452119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A280%3ADyaK3s%252FosVSrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1992&pages=532-536&author=A.+Purohitauthor=A.+A.+Riazauthor=M.+W.+Ghilchikauthor=M.+J.+Reed&title=The+origin+of+oestrone+sulphate+in+normal+and+malignant+breast+tissues+in+postmenopausal+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The origin of oestrone sulphate in normal and malignant breast tissues in postmenopausal women</span></div><div class="casAuthors">Purohit A; Riaz A A; Ghilchik M W; Reed M J</div><div class="citationInfo"><span class="NLM_cas:title">Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">532-6</span>
        ISSN:<span class="NLM_cas:issn">0018-5043</span>.
    </div><div class="casAbstract">Conversion of oestrone sulphate to oestrone has been suggested to make a major contribution to the level of oestrone found in breast tissues.  In order to examine the ability of breast tissues to take up oestrone sulphate (E1S), 3H E1S or E1-35S was infused into postmenopausal women with advanced breast cancer.  For 3 subjects infusion of 3H E1S was repeated after treatment with Danazol, a potential inhibitor of oestrone sulphatase activity.  After infusion of 3H E1S significant levels of 3H E1S were detected in normal and malignant breast tissues (tissue: plasma ratios 0.14 +/- 0.13 and 0.24 +/- 0.12 respectively, mean +/- S.D., n = 5).  Similar 3H E1S tissue: plasma ratios were detected after infusions of 3H E1 indicating that the 3H E1S detected in breast tissues after infusion of 3H E1S may have originated from the hydrolysis of 3H E1S in tissues other than the breast, with subsequent uptake and sulphation in breast tissues.  After infusion of E1-35S no significant levels of radioactivity were detectable in normal or malignant breast tissues.  Treatment with Danazol had no significant effect on tissue levels of 3H E1S or on the CRE1S E1 or MCR-E1S.  It is concluded that oestrone sulphate, as such, is not taken up by breast tissues and that any contribution that oestrone sulphate makes to the oestrogen content of breast tissues will depend upon prior hydrolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRN_Hhbk0mphdUSIfHIn4FfW6udTcc2eb_M1a5lByt_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FosVSrtg%253D%253D&md5=426573d501507b0e9e381cfbb046f7a9</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-1003382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-1003382%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DRiaz%26aufirst%3DA.%2BA.%26aulast%3DGhilchik%26aufirst%3DM.%2BW.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520origin%2520of%2520oestrone%2520sulphate%2520in%2520normal%2520and%2520malignant%2520breast%2520tissues%2520in%2520postmenopausal%2520women%26jtitle%3DHorm.%2520Metab.%2520Res.%26date%3D1992%26volume%3D24%26spage%3D532%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Phosphonates and thiophosphonates as sulphate surrogates: synthesis of estrone 3-methylthiophosphonate, a potent inhibitor of estrone sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=313-318&author=N.+M.+Howarthauthor=G.+Cooperauthor=A.+Purohitauthor=L.+Duncanauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Phosphonates+and+thiophosphonates+as+sulphate+surrogates%3A+synthesis+of+estrone+3-methylthiophosphonate%2C+a+potent+inhibitor+of+estrone+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DCooper%26aufirst%3DG.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DDuncan%26aufirst%3DL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DPhosphonates%2520and%2520thiophosphonates%2520as%2520sulphate%2520surrogates%253A%2520synthesis%2520of%2520estrone%25203-methylthiophosphonate%252C%2520a%2520potent%2520inhibitor%2520of%2520estrone%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1993%26volume%3D3%26spage%3D313%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Duncan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=298-303&author=L.+Duncanauthor=A.+Purohitauthor=N.+M.+Howarthauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+estrone+sulfatase+activity+by+estrone-3-methylthiophosphonate%3A+a+potential+therapeutic+agent+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuncan%26aufirst%3DL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520estrone%2520sulfatase%2520activity%2520by%2520estrone-3-methylthiophosphonate%253A%2520a%2520potential%2520therapeutic%2520agent%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D1993%26volume%3D53%26spage%3D298%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00028a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=219-221&author=N.+M.+Howarthauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Estrone+sulfamates%3A+potent+inhibitors+of+estrone+sulfatase+with+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm00028a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00028a002%26sid%3Dliteratum%253Aachs%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DEstrone%2520sulfamates%253A%2520potent%2520inhibitors%2520of%2520estrone%2520sulfatase%2520with%2520therapeutic%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D219%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inactivation of sulfatase by an active site-directed inhibitor, estrone-3-<i>O</i>-sulfamate</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">11508</span><span class="NLM_x">–</span> <span class="NLM_lpage">11514</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00036a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=11508-11514&author=A.+Purohitauthor=G.+J.+Williamsauthor=N.+M.+Howarthauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inactivation+of+sulfatase+by+an+active+site-directed+inhibitor%2C+estrone-3-O-sulfamate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fbi00036a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00036a025%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInactivation%2520of%2520sulfatase%2520by%2520an%2520active%2520site-directed%2520inhibitor%252C%2520estrone-3-O-sulfamate%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D11508%26epage%3D11514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-<i>O</i>-sulphamate</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2Fijc.2910630119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=7558436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK2MXptlyqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1995&pages=106-111&author=A.+Purohitauthor=G.+J.+Williamsauthor=C.+J.+Robertsauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=In+vivo+inhibition+of+oestrone+sulphatase+and+dehydroepiandrosterone+sulphatase+by+oestrone-3-O-sulphamate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo inhibition of estrone sulfatase and dehydroepiandrosterone sulfatase by estrone-3-O-sulfamate</span></div><div class="casAuthors">Purohit, A.; Williams, G. J.; Roberts, C. J.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-11</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">Many tumors in endocrine-sensitive tissues, such as the breast and endometrium, are hormone-dependent and the hydrolysis of estrone sulfate (EIS) to estrone by estrone sulfatase (E1-STS) is a major source of estrogen in such tumors.  Estrone-3-O-sulfamate (EMATE) has been shown to be a potent E1-STS inhibitor in vitro, and in this study its ability to inhibit enzyme activity in vivo was examd.  EMATE was initially administered to female rats for 7 days, after which liver E1-STS activity was measured.  As EMATE also inhibits a related sulfatase in vitro, dehydroepiandrosterone sulfatase (DHA-STS), its effect on the activity of this enzyme in vivo was also investigated.  DHA-STS has a pivotal role in regulating the synthesis of another steroid with potent estrogenic properties, androstenediol.  Administration of EMATE almost completely inhibited liver E1-STS (99%) and DHA-STS (99%) activities and was active when given by the oral or s.c. routes.  After a single dose of EMATE or following the cessation of multiple doses for 10 days, liver E1-STS activity remained inhibited (>95%) for up to 7 and 10 days, resp.  Other compds., such as 4-hydroxytamoxifen and the "pure" anti-estrogen ICI 182,780, which are reported to inhibited E1-STS activity in vitro, did not inhibit activity in vivo.  In a preliminary study, EMATE, when injected over a 12-day period, effectively reduced the growth of E1S-stimulated nitrosomethyl-urea-induced mammary tumors in ovariectomized rats and inhibited tumor sulfatase activity in treated animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyUTjWkzpc_7Vg90H21EOLACvtfcHk0lhmhnmpzDmEYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlyqt7g%253D&md5=f812f95aeca622d0842ab0b01100f2dc</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910630119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910630119%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DRoberts%26aufirst%3DC.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vivo%2520inhibition%2520of%2520oestrone%2520sulphatase%2520and%2520dehydroepiandrosterone%2520sulphatase%2520by%2520oestrone-3-O-sulphamate%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1995%26volume%3D63%26spage%3D106%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumors</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2F0960-0760%2895%2900087-G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=7626490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK2MXnt1GntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1995&pages=413-420&author=M.+J.+Reedauthor=A.+Purohitauthor=L.+J.+Duncanauthor=A.+Singhauthor=C.+J.+Robertsauthor=G.+J.+Williamsauthor=B.+V.+L.+Potter&title=The+role+of+cytokines+and+sulphatase+inhibitors+in+regulating+oestrogen+synthesis+in+breast+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The role of cytokines and sulfatase inhibitors in regulating estrogen synthesis in breast tumors</span></div><div class="casAuthors">Reed, M. J.; Purohit, A.; Duncan, L. J.; Singh, A.; Roberts, C. J.; Williams, G. J.; Potter, B. V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1-6</span>),
    <span class="NLM_cas:pages">413-20</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 42 refs.  Synthesis of estrogens within breast tissues makes an important contribution to the high concns. of estradiol which are found in breast tumors.  The activities of the enzymes involved in estrogen synthesis, i.e., the aromatase, estradiol dehydrogenase (E2DH) and estrone sulfatase (E1-STS), can be stimulated by several growth factors and cytokines.  As it is possible that some of these factors may be derived from cells of the immune system (macrophages and lymphocytes), the effects of basic fibroblast growth factor (bFGF) and interleukin-2 (IL-2), which are produced by these cells, on E2DH activity was examd. in MCF-7 cells.  Estrone 3-O-sulfamate (EMATE) is a potent, irreversible, inhibitor of E1-STS.  A single dose of EMATE (10 mg/kg) inhibited tissue E1-STS activity in rats by more than 95% for up to 7 days, indicating that this compd. may have considerable therapeutic potential for the treatment of breast cancer.  Evidence is also reviewed that another steroid sulfatase, dehydroepiandrosterone sulfate sulfatase, may have a crucial role in regulating cytokine prodn. and that this may indirectly control tumor estrogen synthesis.  Treatment of these cells with bFGF resulted in a dose-dependent increase in E2DH reductive activity whereas IL-2 was inactive at the concn. tested.  To obtain further evidence that factors produced by macrophages and lymphocytes can modulate the activities of enzymes involved in estrogen synthesis, conditioned medium was collected from these cells and found to stimulate both E1-STS and E2DH activities.  In addn. to understanding the control of estrogen synthesis in breast tumors an inhibitor to block the synthesis of estrone via the estrone sulfatase pathway was developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrED0nR5AiqArVg90H21EOLACvtfcHk0lgtm0gOeXztyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnt1GntLY%253D&md5=b7904f8d39ac016fd0677721b789f0fe</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900087-G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900087-G%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DDuncan%26aufirst%3DL.%2BJ.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DC.%2BJ.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DThe%2520role%2520of%2520cytokines%2520and%2520sulphatase%2520inhibitors%2520in%2520regulating%2520oestrogen%2520synthesis%2520in%2520breast%2520tumors%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D53%26spage%3D413%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Regulation and inhibition of sulfatase activity in breast cancer</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">784</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=784&publication_year=1996&pages=40-49&author=A.+Purohitauthor=M.+J.+Reedauthor=N.+C.+Morrisauthor=G.+J.+Williamsauthor=B.+V.+L.+Potter&title=Regulation+and+inhibition+of+sulfatase+activity+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DMorris%26aufirst%3DN.%2BC.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DRegulation%2520and%2520inhibition%2520of%2520sulfatase%2520activity%2520in%2520breast%2520cancer%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1996%26volume%3D784%26spage%3D40%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Sahm, U. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo Aragones, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouton, C. W.</span><span> </span><span class="NLM_article-title">Development of an oral formulation for oestrone 3-<i>O</i>-sulphamate, a potent sulphatase inhibitor</span> <span class="citation_source-journal">Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28XkvFGkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=17-20&author=U.+G.+Sahmauthor=G.+J.+Williamsauthor=A.+Purohitauthor=I.+Hidalgo+Aragonesauthor=D.+Parishauthor=M.+J.+Reedauthor=B.+V.+L.+Potterauthor=C.+W.+Pouton&title=Development+of+an+oral+formulation+for+oestrone+3-O-sulphamate%2C+a+potent+sulphatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Development of an oral formulation for estrone 3-O-sulfamate, a potent sulfatase inhibitor</span></div><div class="casAuthors">Sahm, Ulrike G.; Williams, Gary J.; Purohit, Atul; Hidalgo Aragones, M. Isabel; Parish, David; Reed, Michael J.; Potter, Barry V. L.; Pouton, Colin W.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-20</span>CODEN:
                <span class="NLM_cas:coden">PHSCFB</span>;
        ISSN:<span class="NLM_cas:issn">1356-6881</span>.
    
            (<span class="NLM_cas:orgname">Royal Pharmaceutical Society of Great Britain</span>)
        </div><div class="casAbstract">Estrone sulfatase is a key enzyme involved in estrogen synthesis in breast tumors in postmenopausal women.  As breast tumors can be endocrine-dependent, it is therefore feasible that blockage of this enzyme may be of value in the treatment of such tumors.  Estrone 3-O-sulfamate (EMATE) is the most potent inhibitor of estrone sulfatase activity described to date.  A preliminary examn. of its physicochem. properties and the development of a self-emulsifying formulation for potential administration of EMATE by the oral route is described.  A preliminary assessment of the absorption of the drug from the gut was undertaken, and pharmacol. activity, detd. as estrone sulfatase inhibition, was studied following i.v. and oral administration.  A high-performance liq. chromatog. (HPLC) assay was developed to measure degrdn. of EMATE in the formulation and also its concn. in rat plasma.  The drug was susceptible to degrdn., but its stability in the formulation was satisfactory when stored at either 4° or room-temp. over the time-span required for a clin. trial.  Plasma EMATE concns. after 2 h were a function of the dose of drug administered orally to rats over the 10-40 mg kg-1 range.  After oral administration in the self-emulsifying system, EMATE appeared to be rapidly absorbed, with the peak plasma concn. being detected at 30 min, after which plasma concns. rapidly decreased.  After i.v. administration, a similar plasma EMATE concn. was detected at 1 h to that obsd. after oral administration.  Rat liver sulfatase activity was almost completely inhibited (>99%) within 30 min of oral or i.v. administration of EMATE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqimZ6fFzBI3rVg90H21EOLACvtfcHk0lgtm0gOeXztyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFGkurc%253D&md5=5d49fe4c0a4c05f8b4fceeee06fbe929</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSahm%26aufirst%3DU.%2BG.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHidalgo%2BAragones%26aufirst%3DI.%26aulast%3DParish%26aufirst%3DD.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DPouton%26aufirst%3DC.%2BW.%26atitle%3DDevelopment%2520of%2520an%2520oral%2520formulation%2520for%2520oestrone%25203-O-sulphamate%252C%2520a%2520potent%2520sulphatase%2520inhibitor%26jtitle%3DPharm.%2520Sci.%26date%3D1996%26volume%3D2%26spage%3D17%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Hidalgo Aragones, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahm, U. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouton, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of oestrone-3-<i>O-</i>sulphamate</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2F0960-0760%2896%2900074-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8918989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28XmvFajsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1996&pages=611-617&author=M.+I.+Hidalgo+Aragonesauthor=A.+Purohitauthor=D.+Parishauthor=U.+G.+Sahmauthor=C.+W.+Poutonauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Pharmacokinetics+of+oestrone-3-O-sulphamate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of estrone-3-O-sulfamate</span></div><div class="casAuthors">Hidalgo Aragones, M. I.; Purohit, A.; Parish, D.; Sahm, U. G.; Pouton, C. W.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">611-617</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The sulfatase pathway is thought to be the major route of estrogen synthesis in breast tumors in postmenopausal women.  There is current considerable interest in developing a potent steroid sulfatase inhibitor to block estrogen synthesis by this route.  One of the most potent inhibitors discovered so far is estrone-3-O-sulfamate (EMATE) which is active in vivo.  In this study, we report the prepn. of a formulation for the administration of EMATE by the oral route.  A method, using high-performance liq. chromatog. (HPLC), was also established to measure concns. of EMATE in rat plasma after its oral or i.v. administration.  Using the oral formulation and HPLC assay, EMATE was readily detected in rat plasma after oral administration.  Plasma EMATE concns. were related to the dose of drug administered orally over the 10-40 mg/kg range.  To examine the pharmacokinetics of EMATE, the compd. (40 mg/kg, single dose) was administered either orally (in the formulation) or i.v. (in propylene glycol) with plasma samples being collected for up to 6 h.  After oral administration, EMATE was rapidly absorbed, with the peak plasma concn. being detected at 30 min, after which plasma concn. rapidly decreased.  After i.v. administration a plasma EMATE concn. was detected at 1 h similar to that after oral administration.  The clearance of EMATE from plasma followed a bi-phasic curve, showing an initial half-life of 30 min, followed by a slower half-life of 4 h 30 min.  Little evidence was obtained for any metab. of EMATE to estrone.  Rat liver sulfatase activity was almost completely inhibited (>99%) within 30 min of oral or i.v. administration of EMATE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaqiQSCB_JOrVg90H21EOLACvtfcHk0lj2qIPUCz_3Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvFajsb0%253D&md5=7891eca64cd4f6fb396ab007a115955c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2896%2900074-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252896%252900074-X%26sid%3Dliteratum%253Aachs%26aulast%3DHidalgo%2BAragones%26aufirst%3DM.%2BI.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DParish%26aufirst%3DD.%26aulast%3DSahm%26aufirst%3DU.%2BG.%26aulast%3DPouton%26aufirst%3DC.%2BW.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DPharmacokinetics%2520of%2520oestrone-3-O-sulphamate%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D58%26spage%3D611%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froome, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Measurement of oestrone sulphatase activity in white blood cells to monitor in vivo inhibition of steroid sulphatase activity by oestrone-3-<i>O</i>-sulphamate</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2897%2900018-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=9366497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1emtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=45-51&author=A.+Purohitauthor=V.+A.+Froomeauthor=D.+Y.+Wangauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Measurement+of+oestrone+sulphatase+activity+in+white+blood+cells+to+monitor+in+vivo+inhibition+of+steroid+sulphatase+activity+by+oestrone-3-O-sulphamate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of estrone sulfatase activity in white blood cells to monitor in vivo inhibition of steroid sulfatase activity by estrone-3-O-sulfamate</span></div><div class="casAuthors">Purohit, A.; Froome, V. A.; Wang, D. Y.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Formation of estrone via the sulfatase pathway is considered to be a major source of the estrogen present in breast tumors.  Several inhibitors of steroid sulfatase have now been developed for use in the treatment of postmenopausal women with breast cancer.  In order to be able to monitor the extent and duration of the inhibition of estrone sulfatase (E1-STS) readily, we have developed a method to measure the activity of this enzyme in white blood cells (WBCs).  Hydrolysis of estrone sulfate by E1-STS in WBCs was linear with respect to time and the vol. of WBCs used.  To examine whether the extent of inhibition of E1-STS activity in WBCs, by the inhibitor estrone-3-O-sulfamate (EMATE), reflected inhibition in other body tissues, activity in WBCs was compared with that in liver and spleen tissue samples from rats.  Two hours after an oral dose of EMATE the extent of inhibition of E1-STS detected in WBCs was the same as in the liver.  The duration of the inhibition of E1-STS by EMATE, examd. over a 1-28 day period in rats, was similar whether monitored in WBCs, liver or spleen.  Measurements of E1-STS activity in WBCs were also used to examine the effectiveness of EMATE (0.5 mg/kg) in two male volunteers.  E1-STS activity was rapidly inhibited and had only recovered by 27% after 1 mo.  A marked decrease in the ratio of plasma dehydroepiandrosterone:dehydroepiandrosterone-sulfate (DHA:DHA-S) concns. was also detected, confirming that EMATE also inhibits DHA-STS activity.  The ability to monitor the extent and duration of steroid sulfatase inhibition in WBCs will facilitate the evaluation of this new form of endocrine therapy in women with breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDnur9MKaZ0rVg90H21EOLACvtfcHk0lj2qIPUCz_3Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1emtbs%253D&md5=a9d553bc273fbf7e0b47431e729615cd</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2897%2900018-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252897%252900018-6%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DFroome%26aufirst%3DV.%2BA.%26aulast%3DWang%26aufirst%3DD.%2BY.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DMeasurement%2520of%2520oestrone%2520sulphatase%2520activity%2520in%2520white%2520blood%2520cells%2520to%2520monitor%2520in%2520vivo%2520inhibition%2520of%2520steroid%2520sulphatase%2520activity%2520by%2520oestrone-3-O-sulphamate%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D62%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightowler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate inhibit estrone sulphatase by a different mechanism</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2F0960-0760%2895%2900244-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8645620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28XjtVegtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1996&pages=79-88&author=L.+W.+L.+Wooauthor=M.+Lightowlerauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Heteroatom-substituted+analogues+of+the+active-site+directed+inhibitor+estra-1%2C3%2C5%2810%29-trien-17-one-3-sulphamate+inhibit+estrone+sulphatase+by+a+different+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Hetero atom-substituted analogs of the active-side directed inhibitor estra-1,3,5(10)-triene-17-one-3-sulfamate inhibit estrone sulfatase by a different mechanism</span></div><div class="casAuthors">Woo, L. W. Lawrence; Lightowler, Mark; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Estrogens have a pivotal role in the growth and development of hormone-dependent breast cancers.  In postmenopausal women, the hydrolysis of the conjugate estrone sulfate (E1S) to estrone (E1) by the enzyme estrone sulfatase is the major source of breast tumor estrogen.  Inhibitors of estrone sulfatase should therefore have considerable therapeutic potential for the treatment of hormone-dependent tumors of the breast, either as the sole agent or in conjunction with aromatase inhibitors.  Several inhibitors of estrone sulfatase have now been developed of which estra-1,3,5(10)-trien-17-one-3-sulfamate (EMATE) is the most potent and also inhibits the enzyme in a time- and concn.-dependent manner, showing that it acts as an irreversible inhibitor.  Analogs of EMATE in which the 3-O-atom is replaced by other heteroatoms (S and N) were prepd. and tested for inhibition against estrone sulfatase.  3-Methoxyphenylsulfamide, 4-chlorothiophenyl-S-(N,N-dimethyl)sulfamate, estra-1,3,5(10)-trien-17-one-3-sulfamide, estra-1,3,5(10)-trien-17-one-3-S-sulfamate, and estra-1,3,5(10)-trien-17-one-3-S-(N,N-dimethyl)sulfamate inhibited estrone sulfatase weakly, but none of these compds. appears to behave as a time-dependent inhibitor.  A model of the mechanism of enzyme inhibition by EMATE is proposed and the authors conclude that the sulfamate bridging oxygen atom of EMATE is essential for active site-directed inhibition of estrone sulfatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlWZCRBBmXtLVg90H21EOLACvtfcHk0lj2qIPUCz_3Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVegtL8%253D&md5=ce13a9f57587179a9d5a3a104fd67740</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900244-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900244-8%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLightowler%26aufirst%3DM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DHeteroatom-substituted%2520analogues%2520of%2520the%2520active-site%2520directed%2520inhibitor%2520estra-1%252C3%252C5%252810%2529-trien-17-one-3-sulphamate%2520inhibit%2520estrone%2520sulphatase%2520by%2520a%2520different%2520mechanism%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D57%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">X-ray crystal structure and mechanism of action of oestrone 3-<i>O</i>-sulphamate, a synthetic active site-directed inhibitor of oestrone sulphatase</span> <span class="citation_source-journal">Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28XkvFGkurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=11-16&author=G.+J.+Williamsauthor=L.+W.+L.+Wooauthor=M.+F.+Mahonauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=X-ray+crystal+structure+and+mechanism+of+action+of+oestrone+3-O-sulphamate%2C+a+synthetic+active+site-directed+inhibitor+of+oestrone+sulphatase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray crystal structure and mechanism of action of estrone 3-O-sulfamate, a synthetic active site-directed inhibitor of estrone sulfatase</span></div><div class="casAuthors">Williams, Gary J.; Woo, L. W. Lawrence; Mahon, Mary F.; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-16</span>CODEN:
                <span class="NLM_cas:coden">PHSCFB</span>;
        ISSN:<span class="NLM_cas:issn">1356-6881</span>.
    
            (<span class="NLM_cas:orgname">Royal Pharmaceutical Society of Great Britain</span>)
        </div><div class="casAbstract">Estrone 3-O-sulfamate moiety is a sulfate group surrogate relative to estrone sulfate, is the most potent estrone sulfatase inhibitor developed to date and inhibits estrone sulfatase in a time- and concn.-dependent manner, showing that it is acting as an active site-directed irreversible inhibitor.  It also inhibits dehydroepiandrosterone sulfatase, the enzyme which regulates the synthesis of androstenediol.  Estrone 3-O-sulfamate has also been shown to inhibit these enzymes in-vivo.  The authors report its crystal structure and the synthesis and inhibitory activities of analogs in which the 3-O atom is replaced by other heteroatoms (N and S).  Estrone 3-N-sulfamate and estrone 3-S-sulfamate were found to inhibit placental microsome estrone sulfatase weakly, i.e. 53% and 12%, resp., at 50 μM (compared with >99% for estrone 3-O-sulfamate), but none of these compds. appears to behave as a time-dependent inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2yQvGcqHZT7Vg90H21EOLACvtfcHk0lj2qIPUCz_3Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFGkurY%253D&md5=7555f9014e507d084ca32ddf0d861f0f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DX-ray%2520crystal%2520structure%2520and%2520mechanism%2520of%2520action%2520of%2520oestrone%25203-O-sulphamate%252C%2520a%2520synthetic%2520active%2520site-directed%2520inhibitor%2520of%2520oestrone%2520sulphatase%26jtitle%3DPharm.%2520Sci.%26date%3D1996%26volume%3D2%26spage%3D11%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Estrone sulfonates as inhibitors of estrone sulfatase</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=346-350&author=N.+M.+Howarthauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Estrone+sulfonates+as+inhibitors+of+estrone+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DEstrone%2520sulfonates%2520as%2520inhibitors%2520of%2520estrone%2520sulfatase%26jtitle%3DSteroids%26date%3D1997%26volume%3D62%26spage%3D346%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Oestrone 3-<i>O</i>-(<i>N</i>-acetyl)sulphamate, a potential molecular probe of the active site of oestrone sulphatase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3075</span><span class="NLM_x">–</span> <span class="NLM_lpage">3080</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=3075-3080&author=L.+W.+L.+Wooauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Oestrone+3-O-%28N-acetyl%29sulphamate%2C+a+potential+molecular+probe+of+the+active+site+of+oestrone+sulphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DOestrone%25203-O-%2528N-acetyl%2529sulphamate%252C%2520a%2520potential%2520molecular%2520probe%2520of%2520the%2520active%2520site%2520of%2520oestrone%2520sulphatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D3075%26epage%3D3080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Elger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heddern, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddersen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, B.</span><span> </span><span class="NLM_article-title">Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2F0960-0760%2895%2900214-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8541236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28XhsVygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=395-403&author=W.+Elgerauthor=S.+Schwarzauthor=A.+Heddernauthor=G.+Reddersenauthor=B.+Schneider&title=Sulfamates+of+various+estrogens+are+prodrugs+with+increased+systemic+and+reduced+hepatic+estrogenicity+at+oral+application"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application</span></div><div class="casAuthors">Elger, Walter; Schwarz, Sigfrid; Hedden, Annemarie; Reddersen, Gudrun; Schneider, Birgitt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">395-403</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Oral therapy with natural or synthetic estrogens, like ethinylestradiol, suffers from low, suboptimally defined bioavailability and excess hepatic estrogen actions.  N,N-alkylated and non-alkylated sulfamates of ethinylestradiol, estradiol and estrone overcome these deficiencies.  Ovariectomized Wistar rats (-7/group) were orally treated for 7 days, and killed on day 8, plasma was gained on days 0, 4, and 8.  Systemic estrogenicity was quantified by assessment of uterine wt., vaginal cornification, and measurement of gonadotropins by homologous RIA.  Estrogenicity in the liver was analyzed.  Angiotensinogen was estd. by RIA of angiotensin-I after incubation of EDTA-plasma with porcine renin.  Total and high-d. cholesterol were measured by enzymic methods.  Preliminary biotransformation studies were performed after oral administration of 10 μg, 5 μ Ci [2,4,6,7-3H]estradiol sulfonate.  Ethinylestradiol led to distinct elevation of angiotensin-I and dramatic depression of cholesterol fractions, reflecting hepatic estrogen effects, already at doses with marginal systemic effects.  Estradiol and estrone had systemic and hepatic estrogenic activity at much higher doses only.  Estrogen sulfamates had systemic estrogen activity 10-90-fold above that of their parent estrogen.  Non-alkylated sulfamates of given estrogens were more active than N-alkylated ones.  Elevation of systemic estrogen activity was always combined with a dramatic redn. of hepatic estrogenicity.  Estradiol sulfamate had a 90-fold elevated systemic estrogen activity vs. estradiol, but lacked hepatic activity including the 30-fold dose inducing vaginal response.  Three hours after administration no unchanged estradiol sulfamate was detectable in plasma.  Rather peaks, probably representing estradiol and estrone, were found.  Estrogen sulfamates are considered prodrugs of their parent estrogen, which do not interact with any liver function during the first-pass.  They represent a new strategy of oral hormone administration.  Their main potential seems to be the systemic generation of natural estrogen when used in oral contraceptives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq93WhQsNTWFbVg90H21EOLACvtfcHk0ljYURWhDRxh_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVygtg%253D%253D&md5=60ff9ba569eb4001a4a023073e8737e0</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900214-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900214-6%26sid%3Dliteratum%253Aachs%26aulast%3DElger%26aufirst%3DW.%26aulast%3DSchwarz%26aufirst%3DS.%26aulast%3DHeddern%26aufirst%3DA.%26aulast%3DReddersen%26aufirst%3DG.%26aulast%3DSchneider%26aufirst%3DB.%26atitle%3DSulfamates%2520of%2520various%2520estrogens%2520are%2520prodrugs%2520with%2520increased%2520systemic%2520and%2520reduced%2520hepatic%2520estrogenicity%2520at%2520oral%2520application%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D55%26spage%3D395%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Elger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedden, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddersen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Züchner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krahl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oettel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span> </span><span class="NLM_article-title">Estrogen sulfamates: a new approach to oral estrogen therapy</span> <span class="citation_source-journal">Reprod., Fertil. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1071%2FRD01029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=11800168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVQ%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=297-305&author=W.+Elgerauthor=A.+Barthauthor=A.+Heddenauthor=G.+Reddersenauthor=P.+Ritterauthor=B.+Schneiderauthor=J.+Z%C3%BCchnerauthor=E.+Krahlauthor=K.+M%C3%BCllerauthor=M.+Oettelauthor=S.+Schwarz&title=Estrogen+sulfamates%3A+a+new+approach+to+oral+estrogen+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen sulfamates: A new approach to oral estrogen therapy</span></div><div class="casAuthors">Elger, W.; Barth, A.; Hedden, A.; Reddersen, G.; Ritter, P.; Schneider, B.; Zuchner, J.; Krahl, E.; Muller, K.; Oettel, M.; Schwarz, Sigfrid</div><div class="citationInfo"><span class="NLM_cas:title">Reproduction, Fertility and Development</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-305</span>CODEN:
                <span class="NLM_cas:coden">RFDEEH</span>;
        ISSN:<span class="NLM_cas:issn">1031-3613</span>.
    
            (<span class="NLM_cas:orgname">CSIRO Publishing</span>)
        </div><div class="casAbstract">Sulfamate substitution (-O-SO2-NH2) at carbon atom 3 of the steroid skeleton leads to orally active prodrugs of estrogens with much higher systemic, but lower hepatic, estrogenic activity than their parent steroids.  This dissocn. is achieved by first passage through the liver in erythrocytes, followed by systemic hydrolysis which releases the "parent" estrogen.  In the rat, orally administered tritiated estradiol sulfamate, unlike estradiol, appears in the circulation at high concns.  At Cmax, approx. one-third of the administered dose forms a depot in the circulation (98% in erythrocytes, 2% in plasma).  Significant estradiol, estrone and estrone sulfate concns. were recorded in plasma during depletion of the red blood cell pool.  Estradiol sulfamate (J995) has no estrogen receptor affinity per se or estrogenic activity in vitro (i.e., without hydrolysis).  Its oral uterotropic activity in rats is approx. 100 times greater than that of estradiol, however, its hepatotropic activity is only marginally elevated.  These functions include bile secretion, the secretion of angiotensinogen, lipoproteins (total and high-d. lipoprotein cholesterol) and IGF-I.  Orally administered estradiol sulfamate led to systemic estrogenic effects without significant hepatic responses, whereas estradiol and other conventional estrogens exerted parallel systemic and hepatic estrogenic effects.  Sulfamate technol. represents an approach to the use of natural estrogens for fertility control and hormone replacement therapy in both genders.  In this context, reduced effects on hemostatic factors, angiotensinogen, bile and IGF-I secretion seem the most important aspects.  In addn., blood concns. of estrogens are less variable than with conventional estrogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEwNk-n7GGhbVg90H21EOLACvtfcHk0ljYURWhDRxh_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVQ%253D&md5=4467be06adf6c62c8b0287297421ffa0</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1071%2FRD01029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1071%252FRD01029%26sid%3Dliteratum%253Aachs%26aulast%3DElger%26aufirst%3DW.%26aulast%3DBarth%26aufirst%3DA.%26aulast%3DHedden%26aufirst%3DA.%26aulast%3DReddersen%26aufirst%3DG.%26aulast%3DRitter%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DB.%26aulast%3DZ%25C3%25BCchner%26aufirst%3DJ.%26aulast%3DKrahl%26aufirst%3DE.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DOettel%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DS.%26atitle%3DEstrogen%2520sulfamates%253A%2520a%2520new%2520approach%2520to%2520oral%2520estrogen%2520therapy%26jtitle%3DReprod.%252C%2520Fertil.%2520Dev.%26date%3D2001%26volume%3D13%26spage%3D297%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Elger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palme, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span> </span><span class="NLM_article-title">Novel oestrogen sulfamates: a new approach to oral hormone therapy</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=575-589&author=W.+Elgerauthor=H.-J.+Palmeauthor=S.+Schwarz&title=Novel+oestrogen+sulfamates%3A+a+new+approach+to+oral+hormone+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElger%26aufirst%3DW.%26aulast%3DPalme%26aufirst%3DH.-J.%26aulast%3DSchwarz%26aufirst%3DS.%26atitle%3DNovel%2520oestrogen%2520sulfamates%253A%2520a%2520new%2520approach%2520to%2520oral%2520hormone%2520therapy%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D1998%26volume%3D7%26spage%3D575%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2004&pages=217-222&author=S.+K.+Chanderauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+role+of+steroid+sulphatase+in+regulating+the+oestrogenicity+of+oestrogen+sulphamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520role%2520of%2520steroid%2520sulphatase%2520in%2520regulating%2520the%2520oestrogenicity%2520of%2520oestrogen%2520sulphamates%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D322%26spage%3D217%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Potter, B. V. L.; Reed, M. J.; Elger, W.; Roddersen, G.; Proske, H.-T.</span><span> </span><span class="NLM_article-title">Composition</span>. US Patent 7335650 B2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+V.+L.+Potter&author=M.+J.+Reed&author=W.+Elger&author=G.+Roddersen&author=H.-T.+Proske&title=Composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DComposition%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1349</span><span class="NLM_x">–</span> <span class="NLM_lpage">1351</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950931z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1349-1351&author=L.+W.+L.+Wooauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Active+site+directed+inhibition+of+estrone+sulfatase+by+nonsteroidal+coumarin+sulfamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm950931z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950931z%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DActive%2520site%2520directed%2520inhibition%2520of%2520estrone%2520sulfatase%2520by%2520nonsteroidal%2520coumarin%2520sulfamates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1349%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winterborn, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">In vivo activity of 4-methylcoumarin-7-<i>O</i>-sulfamate, a nonsteroidal, nonestrogenic sulfatase inhibitor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4950</span><span class="NLM_x">–</span> <span class="NLM_lpage">4955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1996&pages=4950-4955&author=A.+Purohitauthor=L.+W.+L.+Wooauthor=A.+Singhauthor=C.+J.+Winterbornauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=In+vivo+activity+of+4-methylcoumarin-7-O-sulfamate%2C+a+nonsteroidal%2C+nonestrogenic+sulfatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DWinterborn%26aufirst%3DC.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vivo%2520activity%2520of%25204-methylcoumarin-7-O-sulfamate%252C%2520a%2520nonsteroidal%252C%2520nonestrogenic%2520sulfatase%2520inhibitor%26jtitle%3DCancer%2520Res.%26date%3D1996%26volume%3D56%26spage%3D4950%26epage%3D4955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroidal and non-steroidal sulfamates as potent inhibitors of sulfatase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1068</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970527v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1068-1083&author=L.+W.+L.+Wooauthor=N.+M.+Howarthauthor=A.+Purohitauthor=H.+A.+M.+Hejazauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Steroidal+and+non-steroidal+sulfamates+as+potent+inhibitors+of+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm970527v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970527v%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroidal%2520and%2520non-steroidal%2520sulfamates%2520as%2520potent%2520inhibitors%2520of%2520sulfatase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1068%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS1074-5521%2800%2900023-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=11033081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVWitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=773-791&author=L.+W.+L.+Wooauthor=A.+Purohitauthor=B.+Maliniauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Potent+active+site-directed+inhibition+of+steroid+sulphatase+by+tricyclic+coumarin-based+sulphamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Potent active site-directed inhibition of steroid sulfatase by tricyclic coumarin-based sulfamates</span></div><div class="casAuthors">Woo, L. W. Lawrence; Purohit, Atul; Malini, Bindu; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">773-791</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: There is now abundant evidence that inhibition of steroid sulfatase alone or in conjunction with inhibition of aromatase may enhance the response of postmenopausal patients with hormone-dependent breast cancer to this type of endocrine therapy.  Addnl., sulfatase inhibition has been proposed to be of potential therapeutic benefit in the immune system and for neuro-degenerative diseases.  After the finding that the authors first highly potent active site-directed steroid sulfatase inhibitor, estrone-3-O-sulfamate (EMATE), was highly estrogenic, the authors proposed non-steroidal coumarin sulfamates such as 4-methylcoumarin-7-O-sulfamate (COUMATE) as alternative non-steroidal steroid sulfatase inhibitors.  In this work, the authors describe how tricyclic coumarin-based sulfamates have been developed which are even more potent than COUMATE, are non-estrogenic and orally active.  The authors also discuss potential mechanisms of action.  Results: 4-Ethyl-, 4-(n-propyl)-, 3-ethyl-4-methyl-, 4-methyl-3-(n-propyl)coumarin-7-O-sulfamate; the tricyclic derivs. 665COUMATE, 666COUMATE, 667COUMATE, 668COUMATE and the tricyclic oxepin sulfamate were synthesized.  In a placental microsome prepn., all of these analogs were more active than COUMATE in the inhibition of estrone sulfatase, with the most potent inhibitor being 667COUMATE which has an IC50 of 8 nM, some 3-fold lower than that for EMATE (25 nM).  In addn., 667COUMATE was also found to inhibit DHEA-sulfatase some 25-fold more potently than EMATE in a placental microsome prepn.  Like EMATE, 667COUMATE acts in a time- and concn.-dependent manner, suggesting that it is an active site-directed inhibitor.  However, in contrast to EMATE, 667COUMATE has the important advantage of not being estrogenic.  In addn., the authors propose several diverse mechanisms of action for this active site-directed steroid sulfatase inhibitor in the light of recent publications on the crystal structures of human arylsulfatases A and B and the catalytic site topol. for the hydrolysis of a sulfate ester.  Conclusions: A highly potent non-steroidal, non-estrogenic and irreversible steroid sulfatase inhibitor has been developed.  Several mechanisms of action for an active site-directed steroid sulfatase inhibitor are proposed.  With 667COUMATE now in pre-clin. development for clin. trial, this should allow the biol. and/or clin. significance of steroid sulfatase inhibitors in the treatment of postmenopausal women with hormone-dependent breast cancer and other therapeutic indications to be fully evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquu_otJvJPsbVg90H21EOLACvtfcHk0lgCyVVMGthaJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVWitro%253D&md5=263791da6e0cc238ed0e4ad6bf1c60ec</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2800%2900023-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252800%252900023-5%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DMalini%26aufirst%3DB.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DPotent%2520active%2520site-directed%2520inhibition%2520of%2520steroid%2520sulphatase%2520by%2520tricyclic%2520coumarin-based%2520sulphamates%26jtitle%3DChem.%2520Biol.%26date%3D2000%26volume%3D7%26spage%3D773%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3394</span><span class="NLM_x">–</span> <span class="NLM_lpage">3396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=3394-3396&author=A.+Purohitauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=In+vivo+inhibition+of+estrone+sulfatase+activity+and+growth+of+nitrosomethylurea-induced+mammary+tumors+by+667+COUMATE"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vivo%2520inhibition%2520of%2520estrone%2520sulfatase%2520activity%2520and%2520growth%2520of%2520nitrosomethylurea-induced%2520mammary%2520tumors%2520by%2520667%2520COUMATE%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D3394%26epage%3D3396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Malini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganeshapillai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2800%2900178-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=11282279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit12mu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2000&pages=253-258&author=B.+Maliniauthor=A.+Purohitauthor=D.+Ganeshapillaiauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+steroid+sulphatase+activity+by+tricyclic+coumarin+sulphamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates</span></div><div class="casAuthors">Malini, B.; Purohit, A.; Ganeshapillai, D.; Woo, L. W. L.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">253-258</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The identification of the active pharmacophore required for potent inhibition of steroid sulfatase activity, i.e. and aryl-O-sulfamate structure, has led to the synthesis and testing of a large no. of 1-4 ring-based inhibitors.  4-Methylcoumarin-7-O-sulfamate (COUMATE) was one of the first non-steroid based inhibitors identified.  In an attempt to increase the potency of this class of inhibitor a series of tricyclic COUMATEs (665-6615 COUMATEs) have been synthesized and evaluated.  Using placental microsomes as a source of estrone sulfatase (E1-STS) the size of the third ring of the tricyclic COUMATEs was found to have a marked effect on inhibitor potency.  Whereas 665- and 6615-COUMATEs had IC50s of 200 and 370 nM, resp., the most potent inhibitor in vitro in this series was 6610 COUMATE with an IC50 of 1 nM.  Selected inhibitors were tested for their in vivo potency by administration of a single dose (0.1 or 1 mg/kg, p.o.) to female rats.  Surprisingly, in vivo 6615 COUMATE proved to be the most active drug, inhibiting rat liver E1-STS activity by 23 and 94% when assayed 24 h after administration of the 0.1 and 1 mg/kg doses.  E1-STS activity in brain tissue and white blood cells was also inhibited when selected drugs were tested.  These studies have identified a no. of tricyclic COUMATEs with therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr73s_zthZf7Vg90H21EOLACvtfcHk0liVoRUdStBNuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit12mu7s%253D&md5=d76a00fad16ad81338377580a6c2ef5c</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2800%2900178-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252800%252900178-3%26sid%3Dliteratum%253Aachs%26aulast%3DMalini%26aufirst%3DB.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DGaneshapillai%26aufirst%3DD.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520steroid%2520sulphatase%2520activity%2520by%2520tricyclic%2520coumarin%2520sulphamates%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D75%26spage%3D253%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganeshapillai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Structure–activity relationship for the first-in-class clinical sulfatase inhibitor Irosustat (STX64, BN83495)</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2019</span><span class="NLM_x">–</span> <span class="NLM_lpage">2034</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=2019-2034&author=L.+W.+L.+Wooauthor=D.+Ganeshapillaiauthor=M.+P.+Thomasauthor=O.+B.+Sutcliffeauthor=B.+Maliniauthor=M.+F.+Mahonauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Structure%E2%80%93activity+relationship+for+the+first-in-class+clinical+sulfatase+inhibitor+Irosustat+%28STX64%2C+BN83495%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DGaneshapillai%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DMalini%26aufirst%3DB.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520for%2520the%2520first-in-class%2520clinical%2520sulfatase%2520inhibitor%2520Irosustat%2520%2528STX64%252C%2520BN83495%2529%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D2019%26epage%3D2034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Ireson, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1038%2Fsj.bjc.6602130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15328524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFCgtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2004&pages=1399-1404&author=C.+K.+Iresonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=D.+C.+Parishauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Pharmacokinetics+of+the+nonsteroidal+steroid+sulphatase+inhibitor+667+COUMATE+and+its+sequestration+into+red+blood+cells+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats</span></div><div class="casAuthors">Ireson, C. R.; Chander, S. K.; Purohit, A.; Parish, D. C.; Woo, L. W. L.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1399-1404</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Breast cancer is a major cause of mortality in Western countries and there is an urgent requirement for novel treatment strategies.  The nonsteroidal sulphatase inhibitor 667 COUMATE inhibits hepatic steroid sulphatase and growth of oestrone sulfate stimulated tumors in the nitrosomethylurea-induced rat mammary model.  Other compds. that contain an aryl sulphamate moiety, for example, oestrone-3-O-sulphamate, are sequestered into red blood cells (RBCs).  The aims of this study were to det. the pharmacokinetics of 667 COUMATE and to investigate its sequestration into RBCs.  We administered a single p.o. or i.v. dose (10 mg kg-1) of 667 COUMATE to rats and used a high-performance liq. chromatog. method to measure the levels of the agent and its putative metabolites in plasma. 667 COUMATE had a bioavailability of 95% and could be detected in plasma for up to 8 h.  Using two independent anal. methods, we demonstrated that 667 COUMATE is sequestered by RBCs both ex vivo and in vivo.  Previous investigations have revealed that 667 COUMATE is rapidly degraded in plasma ex vivo.  In this study, we demonstrate that 667 COUMATE is stabilized due to its sequestration into RBCs.  In conclusion, the pharmacol. efficacy and high oral bioavailability of 667 COUMATE may be partly a consequence of the ability of RBCs to both protect the agent from metabolic degrdn. and facilitate its transport to tissues.  These data support the further clin. evaluation of this novel endocrine therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYSKz50yUSObVg90H21EOLACvtfcHk0liVoRUdStBNuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFCgtb8%253D&md5=be39d3a5dd9bd2d00ed481d20070dcac</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602130%26sid%3Dliteratum%253Aachs%26aulast%3DIreson%26aufirst%3DC.%2BK.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DParish%26aufirst%3DD.%2BC.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DPharmacokinetics%2520of%2520the%2520nonsteroidal%2520steroid%2520sulphatase%2520inhibitor%2520667%2520COUMATE%2520and%2520its%2520sequestration%2520into%2520red%2520blood%2520cells%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2004%26volume%3D91%26spage%3D1399%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganeshapillai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=909-914&author=Y.+T.+Hoauthor=A.+Purohitauthor=N.+Vickerauthor=S.+P.+Newmanauthor=J.+J.+Robinsonauthor=M.+P.+Leeseauthor=D.+Ganeshapillaiauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+carbonic+anhydrase+II+by+steroidal+and+non-steroidal+sulphamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DVicker%26aufirst%3DN.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DRobinson%26aufirst%3DJ.%2BJ.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DGaneshapillai%26aufirst%3DD.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520carbonic%2520anhydrase%2520II%2520by%2520steroidal%2520and%2520non-steroidal%2520sulphamates%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D305%26spage%3D909%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Abbate, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winum, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=231-234&author=F.+Abbateauthor=J.-Y.+Winumauthor=B.+V.+L.+Potterauthor=A.+Casiniauthor=J.-L.+Monteroauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors%3A+X-ray+crystallographic+structure+of+the+adduct+of+human+isozyme+II+with+EMATE%2C+a+dual+inhibitor+of+carbonic+anhydrases+and+steroid+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbbate%26aufirst%3DF.%26aulast%3DWinum%26aufirst%3DJ.-Y.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DCasini%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DJ.-L.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors%253A%2520X-ray%2520crystallographic%2520structure%2520of%2520the%2520adduct%2520of%2520human%2520isozyme%2520II%2520with%2520EMATE%252C%2520a%2520dual%2520inhibitor%2520of%2520carbonic%2520anhydrases%2520and%2520steroid%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D231%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Lloyd, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiyagarajan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">6858</span><span class="NLM_x">–</span> <span class="NLM_lpage">6866</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi047692e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=6858-6866&author=M.+D.+Lloydauthor=N.+Thiyagarajanauthor=Y.+T.+Hoauthor=L.+W.+L.+Wooauthor=O.+B.+Sutcliffeauthor=A.+Purohitauthor=M.+J.+Reedauthor=K.+R.+Acharyaauthor=B.+V.+L.+Potter&title=First+crystal+structures+of+human+carbonic+anhydrase+II+in+complex+with+dual+aromatase-steroid+sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fbi047692e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi047692e%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThiyagarajan%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DFirst%2520crystal%2520structures%2520of%2520human%2520carbonic%2520anhydrase%2520II%2520in%2520complex%2520with%2520dual%2520aromatase-steroid%2520sulfatase%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D6858%26epage%3D6866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Muzykantov, V. R.</span><span> </span><span class="NLM_article-title">Drug delivery by red blood cells: vascular carriers designed by mother nature</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1517%2F17425241003610633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=20192900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVehsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=403-427&author=V.+R.+Muzykantov&title=Drug+delivery+by+red+blood+cells%3A+vascular+carriers+designed+by+mother+nature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Drug delivery by red blood cells: vascular carriers designed by mother nature</span></div><div class="casAuthors">Muzykantov, Vladimir R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Delivery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-427</span>CODEN:
                <span class="NLM_cas:coden">EODDAW</span>;
        ISSN:<span class="NLM_cas:issn">1742-5247</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Vascular delivery of several classes of therapeutic agents may benefit from carriage by red blood cells (RBC), for example, drugs that require delivery into phagocytic cells and those that must act within the vascular lumen.  The fact that several protocols of infusion of RBC-encapsulated drugs are now being explored in patients illustrates a high biomedical importance for the field.  Areas covered by this review: Two strategies for RBC drug delivery are discussed: encapsulation into isolated RBC ex vivo followed by infusion in compatible recipients and coupling therapeutics to the surface of RBC.  Studies of pharmacokinetics and effects in animal models and in human studies of diverse therapeutic enzymes, antibiotics and other drugs encapsulated in RBC are described and critically analyzed.  Coupling to RBC surface of compds. regulating immune response and complement, affinity ligands, polyethylene glycol alleviating immune response to donor RBC and fibrinolytic plasminogen activators are described.  Also described is a new, translation-prone approach for RBC drug delivery by injection of therapeutics conjugated with fragments of antibodies providing safe anchoring of cargoes to circulating RBC, without need for ex vivo modification and infusion of RBC.  What the reader will gain: Readers will gain historical perspective, current status, challenges and perspectives of medical applications of RBC for drug delivery.  Take home message: RBC represent naturally designed carriers for intravascular drug delivery, characterized by unique longevity in the bloodstream, biocompatibility and safe physiol. mechanisms for metab.  New approaches for encapsulating drugs into RBC and coupling to RBC surface provide promising avenues for safe and widely useful improvement of drug delivery in the vascular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAV15O4Yn0XLVg90H21EOLACvtfcHk0ljeOGItd34Phw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVehsbk%253D&md5=633c3c5ab2949f6b4e271e6ae51b8d89</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1517%2F17425241003610633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425241003610633%26sid%3Dliteratum%253Aachs%26aulast%3DMuzykantov%26aufirst%3DV.%2BR.%26atitle%3DDrug%2520delivery%2520by%2520red%2520blood%2520cells%253A%2520vascular%2520carriers%2520designed%2520by%2520mother%2520nature%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2010%26volume%3D7%26spage%3D403%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Magnani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, L.</span><span> </span><span class="NLM_article-title">Approaches to erythrocyte-mediated drug delivery</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">687</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=677-687&author=M.+Magnaniauthor=L.+Rossi&title=Approaches+to+erythrocyte-mediated+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMagnani%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DL.%26atitle%3DApproaches%2520to%2520erythrocyte-mediated%2520drug%2520delivery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2014%26volume%3D11%26spage%3D677%26epage%3D687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Hernandez-Guzman, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangborn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Structure of human estrone sulfatase suggests functional roles of membrane association</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">22989</span><span class="NLM_x">–</span> <span class="NLM_lpage">22997</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1074%2Fjbc.M211497200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=12657638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksF2iu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=22989-22997&author=F.+G.+Hernandez-Guzmanauthor=T.+Higashiyamaauthor=W.+Pangbornauthor=Y.+Osawaauthor=D.+Ghosh&title=Structure+of+human+estrone+sulfatase+suggests+functional+roles+of+membrane+association"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Human Estrone Sulfatase Suggests Functional Roles of Membrane Association</span></div><div class="casAuthors">Hernandez-Guzman, Francisco G.; Higashiyama, Tadayoshi; Pangborn, Walter; Osawa, Yoshio; Ghosh, Debashis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">22989-22997</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Estrone sulfatase (ES; 562 amino acids), one of the key enzymes responsible for maintaining high levels of estrogens in breast tumor cells, is assocd. with the membrane of the endoplasmic reticulum (ER).  The structure of ES, purified from the microsomal fraction of human placentas, has been detd. at 2.60-Å resoln. by x-ray crystallog.  This structure shows a domain consisting of two antiparallel α-helixes that protrude from the roughly spherical mol., thereby giving the mol. a "mushroom-like" shape.  These highly hydrophobic helixes, each about 40 Å long, are capable of traversing the membrane, thus presumably anchoring the functional domain on the membrane surface facing the ER lumen.  The location of the transmembrane domain is such that the opening to the active site, buried deep in a cavity of the "gill" of the "mushroom," rests near the membrane surface, thereby suggesting a role of the lipid bilayer in catalysis.  This simple architecture could be a prototype utilized by the ER membrane in dictating the form and the function of ER-resident enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVqhs1xfxlQLVg90H21EOLACvtfcHk0ljeOGItd34Phw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksF2iu7s%253D&md5=b4b56bf8e881dce78adc36bdf0f15e40</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M211497200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M211497200%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Guzman%26aufirst%3DF.%2BG.%26aulast%3DHigashiyama%26aufirst%3DT.%26aulast%3DPangborn%26aufirst%3DW.%26aulast%3DOsawa%26aufirst%3DY.%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DStructure%2520of%2520human%2520estrone%2520sulfatase%2520suggests%2520functional%2520roles%2520of%2520membrane%2520association%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D22989%26epage%3D22997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Human sulfatases: a structural perspective to catalysis</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">2013</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs00018-007-7175-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=17558559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFKhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=2013-2022&author=D.+Ghosh&title=Human+sulfatases%3A+a+structural+perspective+to+catalysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Human sulfatases: A structural perspective to catalysis</span></div><div class="casAuthors">Ghosh, D.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2013-2022</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  The sulfatase family of enzymes catalyzes hydrolysis of sulfate ester bonds of a wide variety of substrates.  Seventeen genes have been identified in this class of sulfatases, many of which are assocd. with genetic disorders leading to redn. or loss of function of the corresponding enzymes.  Amino acid sequence homol. suggests that the enzymes have similar overall folds, mechanisms of action, and divalent metal ion-binding sites.  A catalytic Cys residue, strictly conserved in prokaryotic and eukaryotic sulfatases, is post-translationally modified into formylglycine.  Hydroxylation of the formylglycine residue by a water mol. forming the activated hydroxylformylglycine (a formylglycine hydrate or a gem-diol) is a necessary step for the enzyme's sulfatase activity.  Crystal structures of 3 human sulfatases, arylsulfatases A and B (ARSA and ARSB, resp.), and estrone/dehydroepiandrosterone sulfatase or steroid sulfatase (STS), also known as arylsulfatase C, have been detd.  Whereas ARSA and ARSB are water-sol. enzymes, STS has a hydrophobic domain and is an integral membrane protein of the endoplasmic reticulum.  Here, the author compares and contrasts sulfatase structures and revisits the proposed catalytic mechanism in light of available structural and functional data.  Examn. of the STS active site reveals substrate-specific interactions previously identified as the estrogen-recognition motif.  Because of the proximity of the catalytic cleft of STS to the membrane surface, the lipid bilayer has a crit. role in the constitution of the active site, unlike other sulfatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHkDns4I6I2rVg90H21EOLACvtfcHk0ljXgx4O996ikA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFKhtLw%253D&md5=3b168470ad0870dc2753ca05bb99a385</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1007%2Fs00018-007-7175-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-007-7175-y%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DHuman%2520sulfatases%253A%2520a%2520structural%2520perspective%2520to%2520catalysis%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2007%26volume%3D64%26spage%3D2013%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Williams, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denehy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenske, E. H.</span><span> </span><span class="NLM_article-title">Experimental and theoretical insights into the mechanisms of sulfate and sulfamate ester hydrolysis and the end products of type I sulfatase inactivation by aryl sulfamates</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1995</span><span class="NLM_x">–</span> <span class="NLM_lpage">2005</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo4026513" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivVaqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=1995-2005&author=S.+J.+Williamsauthor=E.+Denehyauthor=E.+H.+Krenske&title=Experimental+and+theoretical+insights+into+the+mechanisms+of+sulfate+and+sulfamate+ester+hydrolysis+and+the+end+products+of+type+I+sulfatase+inactivation+by+aryl+sulfamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and Theoretical Insights into the Mechanisms of Sulfate and Sulfamate Ester Hydrolysis and the End Products of Type I Sulfatase Inactivation by Aryl Sulfamates</span></div><div class="casAuthors">Williams, Spencer J.; Denehy, Emma; Krenske, Elizabeth H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1995-2005</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Type I sulfatases catalyze the hydrolysis of sulfate esters through S-O bond cleavage and possess a catalytically essential formylglycine (FGly) active-site residue that is post-translationally derived from either cysteine or serine.  Type I sulfatases are inactivated by aryl sulfamates in a time-dependent, irreversible, and active-site directed manner consistent with covalent modification of the active site.  We report a theor. (SCS-MP2//B3LYP) and exptl. study of the uncatalyzed and enzyme-catalyzed hydrolysis of aryl sulfates and sulfamates.  In soln., aryl sulfate monoanions undergo hydrolysis by an SN2 mechanism whereas aryl sulfamate monoanions follow an SN1 pathway with SO2NH as an intermediate; theory traces this difference to the markedly greater stability of SO2NH vs. SO3.  For Pseudomonas aeruginosa arylsulfatase-catalyzed aryl sulfate hydrolysis, Bronsted anal. (log(Vmax/KM) vs. leaving group pKa value) reveals βLG = -0.86 ± 0.23, consistent with an SN2 at sulfur reaction but substantially smaller than that reported for uncatalyzed hydrolysis (βLG = -1.81).  Common to all proposed mechanisms of sulfatase catalysis is a sulfated FGly intermediate.  Theory indicates a ≥26 kcal/mol preference for the intermediate to release HSO4- by an E2 mechanism, rather than alk. phosphatase-like SN2 substitution by water.  An evaluation of the stabilities of various proposed end-products of sulfamate-induced sulfatase inactivation highlights that an imine N-sulfate derived from FGly is the most likely irreversible adduct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBv-V2eelI47Vg90H21EOLACvtfcHk0ljXgx4O996ikA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivVaqsrk%253D&md5=79e14584585f54b5a6f656e67506cf14</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjo4026513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo4026513%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BJ.%26aulast%3DDenehy%26aufirst%3DE.%26aulast%3DKrenske%26aufirst%3DE.%2BH.%26atitle%3DExperimental%2520and%2520theoretical%2520insights%2520into%2520the%2520mechanisms%2520of%2520sulfate%2520and%2520sulfamate%2520ester%2520hydrolysis%2520and%2520the%2520end%2520products%2520of%2520type%2520I%2520sulfatase%2520inactivation%2520by%2520aryl%2520sulfamates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D1995%26epage%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Stanway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sufi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigushin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanczyk, F. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobbs, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulinskaya, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Phase 1 study of STX64 (667 Coumate) in breast cancer patients: the first study of a sulfatase inhibitor</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1585</span><span class="NLM_x">–</span> <span class="NLM_lpage">1592</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1158%2F1078-0432.CCR-05-1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=16533785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVGmsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1585-1592&author=S.+J.+Stanwayauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=S.+Sufiauthor=D.+Vigushinauthor=R.+Wardauthor=R.+H.+Wilsonauthor=F.+Z.+Stanczykauthor=N.+Dobbsauthor=E.+Kulinskayaauthor=M.+Elliottauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=R.+C.+Coombes&title=Phase+1+study+of+STX64+%28667+Coumate%29+in+breast+cancer+patients%3A+the+first+study+of+a+sulfatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Study of STX 64 (667 Coumate) in Breast Cancer Patients: the First Study of a Steroid Sulfatase Inhibitor</span></div><div class="casAuthors">Stanway, Susannah J.; Purohit, Atul; Woo, L. W. Lawrence; Sufi, Saulat; Vigushin, David; Ward, Rebecca; Wilson, Richard H.; Stanczyk, Frank Z.; Dobbs, Nicola; Kulinskaya, Elena; Elliott, Moira; Potter, Barry V. L.; Reed, Michael J.; Coombes, R. Charles</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1585-1592</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Inhibition of steroid sulfatase (STS), the enzyme responsible for the hydrolysis of steroid sulfates, represents a potential novel treatment for postmenopausal women with hormone-dependent breast cancer.  Estrone and DHEA are formed by this sulfatase pathway and can be converted to steroids (estradiol and androstenediol, resp.), which have potent estrogenic properties.  Exptl. Design: STX64 (667 Coumate), a tricylic coumarin-based sulfamate that irreversibly inhibits STS activity, was selected for entry into the first phase I trial of a STS inhibitor in postmenopausal women with breast cancer.  STX64 was administered orally (nine patients at 5 mg and five patients at 20 mg) as an initial dose followed 1 wk later by 3 x 2 weekly cycles, with each cycle comprising daily dosing for 5 days followed by 9 days off treatment.  Blood and tumor tissue samples were collected for the assessment of STS activity and serum was obtained for steroid hormone measurements before and after treatment.  Results: The median inhibition of STS activity by STX64 was 98% in peripheral blood lymphocytes (PBL) and 99% in breast tumor tissue at the end of the 5-day dosing period.  As expected, serum concns. of estrone, estradiol, androstenediol, and DHEA all decreased significantly from pretreatment levels.  Unexpectedly, androstenedione and testosterone concns. also decreased.  Four patients, all of whom had previously progressed on aromatase inhibitors, showed evidence of stable disease for 2.75 to 7 mo.  The drug was well tolerated with only minor drug-related adverse events recorded.  Conclusion: STX64 is a potent, well-tolerated STS inhibitor.  It inhibits STS activity in PBLs and tumor tissues and causes significant decreases in serum concns. of steroids with estrogenic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvfOgizqc5GLVg90H21EOLACvtfcHk0ljXgx4O996ikA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVGmsL0%253D&md5=91b2349eac6d0b3f27073e7b894b7b6d</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-1996%26sid%3Dliteratum%253Aachs%26aulast%3DStanway%26aufirst%3DS.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSufi%26aufirst%3DS.%26aulast%3DVigushin%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DR.%2BH.%26aulast%3DStanczyk%26aufirst%3DF.%2BZ.%26aulast%3DDobbs%26aufirst%3DN.%26aulast%3DKulinskaya%26aufirst%3DE.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DPhase%25201%2520study%2520of%2520STX64%2520%2528667%2520Coumate%2529%2520in%2520breast%2520cancer%2520patients%253A%2520the%2520first%2520study%2520of%2520a%2520sulfatase%2520inhibitor%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D1585%26epage%3D1592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Stanway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delavault, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurieau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Steroid sulfatase: a new target for the endocrine therapy of breast cancer</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=370-374&author=S.+J.+Stanwayauthor=P.+Delavaultauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=C.+Thurieauauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Steroid+sulfatase%3A+a+new+target+for+the+endocrine+therapy+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStanway%26aufirst%3DS.%2BJ.%26aulast%3DDelavault%26aufirst%3DP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DThurieau%26aufirst%3DC.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DSteroid%2520sulfatase%253A%2520a%2520new%2520target%2520for%2520the%2520endocrine%2520therapy%2520of%2520breast%2520cancer%26jtitle%3DOncologist%26date%3D2007%26volume%3D12%26spage%3D370%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Coombes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soulié, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardoso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besse-Hammer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesimple, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slosman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fohanno, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumoleau, P.</span><span> </span><span class="NLM_article-title">A phase I dose escalation study of sulfatase inhibitor BN83495/STX64 in postmenopausal women with ER positive breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">24 Suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">4097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=4097&issue=24+Suppl&author=R.+Coombesauthor=P.+Schmidauthor=N.+Isambertauthor=P.+Souli%C3%A9author=F.+Cardosoauthor=T.+Besse-Hammerauthor=T.+Lesimpleauthor=D.+Slosmanauthor=A.+Kornowskiauthor=V.+Fohannoauthor=P.+Fumoleau&title=A+phase+I+dose+escalation+study+of+sulfatase+inhibitor+BN83495%2FSTX64+in+postmenopausal+women+with+ER+positive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoombes%26aufirst%3DR.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DSouli%25C3%25A9%26aufirst%3DP.%26aulast%3DCardoso%26aufirst%3DF.%26aulast%3DBesse-Hammer%26aufirst%3DT.%26aulast%3DLesimple%26aufirst%3DT.%26aulast%3DSlosman%26aufirst%3DD.%26aulast%3DKornowski%26aufirst%3DA.%26aulast%3DFohanno%26aufirst%3DV.%26aulast%3DFumoleau%26aufirst%3DP.%26atitle%3DA%2520phase%2520I%2520dose%2520escalation%2520study%2520of%2520sulfatase%2520inhibitor%2520BN83495%252FSTX64%2520in%2520postmenopausal%2520women%2520with%2520ER%2520positive%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26issue%3D24%2520Suppl%26spage%3D4097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardoso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesimple, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soulié, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peraire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fohanno, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, P.</span><span> </span><span class="NLM_article-title">A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-013-2597-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFaju7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2013&pages=73-82&author=R.+C.+Coombesauthor=F.+Cardosoauthor=N.+Isambertauthor=T.+Lesimpleauthor=P.+Souli%C3%A9author=C.+Peraireauthor=V.+Fohannoauthor=A.+Kornowskiauthor=T.+Aliauthor=P.+Schmid&title=A+phase+I+dose+escalation+study+to+determine+the+optimal+biological+dose+of+irosustat%2C+an+oral+sulfatase+inhibitor%2C+in+postmenopausal+women+with+estrogen+receptor-positive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer</span></div><div class="casAuthors">Coombes, R. Charles; Cardoso, Fatima; Isambert, Nicolas; Lesimple, Thierry; Soulie, Patrick; Peraire, Concepcion; Fohanno, Veronique; Kornowski, Anne; Ali, Tauhid; Schmid, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-82</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Steroid sulfatase (STS) inhibition may have a therapeutic role in suppression of endocrine-responsive breast cancer.  This study aimed to det. the optimal biol. dose and recommended dose (RD) of the STS inhibitor irosustat.  A three-part, open-label, multicenter, dose escalation study of irosustat in estrogen receptor-pos. breast cancer patients involved administration of a single dose of irosustat with a 7-day observation period; followed by a daily oral dose of irosustat for 28 days; and an extension phase, in which the daily oral dose of irosustat was continued at the discretion of the investigator and as long as the patient was benefitting from the treatment.  Five doses of irosustat were tested (1, 5, 20, 40, and 80 mg) in 50 patients.  After 28 days of daily administration of irosustat, all the evaluated patients in the 5, 20, 40, and 80 mg cohorts achieved ≥95 % STS inhibition in peripheral blood mononuclear cells and corresponding endocrine suppression.  The max. tolerated dose was not reached, and the 40 mg dose was established as the RD.  The median time to disease progression in the 40 mg cohort was 11.2 wk.  Disease stabilization was achieved in 10 % of patients potentially indicative of drug activity.  Dry skin was the most frequent adverse event.  The RD of irosustat is 40 mg.  Disease stabilization occurred in 10 % of this heavily pretreated patient population.  A larger study is required to define an accurate response rate to irosustat as a single agent and whether co-administration with an aromatase inhibitor is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplaN4ktLK9tLVg90H21EOLACvtfcHk0liwdLg1t8MMfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFaju7bM&md5=4b6801e630587f1cbbe1767330602781</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1007%2Fs10549-013-2597-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-013-2597-8%26sid%3Dliteratum%253Aachs%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DCardoso%26aufirst%3DF.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DLesimple%26aufirst%3DT.%26aulast%3DSouli%25C3%25A9%26aufirst%3DP.%26aulast%3DPeraire%26aufirst%3DC.%26aulast%3DFohanno%26aufirst%3DV.%26aulast%3DKornowski%26aufirst%3DA.%26aulast%3DAli%26aufirst%3DT.%26aulast%3DSchmid%26aufirst%3DP.%26atitle%3DA%2520phase%2520I%2520dose%2520escalation%2520study%2520to%2520determine%2520the%2520optimal%2520biological%2520dose%2520of%2520irosustat%252C%2520an%2520oral%2520sulfatase%2520inhibitor%252C%2520in%2520postmenopausal%2520women%2520with%2520estrogen%2520receptor-positive%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2013%26volume%3D140%26spage%3D73%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Parra-Guillen, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendrós Carreras, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peraire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prunynosa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chetaille, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trocóniz, I. F.</span><span> </span><span class="NLM_article-title">Population pharmacokinetic modelling of Irosustat in postmenopausal women with oestrogen-receptor positive breast cancer incorporating non-linear red blood cell uptake</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=1493-1504&author=Z.+P.+Parra-Guillenauthor=J.+P.+Cendr%C3%B3s+Carrerasauthor=C.+Peraireauthor=R.+Obachauthor=J.+Prunynosaauthor=E.+Chetailleauthor=I.+F.+Troc%C3%B3niz&title=Population+pharmacokinetic+modelling+of+Irosustat+in+postmenopausal+women+with+oestrogen-receptor+positive+breast+cancer+incorporating+non-linear+red+blood+cell+uptake"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParra-Guillen%26aufirst%3DZ.%2BP.%26aulast%3DCendr%25C3%25B3s%2BCarreras%26aufirst%3DJ.%2BP.%26aulast%3DPeraire%26aufirst%3DC.%26aulast%3DObach%26aufirst%3DR.%26aulast%3DPrunynosa%26aufirst%3DJ.%26aulast%3DChetaille%26aufirst%3DE.%26aulast%3DTroc%25C3%25B3niz%26aufirst%3DI.%2BF.%26atitle%3DPopulation%2520pharmacokinetic%2520modelling%2520of%2520Irosustat%2520in%2520postmenopausal%2520women%2520with%2520oestrogen-receptor%2520positive%2520breast%2520cancer%2520incorporating%2520non-linear%2520red%2520blood%2520cell%2520uptake%26jtitle%3DPharm.%2520Res.%26date%3D2015%26volume%3D32%26spage%3D1493%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Palmieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Januszewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1586%2Fera.10.201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=21342037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=179-183&author=C.+Palmieriauthor=A.+Januszewskiauthor=S.+Stanwayauthor=R.+C.+Coombes&title=Irosustat%3A+a+first-generation+steroid+sulfatase+inhibitor+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer</span></div><div class="casAuthors">Palmieri, Carlo; Januszewski, Adam; Stanway, Susie; Coombes, R. Charles</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-183</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Endocrine therapy is a key modality in the management of breast cancer, with current options for postmenopausal women including tamoxifen, aromatase inhibitors and fulvestrant.  Unfortunately, in spite of these advances, many women still relapse or progress on endocrine therapy.  Given that resistance (de novo or acquired resistance) is a major limiting factor in the use of endocrine therapy, addnl. endocrine therapies with novel methods of action are required.  Steroid sulfatase, which is responsible for the conversion of estrone sulfate to estrone, as well as dehydroepiandrosterone sulfate to dehydroepiandrosterone, has been implicated in endocrine resistance.  In this article, we summarize the preclin. and clin. data to support the potential role of steroid sulfatase in breast cancer, as well as the current data on the first available steroid sulfatase inhibitor named irosustat (STX64; 667 Coumate; BN83495), and discuss its potential clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYCPF6U304B7Vg90H21EOLACvtfcHk0liwdLg1t8MMfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWmsbo%253D&md5=3b2a6700bcc25c57653431b7b65720a1</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1586%2Fera.10.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.10.201%26sid%3Dliteratum%253Aachs%26aulast%3DPalmieri%26aufirst%3DC.%26aulast%3DJanuszewski%26aufirst%3DA.%26aulast%3DStanway%26aufirst%3DS.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DIrosustat%253A%2520a%2520first-generation%2520steroid%2520sulfatase%2520inhibitor%2520in%2520breast%2520cancer%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2011%26volume%3D11%26spage%3D179%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Pautier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joly Lobbedez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melichar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutarska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, N.</span><span> </span><span class="NLM_article-title">A phase II multicenter randomized open-label study of oral sulfatase (sulfatase) inhibitor Irosustat (BN83495) versus megestrol acetate (MA) in women with advanced/recurrent endometrial cancer (EC)</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 9</span><span class="NLM_x">) </span> <span class="NLM_fpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=329&issue=Suppl+9&author=P.+Pautierauthor=F.+Joly+Lobbedezauthor=B.+Melicharauthor=E.+Kutarskaauthor=G.+Hallauthor=N.+Reed&title=A+phase+II+multicenter+randomized+open-label+study+of+oral+sulfatase+%28sulfatase%29+inhibitor+Irosustat+%28BN83495%29+versus+megestrol+acetate+%28MA%29+in+women+with+advanced%2Frecurrent+endometrial+cancer+%28EC%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPautier%26aufirst%3DP.%26aulast%3DJoly%2BLobbedez%26aufirst%3DF.%26aulast%3DMelichar%26aufirst%3DB.%26aulast%3DKutarska%26aufirst%3DE.%26aulast%3DHall%26aufirst%3DG.%26aulast%3DReed%26aufirst%3DN.%26atitle%3DA%2520phase%2520II%2520multicenter%2520randomized%2520open-label%2520study%2520of%2520oral%2520sulfatase%2520%2528sulfatase%2529%2520inhibitor%2520Irosustat%2520%2528BN83495%2529%2520versus%2520megestrol%2520acetate%2520%2528MA%2529%2520in%2520women%2520with%2520advanced%252Frecurrent%2520endometrial%2520cancer%2520%2528EC%2529%26jtitle%3DAnn.%2520Oncol.%26date%3D2012%26volume%3D23%26issue%3DSuppl%25209%26spage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutill, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1155</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1155&publication_year=2009&pages=80-87&author=J.+M.+Dayauthor=A.+Purohitauthor=H.+J.+Tutillauthor=P.+A.+Fosterauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+development+of+steroid+sulfatase+inhibitors+for+hormone-dependent+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DTutill%26aufirst%3DH.%2BJ.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520development%2520of%2520steroid%2520sulfatase%2520inhibitors%2520for%2520hormone-dependent%2520cancer%2520therapy%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2009%26volume%3D1155%26spage%3D80%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Arakawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagihara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizokami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namiki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, I.</span><span> </span><span class="NLM_article-title">Enhanced expression of organic anion transporting polypeptides (OATPs) in androgen receptor-positive prostate cancer cells: possible role of OATP1A2 in adaptive cell growth under androgen-depleted conditions</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1070</span><span class="NLM_x">–</span> <span class="NLM_lpage">1077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=1070-1077&author=H.+Arakawaauthor=T.+Nakanishiauthor=C.+Yanagiharaauthor=T.+Nishimotoauthor=T.+Wakayamaauthor=A.+Mizokamiauthor=M.+Namikiauthor=K.+Kawaiauthor=I.+Tamai&title=Enhanced+expression+of+organic+anion+transporting+polypeptides+%28OATPs%29+in+androgen+receptor-positive+prostate+cancer+cells%3A+possible+role+of+OATP1A2+in+adaptive+cell+growth+under+androgen-depleted+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArakawa%26aufirst%3DH.%26aulast%3DNakanishi%26aufirst%3DT.%26aulast%3DYanagihara%26aufirst%3DC.%26aulast%3DNishimoto%26aufirst%3DT.%26aulast%3DWakayama%26aufirst%3DT.%26aulast%3DMizokami%26aufirst%3DA.%26aulast%3DNamiki%26aufirst%3DM.%26aulast%3DKawai%26aufirst%3DK.%26aulast%3DTamai%26aufirst%3DI.%26atitle%3DEnhanced%2520expression%2520of%2520organic%2520anion%2520transporting%2520polypeptides%2520%2528OATPs%2529%2520in%2520androgen%2520receptor-positive%2520prostate%2520cancer%2520cells%253A%2520possible%2520role%2520of%2520OATP1A2%2520in%2520adaptive%2520cell%2520growth%2520under%2520androgen-depleted%2520conditions%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D1070%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Denmeade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peraire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geniaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baton, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chetaille, E.</span><span> </span><span class="NLM_article-title">A phase I pharmacodynamics dose escalation study of steroid sulphatase inhibitor Irosustat in patients with prostate cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">S499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=S499&author=S.+Denmeadeauthor=D.+Georgeauthor=G.+Liuauthor=C.+Peraireauthor=A.+Geniauxauthor=F.+Batonauthor=T.+Aliauthor=E.+Chetaille&title=A+phase+I+pharmacodynamics+dose+escalation+study+of+steroid+sulphatase+inhibitor+Irosustat+in+patients+with+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDenmeade%26aufirst%3DS.%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DPeraire%26aufirst%3DC.%26aulast%3DGeniaux%26aufirst%3DA.%26aulast%3DBaton%26aufirst%3DF.%26aulast%3DAli%26aufirst%3DT.%26aulast%3DChetaille%26aufirst%3DE.%26atitle%3DA%2520phase%2520I%2520pharmacodynamics%2520dose%2520escalation%2520study%2520of%2520steroid%2520sulphatase%2520inhibitor%2520Irosustat%2520in%2520patients%2520with%2520prostate%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2011%26volume%3D47%26spage%3DS499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span> </span><span class="NLM_article-title">A study looking at irosustat for early breast cancer (IPET)</span>; <span class="NLM_publisher-name">Cancer Research UK</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span><a href="http://www.cancerresearchuk.org/about-cancer/trials/a-study-looking-irosustat-early-breast-cancer" class="extLink">http://www.cancerresearchuk.org/about-cancer/trials/a-study-looking-irosustat-early-breast-cancer</a> (accessed May 13, 2015.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+study+looking+at+irosustat+for+early+breast+cancer+%28IPET%29%3B+Cancer+Research+UK%3A+London%2C+2014%3B+http%3A%2F%2Fwww.cancerresearchuk.org%2Fabout-cancer%2Ftrials%2Fa-study-looking-irosustat-early-breast-cancer+%28accessed+May+13%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520study%2520looking%2520at%2520irosustat%2520for%2520early%2520breast%2520cancer%2520%2528IPET%2529%26pub%3DCancer%2520Research%2520UK%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span> </span><span class="NLM_article-title">A Phase II study to assess the safety and efficacy of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER positive locally advanced or metastatic breast cancer patients</span>; <span class="NLM_publisher-name">UK Clinical Research Network</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span><a href="http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=12479" class="extLink">http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=12479</a> (accessed May 13, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase+II+study+to+assess+the+safety+and+efficacy+of+the+steroid+sulfatase+inhibitor+Irosustat+when+added+to+an+aromatase+inhibitor+in+ER+positive+locally+advanced+or+metastatic+breast+cancer+patients%3B+UK+Clinical+Research+Network%3A+London%2C+2014%3B+http%3A%2F%2Fpublic.ukcrn.org.uk%2FSearch%2FStudyDetail.aspx%3FStudyID%3D12479+%28accessed+May+13%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Phase%2520II%2520study%2520to%2520assess%2520the%2520safety%2520and%2520efficacy%2520of%2520the%2520steroid%2520sulfatase%2520inhibitor%2520Irosustat%2520when%2520added%2520to%2520an%2520aromatase%2520inhibitor%2520in%2520ER%2520positive%2520locally%2520advanced%2520or%2520metastatic%2520breast%2520cancer%2520patients%26pub%3DUK%2520Clinical%2520Research%2520Network%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span> </span><span class="NLM_article-title">A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth (IPET)</span>. ClinicalTrials.gov; <span class="NLM_publisher-name">U.S. National Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span><a href="http://clinicaltrials.gov/show/NCT01662726" class="extLink">http://clinicaltrials.gov/show/NCT01662726</a> (accessed May 13, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study+to+Assess+the+Ability+of+a+Novel+Endocrine+Treatment+for+Breast+Cancer%2C+Irosustat%2C+to+Slow+Down+Cancer+Growth+%28IPET%29.+ClinicalTrials.gov%3B+U.S.+National+Institutes+of+Health%3A+Bethesda%2C+MD%2C+2014%3B+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01662726+%28accessed+May+13%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Study%2520to%2520Assess%2520the%2520Ability%2520of%2520a%2520Novel%2520Endocrine%2520Treatment%2520for%2520Breast%2520Cancer%252C%2520Irosustat%252C%2520to%2520Slow%2520Down%2520Cancer%2520Growth%2520%2528IPET%2529%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%2520Institutes%2520of%2520Health%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brosens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy</span> <span class="citation_source-journal">Hum. Reprod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1093%2Fhumrep%2Fdem308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18056119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlCktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=290-297&author=A.+Purohitauthor=L.+Fusiauthor=J.+Brosensauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+steroid+sulphatase+activity+in+endometriotic+implants+by+667+COUMATE%3A+a+potential+new+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy</span></div><div class="casAuthors">Purohit, A.; Fusi, L.; Brosens, J.; Woo, L. W. L.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Human Reproduction</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">290-297</span>CODEN:
                <span class="NLM_cas:coden">HUREEE</span>;
        ISSN:<span class="NLM_cas:issn">0268-1161</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Local biosynthesis of estrogens is thought to be important for the maintenance and growth of endometriotic implants.  In addn. to the formation of estrogen via the aromatase pathway, steroid sulfatase (STS), which is responsible for the hydrolysis of estrogen sulfates, may be an important source of estrogens in endometriosis.  Eutopic and ectopic endometrial samples from 14 women with minimal or mild (MM) endometriosis and from 13 women with moderate to severe (MS) endometriosis were analyzed for aromatase and STS activities.  Aromatase and STS activity were detected in all samples.  STS enzyme activity in both eutopic and ectopic endometrium was considerably higher and less variable than aromatase activity.  Moreover, STS, but not aromatase, activity in endometriotic implants correlated with the severity of the disease (mean ± SEM: 203 ± 38 nmol/4 h/g wet wt. tissue in MM disease vs. 423 ± 44 nmol/4 h/g wet wt. tissue in MS endometriosis, P < 0.001).  The STS inhibitor 667 COUMATE almost completely blocked STS activity (>99%) in both eutopic and ectopic tissues.  The high levels of STS activity detected in ectopic endometrium and the correlation with severity of disease suggest that STS inhibitors could be useful for the treatment of endometriosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplM0Dp3IYesrVg90H21EOLACvtfcHk0lil9tdLVXNq0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlCktw%253D%253D&md5=fd05b2ab67086d147ba78aa5712ebc93</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1093%2Fhumrep%2Fdem308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhumrep%252Fdem308%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DFusi%26aufirst%3DL.%26aulast%3DBrosens%26aufirst%3DJ.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520steroid%2520sulphatase%2520activity%2520in%2520endometriotic%2520implants%2520by%2520667%2520COUMATE%253A%2520a%2520potential%2520new%2520therapy%26jtitle%3DHum.%2520Reprod.%26date%3D2008%26volume%3D23%26spage%3D290%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Fusi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brosens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of sulfatase activity in endometriotic implants by STX64 (667Coumate): a potential new therapy</span> <span class="citation_source-journal">Sci. World J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1325</span><span class="NLM_x">–</span> <span class="NLM_lpage">1327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1100%2Ftsw.2008.164" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1325-1327&author=L.+Fusiauthor=A.+Purohitauthor=J.+Brosensauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+sulfatase+activity+in+endometriotic+implants+by+STX64+%28667Coumate%29%3A+a+potential+new+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1100%2Ftsw.2008.164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1100%252Ftsw.2008.164%26sid%3Dliteratum%253Aachs%26aulast%3DFusi%26aufirst%3DL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DBrosens%26aufirst%3DJ.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520sulfatase%2520activity%2520in%2520endometriotic%2520implants%2520by%2520STX64%2520%2528667Coumate%2529%253A%2520a%2520potential%2520new%2520therapy%26jtitle%3DSci.%2520World%2520J.%26date%3D2008%26volume%3D8%26spage%3D1325%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Colette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defrère, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lousse, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Langendonckt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotteland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loumaye, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnez, J.</span><span> </span><span class="NLM_article-title">Inhibition of sulfatase decreases endometriosis in an in vivo murine model</span> <span class="citation_source-journal">Hum. Reprod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1362</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1093%2Fhumrep%2Fder079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=21441545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXms1ajurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=1362-1370&author=S.+Coletteauthor=S.+Defr%C3%A8reauthor=J.+C.+Lousseauthor=A.+Van+Langendoncktauthor=J.+P.+Gottelandauthor=E.+Loumayeauthor=J.+Donnez&title=Inhibition+of+sulfatase+decreases+endometriosis+in+an+in+vivo+murine+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model</span></div><div class="casAuthors">Colette, S.; Defrere, S.; Lousse, J. C.; Van Langendonckt, A.; Gotteland, J. P.; Loumaye, E.; Donnez, J.</div><div class="citationInfo"><span class="NLM_cas:title">Human Reproduction</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1362-1370</span>CODEN:
                <span class="NLM_cas:coden">HUREEE</span>;
        ISSN:<span class="NLM_cas:issn">0268-1161</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">BACKGROUND: Steroid sulfatase (STS) is involved in estrogen biosynthesis and expressed in eutopic and ectopic endometrium of disease-free and endometriosis patients.  The present study was designed to investigate its role in endometriosis development.  METHODS: Human endometrial explants were cultured on inserts for 24 h to assess the effectiveness of an STS inhibitor (STS-I), estradiol-3-O-sulfamate (E2MATE), on STS activity in endometrial tissue.  Endometriosis was induced in mice, and E2MATE (or vehicle alone) was given orally for 21 days.  Plasma estradiol levels were measured, and STS activity was assessed in murine organs (uterus, liver and leukocytes) and in lesions.  Lesion no., wt. and size (morphometry) were quantified.  Lesion STS and progesterone receptor (PR) expression, proliferation and apoptosis rates were detd. by immunohistochem.  RESULTS: In vitro, addn. of 1 μM E2MATE to the culture medium resulted in decreased STS activity in endometrial explants (P < 0.001).  Treatment of mice with E2MATE (1.0 and 0.5 mg/kg) did not modify plasma estradiol levels, but inhibited STS activity in murine uterus (P < 0.05), liver (P < 0.001) and leukocytes (P < 0.001), as well as in induced lesions (P < 0.05).  E2MATE reduced lesion wt. (P < 0.01) and size (P < 0.05), but had no impact on proliferation or apoptosis rates, nor STS protein expression.  Stromal edema was obsd. in the uterus of animals treated with E2MATE, but not in the stroma of lesions.  Increased PR expression was detected in endometriotic lesions (P < 0.001).  CONCLUSIONS: E2MATE was shown to effectively inhibit STS activity in endometrial tissue in vitro.  In vivo, E2MATE decreased endometriosis development without affecting systemic estradiol levels.  Use of STS-I could therefore be of potential interest in endometriosis treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLmhBqovWAmrVg90H21EOLACvtfcHk0lil9tdLVXNq0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXms1ajurw%253D&md5=262fa9b61e1111779d80875c39bf5597</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1093%2Fhumrep%2Fder079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhumrep%252Fder079%26sid%3Dliteratum%253Aachs%26aulast%3DColette%26aufirst%3DS.%26aulast%3DDefr%25C3%25A8re%26aufirst%3DS.%26aulast%3DLousse%26aufirst%3DJ.%2BC.%26aulast%3DVan%2BLangendonckt%26aufirst%3DA.%26aulast%3DGotteland%26aufirst%3DJ.%2BP.%26aulast%3DLoumaye%26aufirst%3DE.%26aulast%3DDonnez%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520sulfatase%2520decreases%2520endometriosis%2520in%2520an%2520in%2520vivo%2520murine%2520model%26jtitle%3DHum.%2520Reprod.%26date%3D2011%26volume%3D26%26spage%3D1362%26epage%3D1370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Pohl, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bestel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotteland, J.-P.</span><span> </span><span class="NLM_article-title">Synergistic effects of E2MATE and norethindrone acetate on sulfatase inhibition: a randomized phase I proof-of-principle clinical study in women of reproductive age</span> <span class="citation_source-journal">Reprod. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1177%2F1933719114522526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=24604234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFSktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1256-1265&author=O.+Pohlauthor=E.+Bestelauthor=J.-P.+Gotteland&title=Synergistic+effects+of+E2MATE+and+norethindrone+acetate+on+sulfatase+inhibition%3A+a+randomized+phase+I+proof-of-principle+clinical+study+in+women+of+reproductive+age"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic effects of E2MATE and norethindrone acetate on steroid sulfatase inhibition: a randomized phase I proof-of-principle clinical study in women of reproductive age</span></div><div class="casAuthors">Pohl, Oliver; Bestel, Elke; Gotteland, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Reproductive Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1256-1265</span>CODEN:
                <span class="NLM_cas:coden">RSECC3</span>;
        ISSN:<span class="NLM_cas:issn">1933-7191</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The combination of a progestin such as norethindrone acetate (NETA) reducing the ovarian estrogen prodn. with a steroid sulfatase (STS) inhibitor (STS-I) decreasing the local estrogen prodn. could result in a new treatment option for endometriosis.  The study reported was a randomized, double-blind, and placebo-controlled study to investigate the pharmacodynamics, pharmacokinetics, and safety of the STS-I PGL2001 (E2MATE) and NETA.  A total of 24 healthy women of reproductive age were treated with weekly doses of PGL2001 or daily doses of NETA or a combination of both compds. for 4 wk.  Four weeks of treatment with PGL2001 or PGL2001 + NETA reduced the STS activity in the endometrium by 91% (±3%) and 96% (±4%), resp., and comparable values were obsd. 1 mo after the treatment was stopped.  The combined treatment of PGL2001 + NETA led to significantly higher STS inhibition at both times (P <.01 and P <.05, resp.).  This study showed that administration of PGL2001 alone at 4 mg/wk or combined with NETA to healthy women of reproductive age led to STS inhibition and changes in functional STS biomarkers in the endometrium, resulting in synergistic effects of PGL2001 and NETA on STS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHYeBYODu8OLVg90H21EOLACvtfcHk0lgbmO7yms5nvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFSktLk%253D&md5=e0733541e657ca968b16a806d100ad9e</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1177%2F1933719114522526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1933719114522526%26sid%3Dliteratum%253Aachs%26aulast%3DPohl%26aufirst%3DO.%26aulast%3DBestel%26aufirst%3DE.%26aulast%3DGotteland%26aufirst%3DJ.-P.%26atitle%3DSynergistic%2520effects%2520of%2520E2MATE%2520and%2520norethindrone%2520acetate%2520on%2520sulfatase%2520inhibition%253A%2520a%2520randomized%2520phase%2520I%2520proof-of-principle%2520clinical%2520study%2520in%2520women%2520of%2520reproductive%2520age%26jtitle%3DReprod.%2520Sci.%26date%3D2014%26volume%3D21%26spage%3D1256%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span> </span><span class="NLM_article-title">PGL2001 Proof of Concept Study in Symptomatic Endometriosis (AMBER)</span>. ClinicalTrials.gov; <span class="NLM_publisher-name">U.S. National Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span><a href="https://clinicaltrials.gov/ct2/show/NCT01631981" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01631981</a> (accessed May 13, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PGL2001+Proof+of+Concept+Study+in+Symptomatic+Endometriosis+%28AMBER%29.+ClinicalTrials.gov%3B+U.S.+National+Institutes+of+Health%3A+Bethesda%2C+MD%2C+2014%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01631981+%28accessed+May+13%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DPGL2001%2520Proof%2520of%2520Concept%2520Study%2520in%2520Symptomatic%2520Endometriosis%2520%2528AMBER%2529%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%2520Institutes%2520of%2520Health%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Ventura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solà, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peraire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R.</span><span> </span><span class="NLM_article-title">In vitro metabolism of Irosustat, a novel sulfatase inhibitor: interspecies comparison, metabolite identification, and metabolic enzyme identification</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1235-1246&author=V.+Venturaauthor=J.+Sol%C3%A0author=C.+Celmaauthor=C.+Peraireauthor=R.+Obach&title=In+vitro+metabolism+of+Irosustat%2C+a+novel+sulfatase+inhibitor%3A+interspecies+comparison%2C+metabolite+identification%2C+and+metabolic+enzyme+identification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVentura%26aufirst%3DV.%26aulast%3DSol%25C3%25A0%26aufirst%3DJ.%26aulast%3DCelma%26aufirst%3DC.%26aulast%3DPeraire%26aufirst%3DC.%26aulast%3DObach%26aufirst%3DR.%26atitle%3DIn%2520vitro%2520metabolism%2520of%2520Irosustat%252C%2520a%2520novel%2520sulfatase%2520inhibitor%253A%2520interspecies%2520comparison%252C%2520metabolite%2520identification%252C%2520and%2520metabolic%2520enzyme%2520identification%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1235%26epage%3D1246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Ventura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solà, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peraire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brée, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R.</span><span> </span><span class="NLM_article-title">In vitro evaluation of the interaction potential of Irosustat with drug-metabolizing enzymes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1268</span><span class="NLM_x">–</span> <span class="NLM_lpage">1278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1268-1278&author=V.+Venturaauthor=J.+Sol%C3%A0author=C.+Peraireauthor=F.+Br%C3%A9eauthor=R.+Obach&title=In+vitro+evaluation+of+the+interaction+potential+of+Irosustat+with+drug-metabolizing+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVentura%26aufirst%3DV.%26aulast%3DSol%25C3%25A0%26aufirst%3DJ.%26aulast%3DPeraire%26aufirst%3DC.%26aulast%3DBr%25C3%25A9e%26aufirst%3DF.%26aulast%3DObach%26aufirst%3DR.%26atitle%3DIn%2520vitro%2520evaluation%2520of%2520the%2520interaction%2520potential%2520of%2520Irosustat%2520with%2520drug-metabolizing%2520enzymes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1268%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M. F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhalli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1524</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18630506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1WktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=1517-1524&author=A.+Purohitauthor=S.+K.+Chanderauthor=L.+W.+L.+Wooauthor=M.+F.+C.+Parsonsauthor=R.+Jhalliauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+steroid+sulphatase+activity+via+the+percutaneous+route%3A+a+new+option+for+breast+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy</span></div><div class="casAuthors">Purohit, A.; Chander, S. K.; Woo, L. W. L.; Parsons, M. F. C.; Jhalli, R.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3A</span>),
    <span class="NLM_cas:pages">1517-1524</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Steroid sulphatase (STS) inhibitors have been developed primarily for the treatment of hormone-dependent breast cancer, but may also have utility for the treatment of a no. of androgen-dependent skin conditions.  STS regulates the hydrolysis of steroid sulfates, such as oestrone sulfate (E1S) and dehydroepiandrosterone sulfate, (DHEAS).  Liberated oestrone (E1) can be converted to biol. active oestradiol (E2) while dehydroepiandrosterone (DHEA) can undergo redn. to testosterone or aromatisation to E1.  In this study the ability of the STS inhibitor STX64 (BN83495) and its N,N-di-Me analog (STX289) to inhibit liver and skin STS when applied orally or topically to nude mice was examd.  Oral administration at 1 and 10 mg/kg resulted in almost complete inhibition of skin and liver STS.  When applied topically to the dorsal neck region at 1.0 and 10 mg/kg not only skin but, unexpectedly, also liver STS was effectively inhibited.  An investigation into the metab. of these two compds. by HepG2 liver carcinoma cells, with high-performance liq. chromatog. (HPLC) anal., was also undertaken.  In the presence of HepG2 cells a similar degree of desulphamoylation of STX64 (68%) or de-N,N-dimethylsulphamoylation of STX289 (66%) occurred over a 3h period.  In the absence of cells, however, STX289 was resistant to de-N, N-dimethylsulphamoylation whereas STX64 was completely desulphamoylated, demonstrating the more favorable pharmaceutical profile of STX289 for development for topical application.  It is concluded that both STX64 and STX289 are not only effective inhibitors of skin STS, but also liver STS when applied topically.  These findings suggest that it may be possible to develop a formulation for the percutaneous administration of STS inhibitors, but also that this class of compd. may have therapeutic potential for the treatment of a no. of skin disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqqLaVWqV4rbVg90H21EOLACvtfcHk0lgbmO7yms5nvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1WktLw%253D&md5=37668757178eeed716b0e87b03b6ae34</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DParsons%26aufirst%3DM.%2BF.%2BC.%26aulast%3DJhalli%26aufirst%3DR.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520steroid%2520sulphatase%2520activity%2520via%2520the%2520percutaneous%2520route%253A%2520a%2520new%2520option%2520for%2520breast%2520cancer%2520therapy%26jtitle%3DAnticancer%2520Res.%26date%3D2008%26volume%3D28%26spage%3D1517%26epage%3D1524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroid sulphatase inhibitors for the topical treatment of skin disorders</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1358%2Fdof.2008.033.07.1212711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGitr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=597-606&author=M.+J.+Reedauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potter&title=Steroid+sulphatase+inhibitors+for+the+topical+treatment+of+skin+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid sulfatase inhibitors for the topical treatment of skin disorders</span></div><div class="casAuthors">Reed, M. J.; Purohit, A.; Woo, L. W. L.; Potter, B. V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Inhibition of steroid sulfatase (STS) activity in skin is a potential new treatment strategy for a no. of skin disorders, including hirsutism, androgen-dependent alopecia, acne and psoriasis.  In skin and its appendages, STS regulates the hydrolysis of dehydroepiandrosterone sulfate to dehydroepiandrosterone, a weak androgen, which can be converted to the biol. active androgens testosterone and 5α-dihydrotestosterone by other steroidogenic enzymes also present in skin.  A no. of potent, irreversible STS inhibitors have been developed based around a core arylsulfamate ester motif, the active pharmacophore required for potent STS inhibition.  Such inhibitors include AHBS and STX-64.  Topical application of AHBS to the skin of mice or pigs resulted in almost complete inhibition of skin STS activity.  Furthermore, when applied to the skin of Gottingen minipigs daily for 2 wk, by day 10 AHBS had inhibited sebum prodn., a desired requisite for an antiacne drug.  When applied topically to the skin of nude mice at 1.0 and 10.0 mg/kg STX-64 inhibited skin STS activity by > 90%, but it also inhibited liver STS activity.  While preclin. studies have confirmed the ability of topically applied STS inhibitors to inhibit skin STS activity, further studies using preclin. models of skin disorders and clin. trials are needed to test their efficacy in treating skin disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf5TH1qamjiLVg90H21EOLACvtfcHk0lgTfw9Q2Z_rlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGitr3F&md5=6fe9bdae8ddd0d3bded5265a4851d061</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1358%2Fdof.2008.033.07.1212711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2008.033.07.1212711%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroid%2520sulphatase%2520inhibitors%2520for%2520the%2520topical%2520treatment%2520of%2520skin%2520disorders%26jtitle%3DDrugs%2520Future%26date%3D2008%26volume%3D33%26spage%3D597%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Suitters, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wales, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodmer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulkes, R.</span><span> </span><span class="NLM_article-title">Immune enhancing effects of dehydroepiandrosterone and dehydroepiandrosterone sulphate and the role of steroid sulphatase</span> <span class="citation_source-journal">Immunology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1997&pages=314-321&author=A.+J.+Suittersauthor=S.+Shawauthor=M.+R.+Walesauthor=J.+R.+Porterauthor=J.+Leonardauthor=R.+Woodgerauthor=H.+Brandauthor=M.+Bodmerauthor=R.+Foulkes&title=Immune+enhancing+effects+of+dehydroepiandrosterone+and+dehydroepiandrosterone+sulphate+and+the+role+of+steroid+sulphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuitters%26aufirst%3DA.%2BJ.%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DWales%26aufirst%3DM.%2BR.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DLeonard%26aufirst%3DJ.%26aulast%3DWoodger%26aufirst%3DR.%26aulast%3DBrand%26aufirst%3DH.%26aulast%3DBodmer%26aufirst%3DM.%26aulast%3DFoulkes%26aufirst%3DR.%26atitle%3DImmune%2520enhancing%2520effects%2520of%2520dehydroepiandrosterone%2520and%2520dehydroepiandrosterone%2520sulphate%2520and%2520the%2520role%2520of%2520steroid%2520sulphatase%26jtitle%3DImmunology%26date%3D1997%26volume%3D91%26spage%3D314%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Foulkes, R.; Shaw, S.; Suitters, A.</span><span> </span><span class="NLM_article-title">Immunological consequences of inhibiting dehydroepiandrosterone sulfatase in vivo</span>. In  <span class="citation_source-book">Steroid Hormones and the T-Cell Cytokine Profile</span>; <span class="NLM_contrib-group">Rook, G. A. W.; Lightman, S.</span>, Eds.; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2F978-1-4471-0931-0_6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=135-152&author=R.+Foulkes&author=S.+Shaw&author=A.+Suittersauthor=G.+A.+W.+Rook&author=S.+Lightman&title=Steroid+Hormones+and+the+T-Cell+Cytokine+Profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1007%2F978-1-4471-0931-0_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4471-0931-0_6%26sid%3Dliteratum%253Aachs%26aulast%3DFoulkes%26aufirst%3DR.%26atitle%3DImmunological%2520consequences%2520of%2520inhibiting%2520dehydroepiandrosterone%2520sulfatase%2520in%2520vivo%26btitle%3DSteroid%2520Hormones%2520and%2520the%2520T-Cell%2520Cytokine%2520Profile%26aulast%3DRook%26aufirst%3DG.%2BA.%2BW.%26pub%3DSpringer-Verlag%26date%3D1997%26spage%3D135%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Li, P.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. A.</span><span> </span><span class="NLM_article-title">Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-<i>O</i>-sulfamate</span> <span class="citation_source-journal">Cognit. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2F0926-6410%2895%2990016-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8580738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28XmsVeisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=251-254&author=P.-K.+Liauthor=M.+E.+Rhodesauthor=S.+Jagannathanauthor=D.+A.+Johnson&title=Reversal+of+scopolamine+induced+amnesia+in+rats+by+the+steroid+sulfatase+inhibitor+estrone-3-O-sulfamate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-O-sulfamate</span></div><div class="casAuthors">Li, Pui-Kai; Rhodes, Michael E.; Jagannathan, Sharada; Johnson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cognitive Brain Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">251-4</span>CODEN:
                <span class="NLM_cas:coden">CBRREZ</span>;
        ISSN:<span class="NLM_cas:issn">0926-6410</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The intent of the study was to det. whether altering the metab. of neurosteroids via blockade of the enzyme, steroid sulfatase, could enhance retention test performance in rats.  The steroid sulfatase inhibitor estrone-3-O-sulfamate (EMATE) was administered alone and in combination with the neurosteroid dehydroepiandrosterone sulfate (DHEAS) to rats which were then tested for the reversal of scopolamine induced amnesia.  EMATE enhanced the reversal of amnesia by DHEAS as measured by a passive avoidance test.  When administered without DHEAS, as a single acute dose, EMATE had no effect.  When administered without DHEAS over 10 consecutive days, however, EMATE significantly improved retention.  These results suggest that steroid sulfatase inhibition can potentiate the memory enhancing properties of DHEAS.  The study also suggests that increasing the levels of endogenous sulfated neurosteroids via the inhibition of steroid sulfatase activity may enhance learning and/or memory function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ7bC8G6rjzrVg90H21EOLACvtfcHk0lgTfw9Q2Z_rlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsVeisQ%253D%253D&md5=8c9c428c0f17f9773a4a13e14bb35cd6</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2F0926-6410%2895%2990016-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0926-6410%252895%252990016-0%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.-K.%26aulast%3DRhodes%26aufirst%3DM.%2BE.%26aulast%3DJagannathan%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DD.%2BA.%26atitle%3DReversal%2520of%2520scopolamine%2520induced%2520amnesia%2520in%2520rats%2520by%2520the%2520steroid%2520sulfatase%2520inhibitor%2520estrone-3-O-sulfamate%26jtitle%3DCognit.%2520Brain%2520Res.%26date%3D1995%26volume%3D2%26spage%3D251%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Davies, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humby, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddy, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojarikre, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, L. S.</span><span> </span><span class="NLM_article-title">Genetic and pharmacological modulation of the steroid sulfatase axis improves response control; comparison with drugs used in ADHD</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2622</span><span class="NLM_x">–</span> <span class="NLM_lpage">2632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=2622-2632&author=W.+Daviesauthor=T.+Humbyauthor=S.+Trentauthor=J.+B.+Eddyauthor=O.+A.+Ojarikreauthor=L.+S.+Wilkinson&title=Genetic+and+pharmacological+modulation+of+the+steroid+sulfatase+axis+improves+response+control%3B+comparison+with+drugs+used+in+ADHD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DW.%26aulast%3DHumby%26aufirst%3DT.%26aulast%3DTrent%26aufirst%3DS.%26aulast%3DEddy%26aufirst%3DJ.%2BB.%26aulast%3DOjarikre%26aufirst%3DO.%2BA.%26aulast%3DWilkinson%26aufirst%3DL.%2BS.%26atitle%3DGenetic%2520and%2520pharmacological%2520modulation%2520of%2520the%2520steroid%2520sulfatase%2520axis%2520improves%2520response%2520control%253B%2520comparison%2520with%2520drugs%2520used%2520in%2520ADHD%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D2622%26epage%3D2632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Secky, L.; Svoboda, M.; Klameth, L.; Bajna, E.; Hamilton, G.; Zeillinger, R.; Jäger, W.; Thalhammer, T.</span> <span class="citation_source-journal">J. Drug Deliv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span>Article ID <span class="NLM_elocation-id">957605</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23476785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlCmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Secky%2C+L.%3B+Svoboda%2C+M.%3B+Klameth%2C+L.%3B+Bajna%2C+E.%3B+Hamilton%2C+G.%3B+Zeillinger%2C+R.%3B+J%C3%A4ger%2C+W.%3B+Thalhammer%2C+T.J.+Drug+Deliv.+2013%2C+Article+ID+957605."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors</span></div><div class="casAuthors">Secky, Lena; Svoboda, Martin; Klameth, Lukas; Bajna, Erika; Hamilton, Gerhard; Zeillinger, Robert; Jaeger, Walter; Thalhammer, Theresia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Delivery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">957605, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">JDDOCB</span>;
        ISSN:<span class="NLM_cas:issn">2090-3022</span>.
    
            (<span class="NLM_cas:orgname">Hindawi Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  The extragonadal synthesis of biol. active steroid hormones from their inactive precursors in target tissues is named "intracrinol.".  Of particular importance for the progression of estrogen-dependent cancers is the in situ formation of the biol. most active estrogen, 17beta-estradiol (E2).  In cancer cells, conversion of inactive steroid hormone precursors to E2 is accomplished from inactive, sulfated estrogens in the "sulfatase pathway" and from androgens in the "aromatase pathway".  Here, we provide an overview about expression and function of enzymes of the "sulfatase pathway", particularly steroid sulfatase (STS) that activates estrogens and estrogen sulfotransferase (SULT1E1) that converts active estrone (E1) and other estrogens to their inactive sulfates.  High expression of STS and low expression of SULT1E1 will increase levels of active estrogens in malignant tumor cells leading to the stimulation of cell proliferation and cancer progression.  Therefore, blocking the "sulfatase pathway" by STS inhibitors may offer an attractive strategy to reduce levels of active estrogens.  STS inhibitors either applied in combination with aromatase inhibitors or as novel, dual aromatase-steroid sulfatase inhibiting drugs are currently under investigation.  Furthermore, STS inhibitors are also suitable as enzyme-based cancer imaging agents applied in the biomedical imaging technique positron emission tomog. (PET) for cancer diagnosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOKo9KPbZvUbVg90H21EOLACvtfcHk0lglrYp5nr89Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlCmsrg%253D&md5=6e6ad64b7ac2f66e4ba29735e8bbaa98</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSecky%26aufirst%3DL.%26jtitle%3DJ.%2520Drug%2520Deliv.%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Chura, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooker, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomquist, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argenta, P. A.</span><span> </span><span class="NLM_article-title">Steroid-converting enzymes in human ovarian carcinomas</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.mce.2008.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18723074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1OgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2009&pages=51-58&author=J.+C.+Churaauthor=H.+S.+Ryuauthor=M.+Simardauthor=D.+Poirierauthor=Y.+Tremblayauthor=D.+C.+Brookerauthor=C.+H.+Blomquistauthor=P.+A.+Argenta&title=Steroid-converting+enzymes+in+human+ovarian+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid-converting enzymes in human ovarian carcinomas</span></div><div class="casAuthors">Chura, Justin C.; Ryu, Hyung S.; Simard, Marc; Poirier, Donald; Tremblay, Yves; Brooker, Doris C.; Blomquist, Charles H.; Argenta, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">51-58</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Anti-estrogen therapies for treating ovarian carcinoma have had mixed outcomes suggesting some tumors may be estrogen-dependent.  We assayed the activity levels of 17β-hydroxysteroid dehydrogenase (17β-HSD), 3β-hydroxysteroid dehydrogenase (3β-HSD), 3α-hydroxysteroid dehydrogenase (3α-HSD/3-KSR) and estrone sulfatase in a series of ovarian epithelial carcinomas. 17β-HSD activity ratios with estradiol (E2) and testosterone (T), and inhibition by isoform-specific inhibitors were used to est. the contributions of 17β-HSD isoforms.  Activity levels were highest for estrone sulfatase, followed, resp. by 17β-HSD, 3α-HSD/3-KSR, and 3β-HSD.  E2/T activity ratios varied widely between samples.  A 17β-HSD type 1 inhibition pattern was obsd. in 23% of the samples and a type 2 pattern in 25%.  E2 formation from estrone sulfate (E1S) was detected in 98% (47/48) of the samples. 17β-HSD type 1, type 2 and type 5 mRNA was detected in matched primary tumor and metastases.  Evaluation of 17β-HSD and sulfatase activity levels, activity ratios and inhibition patterns may help predict tumor response to endocrine therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxC1SSJQ_TRrVg90H21EOLACvtfcHk0lglrYp5nr89Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1OgsLk%253D&md5=4d23fa9ffdc511a8daa53e3e510a6e13</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2008.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2008.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DChura%26aufirst%3DJ.%2BC.%26aulast%3DRyu%26aufirst%3DH.%2BS.%26aulast%3DSimard%26aufirst%3DM.%26aulast%3DPoirier%26aufirst%3DD.%26aulast%3DTremblay%26aufirst%3DY.%26aulast%3DBrooker%26aufirst%3DD.%2BC.%26aulast%3DBlomquist%26aufirst%3DC.%2BH.%26aulast%3DArgenta%26aufirst%3DP.%2BA.%26atitle%3DSteroid-converting%2520enzymes%2520in%2520human%2520ovarian%2520carcinomas%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2009%26volume%3D301%26spage%3D51%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Iida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakinuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasano, H.</span><span> </span><span class="NLM_article-title">Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1038%2Fbjc.2013.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23531699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Ojs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2013&pages=1415-1424&author=S.+Iidaauthor=H.+Kakinumaauthor=Y.+Mikiauthor=K.+Abeauthor=M.+Sakuraiauthor=S.+Suzukiauthor=H.+Niikawaauthor=J.+Akahiraauthor=T.+Suzukiauthor=H.+Sasano&title=Steroid+sulphatase+and+oestrogen+sulphotransferase+in+human+non-small-cell+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma</span></div><div class="casAuthors">Iida, S.; Kakinuma, H.; Miki, Y.; Abe, K.; Sakurai, M.; Suzuki, S.; Niikawa, H.; Akahira, J.; Suzuki, T.; Sasano, H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1415-1424</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Steroid sulphatase (STS) is one of the steroid-metabolizing enzymes involved in desulfating inactive steroid sulfates and estrogen sulfotransferase (EST) sulfates active estrogen.  The roles of both STS and EST have not been examd. in estrogen-dependent non-small-cell lung cancer (NSCLC).  Methods: We evaluated the immunoreactivity of STS and EST in NSCLC cases using immunohistochem.  The function of STS and EST was further demonstrated using NSCLC cell lines.  Results: The immunoreactivity of STS and EST was detected in 49.5% and 27.8% of NSCLC cases, resp.  The immunoreactivity of STS was significantly higher in female adenocarcinoma cases.  The STS-pos. NSCLCs were also significantly correlated in an inversed manner with tumor size and cell proliferation and tended to be assocd. with better clin. outcome.  However, the immunoreactivity of EST was significantly correlated with intracellular oestradiol concn.  Results of in vitro anal. demonstrated that oestrone sulfate (E1-S) induced and pregnenolone sulfate (Preg-S) inhibited the proliferation in STS-expressing cell lines.  The inhibition by Preg-S was reversed by a specific progesterone receptor blocker.  Simultaneous addn. of E1-S and Preg-S significantly suppressed the proliferation.  Conclusion: In NSCLC patients, STS is considered a good prognostic factor.  Results of our present study also indicated the benefits of potential progesterone therapy for NSCLC patients.  British Journal of Cancer (2013) 108, 1415-1424; doi:10.1038/bjc.2013.84; published online 26 March 2013; www.bjcancer.com.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVA2ZoyC95NbVg90H21EOLACvtfcHk0lglrYp5nr89Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Ojs70%253D&md5=b8899ee34c15eba6b6f4c46dc514f30b</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2013.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2013.84%26sid%3Dliteratum%253Aachs%26aulast%3DIida%26aufirst%3DS.%26aulast%3DKakinuma%26aufirst%3DH.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DSakurai%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DNiikawa%26aufirst%3DH.%26aulast%3DAkahira%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DSasano%26aufirst%3DH.%26atitle%3DSteroid%2520sulphatase%2520and%2520oestrogen%2520sulphotransferase%2520in%2520human%2520non-small-cell%2520lung%2520carcinoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2013%26volume%3D108%26spage%3D1415%26epage%3D1424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Sato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayose, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tateno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasano, H.</span><span> </span><span class="NLM_article-title">Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">914</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=914-922&author=R.+Satoauthor=T.+Suzukiauthor=Y.+Katayoseauthor=K.+Miuraauthor=K.+Shiibaauthor=H.+Tatenoauthor=Y.+Mikiauthor=J.+Akahiraauthor=Y.+Kamogawaauthor=S.+Nagasakiauthor=K.+Yamamotoauthor=T.+Iiauthor=S.+Egawaauthor=D.+B.+Evansauthor=M.+Unnoauthor=H.+Sasano&title=Steroid+sulfatase+and+estrogen+sulfotransferase+in+colon+carcinoma%3A+regulators+of+intratumoral+estrogen+concentrations+and+potent+prognostic+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKatayose%26aufirst%3DY.%26aulast%3DMiura%26aufirst%3DK.%26aulast%3DShiiba%26aufirst%3DK.%26aulast%3DTateno%26aufirst%3DH.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DAkahira%26aufirst%3DJ.%26aulast%3DKamogawa%26aufirst%3DY.%26aulast%3DNagasaki%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DIi%26aufirst%3DT.%26aulast%3DEgawa%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26aulast%3DUnno%26aufirst%3DM.%26aulast%3DSasano%26aufirst%3DH.%26atitle%3DSteroid%2520sulfatase%2520and%2520estrogen%2520sulfotransferase%2520in%2520colon%2520carcinoma%253A%2520regulators%2520of%2520intratumoral%2520estrogen%2520concentrations%2520and%2520potent%2520prognostic%2520factors%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D914%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Eri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanibuchi, H.</span><span> </span><span class="NLM_article-title">Steroid sulfatase promotes invasion and is a useful marker for predicting the progression of bladder cancer</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">iv567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=iv567&issue=Suppl+4&author=S.+Eriauthor=M.+Katoauthor=M.+Weiauthor=S.+Yamanoauthor=M.+Fujiokaauthor=H.+Wanibuchi&title=Steroid+sulfatase+promotes+invasion+and+is+a+useful+marker+for+predicting+the+progression+of+bladder+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEri%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DYamano%26aufirst%3DS.%26aulast%3DFujioka%26aufirst%3DM.%26aulast%3DWanibuchi%26aufirst%3DH.%26atitle%3DSteroid%2520sulfatase%2520promotes%2520invasion%2520and%2520is%2520a%2520useful%2520marker%2520for%2520predicting%2520the%2520progression%2520of%2520bladder%2520cancer%26jtitle%3DAnn.%2520Oncol.%26date%3D2014%26volume%3D25%26issue%3DSuppl%25204%26spage%3Div567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Dias, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selcer, K. W.</span><span> </span><span class="NLM_article-title">Steroid sulfatase mediated growth of human MG-63 pre-osteoblastic cells</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2014&pages=77-82&author=N.+J.+Diasauthor=K.+W.+Selcer&title=Steroid+sulfatase+mediated+growth+of+human+MG-63+pre-osteoblastic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDias%26aufirst%3DN.%2BJ.%26aulast%3DSelcer%26aufirst%3DK.%2BW.%26atitle%3DSteroid%2520sulfatase%2520mediated%2520growth%2520of%2520human%2520MG-63%2520pre-osteoblastic%2520cells%26jtitle%3DSteroids%26date%3D2014%26volume%3D88%26spage%3D77%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernon, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagenaar Hummelinck, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The development of A-ring modified analogues of oestrone-3-<i>O</i>-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2897%2900196-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=9618028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFSqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1998&pages=269-275&author=A.+Purohitauthor=K.+A.+Vernonauthor=A.+E.+Wagenaar+Hummelinckauthor=L.+W.+L.+Wooauthor=H.+A.+M.+Hejazauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+development+of+A-ring+modified+analogues+of+oestrone-3-O-sulphamate+as+potent+steroid+sulphatase+inhibitors+with+reduced+oestrogenicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">The development of A-ring modified analogs of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors with reduced estrogenicity</span></div><div class="casAuthors">Purohit, A.; Vernon, K. A.; Hummelinck, A. E. Wagenaar; Woo, L. W. L.; Hejaz, H. A. M.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">269-275</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Steroid sulfatases regulate the formation of estrogenic steroids which can support the growth of endocrine-dependent breast tumors.  The development of potent steroid sulfatase inhibitors could therefore have considerable therapeutic potential.  Several such inhibitors have now been developed of which the most potent to date is estrone-3-O-sulfamate (EMATE).  Unexpectedly, this inhibitor proved to be a potent estrogen.  In an attempt to reduce the estrogenicity, while retaining the potent sulfatase inhibitory properties assocd. with this type of mol., a no. of A-ring modified derivs. were designed and synthesized.  A-ring modified compds. included the 2-methoxy, 2/4-nitro, 2/4-Pr and 2/4-allyl EMATE analogs.  The ability of these derivs. to inhibit estrone sulfatase activity was examd. using placental microsomes.  The allyl-substituted EMATE derivs. were more potent inhibitors than the Pr analogs but were all considerably less potent than EMATE.  In contrast, the 2-methoxy and 2/4-nitro analogs were potent sulfatase inhibitors with 4-nitro EMATE being 5 times more active than EMATE.  The 4-nitro, 2-methoxy, 4-Pr and 4-allyl derivs. were also tested in vivo for their estrogenicity and ability to inhibit sulfatase activity.  While both 4-nitro and 2-methoxy EMATE were potent inhibitors in vivo, 2-methoxy EMATE had no stimulatory effect on uterine growth in ovariectomized rats.  The identification of a potent steroid sulfatase inhibitor lacking any estrogenicity, such as 2-methoxy EMATE, should be of considerable value in evaluating the potential of steroid sulfatase inhibition for breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXafBnPzDzL7Vg90H21EOLACvtfcHk0ljvu2jr9mCDTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFSqsLs%253D&md5=1607054465d5934ad19e93f7e92acd14</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2897%2900196-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252897%252900196-9%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DVernon%26aufirst%3DK.%2BA.%26aulast%3DWagenaar%2BHummelinck%26aufirst%3DA.%2BE.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520development%2520of%2520A-ring%2520modified%2520analogues%2520of%2520oestrone-3-O-sulphamate%2520as%2520potent%2520steroid%2520sulphatase%2520inhibitors%2520with%2520reduced%2520oestrogenicity%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D64%26spage%3D269%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumor agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3135</span><span class="NLM_x">–</span> <span class="NLM_lpage">3138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3135-3138&author=M.+P.+Leeseauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-Alkylsulfanyl+estrogen+derivatives%3A+synthesis+of+a+novel+class+of+multi-targeted+anti-tumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-Alkylsulfanyl%2520estrogen%2520derivatives%253A%2520synthesis%2520of%2520a%2520novel%2520class%2520of%2520multi-targeted%2520anti-tumor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3135%26epage%3D3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Reed, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-Difluoromethyloestrone 3-<i>O</i>-sulphamate, a highly potent steroid sulphatase inhibitor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2004&pages=169-175&author=J.+E.+Reedauthor=L.+W.+L.+Wooauthor=J.+J.+Robinsonauthor=B.+Leblondauthor=M.+P.+Leeseauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-Difluoromethyloestrone+3-O-sulphamate%2C+a+highly+potent+steroid+sulphatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DJ.%2BE.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DRobinson%26aufirst%3DJ.%2BJ.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-Difluoromethyloestrone%25203-O-sulphamate%252C%2520a%2520highly%2520potent%2520steroid%2520sulphatase%2520inhibitor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D317%26spage%3D169%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">A-Ring-substituted estrogen-3-<i>O</i>-sulfamates: potent multitargeted anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5243</span><span class="NLM_x">–</span> <span class="NLM_lpage">5256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050066a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5243-5256&author=M.+P.+Leeseauthor=H.+A.+M.+Hejazauthor=M.+F.+Mahonauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=A-Ring-substituted+estrogen-3-O-sulfamates%3A+potent+multitargeted+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjm050066a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050066a%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DA-Ring-substituted%2520estrogen-3-O-sulfamates%253A%2520potent%2520multitargeted%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5243%26epage%3D5256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of analogues of estrone-3-<i>O</i>-sulfamate as potent sulfatase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2506</span><span class="NLM_x">–</span> <span class="NLM_lpage">2519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2506-2519&author=L.+W.+L.+Wooauthor=B.+Leblondauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Synthesis+and+evaluation+of+analogues+of+estrone-3-O-sulfamate+as+potent+sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520analogues%2520of%2520estrone-3-O-sulfamate%2520as%2520potent%2520sulfatase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D2506%26epage%3D2519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Ishida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takebayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anazawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakata, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwabara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span> </span><span class="NLM_article-title">A novel steroid selective steroid sulfatase inhibitor KW-2581 inhibits sulphated-estrogen dependent growth of breast cancer cells in vitro and in animal models</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007a</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-007-9495-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=17268815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Cgt7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2007a&pages=215-227&author=H.+Ishidaauthor=T.+Nakataauthor=M.+Suzukiauthor=Y.+Shiotsuauthor=H.+Tanakaauthor=N.+Satoauthor=Y.+Terasakiauthor=M.+Takebayashiauthor=H.+Anazawaauthor=C.+Murakataauthor=P.-K.+Liauthor=T.+Kuwabaraauthor=S.+Akinaga&title=A+novel+steroid+selective+steroid+sulfatase+inhibitor+KW-2581+inhibits+sulphated-estrogen+dependent+growth+of+breast+cancer+cells+in+vitro+and+in+animal+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models</span></div><div class="casAuthors">Ishida, Hiroyuki; Nakata, Taisuke; Suzuki, Masayo; Shiotsu, Yukimasa; Tanaka, Hideyuki; Sato, Natsuko; Terasaki, Yoko; Takebayashi, Miho; Anazawa, Hideharu; Murakata, Chikara; Li, Pui-Kai; Kuwabara, Takashi; Akinaga, Shiro</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-227</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We screened a series of 17β-(N-alkylcarbamoyl)estra-1,3,5(10)triene-3-O-sulfamate derivs., and describe here a potent and selective steroid sulfatase (STS) inhibitor with antitumor effects in breast cancer models in vitro and in vivo.  In biochem. assays using crude enzymes isolated from recombinant Chinese hamster ovary cells expressing human arylsulfatses (ARSs), one of the best compds., KW-2581, inhibited STS activity with an IC50 of 4.0 nM, while > 1000-fold higher concns. were required to inhibit the other ARSs.  The failure to stimulate the growth of MCF-7 human breast cancer cells as well as in uteri in ovariectomized rats indicated the lack of estrogenicity of this compd.  In MCF-7 cells transfected with the STS gene, termed MCS-2 cells, KW-2581 inhibited the growth of cells stimulated by estrone sulfate (E1S) but also 5-androstene-3β, 17β-diol 3-sulfate (ADIOLS) and dehydroepiandrostenedione 3-sulfate.  We found that oral administration of KW-2581 inhibited both E1S- and ADIOLS-stimulated growth of MCS-2 cells in a mouse hollow fiber model.  In a nitrosomethylurea-induced rat mammary tumor model, KW-2581 induced regression of E1S-stimulated tumor growth as effectively as tamoxifen or another STS inhibitor, 667 Coumate.  Dose-response studies in the same rat model demonstrated that more than 90% inhibition of STS activity in tumors was necessary to induce tumor shrinkage.  STS activity in tumors has well correlated with that in leukocytes, suggesting that STS activity in leukocytes could be used as an easily detectable pharmacodynamic marker.  These findings demonstrate that KW-2581 is a candidate for development as a therapeutic agent for the treatment of hormone receptors-pos. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8aZlo84BUBbVg90H21EOLACvtfcHk0lh8zLHV75PMcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Cgt7fI&md5=72825a5aa22bee29394ee73ccf90252e</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1007%2Fs10549-007-9495-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-007-9495-x%26sid%3Dliteratum%253Aachs%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DNakata%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DTerasaki%26aufirst%3DY.%26aulast%3DTakebayashi%26aufirst%3DM.%26aulast%3DAnazawa%26aufirst%3DH.%26aulast%3DMurakata%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DP.-K.%26aulast%3DKuwabara%26aufirst%3DT.%26aulast%3DAkinaga%26aufirst%3DS.%26atitle%3DA%2520novel%2520steroid%2520selective%2520steroid%2520sulfatase%2520inhibitor%2520KW-2581%2520inhibits%2520sulphated-estrogen%2520dependent%2520growth%2520of%2520breast%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520animal%2520models%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007a%26volume%3D106%26spage%3D215%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Ishida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwabara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span> </span><span class="NLM_article-title">Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104b</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-006-9404-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104b&publication_year=2007&pages=211-219&author=H.+Ishidaauthor=T.+Nakataauthor=N.+Satoauthor=P.+K.+Liauthor=T.+Kuwabaraauthor=S.+Akinaga&title=Inhibition+of+steroid+sulfatase+activity+and+cell+proliferation+in+ZR-75-1+and+BT-474+human+breast+cancer+cells+by+KW-2581+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2Fs10549-006-9404-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-006-9404-8%26sid%3Dliteratum%253Aachs%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DNakata%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DP.%2BK.%26aulast%3DKuwabara%26aufirst%3DT.%26aulast%3DAkinaga%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520steroid%2520sulfatase%2520activity%2520and%2520cell%2520proliferation%2520in%2520ZR-75-1%2520and%2520BT-474%2520human%2520breast%2520cancer%2520cells%2520by%2520KW-2581%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007%26volume%3D104b%26spage%3D211%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhalli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">In vivo efficacy of STX213, a second generation sulfatase inhibitor, for hormone-dependent breast cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5543</span><span class="NLM_x">–</span> <span class="NLM_lpage">5549</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1158%2F1078-0432.CCR-06-0632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=17000691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFShtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=5543-5549&author=P.+A.+Fosterauthor=S.+P.+Newmanauthor=S.+K.+Chanderauthor=C.+Stengelauthor=R.+Jhalliauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=In+vivo+efficacy+of+STX213%2C+a+second+generation+sulfatase+inhibitor%2C+for+hormone-dependent+breast+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy</span></div><div class="casAuthors">Foster, Paul A.; Newman, Simon P.; Chander, Surinder K.; Stengel, Chloe; Jhalli, Roma; Woo, Lawrence L. W.; Potter, Barry V. L.; Reed, Michael J.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5543-5549</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Steroid sulfatase (STS) inhibitors that can decrease or prevent the biosynthesis of estrogenic steroids via the sulfatase route may play an important role in the treatment of breast cancer.  We compare the in vivo efficacy of two potent STS inhibitors, STX64, and STX213, in a xenograft breast cancer model.  MCF-7 cells stably expressing STS cDNA (MCF-7STS) were generated.  Ovariectomized MF-1 female nude mice receiving s.c. injections of estradiol sulfate (E2S) and bearing both MCF-7STS and wild-type MCF-7 (MCF-7WT) tumors were orally treated with STX64 and STX213.  Treatment was given for 49 days followed by a recovery period of 35 days in which animals received only E2S.  Mice were weighed, and tumor measurements were taken weekly.  STX64 and STX213 exhibited potent STS inhibition in vivo.  However, STX213 showed a greater duration of activity.  In vehicle-treated nude mice receiving E2S, tumor vols. increased 5.5-fold for MCF-7WT and 3.8-fold for MCF-7STS after 49 days compared with day 0.  MCF-7WT tumor growth was reduced by 56% by STX213 over the dosing period, and subsequent growth was retarded during the recovery period.  All treatments fully inhibited growth of MCF-7STS tumors, and recovery of these tumors was significantly retarded (P < 0.01).  All compds. completely inhibited liver and tumor STS activity.  Addnl., STS mRNA expression in the MCF-7STS tumors directly correlated with the corresponding STS enzyme activity.  This study indicates that STS inhibitors attenuate hormone-dependent human breast cancer growth and therefore offer a potentially novel treatment for this condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGHsuVYIl_GrVg90H21EOLACvtfcHk0lh8zLHV75PMcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFShtro%253D&md5=753a3127f21022dfc9d5379f1d4f70ad</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-0632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-0632%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DJhalli%26aufirst%3DR.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DIn%2520vivo%2520efficacy%2520of%2520STX213%252C%2520a%2520second%2520generation%2520sulfatase%2520inhibitor%252C%2520for%2520hormone-dependent%2520breast%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D5543%26epage%3D5549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Stander, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubert, A.</span><span> </span><span class="NLM_article-title">Docking, synthesis, and in vitro evaluation of antimitotic estrone analogs</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1111%2Fj.1747-0285.2010.01064.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=21244635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivF2ktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=173-181&author=A.+Standerauthor=F.+Joubertauthor=A.+Joubert&title=Docking%2C+synthesis%2C+and+in+vitro+evaluation+of+antimitotic+estrone+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Docking, synthesis, and in vitro evaluation of antimitotic estrone analogs</span></div><div class="casAuthors">Stander, Andre; Joubert, Fourie; Joubert, Annie</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-181</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In the present study, Autodock 4.0 was employed to discover potential carbonic anhydrase IX inhibitors that are able to interfere with microtubule dynamics by binding to the Colchicine binding site of tubulin.  Modifications at position 2' of estrone were made to include moieties that are known to improve the antimitotic activity of estradiol analogs.  2-Ethyl-3-O-sulfamoyl-estra-1,3,5(10),15-tetraen-3-ol-17-one (I) and 2-ethyl-3-O-sulfamoyl-estra-1,3,5(10)16-tetraene (II) were synthesized and tested in vitro.  Growth studies were conducted utilizing spectrophotometrical anal. with crystal violet as DNA stain.  Compds. I and II2 were cytotoxic in MCF-7 and MDA-MB-231 tumorigenic and metastatic breast cancer cells, SNO non-keratinizing squamous epithelium cancer cells and HeLa cells after 48 h exposure.  Compd. I inhibited cell proliferation to 50% of the vehicle-treated controls from 110 to 160 nM and II at concns. ranging from 180 to 220 nM.  Confocal microscopy revealed abnormal spindle morphol. in mitotic cells.  Cell cycle anal. showed an increase in the no. of cells in the G2/M fraction after 24 h and an increase in the no. of cell in the sub-G1 fraction after 48 h, indicating that the compds. are antimitotic and able to induce apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdP1H_hWByfrVg90H21EOLACvtfcHk0litnj3TvN0KFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivF2ktL4%253D&md5=57822f292789ac6de9285fac2b7eafd0</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2010.01064.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2010.01064.x%26sid%3Dliteratum%253Aachs%26aulast%3DStander%26aufirst%3DA.%26aulast%3DJoubert%26aufirst%3DF.%26aulast%3DJoubert%26aufirst%3DA.%26atitle%3DDocking%252C%2520synthesis%252C%2520and%2520in%2520vitro%2520evaluation%2520of%2520antimitotic%2520estrone%2520analogs%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2011%26volume%3D77%26spage%3D173%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Wolmarans, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mqoco, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stander, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nkandeu, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubert, A.</span><span> </span><span class="NLM_article-title">Novel estradiol analogue induces apoptosis and autophagy in esophageal carcinoma cells</span> <span class="citation_source-journal">Cell. Mol. Biol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=98-115&author=E.+Wolmaransauthor=T.+V.+Mqocoauthor=A.+Standerauthor=S.+D.+Nkandeuauthor=K.+Sippelauthor=R.+McKennaauthor=A.+Joubert&title=Novel+estradiol+analogue+induces+apoptosis+and+autophagy+in+esophageal+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWolmarans%26aufirst%3DE.%26aulast%3DMqoco%26aufirst%3DT.%2BV.%26aulast%3DStander%26aufirst%3DA.%26aulast%3DNkandeu%26aufirst%3DS.%2BD.%26aulast%3DSippel%26aufirst%3DK.%26aulast%3DMcKenna%26aufirst%3DR.%26aulast%3DJoubert%26aufirst%3DA.%26atitle%3DNovel%2520estradiol%2520analogue%2520induces%2520apoptosis%2520and%2520autophagy%2520in%2520esophageal%2520carcinoma%2520cells%26jtitle%3DCell.%2520Mol.%2520Biol.%2520Lett.%26date%3D2014%26volume%3D10%26spage%3D98%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Raobaikady, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2803%2900049-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=12711022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFWgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=351-358&author=B.+Raobaikadyauthor=A.+Purohitauthor=S.+K.+Chanderauthor=L.+W.+L.+Wooauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+MCF-7+breast+cancer+cell+proliferation+and+in+vivo+steroid+sulphatase+activity+by+2-methoxyoestradiol-bis-sulphamate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate</span></div><div class="casAuthors">Raobaikady, Bindumalini; Purohit, Atul; Chander, Surinder K.; Woo, L. W. Lawrence; Leese, Mathew P.; Potter, Barry V. L.; Reed, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">351-358</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The endogenous estrogen metabolite, 2-methoxyoestradiol (2-MeOE2) inhibits the growth of breast cancer cells and is also a potent anti-angiogenic agent.  The authors have previously shown that the 3-sulfamoylated derivs. of 2-methoxyoestrogens are more potent than the non-sulfamoylated compds.  In this study, the authors have compared the abilities of 2-methoxyoestradiol-bis-sulfamate (2-MeOE2bisMATE) and 2-MeOE2 to inhibit the growth of MCF-7 breast cancer cells.  Both compds. inhibited cell growth with the IC50 for 2-MeOE2bisMATE (0.4 μM) being six-fold lower than that for 2-MeOE2 (2.5 μM).  Estrogen sulfamates are potent inhibitors of steroid sulfatase (STS) activity.  2-MeOE2bisMATE was found to retain its STS inhibitory activity and in a placental microsome assay system it was equipotent with estrone-3-O-sulfamate (EMATE).  An in vivo study was also carried out to compare the potency of 2-MeOE2bisMATE with that of EMATE and the non-steroidal STS inhibitor, 667 coumarin sulfamate (667 COUMATE).  After a single oral dose (10 mg/kg) some recovery of STS activity was detected by day 3 (10%) with activity partially restored (55%) by day 7 after administration of 667 COUMATE.  For the other two steroidal compds., STS activity remained almost completely inactivated for up to 5 days with complete restoration of activity occurring by day 15.  The anti-proliferative and STS inhibitory properties of 2-MeOE2bisMATE suggest that it has considerable potential for development as a novel anti-cancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxK1ey1nwzvrVg90H21EOLACvtfcHk0litnj3TvN0KFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFWgsLw%253D&md5=264779e33b127c81a9acbf26805ea72e</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900049-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900049-9%26sid%3Dliteratum%253Aachs%26aulast%3DRaobaikady%26aufirst%3DB.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520MCF-7%2520breast%2520cancer%2520cell%2520proliferation%2520and%2520in%2520vivo%2520steroid%2520sulphatase%2520activity%2520by%25202-methoxyoestradiol-bis-sulphamate%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D84%26spage%3D351%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Suzuki, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiol-bis-sulphamate</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2803%2900035-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=12711013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFWgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=269-278&author=R.+N.+Suzukiauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Growth+inhibition+of+multi-drug-resistant+breast+cancer+cells+by+2-methoxyoestradiol-bis-sulphamate+and+2-ethyloestradiol-bis-sulphamate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiol-bis-sulphamate</span></div><div class="casAuthors">Suzuki, R. N.; Newman, S. P.; Purohit, A.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">269-278</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">There is currently considerable interest in the use of the endogenous estrogen metabolite, 2-methoxyestradiol (2-MeOE2) for the treatment and prevention of breast cancer.  The authors have previously shown that sulfamoylation of 2-MeOE2 and related derivs. greatly enhances their ability to inhibit the proliferation of ER+ and ER- breast cancer cells.  In this study, the authors have compared the abilities of 2-methoxyestradiol-bis-sulfamate (2-MeOE2bisMATE) and 2-ethylestradiol-bis-sulfamate (2-EtE2bisMATE) with that of 2-MeOE2 to inhibit the proliferation of breast cancer cells when grown on three different substrata: plastic, collagen I and Matrigel.  The human breast cell line MCF-7 was utilized for these studies together with its doxorubicin resistant variant, MCF-7 DOX40 and mitoxantrone resistant variant, MCF-7 MR, as a longitudinal model of in vitro drug resistance.  On a plastic substratum all three cell lines were sensitive to the effects of 2-MeOE2bisMATE and 2-EtE2bisMATE, whereas MCF-7 cells and the MCF-MR variant cells were resistant to the effects of 2-MeOE2 at 1 μM.  The sensitivity of the cell lines to those compds. also remained significant when grown on more physiol. substrata.  All of the drugs tested arrested cells in the G2/M phase of the cell cycle.  The finding that breast cancer cells that are resistant to conventional chemotherapeutic agents remain sensitive to 2-substituted estrogen sulfamates offers considerable potential for the treatment of women with drug-resistant breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb6AE18dasuLVg90H21EOLACvtfcHk0litnj3TvN0KFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFWgs70%253D&md5=0dcdac441bf459b75af30dd74094b91d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900035-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900035-9%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DR.%2BN.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DGrowth%2520inhibition%2520of%2520multi-drug-resistant%2520breast%2520cancer%2520cells%2520by%25202-methoxyoestradiol-bis-sulphamate%2520and%25202-ethyloestradiol-bis-sulphamate%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D84%26spage%3D269%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The effects of 2-methoxy oestrogens and their sulphamoylated derivatives in conjunction with TNF– on endothelial and fibroblast cell growth, morphology and apoptosis</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2803%2900269-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=14568571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot1yrt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2003&pages=189-196&author=Y.+T.+Hoauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+effects+of+2-methoxy+oestrogens+and+their+sulphamoylated+derivatives+in+conjunction+with+TNF%E2%80%93+on+endothelial+and+fibroblast+cell+growth%2C+morphology+and+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of 2-methoxy oestrogens and their sulphamoylated derivatives in conjunction with TNF-α on endothelial and fibroblast cell growth, morphology and apoptosis</span></div><div class="casAuthors">Ho, Y. T.; Newman, S. P.; Purohit, A.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-196</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">: Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">2-Methoxyoestradiol (2-MeOE2) is a potent anti-angiogenic agent.  Its 3- and 17-sulfamoylated derivs. have been demonstrated to induce G2-M cell cycle arrest and apoptosis in breast cancer cells in vitro as well as tumor regression in rats in vivo with greater potency than the parent estrogen.  To det. whether the anti-cancer properties of these derivs. can be synergistically enhanced with low-dose TNF-α co-treatment, the authors investigated the effects of these treatments in adult human fibroblasts and human umbilical vein endothelial cells (HUVECs).  Treatment of fibroblasts with 0.1 μM 2-methoxyoestradiol-3,17-bis sulfamate (2-MeOE2bisMATE) but not 2-MeOE2 caused a reversible morphol. change and induced G2-M arrest (from 12 to 33%) but not subsequent apoptosis.  In contrast, treatment of HUVECs did not induce morphol. change or G2-M arrest.  Using a nucleosomal ELISA assay, the authors showed that TNF-α (20 ng/mL) combination treatment synergistically increases 0.1 μM 2-MeOE2bisMATE-induced but not 0.1 μM 2-MeOE2-induced apoptosis in HUVECs.  These results suggest that TNF-α co-treatment may be a beneficial method of increasing the potency of 2-substituted estrogens as anti-angiogenic agents through synergistic induction of apoptosis in endothelial cells while maintaining low cytotoxicity to fibroblasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovk_07wL36GbVg90H21EOLACvtfcHk0ljjusaiNYY8FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot1yrt7w%253D&md5=51c5947dcf32d3a04ec70b064aee24a0</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900269-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900269-3%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520effects%2520of%25202-methoxy%2520oestrogens%2520and%2520their%2520sulphamoylated%2520derivatives%2520in%2520conjunction%2520with%2520TNF%25E2%2580%2593%2520on%2520endothelial%2520and%2520fibroblast%2520cell%2520growth%252C%2520morphology%2520and%2520apoptosis%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D86%26spage%3D189%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Wood, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouzakiti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span> </span><span class="NLM_article-title">2-MeOE2bisMATE induces caspase-dependent apoptosis in CAL51 breast cancer cells and overcomes resistance to TRAIL via cooperative activation of caspases</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=323-332&author=L.+Woodauthor=M.+P.+Leeseauthor=A.+Mouzakitiauthor=A.+Purohitauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=G.+Packham&title=2-MeOE2bisMATE+induces+caspase-dependent+apoptosis+in+CAL51+breast+cancer+cells+and+overcomes+resistance+to+TRAIL+via+cooperative+activation+of+caspases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DL.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DMouzakiti%26aufirst%3DA.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26atitle%3D2-MeOE2bisMATE%2520induces%2520caspase-dependent%2520apoptosis%2520in%2520CAL51%2520breast%2520cancer%2520cells%2520and%2520overcomes%2520resistance%2520to%2520TRAIL%2520via%2520cooperative%2520activation%2520of%2520caspases%26jtitle%3DApoptosis%26date%3D2004%26volume%3D9%26spage%3D323%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Utsumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaukroger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2005.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15862969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVKksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=219-227&author=T.+Utsumiauthor=M.+P.+Leeseauthor=S.+K.+Chanderauthor=K.+Gaukrogerauthor=A.+Purohitauthor=S.+P.+Newmanauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+effects+of+2-methoxyoestrogen+sulphamates+on+the+in+vitro+and+in+vivo+proliferation+of+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of 2-methoxyoestrogen sulfamates on the in vitro and in vivo proliferation of breast cancer cells</span></div><div class="casAuthors">Utsumi, T.; Leese, M. P.; Chander, S. K.; Gaukroger, K.; Purohit, A.; Newman, S. P.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">219-227</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">2-Methoxyoestrogen sulfamates are a new class of compds., which inhibit breast cancer cell proliferation and are also potent inhibitors of steroid sulfatase (STS) activity.  In the present study, we have used two cell proliferation assays (MTS and AB) to identify potent new compds. in this class.  Similar IC50 values were obtained using these assays with two of the most potent compds. identified being 2-methoxyoestradiol-bis-sulfamate (2-MeOE2bisMATE) and 2-methoxyoestradiol-17β-cyanomethyl-3-O-sulfamate (2-MeOE2CyMATE).  Both compds. inhibited the proliferation of MCF-7 (ER+) and MDA-MB-231 (ER-) breast cancer cells.  Using the AB assay, which allows repeat measurements of cell proliferation without killing cells, both compds. were shown to inhibit cell proliferation in an irreversible manner.  As STS may be involved in the removal of the sulfamoyl moiety of these compds., which could reduce their potency, their ability to inhibit the proliferation of MCF-7 cells transfected with the cDNA for STS was also examd.  Although the STS activity was 20-fold higher in these cells than in non-transfected MCF-7 cells, no decrease in the ability of these compds. to inhibit cell proliferation was detected.  To test the efficacy of these compds. in vivo, nude mice were inoculated with MCF-7 cells in Matrigel and stimulated to grow with estradiol.  Three weeks after the oral administration of 2-MeOE2bisMATE or 2-MeOE2CyMATE (20 mg/kg/day, 5 days/wk) tumor vols. had regressed by 52% and 22%, resp.  Both compds. also inhibited liver and tumor STS activity by >90%.  The potent anti-proliferative effects of these compds., and their ability to inhibit tumor growth and STS activity in vivo, indicates that they are suitable for development as novel therapeutic agents, which should be active against a wide range of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdtsk486WMBLVg90H21EOLACvtfcHk0ljjusaiNYY8FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVKksLw%253D&md5=ab0ebb6c2671365750741c09e380f050</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2005.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2005.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DUtsumi%26aufirst%3DT.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DGaukroger%26aufirst%3DK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520effects%2520of%25202-methoxyoestrogen%2520sulphamates%2520on%2520the%2520in%2520vitro%2520and%2520in%2520vivo%2520proliferation%2520of%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D94%26spage%3D219%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">3,17-Disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in vitro and in vivo anticancer activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4431</span><span class="NLM_x">–</span> <span class="NLM_lpage">4443</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070405v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4431-4443&author=C.+Bubertauthor=M.+P.+Leeseauthor=M.+F.+Mahonauthor=E.+Ferrandisauthor=S.+Regis-Lydiauthor=P.+G.+Kasprzykauthor=S.+P.+Newmanauthor=Y.+T.+Hoauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=3%2C17-Disubstituted+2-alkylestra-1%2C3%2C5%2810%29-trien-3-ol+derivatives%3A+synthesis%2C+in+vitro+and+in+vivo+anticancer+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm070405v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070405v%26sid%3Dliteratum%253Aachs%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D3%252C17-Disubstituted%25202-alkylestra-1%252C3%252C5%252810%2529-trien-3-ol%2520derivatives%253A%2520synthesis%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520anticancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4431%26epage%3D4443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-Substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7683</span><span class="NLM_x">–</span> <span class="NLM_lpage">7696</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060705x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7683-7696&author=M.+P.+Leeseauthor=B.+Leblondauthor=A.+Smithauthor=S.+P.+Newmanauthor=A.+Di+Fioreauthor=G.+De+Simoneauthor=C.+T.+Supuranauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-Substituted+estradiol+bis-sulfamates%2C+multitargeted+antitumor+agents%3A+synthesis%2C+in+vitro+SAR%2C+protein+crystallography%2C+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm060705x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060705x%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-Substituted%2520estradiol%2520bis-sulfamates%252C%2520multitargeted%2520antitumor%2520agents%253A%2520synthesis%252C%2520in%2520vitro%2520SAR%252C%2520protein%2520crystallography%252C%2520and%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7683%26epage%3D7696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">D’Amato, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">3964</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=3964&author=R.+J.+D%E2%80%99Amatoauthor=C.+M.+Linauthor=E.+Flynnauthor=J.+Folkmanauthor=E.+Hamel&title=2-Methoxyestradiol%2C+an+endogenous+mammalian+metabolite%2C+inhibits+tubulin+polymerization+by+interacting+at+the+colchicine+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Amato%26aufirst%3DR.%2BJ.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DFlynn%26aufirst%3DE.%26aulast%3DFolkman%26aufirst%3DJ.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3D2-Methoxyestradiol%252C%2520an%2520endogenous%2520mammalian%2520metabolite%252C%2520inhibits%2520tubulin%2520polymerization%2520by%2520interacting%2520at%2520the%2520colchicine%2520site%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D3964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Klauber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parangi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amato, R. J.</span><span> </span><span class="NLM_article-title">Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8988045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK2sXjvFOmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=81-86&author=N.+Klauberauthor=S.+Parangiauthor=E.+Flynnauthor=E.+Hamelauthor=R.+J.+D%E2%80%99Amato&title=Inhibition+of+angiogenesis+and+breast+cancer+in+mice+by+the+microtubule+inhibitors+2-methoxyestradiol+and+taxol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol</span></div><div class="casAuthors">Klauber, Nancy; Parangi, Sareh; Flynn, Evelyn; Hamel, Ernest; D'Amato, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-86</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">2-Methoxyestradiol (2-ME), an endogenous estrogen metabolite which disrupts microtubule function, has been shown to inhibit proliferating cells in vitro and suppress certain murine tumors in vivo.  In vitro screening has detd. that breast cancer cell lines are most sensitive to inhibition by 2-ME.  Addnl., 2-ME has been shown to inhibit angiogenesis in vitro.  We tested whether 2-ME suppresses cytokine-induced angiogenesis in vivo and inhibits growth of a human breast carcinoma in severe combined immunodeficient mice.  A model of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF)-induced corneal neovascularization in C57BL/6 mice was used to evaluate the antiangiogenic effects of 2-ME and other microtubule inhibitors such as Taxol, vincristine, and colchicine.  2-ME (150 mg/kg p.o.) inhibited bFGF and VEGF-induced neovascularization by 39% and 54%, resp.  Taxol (6 mg/kg i.p.) inhibited bFGF and VEGF-induced neovascularization by 45% and 37%, resp.  Vincristine (0.2 mg/kg i.p.) and colchicine (0.25 mg/kg i.p.) had no effect.  Treatment with 2-ME (75 mg/kg p.o.) for 1 mo suppressed the growth of a human breast carcinoma in mice by 60% without toxicity.  Recognition of the antiangiogenic and antitumor properties of 2-ME and taxol may be crucial in planning clin. applications to angiogenesis-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbq_DgfUImq7Vg90H21EOLACvtfcHk0lj7yfIVZmlRfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjvFOmtw%253D%253D&md5=88fbe8611dfdb66530160abe5318c2d7</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlauber%26aufirst%3DN.%26aulast%3DParangi%26aufirst%3DS.%26aulast%3DFlynn%26aufirst%3DE.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amato%26aufirst%3DR.%2BJ.%26atitle%3DInhibition%2520of%2520angiogenesis%2520and%2520breast%2520cancer%2520in%2520mice%2520by%2520the%2520microtubule%2520inhibitors%25202-methoxyestradiol%2520and%2520taxol%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D81%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Dahut, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arlen, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nquyen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventiz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparreboom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W.</span><span> </span><span class="NLM_article-title">Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.4161%2Fcbt.5.1.2349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=16357512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvVSntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=22-27&author=W.+L.+Dahutauthor=N.+J.+Lakhaniauthor=J.+L.+Gulleyauthor=P.+M.+Arlenauthor=E.+C.+Kohnauthor=H.+Kotzauthor=D.+McNallyauthor=A.+Parrauthor=D.+Nquyenauthor=S.+X.+Yangauthor=S.+M.+Steinbergauthor=J.+Ventizauthor=A.+Sparreboomauthor=W.+Figg&title=Phase+I+clinical+trial+of+oral+2-methoxyestradiol%2C+an+antiangiogenic+and+apoptotic+agent%2C+in+patients+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors</span></div><div class="casAuthors">Dahut, William L.; Lakhani, Nehal J.; Gulley, James L.; Arlen, Philip M.; Kohn, Elise C.; Kotz, Herbert; McNally, Debbie; Parr, Allyson; Nguyen, Diana; Yang, Sherry X.; Steinberg, Seth M.; Venitz, Jurgen; Sparreboom, Alex; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-27</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Purpose: To det. the max.-tolerated dose (MTD) and toxicity profile of the novel anticancer agent, 2-methoxyestradiol (2ME2) administered orally, in patients with solid tumors.  Materials and methods: Twenty patients with refractory solid tumors were enrolled.  2ME2 was given orally starting at 400 mg bid with dose escalation until 3000 mg bid.  Tumor biopsies were taken before and after starting the drug to assess for microvessel d. by CD 31 and cell proliferation by Ki67 immunohistochem.  Serial plasma samples collected up to 50 h after first single oral dose for characterization of pharmacokinetics, were analyzed using liq. chromatog. tandem mass-spectrometry.  Results: Eleven men and nine women received 2ME2 at dose levels of 400 mg bid (n = 3), 800 mg bid (n = 3), 1600 mg bid (n = 6), 2200 mg bid (n = 5) and 3000 mg bid (n = 3).  There were no dose limiting toxicities, therefore the MTD was not defined.  There was one episode of grade 4 angioedema in the 1600 mg bid dose level 38 days into 2ME2 treatment.  Other toxicities were mild to moderate.  A patient with clear cell carcinoma of the ovary had a partial response at 1600 mg bid dose level lasting over three years.  Conclusion: MTD for 2ME2 was not reached at dose of 3000 mg bid.  The trial was closed due to extremely low plasma concns. of 2ME2 relative to the doses administered.  2ME2 treatment had no effect on microvessel d. (CD31 immunostaining) and cell proliferation (Ki-67 immunostaining).  A new formulation of 2ME2 with improved bioavailability is currently being developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnn5SfJSuSB7Vg90H21EOLACvtfcHk0lj7yfIVZmlRfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvVSntro%253D&md5=4e4021491980ad34411e4637c35ebbc9</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.4161%2Fcbt.5.1.2349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.5.1.2349%26sid%3Dliteratum%253Aachs%26aulast%3DDahut%26aufirst%3DW.%2BL.%26aulast%3DLakhani%26aufirst%3DN.%2BJ.%26aulast%3DGulley%26aufirst%3DJ.%2BL.%26aulast%3DArlen%26aufirst%3DP.%2BM.%26aulast%3DKohn%26aufirst%3DE.%2BC.%26aulast%3DKotz%26aufirst%3DH.%26aulast%3DMcNally%26aufirst%3DD.%26aulast%3DParr%26aufirst%3DA.%26aulast%3DNquyen%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DS.%2BX.%26aulast%3DSteinberg%26aufirst%3DS.%2BM.%26aulast%3DVentiz%26aufirst%3DJ.%26aulast%3DSparreboom%26aufirst%3DA.%26aulast%3DFigg%26aufirst%3DW.%26atitle%3DPhase%2520I%2520clinical%2520trial%2520of%2520oral%25202-methoxyestradiol%252C%2520an%2520antiangiogenic%2520and%2520apoptotic%2520agent%252C%2520in%2520patients%2520with%2520solid%2520tumors%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D22%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Peyrat, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brion, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alami, M.</span><span> </span><span class="NLM_article-title">Synthetic 2-methoxyestradiol derivatives: structure–activity relationships</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4142</span><span class="NLM_x">–</span> <span class="NLM_lpage">4156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.2174%2F092986712802430072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=22709003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFWktrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=4142-4156&author=J.-F.+Peyratauthor=J.-D.+Brionauthor=M.+Alami&title=Synthetic+2-methoxyestradiol+derivatives%3A+structure%E2%80%93activity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic 2-methoxyestradiol derivatives: structure-activity relationships</span></div><div class="casAuthors">Peyrat, Jean-Francois; Brion, Jean-Daniel; Alami, Mouad</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4142-4156</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  2-Methoxyestradiol (2ME2), a natural metabolite of estradiol which has no estrogenic activity, is a potent antitumor and anti-angiogenic compd., currently undergoing clin. trials for treatment of a variety of cancers.  In the last two decades, an ever increasing no. of synthetic 2-methoxyestradiol analogs have been reported.  Structural changes include A/B/C/D-rings modification, homologation, aromatization, and introduction of various substituents on C-2 position along with substitution of alkyl and ethynyl groups for the 17-hydroxy function.  In this review, an attempt has been made to compile the structure-activity relationships of various synthesized 2-methoxyestradiol analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1Os9-GBErZbVg90H21EOLACvtfcHk0ljV8W47SKnrpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFWktrvN&md5=ab71f76ca02723c4c66e63af60c9b31c</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.2174%2F092986712802430072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712802430072%26sid%3Dliteratum%253Aachs%26aulast%3DPeyrat%26aufirst%3DJ.-F.%26aulast%3DBrion%26aufirst%3DJ.-D.%26aulast%3DAlami%26aufirst%3DM.%26atitle%3DSynthetic%25202-methoxyestradiol%2520derivatives%253A%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D4142%26epage%3D4156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCarthy-Morrogh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The effect of 2-methoxyoestrone-3-<i>O</i>-sulphamate on the growth of breast cancer cells and induced mammary tumors</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">584</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2F%28SICI%291097-0215%2820000215%2985%3A4%3C584%3A%3AAID-IJC22%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10699934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A280%3ADC%252BD3c7msVGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=584-589&author=A.+Purohitauthor=H.+A.+M.+Hejazauthor=L.+Waldenauthor=L.+MacCarthy-Morroghauthor=G.+Packhamauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+effect+of+2-methoxyoestrone-3-O-sulphamate+on+the+growth+of+breast+cancer+cells+and+induced+mammary+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours</span></div><div class="casAuthors">Purohit A; Hejaz H A; Walden L; MacCarthy-Morrogh L; Packham G; Potter B V; Reed M J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer. Journal international du cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">584-9</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">2-Methoxyoestrogens are emerging as a new class of drug that can inhibit tumour growth and angiogenesis.  As sulphamoylation of oestrogens enhances their potency and bioavailability we have synthesized 2-methoxyoestrone-3-O-sulphamate (2-MeOEMATE) and compared its ability to inhibit the proliferation of breast cancer cells with that of 2-methoxyoestrone (2-MeOE1). 2-MeOEMATE (1 microM) inhibited the growth of oestrogen receptor positive MCF-7 breast cancer cells by 52% whereas 2-MeOE1 had little effect at this concentration. 2-MeOEMATE also inhibited the growth of oestrogen receptor negative MDA-MB-231 breast cancer cells.  Exposure of cells to 2-MeOEMATE caused them to round up and become detached suggesting that this compound may induce cells to undergo apoptosis.  Cell cycle analysis revealed that 2-MeOEMATE caused cells to arrest in the G(2)/M phase with the increase in G(2)/M arrested cells being detectable by 12 hr.  Exposure of MCF-7 cells to 2 L-MeOEMATE for 24 hr followed by culture in drug-free medium for 24 hr did not reverse the arrest of cells in the G(2)/M phase.  TUNEL analysis confirmed that 2-MeOEMATE induced apoptosis in a significant proportion of treated MCF-7 cells.  In an in vivo study, employing nitrosomethylurea-induced mammary tumours in intact rats, 2-MeOE1 (20mg/kg/d, p.o. for 11 days) had little effect on tumour growth.  In contrast, the same dose of 2-MeOEMATE resulted in the almost complete regression of 2/3 tumours over an 11-day period.  We conclude that 2-MeOEMATE should have considerable therapeutic potential for the treatment of breast tumours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqkhlCxw4mrynGiHuhFGv8fW6udTcc2eZTd_G68IJkN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7msVGkug%253D%253D&md5=75a9c5a896a1a00886a9c17cf2cbe241</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2820000215%2985%3A4%3C584%3A%3AAID-IJC22%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252820000215%252985%253A4%253C584%253A%253AAID-IJC22%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DWalden%26aufirst%3DL.%26aulast%3DMacCarthy-Morrogh%26aufirst%3DL.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520effect%2520of%25202-methoxyoestrone-3-O-sulphamate%2520on%2520the%2520growth%2520of%2520breast%2520cancer%2520cells%2520and%2520induced%2520mammary%2520tumors%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2000%26volume%3D85%26spage%3D584%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Sattler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinnan, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pride, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Even, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraeft, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">2-Methoxyestradiol alters cell motility, migration, and adhesion</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=289-296&author=M.+Sattlerauthor=L.+R.+Quinnanauthor=Y.+B.+Prideauthor=J.+L.+Gramlichauthor=S.+C.+Chuauthor=G.+C.+Evenauthor=S.-K.+Kraeftauthor=L.+B.+Chenauthor=R.+Salgia&title=2-Methoxyestradiol+alters+cell+motility%2C+migration%2C+and+adhesion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DQuinnan%26aufirst%3DL.%2BR.%26aulast%3DPride%26aufirst%3DY.%2BB.%26aulast%3DGramlich%26aufirst%3DJ.%2BL.%26aulast%3DChu%26aufirst%3DS.%2BC.%26aulast%3DEven%26aufirst%3DG.%2BC.%26aulast%3DKraeft%26aufirst%3DS.-K.%26aulast%3DChen%26aufirst%3DL.%2BB.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3D2-Methoxyestradiol%2520alters%2520cell%2520motility%252C%2520migration%252C%2520and%2520adhesion%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26spage%3D289%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Yue, T.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louden, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillarsetti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lysko, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feuerstein, G. Z.</span><span> </span><span class="NLM_article-title">2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">962</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1997&pages=951-962&author=T.-L.+Yueauthor=X.+Wangauthor=C.+S.+Loudenauthor=S.+Guptaauthor=K.+Pillarsettiauthor=J.-L.+Guauthor=T.+K.+Hartauthor=P.+G.+Lyskoauthor=G.+Z.+Feuerstein&title=2-Methoxyestradiol%2C+an+endogenous+estrogen+metabolite%2C+induces+apoptosis+in+endothelial+cells+and+inhibits+angiogenesis%3A+possible+role+for+stress-activated+protein+kinase+signaling+pathway+and+Fas+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DT.-L.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLouden%26aufirst%3DC.%2BS.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DPillarsetti%26aufirst%3DK.%26aulast%3DGu%26aufirst%3DJ.-L.%26aulast%3DHart%26aufirst%3DT.%2BK.%26aulast%3DLysko%26aufirst%3DP.%2BG.%26aulast%3DFeuerstein%26aufirst%3DG.%2BZ.%26atitle%3D2-Methoxyestradiol%252C%2520an%2520endogenous%2520estrogen%2520metabolite%252C%2520induces%2520apoptosis%2520in%2520endothelial%2520cells%2520and%2520inhibits%2520angiogenesis%253A%2520possible%2520role%2520for%2520stress-activated%2520protein%2520kinase%2520signaling%2520pathway%2520and%2520Fas%2520expression%26jtitle%3DMol.%2520Pharmacol.%26date%3D1997%26volume%3D51%26spage%3D951%26epage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Reiser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Way, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, C.</span><span> </span><span class="NLM_article-title">Inhibition of normal and experimental angiotumor endothelial cell proliferation and cell cycle progression by 2-methoxyestradiol</span> <span class="citation_source-journal">Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">219</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.3181%2F00379727-219-44334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=9824543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK1cXnslyqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=1998&pages=211-216&author=F.+Reiserauthor=D.+Wayauthor=M.+Bernasauthor=M.+Witteauthor=C.+Witte&title=Inhibition+of+normal+and+experimental+angiotumor+endothelial+cell+proliferation+and+cell+cycle+progression+by+2-methoxyestradiol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of normal and experimental angiotumor endothelial cell proliferation and cell cycle progression by 2-methoxyestradiol</span></div><div class="casAuthors">Reiser, F.; Way, D.; Bernas, M.; Witte, M.; Witte, C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Society for Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">219</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-216</span>CODEN:
                <span class="NLM_cas:coden">PSEBAA</span>;
        ISSN:<span class="NLM_cas:issn">0037-9727</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">With rapid growth and metab., aggressive cancers require an extensive vascular network, termed tumor angiogenesis.  The body produces a variety of natural angiogenic inhibitors, among which is the mammalian estrogen metabolite, 2-methoxyestradiol (2-MeOE2).  In this study, we compared the effects of 2-MeOE2 on a human umbilical vein cell line (HUVEC-C) and on an immortal, angiotumor-producing rat sinusoidal endothelial cell line (RSE-1).  In vitro, the effects of varying concns. of 2-MeOE2 from 0.01-100.0 μM were measured with cell counts and compared to control cells.  HUVEC-C had an ED50 ∼3.5 μM with ∼27% inhibition of cell growth whereas RSE-1 had an ED50 ∼2.2 μM with ∼50% inhibition of cell growth compared with controls.  The lowest concn. with maximal effect was 10.0 μM 2-MeOE2 for both cell lines.  Using this concn., flow cytometric anal. of cell cycles was performed with propidium iodide stained DNA of HUVEC-C and RSE-1 at 24 and 48 h.  Both demonstrated a significant block at G2M of the cell cycle.  At 48 h, HUVEC-C had 32% of cells in G2M (control = 9% G2M), and RSE-1 had 36% of cells in G2M (control = 18% G2M).  These findings demonstrate a strong in vitro antiproliferative effect of 2-MeOE2 on normal dividing endothelial as well as angiotumor cells mediated through a cell cycle-specific block at G2M.  The antiendothelial, antiangiotumor effect of 2-MeOE2 supports its potential as a therapeutic agent against solid organ cancers, benign or malignant vascular growths, and other pathol. states dependent on angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTRGkZJDPuCLVg90H21EOLACvtfcHk0lgdM0bexL-wSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslyqtLY%253D&md5=2eae49b602a94f37b07c8cd7578f3364</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.3181%2F00379727-219-44334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3181%252F00379727-219-44334%26sid%3Dliteratum%253Aachs%26aulast%3DReiser%26aufirst%3DF.%26aulast%3DWay%26aufirst%3DD.%26aulast%3DBernas%26aufirst%3DM.%26aulast%3DWitte%26aufirst%3DM.%26aulast%3DWitte%26aufirst%3DC.%26atitle%3DInhibition%2520of%2520normal%2520and%2520experimental%2520angiotumor%2520endothelial%2520cell%2520proliferation%2520and%2520cell%2520cycle%2520progression%2520by%25202-methoxyestradiol%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D1998%26volume%3D219%26spage%3D211%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Fotsis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepper, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adlercreutz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montesano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawroth, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweigerer, L.</span><span> </span><span class="NLM_article-title">The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=1994&pages=237-239&author=T.+Fotsisauthor=Y.+Zhangauthor=M.+S.+Pepperauthor=H.+Adlercreutzauthor=R.+Montesanoauthor=P.+P.+Nawrothauthor=L.+Schweigerer&title=The+endogenous+estrogen+metabolite+2-methoxyestradiol+inhibits+angiogenesis+and+suppresses+tumor+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFotsis%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPepper%26aufirst%3DM.%2BS.%26aulast%3DAdlercreutz%26aufirst%3DH.%26aulast%3DMontesano%26aufirst%3DR.%26aulast%3DNawroth%26aufirst%3DP.%2BP.%26aulast%3DSchweigerer%26aufirst%3DL.%26atitle%3DThe%2520endogenous%2520estrogen%2520metabolite%25202-methoxyestradiol%2520inhibits%2520angiogenesis%2520and%2520suppresses%2520tumor%2520growth%26jtitle%3DNature%26date%3D1994%26volume%3D368%26spage%3D237%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">MacCarthy-Morrogh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span> </span><span class="NLM_article-title">Differential effects of estrone and estrone-3-<i>O</i>-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">5441</span><span class="NLM_x">–</span> <span class="NLM_lpage">5450</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=11034086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3cXns1ehtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=5441-5450&author=L.+MacCarthy-Morroghauthor=P.+A.+Townsendauthor=A.+Purohitauthor=H.+A.+M.+Hejazauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=G.+Packham&title=Differential+effects+of+estrone+and+estrone-3-O-sulfamate+derivatives+on+mitotic+arrest%2C+apoptosis%2C+and+microtubule+assembly+in+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells</span></div><div class="casAuthors">MacCarthy-Morrogh, Lucy; Townsend, Paul A.; Purohit, Atul; Hejaz, Hatem A. M.; Potter, Barry V. L.; Reed, Michael J.; Packham, Graham</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5441-5450</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">There is considerable interest in the potential use of estrogen derivs. for the treatment and prevention of breast cancer.  We demonstrated previously that the sulfamoylated estrone deriv. 2-methoxyestrone-3-O-sulfamate (2-MeOEMATE) induced G2-M cell cycle arrest and modest levels of apoptosis in breast cancer cells in vitro, whereas the parent estrone deriv., 2-methoxyestrone, did not, 2-MeOEMATE also induced breast tumor regression in vivo in intact rats.  To further explore the significance of sulfamoylation on the anticancer activity of estrone derivs. and to elucidate their mechanism of action, we synthesized two addnl. agents, 2-ethylestrone and 2-ethylestrone-3-O-sulfamate (2-EtEMATE).  2-MeOEMATE and 2-EtEMATE inhibited the growth of a panel of estrogen receptor-neg. and -pos. breast cancer cell lines in vitro, induced mitotic arrest and apoptosis, and suppressed the long-term clonogenic potential of MCF7 and CAL51 breast cancer cells.  In each assay, the sulfamoylated estrone derivs. were > 10-fold more potent than their parent compds.  The sulfamoylated estrone derivs. were also significantly more potent inhibitors of cell growth than the previously studied endogenous estradiol metabolite 2-methoxyestradiol.  2-MeOEMATE and 2-EtEMATE functioned as antimicrotubule agents and inhibited the ability of paclitaxel to promote tubulin assembly in vitro.  Like other antimicrotubule agents, the sulfamoylated estrone derivs. induced BCL-2 and BCL-XL phosphorylation and increased p53 expression.  2-MeOEMATE and 2-EtEMATE are novel antimicrotubule agents that have potent anticancer activity in breast cancer cells in vitro and may be beneficial as anticancer agents in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwuuBiQck6dLVg90H21EOLACvtfcHk0lgdM0bexL-wSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXns1ehtr8%253D&md5=07ffe177df9adffa388318cc283891ff</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacCarthy-Morrogh%26aufirst%3DL.%26aulast%3DTownsend%26aufirst%3DP.%2BA.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26atitle%3DDifferential%2520effects%2520of%2520estrone%2520and%2520estrone-3-O-sulfamate%2520derivatives%2520on%2520mitotic%2520arrest%252C%2520apoptosis%252C%2520and%2520microtubule%2520assembly%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D5441%26epage%3D5450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Non-steroidal and steroidal sulfamates: new drugs for cancer therapy</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0303-7207%2800%2900428-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=11165021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsVagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2001&pages=129-135&author=A.+Purohitauthor=L.+W.+L.+Wooauthor=D.+Barowauthor=H.+A.+M.+Hejazauthor=R.+I.+Nicholsonauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Non-steroidal+and+steroidal+sulfamates%3A+new+drugs+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Non-steroidal and steroidal sulfamates: new drugs for cancer therapy</span></div><div class="casAuthors">Purohit, A.; Woo, L. W. L.; Barrow, D.; Hejaz, H. A. M.; Nicholson, R. I.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">129-135</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The development of inhibitors to block the formation of estrone and 5-androstenediol from sulfated precursors is an important new strategy for the treatment of breast cancer.  In this study a series of tricyclic coumarin sulfamates (665-668 COUMATE) and a tricyclic oxepin sulfamate have been synthesized and tested for their ability to inhibit estrone sulfatase activity (E1-STS).  In addn. the effect of the steroid-based E1-STS inhibitor, 2-methoxyestrone-3-O-sulfamate (2-MeOEMATE) on the morphol. of MDA-MB-231 cells and breast tumor-derived fibroblasts was also examd.  The tricyclic coumarin sulfamates and oxepin sulfamate were potent inhibitors of E1-STS activity with IC50s ranging from 8 to 250 nM.  Of this series 667 COUMATE was the most potent inhibitor (IC50 = 8 nM) and was three-times more potent than estrone-3-O-sulfamate (EMATE, IC50 = 25 nM). 667 COUMATE did not stimulate the growth of MCF-7 breast cancer cells and is therefore devoid of estrogenicity.  In vivo, 667 COUMATE inhibited E1-STS activity in rat liver tissue to a similar extent to that of EMATE. 2-MeOEMATE had a marked effect on the morphol. of MDA-MB-231 cells and breast tumor-derived fibroblasts causing a significant increase in the no. of rounded cells. 667 COUMATE and 2-MeOEMATE therefore offer considerable potential for development for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq88Wp-vfuf57Vg90H21EOLACvtfcHk0lgdM0bexL-wSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsVagsA%253D%253D&md5=35fea8964370fdbfa57d9186b86a04be</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2FS0303-7207%2800%2900428-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0303-7207%252800%252900428-7%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DBarow%26aufirst%3DD.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DNicholson%26aufirst%3DR.%2BI.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DNon-steroidal%2520and%2520steroidal%2520sulfamates%253A%2520new%2520drugs%2520for%2520cancer%2520therapy%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2001%26volume%3D171%26spage%3D129%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comninos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2803%2900045-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=12711018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFWgs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=317-325&author=J.+M.+Dayauthor=S.+P.+Newmanauthor=A.+Comninosauthor=C.+Solomonauthor=A.+Purohitauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+effects+of+2-substituted+oestrogen+sulphamates+on+the+growth+of+prostate+and+ovarian+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells</span></div><div class="casAuthors">Day, Joanna M.; Newman, Simon P.; Comninos, Alexander; Solomon, Claire; Purohit, Atul; Leese, Matthew P.; Potter, Barry V. L.; Reed, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">317-325</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The human endogenous metabolite 2-methoxyestradiol (2-MeOE2) has been shown to inhibit the proliferation of breast cancer cells.  The authors have previously shown that sulfamoylation of a series of 2-substituted estrogens greatly enhances their ability to inhibit breast cancer cell proliferation and induce apoptosis.  In this study, the authors have investigated the ability of a no. of 2-substituted estrogens and their sulfamoylated derivs. to inhibit the proliferation of two prostate cancer cell lines, an ovarian cancer cell line and its drug-resistant derivs.  2-Methoxyestrone, 2-ethylestrone and 2-ethylestradiol had little effect on the growth of the cell lines tested (IC50>10 μM).  2-MeOE2 did inhibit the growth of the cells (IC50<10 μM), but to a lesser extent than any of the sulfamoylated derivs. tested (IC50<1.0 μM).  Cells treated with the sulfamoylated derivs. became detached and rounded, displaying a characteristic apoptotic appearance.  FACS anal. revealed induced G2/M cell cycle arrest.  Treatment of cells and subsequent drug removal indicated that the effects of the drugs on the cells were irreversible.  Immunoblot anal. indicated that apoptosis may be induced by phosphorylation of BCL-2.  From these studies, 2-substituted estrogen sulfamates are emerging as a potent new class of drug that may be effective against AR+/AR- prostate and ovarian tumors, and against tumors that are resistant to conventional chemotherapeutic regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgRunccQkZ57Vg90H21EOLACvtfcHk0lgk0x-pw5wODQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFWgs7Y%253D&md5=b052e808207ef9dc7db9ece5b5510a7a</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900045-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900045-1%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DComninos%26aufirst%3DA.%26aulast%3DSolomon%26aufirst%3DC.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520effects%2520of%25202-substituted%2520oestrogen%2520sulphamates%2520on%2520the%2520growth%2520of%2520prostate%2520and%2520ovarian%2520cancer%2520cells%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D84%26spage%3D317%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennie, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2Fijc.20045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=14991574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2cXislCisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=533-540&author=S.+P.+Newmanauthor=M.+P.+Leeseauthor=A.+Purohitauthor=D.+R.+C.+Jamesauthor=C.+E.+Rennieauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+in+vitro+angiogenesis+by+2-methoxy-+and+2-ethyl-estrogen+sulfamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates</span></div><div class="casAuthors">Newman, Simon P.; Leese, Mathew P.; Purohit, Atul; James, David. R. C.; Rennie, Catherine E.; Potter, Barry V. L.; Reed, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">533-540</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Sulfamoylation of 2-methoxyestrone (2-MeOE1) was shown previously to enhance its potency as an anti-proliferative agent against breast cancer cells.  We have examd. the ability of a series of 2-methoxyestradiol (2-MeOE2) and 2-ethylestradiol (2-EtE2) sulfamates to inhibit angiogenesis in vitro.  2-MeOE2 bis-sulfamate and 2-EtE2 sulfamate were potent inhibitors of human umbilical vein endothelial cell (HUVEC) proliferation with IC50 values of 0.05 μM and 0.01 μM, resp.  A novel co-culture system, in which endothelial cells were cultured in a matrix of human dermal fibroblasts, was also used to assess the anti-angiogenic potential of these drugs.  In this system endothelial cells proliferate and migrate through the culture matrix to form tubule structures.  Whereas 2-MeOE2 (1.0 μM) caused a small redn. in tubule formation, both 2-MeOE2 bis-sulfamate (0.1 μM) and 2-EtE2 sulfamate (0.1 μM) almost completely abolished tubule formation.  2-MeOE2 bis-sulfamate and 2-EtE2 sulfamate both induced BCL-2 phosphorylation, p53 protein expression and apoptosis in HUVECs.  Microarray anal. of a limited no. of genes known to be involved in the angiogenic process did not show any gross changes in cells treated with the 2-substituted estrogens.  The sulfamoylated derivs. of 2-MeOE2 and 2-EtE2 are potent inhibitors of in vitro angiogenesis and both compds. should have therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjobqvR13TBLVg90H21EOLACvtfcHk0lgk0x-pw5wODQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXislCisro%253D&md5=483da21487f348462926eb1b2b11caad</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1002%2Fijc.20045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20045%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DD.%2BR.%2BC.%26aulast%3DRennie%26aufirst%3DC.%2BE.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520in%2520vitro%2520angiogenesis%2520by%25202-methoxy-%2520and%25202-ethyl-estrogen%2520sulfamates%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2004%26volume%3D109%26spage%3D533%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Ireson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">932</span><span class="NLM_x">–</span> <span class="NLM_lpage">937</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1038%2Fsj.bjc.6601591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=14970876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2cXht12itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=932-937&author=C.+R.+Iresonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=S.+Pereraauthor=S.+P.+Newmanauthor=D.+Parishauthor=M.+P.+Leeseauthor=A.+C.+Smithauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Pharmacokinetics+and+efficacy+of+2-methoxyoestradiol+and+2-methoxyoestradiol-bis-sulphamate+in+vivo+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents</span></div><div class="casAuthors">Ireson, C. R.; Chander, S. K.; Purohit, A.; Perera, S.; Newman, S. P.; Parish, D.; Leese, M. P.; Smith, A. C.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">932-937</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">2-Methoxyoestradiol (2-MeOE2) is an endogenous estrogen metabolite that inhibits the proliferation of cancer cells in vitro, and it is also antiangiogenic.  In vivo 2-MeOE2, when administered at relatively high doses, inhibits the growth of tumors derived from breast cancer cells, sarcomas and melanomas.  Sulphamoylated derivs. of 2-MeOE2 are more potent inhibitors of in vitro breast cancer cell growth than 2-MeOE2.  In the present study, the authors have compared the pharmacokinetic profiles and metab. of 2-MeOE2 and its sulfamoylated deriv., 2-methoxyestradiol-bis-sulfamate (2-MeOE2bisMATE), in adult female rats.  Their ability to inhibit tumor growth was compared in nude mice bearing xenografts derived from MDA-MB-435 (estrogen receptor neg.) melanoma cancer cells.  After a single oral 10 mg kg-1 dose of 2-MeOE2bisMATE, significant concns. of this compd. were still detectable at 24 h.  In contrast, no 2-MeOE2 or metabolites were detected in plasma at any time after a 10 mg kg-1 oral dose.  Thus, the bioavailability of 2-MeOE2 is very low, whereas for 2-MeOE2bisMATE it was 85%.  No significant metabolites of 2-MeOE2bisMATE were detected in plasma after oral or i.v. dosing, showing that this drug is resistant to metab.  In the tumor efficacy model, oral administration of 2-MeOE2bisMATE, at 20 mg kg-1 day-1 daily for 28 days, almost completely inhibited tumor growth.  Inhibition of tumor growth was maintained for a further 28 days after the cessation of dosing.  At this dose level, 2-MeOE2 did not inhibit tumor growth.  The resistance to metab. shown by 2-MeOE2bisMATE and its ability to inhibit tumor growth in vivo suggest that this compd. should have considerable potential for development as a novel anticancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogMoiaDGhPlLVg90H21EOLACvtfcHk0lgk0x-pw5wODQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXht12itbY%253D&md5=e92f1f7f94f9d2fdb3afad25cc41903d</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6601591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6601591%26sid%3Dliteratum%253Aachs%26aulast%3DIreson%26aufirst%3DC.%2BR.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPerera%26aufirst%3DS.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DParish%26aufirst%3DD.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DPharmacokinetics%2520and%2520efficacy%2520of%25202-methoxyoestradiol%2520and%25202-methoxyoestradiol-bis-sulphamate%2520in%2520vivo%2520in%2520rodents%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2004%26volume%3D90%26spage%3D932%26epage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judde, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassalle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevost, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1158%2F1078-0432.CCR-07-1717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18223236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=597-606&author=S.+P.+Newmanauthor=P.+A.+Fosterauthor=C.+Stengelauthor=J.+M.+Dayauthor=Y.+T.+Hoauthor=J.+G.+Juddeauthor=M.+Lassalleauthor=G.+Prevostauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=STX140+is+efficacious+in+vitro+and+in+vivo+in+taxane-resistant+breast+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">STX140 Is Efficacious In vitro and In vivo in Taxane-Resistant Breast Carcinoma Cells</span></div><div class="casAuthors">Newman, Simon P.; Foster, Paul A.; Stengel, Chloe; Day, Joanna M.; Ho, Yaik T.; Judde, Jean-Gabriel; Lassalle, Myriam; Prevost, Gregoire; Leese, Mathew P.; Potter, Barry V. L.; Reed, Michael J.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The aim of these studies was to characterize the action of STX140 in a P-glycoprotein-overexpressing tumor cell line both in vitro and in vivo.  In addn., its efficacy was detd. against xenografts derived from patients who failed docetaxel therapy.  Exptl. Design: The effects of STX140, Taxol, and 2-methoxyestradiol (2-MeOE2) on cell proliferation, cell cycle, and apoptosis were assessed in vitro in drug-resistant cells (MCF-7DOX) and the parental cell line (MCF-7WT).  Mice bearing an MCF-7DOX tumor on one flank and an MCF-7WT tumor on the other flank were used to assess the in vivo efficacy.  Furthermore, the responses to STX140 of three xenografts, derived from drug-resistant patients, were assessed.  RESULTS: In this study, STX140 caused cell cycle arrest, cyclin B1 induction, and subsequent apoptosis of both MCF-7DOX and MCF-7WT cells.  Taxol and 2-MeOE2 were only active in the MCF-7WT parental cell line.  Although both STX140 and Taxol inhibited the growth of xenografts derived from MCF-7WT cells, only STX140 inhibited the growth of tumors derived from MCF-7DOX cells. 2-MeOE2 was ineffective at the dose tested against both tumor types.  Two out of the three newly derived docetaxel-resistant xenografts, including a metastatic triple-neg. tumor, responded to STX140 but not to docetaxel treatment.  CONCLUSIONS: STX140 shows excellent efficacy in both MCF-7WT and MCF-7DOX breast cancer xenograft models, in contrast to Taxol and 2-MeOE2.  The clin. potential of STX140 was further highlighted by the efficacy seen in xenografts recently derived from patients who had failed on taxane therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3lf55ZqF0FLVg90H21EOLACvtfcHk0likqxPZb2k0aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKhtrk%253D&md5=8bfc633408bab42c4ccf5eab3d0e68c5</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1717%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DJudde%26aufirst%3DJ.%2BG.%26aulast%3DLassalle%26aufirst%3DM.%26aulast%3DPrevost%26aufirst%3DG.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DSTX140%2520is%2520efficacious%2520in%2520vitro%2520and%2520in%2520vivo%2520in%2520taxane-resistant%2520breast%2520carcinoma%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D597%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Tagg, S. L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span> </span><span class="NLM_article-title">2-Methoxyoestradiol-3,17-<i>O</i>,<i>O</i>-bis-sulphamate and 2-deoxy-<span class="smallcaps smallerCapital">d</span>-glucose in combination: a potential treatment for breast and prostate cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">1842</span><span class="NLM_x">–</span> <span class="NLM_lpage">1848</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1038%2Fsj.bjc.6604752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18985042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVajtbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=1842-1848&author=S.+L.+C.+Taggauthor=P.+A.+Fosterauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohitauthor=S.+P.+Newman&title=2-Methoxyoestradiol-3%2C17-O%2CO-bis-sulphamate+and+2-deoxy-d-glucose+in+combination%3A+a+potential+treatment+for+breast+and+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer</span></div><div class="casAuthors">Tagg, S. L. C.; Foster, P. A.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A.; Newman, S. P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1842-1848</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drug combination therapy is a key strategy to improve treatment efficacy and survival of cancer patients.  In this study the effects of combining 2-methoxyoestradiol-3,17-O,O-bis-sulphamate (STX140), a microtubule disruptor, with 2-deoxy--glucose (2DG) were assessed in MCF-7 (breast) and LNCaP (prostate) xenograft models in vivo.  In mice bearing MCF-7 xenografts, daily p.o. administration of STX140 (5 mg kg-1) resulted in a 46% (P<0.05) redn. of tumor vol.  However, the combination of STX140 (5 mg kg-1 p.o.) and 2DG (2 g kg-1 i.p.) reduced tumor vol. by 76% (P<0.001). 2-Methoxyoestradiol-3,17-O,O-bis-sulphamate also reduced tumor vessel d. 2-Deoxy--glucose alone had no significant effect on tumor vol. or vessel d.  A similar benefit of the combination treatment was obsd. in the LNCaP prostate xenograft model.  In vitro the degree of inhibition of cell proliferation by STX140 was unaffected by oxygen concns.  In contrast, the inhibition of proliferation by 2DG was enhanced under hypoxia by 20 and 25% in MCF-7 and LNCaP cells, resp.  The combination of STX140 and 2DG in LNCaP cells under normoxia or hypoxia inhibited proliferation to a greater extent than either compd. alone.  These results suggest that the antiangiogenic and microtubule disruption activities of STX140 may make tumors more susceptible to inhibition of glycolysis by 2DG.  This is the first study to show the benefit of combining a microtubule disruptor with 2DG in the two most common solid tumors.  British Journal of Cancer (2008) 99, 1842-1848. doi:10.1038/sj.bjc.6604752 www.bjcancer.com Published online 4 Nov. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG7rOAzcZP97Vg90H21EOLACvtfcHk0likqxPZb2k0aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVajtbvO&md5=da1ec76fbe26eea3216818b583af24e1</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604752%26sid%3Dliteratum%253Aachs%26aulast%3DTagg%26aufirst%3DS.%2BL.%2BC.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26atitle%3D2-Methoxyoestradiol-3%252C17-O%252CO-bis-sulphamate%2520and%25202-deoxy-d-glucose%2520in%2520combination%253A%2520a%2520potential%2520treatment%2520for%2520breast%2520and%2520prostate%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D99%26spage%3D1842%26epage%3D1848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Meyer-Losic, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span> </span><span class="NLM_article-title">STX140, but not Paclitaxel, inhibits mammary tumor initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e80305</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e80305&author=F.+Meyer-Losicauthor=S.+P.+Newmanauthor=J.+M.+Dayauthor=M.+J.+Reedauthor=P.+G.+Kasprzykauthor=A.+Purohitauthor=P.+A.+Foster&title=STX140%2C+but+not+Paclitaxel%2C+inhibits+mammary+tumor+initiation+and+progression+in+C3%281%29%2FSV40+T%2Ft-antigen+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer-Losic%26aufirst%3DF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26atitle%3DSTX140%252C%2520but%2520not%2520Paclitaxel%252C%2520inhibits%2520mammary%2520tumor%2520initiation%2520and%2520progression%2520in%2520C3%25281%2529%252FSV40%2520T%252Ft-antigen%2520transgenic%2520mice%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De80305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Raobaikady, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-<i>O</i>-sulphamates</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2Fijc.21066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15880363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVaht7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2005&pages=150-159&author=B.+Raobaikadyauthor=M.+J.+Reedauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=A.+Purohit&title=Inhibition+of+MDA-MB-231+cell+cycle+progression+and+cell+proliferation+by+C-2-substituted+oestradiol+mono-+and+bis-3-O-sulphamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-O-sulphamates</span></div><div class="casAuthors">Raobaikady, Bindumalini; Reed, Michael J.; Leese, Mathew P.; Potter, Barry V. L.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-159</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A natural metabolite of estradiol (E2), 2-methoxyestradiol (2-MeOE2), exerts both antitumor and antiangiogenic effects.  2-MeOE2 is currently in clin. trials for the treatment of a variety of cancers.  We have previously shown that a no. of sulfamoylated analogs of 2-MeOE2 possess enhanced potency and bioavailability with respect to 2-MeOE2.  In our study, the effects of C-2-substituted E2 derivs., with sulfamoylation at the C-3 and/or C-17 position, on ERα -ve MDA-MB-231 breast cancer cells were evaluated.  Sulfamoylated derivs. were potent inhibitors of cell proliferation, and these effects were irreversible when compared to growth inhibitory effects induced by 2-MeOE2.  Cell cycle anal. suggested that these derivs. caused cells to arrest at the G2-M phase of the cell cycle.  Sulfamoylated analogs suppressed the clonogenic potential of MDA-MB-231 cells and also their growth on Matrigel culture substratum.  Immunofluorescence studies showed fragmented nuclear bodies and an abnormal microtubule cytoskeleton in cells exposed to one of the potent compds., 2-MeOE2-bis-sulfamate.  In addn., these analogs induced phosphorylation of BCL-2, a protein considered to be the guardian of microtubule integrity.  In each of the assays, the sulfamoylated derivs. were at least 10-fold more potent than the parent compd. 2-MeOE2.  In view of the enhanced potencies assocd. with sulfamoylated E2 derivs. in ERα -ve cells, these analogs should hold considerable therapeutic potential for the treatment of hormone-independent breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL0ol5PcTw_7Vg90H21EOLACvtfcHk0likqxPZb2k0aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVaht7vF&md5=1c97e2a89074dcabef7283b12b21c890</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1002%2Fijc.21066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.21066%26sid%3Dliteratum%253Aachs%26aulast%3DRaobaikady%26aufirst%3DB.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520MDA-MB-231%2520cell%2520cycle%2520progression%2520and%2520cell%2520proliferation%2520by%2520C-2-substituted%2520oestradiol%2520mono-%2520and%2520bis-3-O-sulphamates%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2005%26volume%3D117%26spage%3D150%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">2-MeOE2<i>bis</i>MATE and 2-EtE2<i>bis</i>MATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-007-9791-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=17957467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVCntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=251-260&author=P.+A.+Fosterauthor=Y.+T.+Hoauthor=S.+P.+Newmanauthor=P.+G.+Kasprzykauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=2-MeOE2bisMATE+and+2-EtE2bisMATE+induce+cell+cycle+arrest+and+apoptosis+in+breast+cancer+xenografts+as+shown+by+a+novel+ex+vivo+technique"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique</span></div><div class="casAuthors">Foster, Paul A.; Ho, Yaik T.; Newman, Simon P.; Kasprzyk, Philip G.; Leese, Mathew P.; Potter, Barry V. L.; Reed, Michael J.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-260</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Breast cancer is the leading cause of cancer deaths among women worldwide.  The theory of targeting both cancer cells directly and their blood supply has significant therapeutic potential.  However, to date, there are few clin. successful single agents that meet these criteria. 2-Methoxyestradiol-3,17-O,O-bis-sulfamate (2-MeOE2bisMATE) and 2-ethylestradiol-3,17-O,O-bis-sulfamate (2-EtE2bisMATE) are potent inhibitors of proliferation in a range of cancer cells.  The work presented here demonstrates the potent in vitro and in vivo effects of these compds.  They cause apoptosis via the intrinsic mitochondrial pathway in both MDA-MB-231 breast cancer cells and endothelial cells.  Furthermore, they are potent anti-angiogenic inhibitors in vivo, as shown by their ability to reduce endothelial staining in MDA-MB-231 xenograft tumors.  We have developed a novel, flow cytometry based, ex vivo method which shows in cells recovered from MDA-MB-231 tumors treated with 2-MeOE2bisMATE and 2-EtE2bisMATE an increase in intra-tumoral G2-M arrest and apoptosis.  The degree of apoptosis inversely correlates to tumor vol.  Further in vivo studies reveal that both 2-MeOE2bisMATE and 2-EtE2bisMATE are orally bioavailable and extremely efficacious when compared to clin. tested drugs.  As these compds. are anti-proliferative against breast cancer and endothelial cells they have the potential to be potent, dual acting clin. drugs of the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgbHCFTBrF2bVg90H21EOLACvtfcHk0ljzJDT4pVYN0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVCntL0%253D&md5=ea4861632e9bfb78b8c0d4d47e551147</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1007%2Fs10549-007-9791-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-007-9791-5%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3D2-MeOE2bisMATE%2520and%25202-EtE2bisMATE%2520induce%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520in%2520breast%2520cancer%2520xenografts%2520as%2520shown%2520by%2520a%2520novel%2520ex%2520vivo%2520technique%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2008%26volume%3D111%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Mabjeesh, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escuin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVallee, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pribluda, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannakakou, P.</span><span> </span><span class="NLM_article-title">2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=363-375&author=N.+J.+Mabjeeshauthor=D.+Escuinauthor=T.+M.+LaValleeauthor=V.+S.+Pribludaauthor=G.+M.+Swartzauthor=M.+S.+Johnsonauthor=M.+T.+Willardauthor=H.+Zhongauthor=J.+W.+Simonsauthor=P.+Giannakakou&title=2ME2+inhibits+tumor+growth+and+angiogenesis+by+disrupting+microtubules+and+dysregulating+HIF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMabjeesh%26aufirst%3DN.%2BJ.%26aulast%3DEscuin%26aufirst%3DD.%26aulast%3DLaVallee%26aufirst%3DT.%2BM.%26aulast%3DPribluda%26aufirst%3DV.%2BS.%26aulast%3DSwartz%26aufirst%3DG.%2BM.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DWillard%26aufirst%3DM.%2BT.%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DSimons%26aufirst%3DJ.%2BW.%26aulast%3DGiannakakou%26aufirst%3DP.%26atitle%3D2ME2%2520inhibits%2520tumor%2520growth%2520and%2520angiogenesis%2520by%2520disrupting%2520microtubules%2520and%2520dysregulating%2520HIF%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D363%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Semenza, G. L.</span><span> </span><span class="NLM_article-title">Signal transduction to hypoxia-inducible factor 1</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=993-998&author=G.+L.+Semenza&title=Signal+transduction+to+hypoxia-inducible+factor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DSignal%2520transduction%2520to%2520hypoxia-inducible%2520factor%25201%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D993%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Kopacek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barathova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dequiedt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepelakova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorekova, S.</span><span> </span><span class="NLM_article-title">MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1729</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1729&publication_year=2005&pages=41-49&author=J.+Kopacekauthor=M.+Barathovaauthor=F.+Dequiedtauthor=J.+Sepelakovaauthor=R.+Kettmannauthor=J.+Pastorekauthor=S.+Pastorekova&title=MAPK+pathway+contributes+to+density-+and+hypoxia-induced+expression+of+the+tumor-associated+carbonic+anhydrase+IX"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopacek%26aufirst%3DJ.%26aulast%3DBarathova%26aufirst%3DM.%26aulast%3DDequiedt%26aufirst%3DF.%26aulast%3DSepelakova%26aufirst%3DJ.%26aulast%3DKettmann%26aufirst%3DR.%26aulast%3DPastorek%26aufirst%3DJ.%26aulast%3DPastorekova%26aufirst%3DS.%26atitle%3DMAPK%2520pathway%2520contributes%2520to%2520density-%2520and%2520hypoxia-induced%2520expression%2520of%2520the%2520tumor-associated%2520carbonic%2520anhydrase%2520IX%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1729%26spage%3D41%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Monti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span> </span><span class="NLM_article-title">Anticancer carbonic anhydrase inhibitors: a patent review (2008–2013)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1517%2F13543776.2013.798648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23672415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsl2qtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=737-749&author=S.+M.+Montiauthor=C.+T.+Supuranauthor=G.+De+Simone&title=Anticancer+carbonic+anhydrase+inhibitors%3A+a+patent+review+%282008%E2%80%932013%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013)</span></div><div class="casAuthors">Monti, Simona Maria; Supuran, Claudiu T.; De Simone, Giuseppina</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">737-749</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Human carbonic anhydrases (EC 4.2.1.1) IX (hCA IX) and XII (hCA XII) are two tumor-assocd. proteins, being overexpressed in many tumors and involved in crit. processes assocd. with cancer progression and response to therapy.  Both are multi-domain proteins consisting of an extracellular catalytic domain (CA), a transmembrane portion (TM) and an intracytoplasmic (IC) segment.  These domains have peculiar biochem. and physiol. features.  CA IX contains an addnl. proteoglycan-like (PG) domain at the N-terminus which constitutes a unique feature of this enzyme within the CA family.Areas covered: Starting from a brief description of the main mol. and catalytic features of both enzymes, their role in tumor physiol. and their three-dimensional structure, this review describes the main classes of small mol. inhibitors, investigated between 2008 and 2013, able to inhibit these enzymes for both diagnostic and therapeutic applications.Expert opinion: A consistent no. of patents on mols. able to inhibit the catalytic activity of CA IX and CA XII have been recently reported.  Most patents deal with classical sulfonamide derivs., demonstrating that introducing suitable substituents on the inhibitor scaffold, good selectivity can be obtained.  However, the most impressive results are related to compds. contg. novel chemotypes, such as coumarins and thiocumarins.  Thus, it is expected that research in next future will be more dedicated to the development of mols. contg. new chemotypes and a large no. of studies in such field have already been published demonstrating the role of these enzymes in carcinogenesis and metastases formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJBAG0RpDlALVg90H21EOLACvtfcHk0ljzJDT4pVYN0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsl2qtrY%253D&md5=8169a6fa6a70f75654492a326af5a376</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.798648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.798648%26sid%3Dliteratum%253Aachs%26aulast%3DMonti%26aufirst%3DS.%2BM.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26atitle%3DAnticancer%2520carbonic%2520anhydrase%2520inhibitors%253A%2520a%2520patent%2520review%2520%25282008%25E2%2580%25932013%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D737%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Benej, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorkova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorek, J.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase IX: regulation and role in cancer</span> <span class="citation_source-journal">Subcell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2F978-94-007-7359-2_11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=24146381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252Foslekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=199-219&author=M.+Benejauthor=S.+Pastorkovaauthor=J.+Pastorek&title=Carbonic+anhydrase+IX%3A+regulation+and+role+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic anhydrase IX: regulation and role in cancer</span></div><div class="casAuthors">Benej Martin; Pastorekova Silvia; Pastorek Jaromir</div><div class="citationInfo"><span class="NLM_cas:title">Sub-cellular biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">199-219</span>
        ISSN:<span class="NLM_cas:issn">0306-0225</span>.
    </div><div class="casAbstract">Tumor microenvironment substantially influences the process of tumorigenesis.  In many solid tumors, imbalance between the demand of rapidly proliferating cancer cells and the capabilities of the vascular system generates areas with insufficient oxygen supply.  In response to tumor hypoxia, cancer cells modulate their gene expression pattern to match the requirements of the altered microenvironment.  One of the most significant adaptations to this milieu is the shift towards anaerobic glycolysis to keep up the energy demands.  This oncogenic metabolism is often maintained also in aerobic cells.  Lactic acid, its metabolic end-product, accumulates hand-in-hand with carbon dioxide, leading to acidification of the extracellular environment.  Carbonic anhydrase IX (CA IX) is the most widely expressed gene in response to hypoxia.  Its crucial role in intracellular pH maintenance represents the means by which cancer cells adapt to the toxic conditions of the extracellular milieu.  Furthermore, the activity of CA IX stimulates the migratory pathways of cancer cells and is connected with the increase of the aggressive/invasive phenotype of tumors.  CA IX expression in many types of tumors indicates its relevance as a general marker of tumor hypoxia.  Moreover, its expression is closely related to prognosis of the clinical outcome in several tumor types.  All above mentioned facts support the strong position of CA IX as a potential drug therapy target.  Here, we summarize the state-of-the-art knowledge on its regulation and role in cancer development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTEEmqyE37O0WHOrQ6qeX-mfW6udTcc2eZOKl-bhjEZJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252Foslekuw%253D%253D&md5=5e8c2942814e8fbe7e6c2b70f75b8017</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1007%2F978-94-007-7359-2_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-94-007-7359-2_11%26sid%3Dliteratum%253Aachs%26aulast%3DBenej%26aufirst%3DM.%26aulast%3DPastorkova%26aufirst%3DS.%26aulast%3DPastorek%26aufirst%3DJ.%26atitle%3DCarbonic%2520anhydrase%2520IX%253A%2520regulation%2520and%2520role%2520in%2520cancer%26jtitle%3DSubcell.%2520Biochem.%26date%3D2014%26volume%3D75%26spage%3D199%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span> </span><span class="NLM_article-title">Sulfonamides and their isosteres as carbonic anhydrase inhibitors</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.4155%2Ffmc.14.68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=25078135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyjurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1149-1165&author=F.+Cartaauthor=C.+T.+Supuranauthor=A.+Scozzafava&title=Sulfonamides+and+their+isosteres+as+carbonic+anhydrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides and their isosters as carbonic anhydrase inhibitors</span></div><div class="casAuthors">Carta, Fabrizio; Supuran, Claudiu T.; Scozzafava, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1149-1165</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Mols. contg. the sulfonamide group (R-SO2NH2) as well as its structurally related isosters, sulfamido (R-NH-SO2NH2) and sulfamato (R-O-SO2NH2), constitute the most important class of inhibitors acting on the metalloenzyme carbonic anhydrase (EC 4.2.1.1).  Despite their presence in the literature, in general the reports lack of a clear and org. overview linking the main structural features of the clin. used inhibitors with the therapeutic aspects.  The current review is intended to highlight the structural basis of the interactions of sulfonamide-like groups within the active site of the carbonic anhydrases and will summarize the clin. use of the most interesting mols. for the treatment of relevant pathologies, such as glaucoma, obesity, cancer and CNS-affecting diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW53ZOzAOKlbVg90H21EOLACvtfcHk0lhL0KqyQIWT_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyjurjM&md5=4f69d9467027c4cafe72e51bdadbbd9d</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.68%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DScozzafava%26aufirst%3DA.%26atitle%3DSulfonamides%2520and%2520their%2520isosteres%2520as%2520carbonic%2520anhydrase%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1149%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Cozier, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiyagarajan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Structures of human carbonic anhydrase II/inhibitor complexes reveal a second binding site for steroidal and nonsteroidal inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3464</span><span class="NLM_x">–</span> <span class="NLM_lpage">3476</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi902178w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFerurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3464-3476&author=G.+E.+Cozierauthor=M.+P.+Leeseauthor=M.+D.+Lloydauthor=M.+D.+Bakerauthor=N.+Thiyagarajanauthor=K.+R.+Acharyaauthor=B.+V.+L.+Potter&title=Structures+of+human+carbonic+anhydrase+II%2Finhibitor+complexes+reveal+a+second+binding+site+for+steroidal+and+nonsteroidal+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Carbonic Anhydrase II/Inhibitor Complexes Reveal a Second Binding Site for Steroidal and Nonsteroidal Inhibitors,</span></div><div class="casAuthors">Cozier, Gyles E.; Leese, Mathew P.; Lloyd, Matthew D.; Baker, Matthew D.; Thiyagarajan, Nethaji; Acharya, K. Ravi; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3464-3476</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carbonic anhydrase (CA) catalyzes the reversible hydration of carbon dioxide to hydrogen carbonate, and its role in maintaining pH balance has made it an attractive drug target.  Steroidal sulfamate esters, inhibitors of the cancer drug target steroid sulfatase (STS), are sequestered in vivo by CA II in red blood cells, which may be the origin of their excellent drug properties.  Understanding the structural basis of this is important for drug design.  Structures of CA II complexed with 2-methoxyestradiol 3-O-sulfamate (3), 2-ethylestradiol 3,17-O,O-bis(sulfamate) (4), and 2-methoxyestradiol 17-O-sulfamate (5) are reported to 2.10, 1.85, and 1.64 Å, resp.  Inhibitor 3 interacts with the active site Zn(II) ion through the 3-O-sulfamate, while inhibitors 4 and 5 bind through their 17-O-sulfamate.  Comparison of the IC50 values for CA II inhibition gave resp. values of 56, 662, 2113, 169, 770, and 86 nM for estrone 3-O-sulfamate (1), 2-methoxyestradiol 3,17-O,O-bis(sulfamate) (2), 3, 4, 5, and 5'-((4H-1,2,4-triazol-4-yl)methyl)-3-chloro-2'-cyanobiphenyl-4-yl sulfamate (6), a non-steroidal dual aromatase-sulfatase inhibitor.  Inhibitors 2, 5, and 6 showed binding to a second adjacent site that is capable of binding both steroidal and non-steroidal ligands.  Examn. of both IC50 values and crystal structures suggests that 2-substituents on the steroid nucleus hinder binding via a 3-O-sulfamate, leading to coordination through a 17-O-sulfamate if present.  These results underline the influence of small structural changes on affinity and mode of binding, the degree of flexibility in the design of sulfamate-based inhibitors, and suggest a strategy for inhibitors which interact with both the active site and the second adjacent binding site simultaneously that could be both potent and selective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouImDNqlqiM7Vg90H21EOLACvtfcHk0lhL0KqyQIWT_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFerurY%253D&md5=067581896020abe3bb6e49b17063d22f</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fbi902178w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi902178w%26sid%3Dliteratum%253Aachs%26aulast%3DCozier%26aufirst%3DG.%2BE.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DThiyagarajan%26aufirst%3DN.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DStructures%2520of%2520human%2520carbonic%2520anhydrase%2520II%252Finhibitor%2520complexes%2520reveal%2520a%2520second%2520binding%2520site%2520for%2520steroidal%2520and%2520nonsteroidal%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D3464%26epage%3D3476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">De Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alterio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1517%2F17460441.2013.795145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23627619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslCnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=793-810&author=G.+De+Simoneauthor=V.+Alterioauthor=C.+T.+Supuran&title=Exploiting+the+hydrophobic+and+hydrophilic+binding+sites+for+designing+carbonic+anhydrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors</span></div><div class="casAuthors">De Simone, Giuseppina; Alterio, Vincenzo; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">793-810</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Carbonic anhydrases (CAs, EC 4.2.1.1) exist as five genetically distinct families (α, β, γ, δ and ζ) in organisms all over the phylogenetic tree.  Due to the ubiquity of such enzymes, the selective inhibition and polypharmacol. of inhibitors is an important aspect of all drug design campaigns.  There are several classes of CA inhibitors (CAIs): i) metal ion binders (sulfonamides and their isosteres [sulfamates/sulfamides], dithiocarbamates, mercaptans and hydroxamates); ii) compds. anchoring to the zinc-coordinated water mol./hydroxide ion (phenols, carboxylates, polyamines, esters and sulfocoumarins) and iii) coumarins and related compds. which apparently bind even further away from the metal ion.  Areas covered: The authors rationalize the drug design strategies of inhibitors belonging to the first two classes, based on recent X-ray crystallog. data.  More precisely, this is achieved by analyzing how the hydrophobic and hydrophilic halves of the enzyme active site interact with inhibitors.  This task has been eased by the recent report of β-CA-like enzymes possessing carbon disulfide and carbonyl sulfide hydrolase activities, resp., allowing the authors to propose a general approach of structure-based drug design of CAIs.  Expert opinion: Although amazing progress has been made in the structure-based drug design of CAIs, this field is still in progress, with many constantly emerging new findings.  Indeed, several new such enzymes were discovered and characterized recently and novel chemotypes were explored for finding compds. with a better inhibition profile.  It is anticipated that this will continue to be one of the main frontiers in the search of pharmacol. relevant enzyme inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolHwWEtsN36rVg90H21EOLACvtfcHk0lhbEA2rpN2l-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslCnsb0%253D&md5=a17278d030023ae0a92e1efd33531e93</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.795145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.795145%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DExploiting%2520the%2520hydrophobic%2520and%2520hydrophilic%2520binding%2520sites%2520for%2520designing%2520carbonic%2520anhydrase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D793%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Tars, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vullo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazaks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lends, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalubovskis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301625s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=293-300&author=K.+Tarsauthor=D.+Vulloauthor=A.+Kazaksauthor=J.+Leitansauthor=A.+Lendsauthor=A.+Grandaneauthor=R.+Zalubovskisauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Sulfocoumarins+%281%2C2-benzoxathiine-2%2C2-dioxides%29%3A+a+class+of+potent+and+isoform-selective+inhibitors+of+tumor-associated+carbonic+anhydrases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fjm301625s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301625s%26sid%3Dliteratum%253Aachs%26aulast%3DTars%26aufirst%3DK.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DKazaks%26aufirst%3DA.%26aulast%3DLeitans%26aufirst%3DJ.%26aulast%3DLends%26aufirst%3DA.%26aulast%3DGrandane%26aufirst%3DA.%26aulast%3DZalubovskis%26aufirst%3DR.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DSulfocoumarins%2520%25281%252C2-benzoxathiine-2%252C2-dioxides%2529%253A%2520a%2520class%2520of%2520potent%2520and%2520isoform-selective%2520inhibitors%2520of%2520tumor-associated%2520carbonic%2520anhydrases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D293%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Alterio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkkila, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaloni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorekova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span> </span><span class="NLM_article-title">Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">16233</span><span class="NLM_x">–</span> <span class="NLM_lpage">16238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1073%2Fpnas.0908301106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=19805286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Kqt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=16233-16238&author=V.+Alterioauthor=M.+Hilvoauthor=A.+Di+Fioreauthor=C.+T.+Supuranauthor=P.+Panauthor=S.+Parkkilaauthor=A.+Scaloniauthor=J.+Pastorekauthor=S.+Pastorekovaauthor=C.+Pedoneauthor=A.+Scozzafavaauthor=S.+M.+Montiauthor=G.+De+Simone&title=Crystal+structure+of+the+catalytic+domain+of+the+tumor-associated+human+carbonic+anhydrase+IX"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX</span></div><div class="casAuthors">Alterio, Vincenzo; Hilvo, Mika; Di Fiore, Anna; Supuran, Claudiu T.; Pan, Peiwen; Parkkil, Seppo; Scaloni, Andrea; Pastorek, Jaromir; Pastorekova, Silvia; Pedone, Carlo; Scozzafava, Andrea; Monti, Simona Maria; De Simone, Giuseppina</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">16233-16238, S16233/1-S16233/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Carbonic anhydrase (CA) IX is a plasma membrane-assocd. member of the α-CA enzyme family, which is involved in solid tumor acidification.  It is a marker of tumor hypoxia and a prognostic factor in several human cancers.  An aberrant increase in CA IX expression in chronic hypoxia and during development of various carcinomas contributes to tumorigenesis through at least two mechanisms: pH regulation and cell adhesion control.  Here, we report the X-ray structure of the catalytic domain of CA IX in complex with a classical, clin. used sulfonamide inhibitor, acetazolamide.  The structure reveals a typical α-CA fold, which significantly differs from the other CA isoenzymes when the protein quaternary structure is considered.  Thus, two catalytic domains of CA IX assoc. to form a dimer, which is stabilized by the formation of an intermol. disulfide bond.  The active site clefts and the PG domains are located on one face of the dimer, while the C-termini are located on the opposite face to facilitate protein anchoring to the cell membrane.  A correlation between the three-dimensional structure and the physiol. role of the enzyme is suggested, based on the measurement of the pH profile of the catalytic activity for the physiol. reaction, CO2 hydration to bicarbonate and protons.  On the basis of the structural differences obsd. between CA IX and the other membrane-assocd. α-CAs, further prospects for the rational drug design of isoenzyme- specific CA inhibitors are proposed, given that inhibition of this enzyme shows antitumor activity both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw4V_A2HME-7Vg90H21EOLACvtfcHk0lhbEA2rpN2l-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Kqt7nL&md5=2c3d3a64d3d4c19a69609c8ae3c9905c</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908301106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908301106%26sid%3Dliteratum%253Aachs%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DHilvo%26aufirst%3DM.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPan%26aufirst%3DP.%26aulast%3DParkkila%26aufirst%3DS.%26aulast%3DScaloni%26aufirst%3DA.%26aulast%3DPastorek%26aufirst%3DJ.%26aulast%3DPastorekova%26aufirst%3DS.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DS.%2BM.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26atitle%3DCrystal%2520structure%2520of%2520the%2520catalytic%2520domain%2520of%2520the%2520tumor-associated%2520human%2520carbonic%2520anhydrase%2520IX%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D16233%26epage%3D16238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaukroger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of C-17 cyano-substituted estratrienes as anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701319c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1295-1308&author=M.+P.+Leeseauthor=F.+L.+Jourdanauthor=K.+Gaukrogerauthor=M.+F.+Mahonauthor=S.+P.+Newmanauthor=P.+A.+Fosterauthor=C.+Stengelauthor=S.+Regis-Lydiauthor=E.+Ferrandisauthor=A.+Di+Fioreauthor=G.+De+Simoneauthor=C.+T.+Supuranauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Structure%E2%80%93activity+relationships+of+C-17+cyano-substituted+estratrienes+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fjm701319c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701319c%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%2BL.%26aulast%3DGaukroger%26aufirst%3DK.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520C-17%2520cyano-substituted%2520estratrienes%2520as%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1295%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Fischer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">D-Ring modified estrone derivatives as novel potent inhibitors of sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1685</span><span class="NLM_x">–</span> <span class="NLM_lpage">1700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1685-1700&author=D.+S.+Fischerauthor=L.+W.+L.+Wooauthor=M.+F.+Mahonauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=D-Ring+modified+estrone+derivatives+as+novel+potent+inhibitors+of+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DD.%2BS.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DD-Ring%2520modified%2520estrone%2520derivatives%2520as%2520novel%2520potent%2520inhibitors%2520of%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1685%26epage%3D1700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Fischer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Novel D-ring modified steroid derivatives as potent, non-estrogenic, sulfatase inhibitors with in vivo activity</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2803%2900048-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=12711021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFWgsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=343-349&author=D.+S.+Fischerauthor=S.+K.+Chanderauthor=L.+W.+L.+Wooauthor=J.+C.+Fentonauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Novel+D-ring+modified+steroid+derivatives+as+potent%2C+non-estrogenic%2C+sulfatase+inhibitors+with+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity</span></div><div class="casAuthors">Fischer, Delphine S.; Chander, Surinder K.; Woo, L. W. Lawrence; Fenton, Janine C.; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">In pursuit of novel steroid sulfatase (STS) inhibitors devoid of estrogenicity, several D-ring modified steroid derivs. were synthesized.  In vitro evaluation of the compds. identified two highly potent inhibitors, 4a and 4b, which were 18 times more active than estrone-3-O-sulfamate (EMATE), both having IC50 values of ∼1 nM.  These 16,17-seco-estra-1,3,5(10)-triene-16,17-imide derivs. were synthesized from estrone, via the intermediate 1, which was easily alkylated, deprotected and sulfamoylated affording the final compds. in high yields.  To assess their biol. profile, the selected inhibitors were tested for their in vivo inhibitory potency and estrogenicity in ovariectomized rats.  After an oral dose of 10 mg/kg per day for 5 days, 4a and 4b were found to inhibit rat liver steroid sulfatase by 99%.  They were also devoid of estrogenic activity in the uterine wt. gain assay, indicating that these two leads have therapeutic potential for the treatment of hormone-dependent breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLCy9SiTYeo7Vg90H21EOLACvtfcHk0ljupSp17nIw7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFWgsL8%253D&md5=2ed568d3179a5f80a1971d208159c139</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900048-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900048-7%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DD.%2BS.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DFenton%26aufirst%3DJ.%2BC.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DNovel%2520D-ring%2520modified%2520steroid%2520derivatives%2520as%2520potent%252C%2520non-estrogenic%252C%2520sulfatase%2520inhibitors%2520with%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D84%26spage%3D343%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharland, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusselle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Anticancer sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2435</span><span class="NLM_x">–</span> <span class="NLM_lpage">2444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1158%2F1535-7163.MCT-08-0195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18723489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWksL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2435-2444&author=L.+W.+L.+Wooauthor=D.+S.+Fischerauthor=C.+M.+Sharlandauthor=M.+Trusselleauthor=P.+A.+Fosterauthor=S.+K.+Chanderauthor=A.+Di+Fioreauthor=C.+T.+Supuranauthor=G.+De+Simoneauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Anticancer+sulfatase+inhibitors%3A+synthesis+of+a+potent+fluorinated+second-generation+agent%2C+in+vitro+and+in+vivo+activities%2C+molecular+modeling%2C+and+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography</span></div><div class="casAuthors">Woo, L. W. Lawrence; Fischer, Delphine S.; Sharland, Christopher M.; Trusselle, Melanie; Foster, Paul A.; Chander, Surinder K.; Di Fiore, Anna; Supuran, Claudiu T.; De Simone, Giuseppina; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2435-2444</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">An improved steroid sulfatase inhibitor was prepd. by replacing the N-Pr group of the second-generation steroid-like inhibitor (2) with a N-3,3,3-trifluoropropyl group to give (10).  This compd. is 5-fold more potent in vitro, completely inhibits rat liver steroid sulfatase activity after a single oral dose of 0.5 mg/kg, and exhibits a significantly longer duration of inhibition over (2).  These biol. properties are attributed to the increased lipophilicity and metabolic stability of (10) rendered by its trifluoropropyl group and also the potential H-bonding between its fluorine atom(s) and Arg98 in the active site of human steroid sulfatase.  Like other sulfamates, (10) is expected to be sequestered, and transported by, erythrocytes in vivo because it inhibits human carbonic anhydrase II (hCAII) potently (IC50, 3 nmol/L).  A congener (4), which possesses a N-(pyridin-3-ylmethyl) substituent, is even more active (IC50, 0.1 nmol/L).  To rationalize this, the hCAII-(4) adduct, obtained by cocrystn., reveals not only the sulfamate group and the backbone of (4) interacting with the catalytic site and the assocd. hydrophobic pocket, resp., but also the potential H-bonding between the N-(pyridin-3-ylmethyl) group and N.vepsiln.2 of Gln136.  Like (2), both (10) and its phenolic precursor (9) are non-estrogenic using a uterine wt. gain assay.  In summary, a highly potent, long-acting, and nonestrogenic steroid sulfatase inhibitor was designed with hCAII inhibitory properties that should pos. influence in vivo behavior.  Compd. (10) and other related inhibitors of this structural class further expand the armory of steroid sulfatase inhibitors against hormone-dependent breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkaOB1KGICwbVg90H21EOLACvtfcHk0ljupSp17nIw7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWksL%252FL&md5=e23509f634bee4e54e9a814825edac86</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0195%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DFischer%26aufirst%3DD.%2BS.%26aulast%3DSharland%26aufirst%3DC.%2BM.%26aulast%3DTrusselle%26aufirst%3DM.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DAnticancer%2520sulfatase%2520inhibitors%253A%2520synthesis%2520of%2520a%2520potent%2520fluorinated%2520second-generation%2520agent%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520activities%252C%2520molecular%2520modeling%252C%2520and%2520protein%2520crystallography%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2435%26epage%3D2444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M. F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-007-9769-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=17914670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1Wnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=129-138&author=P.+A.+Fosterauthor=S.+K.+Chanderauthor=M.+F.+C.+Parsonsauthor=S.+P.+Newmanauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=Efficacy+of+three+potent+steroid+sulfatase+inhibitors%3A+pre-clinical+investigations+for+their+use+in+the+treatment+of+hormone-dependent+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer</span></div><div class="casAuthors">Foster, Paul A.; Chander, Surinder K.; Parsons, Michael F. C.; Newman, Simon P.; Woo, L. W. Lawrence; Potter, Barry V. L.; Reed, Michael J.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-138</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Estrogenic steroids, such as estradiol, are known to play a crucial role in the development and growth of hormone-dependent breast cancer.  Steroid sulfatase (STS) inhibitors that can prevent the biosynthesis of these steroids via the sulfatase pathway offer therapeutic potential.  We show here the in vivo profile, including the efficacy in a xenograft breast cancer model and pharmacokinetics, of three potent STS inhibitors.  MCF-7 cells stably over-expressing STS cDNA (MCF-7STS) were generated.  Ovariectomized, MF-1, female nude mice receiving s.c. injections of estradiol sulfate (E2S) and bearing MCF-7STS xenografts, were orally treated with the STS inhibitors STX64, STX213, and STX1938.  Treatment was administered once weekly at a dose of 1 mg/kg for 35 days during which animals received E2S three times weekly.  Mice were weighed and tumor measurements taken weekly.  Furthermore, the pharmacokinetics for STX213 was detd. in rats.  STX213 and STX1938 exhibited potent STS inhibition in vivo.  However, STX1938 demonstrated a greater duration of activity.  In vehicle treated nude mice receiving E2S, tumor vols. increased by 260% after 35 days compared to day zero.  STX64 (1 mg/kg) failed to reduce tumor growth when given once weekly.  STX213 and STX1938 (once weekly, 1 mg/kg) significantly inhibited (P < 0.05) tumor growth over this same time period.  These compds. completely inhibited liver and tumor STS activity and significantly reduced the levels of plasma E2.  This study indicates that the STS inhibitor, STX213, exhibits excellent efficacy and pharmacokinetics and therefore offers a potentially novel treatment for hormone-dependent breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFBitbQl_2QrVg90H21EOLACvtfcHk0ljupSp17nIw7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1Wnsb4%253D&md5=3aa214e91484bd890ff106faead5480d</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1007%2Fs10549-007-9769-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-007-9769-3%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DParsons%26aufirst%3DM.%2BF.%2BC.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DEfficacy%2520of%2520three%2520potent%2520steroid%2520sulfatase%2520inhibitors%253A%2520pre-clinical%2520investigations%2520for%2520their%2520use%2520in%2520the%2520treatment%2520of%2520hormone-dependent%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2008%26volume%3D111%26spage%3D129%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">The development of steroid sulphatase inhibitors</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=9-23&author=M.+J.+Reedauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potter&title=The+development+of+steroid+sulphatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DThe%2520development%2520of%2520steroid%2520sulphatase%2520inhibitors%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D1996%26volume%3D3%26spage%3D9%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2759</span><span class="NLM_x">–</span> <span class="NLM_lpage">2772</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2759-2772&author=H.+A.+M.+Hejazauthor=L.+W.+L.+Wooauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Synthesis%2C+in+vitro+and+in+vivo+activity+of+benzophenone-based+inhibitors+of+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520activity%2520of%2520benzophenone-based%2520inhibitors%2520of%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2759%26epage%3D2772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Nussbaumer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winiski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span> </span><span class="NLM_article-title">Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-<i>O</i>-sulfamates: potent inhibitors of human steroid sulfatase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5091</span><span class="NLM_x">–</span> <span class="NLM_lpage">5094</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030926s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5091-5094&author=P.+Nussbaumerauthor=A.+P.+Winiskiauthor=A.+Billich&title=Estrogenic+potential+of+2-alkyl-4-%28thio%29chromenone+6-O-sulfamates%3A+potent+inhibitors+of+human+steroid+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Fjm030926s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030926s%26sid%3Dliteratum%253Aachs%26aulast%3DNussbaumer%26aufirst%3DP.%26aulast%3DWiniski%26aufirst%3DA.%2BP.%26aulast%3DBillich%26aufirst%3DA.%26atitle%3DEstrogenic%2520potential%2520of%25202-alkyl-4-%2528thio%2529chromenone%25206-O-sulfamates%253A%2520potent%2520inhibitors%2520of%2520human%2520steroid%2520sulfatase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5091%26epage%3D5094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Walter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Angerer, E.</span><span> </span><span class="NLM_article-title">2-Phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2003.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15145451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktVKqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2004&pages=409-420&author=G.+Walterauthor=R.+Lieblauthor=E.+von+Angerer&title=2-Phenylindole+sulfamates%3A+inhibitors+of+steroid+sulfatase+with+antiproliferative+activity+in+MCF-7+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">2-Phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells</span></div><div class="casAuthors">Walter, Georg; Liebl, Renate; von Angerer, Erwin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">409-420</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">: Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A no. of 2-phenylindole sulfamates with lipophilic side chains in 1- or 5-position of the indole were synthesized and evaluated as steroid sulfatase (estrone sulfatase) inhibitors.  Most of the new sulfamates inhibited the enzymic hydrolysis of estrone sulfate in MDA-MB 231 breast cancer cells with IC50 values between 2 nM and 1 μM.  A favorable position for a long side chain is the nitrogen of a carbamoyl group at C-5 of the indole when the Ph ring carries the sulfamate function.  These derivs. inhibit gene activation in estrogen receptor (ER)-pos. MCF-7 breast cancer cells in submicromolar concns. and reduce cell proliferation with IC50 values of ∼1 μM.  All of the potent inhibitors were devoid of estrogenic activity and have the potential for in vivo application as steroid sulfatase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyqKvhr1WfxrVg90H21EOLACvtfcHk0ljnFJ2YG440sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktVKqu7o%253D&md5=1477d29f5974d8e63320d69017e409bf</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2003.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2003.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DG.%26aulast%3DLiebl%26aufirst%3DR.%26aulast%3Dvon%2BAngerer%26aufirst%3DE.%26atitle%3D2-Phenylindole%2520sulfamates%253A%2520inhibitors%2520of%2520steroid%2520sulfatase%2520with%2520antiproliferative%2520activity%2520in%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D88%26spage%3D409%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Nussbaumer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span> </span><span class="NLM_article-title">Nortropinyl-arylsulfonylureas as novel, reversible inhibitors of human steroid sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3673</span><span class="NLM_x">–</span> <span class="NLM_lpage">3677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3673-3677&author=P.+Nussbaumerauthor=D.+Geylauthor=A.+Horvathauthor=P.+Lehrauthor=B.+Wolffauthor=A.+Billich&title=Nortropinyl-arylsulfonylureas+as+novel%2C+reversible+inhibitors+of+human+steroid+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNussbaumer%26aufirst%3DP.%26aulast%3DGeyl%26aufirst%3DD.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DLehr%26aufirst%3DP.%26aulast%3DWolff%26aufirst%3DB.%26aulast%3DBillich%26aufirst%3DA.%26atitle%3DNortropinyl-arylsulfonylureas%2520as%2520novel%252C%2520reversible%2520inhibitors%2520of%2520human%2520steroid%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3673%26epage%3D3677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Lehr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussbaumer, P.</span><span> </span><span class="NLM_article-title"><i>N</i>-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1235-1238&author=P.+Lehrauthor=A.+Billichauthor=B.+Wolffauthor=P.+Nussbaumer&title=N-Acyl+arylsulfonamides+as+novel%2C+reversible+inhibitors+of+human+steroid+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLehr%26aufirst%3DP.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DWolff%26aufirst%3DB.%26aulast%3DNussbaumer%26aufirst%3DP.%26atitle%3DN-Acyl%2520arylsulfonamides%2520as%2520novel%252C%2520reversible%2520inhibitors%2520of%2520human%2520steroid%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1235%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimberley, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozier, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiyagarajan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Chimeric microtubule disruptors</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2907</span><span class="NLM_x">–</span> <span class="NLM_lpage">2909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=2907-2909&author=M.+P.+Leeseauthor=F.+Jourdanauthor=M.+R.+Kimberleyauthor=G.+E.+Cozierauthor=N.+Thiyagarajanauthor=C.+Stengelauthor=S.+Regis-Lydiauthor=P.+A.+Fosterauthor=S.+P.+Newmanauthor=K.+R.+Acharyaauthor=E.+Ferrandisauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Chimeric+microtubule+disruptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%26aulast%3DKimberley%26aufirst%3DM.%2BR.%26aulast%3DCozier%26aufirst%3DG.%2BE.%26aulast%3DThiyagarajan%26aufirst%3DN.%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DChimeric%2520microtubule%2520disruptors%26jtitle%3DChem.%2520Commun.%26date%3D2010%26volume%3D46%26spage%3D2907%26epage%3D2909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span> </span><span class="NLM_article-title">In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1038%2Fbjc.2014.188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=24960406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKmt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=300-308&author=C.+Stengelauthor=S.+P.+Newmanauthor=J.+M.+Dayauthor=S.+K.+Chanderauthor=M.+P.+Leeseauthor=E.+Ferrandisauthor=S.+Regis-Lydiauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohitauthor=P.+A.+Foster&title=In+vivo+and+in+vitro+properties+of+STX2484%3A+a+novel+non-steroidal+anti-cancer+compound+active+in+taxane-resistant+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer</span></div><div class="casAuthors">Stengel, C.; Newman, S. P.; Day, J. M.; Chander, S. K.; Jourdan, F. L.; Leese, M. P.; Ferrandis, E.; Regis-Lydi, S.; Potter, B. V. L.; Reed, M. J.; Purohit, A.; Foster, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-308</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: STX2484 is a novel non-steroidal compd. with potent anti-proliferative activity.  These studies aimed to identify STX2484's mechanism of action, in vivo efficacy and activity in taxane-resistant breast cancer models.  Methods: Effects of STX2484 and paclitaxel on proliferation, cell cycle and apoptosis were assessed in vitro in drug-resistant (MCF-7DOX) and non-resistant cells (MCF-7WT).  STX2484 efficacy in βIII tubulin overexpression in MCF-7 cells was also detd.  Anti-angiogenic activity was quantified in vitro by a co-culture model and in vivo using a Matrigel plug assay.  An MDA-MB-231 xenograft model was used to det. STX2484 efficacy in vivo.  Results: STX2484 is a tubulin disruptor, which induces p53 expression, Bcl2 phosphorylation, caspase-3 cleavage, cell cycle arrest and apoptosis.  In addn., STX2484 is a potent anti-angiogenic agent in vitro and in vivo.  In breast cancer xenografts, STX2484 (20 mg kg-1 p.o.) suppressed tumor growth by 84% after 35 days of daily dosing, with limited toxicity.  In contrast to paclitaxel, STX2484 efficacy was unchanged in two clin. relevant drug-resistant models.  Conclusions: STX2484 is an orally bioavailable microtubule-disrupting agent with in vivo anti-angiogenic activity and excellent in vivo efficacy with no apparent toxicity.  Crucially, STX2484 has superior efficacy to paclitaxel in models of clin. drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3uya4N-WEzrVg90H21EOLACvtfcHk0lgKoH7IYtjBwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKmt7nJ&md5=a43451bf87ddc0081c5a953547e5b7c2</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2014.188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2014.188%26sid%3Dliteratum%253Aachs%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520properties%2520of%2520STX2484%253A%2520a%2520novel%2520non-steroidal%2520anti-cancer%2520compound%2520active%2520in%2520taxane-resistant%2520breast%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D111%26spage%3D300%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimberley, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroidomimetic tetrahydroisoquinolines for the design of new microtubule disruptors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200232c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=5-9&author=M.+P.+Leeseauthor=F.+Jourdanauthor=W.+Dohleauthor=M.+R.+Kimberleyauthor=M.+P.+Thomasauthor=R.+Baiauthor=E.+Hamelauthor=E.+Ferrandisauthor=B.+V.+L.+Potter&title=Steroidomimetic+tetrahydroisoquinolines+for+the+design+of+new+microtubule+disruptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fml200232c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200232c%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%26aulast%3DDohle%26aufirst%3DW.%26aulast%3DKimberley%26aufirst%3DM.%2BR.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DBai%26aufirst%3DR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroidomimetic%2520tetrahydroisoquinolines%2520for%2520the%2520design%2520of%2520new%2520microtubule%2520disruptors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D5%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Tetrahydroisoquinoline-based steroidomimetic and chimeric microtubule disruptors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=85-108&author=M.+P.+Leeseauthor=F.+L.+Jourdanauthor=M.+R.+Majorauthor=W.+Dohleauthor=E.+Hamelauthor=E.+Ferrandisauthor=A.+Fioreauthor=P.+G.+Kasprzykauthor=B.+V.+L.+Potter&title=Tetrahydroisoquinoline-based+steroidomimetic+and+chimeric+microtubule+disruptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%2BL.%26aulast%3DMajor%26aufirst%3DM.%2BR.%26aulast%3DDohle%26aufirst%3DW.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DFiore%26aufirst%3DA.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DTetrahydroisoquinoline-based%2520steroidomimetic%2520and%2520chimeric%2520microtubule%2520disruptors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D85%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Dohle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis, antitubulin, and antiproliferative SAR of C3/C1-substituted tetrahydroisoquinolines</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=350-370&author=W.+Dohleauthor=M.+P.+Leeseauthor=F.+L.+Jourdanauthor=M.+R.+Majorauthor=R.+Baiauthor=E.+Hamelauthor=E.+Ferrandisauthor=P.+G.+Kasprzykauthor=A.+Fioreauthor=S.+P.+Newmanauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Synthesis%2C+antitubulin%2C+and+antiproliferative+SAR+of+C3%2FC1-substituted+tetrahydroisoquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDohle%26aufirst%3DW.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%2BL.%26aulast%3DMajor%26aufirst%3DM.%2BR.%26aulast%3DBai%26aufirst%3DR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DFiore%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%252C%2520antitubulin%252C%2520and%2520antiproliferative%2520SAR%2520of%2520C3%252FC1-substituted%2520tetrahydroisoquinolines%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D350%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Dohle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1783</span><span class="NLM_x">–</span> <span class="NLM_lpage">1793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1783-1793&author=W.+Dohleauthor=M.+P.+Leeseauthor=F.+L.+Jourdanauthor=C.+J.+Chapmanauthor=E.+Hamelauthor=E.+Ferrandisauthor=B.+V.+L.+Potter&title=Optimisation+of+tetrahydroisoquinoline-based+chimeric+microtubule+disruptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDohle%26aufirst%3DW.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%2BL.%26aulast%3DChapman%26aufirst%3DC.%2BJ.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DOptimisation%2520of%2520tetrahydroisoquinoline-based%2520chimeric%2520microtubule%2520disruptors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D1783%26epage%3D1793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Ouellet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, É.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, D.</span><span> </span><span class="NLM_article-title">In vitro evaluation of a tetrahydroisoquinoline derivative as a steroid sulfatase inhibitor and a selective estrogen receptor modulator</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=95-103&author=C.+Ouelletauthor=%C3%89.+Ouelletauthor=D.+Poirier&title=In+vitro+evaluation+of+a+tetrahydroisoquinoline+derivative+as+a+steroid+sulfatase+inhibitor+and+a+selective+estrogen+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOuellet%26aufirst%3DC.%26aulast%3DOuellet%26aufirst%3D%25C3%2589.%26aulast%3DPoirier%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520evaluation%2520of%2520a%2520tetrahydroisoquinoline%2520derivative%2520as%2520a%2520steroid%2520sulfatase%2520inhibitor%2520and%2520a%2520selective%2520estrogen%2520receptor%2520modulator%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2014%26volume%3D33%26spage%3D95%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis, anti-tubulin and antiproliferative SAR of steroidomimetic dihydroisoquinolinones</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">798</span><span class="NLM_x">–</span> <span class="NLM_lpage">812</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=798-812&author=M.+P.+Leeseauthor=F.+L.+Jourdanauthor=M.+R.+Majorauthor=W.+Dohleauthor=M.+P.+Thomasauthor=E.+Hamelauthor=E.+Ferrandisauthor=M.+F.+Mahonauthor=S.+P.+Newmanauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Synthesis%2C+anti-tubulin+and+antiproliferative+SAR+of+steroidomimetic+dihydroisoquinolinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%2BL.%26aulast%3DMajor%26aufirst%3DM.%2BR.%26aulast%3DDohle%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%252C%2520anti-tubulin%2520and%2520antiproliferative%2520SAR%2520of%2520steroidomimetic%2520dihydroisoquinolinones%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D798%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Chanplakorn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanplakorn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, M. S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasano, H.</span><span> </span><span class="NLM_article-title">Increased estrogen sulfatase (sulfatase) and 17β-hydroxysteroid dehydrogenase type 1(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-010-0785-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=20151319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1ajur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=639-648&author=N.+Chanplakornauthor=P.+Chanplakornauthor=T.+Suzukiauthor=K.+Onoauthor=M.+S.+M.+Chanauthor=Y.+Mikiauthor=S.+Sajiauthor=T.+Uenoauthor=M.+Toiauthor=H.+Sasano&title=Increased+estrogen+sulfatase+%28sulfatase%29+and+17%CE%B2-hydroxysteroid+dehydrogenase+type+1%2817%CE%B2-HSD1%29+following+neoadjuvant+aromatase+inhibitor+therapy+in+breast+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Increased estrogen sulfatase (STS) and 17β-hydroxysteroid dehydrogenase type 1(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients</span></div><div class="casAuthors">Chanplakorn, Niramol; Chanplakorn, Pongsthorn; Suzuki, Takashi; Ono, Katsuhiko; Chan, Monica S. M.; Miki, Yasuhiro; Saji, Shigetoyo; Ueno, Takayuki; Toi, Masakazu; Sasano, Hironobu</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">639-648</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aromatase inhibitors (AIs) are considered the gold std. for endocrine therapy of estrogen receptor (ER) pos. postmenopausal breast cancer patients.  The therapy may enhance therapeutic response and stabilize disease but resistance and disease progression inevitably occur in the patients.  These are considered at least partly due to an emergence of alternative intratumoral estrogen prodn. pathways.  Therefore, in this study we evaluated effects of exemestane (EXE) upon the enzymes involved in intratumoral estrogen prodn. including estrogen sulfatase (STS), 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1), and estrogen sulfotransferase (EST) and correlated the findings with therapeutic responses including Ki67 labeling index (Ki67). 116 postmenopausal patients with invasive ductal carcinoma, stage II/IIIa, were enrolled in JFMC34-0601 clin. trials between March, 2006 and Jan., 2008.  EXE of 25 mg/day was administered according to the protocol.  Pre- and posttreatment specimens of 49 cases were available for this study.  Status of STS, EST, 17β-HSD1, ER, progesterone receptor (PgR), human epidermal growth factor receptor type 2 (Her2), and Ki67 in pre- and post-specimens were evaluated.  Specimens examd. before the therapy demonstrated following features; ER+ (100%), PgR+ (85.7%), and Her2+ (77.6%).  After treatment, the no. of Ki67, PgR, and ER pos. carcinoma cells demonstrated significant decrement in clin. response (CliR) and pathol. response (PaR) groups.  Significant increment of 17β-HSD1 and STS immunoreactivity was detected in all groups examd. except for STS in PaR.  EST showed significant increment in nonresponsive groups.  Alterations of Ki67 of carcinoma cells before and after therapy were subclassified into three groups according to its degrees.  Significant alterations of intratumoral enzymes, esp. 17β-HSD1 and STS, were correlated with Ki67 redn. after neoadjuvant EXE therapy.  This is the first study demonstrating significant increment of STS and 17β-HSD1 following AI neoadjuvant therapy of postmenopausal ER pos. breast carcinoma patients.  This increment may represent the compensatory response of breast carcinoma tissues to estrogen depletion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDFfZe0ibVgbVg90H21EOLACvtfcHk0li9ZaZZ-UaGdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1ajur8%253D&md5=cd6132650da598a5526cad54005b393a</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1007%2Fs10549-010-0785-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-010-0785-3%26sid%3Dliteratum%253Aachs%26aulast%3DChanplakorn%26aufirst%3DN.%26aulast%3DChanplakorn%26aufirst%3DP.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DM.%2BS.%2BM.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DSaji%26aufirst%3DS.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DToi%26aufirst%3DM.%26aulast%3DSasano%26aufirst%3DH.%26atitle%3DIncreased%2520estrogen%2520sulfatase%2520%2528sulfatase%2529%2520and%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%252817%25CE%25B2-HSD1%2529%2520following%2520neoadjuvant%2520aromatase%2520inhibitor%2520therapy%2520in%2520breast%2520cancer%2520patients%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2010%26volume%3D120%26spage%3D639%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">The physicochemical challenges of designing multiple ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4961</span><span class="NLM_x">–</span> <span class="NLM_lpage">4970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFejtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4961-4970&author=R.+Morphyauthor=Z.+Rankovic&title=The+physicochemical+challenges+of+designing+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">The Physicochemical Challenges of Designing Multiple Ligands</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4961-4970</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. designed to bind more than one target can provide a therapeutic benefit relative to highly target-selective ligands.  The physicochem. properties of designed multiple ligands were found to be less druglike than those for preclin. compds. in general.  These properties are controlled by the superfamily to which the targets belong and the lead discovery strategy that was followed.  The properties for peptide G-protein-coupled receptor (GPCR) ligands were the least favorable for oral delivery, whereas transporter, monoamine GPCR, and oxidase ligands were the most druglike.  The lead discovery strategy, framework combination or screening, exerts a profound influence on the property values.  Combining the frameworks from two selective ligands often results in large, complex dual ligands, but druglike ligands can be achieved if the degree of framework overlap is maximized and the size of the selective ligands minimized.  For some target combinations, a screening approach may provide a route to smaller, less complex leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonGHbXyxgv4LVg90H21EOLACvtfcHk0li9ZaZZ-UaGdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFejtL4%253D&md5=c7a227848516d0aa58ed037a582943fe</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1021%2Fjm0603015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603015%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DThe%2520physicochemical%2520challenges%2520of%2520designing%2520multiple%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4961%26epage%3D4970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, H.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C.</span><span> </span><span class="NLM_article-title">Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-<i>N</i>-hydroxyheptanamide (CUDC-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2000</span><span class="NLM_x">–</span> <span class="NLM_lpage">2009</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901453q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2000-2009&author=X.+Caiauthor=H.-X.+Zhaiauthor=J.+Wangauthor=J.+Forresterauthor=H.+Quauthor=L.+Yinauthor=C.-J.+Laiauthor=R.+Baoauthor=C.+Qian&title=Discovery+of+7-%284-%283-ethynylphenylamino%29-7-methoxyquinazolin-6-yloxy%29-N-hydroxyheptanamide+%28CUDC-101%29+as+a+potent+multi-acting+HDAC%2C+EGFR%2C+and+HER2+inhibitor+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1021%2Fjm901453q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901453q%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26aulast%3DZhai%26aufirst%3DH.-X.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DForrester%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DLai%26aufirst%3DC.-J.%26aulast%3DBao%26aufirst%3DR.%26aulast%3DQian%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25207-%25284-%25283-ethynylphenylamino%2529-7-methoxyquinazolin-6-yloxy%2529-N-hydroxyheptanamide%2520%2528CUDC-101%2529%2520as%2520a%2520potent%2520multi-acting%2520HDAC%252C%2520EGFR%252C%2520and%2520HER2%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2000%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Shimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beeram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasco, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mays, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laliberte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolcher, A. W.</span><span> </span><span class="NLM_article-title">Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5032</span><span class="NLM_x">–</span> <span class="NLM_lpage">5040</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1158%2F1078-0432.CCR-14-0570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=25107918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12gtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=5032-5040&author=T.+Shimizuauthor=P.+M.+LoRussoauthor=K.+P.+Papadopoulosauthor=A.+Patnaikauthor=M.+Beeramauthor=L.+S.+Smithauthor=D.+W.+Rascoauthor=T.+A.+Maysauthor=G.+Chambersauthor=A.+Maauthor=J.+Wangauthor=R.+Laliberteauthor=M.+Voiauthor=A.+W.+Tolcher&title=Phase+I+first-in-human+study+of+CUDC-101%2C+a+multitargeted+inhibitor+of+HDACs%2C+EGFR%2C+and+HER2+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Shimizu, Toshio; LoRusso, Patricia M.; Papadopoulos, Kyri P.; Patnaik, Amita; Beeram, Muralidhar; Smith, Lon S.; Rasco, Drew W.; Mays, Theresa A.; Chambers, Glenda; Ma, Anna; Wang, Jing; Laliberte, Robert; Voi, Maurizio; Tolcher, Anthony W.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5032-5040</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: This first-in-human phase I study evaluated dose-limiting toxicities (DLT) and defined a phase II recommended dose (RD) for CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 as a 1-h i.v. (i.v.) infusion for 5 consecutive days every 2 wk.  Exptl. Design: Twenty-five patients with advanced solid tumors received escalating doses of CUDC-101 (range, 75-300 mg/m2/day) following a std. 3 + 3 dose escalation design.  Results: The MTD was detd. to be 275 mg/m2.  Common grade 1/2 adverse events included nausea, fatigue, vomiting, dyspnea, pyrexia, and dry skin.  DLTs occurred in 1 patient in the 275-mg/m2 dose cohort (grade 2 serum creatinine elevation, n = 1) and 3 patients in the 300-mg/m2 dose cohort (grade 2 serum creatinine elevation, n = 2; pericarditis, n = 1), all of which were transient and reversible.  CUDC-101 exposure increased linearly with the mean max. concn. (Cmax), clearance (CL), vol. of distribution at steady-state (Vdss), area under curve (AUC), and terminal elimination half-life (t1/2) at the MTD dose of 9.3 mg/L, 51.2 L/h, 39.6 L, 9.95 h·ng/mL and 4.4 h, resp.  Acetylated histone H3 induction was obsd. in posttreatment skin samples from 3 patients in the 275-mg/m2 dose cohort, suggesting adequate systemic exposure and target inhibition.  One patient with gastric cancer had a partial response and 6 patients had stable disease.  Conclusion: CUDC-101 administered by 1-h i.v. infusion for 5 consecutive days every 2 wk was generally well tolerated with preliminary evidence of antitumor activity.  A dose of 275 mg/m2 is recommended for further clin. testing.  Clin Cancer Res; 20(19); 5032-40. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUrKXLHOzT6LVg90H21EOLACvtfcHk0lgu7gcuUPA9KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12gtbzP&md5=62860afa08733980f47047880e11a5ba</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-0570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-0570%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DLoRusso%26aufirst%3DP.%2BM.%26aulast%3DPapadopoulos%26aufirst%3DK.%2BP.%26aulast%3DPatnaik%26aufirst%3DA.%26aulast%3DBeeram%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DL.%2BS.%26aulast%3DRasco%26aufirst%3DD.%2BW.%26aulast%3DMays%26aufirst%3DT.%2BA.%26aulast%3DChambers%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLaliberte%26aufirst%3DR.%26aulast%3DVoi%26aufirst%3DM.%26aulast%3DTolcher%26aufirst%3DA.%2BW.%26atitle%3DPhase%2520I%2520first-in-human%2520study%2520of%2520CUDC-101%252C%2520a%2520multitargeted%2520inhibitor%2520of%2520HDACs%252C%2520EGFR%252C%2520and%2520HER2%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D5032%26epage%3D5040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoden, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaminami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isomura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shikama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujikura, T.</span><span> </span><span class="NLM_article-title">Studies on aromatase inhibitors. I. Synthesis and biological evaluation of 4-amino-4<i>H</i>-1,2,4-triazole derivatives</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1871</span><span class="NLM_x">–</span> <span class="NLM_lpage">1879</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1996&pages=1871-1879&author=M.+Okadaauthor=T.+Yodenauthor=E.+Kawaminamiauthor=Y.+Shimadaauthor=M.+Kudohauthor=Y.+Isomuraauthor=H.+Shikamaauthor=T.+Fujikura&title=Studies+on+aromatase+inhibitors.+I.+Synthesis+and+biological+evaluation+of+4-amino-4H-1%2C2%2C4-triazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DYoden%26aufirst%3DT.%26aulast%3DKawaminami%26aufirst%3DE.%26aulast%3DShimada%26aufirst%3DY.%26aulast%3DKudoh%26aufirst%3DM.%26aulast%3DIsomura%26aufirst%3DY.%26aulast%3DShikama%26aufirst%3DH.%26aulast%3DFujikura%26aufirst%3DT.%26atitle%3DStudies%2520on%2520aromatase%2520inhibitors.%2520I.%2520Synthesis%2520and%2520biological%2520evaluation%2520of%25204-amino-4H-1%252C2%252C4-triazole%2520derivatives%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1996%26volume%3D44%26spage%3D1871%26epage%3D1879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">First dual aromatase–sulfatase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3193</span><span class="NLM_x">–</span> <span class="NLM_lpage">3196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034033b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3193-3196&author=L.+W.+L.+Wooauthor=O.+B.+Sutcliffeauthor=C.+Bubertauthor=A.+Grassoauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=First+dual+aromatase%E2%80%93sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Fjm034033b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034033b%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DGrasso%26aufirst%3DA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DFirst%2520dual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3193%26epage%3D3196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Dual aromatase–sulfatase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3540</span><span class="NLM_x">–</span> <span class="NLM_lpage">3560</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061462b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3540-3560&author=L.+W.+L.+Wooauthor=C.+Bubertauthor=O.+B.+Sutcliffeauthor=A.+Smithauthor=S.+K.+Chanderauthor=M.+F.+Mahonauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Dual+aromatase%E2%80%93sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1021%2Fjm061462b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061462b%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DDual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3540%26epage%3D3560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship studies of derivatives of the dual aromatase-sulfatase inhibitor 4-{[(cyanophenyl)(4<i>H</i>-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=779-799&author=L.+W.+L.+Wooauthor=P.+M.+Woodauthor=C.+Bubertauthor=M.+P.+Thomasauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Synthesis+and+structure%E2%80%93activity+relationship+studies+of+derivatives+of+the+dual+aromatase-sulfatase+inhibitor+4-%7B%5B%28cyanophenyl%29%284H-1%2C2%2C4-triazol-4-yl%29amino%5Dmethyl%7Dphenyl+sulfamate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520derivatives%2520of%2520the%2520dual%2520aromatase-sulfatase%2520inhibitor%25204-%257B%255B%2528cyanophenyl%2529%25284H-1%252C2%252C4-triazol-4-yl%2529amino%255Dmethyl%257Dphenyl%2520sulfamate%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D779%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6469</span><span class="NLM_x">–</span> <span class="NLM_lpage">6477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1158%2F1078-0432.CCR-08-1027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18927286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KgtbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=6469-6477&author=P.+A.+Fosterauthor=S.+K.+Chanderauthor=S.+P.+Newmanauthor=L.+W.+L.+Wooauthor=O.+B.+Sutcliffeauthor=C.+Bubertauthor=D.+Zhouauthor=S.+Chenauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=A+new+therapeutic+strategy+against+hormone-dependent+breast+cancer%3A+the+preclinical+development+of+a+dual+aromatase+and+sulfatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">A New Therapeutic Strategy against Hormone-Dependent Breast Cancer: The Preclinical Development of a Dual Aromatase and Sulfatase Inhibitor</span></div><div class="casAuthors">Foster, Paul A.; Chander, Surinder K.; Newman, Simon P.; Woo, L. W. Lawrence; Sutcliffe, Oliver B.; Bubert, Christian; Zhou, Dujin; Chen, Shiuan; Potter, Barry V. L.; Reed, Michael J.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6469-6477</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The prodn. of E2 is paramount for the growth of estrogen receptor-pos. breast cancer.  Various strategies have been used, including the use of enzyme inhibitors against either aromatase (AROM) or steroid sulfatase (STS), in an attempt to ablate E2 levels.  Both these enzymes play a crit. role in the formation of estrogenic steroids and their inhibitors are now showing success in the clinic.  Exptl. Design: We show here, in a xenograft nude mouse model, that the inhibition of both enzymes using STX681, a dual AROM and STS inhibitor (DASI), is a potential new therapeutic strategy against HDBC.  MCF-7 cells stably expressing either AROM cDNA (MCF-7AROM) or STS cDNA (MCF-7STS) were generated.  Ovariectomized MF-1 female nude mice receiving s.c. injections of either androstenedione (A4) or E2 sulfate and bearing either MCF-7AROM or MCF-7STS tumors were orally treated with STX64, letrozole, or STX681.  Treatment was administered for 28 days.  Mice were weighed and tumor measurements were taken weekly.  RESULTS: STX64, a potent STS inhibitor, completely blocked MCF-7STS tumor growth but failed to attenuate MCF-7AROM tumor growth.  In contrast, letrozole inhibited MCF-7AROM tumors but had no effect on MCF-7STS tumors.  STX681 completely inhibited the growth of both tumors.  AROM and STS activity was also completely inhibited by STX681, which was accompanied by a significant redn. in plasma E2 levels.  CONCLUSIONS: This study indicates that targeting both the AROM and the STS enzyme with a DASI inhibits HDBC growth and is therefore a potentially novel treatment for this malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVzXbjDwCamrVg90H21EOLACvtfcHk0lhURGj3vQ9Iwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KgtbjJ&md5=a7c09b3cd371bc1de5e74152df1fd511</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1027%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DA%2520new%2520therapeutic%2520strategy%2520against%2520hormone-dependent%2520breast%2520cancer%253A%2520the%2520preclinical%2520development%2520of%2520a%2520dual%2520aromatase%2520and%2520sulfatase%2520inhibitor%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D6469%26epage%3D6477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis of aromatase inhibitors and dual aromatase sulfatase inhibitors by linking an arylsulfamate motif to 4-(4<i>H</i>-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1708</span><span class="NLM_x">–</span> <span class="NLM_lpage">1730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1708-1730&author=C.+Bubertauthor=L.+W.+L.+Wooauthor=O.+B.+Sutcliffeauthor=M.+F.+Mahonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Synthesis+of+aromatase+inhibitors+and+dual+aromatase+sulfatase+inhibitors+by+linking+an+arylsulfamate+motif+to+4-%284H-1%2C2%2C4-triazol-4-ylamino%29benzonitrile%3A+SAR%2C+crystal+structures%2C+in+vitro+and+in+vivo+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%2520of%2520aromatase%2520inhibitors%2520and%2520dual%2520aromatase%2520sulfatase%2520inhibitors%2520by%2520linking%2520an%2520arylsulfamate%2520motif%2520to%25204-%25284H-1%252C2%252C4-triazol-4-ylamino%2529benzonitrile%253A%2520SAR%252C%2520crystal%2520structures%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520activities%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1708%26epage%3D1730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrosse, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Bicyclic derivatives of the potent dual aromatase–sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4<i>H</i>-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1577</span><span class="NLM_x">–</span> <span class="NLM_lpage">1593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1577-1593&author=P.+M.+Woodauthor=L.+W.+L.+Wooauthor=J.-R.+Labrosseauthor=M.+P.+Thomasauthor=M.+F.+Mahonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Bicyclic+derivatives+of+the+potent+dual+aromatase%E2%80%93sulfatase+inhibitor+2-bromo-4-%7B%5B%284-cyanophenyl%29%284H-1%2C2%2C4-triazol-4-yl%29amino%5Dmethyl%7Dphenylsulfamate%3A+synthesis%2C+SAR%2C+crystal+structure%2C+and+in+vitro+and+in+vivo+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLabrosse%26aufirst%3DJ.-R.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DBicyclic%2520derivatives%2520of%2520the%2520potent%2520dual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitor%25202-bromo-4-%257B%255B%25284-cyanophenyl%2529%25284H-1%252C2%252C4-triazol-4-yl%2529amino%255Dmethyl%257Dphenylsulfamate%253A%2520synthesis%252C%2520SAR%252C%2520crystal%2520structure%252C%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520activities%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1577%26epage%3D1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group">Jackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusselle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Dual aromatase–sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2940</span><span class="NLM_x">–</span> <span class="NLM_lpage">2952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=2940-2952&author=T.+Jacksonauthor=L.+W.+L.+Wooauthor=M.+N.+Trusselleauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Dual+aromatase%E2%80%93sulfatase+inhibitors+based+on+the+anastrozole+template%3A+synthesis%2C+in+vitro+SAR%2C+molecular+modelling+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DT.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DTrusselle%26aufirst%3DM.%2BN.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DDual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitors%2520based%2520on%2520the%2520anastrozole%2520template%253A%2520synthesis%252C%2520in%2520vitro%2520SAR%252C%2520molecular%2520modelling%2520and%2520in%2520vivo%2520activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2007%26volume%3D5%26spage%3D2940%26epage%3D2952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">A letrozole-based dual aromatase–sulphatase inhibitor with in vivo activity</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2004.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15862957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVKksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=123-130&author=P.+M.+Woodauthor=L.+W.+L.+Wooauthor=A.+Humphreysauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=A+letrozole-based+dual+aromatase%E2%80%93sulphatase+inhibitor+with+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">A letrozole-based dual aromatase-sulphatase inhibitor with in vivo activity</span></div><div class="casAuthors">Wood, Paul M.; Woo, L. W. Lawrence; Humphreys, Anna; Chander, Surinder K.; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">123-130</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role of aromatase inhibitors in the treatment of hormone-dependent breast cancer is well established.  However, it is now recognized that steroid sulfatase (STS) inhibitors represent a new form of endocrine therapy.  To explore the potential advantage of dual inhibition by a single agent, we recently developed a series of dual aromatase-sulfatase inhibitors (DASIs) based on the aromatase inhibitor YM511.  We report here a new structural class of DASI obtained by obtained introducing the pharmacophore for STS inhibition, i.e. a phenol sulfamate ester into another established aromatase inhibitor letrozole.  Hence, the bis-sulfamate (I) was synthesized which exhibited IC50 values of 3044 nM for aromatase and >10 μM for STS in JEG-3 cells.  However, at a single oral dose of 10 mg/kg, I inhibited aromatase and rat liver STS by 60% and 88%, resp., 24 h after administration.  A proposed metabolite of I, carbinol (II), was synthesized.  Despite also showing weak STS inhibition in JEG-3 cells, II inhibited rat liver STS activity to the same extent as I at a single oral dose of 10 mg/kg.  Thus, the concept of a letrozole-based DASI has been validated and could be further developed and modified for therapeutic exploitation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo60rSRs5AQELVg90H21EOLACvtfcHk0lhIaPgdHbvfaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVKksrc%253D&md5=90f007c68eeaef39b4ba5dc3fd2157fd</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2004.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2004.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DHumphreys%26aufirst%3DA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DA%2520letrozole-based%2520dual%2520aromatase%25E2%2580%2593sulphatase%2520inhibitor%2520with%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D94%26spage%3D123%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrosse, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusselle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longhi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castiglioni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Chiral aromatase and dual aromatase–sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4226</span><span class="NLM_x">–</span> <span class="NLM_lpage">4238</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800168s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4226-4238&author=P.+M.+Woodauthor=L.+W.+L.+Wooauthor=J.-R.+Labrosseauthor=M.+N.+Trusselleauthor=S.+Abbateauthor=G.+Longhiauthor=E.+Castiglioniauthor=F.+Lebonauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Chiral+aromatase+and+dual+aromatase%E2%80%93sulfatase+inhibitors+from+the+letrozole+template%3A+synthesis%2C+absolute+configuration%2C+and+in+vitro+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fjm800168s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800168s%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLabrosse%26aufirst%3DJ.-R.%26aulast%3DTrusselle%26aufirst%3DM.%2BN.%26aulast%3DAbbate%26aufirst%3DS.%26aulast%3DLonghi%26aufirst%3DG.%26aulast%3DCastiglioni%26aufirst%3DE.%26aulast%3DLebon%26aufirst%3DF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DChiral%2520aromatase%2520and%2520dual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitors%2520from%2520the%2520letrozole%2520template%253A%2520synthesis%252C%2520absolute%2520configuration%252C%2520and%2520in%2520vitro%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4226%26epage%3D4238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Aromatase and dual aromatase–sulfatase inhibitors from the letrozole and vorozole templates</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1423-1438&author=P.+M.+Woodauthor=L.+W.+L.+Wooauthor=M.+P.+Thomasauthor=M.+F.+Mahonauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Aromatase+and+dual+aromatase%E2%80%93sulfatase+inhibitors+from+the+letrozole+and+vorozole+templates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DAromatase%2520and%2520dual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitors%2520from%2520the%2520letrozole%2520and%2520vorozole%2520templates%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1423%26epage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group">Jackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusselle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Non-steroidal aromatase inhibitors based on a biphenyl scaffold: synthesis, in vitro SAR, and molecular modelling</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=603-618&author=T.+Jacksonauthor=L.+W.+L.+Wooauthor=M.+N.+Trusselleauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Non-steroidal+aromatase+inhibitors+based+on+a+biphenyl+scaffold%3A+synthesis%2C+in+vitro+SAR%2C+and+molecular+modelling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DT.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DTrusselle%26aufirst%3DM.%2BN.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DNon-steroidal%2520aromatase%2520inhibitors%2520based%2520on%2520a%2520biphenyl%2520scaffold%253A%2520synthesis%252C%2520in%2520vitro%2520SAR%252C%2520and%2520molecular%2520modelling%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D603%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozier, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Highly potent first examples of dual aromatase–sulfatase inhibitors based on a biphenyl template</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2155</span><span class="NLM_x">–</span> <span class="NLM_lpage">2170</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901705h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2155-2170&author=L.+W.+L.+Wooauthor=T.+Jacksonauthor=A.+Puteyauthor=G.+Cozierauthor=P.+Leonardauthor=K.+R.+Acharyaauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Highly+potent+first+examples+of+dual+aromatase%E2%80%93sulfatase+inhibitors+based+on+a+biphenyl+template"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1021%2Fjm901705h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901705h%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DJackson%26aufirst%3DT.%26aulast%3DPutey%26aufirst%3DA.%26aulast%3DCozier%26aufirst%3DG.%26aulast%3DLeonard%26aufirst%3DP.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DHighly%2520potent%2520first%2520examples%2520of%2520dual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitors%2520based%2520on%2520a%2520biphenyl%2520template%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2155%26epage%3D2170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Hybrid dual aromatase–steroid sulfatase inhibitors with exquisite picomolar inhibitory activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100273k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=243-247&author=L.+W.+L.+Wooauthor=C.+Bubertauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Hybrid+dual+aromatase%E2%80%93steroid+sulfatase+inhibitors+with+exquisite+picomolar+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1021%2Fml100273k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100273k%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DHybrid%2520dual%2520aromatase%25E2%2580%2593steroid%2520sulfatase%2520inhibitors%2520with%2520exquisite%2520picomolar%2520inhibitory%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D243%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group">Rasmussen, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenvang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lykkesfeldt, A. E.</span><span> </span><span class="NLM_article-title">A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-007-9494-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=17268816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1CgtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2007&pages=191-203&author=L.+M.+Rasmussenauthor=N.+T.+Zaveriauthor=J.+Stenvangauthor=R.+H.+Petersauthor=A.+E.+Lykkesfeldt&title=A+novel+dual-target+steroid+sulfatase+inhibitor+and+antiestrogen%3A+SR+16157%2C+a+promising+agent+for+the+therapy+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer</span></div><div class="casAuthors">Rasmussen, Louise M.; Zaveri, Nurulain T.; Stenvang, Jan; Peters, Richard H.; Lykkesfeldt, Anne E.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-203</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Endocrine therapy is the ideal treatment choice for estrogen receptor α (ERα)-pos. breast cancer patients.  Principal used therapies target either the ERα e.g. by selective ERα modulators (SERMs) such as tamoxifen or target estrogen biosynthesis with aromatase inhibitors.  Steroid sulfatase (STS) plays a crucial role in formation of compds. with estrogenic properties, converting inactive sulfate-conjugated steroids to active non-conjugated forms.  Steroid sulfates are considered as a reservoir for active steroids due to their prolonged half-life and increased concn. in plasma.  STS is present in several tissues including the breast, and the STS the mRNA level and enzyme activity is significantly increased in ERα-pos. breast tumors.  Inhibition of STS is therefore a new approach for decreasing estrogenic steroids that stimulate breast cancer.  The novel dual-acting compd. SR 16157 is designed as a sulfamate-contg. STS inhibitor that releases a tissue-selective SERM SR 16137.  Use of a dual-target STS inhibitor and SERM represents a new strategy in the treatment of hormone-dependent breast cancer.  In this study, we tested the potential of SR 16157 and SR 16137 on STS activity, cell growth and ERα function in MCF-7 breast cancer cells.  We confirmed that the dual-target compd. SR 16157 exerts STS inhibition and antiestrogenic effects.  SR 16157 was a highly effective growth inhibitor, being 10 times more potent than the antiestrogens SR 16137 and tamoxifen.  Relative to tamoxifen, SR 16137 displays profoundly improved ERα binding affinity and antiestrogenic effects on expression of estrogen-regulated genes.  Thus, the dual-target SR 16157 is possibly a promising new treatment alternative, superior to tamoxifen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUhGswZEecBbVg90H21EOLACvtfcHk0lglb-j6FqdpLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1CgtL7O&md5=da8c8215112ce62e4830ab559845e73c</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1007%2Fs10549-007-9494-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-007-9494-y%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DL.%2BM.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DStenvang%26aufirst%3DJ.%26aulast%3DPeters%26aufirst%3DR.%2BH.%26aulast%3DLykkesfeldt%26aufirst%3DA.%2BE.%26atitle%3DA%2520novel%2520dual-target%2520steroid%2520sulfatase%2520inhibitor%2520and%2520antiestrogen%253A%2520SR%252016157%252C%2520a%2520promising%2520agent%2520for%2520the%2520therapy%2520of%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007%26volume%3D106%26spage%3D191%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group">Rausch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmetz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeValley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweikart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirsalis, J.</span><span> </span><span class="NLM_article-title">Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1341</span><span class="NLM_x">–</span> <span class="NLM_lpage">1352</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs00280-010-1430-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=20737149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=1341-1352&author=L.+Rauschauthor=C.+Greenauthor=K.+Steinmetzauthor=S.+LeValleyauthor=P.+Catzauthor=N.+Zaveriauthor=K.+Schweikartauthor=J.+Tomaszewskiauthor=J.+Mirsalis&title=Preclinical+pharmacokinetic%2C+toxicological+and+biomarker+evaluation+of+SR16157%2C+a+novel+dual-acting+steroid+sulfatase+inhibitor+and+selective+estrogen+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator</span></div><div class="casAuthors">Rausch, Linda; Green, Carol; Steinmetz, Karen; LeValley, Sue; Catz, Paul; Zaveri, Nurulain; Schweikart, Karen; Tomaszewski, Joseph; Mirsalis, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1341-1352</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">SR16157 is a novel dual-acting inhibitor of estrogen action that irreversibly inhibits the estrogen biosynthetic enzyme steroid sulfatase (STS) and releases the selective estrogen receptor modulator SR16137, which blocks the estrogen receptor.  SR16157 is a promising agent for the endocrine therapy of breast cancer.  We conducted preclin. in vivo toxicity evaluations to det. the max.-tolerated dose (MTD), target organ(s) of toxicity, reversibility, dose-limiting toxicity, no observable adverse effect level (NOAEL), and toxicokinetics (TK) and to investigate a potential biomarker for use in SR16157 clin. trials.  SR16157 was administered to female Fischer 344 rats or beagle dogs by oral gavage (po) or capsule.  I.v. groups were included for the detn. of bioavailability.  Endpoints evaluated included clin. observations, body wts., hematol., serum chem., pharmacokinetics, TK, pathol. of tissues, and STS activity in liver, or peripheral blood mononuclear cells (PBMCs).  For rats, the MTD (i.e., the highest dose that did not cause lethality but produced toxicity) was 33 mg/kg/day (198 mg/m2/day), and the NOAEL was <10 mg/kg/day (60 mg/m2/day).  For dogs, the MTD was estd. to exceed 10 mg/kg/day (200 mg/m2/day), and the NOAEL was estd. to be at or above 2.5 mg/kg/day (50 mg/m2/day).  Our studies demonstrate that SR16157 has excellent pharmacokinetic properties and an acceptable toxicol. profile.  Modulation of STS activity in PBMCs appeared to be a possible biomarker for use in future clin. trials of SR16157.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHhmr9Hyw7J7Vg90H21EOLACvtfcHk0lglb-j6FqdpLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGhsLo%253D&md5=d7d22f7a73ed1b857e27f003cac8449c</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1007%2Fs00280-010-1430-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-010-1430-x%26sid%3Dliteratum%253Aachs%26aulast%3DRausch%26aufirst%3DL.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DSteinmetz%26aufirst%3DK.%26aulast%3DLeValley%26aufirst%3DS.%26aulast%3DCatz%26aufirst%3DP.%26aulast%3DZaveri%26aufirst%3DN.%26aulast%3DSchweikart%26aufirst%3DK.%26aulast%3DTomaszewski%26aufirst%3DJ.%26aulast%3DMirsalis%26aufirst%3DJ.%26atitle%3DPreclinical%2520pharmacokinetic%252C%2520toxicological%2520and%2520biomarker%2520evaluation%2520of%2520SR16157%252C%2520a%2520novel%2520dual-acting%2520steroid%2520sulfatase%2520inhibitor%2520and%2520selective%2520estrogen%2520receptor%2520modulator%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2011%26volume%3D67%26spage%3D1341%26epage%3D1352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group">Ouellet, É.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, D.</span><span> </span><span class="NLM_article-title">Investigation of a tetrahydroisoquinoline scaffold as dual-action steroid sulfatase inhibitors generated by parallel solid-phase synthesis</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=681-692&author=%C3%89.+Ouelletauthor=R.+Maltaisauthor=C.+Ouelletauthor=D.+Poirier&title=Investigation+of+a+tetrahydroisoquinoline+scaffold+as+dual-action+steroid+sulfatase+inhibitors+generated+by+parallel+solid-phase+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOuellet%26aufirst%3D%25C3%2589.%26aulast%3DMaltais%26aufirst%3DR.%26aulast%3DOuellet%26aufirst%3DC.%26aulast%3DPoirier%26aufirst%3DD.%26atitle%3DInvestigation%2520of%2520a%2520tetrahydroisoquinoline%2520scaffold%2520as%2520dual-action%2520steroid%2520sulfatase%2520inhibitors%2520generated%2520by%2520parallel%2520solid-phase%2520synthesis%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D681%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group">Hoy, S. M.</span><span> </span><span class="NLM_article-title">Abiraterone acetate: a review of its use in patients with metastatic castration-resistant prostate cancer</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">–</span> <span class="NLM_lpage">2091</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=2077-2091&author=S.+M.+Hoy&title=Abiraterone+acetate%3A+a+review+of+its+use+in+patients+with+metastatic+castration-resistant+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoy%26aufirst%3DS.%2BM.%26atitle%3DAbiraterone%2520acetate%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520patients%2520with%2520metastatic%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DDrugs%26date%3D2013%26volume%3D73%26spage%3D2077%26epage%3D2091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group">Nakanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, I.</span><span> </span><span class="NLM_article-title">Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancers</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2Fbdd.1915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=25156339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWit7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=463-484&author=T.+Nakanishiauthor=I.+Tamai&title=Putative+roles+of+organic+anion+transporting+polypeptides+%28OATPs%29+in+cell+survival+and+progression+of+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancers</span></div><div class="casAuthors">Nakanishi, Takeo; Tamai, Ikumi</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">463-484</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Transporter proteins classified into the solute carrier (SLC) transporter superfamily are essential for the import of nutrients required for cell survival in organisms.  Various SLC transporters are differentially upregulated in cancer cells, and among them, polyspecific org. anion-transporting polypeptides (OATPs) have been proposed to have pathophysiol. significance in cancer.  This review will briefly introduce OATPs and summarize their proposed roles in cancer, focusing particularly on hormone-dependent breast and prostate cancers.  Over the past two decades, compelling evidence has also accumulated that SLC transporters, including OATPs, interact with clin. important anticancer agents and influence their pharmacokinetics, particularly the processes of absorption, elimination and distribution.  Therefore, a better understanding of not only the pathophysiol. roles, but also the pharmacol. effects of OATPs in cancer cells should be helpful in combating human malignant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpMQcPTkD0TrVg90H21EOLACvtfcHk0lglb-j6FqdpLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWit7nK&md5=50a2231c94b2b7fa529f15537130ca5c</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1002%2Fbdd.1915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.1915%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DT.%26aulast%3DTamai%26aufirst%3DI.%26atitle%3DPutative%2520roles%2520of%2520organic%2520anion%2520transporting%2520polypeptides%2520%2528OATPs%2529%2520in%2520cell%2520survival%2520and%2520progression%2520of%2520human%2520cancers%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2014%26volume%3D35%26spage%3D463%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group">Chura, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomquist, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argenta, P. A.</span><span> </span><span class="NLM_article-title">Estrone sulfatase activity in patients with advanced ovarian cancer</span> <span class="citation_source-journal">Gynecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.ygyno.2008.08.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18947862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFajsL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2009&pages=205-209&author=J.+C.+Churaauthor=C.+H.+Blomquistauthor=H.+S.+Ryuauthor=P.+A.+Argenta&title=Estrone+sulfatase+activity+in+patients+with+advanced+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Estrone sulfatase activity in patients with advanced ovarian cancer</span></div><div class="casAuthors">Chura, Justin C.; Blomquist, Charles H.; Ryu, Hyung S.; Argenta, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-209</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: We sought to identify whether the sulfatase pathway was present in ovarian cancer specimens and then to det. whether a clin. correlation existed between sulfatase activity and survival.  Materials and methods: Enzymic activity was assessed in advanced ovarian cancer specimens via thin layer chromatog. and standardized against total protein.  All enzyme activities are reported in pmol/mg protein/30 min.  Kaplan Meier curves of progression-free and overall survival were constructed to compare outcomes between patients with low sulfatase activity and high sulfatase activity.  Median survival rates were compared using the log-rank test for survival curves.  Differences in proportions between patients with low sulfatase activity vs. high sulfatase activity were compared with the z-test or chi-square anal. as appropriate.  Results: 37 specimens from patients with advanced stage ovarian cancer were analyzed.  Enzymic activity was detected in all specimens except one.  Median progression-free survival was 23.5 mo for patients with low sulfatase activity compared to 6.9 mo for patients with high sulfatase activity (p = 0.008).  Median overall survival favored the low sulfatase group (50.8 vs. 30.6 mo resp.), though statistical difference was not detected (p = 0.16).  No other difference in clin. characteristics between patients with high or low sulfatase activity was detected.  Conclusions: Sulfatase activity is widely present in ovarian cancer specimens.  Increased sulfatase activity is assocd. with worse progression-free survival in patients with advanced stage ovarian cancer.  The sulfatase pathway is a potential therapeutic target in the treatment of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI7edQSbPwpbVg90H21EOLACvtfcHk0lj_b8SJq3HZ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFajsL7J&md5=66e78d0ff1f6e5cc7fd0dc7f5beb4fa4</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2008.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2008.08.037%26sid%3Dliteratum%253Aachs%26aulast%3DChura%26aufirst%3DJ.%2BC.%26aulast%3DBlomquist%26aufirst%3DC.%2BH.%26aulast%3DRyu%26aufirst%3DH.%2BS.%26aulast%3DArgenta%26aufirst%3DP.%2BA.%26atitle%3DEstrone%2520sulfatase%2520activity%2520in%2520patients%2520with%2520advanced%2520ovarian%2520cancer%26jtitle%3DGynecol.%2520Oncol.%26date%3D2009%26volume%3D112%26spage%3D205%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group">Kang, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.-T.</span><span> </span><span class="NLM_article-title">Synthesis and in vitro evaluation of 2-[<sup>11</sup>C] methoxyestradiol-3,17β-<i>O</i>,<i>O</i>-bissulfamate for in vivo studies of angiogenesis</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2Fjlcr.1930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1OhtrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=783-787&author=C.+M.+Kangauthor=Y.+S.+Choeauthor=K.-H.+Jungauthor=J.+Y.+Choiauthor=K.-H.+Leeauthor=B.-T.+Kim&title=Synthesis+and+in+vitro+evaluation+of+2-%5B11C%5D+methoxyestradiol-3%2C17%CE%B2-O%2CO-bissulfamate+for+in+vivo+studies+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro evaluation of 2-[11C]methoxyestradiol-3,17β-O,O-bissulfamate for in vivo studies of angiogenesis</span></div><div class="casAuthors">Kang, Choong Mo; Choe, Yearn Seong; Jung, Kyung-Ho; Choi, Joon Young; Lee, Kyung-Han; Kim, Byung-Tae</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">783-787</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">In the present study, 2-methoxyestradiol-3,17β-O,O-bis-sulfamate (I), a known angiogenesis inhibitor, was prepd. in a radiolabeled form by 11C-methylation of 2-hydroxyestradiol-3,17β-O,O-bis(N-trityl)sulfamate (II) followed by detritylation.  Synthesis of precursor II required a rather long step because of the presence of two sulfamoyl groups.  The decay-cor. radiochem. yield of [11C]I was 19 ± 2% based on [11C]CH3I, and the specific activity was 34-39 GBq/μmol.  Although I is known to significantly inhibit the proliferation of human umbilical vascular endothelial cells (HUVECs), its radiolabeled form, [11C]I was not avidly taken up by HUVECs, and the uptake increased slightly in a time-dependent manner (156% at 60 min relative to a value of 100% at 5 min).  These results suggest that further studies are warranted to det. the mol. target for [11C]I.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEYxGtx_czmrVg90H21EOLACvtfcHk0lj_b8SJq3HZ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1OhtrjK&md5=f4411f83b6470667d3e77953f81a4367</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.1930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.1930%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DC.%2BM.%26aulast%3DChoe%26aufirst%3DY.%2BS.%26aulast%3DJung%26aufirst%3DK.-H.%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DK.-H.%26aulast%3DKim%26aufirst%3DB.-T.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520evaluation%2520of%25202-%255B11C%255D%2520methoxyestradiol-3%252C17%25CE%25B2-O%252CO-bissulfamate%2520for%2520in%2520vivo%2520studies%2520of%2520angiogenesis%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2011%26volume%3D54%26spage%3D783%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mickens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sledge, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Q.-H.</span><span> </span><span class="NLM_article-title">Design and synthesis of carbon-11-labeled dual aromatase–steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancer</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">896</span><span class="NLM_x">–</span> <span class="NLM_lpage">905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=896-905&author=M.+Wangauthor=J.+Mickensauthor=M.+Gaoauthor=K.+D.+Millerauthor=G.+W.+Sledgeauthor=G.+D.+Hutchinsauthor=Q.-H.+Zheng&title=Design+and+synthesis+of+carbon-11-labeled+dual+aromatase%E2%80%93steroid+sulfatase+inhibitors+as+new+potential+PET+agents+for+imaging+of+aromatase+and+steroid+sulfatase+expression+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DMickens%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DSledge%26aufirst%3DG.%2BW.%26aulast%3DHutchins%26aufirst%3DG.%2BD.%26aulast%3DZheng%26aufirst%3DQ.-H.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520carbon-11-labeled%2520dual%2520aromatase%25E2%2580%2593steroid%2520sulfatase%2520inhibitors%2520as%2520new%2520potential%2520PET%2520agents%2520for%2520imaging%2520of%2520aromatase%2520and%2520steroid%2520sulfatase%2520expression%2520in%2520breast%2520cancer%26jtitle%3DSteroids%26date%3D2009%26volume%3D74%26spage%3D896%26epage%3D905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Q.-H.</span><span> </span><span class="NLM_article-title">Synthesis of a new carbon-11-labelled sulfamate derivative as a potential PET tracer for imaging of breast cancer aromatase and steroid sulfatase expression</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1127</span><span class="NLM_x">–</span> <span class="NLM_lpage">1140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1080%2F00397911003797825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1Wnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=1127-1140&author=M.+Wangauthor=M.+Gaoauthor=K.+D.+Millerauthor=Q.-H.+Zheng&title=Synthesis+of+a+new+carbon-11-labelled+sulfamate+derivative+as+a+potential+PET+tracer+for+imaging+of+breast+cancer+aromatase+and+steroid+sulfatase+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a New Carbon-11-Labeled Sulfamate Derivative as a Potential PET Tracer for Imaging of Breast Cancer Aromatase and Steroid Sulfatase Expression</span></div><div class="casAuthors">Wang, Min; Gao, Mingzhang; Miller, Kathy D.; Zheng, Qi-Huang</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1127-1140</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A carbon-11-labeled sulfamate deriv. was designed and synthesized as a new potential positron-emission-tomog. dual aromatase-steroid sulfatase inhibitor radiotracer for imaging of aromatase and steroid sulfatase expression in breast cancer.  The target tracer 2-chloro-4-(((4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino)methyl)-6-[11C]methoxyphenyl sulfamate ([11C]7) was prepd. from its corresponding precursor 2-chloro-4-(((4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino)methyl)-6-hydroxyphenyl sulfamate (18) with [11C]CH3OTf under basic conditions through the O-[11C]methylation and isolated by the reversed-phase high-performance liq. chromatog. in 40-45% radiochem. yields based on [11C]CO2 and decay cor. to end of bombardment.  The specific activity at end of synthesis was 111-185 GBq/μmol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnX1RtmBoq1rVg90H21EOLACvtfcHk0lj_b8SJq3HZ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1Wnsr0%253D&md5=2662ea953464043e70c89a4ea8692f40</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1080%2F00397911003797825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397911003797825%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DZheng%26aufirst%3DQ.-H.%26atitle%3DSynthesis%2520of%2520a%2520new%2520carbon-11-labelled%2520sulfamate%2520derivative%2520as%2520a%2520potential%2520PET%2520tracer%2520for%2520imaging%2520of%2520breast%2520cancer%2520aromatase%2520and%2520steroid%2520sulfatase%2520expression%26jtitle%3DSynth.%2520Commun.%26date%3D2011%26volume%3D41%26spage%3D1127%26epage%3D1140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 50 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Li-Jun Wu, Fan Teng, Gui-Fen Lv, <span class="NLM_string-name hlFld-ContribAuthor">Jin-Heng Li</span>. </span><span class="cited-content_cbyCitation_article-title">Relay Palladium/Copper Catalysis Enabled Silylative [5 + 1] Benzannulation Using Terminal Alkynes as One-Carbon Units. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (21)
                                     , 8544-8549. <a href="https://doi.org/10.1021/acs.orglett.0c03144" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03144%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRelay%252BPalladium%25252FCopper%252BCatalysis%252BEnabled%252BSilylative%252B%25255B5%252B%25252B%252B1%25255D%252BBenzannulation%252BUsing%252BTerminal%252BAlkynes%252Bas%252BOne-Carbon%252BUnits%26aulast%3DWu%26aufirst%3DLi-Jun%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D18092020%26date%3D19102020%26volume%3D22%26issue%3D21%26spage%3D8544%26epage%3D8549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Li-Ming Tao, Chuan-Hua Li, Jun Chen, <span class="NLM_string-name hlFld-ContribAuthor">Hui Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Cobalt(III)-Catalyzed Oxidative Annulation of Benzaldehydes with Internal Alkynes via C–H Functionalization in Poly(ethylene glycol). </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (11)
                                     , 6807-6812. <a href="https://doi.org/10.1021/acs.joc.9b00580" title="DOI URL">https://doi.org/10.1021/acs.joc.9b00580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b00580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b00580%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCobalt%252528III%252529-Catalyzed%252BOxidative%252BAnnulation%252Bof%252BBenzaldehydes%252Bwith%252BInternal%252BAlkynes%252Bvia%252BC%2525E2%252580%252593H%252BFunctionalization%252Bin%252BPoly%252528ethylene%252Bglycol%252529%26aulast%3DTao%26aufirst%3DLi-Ming%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D27022019%26date%3D17052019%26volume%3D84%26issue%3D11%26spage%3D6807%26epage%3D6812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jacob
T. Andring, Wolfgang Dohle, Chingkuang Tu, Barry V. L. Potter, <span class="NLM_string-name hlFld-ContribAuthor">Robert McKenna</span>. </span><span class="cited-content_cbyCitation_article-title">3,17β-Bis-sulfamoyloxy-2-methoxyestra-1,3,5(10)-triene and Nonsteroidal Sulfamate Derivatives Inhibit Carbonic Anhydrase IX: Structure–Activity Optimization for Isoform Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 2202-2212. <a href="https://doi.org/10.1021/acs.jmedchem.8b01990" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01990</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01990%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D3%25252C17%2525CE%2525B2-Bis-sulfamoyloxy-2-methoxyestra-1%25252C3%25252C5%25252810%252529-triene%252Band%252BNonsteroidal%252BSulfamate%252BDerivatives%252BInhibit%252BCarbonic%252BAnhydrase%252BIX%25253A%252BStructure%2525E2%252580%252593Activity%252BOptimization%252Bfor%252BIsoform%252BSelectivity%26aulast%3DAndring%26aufirst%3DJacob%2BT.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D19122018%26date%3D18022019%26date%3D05022019%26volume%3D62%26issue%3D4%26spage%3D2202%26epage%3D2212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lebin Su, Tianbing Ren, Jianyu Dong, Lixin Liu, Shimin Xie, Lin Yuan, Yongbo Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Shuang-Feng Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Cu(I)-Catalyzed 6-endo-dig Cyclization of Terminal Alkynes, 2-Bromoaryl Ketones, and Amides toward 1-Naphthylamines: Applications and Photophysical Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (6)
                                     , 2535-2544. <a href="https://doi.org/10.1021/jacs.8b12495" title="DOI URL">https://doi.org/10.1021/jacs.8b12495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b12495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b12495%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DCu%252528I%252529-Catalyzed%252B6-endo-dig%252BCyclization%252Bof%252BTerminal%252BAlkynes%25252C%252B2-Bromoaryl%252BKetones%25252C%252Band%252BAmides%252Btoward%252B1-Naphthylamines%25253A%252BApplications%252Band%252BPhotophysical%252BProperties%26aulast%3DSu%26aufirst%3DLebin%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D20112018%26date%3D05022019%26date%3D23012019%26volume%3D141%26issue%3D6%26spage%3D2535%26epage%3D2544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wolfgang Dohle, Andrea E. Prota, Grégory Menchon, Ernest Hamel, Michel O. Steinmetz, <span class="NLM_string-name hlFld-ContribAuthor">Barry V. L. Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (1)
                                     , 755-764. <a href="https://doi.org/10.1021/acsomega.8b02879" title="DOI URL">https://doi.org/10.1021/acsomega.8b02879</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b02879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b02879%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DTetrahydroisoquinoline%252BSulfamates%252Bas%252BPotent%252BMicrotubule%252BDisruptors%25253A%252BSynthesis%25252C%252BAntiproliferative%252Band%252BAntitubulin%252BActivity%252Bof%252BDichlorobenzyl-Based%252BDerivatives%25252C%252Band%252Ba%252BTubulin%252BCocrystal%252BStructure%26aulast%3DDohle%26aufirst%3DWolfgang%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D19102018%26date%3D24122018%26volume%3D4%26issue%3D1%26spage%3D755%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dharshini Ganeshapillai, L. W. Lawrence Woo, Mark P. Thomas, Atul Purohit, <span class="NLM_string-name hlFld-ContribAuthor">Barry V. L. Potter</span>. </span><span class="cited-content_cbyCitation_article-title">C-3- and C-4-Substituted Bicyclic Coumarin Sulfamates as Potent Steroid Sulfatase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (9)
                                     , 10748-10772. <a href="https://doi.org/10.1021/acsomega.8b01383" title="DOI URL">https://doi.org/10.1021/acsomega.8b01383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b01383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b01383%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DC-3-%252Band%252BC-4-Substituted%252BBicyclic%252BCoumarin%252BSulfamates%252Bas%252BPotent%252BSteroid%252BSulfatase%252BInhibitors%26aulast%3DGaneshapillai%26aufirst%3DDharshini%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19062018%26date%3D16082018%26volume%3D3%26issue%3D9%26spage%3D10748%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Fabrice L.  Jourdan</span>, <span class="hlFld-ContribAuthor ">Grégory  Menchon</span>, <span class="hlFld-ContribAuthor ">Andrea E.  Prota</span>, <span class="hlFld-ContribAuthor ">Paul A.  Foster</span>, <span class="hlFld-ContribAuthor ">Pascoe  Mannion</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Mark P.  Thomas</span>, <span class="hlFld-ContribAuthor ">Philip G.  Kasprzyk</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrandis</span>, <span class="hlFld-ContribAuthor ">Michel O.  Steinmetz</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, and <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>  . </span><span class="cited-content_cbyCitation_article-title">Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1031-1044. <a href="https://doi.org/10.1021/acs.jmedchem.7b01474" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01474</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01474&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01474%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DQuinazolinone-Based%252BAnticancer%252BAgents%25253A%252BSynthesis%25252C%252BAntiproliferative%252BSAR%25252C%252BAntitubulin%252BActivity%25252C%252Band%252BTubulin%252BCo-crystal%252BStructure%26aulast%3DDohle%26aufirst%3DWolfgang%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D04102017%26date%3D08012018%26date%3D08022018%26date%3D11122017%26volume%3D61%26issue%3D3%26spage%3D1031%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Salah</span>, <span class="hlFld-ContribAuthor ">Ahmed S.  Abdelsamie</span>, and <span class="hlFld-ContribAuthor ">Martin  Frotscher</span>  . </span><span class="cited-content_cbyCitation_article-title">First Dual Inhibitors of Steroid Sulfatase (STS) and 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Designed Multiple Ligands as Novel Potential Therapeutics for Estrogen-Dependent Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 4086-4092. <a href="https://doi.org/10.1021/acs.jmedchem.7b00062" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00062%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFirst%252BDual%252BInhibitors%252Bof%252BSteroid%252BSulfatase%252B%252528STS%252529%252Band%252B17%2525CE%2525B2-Hydroxysteroid%252BDehydrogenase%252BType%252B1%252B%25252817%2525CE%2525B2-HSD1%252529%25253A%252BDesigned%252BMultiple%252BLigands%252Bas%252BNovel%252BPotential%252BTherapeutics%252Bfor%252BEstrogen-Dependent%252BDiseases%26aulast%3DSalah%26aufirst%3DMohamed%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D13012017%26date%3D27042017%26date%3D11052017%26date%3D13042017%26volume%3D60%26issue%3D9%26spage%3D4086%26epage%3D4092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahdiyeh H. S.  Javadi</span>, <span class="hlFld-ContribAuthor ">Aida  Iraji</span>, <span class="hlFld-ContribAuthor ">Maliheh  Safavi</span>, <span class="hlFld-ContribAuthor ">Hamed  Montazeri</span>, <span class="hlFld-ContribAuthor ">Parastoo  Tarighi</span>, <span class="hlFld-ContribAuthor ">Samane  Eftekhari</span>, <span class="hlFld-ContribAuthor ">Latifeh  Navidpour</span>, <span class="hlFld-ContribAuthor ">Seyedeh Sara  Mirfazli</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and apoptosis inducing activity of nonsteroidal flavone-methanesulfonate derivatives on MCF-7 cell line as potential sulfatase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>116 </em><a href="https://doi.org/10.1007/s00044-021-02767-w" title="DOI URL">https://doi.org/10.1007/s00044-021-02767-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-021-02767-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-021-02767-w%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bapoptosis%252Binducing%252Bactivity%252Bof%252Bnonsteroidal%252Bflavone-methanesulfonate%252Bderivatives%252Bon%252BMCF-7%252Bcell%252Bline%252Bas%252Bpotential%252Bsulfatase%252Binhibitor%26aulast%3DJavadi%26aufirst%3DMahdiyeh%2BH.%2BS.%26date%3D2021%26date%3D2021%26volume%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anke  Löhndorf</span>, <span class="hlFld-ContribAuthor ">Leon  Hosang</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Francesca  Odoardi</span>, <span class="hlFld-ContribAuthor ">Sissy-Alina  Waschkowski</span>, <span class="hlFld-ContribAuthor ">Anette  Rosche</span>, <span class="hlFld-ContribAuthor ">Andreas  Bauche</span>, <span class="hlFld-ContribAuthor ">Riekje  Winzer</span>, <span class="hlFld-ContribAuthor ">Eva  Tolosa</span>, <span class="hlFld-ContribAuthor ">Sabine  Windhorst</span>, <span class="hlFld-ContribAuthor ">Stephen  Marry</span>, <span class="hlFld-ContribAuthor ">Alexander  Flügel</span>, <span class="hlFld-ContribAuthor ">Barry V.L.  Potter</span>, <span class="hlFld-ContribAuthor ">Björn-Philipp  Diercks</span>, <span class="hlFld-ContribAuthor ">Andreas H.  Guse</span>. </span><span class="cited-content_cbyCitation_article-title">2-Methoxyestradiol and its derivatives inhibit store-operated Ca2+ entry in T cells: Identification of a new and potent inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</span><span> <strong>2021,</strong> <em>1868 </em>
                                    (6)
                                     , 118988. <a href="https://doi.org/10.1016/j.bbamcr.2021.118988" title="DOI URL">https://doi.org/10.1016/j.bbamcr.2021.118988</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamcr.2021.118988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamcr.2021.118988%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520Cell%2520Research%26atitle%3D2-Methoxyestradiol%252Band%252Bits%252Bderivatives%252Binhibit%252Bstore-operated%252BCa2%25252B%252Bentry%252Bin%252BT%252Bcells%25253A%252BIdentification%252Bof%252Ba%252Bnew%252Band%252Bpotent%252Binhibitor%26aulast%3DL%25C3%25B6hndorf%26aufirst%3DAnke%26date%3D2021%26volume%3D1868%26issue%3D6%26spage%3D118988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donald  Poirier</span>, <span class="hlFld-ContribAuthor ">Jenny  Roy</span>, <span class="hlFld-ContribAuthor ">René  Maltais</span>. </span><span class="cited-content_cbyCitation_article-title">A Targeted-Covalent Inhibitor of 17β-HSD1 Blocks Two Estrogen-Biosynthesis Pathways: In Vitro (Metabolism) and In Vivo (Xenograft) Studies in T-47D Breast Cancer Models. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (8)
                                     , 1841. <a href="https://doi.org/10.3390/cancers13081841" title="DOI URL">https://doi.org/10.3390/cancers13081841</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13081841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13081841%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DA%252BTargeted-Covalent%252BInhibitor%252Bof%252B17%2525CE%2525B2-HSD1%252BBlocks%252BTwo%252BEstrogen-Biosynthesis%252BPathways%25253A%252BIn%252BVitro%252B%252528Metabolism%252529%252Band%252BIn%252BVivo%252B%252528Xenograft%252529%252BStudies%252Bin%252BT-47D%252BBreast%252BCancer%252BModels%26aulast%3DPoirier%26aufirst%3DDonald%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D8%26spage%3D1841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan Wolf  Mueller</span>, <span class="hlFld-ContribAuthor ">Nora  Vogg</span>, <span class="hlFld-ContribAuthor ">Thomas Alec  Lightning</span>, <span class="hlFld-ContribAuthor ">Isabel  Weigand</span>, <span class="hlFld-ContribAuthor ">Cristina L  Ronchi</span>, <span class="hlFld-ContribAuthor ">Paul A  Foster</span>, <span class="hlFld-ContribAuthor ">Matthias  Kroiss</span>. </span><span class="cited-content_cbyCitation_article-title">Steroid Sulfation in Adrenal Tumors. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Clinical Endocrinology & Metabolism</span><span> <strong>2021,</strong> <em>98 </em><a href="https://doi.org/10.1210/clinem/dgab182" title="DOI URL">https://doi.org/10.1210/clinem/dgab182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1210/clinem/dgab182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1210%2Fclinem%2Fdgab182%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Clinical%2520Endocrinology%2520%2526%2520Metabolism%26atitle%3DSteroid%252BSulfation%252Bin%252BAdrenal%252BTumors%26aulast%3DMueller%26aufirst%3DJonathan%2BWolf%26date%3D2021%26date%3D2021%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srimathi  R</span>, <span class="hlFld-ContribAuthor ">Kathiravan  MK</span>. </span><span class="cited-content_cbyCitation_article-title">Lead optimization of 4-(thio)-chromenone 6-
              O
              -sulfamate analogs using QSAR, molecular docking and DFT – a combined approach as steroidal sulfatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2021,</strong> <em>41 </em>
                                    (2)
                                     , 123-137. <a href="https://doi.org/10.1080/10799893.2020.1794004" title="DOI URL">https://doi.org/10.1080/10799893.2020.1794004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10799893.2020.1794004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10799893.2020.1794004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DLead%252Boptimization%252Bof%252B4-%252528thio%252529-chromenone%252B6-%252BO%252B-sulfamate%252Banalogs%252Busing%252BQSAR%25252C%252Bmolecular%252Bdocking%252Band%252BDFT%252B%2525E2%252580%252593%252Ba%252Bcombined%252Bapproach%252Bas%252Bsteroidal%252Bsulfatase%252Binhibitors%26aulast%3DR%26aufirst%3DSrimathi%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D2%26spage%3D123%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas Alec  Lightning</span>, <span class="hlFld-ContribAuthor ">Tarsis F.  Gesteira</span>, <span class="hlFld-ContribAuthor ">Jonathan Wolf  Mueller</span>. </span><span class="cited-content_cbyCitation_article-title">Steroid disulfates - Sulfation double trouble. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Endocrinology</span><span> <strong>2021,</strong> <em>524 </em>, 111161. <a href="https://doi.org/10.1016/j.mce.2021.111161" title="DOI URL">https://doi.org/10.1016/j.mce.2021.111161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mce.2021.111161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mce.2021.111161%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Endocrinology%26atitle%3DSteroid%252Bdisulfates%252B-%252BSulfation%252Bdouble%252Btrouble%26aulast%3DLightning%26aufirst%3DThomas%2BAlec%26date%3D2021%26volume%3D524%26spage%3D111161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Mottinelli</span>, <span class="hlFld-ContribAuthor ">Maša  Sinreih</span>, <span class="hlFld-ContribAuthor ">Tea L.  Rižner</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Leese</span>, <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">N
              ‐Phenyl‐1,2,3,4‐tetrahydroisoquinoline: An Alternative Scaffold for the Design of 17β‐Hydroxysteroid Dehydrogenase 1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (1)
                                     , 259-291. <a href="https://doi.org/10.1002/cmdc.202000762" title="DOI URL">https://doi.org/10.1002/cmdc.202000762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000762%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DN%252B%2525E2%252580%252590Phenyl%2525E2%252580%2525901%25252C2%25252C3%25252C4%2525E2%252580%252590tetrahydroisoquinoline%25253A%252BAn%252BAlternative%252BScaffold%252Bfor%252Bthe%252BDesign%252Bof%252B17%2525CE%2525B2%2525E2%252580%252590Hydroxysteroid%252BDehydrogenase%252B1%252BInhibitors%26aulast%3DMottinelli%26aufirst%3DMarco%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D1%26spage%3D259%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Péter  Traj</span>, <span class="hlFld-ContribAuthor ">Ali Hazhmat  Abdolkhaliq</span>, <span class="hlFld-ContribAuthor ">Anett  Németh</span>, <span class="hlFld-ContribAuthor ">Sámuel Trisztán  Dajcs</span>, <span class="hlFld-ContribAuthor ">Ferenc  Tömösi</span>, <span class="hlFld-ContribAuthor ">Tea  Lanisnik-Rizner</span>, <span class="hlFld-ContribAuthor ">István  Zupkó</span>, <span class="hlFld-ContribAuthor ">Erzsébet  Mernyák</span>. </span><span class="cited-content_cbyCitation_article-title">Transition metal-catalysed A-ring C–H activations and C(sp
              2
              )–C(sp
              2
              ) couplings in the 13α-oestrone series and
              in vitro
              evaluation of antiproliferative properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 895-902. <a href="https://doi.org/10.1080/14756366.2021.1900165" title="DOI URL">https://doi.org/10.1080/14756366.2021.1900165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1900165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1900165%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DTransition%252Bmetal-catalysed%252BA-ring%252BC%2525E2%252580%252593H%252Bactivations%252Band%252BC%252528sp%252B2%252B%252529%2525E2%252580%252593C%252528sp%252B2%252B%252529%252Bcouplings%252Bin%252Bthe%252B13%2525CE%2525B1-oestrone%252Bseries%252Band%252Bin%2525C2%2525A0vitro%252Bevaluation%252Bof%252Bantiproliferative%252Bproperties%26aulast%3DTraj%26aufirst%3DP%25C3%25A9ter%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D895%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leilei  Huang</span>, <span class="hlFld-ContribAuthor ">Jinwen  Huang</span>, <span class="hlFld-ContribAuthor ">Hui  Nie</span>, <span class="hlFld-ContribAuthor ">Yingzi  Li</span>, <span class="hlFld-ContribAuthor ">Lixing  Song</span>, <span class="hlFld-ContribAuthor ">Fanhong  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>61 </em><a href="https://doi.org/10.1039/D0MD00372G" title="DOI URL">https://doi.org/10.1039/D0MD00372G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00372G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00372G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bcombretastatin%252BA-4%252Bsulfamate%252Bderivatives%252Bas%252Bpotential%252Banti-cancer%252Bagents%26aulast%3DHuang%26aufirst%3DLeilei%26date%3D2021%26date%3D2021%26volume%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mateusz  Daśko</span>, <span class="hlFld-ContribAuthor ">Sebastian  Demkowicz</span>, <span class="hlFld-ContribAuthor ">Janusz  Rachon</span>, <span class="hlFld-ContribAuthor ">Karol  Biernacki</span>, <span class="hlFld-ContribAuthor ">Justyna  Aszyk</span>, <span class="hlFld-ContribAuthor ">Witold  Kozak</span>, <span class="hlFld-ContribAuthor ">Maciej  Masłyk</span>, <span class="hlFld-ContribAuthor ">Konrad  Kubiński</span>. </span><span class="cited-content_cbyCitation_article-title">New potent STS inhibitors based on fluorinated 4-(1-phenyl-1
              H
              -[1,2,3]triazol-4-yl)-phenyl sulfamates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Asian Natural Products Research</span><span> <strong>2020,</strong> <em>22 </em>
                                    (11)
                                     , 1037-1044. <a href="https://doi.org/10.1080/10286020.2019.1680642" title="DOI URL">https://doi.org/10.1080/10286020.2019.1680642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10286020.2019.1680642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10286020.2019.1680642%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Asian%2520Natural%2520Products%2520Research%26atitle%3DNew%252Bpotent%252BSTS%252Binhibitors%252Bbased%252Bon%252Bfluorinated%252B4-%2525281-phenyl-1%252BH%252B-%25255B1%25252C2%25252C3%25255Dtriazol-4-yl%252529-phenyl%252Bsulfamates%26aulast%3DDa%25C5%259Bko%26aufirst%3DMateusz%26date%3D2020%26date%3D2019%26volume%3D22%26issue%3D11%26spage%3D1037%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Yang</span>, <span class="hlFld-ContribAuthor ">Chong‐Hui  Xu</span>, <span class="hlFld-ContribAuthor ">Fan  Teng</span>, <span class="hlFld-ContribAuthor ">Jin‐Heng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Dearomatization‐Enabled Visible‐Light‐Induced 1,2‐Alkylsulfonylation of Alkenes Using Sodium Sulfinates and Pyridinium Salts. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (16)
                                     , 3369-3373. <a href="https://doi.org/10.1002/adsc.202000457" title="DOI URL">https://doi.org/10.1002/adsc.202000457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000457%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DDearomatization%2525E2%252580%252590Enabled%252BVisible%2525E2%252580%252590Light%2525E2%252580%252590Induced%252B1%25252C2%2525E2%252580%252590Alkylsulfonylation%252Bof%252BAlkenes%252BUsing%252BSodium%252BSulfinates%252Band%252BPyridinium%252BSalts%26aulast%3DYang%26aufirst%3DYuan%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D16%26spage%3D3369%26epage%3D3373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Fröhlich</span>, <span class="hlFld-ContribAuthor ">Christina  Mai</span>, <span class="hlFld-ContribAuthor ">Roman P.  Bogautdinov</span>, <span class="hlFld-ContribAuthor ">Svetlana N.  Morozkina</span>, <span class="hlFld-ContribAuthor ">Alexander G.  Shavva</span>, <span class="hlFld-ContribAuthor ">Oliver  Friedrich</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Svetlana B.  Tsogoeva</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Tamoxifen‐Artemisinin and Estrogen‐Artemisinin Hybrids Highly Potent Against Breast and Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (15)
                                     , 1473-1479. <a href="https://doi.org/10.1002/cmdc.202000174" title="DOI URL">https://doi.org/10.1002/cmdc.202000174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000174%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Bof%252BTamoxifen%2525E2%252580%252590Artemisinin%252Band%252BEstrogen%2525E2%252580%252590Artemisinin%252BHybrids%252BHighly%252BPotent%252BAgainst%252BBreast%252Band%252BProstate%252BCancer%26aulast%3DFr%25C3%25B6hlich%26aufirst%3DTony%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D15%26spage%3D1473%26epage%3D1479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul B.  Ghuge</span>, <span class="hlFld-ContribAuthor ">Prashant R.  Murumkar</span>, <span class="hlFld-ContribAuthor ">Kailash M.  Choudhary</span>, <span class="hlFld-ContribAuthor ">Karan D.  Joshi</span>, <span class="hlFld-ContribAuthor ">Monica  Chauhan</span>, <span class="hlFld-ContribAuthor ">Rahul R.  Barot</span>, <span class="hlFld-ContribAuthor ">Mange R.  Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Steroidal Aromatase Inhibitors as Potential Anti-breast Cancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Current Enzyme Inhibition</span><span> <strong>2020,</strong> <em>16 </em>
                                    (1)
                                     , 45-62. <a href="https://doi.org/10.2174/1573408016666200212094804" title="DOI URL">https://doi.org/10.2174/1573408016666200212094804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573408016666200212094804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573408016666200212094804%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Enzyme%2520Inhibition%26atitle%3DDevelopment%252Bof%252BSteroidal%252BAromatase%252BInhibitors%252Bas%252BPotential%252BAnti-breast%252BCancer%252BAgents%26aulast%3DGhuge%26aufirst%3DRahul%2BB.%26date%3D2020%26volume%3D16%26issue%3D1%26spage%3D45%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">René  Maltais</span>, <span class="hlFld-ContribAuthor ">Adrien  Ngueta Djiemeny</span>, <span class="hlFld-ContribAuthor ">Jenny  Roy</span>, <span class="hlFld-ContribAuthor ">Xavier  Barbeau</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Lambert</span>, <span class="hlFld-ContribAuthor ">Donald  Poirier</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of dansyl-labeled inhibitors of steroid sulfatase for optical imaging. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (7)
                                     , 115368. <a href="https://doi.org/10.1016/j.bmc.2020.115368" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115368</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115368%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bdansyl-labeled%252Binhibitors%252Bof%252Bsteroid%252Bsulfatase%252Bfor%252Boptical%252Bimaging%26aulast%3DMaltais%26aufirst%3DRen%25C3%25A9%26date%3D2020%26volume%3D28%26issue%3D7%26spage%3D115368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed I.  El-Gamal</span>, <span class="hlFld-ContribAuthor ">Seyed-Omar  Zaraei</span>, <span class="hlFld-ContribAuthor ">Paul A.  Foster</span>, <span class="hlFld-ContribAuthor ">Hanan S.  Anbar</span>, <span class="hlFld-ContribAuthor ">Randa  El-Gamal</span>, <span class="hlFld-ContribAuthor ">Raafat  El-Awady</span>, <span class="hlFld-ContribAuthor ">Barry V.L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (8)
                                     , 115406. <a href="https://doi.org/10.1016/j.bmc.2020.115406" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115406</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115406%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252Bnew%252Bseries%252Bof%252Baryl%252Bsulfamate%252Bderivatives%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%26aulast%3DEl-Gamal%26aufirst%3DMohammed%2BI.%26date%3D2020%26volume%3D28%26issue%3D8%26spage%3D115406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Marra</span>, <span class="hlFld-ContribAuthor ">Cristina  Nativi</span>, <span class="hlFld-ContribAuthor ">Alessandro  Dondoni</span>. </span><span class="cited-content_cbyCitation_article-title">On the scope of SuFEx as a bioorthogonal click process. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2020,</strong> <em>44 </em>
                                    (12)
                                     , 4678-4680. <a href="https://doi.org/10.1039/D0NJ00504E" title="DOI URL">https://doi.org/10.1039/D0NJ00504E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ00504E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ00504E%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DOn%252Bthe%252Bscope%252Bof%252BSuFEx%252Bas%252Ba%252Bbioorthogonal%252Bclick%252Bprocess%26aulast%3DMarra%26aufirst%3DAlberto%26date%3D2020%26date%3D2020%26volume%3D44%26issue%3D12%26spage%3D4678%26epage%3D4680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Hng</span>, <span class="hlFld-ContribAuthor ">Mei-Hsiang  Lin</span>, <span class="hlFld-ContribAuthor ">Tzung-Sheng  Lin</span>, <span class="hlFld-ContribAuthor ">I-Chen  Liu</span>, <span class="hlFld-ContribAuthor ">I-Chun  Lin</span>, <span class="hlFld-ContribAuthor ">Yeh-Lin  Lu</span>, <span class="hlFld-ContribAuthor ">Chiao-Nien  Chang</span>, <span class="hlFld-ContribAuthor ">Pei-Fang  Chiu</span>, <span class="hlFld-ContribAuthor ">Keng-Chang  Tsai</span>, <span class="hlFld-ContribAuthor ">Mei-Jou  Chen</span>, <span class="hlFld-ContribAuthor ">Pi-Hui  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of 3-benzylaminocoumarin-7-O-sulfamate derivatives as steroid sulfatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>96 </em>, 103618. <a href="https://doi.org/10.1016/j.bioorg.2020.103618" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103618%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B3-benzylaminocoumarin-7-O-sulfamate%252Bderivatives%252Bas%252Bsteroid%252Bsulfatase%252Binhibitors%26aulast%3DHng%26aufirst%3DYue%26date%3D2020%26volume%3D96%26spage%3D103618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Liang-Feng  Yang</span>, <span class="hlFld-ContribAuthor ">Jin-Heng  Li</span>, <span class="hlFld-ContribAuthor ">Qiu-An  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Dicarbonylative benzannulation of 3-acetoxy-1,4-enynes with CO and silylboranes by Pd and Cu cooperative catalysis: one-step access to 3-hydroxyarylacylsilanes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (11)
                                     , 1669-1672. <a href="https://doi.org/10.1039/C9CC09077K" title="DOI URL">https://doi.org/10.1039/C9CC09077K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC09077K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC09077K%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DDicarbonylative%252Bbenzannulation%252Bof%252B3-acetoxy-1%25252C4-enynes%252Bwith%252BCO%252Band%252Bsilylboranes%252Bby%252BPd%252Band%252BCu%252Bcooperative%252Bcatalysis%25253A%252Bone-step%252Baccess%252Bto%252B3-hydroxyarylacylsilanes%26aulast%3DWu%26aufirst%3DLi-Jun%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D11%26spage%3D1669%26epage%3D1672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ulrike  Grienke</span>, <span class="hlFld-ContribAuthor ">Teresa  Kaserer</span>, <span class="hlFld-ContribAuthor ">Benjamin  Kirchweger</span>, <span class="hlFld-ContribAuthor ">George  Lambrinidis</span>, <span class="hlFld-ContribAuthor ">Ralph T.  Kandel</span>, <span class="hlFld-ContribAuthor ">Paul A.  Foster</span>, <span class="hlFld-ContribAuthor ">Daniela  Schuster</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Mikros</span>, <span class="hlFld-ContribAuthor ">Judith M.  Rollinger</span>. </span><span class="cited-content_cbyCitation_article-title">Steroid sulfatase inhibiting lanostane triterpenes – Structure activity relationship and in silico insights. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>95 </em>, 103495. <a href="https://doi.org/10.1016/j.bioorg.2019.103495" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103495%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSteroid%252Bsulfatase%252Binhibiting%252Blanostane%252Btriterpenes%252B%2525E2%252580%252593%252BStructure%252Bactivity%252Brelationship%252Band%252Bin%252Bsilico%252Binsights%26aulast%3DGrienke%26aufirst%3DUlrike%26date%3D2020%26volume%3D95%26spage%3D103495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mateusz  Daśko</span>, <span class="hlFld-ContribAuthor ">Sebastian  Demkowicz</span>, <span class="hlFld-ContribAuthor ">Karol  Biernacki</span>, <span class="hlFld-ContribAuthor ">Olga  Ciupak</span>, <span class="hlFld-ContribAuthor ">Witold  Kozak</span>, <span class="hlFld-ContribAuthor ">Maciej  Masłyk</span>, <span class="hlFld-ContribAuthor ">Janusz  Rachon</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in the development of steroid sulphatase inhibitors – examples of the novel and most promising compounds from the last decade. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1163-1184. <a href="https://doi.org/10.1080/14756366.2020.1758692" title="DOI URL">https://doi.org/10.1080/14756366.2020.1758692</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1758692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1758692%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bprogress%252Bin%252Bthe%252Bdevelopment%252Bof%252Bsteroid%252Bsulphatase%252Binhibitors%252B%2525E2%252580%252593%252Bexamples%252Bof%252Bthe%252Bnovel%252Band%252Bmost%252Bpromising%252Bcompounds%252Bfrom%252Bthe%252Blast%252Bdecade%26aulast%3DDa%25C5%259Bko%26aufirst%3DMateusz%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1163%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chanamon  Chamduang</span>, <span class="hlFld-ContribAuthor ">Ratchanok  Pingaew</span>, <span class="hlFld-ContribAuthor ">Veda  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Supaluk  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Somsak  Ruchirawat</span>, <span class="hlFld-ContribAuthor ">Virapong  Prachayasittikul</span>. </span><span class="cited-content_cbyCitation_article-title">Novel triazole-tetrahydroisoquinoline hybrids as human aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>93 </em>, 103327. <a href="https://doi.org/10.1016/j.bioorg.2019.103327" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103327%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Btriazole-tetrahydroisoquinoline%252Bhybrids%252Bas%252Bhuman%252Baromatase%252Binhibitors%26aulast%3DChamduang%26aufirst%3DChanamon%26date%3D2019%26volume%3D93%26spage%3D103327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-chi  Shen</span>, <span class="hlFld-ContribAuthor ">Caroline  Arellano-Garcia</span>, <span class="hlFld-ContribAuthor ">Rosa E.  Menjivar</span>, <span class="hlFld-ContribAuthor ">Ethan M.  Jewett</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Dohle</span>, <span class="hlFld-ContribAuthor ">Sofiia  Karchugina</span>, <span class="hlFld-ContribAuthor ">Jonathan  Chernoff</span>, <span class="hlFld-ContribAuthor ">Barry V. L.  Potter</span>, <span class="hlFld-ContribAuthor ">Kate F.  Barald</span>. </span><span class="cited-content_cbyCitation_article-title">Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2). </span><span class="cited-content_cbyCitation_journal-name">BMC Pharmacology and Toxicology</span><span> <strong>2019,</strong> <em>20 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40360-019-0369-8" title="DOI URL">https://doi.org/10.1186/s40360-019-0369-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40360-019-0369-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40360-019-0369-8%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Pharmacology%2520and%2520Toxicology%26atitle%3DNonsteroidal%252Bsulfamate%252Bderivatives%252Bas%252Bnew%252Btherapeutic%252Bapproaches%252Bfor%252BNeurofibromatosis%252B2%252B%252528NF2%252529%26aulast%3DShen%26aufirst%3DYu-chi%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Davide  Moi</span>, <span class="hlFld-ContribAuthor ">Paul A.  Foster</span>, <span class="hlFld-ContribAuthor ">Lucy G.  Rimmer</span>, <span class="hlFld-ContribAuthor ">Alisha  Jaffri</span>, <span class="hlFld-ContribAuthor ">Alessandro  Deplano</span>, <span class="hlFld-ContribAuthor ">Gianfranco  Balboni</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>, <span class="hlFld-ContribAuthor ">Barry V.L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111614. <a href="https://doi.org/10.1016/j.ejmech.2019.111614" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111614</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111614%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bin%2525C2%2525A0vitro%252Bevaluation%252Bof%252Bpiperazinyl-ureido%252Bsulfamates%252Bas%252Bsteroid%252Bsulfatase%252Binhibitors%26aulast%3DMoi%26aufirst%3DDavide%26date%3D2019%26volume%3D182%26spage%3D111614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mateusz  Daśko</span>, <span class="hlFld-ContribAuthor ">Sebastian  Demkowicz</span>, <span class="hlFld-ContribAuthor ">Karol  Biernacki</span>, <span class="hlFld-ContribAuthor ">Amira  Harrous</span>, <span class="hlFld-ContribAuthor ">Janusz  Rachon</span>, <span class="hlFld-ContribAuthor ">Witold  Kozak</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Martyna</span>, <span class="hlFld-ContribAuthor ">Maciej  Masłyk</span>, <span class="hlFld-ContribAuthor ">Konrad  Kubiński</span>, <span class="hlFld-ContribAuthor ">Anna  Boguszewska‐Czubara</span>. </span><span class="cited-content_cbyCitation_article-title">Novel steroid sulfatase inhibitors based on
              N
              ‐thiophosphorylated 3‐(4‐aminophenyl)‐coumarin‐7‐O‐sulfamates. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2019,</strong> <em>80 </em>
                                    (6)
                                     , 857-866. <a href="https://doi.org/10.1002/ddr.21569" title="DOI URL">https://doi.org/10.1002/ddr.21569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21569%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DNovel%252Bsteroid%252Bsulfatase%252Binhibitors%252Bbased%252Bon%252BN%252B%2525E2%252580%252590thiophosphorylated%252B3%2525E2%252580%252590%2525284%2525E2%252580%252590aminophenyl%252529%2525E2%252580%252590coumarin%2525E2%252580%2525907%2525E2%252580%252590O%2525E2%252580%252590sulfamates%26aulast%3DDa%25C5%259Bko%26aufirst%3DMateusz%26date%3D2019%26date%3D2019%26volume%3D80%26issue%3D6%26spage%3D857%26epage%3D866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cong  Wang</span>, <span class="hlFld-ContribAuthor ">Leilei  Li</span>, <span class="hlFld-ContribAuthor ">Dongyang  Fu</span>, <span class="hlFld-ContribAuthor ">Tiantian  Qin</span>, <span class="hlFld-ContribAuthor ">Yange  Ran</span>, <span class="hlFld-ContribAuthor ">Feng  Xu</span>, <span class="hlFld-ContribAuthor ">Xinrui  Du</span>, <span class="hlFld-ContribAuthor ">Haiying  Gao</span>, <span class="hlFld-ContribAuthor ">Shuaijun  Sun</span>, <span class="hlFld-ContribAuthor ">Tengjiao  Yang</span>, <span class="hlFld-ContribAuthor ">Xueyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Junfeng  Huo</span>, <span class="hlFld-ContribAuthor ">Wen  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhenzhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiufang  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of chalcone-modified estradiol analogs as antitumour agents that Inhibit tumour angiogenesis and epithelial to mesenchymal transition. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>176 </em>, 135-148. <a href="https://doi.org/10.1016/j.ejmech.2019.04.071" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.04.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.04.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.04.071%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bchalcone-modified%252Bestradiol%252Banalogs%252Bas%252Bantitumour%252Bagents%252Bthat%252BInhibit%252Btumour%252Bangiogenesis%252Band%252Bepithelial%252Bto%252Bmesenchymal%252Btransition%26aulast%3DWang%26aufirst%3DCong%26date%3D2019%26volume%3D176%26spage%3D135%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard  Schroeder</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Grenning</span>. </span><span class="cited-content_cbyCitation_article-title">Accessing the decarboxylative allylation–divinylcyclopropane-cycloheptadiene rearrangement from the ketone/aldehyde substrate pool. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2019,</strong> <em>75 </em>
                                    (24)
                                     , 3231-3238. <a href="https://doi.org/10.1016/j.tet.2019.03.036" title="DOI URL">https://doi.org/10.1016/j.tet.2019.03.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2019.03.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2019.03.036%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAccessing%252Bthe%252Bdecarboxylative%252Ballylation%2525E2%252580%252593divinylcyclopropane-cycloheptadiene%252Brearrangement%252Bfrom%252Bthe%252Bketone%25252Faldehyde%252Bsubstrate%252Bpool%26aulast%3DSchroeder%26aufirst%3DRichard%26date%3D2019%26volume%3D75%26issue%3D24%26spage%3D3231%26epage%3D3238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ehsan  Fereyduni</span>, <span class="hlFld-ContribAuthor ">Jacob N.  Sanders</span>, <span class="hlFld-ContribAuthor ">Gabriel  Gonzalez</span>, <span class="hlFld-ContribAuthor ">K. N.  Houk</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Grenning</span>. </span><span class="cited-content_cbyCitation_article-title">Transient [3,3] Cope rearrangement of 3,3-dicyano-1,5-dienes: computational analysis and 2-step synthesis of arylcycloheptanes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2018,</strong> <em>9 </em>
                                    (46)
                                     , 8760-8764. <a href="https://doi.org/10.1039/C8SC03057J" title="DOI URL">https://doi.org/10.1039/C8SC03057J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8SC03057J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8SC03057J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DTransient%252B%25255B3%25252C3%25255D%252BCope%252Brearrangement%252Bof%252B3%25252C3-dicyano-1%25252C5-dienes%25253A%252Bcomputational%252Banalysis%252Band%252B2-step%252Bsynthesis%252Bof%252Barylcycloheptanes%26aulast%3DFereyduni%26aufirst%3DEhsan%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D46%26spage%3D8760%26epage%3D8764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li‐Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Ren‐Jie  Song</span>, <span class="hlFld-ContribAuthor ">Shenglian  Luo</span>, <span class="hlFld-ContribAuthor ">Jin‐Heng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium‐Catalyzed Reductive [5+1] Cycloaddition of 3‐Acetoxy‐1,4‐enynes with CO: Access to Phenols Enabled by Hydrosilanes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2018,</strong> <em>130 </em>
                                    (40)
                                     , 13492-13496. <a href="https://doi.org/10.1002/ange.201808388" title="DOI URL">https://doi.org/10.1002/ange.201808388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201808388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201808388%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DPalladium%2525E2%252580%252590Catalyzed%252BReductive%252B%25255B5%25252B1%25255D%252BCycloaddition%252Bof%252B3%2525E2%252580%252590Acetoxy%2525E2%252580%2525901%25252C4%2525E2%252580%252590enynes%252Bwith%252BCO%25253A%252BAccess%252Bto%252BPhenols%252BEnabled%252Bby%252BHydrosilanes%26aulast%3DWu%26aufirst%3DLi%25E2%2580%2590Jun%26date%3D2018%26date%3D2018%26volume%3D130%26issue%3D40%26spage%3D13492%26epage%3D13496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li‐Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Ren‐Jie  Song</span>, <span class="hlFld-ContribAuthor ">Shenglian  Luo</span>, <span class="hlFld-ContribAuthor ">Jin‐Heng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium‐Catalyzed Reductive [5+1] Cycloaddition of 3‐Acetoxy‐1,4‐enynes with CO: Access to Phenols Enabled by Hydrosilanes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2018,</strong> <em>57 </em>
                                    (40)
                                     , 13308-13312. <a href="https://doi.org/10.1002/anie.201808388" title="DOI URL">https://doi.org/10.1002/anie.201808388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201808388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201808388%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DPalladium%2525E2%252580%252590Catalyzed%252BReductive%252B%25255B5%25252B1%25255D%252BCycloaddition%252Bof%252B3%2525E2%252580%252590Acetoxy%2525E2%252580%2525901%25252C4%2525E2%252580%252590enynes%252Bwith%252BCO%25253A%252BAccess%252Bto%252BPhenols%252BEnabled%252Bby%252BHydrosilanes%26aulast%3DWu%26aufirst%3DLi%25E2%2580%2590Jun%26date%3D2018%26volume%3D57%26issue%3D40%26spage%3D13308%26epage%3D13312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ratchanok  Pingaew</span>, <span class="hlFld-ContribAuthor ">Veda  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Nuttapat  Anuwongcharoen</span>, <span class="hlFld-ContribAuthor ">Supaluk  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Somsak  Ruchirawat</span>, <span class="hlFld-ContribAuthor ">Virapong  Prachayasittikul</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and molecular docking of N,N′-disubstituted thiourea derivatives as novel aromatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>79 </em>, 171-178. <a href="https://doi.org/10.1016/j.bioorg.2018.05.002" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bmolecular%252Bdocking%252Bof%252BN%25252CN%2525E2%252580%2525B2-disubstituted%252Bthiourea%252Bderivatives%252Bas%252Bnovel%252Baromatase%252Binhibitors%26aulast%3DPingaew%26aufirst%3DRatchanok%26date%3D2018%26volume%3D79%26spage%3D171%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barry V L  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Endocrinology</span><span> <strong>2018,</strong> <em>61 </em>
                                    (2)
                                     , T233-T252. <a href="https://doi.org/10.1530/JME-18-0045" title="DOI URL">https://doi.org/10.1530/JME-18-0045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1530/JME-18-0045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1530%2FJME-18-0045%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Endocrinology%26atitle%3DSULFATION%252BPATHWAYS%25253A%252BSteroid%252Bsulphatase%252Binhibition%252Bvia%252Baryl%252Bsulphamates%25253A%252Bclinical%252Bprogress%25252C%252Bmechanism%252Band%252Bfuture%252Bprospects%26aulast%3DPotter%26aufirst%3DBarry%2BV%2BL%26date%3D2018%26volume%3D61%26issue%3D2%26spage%3DT233%26epage%3DT252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asako  Kaise</span>, <span class="hlFld-ContribAuthor ">Kiminori  Ohta</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Endo</span>. </span><span class="cited-content_cbyCitation_article-title">Novel p-carborane-containing multitarget anticancer agents inspired by the metabolism of 17β-estradiol. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (24)
                                     , 6371-6378. <a href="https://doi.org/10.1016/j.bmc.2017.10.006" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bp-carborane-containing%252Bmultitarget%252Banticancer%252Bagents%252Binspired%252Bby%252Bthe%252Bmetabolism%252Bof%252B17%2525CE%2525B2-estradiol%26aulast%3DKaise%26aufirst%3DAsako%26date%3D2017%26volume%3D25%26issue%3D24%26spage%3D6371%26epage%3D6378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asako  Kaise</span>, <span class="hlFld-ContribAuthor ">Kiminori  Ohta</span>, <span class="hlFld-ContribAuthor ">Chinami  Shirata</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Endo</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of p-carborane-containing sulfamates as multitarget anti-breast cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (24)
                                     , 6417-6426. <a href="https://doi.org/10.1016/j.bmc.2017.10.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bp-carborane-containing%252Bsulfamates%252Bas%252Bmultitarget%252Banti-breast%252Bcancer%252Bagents%26aulast%3DKaise%26aufirst%3DAsako%26date%3D2017%26volume%3D25%26issue%3D24%26spage%3D6417%26epage%3D6426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiufang  Shi</span>, <span class="hlFld-ContribAuthor ">Zhihao  Wang</span>, <span class="hlFld-ContribAuthor ">Feng  Xu</span>, <span class="hlFld-ContribAuthor ">Xiang  Lu</span>, <span class="hlFld-ContribAuthor ">Haifeng  Yao</span>, <span class="hlFld-ContribAuthor ">Dandan  Wu</span>, <span class="hlFld-ContribAuthor ">Shuaijun  Sun</span>, <span class="hlFld-ContribAuthor ">Ruifang  Nie</span>, <span class="hlFld-ContribAuthor ">Shuo  Gao</span>, <span class="hlFld-ContribAuthor ">Panpan  Li</span>, <span class="hlFld-ContribAuthor ">Liwen  Xia</span>, <span class="hlFld-ContribAuthor ">Zhenzhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Cong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antiproliferative effect of 17β-amide derivatives of 2-methoxyestradiol and their studies on pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2017,</strong> <em>128 </em>, 6-14. <a href="https://doi.org/10.1016/j.steroids.2017.09.013" title="DOI URL">https://doi.org/10.1016/j.steroids.2017.09.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2017.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2017.09.013%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantiproliferative%252Beffect%252Bof%252B17%2525CE%2525B2-amide%252Bderivatives%252Bof%252B2-methoxyestradiol%252Band%252Btheir%252Bstudies%252Bon%252Bpharmacokinetics%26aulast%3DShi%26aufirst%3DXiufang%26date%3D2017%26volume%3D128%26spage%3D6%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mateusz  Daśko</span>, <span class="hlFld-ContribAuthor ">Janusz  Rachon</span>, <span class="hlFld-ContribAuthor ">Maciej  Masłyk</span>, <span class="hlFld-ContribAuthor ">Konrad  Kubiński</span>, <span class="hlFld-ContribAuthor ">Sebastian  Demkowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of
              N
              -acylated tyramine sulfamates containing C-F bonds as steroid sulfatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2017,</strong> <em>90 </em>
                                    (1)
                                     , 156-161. <a href="https://doi.org/10.1111/cbdd.12931" title="DOI URL">https://doi.org/10.1111/cbdd.12931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12931%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN%252B-acylated%252Btyramine%252Bsulfamates%252Bcontaining%252BC-F%252Bbonds%252Bas%252Bsteroid%252Bsulfatase%252Binhibitors%26aulast%3DDa%25C5%259Bko%26aufirst%3DMateusz%26date%3D2017%26date%3D2017%26volume%3D90%26issue%3D1%26spage%3D156%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katharina R.  Beck</span>, <span class="hlFld-ContribAuthor ">Teresa  Kaserer</span>, <span class="hlFld-ContribAuthor ">Daniela  Schuster</span>, <span class="hlFld-ContribAuthor ">Alex  Odermatt</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual screening applications in short-chain dehydrogenase/reductase research. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Steroid Biochemistry and Molecular Biology</span><span> <strong>2017,</strong> <em>171 </em>, 157-177. <a href="https://doi.org/10.1016/j.jsbmb.2017.03.008" title="DOI URL">https://doi.org/10.1016/j.jsbmb.2017.03.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsbmb.2017.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsbmb.2017.03.008%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Steroid%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DVirtual%252Bscreening%252Bapplications%252Bin%252Bshort-chain%252Bdehydrogenase%25252Freductase%252Bresearch%26aulast%3DBeck%26aufirst%3DKatharina%2BR.%26date%3D2017%26volume%3D171%26spage%3D157%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mateusz  Daśko</span>, <span class="hlFld-ContribAuthor ">Maja  Przybyłowska</span>, <span class="hlFld-ContribAuthor ">Janusz  Rachon</span>, <span class="hlFld-ContribAuthor ">Maciej  Masłyk</span>, <span class="hlFld-ContribAuthor ">Konrad  Kubiński</span>, <span class="hlFld-ContribAuthor ">Majus  Misiak</span>, <span class="hlFld-ContribAuthor ">Andrzej  Składanowski</span>, <span class="hlFld-ContribAuthor ">Sebastian  Demkowicz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of fluorinated N -benzoyl and N -phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7- O -sulfamate as steroid sulfatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>128 </em>, 79-87. <a href="https://doi.org/10.1016/j.ejmech.2017.01.028" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.01.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.01.028%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bfluorinated%252BN%252B-benzoyl%252Band%252BN%252B-phenylacetoyl%252Bderivatives%252Bof%252B3-%2525284-aminophenyl%252529-coumarin-7-%252BO%252B-sulfamate%252Bas%252Bsteroid%252Bsulfatase%252Binhibitors%26aulast%3DDa%25C5%259Bko%26aufirst%3DMateusz%26date%3D2017%26volume%3D128%26spage%3D79%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed I.  El-Gamal</span>, <span class="hlFld-ContribAuthor ">Mohammad H.  Semreen</span>, <span class="hlFld-ContribAuthor ">Paul A.  Foster</span>, <span class="hlFld-ContribAuthor ">Barry V.L.  Potter</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (12)
                                     , 2762-2767. <a href="https://doi.org/10.1016/j.bmc.2016.04.040" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.04.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.04.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252Barylamide%252Bderivatives%252Bpossessing%252Bsulfonate%252Bor%252Bsulfamate%252Bmoieties%252Bas%252Bsteroid%252Bsulfatase%252Benzyme%252Binhibitors%26aulast%3DEl-Gamal%26aufirst%3DMohammed%2BI.%26date%3D2016%26volume%3D24%26issue%3D12%26spage%3D2762%26epage%3D2767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sebastian  Demkowicz</span>, <span class="hlFld-ContribAuthor ">Mateusz  Daśko</span>, <span class="hlFld-ContribAuthor ">Witold  Kozak</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Krawczyk</span>, <span class="hlFld-ContribAuthor ">Dariusz  Witt</span>, <span class="hlFld-ContribAuthor ">Maciej  Masłyk</span>, <span class="hlFld-ContribAuthor ">Konrad  Kubiński</span>, <span class="hlFld-ContribAuthor ">Janusz  Rachon</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Fluorinated 3-Phenylcoumarin-7-
              O
              -Sulfamate Derivatives as Steroid Sulfatase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2016,</strong> <em>87 </em>
                                    (2)
                                     , 233-238. <a href="https://doi.org/10.1111/cbdd.12652" title="DOI URL">https://doi.org/10.1111/cbdd.12652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12652%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BFluorinated%252B3-Phenylcoumarin-7-%252BO%252B-Sulfamate%252BDerivatives%252Bas%252BSteroid%252BSulfatase%252BInhibitors%26aulast%3DDemkowicz%26aufirst%3DSebastian%26date%3D2016%26date%3D2015%26volume%3D87%26issue%3D2%26spage%3D233%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natasha J.  Dias</span>, <span class="hlFld-ContribAuthor ">Kyle W.  Selcer</span>. </span><span class="cited-content_cbyCitation_article-title">Steroid sulfatase in the human MG-63 preosteoblastic cell line: Antagonistic regulation by glucocorticoids and NFκB. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Endocrinology</span><span> <strong>2016,</strong> <em>420 </em>, 85-96. <a href="https://doi.org/10.1016/j.mce.2015.11.029" title="DOI URL">https://doi.org/10.1016/j.mce.2015.11.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mce.2015.11.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mce.2015.11.029%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Endocrinology%26atitle%3DSteroid%252Bsulfatase%252Bin%252Bthe%252Bhuman%252BMG-63%252Bpreosteoblastic%252Bcell%252Bline%25253A%252BAntagonistic%252Bregulation%252Bby%252Bglucocorticoids%252Band%252BNF%2525CE%2525BAB%26aulast%3DDias%26aufirst%3DNatasha%2BJ.%26date%3D2016%26volume%3D420%26spage%3D85%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tristan  Reuillon</span>, <span class="hlFld-ContribAuthor ">Sari F.  Alhasan</span>, <span class="hlFld-ContribAuthor ">Gary S.  Beale</span>, <span class="hlFld-ContribAuthor ">Annalisa  Bertoli</span>, <span class="hlFld-ContribAuthor ">Alfie  Brennan</span>, <span class="hlFld-ContribAuthor ">Celine  Cano</span>, <span class="hlFld-ContribAuthor ">Helen L.  Reeves</span>, <span class="hlFld-ContribAuthor ">David R.  Newell</span>, <span class="hlFld-ContribAuthor ">Bernard T.  Golding</span>, <span class="hlFld-ContribAuthor ">Duncan C.  Miller</span>, <span class="hlFld-ContribAuthor ">Roger J.  Griffin</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of biphenyl and biphenyl ether inhibitors of sulfatases. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2016,</strong> <em>7 </em>
                                    (4)
                                     , 2821-2826. <a href="https://doi.org/10.1039/C5SC03612G" title="DOI URL">https://doi.org/10.1039/C5SC03612G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5SC03612G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5SC03612G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bbiphenyl%252Band%252Bbiphenyl%252Bether%252Binhibitors%252Bof%252Bsulfatases%26aulast%3DReuillon%26aufirst%3DTristan%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D4%26spage%3D2821%26epage%3D2826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Mihoubi</span>, <span class="hlFld-ContribAuthor ">Nicola  Micale</span>, <span class="hlFld-ContribAuthor ">Angela  Scala</span>, <span class="hlFld-ContribAuthor ">Raoudha  Jarraya</span>, <span class="hlFld-ContribAuthor ">Amira  Bouaziz</span>, <span class="hlFld-ContribAuthor ">Tanja  Schirmeister</span>, <span class="hlFld-ContribAuthor ">Francesco  Risitano</span>, <span class="hlFld-ContribAuthor ">Anna  Piperno</span>, <span class="hlFld-ContribAuthor ">Giovanni  Grassi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of C3/C1-Substituted Tetrahydroisoquinolines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (8)
                                     , 14902-14914. <a href="https://doi.org/10.3390/molecules200814902" title="DOI URL">https://doi.org/10.3390/molecules200814902</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules200814902&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules200814902%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Bof%252BC3%25252FC1-Substituted%252BTetrahydroisoquinolines%26aulast%3DMihoubi%26aufirst%3DMohamed%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D8%26spage%3D14902%26epage%3D14914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0033.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00386&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0028.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Origin of estrogenic steroids in postmenopausal women with hormone-dependent breast cancer. Also shown is the steroid ring labeling and atom numbering system. Cyp<sub>450</sub>, cytochrome P<sub>450</sub>; ER, estrogen receptor; 3β-HSDI, 3β-hydroxysteroid dehydrogenase C5,C4-isomerase; 17β-HSD, 17β-hydroxysteroid dehydrogenase, the numeral after the HSD denotes the α-subtype of this enzyme.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00386&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0029.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Some sulfamate-based drugs and drug candidates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00386&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/medium/jm-2015-00386w_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0030.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Three-point pharmacophore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-19/acs.jmedchem.5b00386/20151002/images/large/jm-2015-00386w_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00386&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64418" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64418" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 203 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sandoval, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forte, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein-Geltink, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, H.</span><span> </span><span class="NLM_article-title">Indicator measures ER/PR and HER2 testing among women with invasive breast cancer</span> <span class="citation_source-journal">Curr. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23443917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A280%3ADC%252BC3svhslCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=62-63&author=C.+Sandovalauthor=R.+Rahalauthor=T.+Forteauthor=J.+Klein-Geltinkauthor=D.+Heauthor=H.+Bryant&title=Indicator+measures+ER%2FPR+and+HER2+testing+among+women+with+invasive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Indicator measures er/pr and her2 testing among women with invasive breast cancer</span></div><div class="casAuthors">Sandoval C; Rahal R; Forte T; Klein-Geltink J; He D; Bryant H</div><div class="citationInfo"><span class="NLM_cas:title">Current oncology (Toronto, Ont.)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-3</span>
        ISSN:<span class="NLM_cas:issn">1198-0052</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTO7KaYO6iGv3jf77P2BG3fW6udTcc2ebCIzRvK2ybYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svhslCqtA%253D%253D&md5=33adb477c94acfffecf8fb55927c392d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSandoval%26aufirst%3DC.%26aulast%3DRahal%26aufirst%3DR.%26aulast%3DForte%26aufirst%3DT.%26aulast%3DKlein-Geltink%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DD.%26aulast%3DBryant%26aufirst%3DH.%26atitle%3DIndicator%2520measures%2520ER%252FPR%2520and%2520HER2%2520testing%2520among%2520women%2520with%2520invasive%2520breast%2520cancer%26jtitle%3DCurr.%2520Oncol.%26date%3D2013%26volume%3D20%26spage%3D62%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Spinola, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferand, L.</span><span> </span><span class="NLM_article-title">Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2FBF01807337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=2954599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaL2sXltV2ls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1986&pages=241-248&author=P.+G.+Spinolaauthor=B.+Marchettiauthor=L.+Ferand&title=Adrenal+steroids+stimulate+growth+and+progesterone+receptor+levels+in+rat+uterus+and+DMBA-induced+mammary+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors</span></div><div class="casAuthors">Spinola, Paulo G.; Marchetti, Bianca; Labrie, Fernand</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">241-8</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    </div><div class="casAbstract">The effects of treatment with the adrenal steroids androst-5-ene-3β,17β-diol (Δ5-diol) and dehydroepiandrosterone (DHEA) on the growth and progesterone receptor levels of dimethylbenz[a]anthracene (DMBA)-induced mammary tumors and uteri in the rat were studied.  Although the total no. of tumors in ovariectomized animals was 0.60 tumor per rat after 24 days, it increased to 2.54 and 1.42 in the Δ5-diol- and DHEA (2 mg, twice daily)-treated animals, resp.  Very few new tumors developed during a 24-day period in ovariectomized animals (0.07/rat), but an av. of 0.47 new tumor per animal appeared in intact rats.  In ovariectomized animals treated with Δ5-diol or DHEA, the nos. of new tumors were 0.77 and 0.42, resp.  An even more striking effect was obsd. on av. total tumor area, which decreased from 4.70 cm2 in intact animals to 0.75 cm2 following ovariectomy.  Values of 9.79 and 3.93 cm2 were found in the Δ5-diol- and DHEA-treated ovariectomized animals, resp.  Treatment of ovariectomized animals with Δ5-diol and DHEA increased progesterone receptor levels in both the uteri and DMBA-induced mammary tumors.  Uterine wt. was also increased by treatment with the 2 adrenal steroids.  Thus, 2 adrenal C19-Δ5 steroids, Δ5-diol and DHEA, possess stimulatory effects analogous to those of estrogens on DMBA-induced mammary tumor growth and progesterone receptor levels in the rat, which supports the suggestion of an important role of these adrenal steroids in breast cancer and other estrogen-sensitive diseases in the human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zH3xH1E6LbVg90H21EOLACvtfcHk0li3-8HeRhgPMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXltV2ls7g%253D&md5=fa34d6fe9a090224c667bff47daa07a1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2FBF01807337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01807337%26sid%3Dliteratum%253Aachs%26aulast%3DSpinola%26aufirst%3DP.%2BG.%26aulast%3DMarchetti%26aufirst%3DB.%26aulast%3DFerand%26aufirst%3DL.%26atitle%3DAdrenal%2520steroids%2520stimulate%2520growth%2520and%2520progesterone%2520receptor%2520levels%2520in%2520rat%2520uterus%2520and%2520DMBA-induced%2520mammary%2520tumors%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D1986%26volume%3D8%26spage%3D241%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Komm, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirkin, S.</span><span> </span><span class="NLM_article-title">An overview of current and emerging SERMs</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2014.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=24667357" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVaksrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2014&pages=207-222&author=B.+S.+Kommauthor=S.+Mirkin&title=An+overview+of+current+and+emerging+SERMs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of current and emerging SERMs</span></div><div class="casAuthors">Komm, Barry S.; Mirkin, Sebastian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">207-222</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Selective estrogen receptor modulators (SERMs) are compds. that exhibit tissue-specific estrogen receptor (ER) agonist or antagonist activity, and are used for various indications, including treatment of breast cancer, osteoporosis, and menopausal symptoms.  Endometrial safety has been a key differentiator between SERMs in clin. practice.  For example, tamoxifen exhibits ER agonist activity in the uterus, resulting in an increased risk of endometrial hyperplasia and malignancy, whereas raloxifene and bazedoxifene have neutral effects on the uterus.  Based on their efficacy and long-term safety, SERMs are increasingly being prescribed for women who cannot tolerate other treatment options and for younger women at an increased risk of fracture who may remain on therapy for long periods of time.  Continuing advances in the understanding of SERM mechanisms of action and structural interactions with the ER may lead to the development of new agents and combinations of agents to provide optimal treatments to meet the varying needs of postmenopausal women.  One such example is the tissue selective estrogen complex, which partners a SERM with 1 or more estrogens, with the aim of blending the desired estrogen-receptor agonist activities of estrogens on vasomotor symptoms, vulvar-vaginal atrophy, and loss of bone mass with the tissue selectivity of a SERM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOCA6pLjN2GrVg90H21EOLACvtfcHk0liUI9nAdNgA_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVaksrjK&md5=18074eedb314d30864441d3f57cc4880</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2014.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2014.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DKomm%26aufirst%3DB.%2BS.%26aulast%3DMirkin%26aufirst%3DS.%26atitle%3DAn%2520overview%2520of%2520current%2520and%2520emerging%2520SERMs%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D143%26spage%3D207%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Santner, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feil, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santen, R. J.</span><span> </span><span class="NLM_article-title">In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1210%2Fjcem-59-1-29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=6725522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaL2cXks1Khtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1984&pages=29-33&author=S.+J.+Santnerauthor=P.+D.+Feilauthor=R.+J.+Santen&title=In+situ+estrogen+production+via+the+estrone+sulfatase+pathway+in+breast+tumors%3A+relative+importance+versus+the+aromatase+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">In situ estrogen production via the estrone sulfatase pathway in breast tumors:  relative importance versus the aromatase pathway</span></div><div class="casAuthors">Santner, S. J.; Feil, P. D.; Santen, R. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-33</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">Breast tumor estrogen prodn. via the estrone sulfate  [481-97-0] to estrone  [53-16-7] (i.e., estrone sulfatase  [59298-96-3]) pathway was evaluated and compared with the androstenedione  [63-05-8] to estrone (aromatase  [9039-48-9]) system in human and rodent mammary tumors.  Estrone prodn. from estrone sulfate was related linearly with time and tissue concns., exhibited an apparent Km of 20 μM, and produced a linear Eadie-Hofstee kinetic plot consistent with a single class of enzymic sites.  Measurement of sulfatase in 35 human breast tumors using enzyme satg. conditions revealed estrone prodn. ranging 0.8-125 μmol/g protein·h.  The corresponding range in host mammary tumors was 3.5-7.1 μmol/g protein·h.  In human breast tumors, sulfatase activity did not correlate with the levels of estrogen receptor or progesterone receptor.  Comparison of sulfatase with aromatase activity in human tumors at physiol. levels of substrate revealed estrone formation via sulfatase of 2.8 pmol estrone produced/g protein·h, whereas aromatase produced only 0.27 pmol/g protein·h.  In rat mammary tumors, sulfatase activity was similar to that in human tumors, whereas aromatase activity was not detected.  Thus, estrone sulfatase appears to be the enzyme primarily responsible for intratissue estrone prodn. in hormone-dependent breast carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOaFBTVgqU8bVg90H21EOLACvtfcHk0liUI9nAdNgA_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXks1Khtrk%253D&md5=53b9e2be2e2892cc16de570f826dc443</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1210%2Fjcem-59-1-29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjcem-59-1-29%26sid%3Dliteratum%253Aachs%26aulast%3DSantner%26aufirst%3DS.%2BJ.%26aulast%3DFeil%26aufirst%3DP.%2BD.%26aulast%3DSanten%26aufirst%3DR.%2BJ.%26atitle%3DIn%2520situ%2520estrogen%2520production%2520via%2520the%2520estrone%2520sulfatase%2520pathway%2520in%2520breast%2520tumors%253A%2520relative%2520importance%2520versus%2520the%2520aromatase%2520pathway%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1984%26volume%3D59%26spage%3D29%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">van Landeghem, A. A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poortman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabuurs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thijssen, J. H. H.</span><span> </span><span class="NLM_article-title">Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2907</span><span class="NLM_x">–</span> <span class="NLM_lpage">2912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=2907-2912&author=A.+A.+J.+van+Landeghemauthor=J.+Poortmanauthor=M.+Nabuursauthor=J.+H.+H.+Thijssen&title=Endogenous+concentration+and+subcellular+distribution+of+androgens+in+normal+and+malignant+human+breast+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BLandeghem%26aufirst%3DA.%2BA.%2BJ.%26aulast%3DPoortman%26aufirst%3DJ.%26aulast%3DNabuurs%26aufirst%3DM.%26aulast%3DThijssen%26aufirst%3DJ.%2BH.%2BH.%26atitle%3DEndogenous%2520concentration%2520and%2520subcellular%2520distribution%2520of%2520androgens%2520in%2520normal%2520and%2520malignant%2520human%2520breast%2520tissue%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26spage%3D2907%26epage%3D2912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pasqualini, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chetrite, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blacker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delalonde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloche, C.</span><span> </span><span class="NLM_article-title">Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1460</span><span class="NLM_x">–</span> <span class="NLM_lpage">1464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1210%2Fjc.81.4.1460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8636351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28Xit1OnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1996&pages=1460-1464&author=J.+R.+Pasqualiniauthor=G.+Chetriteauthor=C.+Blackerauthor=M.+C.+Feinsteinauthor=L.+Delalondeauthor=M.+Talbiauthor=C.+Maloche&title=Concentrations+of+estrone%2C+estradiol%2C+and+estrone+sulfate+and+evaluation+of+sulfatase+and+aromatase+activities+in+pre-+and+postmenopausal+breast+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients</span></div><div class="casAuthors">Pasqualini, J. R.; Chetrite, G.; Blacker, C.; Feinstein, M.-C.; Delalonde, L.; Talbi, M.; Maloche, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1460-4</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">This report concerns the evaluation of various estrogens, estrone (E1), estradiol (E2), and estrone (E1S), as well as E1S-sulfatase and aromatase activities in pre- and postmenopausal women with breast cancer.  The levels (in picomoles per g; mean ± SEM) of the various estrogens in the breast tissue from premenopausal patients (n = 11) are:  E1, 1.4 ± 0.5; E2, 1.2 ± 0.6; and E2S, 1.2 ± 0.3.  In postmenopausal patients (n = 23), the values are, resp., 1.0 ± 0.4, 1.4 ± 0.7, and 3.3 ± 1.9.  These concns. of estrogens in the tumors of postmenopausal patients are significantly higher than those found in plasma.  The activity of E1S-sulfatase in both pre- and postmenopausal patients was 50-200 times higher than that of aromatase.  E1S-sulfatase and aromatase activities are significantly higher in post-menopausal than in cycling patients.  It is concluded that despite the low levels of circulating estrogens in postmenopausal patients, the tissue concns. of these steroids are several-fold higher than those in plasma, suggesting tumor accumulation of these estrogens.  The physiopathol. and clincal significance of these high levels of the various estrogens (E1, E2, and E1S) as well as sulfatase and aromatase activities in postmenopausal patients with breast cancer is yet to be explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6nga1SVOv8rVg90H21EOLACvtfcHk0ljCwcPv1yyvhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xit1OnsLs%253D&md5=1a694ce52708f818b8f13bc29ee20592</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1210%2Fjc.81.4.1460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.81.4.1460%26sid%3Dliteratum%253Aachs%26aulast%3DPasqualini%26aufirst%3DJ.%2BR.%26aulast%3DChetrite%26aufirst%3DG.%26aulast%3DBlacker%26aufirst%3DC.%26aulast%3DFeinstein%26aufirst%3DM.%2BC.%26aulast%3DDelalonde%26aufirst%3DL.%26aulast%3DTalbi%26aufirst%3DM.%26aulast%3DMaloche%26aufirst%3DC.%26atitle%3DConcentrations%2520of%2520estrone%252C%2520estradiol%252C%2520and%2520estrone%2520sulfate%2520and%2520evaluation%2520of%2520sulfatase%2520and%2520aromatase%2520activities%2520in%2520pre-%2520and%2520postmenopausal%2520breast%2520cancer%2520patients%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1996%26volume%3D81%26spage%3D1460%26epage%3D1464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gunnarsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stål, O.</span><span> </span><span class="NLM_article-title">and Members of the Southeast Sweden Breast Cancer Group. Abnormal expression of 17-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">8448</span><span class="NLM_x">–</span> <span class="NLM_lpage">8451</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=8448-8451&author=C.+Gunnarssonauthor=B.+M.+Olssonauthor=O.+St%C3%A5l&title=and+Members+of+the+Southeast+Sweden+Breast+Cancer+Group.+Abnormal+expression+of+17-hydroxysteroid+dehydrogenases+in+breast+cancer+predicts+late+recurrence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGunnarsson%26aufirst%3DC.%26aulast%3DOlsson%26aufirst%3DB.%2BM.%26aulast%3DSt%25C3%25A5l%26aufirst%3DO.%26atitle%3Dand%2520Members%2520of%2520the%2520Southeast%2520Sweden%2520Breast%2520Cancer%2520Group.%2520Abnormal%2520expression%2520of%252017-hydroxysteroid%2520dehydrogenases%2520in%2520breast%2520cancer%2520predicts%2520late%2520recurrence%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D8448%26epage%3D8451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Pasqualini, J. R.</span><span> </span><span class="NLM_article-title">The selective estrogen enzyme modulators in breast cancer: a review</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1654</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1654&publication_year=2004&pages=123-143&author=J.+R.+Pasqualini&title=The+selective+estrogen+enzyme+modulators+in+breast+cancer%3A+a+review"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasqualini%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520selective%2520estrogen%2520enzyme%2520modulators%2520in%2520breast%2520cancer%253A%2520a%2520review%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2004%26volume%3D1654%26spage%3D123%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Vihko, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrala, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Härkönen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isomaa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaija, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurkela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulkka, A.</span><span> </span><span class="NLM_article-title">Control of cell proliferation of steroids: the role of 17HSDs</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.mce.2005.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=16406264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Wgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=2006&pages=141-148&author=P.+Vihkoauthor=A.+Herralaauthor=P.+H%C3%A4rk%C3%B6nenauthor=V.+Isomaaauthor=H.+Kaijaauthor=R.+Kurkelaauthor=A.+Pulkka&title=Control+of+cell+proliferation+of+steroids%3A+the+role+of+17HSDs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Control of cell proliferation by steroids: The role of 17HSDs</span></div><div class="casAuthors">Vihko, P.; Herrala, A.; Haerkoenen, P.; Isomaa, V.; Kaija, H.; Kurkela, R.; Pulkka, A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">141-148</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sex steroid hormone signaling regulates the development, growth, and functioning of the breast and the prostate and plays a role in the development and progression of cancer in these organs.  The intracellular concn. of active sex steroid hormones in target tissues is regulated by several enzymes, including 17β-hydroxysteroid dehydrogenases (17HSDs).  Changes in the expression patterns of these enzymes may play a pathophysiol. role in malignant transformation.  We recently analyzed the mRNA expressions of the 17HSD type 1, 2, and 5 enzymes in about 800 breast carcinoma specimens.  Both 17HSD type 1 and 2 mRNAs were detected in normal breast tissue from premenopausal women but not in specimens from postmenopausal women.  The patients with tumors expressing 17HSD type 1 mRNA or protein had significantly shorter overall and disease-free survival than the other patients.  The expression of 17HSD type 5 was significantly higher in breast tumor specimens than in normal tissue.  Cox multivariate analyses showed that 17HSD type 1, tumor size, and estrogen receptor alpha (ERα) had independent prognostic significance.  We developed, using a LNCaP prostate cancer cell line, a model to study the malignant transformation of prostate cancer and showed that androgen-sensitive LNCaP cells are transformed into neuroendocrine-like cells when cultured without androgens and, eventually into highly proliferating androgen-independent cells.  We conducted Northern hybridizations and microarrays to analyze the gene expression during these processes.  Substantial changes in the expressions of steroid metabolizing enzymes occurred during the transformation process.  The variations in steroid-metabolizing enzymes during cancer progression may be crucial in the regulation of the growth and function of organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj00uWp8UAurVg90H21EOLACvtfcHk0liunGkqGYvToQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Wgtbg%253D&md5=d48719dd79f7bb9ecd218490b979f237</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2005.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2005.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DVihko%26aufirst%3DP.%26aulast%3DHerrala%26aufirst%3DA.%26aulast%3DH%25C3%25A4rk%25C3%25B6nen%26aufirst%3DP.%26aulast%3DIsomaa%26aufirst%3DV.%26aulast%3DKaija%26aufirst%3DH.%26aulast%3DKurkela%26aufirst%3DR.%26aulast%3DPulkka%26aufirst%3DA.%26atitle%3DControl%2520of%2520cell%2520proliferation%2520of%2520steroids%253A%2520the%2520role%2520of%252017HSDs%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2006%26volume%3D248%26spage%3D141%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Simpson, E. R.</span><span> </span><span class="NLM_article-title">Sources of estrogen and their importance</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2803%2900360-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=14623515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVemsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2003&pages=225-230&author=E.+R.+Simpson&title=Sources+of+estrogen+and+their+importance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Sources of estrogen and their importance</span></div><div class="casAuthors">Simpson, E. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3-5</span>),
    <span class="NLM_cas:pages">225-230</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">: Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  In premenopausal women, the ovaries are the principle source of estradiol, which functions as a circulating hormone to act on distal target tissues.  However, in postmenopausal women when the ovaries cease to produce estrogen, and in men, this is no longer the case, because estradiol is no longer solely an endocrine factor.  Instead, it is produced in a no. of extra-gonadal sites and acts locally at these sites as a paracrine or even intracrine factor.  These sites include the mesenchymal cells of adipose tissue including that of the breast, osteoblasts and chondrocytes of bone, the vascular endothelium and aortic smooth muscle cells, and numerous sites in the brain.  Thus, circulating levels of estrogens in postmenopausal women and in men are not the drivers of estrogen action, they are reactive rather than proactive.  This is because in these cases circulating estrogen originates in the extra-gonadal sites where it acts locally, and if it escapes local metab. then it enters the circulation.  Therefore, circulating levels reflect rather than direct estrogen action in postmenopausal women and in men.  Tissue-specific regulation of CYP19 expression is achieved through the use of distinct promoters, each of which is regulated by different hormonal factors and second messenger signaling pathways.  Thus, in the ovary, CYP19 expression is regulated by FSH which acts through cAMP via the proximal promoter II, whereas in placenta the distal promoter I.1 regulates CYP19 expression in response to retinoids.  In adipose tissue and bone by contrast, another distal promoter-promoter I.4-drives CYP19 expression under the control of glucocorticoids, class 1 cytokines and TNFα.  The importance of this unique aspect of the tissue-specific regulation of aromatase expression lies in the fact that the low circulating levels of estrogens which are obsd. in postmenopausal women have little bearing on the concns. of estrogen in, for example, a breast tumor, which can reach levels at least one order of magnitude greater than those present in the circulation, due to local synthesis within the breast.  Thus, the estrogen which is responsible for breast cancer development, for the maintenance of bone mineralization and for the maintenance of cognitive function is not circulating estrogen but rather that which is produced locally at these specific sites within the breast, bone and brain.  In breast adipose of breast cancer patients, aromatase activity and CYP19 expression are elevated.  This occurs in response to tumor-derived factors such as prostaglandin E2 produced by breast tumor fibroblasts and epithelium as well as infiltrating macrophages.  This increased CYP19 expression is assocd. with a switch in promoter usage from the normal adipose-specific promoter I.4 to the cAMP responsive promoter, promoter II.  Since these two promoters are regulated by different cohorts of transcription factors and coactivators, it follows that the differential regulation of CYP19 expression via alternative promoters in disease-free and cancerous breast adipose tissue may permit the development of selective aromatase modulators (SAMs) that target the aberrant overexpression of aromatase in cancerous breast, while sparing estrogen synthesis in other sites such as normal adipose tissue, bone and brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXkuXyHF9aebVg90H21EOLACvtfcHk0liunGkqGYvToQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVemsr4%253D&md5=c1624c91faeee8db6aec04c2be84b3a2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900360-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900360-1%26sid%3Dliteratum%253Aachs%26aulast%3DSimpson%26aufirst%3DE.%2BR.%26atitle%3DSources%2520of%2520estrogen%2520and%2520their%2520importance%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D86%26spage%3D225%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Labrie, F.</span><span> </span><span class="NLM_article-title">All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2014.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=24923731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvFWltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2015&pages=133-138&author=F.+Labrie&title=All+sex+steroids+are+made+intracellularly+in+peripheral+tissues+by+the+mechanisms+of+intracrinology+after+menopause"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause</span></div><div class="casAuthors">Labrie, Fernand</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133-138</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Following the arrest of estradiol secretion by the ovaries at menopause, all estrogens and all androgens in postmenopausal women are made locally in peripheral target tissues according to the physiol. mechanisms of intracrinol.  The locally made sex steroids exert their action and are inactivated intracellularly without biol. significant release of the active sex steroids in the circulation.  The level of expression of the steroid-forming and steroid-inactivating enzymes is specific to each cell type in each tissue, thus permitting to each cell/tissue to synthesize a small amt. of androgens and/or estrogens in order to meet the local physiol. needs without affecting the other tissues of the organism.  Achieved after 500 million years of evolution, combination of the arrest of ovarian estrogen secretion, the availability of high circulating levels of DHEA and the expression of the peripheral sex steroid-forming enzymes have permitted the appearance of menopause with a continuing access to intratissular sex steroids for the individual cells/tissues without systemic exposure to circulating estradiol.  In fact, one essential condition of menopause is to maintain serum estradiol at biol. inactive (substhreshold) concns., thus avoiding stimulation of the endometrium and risk of endometrial cancer.  Measurement of the low levels of serum estrogens and androgens in postmenopausal women absolutely requires the use of MS/MS-based technol. in order to obtain reliable accurate, specific and precise assays.While the activity of the series of steroidogenic enzymes can vary, the serum levels of DHEA show large individual variations going from barely detectable to practically normal "premenopausal" values, thus explaining the absence of menopausal symptoms in about 25% of women.  It should be added that the intracrine system has no feedback elements to adjust the serum levels of DHEA, thus meaning that women with low DHEA activity will not be improved without external supplementation.  Exogenous DHEA, however, follows the same intracrine rules as described for endogenous DHEA, thus maintaining serum estrogen levels at substhreshold or biol. inactive concns.  Such blood concns. are not different from those obsd. in normal postmenopausal women having high serum DHEA concns.  Androgens, on the other hand, are practically all made intracellularly from DHEA by the mechanisms of intracrinol. and are always maintained at very low levels in the blood in both pre- and postmenopausal women.  Proof of the importance of intracrinol. is also provided, among others, by the well-recognized benefits of aromatase inhibitors and antiestrogens used successfully for the treatment of breast cancer in postmenopausal women where all estrogens are made locally.  Each medical indication for the use of DHEA, however, requires clin. trials performed according to the FDA guidelines and the best rules of clin. medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh8ztXVFD0f7Vg90H21EOLACvtfcHk0liunGkqGYvToQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvFWltLw%253D&md5=9cd148db461f2b020210f06f0a6e8585</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2014.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2014.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DLabrie%26aufirst%3DF.%26atitle%3DAll%2520sex%2520steroids%2520are%2520made%2520intracellularly%2520in%2520peripheral%2520tissues%2520by%2520the%2520mechanisms%2520of%2520intracrinology%2520after%2520menopause%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D145%26spage%3D133%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">McNamara, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasano, H.</span><span> </span><span class="NLM_article-title">The intracrinology of breast cancer</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2014.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=24751707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslGntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2015&pages=172-178&author=K.+M.+McNamaraauthor=H.+Sasano&title=The+intracrinology+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The intracrinology of breast cancer</span></div><div class="casAuthors">McNamara, Keely May; Sasano, Hironobu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">172-178</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The importance of intracrinol., or in situ prodn. of steroids from circulating precursors, in breast cancer has been firmly established in estrogen actions on postmenopausal patients.  Expression levels of various steroid synthesizing and/or metabolizing enzymes have been examd. in human breast cancer tissues by a no. of groups.  The enzymes examd. include those capable of converting circulating DHEA-S to sex steroids (STS and 3βHSDΔ4-5 isomerase), the group of enzymes that modulate the strength of both androgens and estrogens (17βHSD family) as well as the androgenic 5αR enzymes and the estrogenic aromatase enzyme.  In addn. to these DHEA-related metab. pathways, other intracrine pathways involving progesterone and cholesterol have also been examd.  Some risk factors of breast cancer development, including obesity, have also been postulated to interact with steroid metabolising pathways.  In this review, we aimed to summarise the current state of knowledge regarding intracrine metab. including expression levels of various enzymes and receptors, focusing particularly upon the importance of the prodn. of biol. potent steroids from circulating sulfated precursors such as DHEA-S.  In addn., we attempted to summarise the factors, both steroidal and non-steroidal, involved in the regulation of these enzymes and propose future directions for research in this particular field.  The concept of intracrinol. was first proposed over 20 years ago but there still remain many unanswered questions which could open new horizons for the understanding of intracrine metab. in the breast.This article is part of a Special Issue entitled 'Essential role of DHEA'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPUqPBD8ilp7Vg90H21EOLACvtfcHk0ljWEqL1PsQz_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslGntL8%253D&md5=4ef9d4e5963930edc03b70053c95ef0c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2014.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2014.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamara%26aufirst%3DK.%2BM.%26aulast%3DSasano%26aufirst%3DH.%26atitle%3DThe%2520intracrinology%2520of%2520breast%2520cancer%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2015%26volume%3D145%26spage%3D172%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Utsumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, N.</span><span> </span><span class="NLM_article-title">Elevated steroid sulfatase expression in breast cancers</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2800%2900060-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10925213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvVCgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2000&pages=141-145&author=T.+Utsumiauthor=N.+Yoshimuraauthor=S.+Takeuchiauthor=M.+Marutaauthor=K.+Maedaauthor=N.+Harada&title=Elevated+steroid+sulfatase+expression+in+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated steroid sulfatase expression in breast cancers</span></div><div class="casAuthors">Utsumi, Toshiaki; Yoshimura, Noriko; Takeuchi, Shinji; Maruta, Morito; Maeda, Kotaro; Harada, Nobuhiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">141-145</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">In situ estrogen synthesis makes an important contribution to the high estrogen concn. found in breast cancer tissues.  Steroid sulfatase which hydrolyzes several sulfated steroids such as estrone sulfate, dehydroepiandrosterone sulfate, and cholesterol sulfate may be involved.  In the present study, the authors therefore, assessed steroid sulfatase mRNA levels in breast malignancies and background tissues from 38 patients by reverse transcription and polymerase chain reaction.  The levels in breast cancer tissues were significantly increased at 1458.4 amol/mg RNA (mean) as compared with 535.6 amol/mg RNA for non-malignant tissues.  Thus, increased steroid sulfatase expression may be partly responsible for local overprodn. of estrogen and provide a growth advantage for tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBshQnCaEe-bVg90H21EOLACvtfcHk0ljWEqL1PsQz_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvVCgtb4%253D&md5=6343f061e266720d9624efb7e9ae4003</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2800%2900060-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252800%252900060-1%26sid%3Dliteratum%253Aachs%26aulast%3DUtsumi%26aufirst%3DT.%26aulast%3DYoshimura%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DS.%26aulast%3DMaruta%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DN.%26atitle%3DElevated%2520steroid%2520sulfatase%2520expression%2520in%2520breast%2520cancers%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D73%26spage%3D141%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Utsumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, N.</span><span> </span><span class="NLM_article-title">Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=377-381&author=T.+Utsumiauthor=N.+Yoshimuraauthor=S.+Takeuchiauthor=J.+Andoauthor=M.+Marutaauthor=K.+Maedaauthor=N.+Harada&title=Steroid+sulfatase+expression+is+an+independent+predictor+of+recurrence+in+human+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUtsumi%26aufirst%3DT.%26aulast%3DYoshimura%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DS.%26aulast%3DAndo%26aufirst%3DJ.%26aulast%3DMaruta%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DHarada%26aufirst%3DN.%26atitle%3DSteroid%2520sulfatase%2520expression%2520is%2520an%2520independent%2520predictor%2520of%2520recurrence%2520in%2520human%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D377%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasano, H.</span><span> </span><span class="NLM_article-title">Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">2762</span><span class="NLM_x">–</span> <span class="NLM_lpage">2770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2762-2770&author=T.+Suzukiauthor=T.+Nakataauthor=Y.+Mikiauthor=C.+Kanekoauthor=T.+Moriyaauthor=T.+Ishidaauthor=S.+Akinagaauthor=H.+Hirakawaauthor=M.+Kimuraauthor=H.+Sasano&title=Estrogen+sulfotransferase+and+steroid+sulfatase+in+human+breast+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DNakata%26aufirst%3DT.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DKaneko%26aufirst%3DC.%26aulast%3DMoriya%26aufirst%3DT.%26aulast%3DIshida%26aufirst%3DT.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DHirakawa%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DM.%26aulast%3DSasano%26aufirst%3DH.%26atitle%3DEstrogen%2520sulfotransferase%2520and%2520steroid%2520sulfatase%2520in%2520human%2520breast%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D2762%26epage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussbaumer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehr, P.</span><span> </span><span class="NLM_article-title">Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2800%2900077-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=11070351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFWnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2000&pages=225-235&author=A.+Billichauthor=P.+Nussbaumerauthor=P.+Lehr&title=Stimulation+of+MCF-7+breast+cancer+cell+proliferation+by+estrone+sulfate+and+dehydroepiandrosterone+sulfate%3A+inhibition+by+novel+non-steroidal+steroid+sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors</span></div><div class="casAuthors">Billich, Andreas; Nussbaumer, Peter; Lehr, Philipp</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">225-235</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Steroid sulfatase (STS) regulates the formation of active steroids from systemic precursors, such as estrone sulfate and dehydroepiandrosterone sulfate (DHEAS).  In breast tissues, this pathway is a source for local prodn. of estrogens, which support the growth of endocrine-dependent tumors.  Therefore, inhibitors of STS could have therapeutic potential.  In this study, the authors report on substituted chromenone sulfamates as a novel class of non-steroidal irreversible inhibitors of STS.  The compds. are substantially more potent (6- to 80-fold) than previously described types of non-steroidal inhibitors when tested against purified STS.  In MCF-7 breast cancer cells, they inhibit STS activity with IC50 below 100 pM.  Importantly, the compds. also potently block estrone sulfate-stimulated growth of MCF-7 cells, again with IC50 below 100 pM.  For one compd., the authors also obsd. a lack of any estrogenic effect at high concns. (1 μM).  The authors also demonstrate for the first time that STS inhibitors can block the DHEAS-stimulated growth of MCF-7 cells.  Interestingly, this cannot be achieved with specific inhibitors of the aromatase, suggesting that stimulation of MCF-7 cell growth by DHEAS follows an aromatase-independent pathway.  This gives further justification to consider steroid sulfatase inhibitors as potential drugs in the therapy of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGony8N4_gmv6LVg90H21EOLACvtfcHk0li00Poqg7emiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFWnsrk%253D&md5=bc48d55d2638440308400788df0cf026</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2800%2900077-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252800%252900077-7%26sid%3Dliteratum%253Aachs%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DNussbaumer%26aufirst%3DP.%26aulast%3DLehr%26aufirst%3DP.%26atitle%3DStimulation%2520of%2520MCF-7%2520breast%2520cancer%2520cell%2520proliferation%2520by%2520estrone%2520sulfate%2520and%2520dehydroepiandrosterone%2520sulfate%253A%2520inhibition%2520by%2520novel%2520non-steroidal%2520steroid%2520sulfatase%2520inhibitors%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D73%26spage%3D225%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Obiorah, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, V. C.</span><span> </span><span class="NLM_article-title">Progress in endocrine approaches to the treatment and prevention of breast cancer</span> <span class="citation_source-journal">Maturitas</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=315-321&author=I.+Obiorahauthor=V.+C.+Jordan&title=Progress+in+endocrine+approaches+to+the+treatment+and+prevention+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObiorah%26aufirst%3DI.%26aulast%3DJordan%26aufirst%3DV.%2BC.%26atitle%3DProgress%2520in%2520endocrine%2520approaches%2520to%2520the%2520treatment%2520and%2520prevention%2520of%2520breast%2520cancer%26jtitle%3DMaturitas%26date%3D2011%26volume%3D70%26spage%3D315%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Cuzick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sestak, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cawthorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansel, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Minckwitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonanni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, A.</span><span> </span><span class="NLM_article-title">IBIS-II investigators. Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">383</span><span class="NLM_x">, </span> <span class="NLM_fpage">1041</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2014&pages=1041-1048&author=J.+Cuzickauthor=I.+Sestakauthor=J.+F.+Forbesauthor=M.+Dowsettauthor=J.+Knoxauthor=S.+Cawthornauthor=C.+Saundersauthor=N.+Rocheauthor=R.+E.+Manselauthor=G.+von+Minckwitzauthor=B.+Bonanniauthor=T.+Palvaauthor=A.+Howell&title=IBIS-II+investigators.+Anastrozole+for+prevention+of+breast+cancer+in+high-risk+postmenopausal+women+%28IBIS-II%29%3A+an+international%2C+double-blind%2C+randomised+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuzick%26aufirst%3DJ.%26aulast%3DSestak%26aufirst%3DI.%26aulast%3DForbes%26aufirst%3DJ.%2BF.%26aulast%3DDowsett%26aufirst%3DM.%26aulast%3DKnox%26aufirst%3DJ.%26aulast%3DCawthorn%26aufirst%3DS.%26aulast%3DSaunders%26aufirst%3DC.%26aulast%3DRoche%26aufirst%3DN.%26aulast%3DMansel%26aufirst%3DR.%2BE.%26aulast%3Dvon%2BMinckwitz%26aufirst%3DG.%26aulast%3DBonanni%26aufirst%3DB.%26aulast%3DPalva%26aufirst%3DT.%26aulast%3DHowell%26aufirst%3DA.%26atitle%3DIBIS-II%2520investigators.%2520Anastrozole%2520for%2520prevention%2520of%2520breast%2520cancer%2520in%2520high-risk%2520postmenopausal%2520women%2520%2528IBIS-II%2529%253A%2520an%2520international%252C%2520double-blind%252C%2520randomised%2520placebo-controlled%2520trial%26jtitle%3DLancet%26date%3D2014%26volume%3D383%26spage%3D1041%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauvois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The hydrolysis of estrone sulphate and dehydroepiandrosterone sulphate by human sulfatase expressed in transfected COS-1 cells</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2F0960-0760%2894%2990177-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8049127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK2cXlt1GmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=101-104&author=A.+Purohitauthor=S.+Dauvoisauthor=M.+G.+Parkerauthor=B.+V.+L.+Potterauthor=G.+J.+Williamsauthor=M.+J.+Reed&title=The+hydrolysis+of+estrone+sulphate+and+dehydroepiandrosterone+sulphate+by+human+sulfatase+expressed+in+transfected+COS-1+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by human steroid sulfatase expressed in transfected COS-1 cells</span></div><div class="casAuthors">Purohit, A.; Dauvois, Sophie; Parker, M. G.; Potter, B. V. L.; Williams, G. J.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">101-4</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    </div><div class="casAbstract">Whether the same or distinct steroid sulfatases (STS) are involved in the hydrolysis of alkyl and aryl steroid sulfates remains controversial.  The authors have examd. the ability of a placental steroid sulfatase to hydrolyze estrone sulfate and/or dehydroepiandrosterone sulfate (DHA-S) by expressing the enzyme in COS-1 cells.  Using either intact cells or broken cell prepns., the expressed sulfatase was found to hydrolyze both estrone sulfate and DHA-S.  The catalysis of estrone sulfate and DHA-S by the expressed sulfatase was almost completely abolished by the steroid sulfatase inhibitor, estrone-3-O-sulfamate.  It is concluded that both alkyl and aryl steroid sulfates can be hydrolyzed by the same steroid sulfatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqvHhWUBDjKLVg90H21EOLACvtfcHk0li00Poqg7emiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlt1GmtLo%253D&md5=f534aee5fecd4be2c90f0bd0d9c8090d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2894%2990177-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252894%252990177-5%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DDauvois%26aufirst%3DS.%26aulast%3DParker%26aufirst%3DM.%2BG.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520hydrolysis%2520of%2520estrone%2520sulphate%2520and%2520dehydroepiandrosterone%2520sulphate%2520by%2520human%2520sulfatase%2520expressed%2520in%2520transfected%2520COS-1%2520cells%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1994%26volume%3D50%26spage%3D101%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">The structural biology of oestrogen metabolism</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2012.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23291110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2013&pages=27-49&author=M.+P.+Thomasauthor=B.+V.+L.+Potter&title=The+structural+biology+of+oestrogen+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The structural biology of oestrogen metabolism</span></div><div class="casAuthors">Thomas, Mark P.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-49</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Many enzymes catalyze reactions that have an estrogen as a substrate and/or a product.  The reactions catalyzed include aromatization, oxidn., redn., sulfonation, desulfonation, hydroxylation and methoxylation.  The enzymes that catalyze these reactions must all recognize and bind estrogen but, despite this, they have diverse structures.  This review looks at each of these enzymes in turn, describing the structure and discussing the mechanism of the catalyzed reaction.  Since estrogen has a role in many disease states inhibition of the enzymes of estrogen metab. may have an impact on the state or progression of the disease and inhibitors of these enzymes are briefly discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozRHAveD8_NrVg90H21EOLACvtfcHk0lgzKs2J5VIJ7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCnsL8%253D&md5=5c005e36a520fbe3e30fc7777c084a3f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2012.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2012.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DThe%2520structural%2520biology%2520of%2520oestrogen%2520metabolism%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D137%26spage%3D27%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lønning, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eikesdal, H. P.</span><span> </span><span class="NLM_article-title">Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">R183</span><span class="NLM_x">–</span> <span class="NLM_lpage">R201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=R183-R201&author=P.+E.+L%C3%B8nningauthor=H.+P.+Eikesdal&title=Aromatase+inhibition+2013%3A+clinical+state+of+the+art+and+questions+that+remain+to+be+solved"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B8nning%26aufirst%3DP.%2BE.%26aulast%3DEikesdal%26aufirst%3DH.%2BP.%26atitle%3DAromatase%2520inhibition%25202013%253A%2520clinical%2520state%2520of%2520the%2520art%2520and%2520questions%2520that%2520remain%2520to%2520be%2520solved%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2013%26volume%3D20%26spage%3DR183%26epage%3DR201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroid sulphatase inhibitors: a new endocrine therapy</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1994&pages=673-680&author=M.+J.+Reedauthor=A.+Purohitauthor=N.+M.+Howarthauthor=B.+V.+L.+Potter&title=Steroid+sulphatase+inhibitors%3A+a+new+endocrine+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroid%2520sulphatase%2520inhibitors%253A%2520a%2520new%2520endocrine%2520therapy%26jtitle%3DDrugs%2520Future%26date%3D1994%26volume%3D19%26spage%3D673%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hanson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Best, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.-H.</span><span> </span><span class="NLM_article-title">Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">5736</span><span class="NLM_x">–</span> <span class="NLM_lpage">5763</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=5736-5763&author=S.+R.+Hansonauthor=M.+D.+Bestauthor=C.-H.+Wong&title=Sulfatases%3A+structure%2C+mechanism%2C+biological+activity%2C+inhibition%2C+and+synthetic+utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DS.%2BR.%26aulast%3DBest%26aufirst%3DM.%2BD.%26aulast%3DWong%26aufirst%3DC.-H.%26atitle%3DSulfatases%253A%2520structure%252C%2520mechanism%252C%2520biological%2520activity%252C%2520inhibition%252C%2520and%2520synthetic%2520utility%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2004%26volume%3D43%26spage%3D5736%26epage%3D5763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroid sulfatase: molecular biology, regulation, and inhibition</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1210%2Fer.2004-0003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15561802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslGjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=171-202&author=M.+J.+Reedauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=S.+P.+Newmanauthor=B.+V.+L.+Potter&title=Steroid+sulfatase%3A+molecular+biology%2C+regulation%2C+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid sulfatase: Molecular biology, regulation, and inhibition</span></div><div class="casAuthors">Reed, M. J.; Purohit, A.; Woo, L. W. L.; Newman, S. P.; Potter, B. V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-202</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Steroid sulfatase (STS) is responsible for the hydrolysis of aryl and alkyl steroid sulfates and therefore has a pivotal role in regulating the formation of biol. active steroids.  STS is widely distributed throughout the body, and its action is implicated in physiol. processes and pathol. conditions.  The crystal structure of STS has been resolved, but relatively little is known about what regulates its expression or activity.  Research into the control and inhibition of this enzyme has been stimulated by its important role in supporting the growth of hormone-dependent tumors of the breast and prostate.  STS is responsible for the hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate to estrone and dehydroepiandrosterone, resp., both of which can be converted to steroids with estrogenic properties (i.e., estradiol and androstenediol) that can stimulate tumor growth.  STS expression is increased in breast tumors and has prognostic significance.  The role of STS in supporting tumor growth prompted the development of potent STS inhibitors.  Several steroidal and nonsteroidal STS inhibitors are now available, with the irreversible type of inhibitor having a phenol sulfamate ester as its active pharmacophore.  One such inhibitor, 667 COUMATE, has now entered a phase I trial in postmenopausal women with breast cancer.  The skin is also an important site of STS activity, and deficiency of this enzyme is assocd. with X-linked ichthyosis.  STS may also be involved in regulating part of the immune response and some aspects of cognitive function.  The development of potent STS inhibitors will allow investigation of the role of this enzyme in physiol. and pathol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvDkv9jdOyZ7Vg90H21EOLACvtfcHk0lgzKs2J5VIJ7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslGjtr4%253D&md5=5ea6cff3a5f23b3f31d08506c724df06</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1210%2Fer.2004-0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2004-0003%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroid%2520sulfatase%253A%2520molecular%2520biology%252C%2520regulation%252C%2520and%2520inhibition%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26spage%3D171%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Maltais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, D.</span><span> </span><span class="NLM_article-title">Steroid sulfatase inhibitors: A review covering the promising 2000–2010 decade</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2011&pages=929-948&author=R.+Maltaisauthor=D.+Poirier&title=Steroid+sulfatase+inhibitors%3A+A+review+covering+the+promising+2000%E2%80%932010+decade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaltais%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DD.%26atitle%3DSteroid%2520sulfatase%2520inhibitors%253A%2520A%2520review%2520covering%2520the%2520promising%25202000%25E2%2580%25932010%2520decade%26jtitle%3DSteroids%26date%3D2011%26volume%3D76%26spage%3D929%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Development of sulfatase inhibitors</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.mce.2010.12.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=21238537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFyrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2011&pages=175-185&author=L.+W.+L.+Wooauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Development+of+sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Development of steroid sulfatase inhibitors</span></div><div class="casAuthors">Woo, L. W. Lawrence; Purohit, Atul; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-185</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Hydrolysis of biol. inactive steroid sulfates to unconjugated steroids by steroid sulfatase (STS) is strongly implicated in rendering estrogenic stimulation to hormone-dependent cancers such as those of the breast.  Considerable progress has been made in the past two decades with regard to the discovery, design and development of STS inhibitors.  We outline historical aspects of their development, cumulating in the discovery of the first clin. trial candidate STX64 (BN83495, Irosustat) and other sulfamate-based inhibitors.  The development of reversible STS inhibitors and the design of dual inhibitors of both aromatase and STS is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVFcnJi-qZY7Vg90H21EOLACvtfcHk0ljtccoo3qYr3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFyrtLc%253D&md5=51d494bcb6a02d6b64dddfcb29bfdb06</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2010.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2010.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DDevelopment%2520of%2520sulfatase%2520inhibitors%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2011%26volume%3D340%26spage%3D175%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Secky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svoboda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klameth, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajna, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeillinger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jäger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thalhammer, T.</span><span> </span><span class="NLM_article-title">The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors</span> <span class="citation_source-journal">J. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">957605</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=957605&author=L.+Seckyauthor=M.+Svobodaauthor=L.+Klamethauthor=E.+Bajnaauthor=G.+Hamiltonauthor=R.+Zeillingerauthor=W.+J%C3%A4gerauthor=T.+Thalhammer&title=The+sulfatase+pathway+for+estrogen+formation%3A+targets+for+the+treatment+and+diagnosis+of+hormone-associated+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSecky%26aufirst%3DL.%26aulast%3DSvoboda%26aufirst%3DM.%26aulast%3DKlameth%26aufirst%3DL.%26aulast%3DBajna%26aufirst%3DE.%26aulast%3DHamilton%26aufirst%3DG.%26aulast%3DZeillinger%26aufirst%3DR.%26aulast%3DJ%25C3%25A4ger%26aufirst%3DW.%26aulast%3DThalhammer%26aufirst%3DT.%26atitle%3DThe%2520sulfatase%2520pathway%2520for%2520estrogen%2520formation%253A%2520targets%2520for%2520the%2520treatment%2520and%2520diagnosis%2520of%2520hormone-associated%2520tumors%26jtitle%3DJ.%2520Drug%2520Delivery%26date%3D2013%26spage%3D957605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Williams, S. J.</span><span> </span><span class="NLM_article-title">Sulfatase inhibitors: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1517%2F13543776.2013.736965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23136854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCksr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=79-98&author=S.+J.+Williams&title=Sulfatase+inhibitors%3A+a+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfatase inhibitors: a patent review</span></div><div class="casAuthors">Williams, Spencer J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-98</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Steroid sulfatase (STS) converts sulfated hormones to free hormones of importance in hormone-dependent diseases such as breast cancer and endometriosis.  Carbohydrate sulfatases degrade complex carbohydrates as part of normal cellular turnover; certain lysosomal storage disorders (LSDs) involve defective processing of sulfated glycosaminoglycans by mutant sulfatases.Areas covered: Aryl sulfamates have been developed as STS inhibitors, and STX64 and PGL2001 are under evaluation in Phase I and II clin. trials for treatment of endometrial and metastatic breast and prostate cancers and endometriosis.  Dual-acting compds. have emerged that are aromatase inhibitors (AIs), selective estrogen receptor antagonists, or inhibitors of microtubule polymn.  Sulfamidase inhibitors as pharmacol. chaperones to assist maturation of folding-defective mutants for the treatment of Sanfilippo type A disease are under investigation.  Coverage: The patent literature after the mid-1990s.Expert opinion: The failure of STX64 in a Phase II monotherapy clin. trial should not dissuade further investigations in multidrug regimens, particularly in combination with AIs.  The recent development of dual-acting compds. may enhance the potential for success in the clinic.  Further investigations into aryl sulfamates are required to clarify the mol. mechanism of action; addnl., new reversible sulfatase inhibition concepts are needed for the development of pharmacol. chaperones for sulfatase LSDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZuermyRH1ibVg90H21EOLACvtfcHk0ljtccoo3qYr3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCksr3F&md5=bc07e9358b004543cb4ac5c85f578f30</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.736965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.736965%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BJ.%26atitle%3DSulfatase%2520inhibitors%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D79%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Audrieth, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sveda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisler, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, M. J.</span><span> </span><span class="NLM_article-title">Sulfamic acid, sulfamide, and related aquo-ammonosulfuric acids</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1940</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr60083a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1940&pages=49-94&author=L.+F.+Audriethauthor=M.+Svedaauthor=H.+H.+Sislerauthor=M.+J.+Butler&title=Sulfamic+acid%2C+sulfamide%2C+and+related+aquo-ammonosulfuric+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcr60083a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60083a003%26sid%3Dliteratum%253Aachs%26aulast%3DAudrieth%26aufirst%3DL.%2BF.%26aulast%3DSveda%26aufirst%3DM.%26aulast%3DSisler%26aufirst%3DH.%2BH.%26aulast%3DButler%26aufirst%3DM.%2BJ.%26atitle%3DSulfamic%2520acid%252C%2520sulfamide%252C%2520and%2520related%2520aquo-ammonosulfuric%2520acids%26jtitle%3DChem.%2520Rev.%26date%3D1940%26volume%3D26%26spage%3D49%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Benson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillane, W. J.</span><span> </span><span class="NLM_article-title">Sulfamic acid and its <i>N</i>-substituted derivatives</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr60324a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1980&pages=151-186&author=G.+A.+Bensonauthor=W.+J.+Spillane&title=Sulfamic+acid+and+its+N-substituted+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fcr60324a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr60324a002%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DG.%2BA.%26aulast%3DSpillane%26aufirst%3DW.%2BJ.%26atitle%3DSulfamic%2520acid%2520and%2520its%2520N-substituted%2520derivatives%26jtitle%3DChem.%2520Rev.%26date%3D1980%26volume%3D80%26spage%3D151%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Benson, G. A.; Spillane, W. J.</span><span> </span><span class="NLM_article-title">Sulfamic acid and derivatives</span>. In  <span class="citation_source-book">The Chemistry of Sulfonic Acids, Esters and their Derivatives</span>; <span class="NLM_contrib-group">Patai, S.; Rappoport, Z.</span>, Eds.; <span class="NLM_publisher-name">John Wiley & Sons</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1991</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">947</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2F0470034394.ch22" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1991&pages=947-1036&author=G.+A.+Benson&author=W.+J.+Spillaneauthor=S.+Patai&author=Z.+Rappoport&title=The+Chemistry+of+Sulfonic+Acids%2C+Esters+and+their+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2F0470034394.ch22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0470034394.ch22%26sid%3Dliteratum%253Aachs%26aulast%3DBenson%26aufirst%3DG.%2BA.%26atitle%3DSulfamic%2520acid%2520and%2520derivatives%26btitle%3DThe%2520Chemistry%2520of%2520Sulfonic%2520Acids%252C%2520Esters%2520and%2520their%2520Derivatives%26aulast%3DPatai%26aufirst%3DS.%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%26date%3D1991%26spage%3D947%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Spillane, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaubier, J.-B.</span><span> </span><span class="NLM_article-title">Sulfamic acid and its <i>N</i>- and <i>O</i>-substituted derivatives</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">2507</span><span class="NLM_x">–</span> <span class="NLM_lpage">2586</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr400230c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFeqtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=2507-2586&author=W.+Spillaneauthor=J.-B.+Malaubier&title=Sulfamic+acid+and+its+N-+and+O-substituted+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamic Acid and Its N- and O-Substituted Derivatives</span></div><div class="casAuthors">Spillane, William; Malaubier, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2507-2586</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Sulfamic acid and its N- and O- substituted derivs. is reviewed.  In the present review, the 21 yr period from 1991 to the end of 2011 is covered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfdqd-0CdcP7Vg90H21EOLACvtfcHk0ljDsxSr3AMLvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFeqtrrJ&md5=6e9dbf02dbb2985b70133d9f766f09a2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fcr400230c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr400230c%26sid%3Dliteratum%253Aachs%26aulast%3DSpillane%26aufirst%3DW.%26aulast%3DMalaubier%26aufirst%3DJ.-B.%26atitle%3DSulfamic%2520acid%2520and%2520its%2520N-%2520and%2520O-substituted%2520derivatives%26jtitle%3DChem.%2520Rev.%26date%3D2014%26volume%3D114%26spage%3D2507%26epage%3D2586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Winum, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, J.-l.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Sulfamates and their therapeutic potential</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2Fmed.20021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15478125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlWhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=186-228&author=J.-Y.+Winumauthor=A.+Scozzafavaauthor=J.-l.+Monteroauthor=C.+T.+Supuran&title=Sulfamates+and+their+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamates and their therapeutic potential</span></div><div class="casAuthors">Winum, Jean-Yves; Scozzafava, Andrea; Montero, Jean-Louis; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">186-228</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Starting from the very simple mol. sulfamic acid, O-substituted-, N-substituted-, or di-/tri-substituted sulfamates may be obtained, which show specific biol. activities which were or started to be exploited for the design of many types of therapeutic agents.  Among them, sulfamate inhibitors of aminoacyl-tRNA synthetases (aaRSs) were recently reported, constituting completely new classes of antibiotics, useful in the fight of drug-resistant infections.  Anti-viral agents incorporating sulfamate moieties have also been obtained, with at least two types of such derivs. investigated: the nucleoside/nucleotide human immunodeficiency virus (HIV) reverse transcriptase inhibitors, and the HIV protease inhibitors (PIs).  In the increasing armamentarium of anti-cancer drugs, the sulfamates occupy a special position, with at least two important targets evidenced so far: the steroid sulfatases (STSs) and the carbonic anhydrases (CAs).  An impressing no. of inhibitors of STSs of the sulfamate type have been reported in the last years, with several compds., such as 667 COUMATE among others, progressing to clin. trials for the treatment of hormone-dependent tumors (breast and prostate cancers).  This field is rapidly evolving, with many types of new inhibitors being constantly reported and designed in such a way as to increase their anti-tumor properties, and decrease undesired features (for example, estrogenicity, a problem encountered with the first generation such inhibitors, such as EMATE).  Among the many isoenzymes of CAs, at least two, CA IX and CA XII, are highly overexpressed in tumors, being generally absent in the normal tissues.  Inhibition of tumor-assocd. CAs was hypothesized to lead to novel therapeutic approaches for the treatment of cancer.  Many sulfamates act as very potent (low nanomolar) CA inhibitors.  The x-ray crystal structure of the best-studied isoenzyme, CA II, with three sulfamates (sulfamic acid, topiramate, and EMATE) has recently been reported, which allowed for a rationale drug design of new inhibitors.  Indeed, low nanomolar CA IX inhibitors of the sulfamate type have been reported, although such compds. also act as efficient inhibitors of isoenzymes CA I and II, which are not assocd. with tumors.  A large no. of anti-convulsant sulfamates have been described, with one such compd., topiramate, being widely used clin. as anti-epileptic drug.  By taking into consideration a side effect of topiramate, an anti-epileptic drug leading to wt. loss in some patients, it has recently been proposed to use this drug and related sulfamates for the treatment of obesity.  The rationale of this use is based on the inhibition of the mitochondrial CA isoenzyme, CA V, involved in lipogenesis.  Some sulfamates were also shown to possess potent inhibitory activity against acyl CoA:cholesterol acyltransferase, an enzyme involved in cholesterol metab.  One such agent, avasimibe, is in advanced clin. trials for the treatment of hyperlipidemia and atherosclerosis.  Thus, the sulfamate moiety offers very attractive possibilities for the drug design of various pharmacol. agents, which are on one hand due to the relative ease with which such compds. are synthesized, and on the other one, due to the fact that biol. activity of most of them is impressive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIqLDcmtZep7Vg90H21EOLACvtfcHk0lgyAD7JkfIEaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlWhsL4%253D&md5=d9d2f31b7cdf47a11d204227813c0f2a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fmed.20021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20021%26sid%3Dliteratum%253Aachs%26aulast%3DWinum%26aufirst%3DJ.-Y.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DJ.-l.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DSulfamates%2520and%2520their%2520therapeutic%2520potential%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2005%26volume%3D25%26spage%3D186%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Spillane, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Concagh, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, S. N.</span><span> </span><span class="NLM_article-title">Sulfamate sweeteners</span> <span class="citation_source-journal">Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1996&pages=255-261&author=W.+J.+Spillaneauthor=C.+A.+Ryderauthor=M.+R.+Walshauthor=P.+J.+Curranauthor=D.+G.+Concaghauthor=S.+N.+Wall&title=Sulfamate+sweeteners"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpillane%26aufirst%3DW.%2BJ.%26aulast%3DRyder%26aufirst%3DC.%2BA.%26aulast%3DWalsh%26aufirst%3DM.%2BR.%26aulast%3DCurran%26aufirst%3DP.%2BJ.%26aulast%3DConcagh%26aufirst%3DD.%2BG.%26aulast%3DWall%26aufirst%3DS.%2BN.%26atitle%3DSulfamate%2520sweeteners%26jtitle%3DFood%2520Chem.%26date%3D1996%26volume%3D56%26spage%3D255%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Florini, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bird, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, P. H.</span><span> </span><span class="NLM_article-title">Inhibition of protein synthesis in vitro and in vivo by nucleocidin, an antitrypanosomal antibiotic</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">241</span><span class="NLM_x">, </span> <span class="NLM_fpage">1091</span><span class="NLM_x">–</span> <span class="NLM_lpage">1098</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=1966&pages=1091-1098&author=J.+R.+Floriniauthor=H.+H.+Birdauthor=P.+H.+Bell&title=Inhibition+of+protein+synthesis+in+vitro+and+in+vivo+by+nucleocidin%2C+an+antitrypanosomal+antibiotic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlorini%26aufirst%3DJ.%2BR.%26aulast%3DBird%26aufirst%3DH.%2BH.%26aulast%3DBell%26aufirst%3DP.%2BH.%26atitle%3DInhibition%2520of%2520protein%2520synthesis%2520in%2520vitro%2520and%2520in%2520vivo%2520by%2520nucleocidin%252C%2520an%2520antitrypanosomal%2520antibiotic%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1966%26volume%3D241%26spage%3D1091%26epage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Rosenfeld, W. E.</span><span> </span><span class="NLM_article-title">Topiramate: a review of preclinical, pharmacokinetic, and clinical data</span> <span class="citation_source-journal">Clin. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1294</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0149-2918%2897%2980006-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=9444441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK1cXjslGgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1997&pages=1294-1308&author=W.+E.+Rosenfeld&title=Topiramate%3A+a+review+of+preclinical%2C+pharmacokinetic%2C+and+clinical+data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Topiramate: a review of preclinical, pharmacokinetic, and clinical data</span></div><div class="casAuthors">Rosenfeld, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1294-1308</span>CODEN:
                <span class="NLM_cas:coden">CLTHDG</span>;
        ISSN:<span class="NLM_cas:issn">0149-2918</span>.
    
            (<span class="NLM_cas:orgname">Excerpta Medica</span>)
        </div><div class="casAbstract">A review with 35 refs. The antiepileptic drug (AED) topiramate is a monosaccharide deriv. with a sulfamate functionality.  It modulates voltage-dependent sodium conductance, potentiates GABA-evoked currents, and blocks the kainate/AMPA (α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) subtype of the glutamate receptor.  Topiramate is rapidly absorbed and has linear, proportional, steady-state pharmacokinetics.  It has no known clin. significant effect on plasma levels of carbamazepine, valproic acid, or phenobarbital, although it may increase plasma concns. of phenytoin in some patients.  When topiramate is used with hepatic enzyme-inducing AEDs, its plasma concns. are approx. 50% lower than when it is administered alone.  The efficacy of topiramate administered at 200-1000 mg/day in 2 divided doses as adjunctive therapy for partial-onset seizures has been investigated in 5 double-masked, placebo-controlled trials.  The median percentage redn. in av. monthly seizure frequency from basal values was 12% for placebo, compared with 30% for the 200-mg/day group and 48% for the 400-mg/day group.  At a dosage of 400 mg/day, a seizure redn. of ≥75% was seen in 22% of topiramate patients, compared with 7% of those receiving placebo; ≤9% of topiramate patients, compared with none of those receiving placebo, became seizure free.  Although little addnl. efficacy was seen at dosages of 600, 800, and 1000 mg/day, doses should be individualized, because some patients may respond to higher dosages.  When topiramate is combined with other AEDs, the most common side effects at dosages of 200-400 mg/day are somnolence, dizziness, ataxia, psychomotor slowing, hesitant speech, and word-finding difficulties.  Most patients who experienced adverse events during the 1st 8 wk of the trials no longer experienced them by their last visit.  Although there was a 1.5% incidence of renal stones that may be assocd. with carbonic anhydrase inhibition, >75% of the patients experiencing a stone continued on therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6U15oCfnJUbVg90H21EOLACvtfcHk0lhi6pWUqrVVEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslGgsw%253D%253D&md5=ac886f9be8493e4debd214e1a2d24576</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0149-2918%2897%2980006-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-2918%252897%252980006-9%26sid%3Dliteratum%253Aachs%26aulast%3DRosenfeld%26aufirst%3DW.%2BE.%26atitle%3DTopiramate%253A%2520a%2520review%2520of%2520preclinical%252C%2520pharmacokinetic%252C%2520and%2520clinical%2520data%26jtitle%3DClin.%2520Ther.%26date%3D1997%26volume%3D19%26spage%3D1294%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Recacha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, D.</span><span> </span><span class="NLM_article-title">Crystal structure of human carbonic anhydrase II complexed with an anti-convulsant sugar sulfamate</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2002&pages=437-441&author=R.+Recachaauthor=M.+J.+Costanzoauthor=B.+E.+Maryanoffauthor=D.+Chattopadhyay&title=Crystal+structure+of+human+carbonic+anhydrase+II+complexed+with+an+anti-convulsant+sugar+sulfamate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRecacha%26aufirst%3DR.%26aulast%3DCostanzo%26aufirst%3DM.%2BJ.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26aulast%3DChattopadhyay%26aufirst%3DD.%26atitle%3DCrystal%2520structure%2520of%2520human%2520carbonic%2520anhydrase%2520II%2520complexed%2520with%2520an%2520anti-convulsant%2520sugar%2520sulfamate%26jtitle%3DBiochem.%2520J.%26date%3D2002%26volume%3D361%26spage%3D437%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Bedford, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownell, J. E.</span><span> </span><span class="NLM_article-title">Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">46</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=29-46&author=L.+Bedfordauthor=J.+Loweauthor=L.+R.+Dickauthor=R.+J.+Mayerauthor=J.+E.+Brownell&title=Ubiquitin-like+protein+conjugation+and+the+ubiquitin%E2%80%93proteasome+system+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBedford%26aufirst%3DL.%26aulast%3DLowe%26aufirst%3DJ.%26aulast%3DDick%26aufirst%3DL.%2BR.%26aulast%3DMayer%26aufirst%3DR.%2BJ.%26aulast%3DBrownell%26aufirst%3DJ.%2BE.%26atitle%3DUbiquitin-like%2520protein%2520conjugation%2520and%2520the%2520ubiquitin%25E2%2580%2593proteasome%2520system%2520as%2520drug%2520targets%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D29%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Brownell, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzese, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bump, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soucy, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milhollen, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhardt, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loke, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingaraj, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamman, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spelman, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langston, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyskocil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sells, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallender, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visiers, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, L. R.</span><span> </span><span class="NLM_article-title">Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=102-111&author=J.+E.+Brownellauthor=M.+D.+Sintchakauthor=J.+M.+Gavinauthor=H.+Liaoauthor=F.+J.+Bruzzeseauthor=N.+J.+Bumpauthor=T.+A.+Soucyauthor=M.+A.+Milhollenauthor=X.+Yangauthor=A.+L.+Burkhardtauthor=J.+Maauthor=H.-K.+Lokeauthor=T.+Lingarajauthor=D.+Wuauthor=K.+B.+Hammanauthor=J.+J.+Spelmanauthor=C.+A.+Cullisauthor=S.+P.+Langstonauthor=S.+Vyskocilauthor=T.+B.+Sellsauthor=W.+D.+Mallenderauthor=I.+Visiersauthor=P.+Liauthor=C.+F.+Claiborneauthor=M.+Rolfeauthor=J.+B.+Bolenauthor=L.+R.+Dick&title=Substrate-assisted+inhibition+of+ubiquitin-like+protein-activating+enzymes%3A+the+NEDD8+E1+inhibitor+MLN4924+forms+a+NEDD8-AMP+mimetic+in+situ"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrownell%26aufirst%3DJ.%2BE.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DGavin%26aufirst%3DJ.%2BM.%26aulast%3DLiao%26aufirst%3DH.%26aulast%3DBruzzese%26aufirst%3DF.%2BJ.%26aulast%3DBump%26aufirst%3DN.%2BJ.%26aulast%3DSoucy%26aufirst%3DT.%2BA.%26aulast%3DMilhollen%26aufirst%3DM.%2BA.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DBurkhardt%26aufirst%3DA.%2BL.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DLoke%26aufirst%3DH.-K.%26aulast%3DLingaraj%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DHamman%26aufirst%3DK.%2BB.%26aulast%3DSpelman%26aufirst%3DJ.%2BJ.%26aulast%3DCullis%26aufirst%3DC.%2BA.%26aulast%3DLangston%26aufirst%3DS.%2BP.%26aulast%3DVyskocil%26aufirst%3DS.%26aulast%3DSells%26aufirst%3DT.%2BB.%26aulast%3DMallender%26aufirst%3DW.%2BD.%26aulast%3DVisiers%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DClaiborne%26aufirst%3DC.%2BF.%26aulast%3DRolfe%26aufirst%3DM.%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DDick%26aufirst%3DL.%2BR.%26atitle%3DSubstrate-assisted%2520inhibition%2520of%2520ubiquitin-like%2520protein-activating%2520enzymes%253A%2520the%2520NEDD8%2520E1%2520inhibitor%2520MLN4924%2520forms%2520a%2520NEDD8-AMP%2520mimetic%2520in%2520situ%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D37%26spage%3D102%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Reed, M. J.; Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroid sulphatase inhibitors</span>. United States Patent 5,616,574,<span class="NLM_x"> </span><span class="NLM_year">1997</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=M.+J.+Reed&author=B.+V.+L.+Potter&title=Steroid+sulphatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DSteroid%2520sulphatase%2520inhibitors%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Lo, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maren, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welstead, W. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gripshover, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shamblee, D. A.</span><span> </span><span class="NLM_article-title">Synthesis and physicochemical properties of sulfamate derivatives as topical antiglaucoma agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">4790</span><span class="NLM_x">–</span> <span class="NLM_lpage">4794</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00104a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=4790-4794&author=Y.+S.+Loauthor=J.+C.+Nolanauthor=T.+H.+Marenauthor=W.+J.+Welsteadauthor=D.+F.+Gripshoverauthor=D.+A.+Shamblee&title=Synthesis+and+physicochemical+properties+of+sulfamate+derivatives+as+topical+antiglaucoma+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm00104a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00104a003%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DY.%2BS.%26aulast%3DNolan%26aufirst%3DJ.%2BC.%26aulast%3DMaren%26aufirst%3DT.%2BH.%26aulast%3DWelstead%26aufirst%3DW.%2BJ.%26aulast%3DGripshover%26aufirst%3DD.%2BF.%26aulast%3DShamblee%26aufirst%3DD.%2BA.%26atitle%3DSynthesis%2520and%2520physicochemical%2520properties%2520of%2520sulfamate%2520derivatives%2520as%2520topical%2520antiglaucoma%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D4790%26epage%3D4794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Llaverías, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laguna, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alegret, M.</span><span> </span><span class="NLM_article-title">Pharmacology of the ACAT inhibitor Avasimibe (CI-1011)</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=33-50&author=G.+Llaver%C3%ADasauthor=J.+C.+Lagunaauthor=M.+Alegret&title=Pharmacology+of+the+ACAT+inhibitor+Avasimibe+%28CI-1011%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlaver%25C3%25ADas%26aufirst%3DG.%26aulast%3DLaguna%26aufirst%3DJ.%2BC.%26aulast%3DAlegret%26aufirst%3DM.%26atitle%3DPharmacology%2520of%2520the%2520ACAT%2520inhibitor%2520Avasimibe%2520%2528CI-1011%2529%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2003%26volume%3D21%26spage%3D33%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Carlström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Döberl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pousette, Å.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rannevik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilking, N.</span><span> </span><span class="NLM_article-title">Inhibition of steroid sulfatase activity by danazol</span> <span class="citation_source-journal">Acta Obstet. Gynecol. Scand</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 123</span><span class="NLM_x">) </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.3109%2F00016348409156994" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1984&pages=107-111&issue=Suppl+123&author=K.+Carlstr%C3%B6mauthor=A.+D%C3%B6berlauthor=%C3%85.+Pousetteauthor=G.+Rannevikauthor=N.+Wilking&title=Inhibition+of+steroid+sulfatase+activity+by+danazol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.3109%2F00016348409156994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F00016348409156994%26sid%3Dliteratum%253Aachs%26aulast%3DCarlstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DD%25C3%25B6berl%26aufirst%3DA.%26aulast%3DPousette%26aufirst%3D%25C3%2585.%26aulast%3DRannevik%26aufirst%3DG.%26aulast%3DWilking%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520steroid%2520sulfatase%2520activity%2520by%2520danazol%26jtitle%3DActa%2520Obstet.%2520Gynecol.%2520Scand%26date%3D1984%26volume%3D63%26issue%3DSuppl%2520123%26spage%3D107%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riaz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilchik, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The origin of oestrone sulphate in normal and malignant breast tissues in postmenopausal women</span> <span class="citation_source-journal">Horm. Metab. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">532</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1055%2Fs-2007-1003382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1452119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A280%3ADyaK3s%252FosVSrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1992&pages=532-536&author=A.+Purohitauthor=A.+A.+Riazauthor=M.+W.+Ghilchikauthor=M.+J.+Reed&title=The+origin+of+oestrone+sulphate+in+normal+and+malignant+breast+tissues+in+postmenopausal+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The origin of oestrone sulphate in normal and malignant breast tissues in postmenopausal women</span></div><div class="casAuthors">Purohit A; Riaz A A; Ghilchik M W; Reed M J</div><div class="citationInfo"><span class="NLM_cas:title">Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">532-6</span>
        ISSN:<span class="NLM_cas:issn">0018-5043</span>.
    </div><div class="casAbstract">Conversion of oestrone sulphate to oestrone has been suggested to make a major contribution to the level of oestrone found in breast tissues.  In order to examine the ability of breast tissues to take up oestrone sulphate (E1S), 3H E1S or E1-35S was infused into postmenopausal women with advanced breast cancer.  For 3 subjects infusion of 3H E1S was repeated after treatment with Danazol, a potential inhibitor of oestrone sulphatase activity.  After infusion of 3H E1S significant levels of 3H E1S were detected in normal and malignant breast tissues (tissue: plasma ratios 0.14 +/- 0.13 and 0.24 +/- 0.12 respectively, mean +/- S.D., n = 5).  Similar 3H E1S tissue: plasma ratios were detected after infusions of 3H E1 indicating that the 3H E1S detected in breast tissues after infusion of 3H E1S may have originated from the hydrolysis of 3H E1S in tissues other than the breast, with subsequent uptake and sulphation in breast tissues.  After infusion of E1-35S no significant levels of radioactivity were detectable in normal or malignant breast tissues.  Treatment with Danazol had no significant effect on tissue levels of 3H E1S or on the CRE1S E1 or MCR-E1S.  It is concluded that oestrone sulphate, as such, is not taken up by breast tissues and that any contribution that oestrone sulphate makes to the oestrogen content of breast tissues will depend upon prior hydrolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRN_Hhbk0mphdUSIfHIn4FfW6udTcc2eZN22h-53tg0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s%252FosVSrtg%253D%253D&md5=426573d501507b0e9e381cfbb046f7a9</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-1003382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-1003382%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DRiaz%26aufirst%3DA.%2BA.%26aulast%3DGhilchik%26aufirst%3DM.%2BW.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520origin%2520of%2520oestrone%2520sulphate%2520in%2520normal%2520and%2520malignant%2520breast%2520tissues%2520in%2520postmenopausal%2520women%26jtitle%3DHorm.%2520Metab.%2520Res.%26date%3D1992%26volume%3D24%26spage%3D532%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Phosphonates and thiophosphonates as sulphate surrogates: synthesis of estrone 3-methylthiophosphonate, a potent inhibitor of estrone sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=313-318&author=N.+M.+Howarthauthor=G.+Cooperauthor=A.+Purohitauthor=L.+Duncanauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Phosphonates+and+thiophosphonates+as+sulphate+surrogates%3A+synthesis+of+estrone+3-methylthiophosphonate%2C+a+potent+inhibitor+of+estrone+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DCooper%26aufirst%3DG.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DDuncan%26aufirst%3DL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DPhosphonates%2520and%2520thiophosphonates%2520as%2520sulphate%2520surrogates%253A%2520synthesis%2520of%2520estrone%25203-methylthiophosphonate%252C%2520a%2520potent%2520inhibitor%2520of%2520estrone%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1993%26volume%3D3%26spage%3D313%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Duncan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=298-303&author=L.+Duncanauthor=A.+Purohitauthor=N.+M.+Howarthauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+estrone+sulfatase+activity+by+estrone-3-methylthiophosphonate%3A+a+potential+therapeutic+agent+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuncan%26aufirst%3DL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520estrone%2520sulfatase%2520activity%2520by%2520estrone-3-methylthiophosphonate%253A%2520a%2520potential%2520therapeutic%2520agent%2520in%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D1993%26volume%3D53%26spage%3D298%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00028a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=219-221&author=N.+M.+Howarthauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Estrone+sulfamates%3A+potent+inhibitors+of+estrone+sulfatase+with+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm00028a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00028a002%26sid%3Dliteratum%253Aachs%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DEstrone%2520sulfamates%253A%2520potent%2520inhibitors%2520of%2520estrone%2520sulfatase%2520with%2520therapeutic%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26spage%3D219%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inactivation of sulfatase by an active site-directed inhibitor, estrone-3-<i>O</i>-sulfamate</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">11508</span><span class="NLM_x">–</span> <span class="NLM_lpage">11514</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00036a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1995&pages=11508-11514&author=A.+Purohitauthor=G.+J.+Williamsauthor=N.+M.+Howarthauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inactivation+of+sulfatase+by+an+active+site-directed+inhibitor%2C+estrone-3-O-sulfamate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fbi00036a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00036a025%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInactivation%2520of%2520sulfatase%2520by%2520an%2520active%2520site-directed%2520inhibitor%252C%2520estrone-3-O-sulfamate%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D34%26spage%3D11508%26epage%3D11514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-<i>O</i>-sulphamate</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2Fijc.2910630119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=7558436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK2MXptlyqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=1995&pages=106-111&author=A.+Purohitauthor=G.+J.+Williamsauthor=C.+J.+Robertsauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=In+vivo+inhibition+of+oestrone+sulphatase+and+dehydroepiandrosterone+sulphatase+by+oestrone-3-O-sulphamate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo inhibition of estrone sulfatase and dehydroepiandrosterone sulfatase by estrone-3-O-sulfamate</span></div><div class="casAuthors">Purohit, A.; Williams, G. J.; Roberts, C. J.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">106-11</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss</span>)
        </div><div class="casAbstract">Many tumors in endocrine-sensitive tissues, such as the breast and endometrium, are hormone-dependent and the hydrolysis of estrone sulfate (EIS) to estrone by estrone sulfatase (E1-STS) is a major source of estrogen in such tumors.  Estrone-3-O-sulfamate (EMATE) has been shown to be a potent E1-STS inhibitor in vitro, and in this study its ability to inhibit enzyme activity in vivo was examd.  EMATE was initially administered to female rats for 7 days, after which liver E1-STS activity was measured.  As EMATE also inhibits a related sulfatase in vitro, dehydroepiandrosterone sulfatase (DHA-STS), its effect on the activity of this enzyme in vivo was also investigated.  DHA-STS has a pivotal role in regulating the synthesis of another steroid with potent estrogenic properties, androstenediol.  Administration of EMATE almost completely inhibited liver E1-STS (99%) and DHA-STS (99%) activities and was active when given by the oral or s.c. routes.  After a single dose of EMATE or following the cessation of multiple doses for 10 days, liver E1-STS activity remained inhibited (>95%) for up to 7 and 10 days, resp.  Other compds., such as 4-hydroxytamoxifen and the "pure" anti-estrogen ICI 182,780, which are reported to inhibited E1-STS activity in vitro, did not inhibit activity in vivo.  In a preliminary study, EMATE, when injected over a 12-day period, effectively reduced the growth of E1S-stimulated nitrosomethyl-urea-induced mammary tumors in ovariectomized rats and inhibited tumor sulfatase activity in treated animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyUTjWkzpc_7Vg90H21EOLACvtfcHk0lhhmcz6KW7J-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlyqt7g%253D&md5=f812f95aeca622d0842ab0b01100f2dc</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910630119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910630119%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DRoberts%26aufirst%3DC.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vivo%2520inhibition%2520of%2520oestrone%2520sulphatase%2520and%2520dehydroepiandrosterone%2520sulphatase%2520by%2520oestrone-3-O-sulphamate%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1995%26volume%3D63%26spage%3D106%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumors</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2F0960-0760%2895%2900087-G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=7626490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK2MXnt1GntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1995&pages=413-420&author=M.+J.+Reedauthor=A.+Purohitauthor=L.+J.+Duncanauthor=A.+Singhauthor=C.+J.+Robertsauthor=G.+J.+Williamsauthor=B.+V.+L.+Potter&title=The+role+of+cytokines+and+sulphatase+inhibitors+in+regulating+oestrogen+synthesis+in+breast+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The role of cytokines and sulfatase inhibitors in regulating estrogen synthesis in breast tumors</span></div><div class="casAuthors">Reed, M. J.; Purohit, A.; Duncan, L. J.; Singh, A.; Roberts, C. J.; Williams, G. J.; Potter, B. V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1-6</span>),
    <span class="NLM_cas:pages">413-20</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 42 refs.  Synthesis of estrogens within breast tissues makes an important contribution to the high concns. of estradiol which are found in breast tumors.  The activities of the enzymes involved in estrogen synthesis, i.e., the aromatase, estradiol dehydrogenase (E2DH) and estrone sulfatase (E1-STS), can be stimulated by several growth factors and cytokines.  As it is possible that some of these factors may be derived from cells of the immune system (macrophages and lymphocytes), the effects of basic fibroblast growth factor (bFGF) and interleukin-2 (IL-2), which are produced by these cells, on E2DH activity was examd. in MCF-7 cells.  Estrone 3-O-sulfamate (EMATE) is a potent, irreversible, inhibitor of E1-STS.  A single dose of EMATE (10 mg/kg) inhibited tissue E1-STS activity in rats by more than 95% for up to 7 days, indicating that this compd. may have considerable therapeutic potential for the treatment of breast cancer.  Evidence is also reviewed that another steroid sulfatase, dehydroepiandrosterone sulfate sulfatase, may have a crucial role in regulating cytokine prodn. and that this may indirectly control tumor estrogen synthesis.  Treatment of these cells with bFGF resulted in a dose-dependent increase in E2DH reductive activity whereas IL-2 was inactive at the concn. tested.  To obtain further evidence that factors produced by macrophages and lymphocytes can modulate the activities of enzymes involved in estrogen synthesis, conditioned medium was collected from these cells and found to stimulate both E1-STS and E2DH activities.  In addn. to understanding the control of estrogen synthesis in breast tumors an inhibitor to block the synthesis of estrone via the estrone sulfatase pathway was developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrED0nR5AiqArVg90H21EOLACvtfcHk0lhhmcz6KW7J-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnt1GntLY%253D&md5=b7904f8d39ac016fd0677721b789f0fe</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900087-G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900087-G%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DDuncan%26aufirst%3DL.%2BJ.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DC.%2BJ.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DThe%2520role%2520of%2520cytokines%2520and%2520sulphatase%2520inhibitors%2520in%2520regulating%2520oestrogen%2520synthesis%2520in%2520breast%2520tumors%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D53%26spage%3D413%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Regulation and inhibition of sulfatase activity in breast cancer</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">784</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=784&publication_year=1996&pages=40-49&author=A.+Purohitauthor=M.+J.+Reedauthor=N.+C.+Morrisauthor=G.+J.+Williamsauthor=B.+V.+L.+Potter&title=Regulation+and+inhibition+of+sulfatase+activity+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DMorris%26aufirst%3DN.%2BC.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DRegulation%2520and%2520inhibition%2520of%2520sulfatase%2520activity%2520in%2520breast%2520cancer%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1996%26volume%3D784%26spage%3D40%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Sahm, U. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hidalgo Aragones, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouton, C. W.</span><span> </span><span class="NLM_article-title">Development of an oral formulation for oestrone 3-<i>O</i>-sulphamate, a potent sulphatase inhibitor</span> <span class="citation_source-journal">Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28XkvFGkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=17-20&author=U.+G.+Sahmauthor=G.+J.+Williamsauthor=A.+Purohitauthor=I.+Hidalgo+Aragonesauthor=D.+Parishauthor=M.+J.+Reedauthor=B.+V.+L.+Potterauthor=C.+W.+Pouton&title=Development+of+an+oral+formulation+for+oestrone+3-O-sulphamate%2C+a+potent+sulphatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Development of an oral formulation for estrone 3-O-sulfamate, a potent sulfatase inhibitor</span></div><div class="casAuthors">Sahm, Ulrike G.; Williams, Gary J.; Purohit, Atul; Hidalgo Aragones, M. Isabel; Parish, David; Reed, Michael J.; Potter, Barry V. L.; Pouton, Colin W.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-20</span>CODEN:
                <span class="NLM_cas:coden">PHSCFB</span>;
        ISSN:<span class="NLM_cas:issn">1356-6881</span>.
    
            (<span class="NLM_cas:orgname">Royal Pharmaceutical Society of Great Britain</span>)
        </div><div class="casAbstract">Estrone sulfatase is a key enzyme involved in estrogen synthesis in breast tumors in postmenopausal women.  As breast tumors can be endocrine-dependent, it is therefore feasible that blockage of this enzyme may be of value in the treatment of such tumors.  Estrone 3-O-sulfamate (EMATE) is the most potent inhibitor of estrone sulfatase activity described to date.  A preliminary examn. of its physicochem. properties and the development of a self-emulsifying formulation for potential administration of EMATE by the oral route is described.  A preliminary assessment of the absorption of the drug from the gut was undertaken, and pharmacol. activity, detd. as estrone sulfatase inhibition, was studied following i.v. and oral administration.  A high-performance liq. chromatog. (HPLC) assay was developed to measure degrdn. of EMATE in the formulation and also its concn. in rat plasma.  The drug was susceptible to degrdn., but its stability in the formulation was satisfactory when stored at either 4° or room-temp. over the time-span required for a clin. trial.  Plasma EMATE concns. after 2 h were a function of the dose of drug administered orally to rats over the 10-40 mg kg-1 range.  After oral administration in the self-emulsifying system, EMATE appeared to be rapidly absorbed, with the peak plasma concn. being detected at 30 min, after which plasma concns. rapidly decreased.  After i.v. administration, a similar plasma EMATE concn. was detected at 1 h to that obsd. after oral administration.  Rat liver sulfatase activity was almost completely inhibited (>99%) within 30 min of oral or i.v. administration of EMATE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqimZ6fFzBI3rVg90H21EOLACvtfcHk0lhhmcz6KW7J-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFGkurc%253D&md5=5d49fe4c0a4c05f8b4fceeee06fbe929</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSahm%26aufirst%3DU.%2BG.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHidalgo%2BAragones%26aufirst%3DI.%26aulast%3DParish%26aufirst%3DD.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DPouton%26aufirst%3DC.%2BW.%26atitle%3DDevelopment%2520of%2520an%2520oral%2520formulation%2520for%2520oestrone%25203-O-sulphamate%252C%2520a%2520potent%2520sulphatase%2520inhibitor%26jtitle%3DPharm.%2520Sci.%26date%3D1996%26volume%3D2%26spage%3D17%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Hidalgo Aragones, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahm, U. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouton, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of oestrone-3-<i>O-</i>sulphamate</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">611</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2F0960-0760%2896%2900074-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8918989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28XmvFajsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1996&pages=611-617&author=M.+I.+Hidalgo+Aragonesauthor=A.+Purohitauthor=D.+Parishauthor=U.+G.+Sahmauthor=C.+W.+Poutonauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Pharmacokinetics+of+oestrone-3-O-sulphamate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of estrone-3-O-sulfamate</span></div><div class="casAuthors">Hidalgo Aragones, M. I.; Purohit, A.; Parish, D.; Sahm, U. G.; Pouton, C. W.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">611-617</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The sulfatase pathway is thought to be the major route of estrogen synthesis in breast tumors in postmenopausal women.  There is current considerable interest in developing a potent steroid sulfatase inhibitor to block estrogen synthesis by this route.  One of the most potent inhibitors discovered so far is estrone-3-O-sulfamate (EMATE) which is active in vivo.  In this study, we report the prepn. of a formulation for the administration of EMATE by the oral route.  A method, using high-performance liq. chromatog. (HPLC), was also established to measure concns. of EMATE in rat plasma after its oral or i.v. administration.  Using the oral formulation and HPLC assay, EMATE was readily detected in rat plasma after oral administration.  Plasma EMATE concns. were related to the dose of drug administered orally over the 10-40 mg/kg range.  To examine the pharmacokinetics of EMATE, the compd. (40 mg/kg, single dose) was administered either orally (in the formulation) or i.v. (in propylene glycol) with plasma samples being collected for up to 6 h.  After oral administration, EMATE was rapidly absorbed, with the peak plasma concn. being detected at 30 min, after which plasma concn. rapidly decreased.  After i.v. administration a plasma EMATE concn. was detected at 1 h similar to that after oral administration.  The clearance of EMATE from plasma followed a bi-phasic curve, showing an initial half-life of 30 min, followed by a slower half-life of 4 h 30 min.  Little evidence was obtained for any metab. of EMATE to estrone.  Rat liver sulfatase activity was almost completely inhibited (>99%) within 30 min of oral or i.v. administration of EMATE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaqiQSCB_JOrVg90H21EOLACvtfcHk0lhXRZNDvxf9Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvFajsb0%253D&md5=7891eca64cd4f6fb396ab007a115955c</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2896%2900074-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252896%252900074-X%26sid%3Dliteratum%253Aachs%26aulast%3DHidalgo%2BAragones%26aufirst%3DM.%2BI.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DParish%26aufirst%3DD.%26aulast%3DSahm%26aufirst%3DU.%2BG.%26aulast%3DPouton%26aufirst%3DC.%2BW.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DPharmacokinetics%2520of%2520oestrone-3-O-sulphamate%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D58%26spage%3D611%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froome, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Measurement of oestrone sulphatase activity in white blood cells to monitor in vivo inhibition of steroid sulphatase activity by oestrone-3-<i>O</i>-sulphamate</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2897%2900018-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=9366497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK2sXnt1emtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=45-51&author=A.+Purohitauthor=V.+A.+Froomeauthor=D.+Y.+Wangauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Measurement+of+oestrone+sulphatase+activity+in+white+blood+cells+to+monitor+in+vivo+inhibition+of+steroid+sulphatase+activity+by+oestrone-3-O-sulphamate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Measurement of estrone sulfatase activity in white blood cells to monitor in vivo inhibition of steroid sulfatase activity by estrone-3-O-sulfamate</span></div><div class="casAuthors">Purohit, A.; Froome, V. A.; Wang, D. Y.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Formation of estrone via the sulfatase pathway is considered to be a major source of the estrogen present in breast tumors.  Several inhibitors of steroid sulfatase have now been developed for use in the treatment of postmenopausal women with breast cancer.  In order to be able to monitor the extent and duration of the inhibition of estrone sulfatase (E1-STS) readily, we have developed a method to measure the activity of this enzyme in white blood cells (WBCs).  Hydrolysis of estrone sulfate by E1-STS in WBCs was linear with respect to time and the vol. of WBCs used.  To examine whether the extent of inhibition of E1-STS activity in WBCs, by the inhibitor estrone-3-O-sulfamate (EMATE), reflected inhibition in other body tissues, activity in WBCs was compared with that in liver and spleen tissue samples from rats.  Two hours after an oral dose of EMATE the extent of inhibition of E1-STS detected in WBCs was the same as in the liver.  The duration of the inhibition of E1-STS by EMATE, examd. over a 1-28 day period in rats, was similar whether monitored in WBCs, liver or spleen.  Measurements of E1-STS activity in WBCs were also used to examine the effectiveness of EMATE (0.5 mg/kg) in two male volunteers.  E1-STS activity was rapidly inhibited and had only recovered by 27% after 1 mo.  A marked decrease in the ratio of plasma dehydroepiandrosterone:dehydroepiandrosterone-sulfate (DHA:DHA-S) concns. was also detected, confirming that EMATE also inhibits DHA-STS activity.  The ability to monitor the extent and duration of steroid sulfatase inhibition in WBCs will facilitate the evaluation of this new form of endocrine therapy in women with breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDnur9MKaZ0rVg90H21EOLACvtfcHk0lhXRZNDvxf9Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnt1emtbs%253D&md5=a9d553bc273fbf7e0b47431e729615cd</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2897%2900018-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252897%252900018-6%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DFroome%26aufirst%3DV.%2BA.%26aulast%3DWang%26aufirst%3DD.%2BY.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DMeasurement%2520of%2520oestrone%2520sulphatase%2520activity%2520in%2520white%2520blood%2520cells%2520to%2520monitor%2520in%2520vivo%2520inhibition%2520of%2520steroid%2520sulphatase%2520activity%2520by%2520oestrone-3-O-sulphamate%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D62%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightowler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate inhibit estrone sulphatase by a different mechanism</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2F0960-0760%2895%2900244-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8645620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28XjtVegtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1996&pages=79-88&author=L.+W.+L.+Wooauthor=M.+Lightowlerauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Heteroatom-substituted+analogues+of+the+active-site+directed+inhibitor+estra-1%2C3%2C5%2810%29-trien-17-one-3-sulphamate+inhibit+estrone+sulphatase+by+a+different+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Hetero atom-substituted analogs of the active-side directed inhibitor estra-1,3,5(10)-triene-17-one-3-sulfamate inhibit estrone sulfatase by a different mechanism</span></div><div class="casAuthors">Woo, L. W. Lawrence; Lightowler, Mark; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Estrogens have a pivotal role in the growth and development of hormone-dependent breast cancers.  In postmenopausal women, the hydrolysis of the conjugate estrone sulfate (E1S) to estrone (E1) by the enzyme estrone sulfatase is the major source of breast tumor estrogen.  Inhibitors of estrone sulfatase should therefore have considerable therapeutic potential for the treatment of hormone-dependent tumors of the breast, either as the sole agent or in conjunction with aromatase inhibitors.  Several inhibitors of estrone sulfatase have now been developed of which estra-1,3,5(10)-trien-17-one-3-sulfamate (EMATE) is the most potent and also inhibits the enzyme in a time- and concn.-dependent manner, showing that it acts as an irreversible inhibitor.  Analogs of EMATE in which the 3-O-atom is replaced by other heteroatoms (S and N) were prepd. and tested for inhibition against estrone sulfatase.  3-Methoxyphenylsulfamide, 4-chlorothiophenyl-S-(N,N-dimethyl)sulfamate, estra-1,3,5(10)-trien-17-one-3-sulfamide, estra-1,3,5(10)-trien-17-one-3-S-sulfamate, and estra-1,3,5(10)-trien-17-one-3-S-(N,N-dimethyl)sulfamate inhibited estrone sulfatase weakly, but none of these compds. appears to behave as a time-dependent inhibitor.  A model of the mechanism of enzyme inhibition by EMATE is proposed and the authors conclude that the sulfamate bridging oxygen atom of EMATE is essential for active site-directed inhibition of estrone sulfatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlWZCRBBmXtLVg90H21EOLACvtfcHk0lhsuZP67g4eRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVegtL8%253D&md5=ce13a9f57587179a9d5a3a104fd67740</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900244-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900244-8%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLightowler%26aufirst%3DM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DHeteroatom-substituted%2520analogues%2520of%2520the%2520active-site%2520directed%2520inhibitor%2520estra-1%252C3%252C5%252810%2529-trien-17-one-3-sulphamate%2520inhibit%2520estrone%2520sulphatase%2520by%2520a%2520different%2520mechanism%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1996%26volume%3D57%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Williams, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">X-ray crystal structure and mechanism of action of oestrone 3-<i>O</i>-sulphamate, a synthetic active site-directed inhibitor of oestrone sulphatase</span> <span class="citation_source-journal">Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28XkvFGkurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=11-16&author=G.+J.+Williamsauthor=L.+W.+L.+Wooauthor=M.+F.+Mahonauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=X-ray+crystal+structure+and+mechanism+of+action+of+oestrone+3-O-sulphamate%2C+a+synthetic+active+site-directed+inhibitor+of+oestrone+sulphatase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray crystal structure and mechanism of action of estrone 3-O-sulfamate, a synthetic active site-directed inhibitor of estrone sulfatase</span></div><div class="casAuthors">Williams, Gary J.; Woo, L. W. Lawrence; Mahon, Mary F.; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-16</span>CODEN:
                <span class="NLM_cas:coden">PHSCFB</span>;
        ISSN:<span class="NLM_cas:issn">1356-6881</span>.
    
            (<span class="NLM_cas:orgname">Royal Pharmaceutical Society of Great Britain</span>)
        </div><div class="casAbstract">Estrone 3-O-sulfamate moiety is a sulfate group surrogate relative to estrone sulfate, is the most potent estrone sulfatase inhibitor developed to date and inhibits estrone sulfatase in a time- and concn.-dependent manner, showing that it is acting as an active site-directed irreversible inhibitor.  It also inhibits dehydroepiandrosterone sulfatase, the enzyme which regulates the synthesis of androstenediol.  Estrone 3-O-sulfamate has also been shown to inhibit these enzymes in-vivo.  The authors report its crystal structure and the synthesis and inhibitory activities of analogs in which the 3-O atom is replaced by other heteroatoms (N and S).  Estrone 3-N-sulfamate and estrone 3-S-sulfamate were found to inhibit placental microsome estrone sulfatase weakly, i.e. 53% and 12%, resp., at 50 μM (compared with >99% for estrone 3-O-sulfamate), but none of these compds. appears to behave as a time-dependent inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2yQvGcqHZT7Vg90H21EOLACvtfcHk0lhsuZP67g4eRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFGkurY%253D&md5=7555f9014e507d084ca32ddf0d861f0f</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DX-ray%2520crystal%2520structure%2520and%2520mechanism%2520of%2520action%2520of%2520oestrone%25203-O-sulphamate%252C%2520a%2520synthetic%2520active%2520site-directed%2520inhibitor%2520of%2520oestrone%2520sulphatase%26jtitle%3DPharm.%2520Sci.%26date%3D1996%26volume%3D2%26spage%3D11%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Estrone sulfonates as inhibitors of estrone sulfatase</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=346-350&author=N.+M.+Howarthauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Estrone+sulfonates+as+inhibitors+of+estrone+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DEstrone%2520sulfonates%2520as%2520inhibitors%2520of%2520estrone%2520sulfatase%26jtitle%3DSteroids%26date%3D1997%26volume%3D62%26spage%3D346%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Oestrone 3-<i>O</i>-(<i>N</i>-acetyl)sulphamate, a potential molecular probe of the active site of oestrone sulphatase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3075</span><span class="NLM_x">–</span> <span class="NLM_lpage">3080</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=3075-3080&author=L.+W.+L.+Wooauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Oestrone+3-O-%28N-acetyl%29sulphamate%2C+a+potential+molecular+probe+of+the+active+site+of+oestrone+sulphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DOestrone%25203-O-%2528N-acetyl%2529sulphamate%252C%2520a%2520potential%2520molecular%2520probe%2520of%2520the%2520active%2520site%2520of%2520oestrone%2520sulphatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D3075%26epage%3D3080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Elger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heddern, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddersen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, B.</span><span> </span><span class="NLM_article-title">Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2F0960-0760%2895%2900214-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8541236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28XhsVygtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=395-403&author=W.+Elgerauthor=S.+Schwarzauthor=A.+Heddernauthor=G.+Reddersenauthor=B.+Schneider&title=Sulfamates+of+various+estrogens+are+prodrugs+with+increased+systemic+and+reduced+hepatic+estrogenicity+at+oral+application"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application</span></div><div class="casAuthors">Elger, Walter; Schwarz, Sigfrid; Hedden, Annemarie; Reddersen, Gudrun; Schneider, Birgitt</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">395-403</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Oral therapy with natural or synthetic estrogens, like ethinylestradiol, suffers from low, suboptimally defined bioavailability and excess hepatic estrogen actions.  N,N-alkylated and non-alkylated sulfamates of ethinylestradiol, estradiol and estrone overcome these deficiencies.  Ovariectomized Wistar rats (-7/group) were orally treated for 7 days, and killed on day 8, plasma was gained on days 0, 4, and 8.  Systemic estrogenicity was quantified by assessment of uterine wt., vaginal cornification, and measurement of gonadotropins by homologous RIA.  Estrogenicity in the liver was analyzed.  Angiotensinogen was estd. by RIA of angiotensin-I after incubation of EDTA-plasma with porcine renin.  Total and high-d. cholesterol were measured by enzymic methods.  Preliminary biotransformation studies were performed after oral administration of 10 μg, 5 μ Ci [2,4,6,7-3H]estradiol sulfonate.  Ethinylestradiol led to distinct elevation of angiotensin-I and dramatic depression of cholesterol fractions, reflecting hepatic estrogen effects, already at doses with marginal systemic effects.  Estradiol and estrone had systemic and hepatic estrogenic activity at much higher doses only.  Estrogen sulfamates had systemic estrogen activity 10-90-fold above that of their parent estrogen.  Non-alkylated sulfamates of given estrogens were more active than N-alkylated ones.  Elevation of systemic estrogen activity was always combined with a dramatic redn. of hepatic estrogenicity.  Estradiol sulfamate had a 90-fold elevated systemic estrogen activity vs. estradiol, but lacked hepatic activity including the 30-fold dose inducing vaginal response.  Three hours after administration no unchanged estradiol sulfamate was detectable in plasma.  Rather peaks, probably representing estradiol and estrone, were found.  Estrogen sulfamates are considered prodrugs of their parent estrogen, which do not interact with any liver function during the first-pass.  They represent a new strategy of oral hormone administration.  Their main potential seems to be the systemic generation of natural estrogen when used in oral contraceptives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq93WhQsNTWFbVg90H21EOLACvtfcHk0lhjvjB0flnDdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhsVygtg%253D%253D&md5=60ff9ba569eb4001a4a023073e8737e0</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2F0960-0760%2895%2900214-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-0760%252895%252900214-6%26sid%3Dliteratum%253Aachs%26aulast%3DElger%26aufirst%3DW.%26aulast%3DSchwarz%26aufirst%3DS.%26aulast%3DHeddern%26aufirst%3DA.%26aulast%3DReddersen%26aufirst%3DG.%26aulast%3DSchneider%26aufirst%3DB.%26atitle%3DSulfamates%2520of%2520various%2520estrogens%2520are%2520prodrugs%2520with%2520increased%2520systemic%2520and%2520reduced%2520hepatic%2520estrogenicity%2520at%2520oral%2520application%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D55%26spage%3D395%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Elger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedden, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddersen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Züchner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krahl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oettel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span> </span><span class="NLM_article-title">Estrogen sulfamates: a new approach to oral estrogen therapy</span> <span class="citation_source-journal">Reprod., Fertil. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1071%2FRD01029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=11800168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVQ%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=297-305&author=W.+Elgerauthor=A.+Barthauthor=A.+Heddenauthor=G.+Reddersenauthor=P.+Ritterauthor=B.+Schneiderauthor=J.+Z%C3%BCchnerauthor=E.+Krahlauthor=K.+M%C3%BCllerauthor=M.+Oettelauthor=S.+Schwarz&title=Estrogen+sulfamates%3A+a+new+approach+to+oral+estrogen+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Estrogen sulfamates: A new approach to oral estrogen therapy</span></div><div class="casAuthors">Elger, W.; Barth, A.; Hedden, A.; Reddersen, G.; Ritter, P.; Schneider, B.; Zuchner, J.; Krahl, E.; Muller, K.; Oettel, M.; Schwarz, Sigfrid</div><div class="citationInfo"><span class="NLM_cas:title">Reproduction, Fertility and Development</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-305</span>CODEN:
                <span class="NLM_cas:coden">RFDEEH</span>;
        ISSN:<span class="NLM_cas:issn">1031-3613</span>.
    
            (<span class="NLM_cas:orgname">CSIRO Publishing</span>)
        </div><div class="casAbstract">Sulfamate substitution (-O-SO2-NH2) at carbon atom 3 of the steroid skeleton leads to orally active prodrugs of estrogens with much higher systemic, but lower hepatic, estrogenic activity than their parent steroids.  This dissocn. is achieved by first passage through the liver in erythrocytes, followed by systemic hydrolysis which releases the "parent" estrogen.  In the rat, orally administered tritiated estradiol sulfamate, unlike estradiol, appears in the circulation at high concns.  At Cmax, approx. one-third of the administered dose forms a depot in the circulation (98% in erythrocytes, 2% in plasma).  Significant estradiol, estrone and estrone sulfate concns. were recorded in plasma during depletion of the red blood cell pool.  Estradiol sulfamate (J995) has no estrogen receptor affinity per se or estrogenic activity in vitro (i.e., without hydrolysis).  Its oral uterotropic activity in rats is approx. 100 times greater than that of estradiol, however, its hepatotropic activity is only marginally elevated.  These functions include bile secretion, the secretion of angiotensinogen, lipoproteins (total and high-d. lipoprotein cholesterol) and IGF-I.  Orally administered estradiol sulfamate led to systemic estrogenic effects without significant hepatic responses, whereas estradiol and other conventional estrogens exerted parallel systemic and hepatic estrogenic effects.  Sulfamate technol. represents an approach to the use of natural estrogens for fertility control and hormone replacement therapy in both genders.  In this context, reduced effects on hemostatic factors, angiotensinogen, bile and IGF-I secretion seem the most important aspects.  In addn., blood concns. of estrogens are less variable than with conventional estrogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEwNk-n7GGhbVg90H21EOLACvtfcHk0lhjvjB0flnDdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVQ%253D&md5=4467be06adf6c62c8b0287297421ffa0</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1071%2FRD01029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1071%252FRD01029%26sid%3Dliteratum%253Aachs%26aulast%3DElger%26aufirst%3DW.%26aulast%3DBarth%26aufirst%3DA.%26aulast%3DHedden%26aufirst%3DA.%26aulast%3DReddersen%26aufirst%3DG.%26aulast%3DRitter%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DB.%26aulast%3DZ%25C3%25BCchner%26aufirst%3DJ.%26aulast%3DKrahl%26aufirst%3DE.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DOettel%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DS.%26atitle%3DEstrogen%2520sulfamates%253A%2520a%2520new%2520approach%2520to%2520oral%2520estrogen%2520therapy%26jtitle%3DReprod.%252C%2520Fertil.%2520Dev.%26date%3D2001%26volume%3D13%26spage%3D297%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Elger, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palme, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span> </span><span class="NLM_article-title">Novel oestrogen sulfamates: a new approach to oral hormone therapy</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=575-589&author=W.+Elgerauthor=H.-J.+Palmeauthor=S.+Schwarz&title=Novel+oestrogen+sulfamates%3A+a+new+approach+to+oral+hormone+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElger%26aufirst%3DW.%26aulast%3DPalme%26aufirst%3DH.-J.%26aulast%3DSchwarz%26aufirst%3DS.%26atitle%3DNovel%2520oestrogen%2520sulfamates%253A%2520a%2520new%2520approach%2520to%2520oral%2520hormone%2520therapy%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D1998%26volume%3D7%26spage%3D575%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2004&pages=217-222&author=S.+K.+Chanderauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+role+of+steroid+sulphatase+in+regulating+the+oestrogenicity+of+oestrogen+sulphamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520role%2520of%2520steroid%2520sulphatase%2520in%2520regulating%2520the%2520oestrogenicity%2520of%2520oestrogen%2520sulphamates%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D322%26spage%3D217%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Potter, B. V. L.; Reed, M. J.; Elger, W.; Roddersen, G.; Proske, H.-T.</span><span> </span><span class="NLM_article-title">Composition</span>. US Patent 7335650 B2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=B.+V.+L.+Potter&author=M.+J.+Reed&author=W.+Elger&author=G.+Roddersen&author=H.-T.+Proske&title=Composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DComposition%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1349</span><span class="NLM_x">–</span> <span class="NLM_lpage">1351</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950931z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1349-1351&author=L.+W.+L.+Wooauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Active+site+directed+inhibition+of+estrone+sulfatase+by+nonsteroidal+coumarin+sulfamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjm950931z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950931z%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DActive%2520site%2520directed%2520inhibition%2520of%2520estrone%2520sulfatase%2520by%2520nonsteroidal%2520coumarin%2520sulfamates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1349%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winterborn, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">In vivo activity of 4-methylcoumarin-7-<i>O</i>-sulfamate, a nonsteroidal, nonestrogenic sulfatase inhibitor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4950</span><span class="NLM_x">–</span> <span class="NLM_lpage">4955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1996&pages=4950-4955&author=A.+Purohitauthor=L.+W.+L.+Wooauthor=A.+Singhauthor=C.+J.+Winterbornauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=In+vivo+activity+of+4-methylcoumarin-7-O-sulfamate%2C+a+nonsteroidal%2C+nonestrogenic+sulfatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DWinterborn%26aufirst%3DC.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vivo%2520activity%2520of%25204-methylcoumarin-7-O-sulfamate%252C%2520a%2520nonsteroidal%252C%2520nonestrogenic%2520sulfatase%2520inhibitor%26jtitle%3DCancer%2520Res.%26date%3D1996%26volume%3D56%26spage%3D4950%26epage%3D4955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroidal and non-steroidal sulfamates as potent inhibitors of sulfatase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1068</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970527v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1068-1083&author=L.+W.+L.+Wooauthor=N.+M.+Howarthauthor=A.+Purohitauthor=H.+A.+M.+Hejazauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Steroidal+and+non-steroidal+sulfamates+as+potent+inhibitors+of+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm970527v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970527v%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DHowarth%26aufirst%3DN.%2BM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroidal%2520and%2520non-steroidal%2520sulfamates%2520as%2520potent%2520inhibitors%2520of%2520sulfatase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1068%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS1074-5521%2800%2900023-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=11033081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVWitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=773-791&author=L.+W.+L.+Wooauthor=A.+Purohitauthor=B.+Maliniauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Potent+active+site-directed+inhibition+of+steroid+sulphatase+by+tricyclic+coumarin-based+sulphamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Potent active site-directed inhibition of steroid sulfatase by tricyclic coumarin-based sulfamates</span></div><div class="casAuthors">Woo, L. W. Lawrence; Purohit, Atul; Malini, Bindu; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">773-791</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: There is now abundant evidence that inhibition of steroid sulfatase alone or in conjunction with inhibition of aromatase may enhance the response of postmenopausal patients with hormone-dependent breast cancer to this type of endocrine therapy.  Addnl., sulfatase inhibition has been proposed to be of potential therapeutic benefit in the immune system and for neuro-degenerative diseases.  After the finding that the authors first highly potent active site-directed steroid sulfatase inhibitor, estrone-3-O-sulfamate (EMATE), was highly estrogenic, the authors proposed non-steroidal coumarin sulfamates such as 4-methylcoumarin-7-O-sulfamate (COUMATE) as alternative non-steroidal steroid sulfatase inhibitors.  In this work, the authors describe how tricyclic coumarin-based sulfamates have been developed which are even more potent than COUMATE, are non-estrogenic and orally active.  The authors also discuss potential mechanisms of action.  Results: 4-Ethyl-, 4-(n-propyl)-, 3-ethyl-4-methyl-, 4-methyl-3-(n-propyl)coumarin-7-O-sulfamate; the tricyclic derivs. 665COUMATE, 666COUMATE, 667COUMATE, 668COUMATE and the tricyclic oxepin sulfamate were synthesized.  In a placental microsome prepn., all of these analogs were more active than COUMATE in the inhibition of estrone sulfatase, with the most potent inhibitor being 667COUMATE which has an IC50 of 8 nM, some 3-fold lower than that for EMATE (25 nM).  In addn., 667COUMATE was also found to inhibit DHEA-sulfatase some 25-fold more potently than EMATE in a placental microsome prepn.  Like EMATE, 667COUMATE acts in a time- and concn.-dependent manner, suggesting that it is an active site-directed inhibitor.  However, in contrast to EMATE, 667COUMATE has the important advantage of not being estrogenic.  In addn., the authors propose several diverse mechanisms of action for this active site-directed steroid sulfatase inhibitor in the light of recent publications on the crystal structures of human arylsulfatases A and B and the catalytic site topol. for the hydrolysis of a sulfate ester.  Conclusions: A highly potent non-steroidal, non-estrogenic and irreversible steroid sulfatase inhibitor has been developed.  Several mechanisms of action for an active site-directed steroid sulfatase inhibitor are proposed.  With 667COUMATE now in pre-clin. development for clin. trial, this should allow the biol. and/or clin. significance of steroid sulfatase inhibitors in the treatment of postmenopausal women with hormone-dependent breast cancer and other therapeutic indications to be fully evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquu_otJvJPsbVg90H21EOLACvtfcHk0lh9AgjbA-9YRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVWitro%253D&md5=263791da6e0cc238ed0e4ad6bf1c60ec</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2800%2900023-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252800%252900023-5%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DMalini%26aufirst%3DB.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DPotent%2520active%2520site-directed%2520inhibition%2520of%2520steroid%2520sulphatase%2520by%2520tricyclic%2520coumarin-based%2520sulphamates%26jtitle%3DChem.%2520Biol.%26date%3D2000%26volume%3D7%26spage%3D773%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3394</span><span class="NLM_x">–</span> <span class="NLM_lpage">3396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=3394-3396&author=A.+Purohitauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=In+vivo+inhibition+of+estrone+sulfatase+activity+and+growth+of+nitrosomethylurea-induced+mammary+tumors+by+667+COUMATE"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vivo%2520inhibition%2520of%2520estrone%2520sulfatase%2520activity%2520and%2520growth%2520of%2520nitrosomethylurea-induced%2520mammary%2520tumors%2520by%2520667%2520COUMATE%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D3394%26epage%3D3396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Malini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganeshapillai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2800%2900178-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=11282279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit12mu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2000&pages=253-258&author=B.+Maliniauthor=A.+Purohitauthor=D.+Ganeshapillaiauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+steroid+sulphatase+activity+by+tricyclic+coumarin+sulphamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates</span></div><div class="casAuthors">Malini, B.; Purohit, A.; Ganeshapillai, D.; Woo, L. W. L.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">253-258</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The identification of the active pharmacophore required for potent inhibition of steroid sulfatase activity, i.e. and aryl-O-sulfamate structure, has led to the synthesis and testing of a large no. of 1-4 ring-based inhibitors.  4-Methylcoumarin-7-O-sulfamate (COUMATE) was one of the first non-steroid based inhibitors identified.  In an attempt to increase the potency of this class of inhibitor a series of tricyclic COUMATEs (665-6615 COUMATEs) have been synthesized and evaluated.  Using placental microsomes as a source of estrone sulfatase (E1-STS) the size of the third ring of the tricyclic COUMATEs was found to have a marked effect on inhibitor potency.  Whereas 665- and 6615-COUMATEs had IC50s of 200 and 370 nM, resp., the most potent inhibitor in vitro in this series was 6610 COUMATE with an IC50 of 1 nM.  Selected inhibitors were tested for their in vivo potency by administration of a single dose (0.1 or 1 mg/kg, p.o.) to female rats.  Surprisingly, in vivo 6615 COUMATE proved to be the most active drug, inhibiting rat liver E1-STS activity by 23 and 94% when assayed 24 h after administration of the 0.1 and 1 mg/kg doses.  E1-STS activity in brain tissue and white blood cells was also inhibited when selected drugs were tested.  These studies have identified a no. of tricyclic COUMATEs with therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr73s_zthZf7Vg90H21EOLACvtfcHk0lh9AgjbA-9YRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit12mu7s%253D&md5=d76a00fad16ad81338377580a6c2ef5c</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2800%2900178-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252800%252900178-3%26sid%3Dliteratum%253Aachs%26aulast%3DMalini%26aufirst%3DB.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DGaneshapillai%26aufirst%3DD.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520steroid%2520sulphatase%2520activity%2520by%2520tricyclic%2520coumarin%2520sulphamates%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D75%26spage%3D253%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganeshapillai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Structure–activity relationship for the first-in-class clinical sulfatase inhibitor Irosustat (STX64, BN83495)</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2019</span><span class="NLM_x">–</span> <span class="NLM_lpage">2034</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=2019-2034&author=L.+W.+L.+Wooauthor=D.+Ganeshapillaiauthor=M.+P.+Thomasauthor=O.+B.+Sutcliffeauthor=B.+Maliniauthor=M.+F.+Mahonauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Structure%E2%80%93activity+relationship+for+the+first-in-class+clinical+sulfatase+inhibitor+Irosustat+%28STX64%2C+BN83495%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DGaneshapillai%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DMalini%26aufirst%3DB.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520for%2520the%2520first-in-class%2520clinical%2520sulfatase%2520inhibitor%2520Irosustat%2520%2528STX64%252C%2520BN83495%2529%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D2019%26epage%3D2034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Ireson, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1038%2Fsj.bjc.6602130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15328524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFCgtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2004&pages=1399-1404&author=C.+K.+Iresonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=D.+C.+Parishauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Pharmacokinetics+of+the+nonsteroidal+steroid+sulphatase+inhibitor+667+COUMATE+and+its+sequestration+into+red+blood+cells+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics of the nonsteroidal steroid sulphatase inhibitor 667 COUMATE and its sequestration into red blood cells in rats</span></div><div class="casAuthors">Ireson, C. R.; Chander, S. K.; Purohit, A.; Parish, D. C.; Woo, L. W. L.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1399-1404</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Breast cancer is a major cause of mortality in Western countries and there is an urgent requirement for novel treatment strategies.  The nonsteroidal sulphatase inhibitor 667 COUMATE inhibits hepatic steroid sulphatase and growth of oestrone sulfate stimulated tumors in the nitrosomethylurea-induced rat mammary model.  Other compds. that contain an aryl sulphamate moiety, for example, oestrone-3-O-sulphamate, are sequestered into red blood cells (RBCs).  The aims of this study were to det. the pharmacokinetics of 667 COUMATE and to investigate its sequestration into RBCs.  We administered a single p.o. or i.v. dose (10 mg kg-1) of 667 COUMATE to rats and used a high-performance liq. chromatog. method to measure the levels of the agent and its putative metabolites in plasma. 667 COUMATE had a bioavailability of 95% and could be detected in plasma for up to 8 h.  Using two independent anal. methods, we demonstrated that 667 COUMATE is sequestered by RBCs both ex vivo and in vivo.  Previous investigations have revealed that 667 COUMATE is rapidly degraded in plasma ex vivo.  In this study, we demonstrate that 667 COUMATE is stabilized due to its sequestration into RBCs.  In conclusion, the pharmacol. efficacy and high oral bioavailability of 667 COUMATE may be partly a consequence of the ability of RBCs to both protect the agent from metabolic degrdn. and facilitate its transport to tissues.  These data support the further clin. evaluation of this novel endocrine therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYSKz50yUSObVg90H21EOLACvtfcHk0lh3LjxusdmRmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFCgtb8%253D&md5=be39d3a5dd9bd2d00ed481d20070dcac</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602130%26sid%3Dliteratum%253Aachs%26aulast%3DIreson%26aufirst%3DC.%2BK.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DParish%26aufirst%3DD.%2BC.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DPharmacokinetics%2520of%2520the%2520nonsteroidal%2520steroid%2520sulphatase%2520inhibitor%2520667%2520COUMATE%2520and%2520its%2520sequestration%2520into%2520red%2520blood%2520cells%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2004%26volume%3D91%26spage%3D1399%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganeshapillai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2003&pages=909-914&author=Y.+T.+Hoauthor=A.+Purohitauthor=N.+Vickerauthor=S.+P.+Newmanauthor=J.+J.+Robinsonauthor=M.+P.+Leeseauthor=D.+Ganeshapillaiauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+carbonic+anhydrase+II+by+steroidal+and+non-steroidal+sulphamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DVicker%26aufirst%3DN.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DRobinson%26aufirst%3DJ.%2BJ.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DGaneshapillai%26aufirst%3DD.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520carbonic%2520anhydrase%2520II%2520by%2520steroidal%2520and%2520non-steroidal%2520sulphamates%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D305%26spage%3D909%26epage%3D914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Abbate, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winum, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montero, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=231-234&author=F.+Abbateauthor=J.-Y.+Winumauthor=B.+V.+L.+Potterauthor=A.+Casiniauthor=J.-L.+Monteroauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Carbonic+anhydrase+inhibitors%3A+X-ray+crystallographic+structure+of+the+adduct+of+human+isozyme+II+with+EMATE%2C+a+dual+inhibitor+of+carbonic+anhydrases+and+steroid+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbbate%26aufirst%3DF.%26aulast%3DWinum%26aufirst%3DJ.-Y.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DCasini%26aufirst%3DA.%26aulast%3DMontero%26aufirst%3DJ.-L.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DCarbonic%2520anhydrase%2520inhibitors%253A%2520X-ray%2520crystallographic%2520structure%2520of%2520the%2520adduct%2520of%2520human%2520isozyme%2520II%2520with%2520EMATE%252C%2520a%2520dual%2520inhibitor%2520of%2520carbonic%2520anhydrases%2520and%2520steroid%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D231%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Lloyd, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiyagarajan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">6858</span><span class="NLM_x">–</span> <span class="NLM_lpage">6866</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi047692e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=6858-6866&author=M.+D.+Lloydauthor=N.+Thiyagarajanauthor=Y.+T.+Hoauthor=L.+W.+L.+Wooauthor=O.+B.+Sutcliffeauthor=A.+Purohitauthor=M.+J.+Reedauthor=K.+R.+Acharyaauthor=B.+V.+L.+Potter&title=First+crystal+structures+of+human+carbonic+anhydrase+II+in+complex+with+dual+aromatase-steroid+sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fbi047692e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi047692e%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThiyagarajan%26aufirst%3DN.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DFirst%2520crystal%2520structures%2520of%2520human%2520carbonic%2520anhydrase%2520II%2520in%2520complex%2520with%2520dual%2520aromatase-steroid%2520sulfatase%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2005%26volume%3D44%26spage%3D6858%26epage%3D6866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Muzykantov, V. R.</span><span> </span><span class="NLM_article-title">Drug delivery by red blood cells: vascular carriers designed by mother nature</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1517%2F17425241003610633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=20192900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVehsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=403-427&author=V.+R.+Muzykantov&title=Drug+delivery+by+red+blood+cells%3A+vascular+carriers+designed+by+mother+nature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Drug delivery by red blood cells: vascular carriers designed by mother nature</span></div><div class="casAuthors">Muzykantov, Vladimir R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Delivery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-427</span>CODEN:
                <span class="NLM_cas:coden">EODDAW</span>;
        ISSN:<span class="NLM_cas:issn">1742-5247</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Vascular delivery of several classes of therapeutic agents may benefit from carriage by red blood cells (RBC), for example, drugs that require delivery into phagocytic cells and those that must act within the vascular lumen.  The fact that several protocols of infusion of RBC-encapsulated drugs are now being explored in patients illustrates a high biomedical importance for the field.  Areas covered by this review: Two strategies for RBC drug delivery are discussed: encapsulation into isolated RBC ex vivo followed by infusion in compatible recipients and coupling therapeutics to the surface of RBC.  Studies of pharmacokinetics and effects in animal models and in human studies of diverse therapeutic enzymes, antibiotics and other drugs encapsulated in RBC are described and critically analyzed.  Coupling to RBC surface of compds. regulating immune response and complement, affinity ligands, polyethylene glycol alleviating immune response to donor RBC and fibrinolytic plasminogen activators are described.  Also described is a new, translation-prone approach for RBC drug delivery by injection of therapeutics conjugated with fragments of antibodies providing safe anchoring of cargoes to circulating RBC, without need for ex vivo modification and infusion of RBC.  What the reader will gain: Readers will gain historical perspective, current status, challenges and perspectives of medical applications of RBC for drug delivery.  Take home message: RBC represent naturally designed carriers for intravascular drug delivery, characterized by unique longevity in the bloodstream, biocompatibility and safe physiol. mechanisms for metab.  New approaches for encapsulating drugs into RBC and coupling to RBC surface provide promising avenues for safe and widely useful improvement of drug delivery in the vascular system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAV15O4Yn0XLVg90H21EOLACvtfcHk0ljx4PbBkKG0kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVehsbk%253D&md5=633c3c5ab2949f6b4e271e6ae51b8d89</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1517%2F17425241003610633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425241003610633%26sid%3Dliteratum%253Aachs%26aulast%3DMuzykantov%26aufirst%3DV.%2BR.%26atitle%3DDrug%2520delivery%2520by%2520red%2520blood%2520cells%253A%2520vascular%2520carriers%2520designed%2520by%2520mother%2520nature%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2010%26volume%3D7%26spage%3D403%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Magnani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, L.</span><span> </span><span class="NLM_article-title">Approaches to erythrocyte-mediated drug delivery</span> <span class="citation_source-journal">Expert Opin. Drug Delivery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">687</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=677-687&author=M.+Magnaniauthor=L.+Rossi&title=Approaches+to+erythrocyte-mediated+drug+delivery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMagnani%26aufirst%3DM.%26aulast%3DRossi%26aufirst%3DL.%26atitle%3DApproaches%2520to%2520erythrocyte-mediated%2520drug%2520delivery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2014%26volume%3D11%26spage%3D677%26epage%3D687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Hernandez-Guzman, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangborn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Structure of human estrone sulfatase suggests functional roles of membrane association</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">22989</span><span class="NLM_x">–</span> <span class="NLM_lpage">22997</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1074%2Fjbc.M211497200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=12657638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksF2iu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=22989-22997&author=F.+G.+Hernandez-Guzmanauthor=T.+Higashiyamaauthor=W.+Pangbornauthor=Y.+Osawaauthor=D.+Ghosh&title=Structure+of+human+estrone+sulfatase+suggests+functional+roles+of+membrane+association"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of Human Estrone Sulfatase Suggests Functional Roles of Membrane Association</span></div><div class="casAuthors">Hernandez-Guzman, Francisco G.; Higashiyama, Tadayoshi; Pangborn, Walter; Osawa, Yoshio; Ghosh, Debashis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">22989-22997</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Estrone sulfatase (ES; 562 amino acids), one of the key enzymes responsible for maintaining high levels of estrogens in breast tumor cells, is assocd. with the membrane of the endoplasmic reticulum (ER).  The structure of ES, purified from the microsomal fraction of human placentas, has been detd. at 2.60-Å resoln. by x-ray crystallog.  This structure shows a domain consisting of two antiparallel α-helixes that protrude from the roughly spherical mol., thereby giving the mol. a "mushroom-like" shape.  These highly hydrophobic helixes, each about 40 Å long, are capable of traversing the membrane, thus presumably anchoring the functional domain on the membrane surface facing the ER lumen.  The location of the transmembrane domain is such that the opening to the active site, buried deep in a cavity of the "gill" of the "mushroom," rests near the membrane surface, thereby suggesting a role of the lipid bilayer in catalysis.  This simple architecture could be a prototype utilized by the ER membrane in dictating the form and the function of ER-resident enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVqhs1xfxlQLVg90H21EOLACvtfcHk0ljx4PbBkKG0kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksF2iu7s%253D&md5=b4b56bf8e881dce78adc36bdf0f15e40</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M211497200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M211497200%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Guzman%26aufirst%3DF.%2BG.%26aulast%3DHigashiyama%26aufirst%3DT.%26aulast%3DPangborn%26aufirst%3DW.%26aulast%3DOsawa%26aufirst%3DY.%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DStructure%2520of%2520human%2520estrone%2520sulfatase%2520suggests%2520functional%2520roles%2520of%2520membrane%2520association%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D22989%26epage%3D22997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Ghosh, D.</span><span> </span><span class="NLM_article-title">Human sulfatases: a structural perspective to catalysis</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">2013</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs00018-007-7175-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=17558559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFKhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2007&pages=2013-2022&author=D.+Ghosh&title=Human+sulfatases%3A+a+structural+perspective+to+catalysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Human sulfatases: A structural perspective to catalysis</span></div><div class="casAuthors">Ghosh, D.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2013-2022</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  The sulfatase family of enzymes catalyzes hydrolysis of sulfate ester bonds of a wide variety of substrates.  Seventeen genes have been identified in this class of sulfatases, many of which are assocd. with genetic disorders leading to redn. or loss of function of the corresponding enzymes.  Amino acid sequence homol. suggests that the enzymes have similar overall folds, mechanisms of action, and divalent metal ion-binding sites.  A catalytic Cys residue, strictly conserved in prokaryotic and eukaryotic sulfatases, is post-translationally modified into formylglycine.  Hydroxylation of the formylglycine residue by a water mol. forming the activated hydroxylformylglycine (a formylglycine hydrate or a gem-diol) is a necessary step for the enzyme's sulfatase activity.  Crystal structures of 3 human sulfatases, arylsulfatases A and B (ARSA and ARSB, resp.), and estrone/dehydroepiandrosterone sulfatase or steroid sulfatase (STS), also known as arylsulfatase C, have been detd.  Whereas ARSA and ARSB are water-sol. enzymes, STS has a hydrophobic domain and is an integral membrane protein of the endoplasmic reticulum.  Here, the author compares and contrasts sulfatase structures and revisits the proposed catalytic mechanism in light of available structural and functional data.  Examn. of the STS active site reveals substrate-specific interactions previously identified as the estrogen-recognition motif.  Because of the proximity of the catalytic cleft of STS to the membrane surface, the lipid bilayer has a crit. role in the constitution of the active site, unlike other sulfatases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHkDns4I6I2rVg90H21EOLACvtfcHk0ljx4PbBkKG0kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFKhtLw%253D&md5=3b168470ad0870dc2753ca05bb99a385</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1007%2Fs00018-007-7175-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-007-7175-y%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26atitle%3DHuman%2520sulfatases%253A%2520a%2520structural%2520perspective%2520to%2520catalysis%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2007%26volume%3D64%26spage%3D2013%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Williams, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denehy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenske, E. H.</span><span> </span><span class="NLM_article-title">Experimental and theoretical insights into the mechanisms of sulfate and sulfamate ester hydrolysis and the end products of type I sulfatase inactivation by aryl sulfamates</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1995</span><span class="NLM_x">–</span> <span class="NLM_lpage">2005</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo4026513" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXivVaqsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2014&pages=1995-2005&author=S.+J.+Williamsauthor=E.+Denehyauthor=E.+H.+Krenske&title=Experimental+and+theoretical+insights+into+the+mechanisms+of+sulfate+and+sulfamate+ester+hydrolysis+and+the+end+products+of+type+I+sulfatase+inactivation+by+aryl+sulfamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and Theoretical Insights into the Mechanisms of Sulfate and Sulfamate Ester Hydrolysis and the End Products of Type I Sulfatase Inactivation by Aryl Sulfamates</span></div><div class="casAuthors">Williams, Spencer J.; Denehy, Emma; Krenske, Elizabeth H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1995-2005</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Type I sulfatases catalyze the hydrolysis of sulfate esters through S-O bond cleavage and possess a catalytically essential formylglycine (FGly) active-site residue that is post-translationally derived from either cysteine or serine.  Type I sulfatases are inactivated by aryl sulfamates in a time-dependent, irreversible, and active-site directed manner consistent with covalent modification of the active site.  We report a theor. (SCS-MP2//B3LYP) and exptl. study of the uncatalyzed and enzyme-catalyzed hydrolysis of aryl sulfates and sulfamates.  In soln., aryl sulfate monoanions undergo hydrolysis by an SN2 mechanism whereas aryl sulfamate monoanions follow an SN1 pathway with SO2NH as an intermediate; theory traces this difference to the markedly greater stability of SO2NH vs. SO3.  For Pseudomonas aeruginosa arylsulfatase-catalyzed aryl sulfate hydrolysis, Bronsted anal. (log(Vmax/KM) vs. leaving group pKa value) reveals βLG = -0.86 ± 0.23, consistent with an SN2 at sulfur reaction but substantially smaller than that reported for uncatalyzed hydrolysis (βLG = -1.81).  Common to all proposed mechanisms of sulfatase catalysis is a sulfated FGly intermediate.  Theory indicates a ≥26 kcal/mol preference for the intermediate to release HSO4- by an E2 mechanism, rather than alk. phosphatase-like SN2 substitution by water.  An evaluation of the stabilities of various proposed end-products of sulfamate-induced sulfatase inactivation highlights that an imine N-sulfate derived from FGly is the most likely irreversible adduct.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBv-V2eelI47Vg90H21EOLACvtfcHk0lgAgVqyKnAhrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXivVaqsrk%253D&md5=79e14584585f54b5a6f656e67506cf14</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjo4026513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo4026513%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BJ.%26aulast%3DDenehy%26aufirst%3DE.%26aulast%3DKrenske%26aufirst%3DE.%2BH.%26atitle%3DExperimental%2520and%2520theoretical%2520insights%2520into%2520the%2520mechanisms%2520of%2520sulfate%2520and%2520sulfamate%2520ester%2520hydrolysis%2520and%2520the%2520end%2520products%2520of%2520type%2520I%2520sulfatase%2520inactivation%2520by%2520aryl%2520sulfamates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2014%26volume%3D79%26spage%3D1995%26epage%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Stanway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sufi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigushin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanczyk, F. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobbs, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulinskaya, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Phase 1 study of STX64 (667 Coumate) in breast cancer patients: the first study of a sulfatase inhibitor</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1585</span><span class="NLM_x">–</span> <span class="NLM_lpage">1592</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1158%2F1078-0432.CCR-05-1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=16533785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVGmsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1585-1592&author=S.+J.+Stanwayauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=S.+Sufiauthor=D.+Vigushinauthor=R.+Wardauthor=R.+H.+Wilsonauthor=F.+Z.+Stanczykauthor=N.+Dobbsauthor=E.+Kulinskayaauthor=M.+Elliottauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=R.+C.+Coombes&title=Phase+1+study+of+STX64+%28667+Coumate%29+in+breast+cancer+patients%3A+the+first+study+of+a+sulfatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Study of STX 64 (667 Coumate) in Breast Cancer Patients: the First Study of a Steroid Sulfatase Inhibitor</span></div><div class="casAuthors">Stanway, Susannah J.; Purohit, Atul; Woo, L. W. Lawrence; Sufi, Saulat; Vigushin, David; Ward, Rebecca; Wilson, Richard H.; Stanczyk, Frank Z.; Dobbs, Nicola; Kulinskaya, Elena; Elliott, Moira; Potter, Barry V. L.; Reed, Michael J.; Coombes, R. Charles</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1585-1592</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Inhibition of steroid sulfatase (STS), the enzyme responsible for the hydrolysis of steroid sulfates, represents a potential novel treatment for postmenopausal women with hormone-dependent breast cancer.  Estrone and DHEA are formed by this sulfatase pathway and can be converted to steroids (estradiol and androstenediol, resp.), which have potent estrogenic properties.  Exptl. Design: STX64 (667 Coumate), a tricylic coumarin-based sulfamate that irreversibly inhibits STS activity, was selected for entry into the first phase I trial of a STS inhibitor in postmenopausal women with breast cancer.  STX64 was administered orally (nine patients at 5 mg and five patients at 20 mg) as an initial dose followed 1 wk later by 3 x 2 weekly cycles, with each cycle comprising daily dosing for 5 days followed by 9 days off treatment.  Blood and tumor tissue samples were collected for the assessment of STS activity and serum was obtained for steroid hormone measurements before and after treatment.  Results: The median inhibition of STS activity by STX64 was 98% in peripheral blood lymphocytes (PBL) and 99% in breast tumor tissue at the end of the 5-day dosing period.  As expected, serum concns. of estrone, estradiol, androstenediol, and DHEA all decreased significantly from pretreatment levels.  Unexpectedly, androstenedione and testosterone concns. also decreased.  Four patients, all of whom had previously progressed on aromatase inhibitors, showed evidence of stable disease for 2.75 to 7 mo.  The drug was well tolerated with only minor drug-related adverse events recorded.  Conclusion: STX64 is a potent, well-tolerated STS inhibitor.  It inhibits STS activity in PBLs and tumor tissues and causes significant decreases in serum concns. of steroids with estrogenic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvfOgizqc5GLVg90H21EOLACvtfcHk0lgAgVqyKnAhrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVGmsL0%253D&md5=91b2349eac6d0b3f27073e7b894b7b6d</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-1996%26sid%3Dliteratum%253Aachs%26aulast%3DStanway%26aufirst%3DS.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSufi%26aufirst%3DS.%26aulast%3DVigushin%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DR.%26aulast%3DWilson%26aufirst%3DR.%2BH.%26aulast%3DStanczyk%26aufirst%3DF.%2BZ.%26aulast%3DDobbs%26aufirst%3DN.%26aulast%3DKulinskaya%26aufirst%3DE.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DPhase%25201%2520study%2520of%2520STX64%2520%2528667%2520Coumate%2529%2520in%2520breast%2520cancer%2520patients%253A%2520the%2520first%2520study%2520of%2520a%2520sulfatase%2520inhibitor%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D1585%26epage%3D1592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Stanway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delavault, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurieau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Steroid sulfatase: a new target for the endocrine therapy of breast cancer</span> <span class="citation_source-journal">Oncologist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=370-374&author=S.+J.+Stanwayauthor=P.+Delavaultauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=C.+Thurieauauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Steroid+sulfatase%3A+a+new+target+for+the+endocrine+therapy+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStanway%26aufirst%3DS.%2BJ.%26aulast%3DDelavault%26aufirst%3DP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DThurieau%26aufirst%3DC.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DSteroid%2520sulfatase%253A%2520a%2520new%2520target%2520for%2520the%2520endocrine%2520therapy%2520of%2520breast%2520cancer%26jtitle%3DOncologist%26date%3D2007%26volume%3D12%26spage%3D370%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Coombes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soulié, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardoso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besse-Hammer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesimple, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slosman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fohanno, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fumoleau, P.</span><span> </span><span class="NLM_article-title">A phase I dose escalation study of sulfatase inhibitor BN83495/STX64 in postmenopausal women with ER positive breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">24 Suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">4097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=4097&issue=24+Suppl&author=R.+Coombesauthor=P.+Schmidauthor=N.+Isambertauthor=P.+Souli%C3%A9author=F.+Cardosoauthor=T.+Besse-Hammerauthor=T.+Lesimpleauthor=D.+Slosmanauthor=A.+Kornowskiauthor=V.+Fohannoauthor=P.+Fumoleau&title=A+phase+I+dose+escalation+study+of+sulfatase+inhibitor+BN83495%2FSTX64+in+postmenopausal+women+with+ER+positive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoombes%26aufirst%3DR.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DSouli%25C3%25A9%26aufirst%3DP.%26aulast%3DCardoso%26aufirst%3DF.%26aulast%3DBesse-Hammer%26aufirst%3DT.%26aulast%3DLesimple%26aufirst%3DT.%26aulast%3DSlosman%26aufirst%3DD.%26aulast%3DKornowski%26aufirst%3DA.%26aulast%3DFohanno%26aufirst%3DV.%26aulast%3DFumoleau%26aufirst%3DP.%26atitle%3DA%2520phase%2520I%2520dose%2520escalation%2520study%2520of%2520sulfatase%2520inhibitor%2520BN83495%252FSTX64%2520in%2520postmenopausal%2520women%2520with%2520ER%2520positive%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26issue%3D24%2520Suppl%26spage%3D4097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Coombes, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardoso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isambert, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesimple, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soulié, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peraire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fohanno, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, P.</span><span> </span><span class="NLM_article-title">A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-013-2597-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFaju7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2013&pages=73-82&author=R.+C.+Coombesauthor=F.+Cardosoauthor=N.+Isambertauthor=T.+Lesimpleauthor=P.+Souli%C3%A9author=C.+Peraireauthor=V.+Fohannoauthor=A.+Kornowskiauthor=T.+Aliauthor=P.+Schmid&title=A+phase+I+dose+escalation+study+to+determine+the+optimal+biological+dose+of+irosustat%2C+an+oral+sulfatase+inhibitor%2C+in+postmenopausal+women+with+estrogen+receptor-positive+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer</span></div><div class="casAuthors">Coombes, R. Charles; Cardoso, Fatima; Isambert, Nicolas; Lesimple, Thierry; Soulie, Patrick; Peraire, Concepcion; Fohanno, Veronique; Kornowski, Anne; Ali, Tauhid; Schmid, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-82</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Steroid sulfatase (STS) inhibition may have a therapeutic role in suppression of endocrine-responsive breast cancer.  This study aimed to det. the optimal biol. dose and recommended dose (RD) of the STS inhibitor irosustat.  A three-part, open-label, multicenter, dose escalation study of irosustat in estrogen receptor-pos. breast cancer patients involved administration of a single dose of irosustat with a 7-day observation period; followed by a daily oral dose of irosustat for 28 days; and an extension phase, in which the daily oral dose of irosustat was continued at the discretion of the investigator and as long as the patient was benefitting from the treatment.  Five doses of irosustat were tested (1, 5, 20, 40, and 80 mg) in 50 patients.  After 28 days of daily administration of irosustat, all the evaluated patients in the 5, 20, 40, and 80 mg cohorts achieved ≥95 % STS inhibition in peripheral blood mononuclear cells and corresponding endocrine suppression.  The max. tolerated dose was not reached, and the 40 mg dose was established as the RD.  The median time to disease progression in the 40 mg cohort was 11.2 wk.  Disease stabilization was achieved in 10 % of patients potentially indicative of drug activity.  Dry skin was the most frequent adverse event.  The RD of irosustat is 40 mg.  Disease stabilization occurred in 10 % of this heavily pretreated patient population.  A larger study is required to define an accurate response rate to irosustat as a single agent and whether co-administration with an aromatase inhibitor is needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplaN4ktLK9tLVg90H21EOLACvtfcHk0lj2V1SIYBwM_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFaju7bM&md5=4b6801e630587f1cbbe1767330602781</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1007%2Fs10549-013-2597-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-013-2597-8%26sid%3Dliteratum%253Aachs%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26aulast%3DCardoso%26aufirst%3DF.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DLesimple%26aufirst%3DT.%26aulast%3DSouli%25C3%25A9%26aufirst%3DP.%26aulast%3DPeraire%26aufirst%3DC.%26aulast%3DFohanno%26aufirst%3DV.%26aulast%3DKornowski%26aufirst%3DA.%26aulast%3DAli%26aufirst%3DT.%26aulast%3DSchmid%26aufirst%3DP.%26atitle%3DA%2520phase%2520I%2520dose%2520escalation%2520study%2520to%2520determine%2520the%2520optimal%2520biological%2520dose%2520of%2520irosustat%252C%2520an%2520oral%2520sulfatase%2520inhibitor%252C%2520in%2520postmenopausal%2520women%2520with%2520estrogen%2520receptor-positive%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2013%26volume%3D140%26spage%3D73%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Parra-Guillen, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendrós Carreras, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peraire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prunynosa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chetaille, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trocóniz, I. F.</span><span> </span><span class="NLM_article-title">Population pharmacokinetic modelling of Irosustat in postmenopausal women with oestrogen-receptor positive breast cancer incorporating non-linear red blood cell uptake</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=1493-1504&author=Z.+P.+Parra-Guillenauthor=J.+P.+Cendr%C3%B3s+Carrerasauthor=C.+Peraireauthor=R.+Obachauthor=J.+Prunynosaauthor=E.+Chetailleauthor=I.+F.+Troc%C3%B3niz&title=Population+pharmacokinetic+modelling+of+Irosustat+in+postmenopausal+women+with+oestrogen-receptor+positive+breast+cancer+incorporating+non-linear+red+blood+cell+uptake"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParra-Guillen%26aufirst%3DZ.%2BP.%26aulast%3DCendr%25C3%25B3s%2BCarreras%26aufirst%3DJ.%2BP.%26aulast%3DPeraire%26aufirst%3DC.%26aulast%3DObach%26aufirst%3DR.%26aulast%3DPrunynosa%26aufirst%3DJ.%26aulast%3DChetaille%26aufirst%3DE.%26aulast%3DTroc%25C3%25B3niz%26aufirst%3DI.%2BF.%26atitle%3DPopulation%2520pharmacokinetic%2520modelling%2520of%2520Irosustat%2520in%2520postmenopausal%2520women%2520with%2520oestrogen-receptor%2520positive%2520breast%2520cancer%2520incorporating%2520non-linear%2520red%2520blood%2520cell%2520uptake%26jtitle%3DPharm.%2520Res.%26date%3D2015%26volume%3D32%26spage%3D1493%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Palmieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Januszewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombes, R. C.</span><span> </span><span class="NLM_article-title">Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1586%2Fera.10.201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=21342037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=179-183&author=C.+Palmieriauthor=A.+Januszewskiauthor=S.+Stanwayauthor=R.+C.+Coombes&title=Irosustat%3A+a+first-generation+steroid+sulfatase+inhibitor+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Irosustat: a first-generation steroid sulfatase inhibitor in breast cancer</span></div><div class="casAuthors">Palmieri, Carlo; Januszewski, Adam; Stanway, Susie; Coombes, R. Charles</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-183</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Endocrine therapy is a key modality in the management of breast cancer, with current options for postmenopausal women including tamoxifen, aromatase inhibitors and fulvestrant.  Unfortunately, in spite of these advances, many women still relapse or progress on endocrine therapy.  Given that resistance (de novo or acquired resistance) is a major limiting factor in the use of endocrine therapy, addnl. endocrine therapies with novel methods of action are required.  Steroid sulfatase, which is responsible for the conversion of estrone sulfate to estrone, as well as dehydroepiandrosterone sulfate to dehydroepiandrosterone, has been implicated in endocrine resistance.  In this article, we summarize the preclin. and clin. data to support the potential role of steroid sulfatase in breast cancer, as well as the current data on the first available steroid sulfatase inhibitor named irosustat (STX64; 667 Coumate; BN83495), and discuss its potential clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYCPF6U304B7Vg90H21EOLACvtfcHk0lj2V1SIYBwM_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWmsbo%253D&md5=3b2a6700bcc25c57653431b7b65720a1</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1586%2Fera.10.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.10.201%26sid%3Dliteratum%253Aachs%26aulast%3DPalmieri%26aufirst%3DC.%26aulast%3DJanuszewski%26aufirst%3DA.%26aulast%3DStanway%26aufirst%3DS.%26aulast%3DCoombes%26aufirst%3DR.%2BC.%26atitle%3DIrosustat%253A%2520a%2520first-generation%2520steroid%2520sulfatase%2520inhibitor%2520in%2520breast%2520cancer%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2011%26volume%3D11%26spage%3D179%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Pautier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joly Lobbedez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melichar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutarska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, N.</span><span> </span><span class="NLM_article-title">A phase II multicenter randomized open-label study of oral sulfatase (sulfatase) inhibitor Irosustat (BN83495) versus megestrol acetate (MA) in women with advanced/recurrent endometrial cancer (EC)</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 9</span><span class="NLM_x">) </span> <span class="NLM_fpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=329&issue=Suppl+9&author=P.+Pautierauthor=F.+Joly+Lobbedezauthor=B.+Melicharauthor=E.+Kutarskaauthor=G.+Hallauthor=N.+Reed&title=A+phase+II+multicenter+randomized+open-label+study+of+oral+sulfatase+%28sulfatase%29+inhibitor+Irosustat+%28BN83495%29+versus+megestrol+acetate+%28MA%29+in+women+with+advanced%2Frecurrent+endometrial+cancer+%28EC%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPautier%26aufirst%3DP.%26aulast%3DJoly%2BLobbedez%26aufirst%3DF.%26aulast%3DMelichar%26aufirst%3DB.%26aulast%3DKutarska%26aufirst%3DE.%26aulast%3DHall%26aufirst%3DG.%26aulast%3DReed%26aufirst%3DN.%26atitle%3DA%2520phase%2520II%2520multicenter%2520randomized%2520open-label%2520study%2520of%2520oral%2520sulfatase%2520%2528sulfatase%2529%2520inhibitor%2520Irosustat%2520%2528BN83495%2529%2520versus%2520megestrol%2520acetate%2520%2528MA%2529%2520in%2520women%2520with%2520advanced%252Frecurrent%2520endometrial%2520cancer%2520%2528EC%2529%26jtitle%3DAnn.%2520Oncol.%26date%3D2012%26volume%3D23%26issue%3DSuppl%25209%26spage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutill, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1155</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1155&publication_year=2009&pages=80-87&author=J.+M.+Dayauthor=A.+Purohitauthor=H.+J.+Tutillauthor=P.+A.+Fosterauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+development+of+steroid+sulfatase+inhibitors+for+hormone-dependent+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DTutill%26aufirst%3DH.%2BJ.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520development%2520of%2520steroid%2520sulfatase%2520inhibitors%2520for%2520hormone-dependent%2520cancer%2520therapy%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2009%26volume%3D1155%26spage%3D80%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Arakawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagihara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizokami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namiki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, I.</span><span> </span><span class="NLM_article-title">Enhanced expression of organic anion transporting polypeptides (OATPs) in androgen receptor-positive prostate cancer cells: possible role of OATP1A2 in adaptive cell growth under androgen-depleted conditions</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">1070</span><span class="NLM_x">–</span> <span class="NLM_lpage">1077</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=1070-1077&author=H.+Arakawaauthor=T.+Nakanishiauthor=C.+Yanagiharaauthor=T.+Nishimotoauthor=T.+Wakayamaauthor=A.+Mizokamiauthor=M.+Namikiauthor=K.+Kawaiauthor=I.+Tamai&title=Enhanced+expression+of+organic+anion+transporting+polypeptides+%28OATPs%29+in+androgen+receptor-positive+prostate+cancer+cells%3A+possible+role+of+OATP1A2+in+adaptive+cell+growth+under+androgen-depleted+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArakawa%26aufirst%3DH.%26aulast%3DNakanishi%26aufirst%3DT.%26aulast%3DYanagihara%26aufirst%3DC.%26aulast%3DNishimoto%26aufirst%3DT.%26aulast%3DWakayama%26aufirst%3DT.%26aulast%3DMizokami%26aufirst%3DA.%26aulast%3DNamiki%26aufirst%3DM.%26aulast%3DKawai%26aufirst%3DK.%26aulast%3DTamai%26aufirst%3DI.%26atitle%3DEnhanced%2520expression%2520of%2520organic%2520anion%2520transporting%2520polypeptides%2520%2528OATPs%2529%2520in%2520androgen%2520receptor-positive%2520prostate%2520cancer%2520cells%253A%2520possible%2520role%2520of%2520OATP1A2%2520in%2520adaptive%2520cell%2520growth%2520under%2520androgen-depleted%2520conditions%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26spage%3D1070%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Denmeade, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peraire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geniaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baton, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chetaille, E.</span><span> </span><span class="NLM_article-title">A phase I pharmacodynamics dose escalation study of steroid sulphatase inhibitor Irosustat in patients with prostate cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">S499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=S499&author=S.+Denmeadeauthor=D.+Georgeauthor=G.+Liuauthor=C.+Peraireauthor=A.+Geniauxauthor=F.+Batonauthor=T.+Aliauthor=E.+Chetaille&title=A+phase+I+pharmacodynamics+dose+escalation+study+of+steroid+sulphatase+inhibitor+Irosustat+in+patients+with+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDenmeade%26aufirst%3DS.%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DPeraire%26aufirst%3DC.%26aulast%3DGeniaux%26aufirst%3DA.%26aulast%3DBaton%26aufirst%3DF.%26aulast%3DAli%26aufirst%3DT.%26aulast%3DChetaille%26aufirst%3DE.%26atitle%3DA%2520phase%2520I%2520pharmacodynamics%2520dose%2520escalation%2520study%2520of%2520steroid%2520sulphatase%2520inhibitor%2520Irosustat%2520in%2520patients%2520with%2520prostate%2520cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2011%26volume%3D47%26spage%3DS499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span> </span><span class="NLM_article-title">A study looking at irosustat for early breast cancer (IPET)</span>; <span class="NLM_publisher-name">Cancer Research UK</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span><a href="http://www.cancerresearchuk.org/about-cancer/trials/a-study-looking-irosustat-early-breast-cancer" class="extLink">http://www.cancerresearchuk.org/about-cancer/trials/a-study-looking-irosustat-early-breast-cancer</a> (accessed May 13, 2015.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+study+looking+at+irosustat+for+early+breast+cancer+%28IPET%29%3B+Cancer+Research+UK%3A+London%2C+2014%3B+http%3A%2F%2Fwww.cancerresearchuk.org%2Fabout-cancer%2Ftrials%2Fa-study-looking-irosustat-early-breast-cancer+%28accessed+May+13%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520study%2520looking%2520at%2520irosustat%2520for%2520early%2520breast%2520cancer%2520%2528IPET%2529%26pub%3DCancer%2520Research%2520UK%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span> </span><span class="NLM_article-title">A Phase II study to assess the safety and efficacy of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER positive locally advanced or metastatic breast cancer patients</span>; <span class="NLM_publisher-name">UK Clinical Research Network</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span><a href="http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=12479" class="extLink">http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=12479</a> (accessed May 13, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Phase+II+study+to+assess+the+safety+and+efficacy+of+the+steroid+sulfatase+inhibitor+Irosustat+when+added+to+an+aromatase+inhibitor+in+ER+positive+locally+advanced+or+metastatic+breast+cancer+patients%3B+UK+Clinical+Research+Network%3A+London%2C+2014%3B+http%3A%2F%2Fpublic.ukcrn.org.uk%2FSearch%2FStudyDetail.aspx%3FStudyID%3D12479+%28accessed+May+13%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Phase%2520II%2520study%2520to%2520assess%2520the%2520safety%2520and%2520efficacy%2520of%2520the%2520steroid%2520sulfatase%2520inhibitor%2520Irosustat%2520when%2520added%2520to%2520an%2520aromatase%2520inhibitor%2520in%2520ER%2520positive%2520locally%2520advanced%2520or%2520metastatic%2520breast%2520cancer%2520patients%26pub%3DUK%2520Clinical%2520Research%2520Network%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span> </span><span class="NLM_article-title">A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth (IPET)</span>. ClinicalTrials.gov; <span class="NLM_publisher-name">U.S. National Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span><a href="http://clinicaltrials.gov/show/NCT01662726" class="extLink">http://clinicaltrials.gov/show/NCT01662726</a> (accessed May 13, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=A+Study+to+Assess+the+Ability+of+a+Novel+Endocrine+Treatment+for+Breast+Cancer%2C+Irosustat%2C+to+Slow+Down+Cancer+Growth+%28IPET%29.+ClinicalTrials.gov%3B+U.S.+National+Institutes+of+Health%3A+Bethesda%2C+MD%2C+2014%3B+http%3A%2F%2Fclinicaltrials.gov%2Fshow%2FNCT01662726+%28accessed+May+13%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Study%2520to%2520Assess%2520the%2520Ability%2520of%2520a%2520Novel%2520Endocrine%2520Treatment%2520for%2520Breast%2520Cancer%252C%2520Irosustat%252C%2520to%2520Slow%2520Down%2520Cancer%2520Growth%2520%2528IPET%2529%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%2520Institutes%2520of%2520Health%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brosens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy</span> <span class="citation_source-journal">Hum. Reprod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1093%2Fhumrep%2Fdem308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18056119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlCktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=290-297&author=A.+Purohitauthor=L.+Fusiauthor=J.+Brosensauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+steroid+sulphatase+activity+in+endometriotic+implants+by+667+COUMATE%3A+a+potential+new+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy</span></div><div class="casAuthors">Purohit, A.; Fusi, L.; Brosens, J.; Woo, L. W. L.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Human Reproduction</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">290-297</span>CODEN:
                <span class="NLM_cas:coden">HUREEE</span>;
        ISSN:<span class="NLM_cas:issn">0268-1161</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Local biosynthesis of estrogens is thought to be important for the maintenance and growth of endometriotic implants.  In addn. to the formation of estrogen via the aromatase pathway, steroid sulfatase (STS), which is responsible for the hydrolysis of estrogen sulfates, may be an important source of estrogens in endometriosis.  Eutopic and ectopic endometrial samples from 14 women with minimal or mild (MM) endometriosis and from 13 women with moderate to severe (MS) endometriosis were analyzed for aromatase and STS activities.  Aromatase and STS activity were detected in all samples.  STS enzyme activity in both eutopic and ectopic endometrium was considerably higher and less variable than aromatase activity.  Moreover, STS, but not aromatase, activity in endometriotic implants correlated with the severity of the disease (mean ± SEM: 203 ± 38 nmol/4 h/g wet wt. tissue in MM disease vs. 423 ± 44 nmol/4 h/g wet wt. tissue in MS endometriosis, P < 0.001).  The STS inhibitor 667 COUMATE almost completely blocked STS activity (>99%) in both eutopic and ectopic tissues.  The high levels of STS activity detected in ectopic endometrium and the correlation with severity of disease suggest that STS inhibitors could be useful for the treatment of endometriosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplM0Dp3IYesrVg90H21EOLACvtfcHk0ljY59aacG3DAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlCktw%253D%253D&md5=fd05b2ab67086d147ba78aa5712ebc93</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1093%2Fhumrep%2Fdem308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhumrep%252Fdem308%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DFusi%26aufirst%3DL.%26aulast%3DBrosens%26aufirst%3DJ.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520steroid%2520sulphatase%2520activity%2520in%2520endometriotic%2520implants%2520by%2520667%2520COUMATE%253A%2520a%2520potential%2520new%2520therapy%26jtitle%3DHum.%2520Reprod.%26date%3D2008%26volume%3D23%26spage%3D290%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Fusi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brosens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of sulfatase activity in endometriotic implants by STX64 (667Coumate): a potential new therapy</span> <span class="citation_source-journal">Sci. World J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1325</span><span class="NLM_x">–</span> <span class="NLM_lpage">1327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1100%2Ftsw.2008.164" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1325-1327&author=L.+Fusiauthor=A.+Purohitauthor=J.+Brosensauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+sulfatase+activity+in+endometriotic+implants+by+STX64+%28667Coumate%29%3A+a+potential+new+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1100%2Ftsw.2008.164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1100%252Ftsw.2008.164%26sid%3Dliteratum%253Aachs%26aulast%3DFusi%26aufirst%3DL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DBrosens%26aufirst%3DJ.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520sulfatase%2520activity%2520in%2520endometriotic%2520implants%2520by%2520STX64%2520%2528667Coumate%2529%253A%2520a%2520potential%2520new%2520therapy%26jtitle%3DSci.%2520World%2520J.%26date%3D2008%26volume%3D8%26spage%3D1325%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Colette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defrère, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lousse, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Langendonckt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotteland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loumaye, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donnez, J.</span><span> </span><span class="NLM_article-title">Inhibition of sulfatase decreases endometriosis in an in vivo murine model</span> <span class="citation_source-journal">Hum. Reprod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1362</span><span class="NLM_x">–</span> <span class="NLM_lpage">1370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1093%2Fhumrep%2Fder079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=21441545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXms1ajurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=1362-1370&author=S.+Coletteauthor=S.+Defr%C3%A8reauthor=J.+C.+Lousseauthor=A.+Van+Langendoncktauthor=J.+P.+Gottelandauthor=E.+Loumayeauthor=J.+Donnez&title=Inhibition+of+sulfatase+decreases+endometriosis+in+an+in+vivo+murine+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model</span></div><div class="casAuthors">Colette, S.; Defrere, S.; Lousse, J. C.; Van Langendonckt, A.; Gotteland, J. P.; Loumaye, E.; Donnez, J.</div><div class="citationInfo"><span class="NLM_cas:title">Human Reproduction</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1362-1370</span>CODEN:
                <span class="NLM_cas:coden">HUREEE</span>;
        ISSN:<span class="NLM_cas:issn">0268-1161</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">BACKGROUND: Steroid sulfatase (STS) is involved in estrogen biosynthesis and expressed in eutopic and ectopic endometrium of disease-free and endometriosis patients.  The present study was designed to investigate its role in endometriosis development.  METHODS: Human endometrial explants were cultured on inserts for 24 h to assess the effectiveness of an STS inhibitor (STS-I), estradiol-3-O-sulfamate (E2MATE), on STS activity in endometrial tissue.  Endometriosis was induced in mice, and E2MATE (or vehicle alone) was given orally for 21 days.  Plasma estradiol levels were measured, and STS activity was assessed in murine organs (uterus, liver and leukocytes) and in lesions.  Lesion no., wt. and size (morphometry) were quantified.  Lesion STS and progesterone receptor (PR) expression, proliferation and apoptosis rates were detd. by immunohistochem.  RESULTS: In vitro, addn. of 1 μM E2MATE to the culture medium resulted in decreased STS activity in endometrial explants (P < 0.001).  Treatment of mice with E2MATE (1.0 and 0.5 mg/kg) did not modify plasma estradiol levels, but inhibited STS activity in murine uterus (P < 0.05), liver (P < 0.001) and leukocytes (P < 0.001), as well as in induced lesions (P < 0.05).  E2MATE reduced lesion wt. (P < 0.01) and size (P < 0.05), but had no impact on proliferation or apoptosis rates, nor STS protein expression.  Stromal edema was obsd. in the uterus of animals treated with E2MATE, but not in the stroma of lesions.  Increased PR expression was detected in endometriotic lesions (P < 0.001).  CONCLUSIONS: E2MATE was shown to effectively inhibit STS activity in endometrial tissue in vitro.  In vivo, E2MATE decreased endometriosis development without affecting systemic estradiol levels.  Use of STS-I could therefore be of potential interest in endometriosis treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLmhBqovWAmrVg90H21EOLACvtfcHk0liBQgkOtiSkPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXms1ajurw%253D&md5=262fa9b61e1111779d80875c39bf5597</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1093%2Fhumrep%2Fder079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhumrep%252Fder079%26sid%3Dliteratum%253Aachs%26aulast%3DColette%26aufirst%3DS.%26aulast%3DDefr%25C3%25A8re%26aufirst%3DS.%26aulast%3DLousse%26aufirst%3DJ.%2BC.%26aulast%3DVan%2BLangendonckt%26aufirst%3DA.%26aulast%3DGotteland%26aufirst%3DJ.%2BP.%26aulast%3DLoumaye%26aufirst%3DE.%26aulast%3DDonnez%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520sulfatase%2520decreases%2520endometriosis%2520in%2520an%2520in%2520vivo%2520murine%2520model%26jtitle%3DHum.%2520Reprod.%26date%3D2011%26volume%3D26%26spage%3D1362%26epage%3D1370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Pohl, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bestel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotteland, J.-P.</span><span> </span><span class="NLM_article-title">Synergistic effects of E2MATE and norethindrone acetate on sulfatase inhibition: a randomized phase I proof-of-principle clinical study in women of reproductive age</span> <span class="citation_source-journal">Reprod. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1256</span><span class="NLM_x">–</span> <span class="NLM_lpage">1265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1177%2F1933719114522526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=24604234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFSktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1256-1265&author=O.+Pohlauthor=E.+Bestelauthor=J.-P.+Gotteland&title=Synergistic+effects+of+E2MATE+and+norethindrone+acetate+on+sulfatase+inhibition%3A+a+randomized+phase+I+proof-of-principle+clinical+study+in+women+of+reproductive+age"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic effects of E2MATE and norethindrone acetate on steroid sulfatase inhibition: a randomized phase I proof-of-principle clinical study in women of reproductive age</span></div><div class="casAuthors">Pohl, Oliver; Bestel, Elke; Gotteland, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Reproductive Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1256-1265</span>CODEN:
                <span class="NLM_cas:coden">RSECC3</span>;
        ISSN:<span class="NLM_cas:issn">1933-7191</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The combination of a progestin such as norethindrone acetate (NETA) reducing the ovarian estrogen prodn. with a steroid sulfatase (STS) inhibitor (STS-I) decreasing the local estrogen prodn. could result in a new treatment option for endometriosis.  The study reported was a randomized, double-blind, and placebo-controlled study to investigate the pharmacodynamics, pharmacokinetics, and safety of the STS-I PGL2001 (E2MATE) and NETA.  A total of 24 healthy women of reproductive age were treated with weekly doses of PGL2001 or daily doses of NETA or a combination of both compds. for 4 wk.  Four weeks of treatment with PGL2001 or PGL2001 + NETA reduced the STS activity in the endometrium by 91% (±3%) and 96% (±4%), resp., and comparable values were obsd. 1 mo after the treatment was stopped.  The combined treatment of PGL2001 + NETA led to significantly higher STS inhibition at both times (P <.01 and P <.05, resp.).  This study showed that administration of PGL2001 alone at 4 mg/wk or combined with NETA to healthy women of reproductive age led to STS inhibition and changes in functional STS biomarkers in the endometrium, resulting in synergistic effects of PGL2001 and NETA on STS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHYeBYODu8OLVg90H21EOLACvtfcHk0liBQgkOtiSkPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFSktLk%253D&md5=e0733541e657ca968b16a806d100ad9e</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1177%2F1933719114522526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1933719114522526%26sid%3Dliteratum%253Aachs%26aulast%3DPohl%26aufirst%3DO.%26aulast%3DBestel%26aufirst%3DE.%26aulast%3DGotteland%26aufirst%3DJ.-P.%26atitle%3DSynergistic%2520effects%2520of%2520E2MATE%2520and%2520norethindrone%2520acetate%2520on%2520sulfatase%2520inhibition%253A%2520a%2520randomized%2520phase%2520I%2520proof-of-principle%2520clinical%2520study%2520in%2520women%2520of%2520reproductive%2520age%26jtitle%3DReprod.%2520Sci.%26date%3D2014%26volume%3D21%26spage%3D1256%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span> </span><span class="NLM_article-title">PGL2001 Proof of Concept Study in Symptomatic Endometriosis (AMBER)</span>. ClinicalTrials.gov; <span class="NLM_publisher-name">U.S. National Institutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span><a href="https://clinicaltrials.gov/ct2/show/NCT01631981" class="extLink">https://clinicaltrials.gov/ct2/show/NCT01631981</a> (accessed May 13, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PGL2001+Proof+of+Concept+Study+in+Symptomatic+Endometriosis+%28AMBER%29.+ClinicalTrials.gov%3B+U.S.+National+Institutes+of+Health%3A+Bethesda%2C+MD%2C+2014%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01631981+%28accessed+May+13%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DPGL2001%2520Proof%2520of%2520Concept%2520Study%2520in%2520Symptomatic%2520Endometriosis%2520%2528AMBER%2529%26jtitle%3DClinicalTrials.gov%26pub%3DU.S.%2520National%2520Institutes%2520of%2520Health%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Ventura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solà, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peraire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R.</span><span> </span><span class="NLM_article-title">In vitro metabolism of Irosustat, a novel sulfatase inhibitor: interspecies comparison, metabolite identification, and metabolic enzyme identification</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=1235-1246&author=V.+Venturaauthor=J.+Sol%C3%A0author=C.+Celmaauthor=C.+Peraireauthor=R.+Obach&title=In+vitro+metabolism+of+Irosustat%2C+a+novel+sulfatase+inhibitor%3A+interspecies+comparison%2C+metabolite+identification%2C+and+metabolic+enzyme+identification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVentura%26aufirst%3DV.%26aulast%3DSol%25C3%25A0%26aufirst%3DJ.%26aulast%3DCelma%26aufirst%3DC.%26aulast%3DPeraire%26aufirst%3DC.%26aulast%3DObach%26aufirst%3DR.%26atitle%3DIn%2520vitro%2520metabolism%2520of%2520Irosustat%252C%2520a%2520novel%2520sulfatase%2520inhibitor%253A%2520interspecies%2520comparison%252C%2520metabolite%2520identification%252C%2520and%2520metabolic%2520enzyme%2520identification%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2011%26volume%3D39%26spage%3D1235%26epage%3D1246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Ventura, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solà, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peraire, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brée, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R.</span><span> </span><span class="NLM_article-title">In vitro evaluation of the interaction potential of Irosustat with drug-metabolizing enzymes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1268</span><span class="NLM_x">–</span> <span class="NLM_lpage">1278</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=1268-1278&author=V.+Venturaauthor=J.+Sol%C3%A0author=C.+Peraireauthor=F.+Br%C3%A9eauthor=R.+Obach&title=In+vitro+evaluation+of+the+interaction+potential+of+Irosustat+with+drug-metabolizing+enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVentura%26aufirst%3DV.%26aulast%3DSol%25C3%25A0%26aufirst%3DJ.%26aulast%3DPeraire%26aufirst%3DC.%26aulast%3DBr%25C3%25A9e%26aufirst%3DF.%26aulast%3DObach%26aufirst%3DR.%26atitle%3DIn%2520vitro%2520evaluation%2520of%2520the%2520interaction%2520potential%2520of%2520Irosustat%2520with%2520drug-metabolizing%2520enzymes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D1268%26epage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M. F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhalli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1517</span><span class="NLM_x">–</span> <span class="NLM_lpage">1524</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18630506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1WktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=1517-1524&author=A.+Purohitauthor=S.+K.+Chanderauthor=L.+W.+L.+Wooauthor=M.+F.+C.+Parsonsauthor=R.+Jhalliauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+steroid+sulphatase+activity+via+the+percutaneous+route%3A+a+new+option+for+breast+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy</span></div><div class="casAuthors">Purohit, A.; Chander, S. K.; Woo, L. W. L.; Parsons, M. F. C.; Jhalli, R.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3A</span>),
    <span class="NLM_cas:pages">1517-1524</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Steroid sulphatase (STS) inhibitors have been developed primarily for the treatment of hormone-dependent breast cancer, but may also have utility for the treatment of a no. of androgen-dependent skin conditions.  STS regulates the hydrolysis of steroid sulfates, such as oestrone sulfate (E1S) and dehydroepiandrosterone sulfate, (DHEAS).  Liberated oestrone (E1) can be converted to biol. active oestradiol (E2) while dehydroepiandrosterone (DHEA) can undergo redn. to testosterone or aromatisation to E1.  In this study the ability of the STS inhibitor STX64 (BN83495) and its N,N-di-Me analog (STX289) to inhibit liver and skin STS when applied orally or topically to nude mice was examd.  Oral administration at 1 and 10 mg/kg resulted in almost complete inhibition of skin and liver STS.  When applied topically to the dorsal neck region at 1.0 and 10 mg/kg not only skin but, unexpectedly, also liver STS was effectively inhibited.  An investigation into the metab. of these two compds. by HepG2 liver carcinoma cells, with high-performance liq. chromatog. (HPLC) anal., was also undertaken.  In the presence of HepG2 cells a similar degree of desulphamoylation of STX64 (68%) or de-N,N-dimethylsulphamoylation of STX289 (66%) occurred over a 3h period.  In the absence of cells, however, STX289 was resistant to de-N, N-dimethylsulphamoylation whereas STX64 was completely desulphamoylated, demonstrating the more favorable pharmaceutical profile of STX289 for development for topical application.  It is concluded that both STX64 and STX289 are not only effective inhibitors of skin STS, but also liver STS when applied topically.  These findings suggest that it may be possible to develop a formulation for the percutaneous administration of STS inhibitors, but also that this class of compd. may have therapeutic potential for the treatment of a no. of skin disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqqLaVWqV4rbVg90H21EOLACvtfcHk0ljAlg4lNUhN0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1WktLw%253D&md5=37668757178eeed716b0e87b03b6ae34</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DParsons%26aufirst%3DM.%2BF.%2BC.%26aulast%3DJhalli%26aufirst%3DR.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520steroid%2520sulphatase%2520activity%2520via%2520the%2520percutaneous%2520route%253A%2520a%2520new%2520option%2520for%2520breast%2520cancer%2520therapy%26jtitle%3DAnticancer%2520Res.%26date%3D2008%26volume%3D28%26spage%3D1517%26epage%3D1524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroid sulphatase inhibitors for the topical treatment of skin disorders</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1358%2Fdof.2008.033.07.1212711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGitr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=597-606&author=M.+J.+Reedauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potter&title=Steroid+sulphatase+inhibitors+for+the+topical+treatment+of+skin+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid sulfatase inhibitors for the topical treatment of skin disorders</span></div><div class="casAuthors">Reed, M. J.; Purohit, A.; Woo, L. W. L.; Potter, B. V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Inhibition of steroid sulfatase (STS) activity in skin is a potential new treatment strategy for a no. of skin disorders, including hirsutism, androgen-dependent alopecia, acne and psoriasis.  In skin and its appendages, STS regulates the hydrolysis of dehydroepiandrosterone sulfate to dehydroepiandrosterone, a weak androgen, which can be converted to the biol. active androgens testosterone and 5α-dihydrotestosterone by other steroidogenic enzymes also present in skin.  A no. of potent, irreversible STS inhibitors have been developed based around a core arylsulfamate ester motif, the active pharmacophore required for potent STS inhibition.  Such inhibitors include AHBS and STX-64.  Topical application of AHBS to the skin of mice or pigs resulted in almost complete inhibition of skin STS activity.  Furthermore, when applied to the skin of Gottingen minipigs daily for 2 wk, by day 10 AHBS had inhibited sebum prodn., a desired requisite for an antiacne drug.  When applied topically to the skin of nude mice at 1.0 and 10.0 mg/kg STX-64 inhibited skin STS activity by > 90%, but it also inhibited liver STS activity.  While preclin. studies have confirmed the ability of topically applied STS inhibitors to inhibit skin STS activity, further studies using preclin. models of skin disorders and clin. trials are needed to test their efficacy in treating skin disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf5TH1qamjiLVg90H21EOLACvtfcHk0ljAlg4lNUhN0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGitr3F&md5=6fe9bdae8ddd0d3bded5265a4851d061</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1358%2Fdof.2008.033.07.1212711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2008.033.07.1212711%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroid%2520sulphatase%2520inhibitors%2520for%2520the%2520topical%2520treatment%2520of%2520skin%2520disorders%26jtitle%3DDrugs%2520Future%26date%3D2008%26volume%3D33%26spage%3D597%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Suitters, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wales, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodmer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foulkes, R.</span><span> </span><span class="NLM_article-title">Immune enhancing effects of dehydroepiandrosterone and dehydroepiandrosterone sulphate and the role of steroid sulphatase</span> <span class="citation_source-journal">Immunology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1997&pages=314-321&author=A.+J.+Suittersauthor=S.+Shawauthor=M.+R.+Walesauthor=J.+R.+Porterauthor=J.+Leonardauthor=R.+Woodgerauthor=H.+Brandauthor=M.+Bodmerauthor=R.+Foulkes&title=Immune+enhancing+effects+of+dehydroepiandrosterone+and+dehydroepiandrosterone+sulphate+and+the+role+of+steroid+sulphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuitters%26aufirst%3DA.%2BJ.%26aulast%3DShaw%26aufirst%3DS.%26aulast%3DWales%26aufirst%3DM.%2BR.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DLeonard%26aufirst%3DJ.%26aulast%3DWoodger%26aufirst%3DR.%26aulast%3DBrand%26aufirst%3DH.%26aulast%3DBodmer%26aufirst%3DM.%26aulast%3DFoulkes%26aufirst%3DR.%26atitle%3DImmune%2520enhancing%2520effects%2520of%2520dehydroepiandrosterone%2520and%2520dehydroepiandrosterone%2520sulphate%2520and%2520the%2520role%2520of%2520steroid%2520sulphatase%26jtitle%3DImmunology%26date%3D1997%26volume%3D91%26spage%3D314%26epage%3D321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Foulkes, R.; Shaw, S.; Suitters, A.</span><span> </span><span class="NLM_article-title">Immunological consequences of inhibiting dehydroepiandrosterone sulfatase in vivo</span>. In  <span class="citation_source-book">Steroid Hormones and the T-Cell Cytokine Profile</span>; <span class="NLM_contrib-group">Rook, G. A. W.; Lightman, S.</span>, Eds.; <span class="NLM_publisher-name">Springer-Verlag</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2F978-1-4471-0931-0_6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=135-152&author=R.+Foulkes&author=S.+Shaw&author=A.+Suittersauthor=G.+A.+W.+Rook&author=S.+Lightman&title=Steroid+Hormones+and+the+T-Cell+Cytokine+Profile"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1007%2F978-1-4471-0931-0_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4471-0931-0_6%26sid%3Dliteratum%253Aachs%26aulast%3DFoulkes%26aufirst%3DR.%26atitle%3DImmunological%2520consequences%2520of%2520inhibiting%2520dehydroepiandrosterone%2520sulfatase%2520in%2520vivo%26btitle%3DSteroid%2520Hormones%2520and%2520the%2520T-Cell%2520Cytokine%2520Profile%26aulast%3DRook%26aufirst%3DG.%2BA.%2BW.%26pub%3DSpringer-Verlag%26date%3D1997%26spage%3D135%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Li, P.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. A.</span><span> </span><span class="NLM_article-title">Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-<i>O</i>-sulfamate</span> <span class="citation_source-journal">Cognit. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2F0926-6410%2895%2990016-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8580738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK28XmsVeisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=251-254&author=P.-K.+Liauthor=M.+E.+Rhodesauthor=S.+Jagannathanauthor=D.+A.+Johnson&title=Reversal+of+scopolamine+induced+amnesia+in+rats+by+the+steroid+sulfatase+inhibitor+estrone-3-O-sulfamate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-O-sulfamate</span></div><div class="casAuthors">Li, Pui-Kai; Rhodes, Michael E.; Jagannathan, Sharada; Johnson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cognitive Brain Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">251-4</span>CODEN:
                <span class="NLM_cas:coden">CBRREZ</span>;
        ISSN:<span class="NLM_cas:issn">0926-6410</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The intent of the study was to det. whether altering the metab. of neurosteroids via blockade of the enzyme, steroid sulfatase, could enhance retention test performance in rats.  The steroid sulfatase inhibitor estrone-3-O-sulfamate (EMATE) was administered alone and in combination with the neurosteroid dehydroepiandrosterone sulfate (DHEAS) to rats which were then tested for the reversal of scopolamine induced amnesia.  EMATE enhanced the reversal of amnesia by DHEAS as measured by a passive avoidance test.  When administered without DHEAS, as a single acute dose, EMATE had no effect.  When administered without DHEAS over 10 consecutive days, however, EMATE significantly improved retention.  These results suggest that steroid sulfatase inhibition can potentiate the memory enhancing properties of DHEAS.  The study also suggests that increasing the levels of endogenous sulfated neurosteroids via the inhibition of steroid sulfatase activity may enhance learning and/or memory function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ7bC8G6rjzrVg90H21EOLACvtfcHk0lg6czjauqRr_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmsVeisQ%253D%253D&md5=8c9c428c0f17f9773a4a13e14bb35cd6</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2F0926-6410%2895%2990016-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0926-6410%252895%252990016-0%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.-K.%26aulast%3DRhodes%26aufirst%3DM.%2BE.%26aulast%3DJagannathan%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DD.%2BA.%26atitle%3DReversal%2520of%2520scopolamine%2520induced%2520amnesia%2520in%2520rats%2520by%2520the%2520steroid%2520sulfatase%2520inhibitor%2520estrone-3-O-sulfamate%26jtitle%3DCognit.%2520Brain%2520Res.%26date%3D1995%26volume%3D2%26spage%3D251%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Davies, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humby, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddy, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojarikre, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, L. S.</span><span> </span><span class="NLM_article-title">Genetic and pharmacological modulation of the steroid sulfatase axis improves response control; comparison with drugs used in ADHD</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2622</span><span class="NLM_x">–</span> <span class="NLM_lpage">2632</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=2622-2632&author=W.+Daviesauthor=T.+Humbyauthor=S.+Trentauthor=J.+B.+Eddyauthor=O.+A.+Ojarikreauthor=L.+S.+Wilkinson&title=Genetic+and+pharmacological+modulation+of+the+steroid+sulfatase+axis+improves+response+control%3B+comparison+with+drugs+used+in+ADHD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DW.%26aulast%3DHumby%26aufirst%3DT.%26aulast%3DTrent%26aufirst%3DS.%26aulast%3DEddy%26aufirst%3DJ.%2BB.%26aulast%3DOjarikre%26aufirst%3DO.%2BA.%26aulast%3DWilkinson%26aufirst%3DL.%2BS.%26atitle%3DGenetic%2520and%2520pharmacological%2520modulation%2520of%2520the%2520steroid%2520sulfatase%2520axis%2520improves%2520response%2520control%253B%2520comparison%2520with%2520drugs%2520used%2520in%2520ADHD%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D2622%26epage%3D2632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Secky, L.; Svoboda, M.; Klameth, L.; Bajna, E.; Hamilton, G.; Zeillinger, R.; Jäger, W.; Thalhammer, T.</span> <span class="citation_source-journal">J. Drug Deliv.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span>Article ID <span class="NLM_elocation-id">957605</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23476785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlCmsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Secky%2C+L.%3B+Svoboda%2C+M.%3B+Klameth%2C+L.%3B+Bajna%2C+E.%3B+Hamilton%2C+G.%3B+Zeillinger%2C+R.%3B+J%C3%A4ger%2C+W.%3B+Thalhammer%2C+T.J.+Drug+Deliv.+2013%2C+Article+ID+957605."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors</span></div><div class="casAuthors">Secky, Lena; Svoboda, Martin; Klameth, Lukas; Bajna, Erika; Hamilton, Gerhard; Zeillinger, Robert; Jaeger, Walter; Thalhammer, Theresia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Delivery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">957605, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">JDDOCB</span>;
        ISSN:<span class="NLM_cas:issn">2090-3022</span>.
    
            (<span class="NLM_cas:orgname">Hindawi Publishing Corp.</span>)
        </div><div class="casAbstract">A review.  The extragonadal synthesis of biol. active steroid hormones from their inactive precursors in target tissues is named "intracrinol.".  Of particular importance for the progression of estrogen-dependent cancers is the in situ formation of the biol. most active estrogen, 17beta-estradiol (E2).  In cancer cells, conversion of inactive steroid hormone precursors to E2 is accomplished from inactive, sulfated estrogens in the "sulfatase pathway" and from androgens in the "aromatase pathway".  Here, we provide an overview about expression and function of enzymes of the "sulfatase pathway", particularly steroid sulfatase (STS) that activates estrogens and estrogen sulfotransferase (SULT1E1) that converts active estrone (E1) and other estrogens to their inactive sulfates.  High expression of STS and low expression of SULT1E1 will increase levels of active estrogens in malignant tumor cells leading to the stimulation of cell proliferation and cancer progression.  Therefore, blocking the "sulfatase pathway" by STS inhibitors may offer an attractive strategy to reduce levels of active estrogens.  STS inhibitors either applied in combination with aromatase inhibitors or as novel, dual aromatase-steroid sulfatase inhibiting drugs are currently under investigation.  Furthermore, STS inhibitors are also suitable as enzyme-based cancer imaging agents applied in the biomedical imaging technique positron emission tomog. (PET) for cancer diagnosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOKo9KPbZvUbVg90H21EOLACvtfcHk0lg6czjauqRr_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlCmsrg%253D&md5=6e6ad64b7ac2f66e4ba29735e8bbaa98</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSecky%26aufirst%3DL.%26jtitle%3DJ.%2520Drug%2520Deliv.%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Chura, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooker, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomquist, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argenta, P. A.</span><span> </span><span class="NLM_article-title">Steroid-converting enzymes in human ovarian carcinomas</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.mce.2008.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18723074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1OgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2009&pages=51-58&author=J.+C.+Churaauthor=H.+S.+Ryuauthor=M.+Simardauthor=D.+Poirierauthor=Y.+Tremblayauthor=D.+C.+Brookerauthor=C.+H.+Blomquistauthor=P.+A.+Argenta&title=Steroid-converting+enzymes+in+human+ovarian+carcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid-converting enzymes in human ovarian carcinomas</span></div><div class="casAuthors">Chura, Justin C.; Ryu, Hyung S.; Simard, Marc; Poirier, Donald; Tremblay, Yves; Brooker, Doris C.; Blomquist, Charles H.; Argenta, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">51-58</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Anti-estrogen therapies for treating ovarian carcinoma have had mixed outcomes suggesting some tumors may be estrogen-dependent.  We assayed the activity levels of 17β-hydroxysteroid dehydrogenase (17β-HSD), 3β-hydroxysteroid dehydrogenase (3β-HSD), 3α-hydroxysteroid dehydrogenase (3α-HSD/3-KSR) and estrone sulfatase in a series of ovarian epithelial carcinomas. 17β-HSD activity ratios with estradiol (E2) and testosterone (T), and inhibition by isoform-specific inhibitors were used to est. the contributions of 17β-HSD isoforms.  Activity levels were highest for estrone sulfatase, followed, resp. by 17β-HSD, 3α-HSD/3-KSR, and 3β-HSD.  E2/T activity ratios varied widely between samples.  A 17β-HSD type 1 inhibition pattern was obsd. in 23% of the samples and a type 2 pattern in 25%.  E2 formation from estrone sulfate (E1S) was detected in 98% (47/48) of the samples. 17β-HSD type 1, type 2 and type 5 mRNA was detected in matched primary tumor and metastases.  Evaluation of 17β-HSD and sulfatase activity levels, activity ratios and inhibition patterns may help predict tumor response to endocrine therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxC1SSJQ_TRrVg90H21EOLACvtfcHk0lg6czjauqRr_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1OgsLk%253D&md5=4d23fa9ffdc511a8daa53e3e510a6e13</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2008.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2008.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DChura%26aufirst%3DJ.%2BC.%26aulast%3DRyu%26aufirst%3DH.%2BS.%26aulast%3DSimard%26aufirst%3DM.%26aulast%3DPoirier%26aufirst%3DD.%26aulast%3DTremblay%26aufirst%3DY.%26aulast%3DBrooker%26aufirst%3DD.%2BC.%26aulast%3DBlomquist%26aufirst%3DC.%2BH.%26aulast%3DArgenta%26aufirst%3DP.%2BA.%26atitle%3DSteroid-converting%2520enzymes%2520in%2520human%2520ovarian%2520carcinomas%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2009%26volume%3D301%26spage%3D51%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Iida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakinuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niikawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasano, H.</span><span> </span><span class="NLM_article-title">Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1038%2Fbjc.2013.84" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23531699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Ojs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2013&pages=1415-1424&author=S.+Iidaauthor=H.+Kakinumaauthor=Y.+Mikiauthor=K.+Abeauthor=M.+Sakuraiauthor=S.+Suzukiauthor=H.+Niikawaauthor=J.+Akahiraauthor=T.+Suzukiauthor=H.+Sasano&title=Steroid+sulphatase+and+oestrogen+sulphotransferase+in+human+non-small-cell+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma</span></div><div class="casAuthors">Iida, S.; Kakinuma, H.; Miki, Y.; Abe, K.; Sakurai, M.; Suzuki, S.; Niikawa, H.; Akahira, J.; Suzuki, T.; Sasano, H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1415-1424</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Steroid sulphatase (STS) is one of the steroid-metabolizing enzymes involved in desulfating inactive steroid sulfates and estrogen sulfotransferase (EST) sulfates active estrogen.  The roles of both STS and EST have not been examd. in estrogen-dependent non-small-cell lung cancer (NSCLC).  Methods: We evaluated the immunoreactivity of STS and EST in NSCLC cases using immunohistochem.  The function of STS and EST was further demonstrated using NSCLC cell lines.  Results: The immunoreactivity of STS and EST was detected in 49.5% and 27.8% of NSCLC cases, resp.  The immunoreactivity of STS was significantly higher in female adenocarcinoma cases.  The STS-pos. NSCLCs were also significantly correlated in an inversed manner with tumor size and cell proliferation and tended to be assocd. with better clin. outcome.  However, the immunoreactivity of EST was significantly correlated with intracellular oestradiol concn.  Results of in vitro anal. demonstrated that oestrone sulfate (E1-S) induced and pregnenolone sulfate (Preg-S) inhibited the proliferation in STS-expressing cell lines.  The inhibition by Preg-S was reversed by a specific progesterone receptor blocker.  Simultaneous addn. of E1-S and Preg-S significantly suppressed the proliferation.  Conclusion: In NSCLC patients, STS is considered a good prognostic factor.  Results of our present study also indicated the benefits of potential progesterone therapy for NSCLC patients.  British Journal of Cancer (2013) 108, 1415-1424; doi:10.1038/bjc.2013.84; published online 26 March 2013; www.bjcancer.com.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVA2ZoyC95NbVg90H21EOLACvtfcHk0lhDZZvKnjxRgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Ojs70%253D&md5=b8899ee34c15eba6b6f4c46dc514f30b</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2013.84&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2013.84%26sid%3Dliteratum%253Aachs%26aulast%3DIida%26aufirst%3DS.%26aulast%3DKakinuma%26aufirst%3DH.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DSakurai%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DS.%26aulast%3DNiikawa%26aufirst%3DH.%26aulast%3DAkahira%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DSasano%26aufirst%3DH.%26atitle%3DSteroid%2520sulphatase%2520and%2520oestrogen%2520sulphotransferase%2520in%2520human%2520non-small-cell%2520lung%2520carcinoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2013%26volume%3D108%26spage%3D1415%26epage%3D1424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Sato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayose, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tateno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahira, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamogawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ii, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasano, H.</span><span> </span><span class="NLM_article-title">Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">914</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=914-922&author=R.+Satoauthor=T.+Suzukiauthor=Y.+Katayoseauthor=K.+Miuraauthor=K.+Shiibaauthor=H.+Tatenoauthor=Y.+Mikiauthor=J.+Akahiraauthor=Y.+Kamogawaauthor=S.+Nagasakiauthor=K.+Yamamotoauthor=T.+Iiauthor=S.+Egawaauthor=D.+B.+Evansauthor=M.+Unnoauthor=H.+Sasano&title=Steroid+sulfatase+and+estrogen+sulfotransferase+in+colon+carcinoma%3A+regulators+of+intratumoral+estrogen+concentrations+and+potent+prognostic+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DR.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKatayose%26aufirst%3DY.%26aulast%3DMiura%26aufirst%3DK.%26aulast%3DShiiba%26aufirst%3DK.%26aulast%3DTateno%26aufirst%3DH.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DAkahira%26aufirst%3DJ.%26aulast%3DKamogawa%26aufirst%3DY.%26aulast%3DNagasaki%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DIi%26aufirst%3DT.%26aulast%3DEgawa%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26aulast%3DUnno%26aufirst%3DM.%26aulast%3DSasano%26aufirst%3DH.%26atitle%3DSteroid%2520sulfatase%2520and%2520estrogen%2520sulfotransferase%2520in%2520colon%2520carcinoma%253A%2520regulators%2520of%2520intratumoral%2520estrogen%2520concentrations%2520and%2520potent%2520prognostic%2520factors%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D914%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Eri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanibuchi, H.</span><span> </span><span class="NLM_article-title">Steroid sulfatase promotes invasion and is a useful marker for predicting the progression of bladder cancer</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">iv567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=iv567&issue=Suppl+4&author=S.+Eriauthor=M.+Katoauthor=M.+Weiauthor=S.+Yamanoauthor=M.+Fujiokaauthor=H.+Wanibuchi&title=Steroid+sulfatase+promotes+invasion+and+is+a+useful+marker+for+predicting+the+progression+of+bladder+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEri%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DYamano%26aufirst%3DS.%26aulast%3DFujioka%26aufirst%3DM.%26aulast%3DWanibuchi%26aufirst%3DH.%26atitle%3DSteroid%2520sulfatase%2520promotes%2520invasion%2520and%2520is%2520a%2520useful%2520marker%2520for%2520predicting%2520the%2520progression%2520of%2520bladder%2520cancer%26jtitle%3DAnn.%2520Oncol.%26date%3D2014%26volume%3D25%26issue%3DSuppl%25204%26spage%3Div567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Dias, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selcer, K. W.</span><span> </span><span class="NLM_article-title">Steroid sulfatase mediated growth of human MG-63 pre-osteoblastic cells</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2014&pages=77-82&author=N.+J.+Diasauthor=K.+W.+Selcer&title=Steroid+sulfatase+mediated+growth+of+human+MG-63+pre-osteoblastic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDias%26aufirst%3DN.%2BJ.%26aulast%3DSelcer%26aufirst%3DK.%2BW.%26atitle%3DSteroid%2520sulfatase%2520mediated%2520growth%2520of%2520human%2520MG-63%2520pre-osteoblastic%2520cells%26jtitle%3DSteroids%26date%3D2014%26volume%3D88%26spage%3D77%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernon, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagenaar Hummelinck, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The development of A-ring modified analogues of oestrone-3-<i>O</i>-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2897%2900196-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=9618028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK1cXjsFSqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1998&pages=269-275&author=A.+Purohitauthor=K.+A.+Vernonauthor=A.+E.+Wagenaar+Hummelinckauthor=L.+W.+L.+Wooauthor=H.+A.+M.+Hejazauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+development+of+A-ring+modified+analogues+of+oestrone-3-O-sulphamate+as+potent+steroid+sulphatase+inhibitors+with+reduced+oestrogenicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">The development of A-ring modified analogs of estrone-3-O-sulfamate as potent steroid sulfatase inhibitors with reduced estrogenicity</span></div><div class="casAuthors">Purohit, A.; Vernon, K. A.; Hummelinck, A. E. Wagenaar; Woo, L. W. L.; Hejaz, H. A. M.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">269-275</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Steroid sulfatases regulate the formation of estrogenic steroids which can support the growth of endocrine-dependent breast tumors.  The development of potent steroid sulfatase inhibitors could therefore have considerable therapeutic potential.  Several such inhibitors have now been developed of which the most potent to date is estrone-3-O-sulfamate (EMATE).  Unexpectedly, this inhibitor proved to be a potent estrogen.  In an attempt to reduce the estrogenicity, while retaining the potent sulfatase inhibitory properties assocd. with this type of mol., a no. of A-ring modified derivs. were designed and synthesized.  A-ring modified compds. included the 2-methoxy, 2/4-nitro, 2/4-Pr and 2/4-allyl EMATE analogs.  The ability of these derivs. to inhibit estrone sulfatase activity was examd. using placental microsomes.  The allyl-substituted EMATE derivs. were more potent inhibitors than the Pr analogs but were all considerably less potent than EMATE.  In contrast, the 2-methoxy and 2/4-nitro analogs were potent sulfatase inhibitors with 4-nitro EMATE being 5 times more active than EMATE.  The 4-nitro, 2-methoxy, 4-Pr and 4-allyl derivs. were also tested in vivo for their estrogenicity and ability to inhibit sulfatase activity.  While both 4-nitro and 2-methoxy EMATE were potent inhibitors in vivo, 2-methoxy EMATE had no stimulatory effect on uterine growth in ovariectomized rats.  The identification of a potent steroid sulfatase inhibitor lacking any estrogenicity, such as 2-methoxy EMATE, should be of considerable value in evaluating the potential of steroid sulfatase inhibition for breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXafBnPzDzL7Vg90H21EOLACvtfcHk0liWGKkixPR9vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjsFSqsLs%253D&md5=1607054465d5934ad19e93f7e92acd14</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2897%2900196-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252897%252900196-9%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DVernon%26aufirst%3DK.%2BA.%26aulast%3DWagenaar%2BHummelinck%26aufirst%3DA.%2BE.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520development%2520of%2520A-ring%2520modified%2520analogues%2520of%2520oestrone-3-O-sulphamate%2520as%2520potent%2520steroid%2520sulphatase%2520inhibitors%2520with%2520reduced%2520oestrogenicity%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D64%26spage%3D269%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumor agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3135</span><span class="NLM_x">–</span> <span class="NLM_lpage">3138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3135-3138&author=M.+P.+Leeseauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-Alkylsulfanyl+estrogen+derivatives%3A+synthesis+of+a+novel+class+of+multi-targeted+anti-tumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-Alkylsulfanyl%2520estrogen%2520derivatives%253A%2520synthesis%2520of%2520a%2520novel%2520class%2520of%2520multi-targeted%2520anti-tumor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3135%26epage%3D3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Reed, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-Difluoromethyloestrone 3-<i>O</i>-sulphamate, a highly potent steroid sulphatase inhibitor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2004&pages=169-175&author=J.+E.+Reedauthor=L.+W.+L.+Wooauthor=J.+J.+Robinsonauthor=B.+Leblondauthor=M.+P.+Leeseauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-Difluoromethyloestrone+3-O-sulphamate%2C+a+highly+potent+steroid+sulphatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DJ.%2BE.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DRobinson%26aufirst%3DJ.%2BJ.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-Difluoromethyloestrone%25203-O-sulphamate%252C%2520a%2520highly%2520potent%2520steroid%2520sulphatase%2520inhibitor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D317%26spage%3D169%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">A-Ring-substituted estrogen-3-<i>O</i>-sulfamates: potent multitargeted anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5243</span><span class="NLM_x">–</span> <span class="NLM_lpage">5256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050066a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5243-5256&author=M.+P.+Leeseauthor=H.+A.+M.+Hejazauthor=M.+F.+Mahonauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=A-Ring-substituted+estrogen-3-O-sulfamates%3A+potent+multitargeted+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Fjm050066a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050066a%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DA-Ring-substituted%2520estrogen-3-O-sulfamates%253A%2520potent%2520multitargeted%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5243%26epage%3D5256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of analogues of estrone-3-<i>O</i>-sulfamate as potent sulfatase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2506</span><span class="NLM_x">–</span> <span class="NLM_lpage">2519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=2506-2519&author=L.+W.+L.+Wooauthor=B.+Leblondauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Synthesis+and+evaluation+of+analogues+of+estrone-3-O-sulfamate+as+potent+sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520analogues%2520of%2520estrone-3-O-sulfamate%2520as%2520potent%2520sulfatase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D2506%26epage%3D2519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Ishida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takebayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anazawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakata, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwabara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span> </span><span class="NLM_article-title">A novel steroid selective steroid sulfatase inhibitor KW-2581 inhibits sulphated-estrogen dependent growth of breast cancer cells in vitro and in animal models</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007a</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-007-9495-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=17268815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Cgt7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2007a&pages=215-227&author=H.+Ishidaauthor=T.+Nakataauthor=M.+Suzukiauthor=Y.+Shiotsuauthor=H.+Tanakaauthor=N.+Satoauthor=Y.+Terasakiauthor=M.+Takebayashiauthor=H.+Anazawaauthor=C.+Murakataauthor=P.-K.+Liauthor=T.+Kuwabaraauthor=S.+Akinaga&title=A+novel+steroid+selective+steroid+sulfatase+inhibitor+KW-2581+inhibits+sulphated-estrogen+dependent+growth+of+breast+cancer+cells+in+vitro+and+in+animal+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models</span></div><div class="casAuthors">Ishida, Hiroyuki; Nakata, Taisuke; Suzuki, Masayo; Shiotsu, Yukimasa; Tanaka, Hideyuki; Sato, Natsuko; Terasaki, Yoko; Takebayashi, Miho; Anazawa, Hideharu; Murakata, Chikara; Li, Pui-Kai; Kuwabara, Takashi; Akinaga, Shiro</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-227</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">We screened a series of 17β-(N-alkylcarbamoyl)estra-1,3,5(10)triene-3-O-sulfamate derivs., and describe here a potent and selective steroid sulfatase (STS) inhibitor with antitumor effects in breast cancer models in vitro and in vivo.  In biochem. assays using crude enzymes isolated from recombinant Chinese hamster ovary cells expressing human arylsulfatses (ARSs), one of the best compds., KW-2581, inhibited STS activity with an IC50 of 4.0 nM, while > 1000-fold higher concns. were required to inhibit the other ARSs.  The failure to stimulate the growth of MCF-7 human breast cancer cells as well as in uteri in ovariectomized rats indicated the lack of estrogenicity of this compd.  In MCF-7 cells transfected with the STS gene, termed MCS-2 cells, KW-2581 inhibited the growth of cells stimulated by estrone sulfate (E1S) but also 5-androstene-3β, 17β-diol 3-sulfate (ADIOLS) and dehydroepiandrostenedione 3-sulfate.  We found that oral administration of KW-2581 inhibited both E1S- and ADIOLS-stimulated growth of MCS-2 cells in a mouse hollow fiber model.  In a nitrosomethylurea-induced rat mammary tumor model, KW-2581 induced regression of E1S-stimulated tumor growth as effectively as tamoxifen or another STS inhibitor, 667 Coumate.  Dose-response studies in the same rat model demonstrated that more than 90% inhibition of STS activity in tumors was necessary to induce tumor shrinkage.  STS activity in tumors has well correlated with that in leukocytes, suggesting that STS activity in leukocytes could be used as an easily detectable pharmacodynamic marker.  These findings demonstrate that KW-2581 is a candidate for development as a therapeutic agent for the treatment of hormone receptors-pos. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8aZlo84BUBbVg90H21EOLACvtfcHk0liWGKkixPR9vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Cgt7fI&md5=72825a5aa22bee29394ee73ccf90252e</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1007%2Fs10549-007-9495-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-007-9495-x%26sid%3Dliteratum%253Aachs%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DNakata%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DShiotsu%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DTerasaki%26aufirst%3DY.%26aulast%3DTakebayashi%26aufirst%3DM.%26aulast%3DAnazawa%26aufirst%3DH.%26aulast%3DMurakata%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DP.-K.%26aulast%3DKuwabara%26aufirst%3DT.%26aulast%3DAkinaga%26aufirst%3DS.%26atitle%3DA%2520novel%2520steroid%2520selective%2520steroid%2520sulfatase%2520inhibitor%2520KW-2581%2520inhibits%2520sulphated-estrogen%2520dependent%2520growth%2520of%2520breast%2520cancer%2520cells%2520in%2520vitro%2520and%2520in%2520animal%2520models%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007a%26volume%3D106%26spage%3D215%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Ishida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwabara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span> </span><span class="NLM_article-title">Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104b</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-006-9404-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104b&publication_year=2007&pages=211-219&author=H.+Ishidaauthor=T.+Nakataauthor=N.+Satoauthor=P.+K.+Liauthor=T.+Kuwabaraauthor=S.+Akinaga&title=Inhibition+of+steroid+sulfatase+activity+and+cell+proliferation+in+ZR-75-1+and+BT-474+human+breast+cancer+cells+by+KW-2581+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2Fs10549-006-9404-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-006-9404-8%26sid%3Dliteratum%253Aachs%26aulast%3DIshida%26aufirst%3DH.%26aulast%3DNakata%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DP.%2BK.%26aulast%3DKuwabara%26aufirst%3DT.%26aulast%3DAkinaga%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520steroid%2520sulfatase%2520activity%2520and%2520cell%2520proliferation%2520in%2520ZR-75-1%2520and%2520BT-474%2520human%2520breast%2520cancer%2520cells%2520by%2520KW-2581%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007%26volume%3D104b%26spage%3D211%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhalli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">In vivo efficacy of STX213, a second generation sulfatase inhibitor, for hormone-dependent breast cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5543</span><span class="NLM_x">–</span> <span class="NLM_lpage">5549</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1158%2F1078-0432.CCR-06-0632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=17000691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFShtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=5543-5549&author=P.+A.+Fosterauthor=S.+P.+Newmanauthor=S.+K.+Chanderauthor=C.+Stengelauthor=R.+Jhalliauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=In+vivo+efficacy+of+STX213%2C+a+second+generation+sulfatase+inhibitor%2C+for+hormone-dependent+breast+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo efficacy of STX213, a second-generation steroid sulfatase inhibitor, for hormone-dependent breast cancer therapy</span></div><div class="casAuthors">Foster, Paul A.; Newman, Simon P.; Chander, Surinder K.; Stengel, Chloe; Jhalli, Roma; Woo, Lawrence L. W.; Potter, Barry V. L.; Reed, Michael J.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5543-5549</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Steroid sulfatase (STS) inhibitors that can decrease or prevent the biosynthesis of estrogenic steroids via the sulfatase route may play an important role in the treatment of breast cancer.  We compare the in vivo efficacy of two potent STS inhibitors, STX64, and STX213, in a xenograft breast cancer model.  MCF-7 cells stably expressing STS cDNA (MCF-7STS) were generated.  Ovariectomized MF-1 female nude mice receiving s.c. injections of estradiol sulfate (E2S) and bearing both MCF-7STS and wild-type MCF-7 (MCF-7WT) tumors were orally treated with STX64 and STX213.  Treatment was given for 49 days followed by a recovery period of 35 days in which animals received only E2S.  Mice were weighed, and tumor measurements were taken weekly.  STX64 and STX213 exhibited potent STS inhibition in vivo.  However, STX213 showed a greater duration of activity.  In vehicle-treated nude mice receiving E2S, tumor vols. increased 5.5-fold for MCF-7WT and 3.8-fold for MCF-7STS after 49 days compared with day 0.  MCF-7WT tumor growth was reduced by 56% by STX213 over the dosing period, and subsequent growth was retarded during the recovery period.  All treatments fully inhibited growth of MCF-7STS tumors, and recovery of these tumors was significantly retarded (P < 0.01).  All compds. completely inhibited liver and tumor STS activity.  Addnl., STS mRNA expression in the MCF-7STS tumors directly correlated with the corresponding STS enzyme activity.  This study indicates that STS inhibitors attenuate hormone-dependent human breast cancer growth and therefore offer a potentially novel treatment for this condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGHsuVYIl_GrVg90H21EOLACvtfcHk0lhu5wdpRtNtUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFShtro%253D&md5=753a3127f21022dfc9d5379f1d4f70ad</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-0632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-0632%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DJhalli%26aufirst%3DR.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DIn%2520vivo%2520efficacy%2520of%2520STX213%252C%2520a%2520second%2520generation%2520sulfatase%2520inhibitor%252C%2520for%2520hormone-dependent%2520breast%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D5543%26epage%3D5549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Stander, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubert, A.</span><span> </span><span class="NLM_article-title">Docking, synthesis, and in vitro evaluation of antimitotic estrone analogs</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1111%2Fj.1747-0285.2010.01064.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=21244635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivF2ktL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2011&pages=173-181&author=A.+Standerauthor=F.+Joubertauthor=A.+Joubert&title=Docking%2C+synthesis%2C+and+in+vitro+evaluation+of+antimitotic+estrone+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Docking, synthesis, and in vitro evaluation of antimitotic estrone analogs</span></div><div class="casAuthors">Stander, Andre; Joubert, Fourie; Joubert, Annie</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-181</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In the present study, Autodock 4.0 was employed to discover potential carbonic anhydrase IX inhibitors that are able to interfere with microtubule dynamics by binding to the Colchicine binding site of tubulin.  Modifications at position 2' of estrone were made to include moieties that are known to improve the antimitotic activity of estradiol analogs.  2-Ethyl-3-O-sulfamoyl-estra-1,3,5(10),15-tetraen-3-ol-17-one (I) and 2-ethyl-3-O-sulfamoyl-estra-1,3,5(10)16-tetraene (II) were synthesized and tested in vitro.  Growth studies were conducted utilizing spectrophotometrical anal. with crystal violet as DNA stain.  Compds. I and II2 were cytotoxic in MCF-7 and MDA-MB-231 tumorigenic and metastatic breast cancer cells, SNO non-keratinizing squamous epithelium cancer cells and HeLa cells after 48 h exposure.  Compd. I inhibited cell proliferation to 50% of the vehicle-treated controls from 110 to 160 nM and II at concns. ranging from 180 to 220 nM.  Confocal microscopy revealed abnormal spindle morphol. in mitotic cells.  Cell cycle anal. showed an increase in the no. of cells in the G2/M fraction after 24 h and an increase in the no. of cell in the sub-G1 fraction after 48 h, indicating that the compds. are antimitotic and able to induce apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdP1H_hWByfrVg90H21EOLACvtfcHk0lhu5wdpRtNtUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivF2ktL4%253D&md5=57822f292789ac6de9285fac2b7eafd0</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2010.01064.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2010.01064.x%26sid%3Dliteratum%253Aachs%26aulast%3DStander%26aufirst%3DA.%26aulast%3DJoubert%26aufirst%3DF.%26aulast%3DJoubert%26aufirst%3DA.%26atitle%3DDocking%252C%2520synthesis%252C%2520and%2520in%2520vitro%2520evaluation%2520of%2520antimitotic%2520estrone%2520analogs%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2011%26volume%3D77%26spage%3D173%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Wolmarans, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mqoco, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stander, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nkandeu, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joubert, A.</span><span> </span><span class="NLM_article-title">Novel estradiol analogue induces apoptosis and autophagy in esophageal carcinoma cells</span> <span class="citation_source-journal">Cell. Mol. Biol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">98</span><span class="NLM_x">–</span> <span class="NLM_lpage">115</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=98-115&author=E.+Wolmaransauthor=T.+V.+Mqocoauthor=A.+Standerauthor=S.+D.+Nkandeuauthor=K.+Sippelauthor=R.+McKennaauthor=A.+Joubert&title=Novel+estradiol+analogue+induces+apoptosis+and+autophagy+in+esophageal+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWolmarans%26aufirst%3DE.%26aulast%3DMqoco%26aufirst%3DT.%2BV.%26aulast%3DStander%26aufirst%3DA.%26aulast%3DNkandeu%26aufirst%3DS.%2BD.%26aulast%3DSippel%26aufirst%3DK.%26aulast%3DMcKenna%26aufirst%3DR.%26aulast%3DJoubert%26aufirst%3DA.%26atitle%3DNovel%2520estradiol%2520analogue%2520induces%2520apoptosis%2520and%2520autophagy%2520in%2520esophageal%2520carcinoma%2520cells%26jtitle%3DCell.%2520Mol.%2520Biol.%2520Lett.%26date%3D2014%26volume%3D10%26spage%3D98%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Raobaikady, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2803%2900049-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=12711022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFWgsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=351-358&author=B.+Raobaikadyauthor=A.+Purohitauthor=S.+K.+Chanderauthor=L.+W.+L.+Wooauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+MCF-7+breast+cancer+cell+proliferation+and+in+vivo+steroid+sulphatase+activity+by+2-methoxyoestradiol-bis-sulphamate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate</span></div><div class="casAuthors">Raobaikady, Bindumalini; Purohit, Atul; Chander, Surinder K.; Woo, L. W. Lawrence; Leese, Mathew P.; Potter, Barry V. L.; Reed, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">351-358</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The endogenous estrogen metabolite, 2-methoxyoestradiol (2-MeOE2) inhibits the growth of breast cancer cells and is also a potent anti-angiogenic agent.  The authors have previously shown that the 3-sulfamoylated derivs. of 2-methoxyoestrogens are more potent than the non-sulfamoylated compds.  In this study, the authors have compared the abilities of 2-methoxyoestradiol-bis-sulfamate (2-MeOE2bisMATE) and 2-MeOE2 to inhibit the growth of MCF-7 breast cancer cells.  Both compds. inhibited cell growth with the IC50 for 2-MeOE2bisMATE (0.4 μM) being six-fold lower than that for 2-MeOE2 (2.5 μM).  Estrogen sulfamates are potent inhibitors of steroid sulfatase (STS) activity.  2-MeOE2bisMATE was found to retain its STS inhibitory activity and in a placental microsome assay system it was equipotent with estrone-3-O-sulfamate (EMATE).  An in vivo study was also carried out to compare the potency of 2-MeOE2bisMATE with that of EMATE and the non-steroidal STS inhibitor, 667 coumarin sulfamate (667 COUMATE).  After a single oral dose (10 mg/kg) some recovery of STS activity was detected by day 3 (10%) with activity partially restored (55%) by day 7 after administration of 667 COUMATE.  For the other two steroidal compds., STS activity remained almost completely inactivated for up to 5 days with complete restoration of activity occurring by day 15.  The anti-proliferative and STS inhibitory properties of 2-MeOE2bisMATE suggest that it has considerable potential for development as a novel anti-cancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxK1ey1nwzvrVg90H21EOLACvtfcHk0ljFn-BWUYRmuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFWgsLw%253D&md5=264779e33b127c81a9acbf26805ea72e</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900049-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900049-9%26sid%3Dliteratum%253Aachs%26aulast%3DRaobaikady%26aufirst%3DB.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520MCF-7%2520breast%2520cancer%2520cell%2520proliferation%2520and%2520in%2520vivo%2520steroid%2520sulphatase%2520activity%2520by%25202-methoxyoestradiol-bis-sulphamate%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D84%26spage%3D351%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Suzuki, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiol-bis-sulphamate</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">278</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2803%2900035-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=12711013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFWgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=269-278&author=R.+N.+Suzukiauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Growth+inhibition+of+multi-drug-resistant+breast+cancer+cells+by+2-methoxyoestradiol-bis-sulphamate+and+2-ethyloestradiol-bis-sulphamate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiol-bis-sulphamate</span></div><div class="casAuthors">Suzuki, R. N.; Newman, S. P.; Purohit, A.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">269-278</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">There is currently considerable interest in the use of the endogenous estrogen metabolite, 2-methoxyestradiol (2-MeOE2) for the treatment and prevention of breast cancer.  The authors have previously shown that sulfamoylation of 2-MeOE2 and related derivs. greatly enhances their ability to inhibit the proliferation of ER+ and ER- breast cancer cells.  In this study, the authors have compared the abilities of 2-methoxyestradiol-bis-sulfamate (2-MeOE2bisMATE) and 2-ethylestradiol-bis-sulfamate (2-EtE2bisMATE) with that of 2-MeOE2 to inhibit the proliferation of breast cancer cells when grown on three different substrata: plastic, collagen I and Matrigel.  The human breast cell line MCF-7 was utilized for these studies together with its doxorubicin resistant variant, MCF-7 DOX40 and mitoxantrone resistant variant, MCF-7 MR, as a longitudinal model of in vitro drug resistance.  On a plastic substratum all three cell lines were sensitive to the effects of 2-MeOE2bisMATE and 2-EtE2bisMATE, whereas MCF-7 cells and the MCF-MR variant cells were resistant to the effects of 2-MeOE2 at 1 μM.  The sensitivity of the cell lines to those compds. also remained significant when grown on more physiol. substrata.  All of the drugs tested arrested cells in the G2/M phase of the cell cycle.  The finding that breast cancer cells that are resistant to conventional chemotherapeutic agents remain sensitive to 2-substituted estrogen sulfamates offers considerable potential for the treatment of women with drug-resistant breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb6AE18dasuLVg90H21EOLACvtfcHk0ljFn-BWUYRmuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFWgs70%253D&md5=0dcdac441bf459b75af30dd74094b91d</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900035-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900035-9%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DR.%2BN.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DGrowth%2520inhibition%2520of%2520multi-drug-resistant%2520breast%2520cancer%2520cells%2520by%25202-methoxyoestradiol-bis-sulphamate%2520and%25202-ethyloestradiol-bis-sulphamate%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D84%26spage%3D269%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The effects of 2-methoxy oestrogens and their sulphamoylated derivatives in conjunction with TNF– on endothelial and fibroblast cell growth, morphology and apoptosis</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2803%2900269-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=14568571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot1yrt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2003&pages=189-196&author=Y.+T.+Hoauthor=S.+P.+Newmanauthor=A.+Purohitauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+effects+of+2-methoxy+oestrogens+and+their+sulphamoylated+derivatives+in+conjunction+with+TNF%E2%80%93+on+endothelial+and+fibroblast+cell+growth%2C+morphology+and+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of 2-methoxy oestrogens and their sulphamoylated derivatives in conjunction with TNF-α on endothelial and fibroblast cell growth, morphology and apoptosis</span></div><div class="casAuthors">Ho, Y. T.; Newman, S. P.; Purohit, A.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-196</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">: Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">2-Methoxyoestradiol (2-MeOE2) is a potent anti-angiogenic agent.  Its 3- and 17-sulfamoylated derivs. have been demonstrated to induce G2-M cell cycle arrest and apoptosis in breast cancer cells in vitro as well as tumor regression in rats in vivo with greater potency than the parent estrogen.  To det. whether the anti-cancer properties of these derivs. can be synergistically enhanced with low-dose TNF-α co-treatment, the authors investigated the effects of these treatments in adult human fibroblasts and human umbilical vein endothelial cells (HUVECs).  Treatment of fibroblasts with 0.1 μM 2-methoxyoestradiol-3,17-bis sulfamate (2-MeOE2bisMATE) but not 2-MeOE2 caused a reversible morphol. change and induced G2-M arrest (from 12 to 33%) but not subsequent apoptosis.  In contrast, treatment of HUVECs did not induce morphol. change or G2-M arrest.  Using a nucleosomal ELISA assay, the authors showed that TNF-α (20 ng/mL) combination treatment synergistically increases 0.1 μM 2-MeOE2bisMATE-induced but not 0.1 μM 2-MeOE2-induced apoptosis in HUVECs.  These results suggest that TNF-α co-treatment may be a beneficial method of increasing the potency of 2-substituted estrogens as anti-angiogenic agents through synergistic induction of apoptosis in endothelial cells while maintaining low cytotoxicity to fibroblasts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovk_07wL36GbVg90H21EOLACvtfcHk0ljB-op8qxXOgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot1yrt7w%253D&md5=51c5947dcf32d3a04ec70b064aee24a0</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900269-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900269-3%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520effects%2520of%25202-methoxy%2520oestrogens%2520and%2520their%2520sulphamoylated%2520derivatives%2520in%2520conjunction%2520with%2520TNF%25E2%2580%2593%2520on%2520endothelial%2520and%2520fibroblast%2520cell%2520growth%252C%2520morphology%2520and%2520apoptosis%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D86%26spage%3D189%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Wood, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouzakiti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span> </span><span class="NLM_article-title">2-MeOE2bisMATE induces caspase-dependent apoptosis in CAL51 breast cancer cells and overcomes resistance to TRAIL via cooperative activation of caspases</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=323-332&author=L.+Woodauthor=M.+P.+Leeseauthor=A.+Mouzakitiauthor=A.+Purohitauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=G.+Packham&title=2-MeOE2bisMATE+induces+caspase-dependent+apoptosis+in+CAL51+breast+cancer+cells+and+overcomes+resistance+to+TRAIL+via+cooperative+activation+of+caspases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DL.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DMouzakiti%26aufirst%3DA.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26atitle%3D2-MeOE2bisMATE%2520induces%2520caspase-dependent%2520apoptosis%2520in%2520CAL51%2520breast%2520cancer%2520cells%2520and%2520overcomes%2520resistance%2520to%2520TRAIL%2520via%2520cooperative%2520activation%2520of%2520caspases%26jtitle%3DApoptosis%26date%3D2004%26volume%3D9%26spage%3D323%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Utsumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaukroger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2005.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15862969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVKksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=219-227&author=T.+Utsumiauthor=M.+P.+Leeseauthor=S.+K.+Chanderauthor=K.+Gaukrogerauthor=A.+Purohitauthor=S.+P.+Newmanauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+effects+of+2-methoxyoestrogen+sulphamates+on+the+in+vitro+and+in+vivo+proliferation+of+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of 2-methoxyoestrogen sulfamates on the in vitro and in vivo proliferation of breast cancer cells</span></div><div class="casAuthors">Utsumi, T.; Leese, M. P.; Chander, S. K.; Gaukroger, K.; Purohit, A.; Newman, S. P.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">219-227</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">2-Methoxyoestrogen sulfamates are a new class of compds., which inhibit breast cancer cell proliferation and are also potent inhibitors of steroid sulfatase (STS) activity.  In the present study, we have used two cell proliferation assays (MTS and AB) to identify potent new compds. in this class.  Similar IC50 values were obtained using these assays with two of the most potent compds. identified being 2-methoxyoestradiol-bis-sulfamate (2-MeOE2bisMATE) and 2-methoxyoestradiol-17β-cyanomethyl-3-O-sulfamate (2-MeOE2CyMATE).  Both compds. inhibited the proliferation of MCF-7 (ER+) and MDA-MB-231 (ER-) breast cancer cells.  Using the AB assay, which allows repeat measurements of cell proliferation without killing cells, both compds. were shown to inhibit cell proliferation in an irreversible manner.  As STS may be involved in the removal of the sulfamoyl moiety of these compds., which could reduce their potency, their ability to inhibit the proliferation of MCF-7 cells transfected with the cDNA for STS was also examd.  Although the STS activity was 20-fold higher in these cells than in non-transfected MCF-7 cells, no decrease in the ability of these compds. to inhibit cell proliferation was detected.  To test the efficacy of these compds. in vivo, nude mice were inoculated with MCF-7 cells in Matrigel and stimulated to grow with estradiol.  Three weeks after the oral administration of 2-MeOE2bisMATE or 2-MeOE2CyMATE (20 mg/kg/day, 5 days/wk) tumor vols. had regressed by 52% and 22%, resp.  Both compds. also inhibited liver and tumor STS activity by >90%.  The potent anti-proliferative effects of these compds., and their ability to inhibit tumor growth and STS activity in vivo, indicates that they are suitable for development as novel therapeutic agents, which should be active against a wide range of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdtsk486WMBLVg90H21EOLACvtfcHk0lh9d_-FKhHJ1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVKksLw%253D&md5=ab0ebb6c2671365750741c09e380f050</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2005.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2005.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DUtsumi%26aufirst%3DT.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DGaukroger%26aufirst%3DK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520effects%2520of%25202-methoxyoestrogen%2520sulphamates%2520on%2520the%2520in%2520vitro%2520and%2520in%2520vivo%2520proliferation%2520of%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D94%26spage%3D219%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">3,17-Disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in vitro and in vivo anticancer activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4431</span><span class="NLM_x">–</span> <span class="NLM_lpage">4443</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070405v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4431-4443&author=C.+Bubertauthor=M.+P.+Leeseauthor=M.+F.+Mahonauthor=E.+Ferrandisauthor=S.+Regis-Lydiauthor=P.+G.+Kasprzykauthor=S.+P.+Newmanauthor=Y.+T.+Hoauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=3%2C17-Disubstituted+2-alkylestra-1%2C3%2C5%2810%29-trien-3-ol+derivatives%3A+synthesis%2C+in+vitro+and+in+vivo+anticancer+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm070405v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070405v%26sid%3Dliteratum%253Aachs%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D3%252C17-Disubstituted%25202-alkylestra-1%252C3%252C5%252810%2529-trien-3-ol%2520derivatives%253A%2520synthesis%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520anticancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4431%26epage%3D4443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">2-Substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7683</span><span class="NLM_x">–</span> <span class="NLM_lpage">7696</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060705x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7683-7696&author=M.+P.+Leeseauthor=B.+Leblondauthor=A.+Smithauthor=S.+P.+Newmanauthor=A.+Di+Fioreauthor=G.+De+Simoneauthor=C.+T.+Supuranauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=2-Substituted+estradiol+bis-sulfamates%2C+multitargeted+antitumor+agents%3A+synthesis%2C+in+vitro+SAR%2C+protein+crystallography%2C+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm060705x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060705x%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DLeblond%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3D2-Substituted%2520estradiol%2520bis-sulfamates%252C%2520multitargeted%2520antitumor%2520agents%253A%2520synthesis%252C%2520in%2520vitro%2520SAR%252C%2520protein%2520crystallography%252C%2520and%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7683%26epage%3D7696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">D’Amato, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span> </span><span class="NLM_article-title">2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">3964</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=3964&author=R.+J.+D%E2%80%99Amatoauthor=C.+M.+Linauthor=E.+Flynnauthor=J.+Folkmanauthor=E.+Hamel&title=2-Methoxyestradiol%2C+an+endogenous+mammalian+metabolite%2C+inhibits+tubulin+polymerization+by+interacting+at+the+colchicine+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%25E2%2580%2599Amato%26aufirst%3DR.%2BJ.%26aulast%3DLin%26aufirst%3DC.%2BM.%26aulast%3DFlynn%26aufirst%3DE.%26aulast%3DFolkman%26aufirst%3DJ.%26aulast%3DHamel%26aufirst%3DE.%26atitle%3D2-Methoxyestradiol%252C%2520an%2520endogenous%2520mammalian%2520metabolite%252C%2520inhibits%2520tubulin%2520polymerization%2520by%2520interacting%2520at%2520the%2520colchicine%2520site%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D3964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Klauber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parangi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amato, R. J.</span><span> </span><span class="NLM_article-title">Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">86</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=8988045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK2sXjvFOmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=81-86&author=N.+Klauberauthor=S.+Parangiauthor=E.+Flynnauthor=E.+Hamelauthor=R.+J.+D%E2%80%99Amato&title=Inhibition+of+angiogenesis+and+breast+cancer+in+mice+by+the+microtubule+inhibitors+2-methoxyestradiol+and+taxol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol</span></div><div class="casAuthors">Klauber, Nancy; Parangi, Sareh; Flynn, Evelyn; Hamel, Ernest; D'Amato, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-86</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">2-Methoxyestradiol (2-ME), an endogenous estrogen metabolite which disrupts microtubule function, has been shown to inhibit proliferating cells in vitro and suppress certain murine tumors in vivo.  In vitro screening has detd. that breast cancer cell lines are most sensitive to inhibition by 2-ME.  Addnl., 2-ME has been shown to inhibit angiogenesis in vitro.  We tested whether 2-ME suppresses cytokine-induced angiogenesis in vivo and inhibits growth of a human breast carcinoma in severe combined immunodeficient mice.  A model of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF)-induced corneal neovascularization in C57BL/6 mice was used to evaluate the antiangiogenic effects of 2-ME and other microtubule inhibitors such as Taxol, vincristine, and colchicine.  2-ME (150 mg/kg p.o.) inhibited bFGF and VEGF-induced neovascularization by 39% and 54%, resp.  Taxol (6 mg/kg i.p.) inhibited bFGF and VEGF-induced neovascularization by 45% and 37%, resp.  Vincristine (0.2 mg/kg i.p.) and colchicine (0.25 mg/kg i.p.) had no effect.  Treatment with 2-ME (75 mg/kg p.o.) for 1 mo suppressed the growth of a human breast carcinoma in mice by 60% without toxicity.  Recognition of the antiangiogenic and antitumor properties of 2-ME and taxol may be crucial in planning clin. applications to angiogenesis-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbq_DgfUImq7Vg90H21EOLACvtfcHk0lieaaBRi0MvRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjvFOmtw%253D%253D&md5=88fbe8611dfdb66530160abe5318c2d7</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlauber%26aufirst%3DN.%26aulast%3DParangi%26aufirst%3DS.%26aulast%3DFlynn%26aufirst%3DE.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amato%26aufirst%3DR.%2BJ.%26atitle%3DInhibition%2520of%2520angiogenesis%2520and%2520breast%2520cancer%2520in%2520mice%2520by%2520the%2520microtubule%2520inhibitors%25202-methoxyestradiol%2520and%2520taxol%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D81%26epage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Dahut, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakhani, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arlen, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNally, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nquyen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ventiz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparreboom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W.</span><span> </span><span class="NLM_article-title">Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.4161%2Fcbt.5.1.2349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=16357512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvVSntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=22-27&author=W.+L.+Dahutauthor=N.+J.+Lakhaniauthor=J.+L.+Gulleyauthor=P.+M.+Arlenauthor=E.+C.+Kohnauthor=H.+Kotzauthor=D.+McNallyauthor=A.+Parrauthor=D.+Nquyenauthor=S.+X.+Yangauthor=S.+M.+Steinbergauthor=J.+Ventizauthor=A.+Sparreboomauthor=W.+Figg&title=Phase+I+clinical+trial+of+oral+2-methoxyestradiol%2C+an+antiangiogenic+and+apoptotic+agent%2C+in+patients+with+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors</span></div><div class="casAuthors">Dahut, William L.; Lakhani, Nehal J.; Gulley, James L.; Arlen, Philip M.; Kohn, Elise C.; Kotz, Herbert; McNally, Debbie; Parr, Allyson; Nguyen, Diana; Yang, Sherry X.; Steinberg, Seth M.; Venitz, Jurgen; Sparreboom, Alex; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-27</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Purpose: To det. the max.-tolerated dose (MTD) and toxicity profile of the novel anticancer agent, 2-methoxyestradiol (2ME2) administered orally, in patients with solid tumors.  Materials and methods: Twenty patients with refractory solid tumors were enrolled.  2ME2 was given orally starting at 400 mg bid with dose escalation until 3000 mg bid.  Tumor biopsies were taken before and after starting the drug to assess for microvessel d. by CD 31 and cell proliferation by Ki67 immunohistochem.  Serial plasma samples collected up to 50 h after first single oral dose for characterization of pharmacokinetics, were analyzed using liq. chromatog. tandem mass-spectrometry.  Results: Eleven men and nine women received 2ME2 at dose levels of 400 mg bid (n = 3), 800 mg bid (n = 3), 1600 mg bid (n = 6), 2200 mg bid (n = 5) and 3000 mg bid (n = 3).  There were no dose limiting toxicities, therefore the MTD was not defined.  There was one episode of grade 4 angioedema in the 1600 mg bid dose level 38 days into 2ME2 treatment.  Other toxicities were mild to moderate.  A patient with clear cell carcinoma of the ovary had a partial response at 1600 mg bid dose level lasting over three years.  Conclusion: MTD for 2ME2 was not reached at dose of 3000 mg bid.  The trial was closed due to extremely low plasma concns. of 2ME2 relative to the doses administered.  2ME2 treatment had no effect on microvessel d. (CD31 immunostaining) and cell proliferation (Ki-67 immunostaining).  A new formulation of 2ME2 with improved bioavailability is currently being developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnn5SfJSuSB7Vg90H21EOLACvtfcHk0lieaaBRi0MvRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvVSntro%253D&md5=4e4021491980ad34411e4637c35ebbc9</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.4161%2Fcbt.5.1.2349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.5.1.2349%26sid%3Dliteratum%253Aachs%26aulast%3DDahut%26aufirst%3DW.%2BL.%26aulast%3DLakhani%26aufirst%3DN.%2BJ.%26aulast%3DGulley%26aufirst%3DJ.%2BL.%26aulast%3DArlen%26aufirst%3DP.%2BM.%26aulast%3DKohn%26aufirst%3DE.%2BC.%26aulast%3DKotz%26aufirst%3DH.%26aulast%3DMcNally%26aufirst%3DD.%26aulast%3DParr%26aufirst%3DA.%26aulast%3DNquyen%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DS.%2BX.%26aulast%3DSteinberg%26aufirst%3DS.%2BM.%26aulast%3DVentiz%26aufirst%3DJ.%26aulast%3DSparreboom%26aufirst%3DA.%26aulast%3DFigg%26aufirst%3DW.%26atitle%3DPhase%2520I%2520clinical%2520trial%2520of%2520oral%25202-methoxyestradiol%252C%2520an%2520antiangiogenic%2520and%2520apoptotic%2520agent%252C%2520in%2520patients%2520with%2520solid%2520tumors%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D22%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Peyrat, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brion, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alami, M.</span><span> </span><span class="NLM_article-title">Synthetic 2-methoxyestradiol derivatives: structure–activity relationships</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4142</span><span class="NLM_x">–</span> <span class="NLM_lpage">4156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.2174%2F092986712802430072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=22709003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFWktrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=4142-4156&author=J.-F.+Peyratauthor=J.-D.+Brionauthor=M.+Alami&title=Synthetic+2-methoxyestradiol+derivatives%3A+structure%E2%80%93activity+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic 2-methoxyestradiol derivatives: structure-activity relationships</span></div><div class="casAuthors">Peyrat, Jean-Francois; Brion, Jean-Daniel; Alami, Mouad</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4142-4156</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  2-Methoxyestradiol (2ME2), a natural metabolite of estradiol which has no estrogenic activity, is a potent antitumor and anti-angiogenic compd., currently undergoing clin. trials for treatment of a variety of cancers.  In the last two decades, an ever increasing no. of synthetic 2-methoxyestradiol analogs have been reported.  Structural changes include A/B/C/D-rings modification, homologation, aromatization, and introduction of various substituents on C-2 position along with substitution of alkyl and ethynyl groups for the 17-hydroxy function.  In this review, an attempt has been made to compile the structure-activity relationships of various synthesized 2-methoxyestradiol analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1Os9-GBErZbVg90H21EOLACvtfcHk0ljxDdCX_nfKjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFWktrvN&md5=ab71f76ca02723c4c66e63af60c9b31c</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.2174%2F092986712802430072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712802430072%26sid%3Dliteratum%253Aachs%26aulast%3DPeyrat%26aufirst%3DJ.-F.%26aulast%3DBrion%26aufirst%3DJ.-D.%26aulast%3DAlami%26aufirst%3DM.%26atitle%3DSynthetic%25202-methoxyestradiol%2520derivatives%253A%2520structure%25E2%2580%2593activity%2520relationships%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D4142%26epage%3D4156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCarthy-Morrogh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The effect of 2-methoxyoestrone-3-<i>O</i>-sulphamate on the growth of breast cancer cells and induced mammary tumors</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">584</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2F%28SICI%291097-0215%2820000215%2985%3A4%3C584%3A%3AAID-IJC22%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10699934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A280%3ADC%252BD3c7msVGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2000&pages=584-589&author=A.+Purohitauthor=H.+A.+M.+Hejazauthor=L.+Waldenauthor=L.+MacCarthy-Morroghauthor=G.+Packhamauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+effect+of+2-methoxyoestrone-3-O-sulphamate+on+the+growth+of+breast+cancer+cells+and+induced+mammary+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours</span></div><div class="casAuthors">Purohit A; Hejaz H A; Walden L; MacCarthy-Morrogh L; Packham G; Potter B V; Reed M J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cancer. Journal international du cancer</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">584-9</span>
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">2-Methoxyoestrogens are emerging as a new class of drug that can inhibit tumour growth and angiogenesis.  As sulphamoylation of oestrogens enhances their potency and bioavailability we have synthesized 2-methoxyoestrone-3-O-sulphamate (2-MeOEMATE) and compared its ability to inhibit the proliferation of breast cancer cells with that of 2-methoxyoestrone (2-MeOE1). 2-MeOEMATE (1 microM) inhibited the growth of oestrogen receptor positive MCF-7 breast cancer cells by 52% whereas 2-MeOE1 had little effect at this concentration. 2-MeOEMATE also inhibited the growth of oestrogen receptor negative MDA-MB-231 breast cancer cells.  Exposure of cells to 2-MeOEMATE caused them to round up and become detached suggesting that this compound may induce cells to undergo apoptosis.  Cell cycle analysis revealed that 2-MeOEMATE caused cells to arrest in the G(2)/M phase with the increase in G(2)/M arrested cells being detectable by 12 hr.  Exposure of MCF-7 cells to 2 L-MeOEMATE for 24 hr followed by culture in drug-free medium for 24 hr did not reverse the arrest of cells in the G(2)/M phase.  TUNEL analysis confirmed that 2-MeOEMATE induced apoptosis in a significant proportion of treated MCF-7 cells.  In an in vivo study, employing nitrosomethylurea-induced mammary tumours in intact rats, 2-MeOE1 (20mg/kg/d, p.o. for 11 days) had little effect on tumour growth.  In contrast, the same dose of 2-MeOEMATE resulted in the almost complete regression of 2/3 tumours over an 11-day period.  We conclude that 2-MeOEMATE should have considerable therapeutic potential for the treatment of breast tumours.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqkhlCxw4mrynGiHuhFGv8fW6udTcc2eZDQAxVeqGfmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7msVGkug%253D%253D&md5=75a9c5a896a1a00886a9c17cf2cbe241</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0215%2820000215%2985%3A4%3C584%3A%3AAID-IJC22%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0215%252820000215%252985%253A4%253C584%253A%253AAID-IJC22%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DWalden%26aufirst%3DL.%26aulast%3DMacCarthy-Morrogh%26aufirst%3DL.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520effect%2520of%25202-methoxyoestrone-3-O-sulphamate%2520on%2520the%2520growth%2520of%2520breast%2520cancer%2520cells%2520and%2520induced%2520mammary%2520tumors%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2000%26volume%3D85%26spage%3D584%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Sattler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinnan, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pride, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gramlich, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Even, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraeft, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">2-Methoxyestradiol alters cell motility, migration, and adhesion</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=289-296&author=M.+Sattlerauthor=L.+R.+Quinnanauthor=Y.+B.+Prideauthor=J.+L.+Gramlichauthor=S.+C.+Chuauthor=G.+C.+Evenauthor=S.-K.+Kraeftauthor=L.+B.+Chenauthor=R.+Salgia&title=2-Methoxyestradiol+alters+cell+motility%2C+migration%2C+and+adhesion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSattler%26aufirst%3DM.%26aulast%3DQuinnan%26aufirst%3DL.%2BR.%26aulast%3DPride%26aufirst%3DY.%2BB.%26aulast%3DGramlich%26aufirst%3DJ.%2BL.%26aulast%3DChu%26aufirst%3DS.%2BC.%26aulast%3DEven%26aufirst%3DG.%2BC.%26aulast%3DKraeft%26aufirst%3DS.-K.%26aulast%3DChen%26aufirst%3DL.%2BB.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3D2-Methoxyestradiol%2520alters%2520cell%2520motility%252C%2520migration%252C%2520and%2520adhesion%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26spage%3D289%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Yue, T.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louden, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillarsetti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lysko, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feuerstein, G. Z.</span><span> </span><span class="NLM_article-title">2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">962</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1997&pages=951-962&author=T.-L.+Yueauthor=X.+Wangauthor=C.+S.+Loudenauthor=S.+Guptaauthor=K.+Pillarsettiauthor=J.-L.+Guauthor=T.+K.+Hartauthor=P.+G.+Lyskoauthor=G.+Z.+Feuerstein&title=2-Methoxyestradiol%2C+an+endogenous+estrogen+metabolite%2C+induces+apoptosis+in+endothelial+cells+and+inhibits+angiogenesis%3A+possible+role+for+stress-activated+protein+kinase+signaling+pathway+and+Fas+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DT.-L.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLouden%26aufirst%3DC.%2BS.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DPillarsetti%26aufirst%3DK.%26aulast%3DGu%26aufirst%3DJ.-L.%26aulast%3DHart%26aufirst%3DT.%2BK.%26aulast%3DLysko%26aufirst%3DP.%2BG.%26aulast%3DFeuerstein%26aufirst%3DG.%2BZ.%26atitle%3D2-Methoxyestradiol%252C%2520an%2520endogenous%2520estrogen%2520metabolite%252C%2520induces%2520apoptosis%2520in%2520endothelial%2520cells%2520and%2520inhibits%2520angiogenesis%253A%2520possible%2520role%2520for%2520stress-activated%2520protein%2520kinase%2520signaling%2520pathway%2520and%2520Fas%2520expression%26jtitle%3DMol.%2520Pharmacol.%26date%3D1997%26volume%3D51%26spage%3D951%26epage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Reiser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Way, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, C.</span><span> </span><span class="NLM_article-title">Inhibition of normal and experimental angiotumor endothelial cell proliferation and cell cycle progression by 2-methoxyestradiol</span> <span class="citation_source-journal">Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">219</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.3181%2F00379727-219-44334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=9824543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADyaK1cXnslyqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=219&publication_year=1998&pages=211-216&author=F.+Reiserauthor=D.+Wayauthor=M.+Bernasauthor=M.+Witteauthor=C.+Witte&title=Inhibition+of+normal+and+experimental+angiotumor+endothelial+cell+proliferation+and+cell+cycle+progression+by+2-methoxyestradiol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of normal and experimental angiotumor endothelial cell proliferation and cell cycle progression by 2-methoxyestradiol</span></div><div class="casAuthors">Reiser, F.; Way, D.; Bernas, M.; Witte, M.; Witte, C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Society for Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">219</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-216</span>CODEN:
                <span class="NLM_cas:coden">PSEBAA</span>;
        ISSN:<span class="NLM_cas:issn">0037-9727</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">With rapid growth and metab., aggressive cancers require an extensive vascular network, termed tumor angiogenesis.  The body produces a variety of natural angiogenic inhibitors, among which is the mammalian estrogen metabolite, 2-methoxyestradiol (2-MeOE2).  In this study, we compared the effects of 2-MeOE2 on a human umbilical vein cell line (HUVEC-C) and on an immortal, angiotumor-producing rat sinusoidal endothelial cell line (RSE-1).  In vitro, the effects of varying concns. of 2-MeOE2 from 0.01-100.0 μM were measured with cell counts and compared to control cells.  HUVEC-C had an ED50 ∼3.5 μM with ∼27% inhibition of cell growth whereas RSE-1 had an ED50 ∼2.2 μM with ∼50% inhibition of cell growth compared with controls.  The lowest concn. with maximal effect was 10.0 μM 2-MeOE2 for both cell lines.  Using this concn., flow cytometric anal. of cell cycles was performed with propidium iodide stained DNA of HUVEC-C and RSE-1 at 24 and 48 h.  Both demonstrated a significant block at G2M of the cell cycle.  At 48 h, HUVEC-C had 32% of cells in G2M (control = 9% G2M), and RSE-1 had 36% of cells in G2M (control = 18% G2M).  These findings demonstrate a strong in vitro antiproliferative effect of 2-MeOE2 on normal dividing endothelial as well as angiotumor cells mediated through a cell cycle-specific block at G2M.  The antiendothelial, antiangiotumor effect of 2-MeOE2 supports its potential as a therapeutic agent against solid organ cancers, benign or malignant vascular growths, and other pathol. states dependent on angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTRGkZJDPuCLVg90H21EOLACvtfcHk0lh4AgA6LMnnfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslyqtLY%253D&md5=2eae49b602a94f37b07c8cd7578f3364</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.3181%2F00379727-219-44334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3181%252F00379727-219-44334%26sid%3Dliteratum%253Aachs%26aulast%3DReiser%26aufirst%3DF.%26aulast%3DWay%26aufirst%3DD.%26aulast%3DBernas%26aufirst%3DM.%26aulast%3DWitte%26aufirst%3DM.%26aulast%3DWitte%26aufirst%3DC.%26atitle%3DInhibition%2520of%2520normal%2520and%2520experimental%2520angiotumor%2520endothelial%2520cell%2520proliferation%2520and%2520cell%2520cycle%2520progression%2520by%25202-methoxyestradiol%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D1998%26volume%3D219%26spage%3D211%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Fotsis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepper, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adlercreutz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montesano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawroth, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweigerer, L.</span><span> </span><span class="NLM_article-title">The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=1994&pages=237-239&author=T.+Fotsisauthor=Y.+Zhangauthor=M.+S.+Pepperauthor=H.+Adlercreutzauthor=R.+Montesanoauthor=P.+P.+Nawrothauthor=L.+Schweigerer&title=The+endogenous+estrogen+metabolite+2-methoxyestradiol+inhibits+angiogenesis+and+suppresses+tumor+growth"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFotsis%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPepper%26aufirst%3DM.%2BS.%26aulast%3DAdlercreutz%26aufirst%3DH.%26aulast%3DMontesano%26aufirst%3DR.%26aulast%3DNawroth%26aufirst%3DP.%2BP.%26aulast%3DSchweigerer%26aufirst%3DL.%26atitle%3DThe%2520endogenous%2520estrogen%2520metabolite%25202-methoxyestradiol%2520inhibits%2520angiogenesis%2520and%2520suppresses%2520tumor%2520growth%26jtitle%3DNature%26date%3D1994%26volume%3D368%26spage%3D237%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">MacCarthy-Morrogh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span> </span><span class="NLM_article-title">Differential effects of estrone and estrone-3-<i>O</i>-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">5441</span><span class="NLM_x">–</span> <span class="NLM_lpage">5450</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=11034086" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3cXns1ehtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=5441-5450&author=L.+MacCarthy-Morroghauthor=P.+A.+Townsendauthor=A.+Purohitauthor=H.+A.+M.+Hejazauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=G.+Packham&title=Differential+effects+of+estrone+and+estrone-3-O-sulfamate+derivatives+on+mitotic+arrest%2C+apoptosis%2C+and+microtubule+assembly+in+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells</span></div><div class="casAuthors">MacCarthy-Morrogh, Lucy; Townsend, Paul A.; Purohit, Atul; Hejaz, Hatem A. M.; Potter, Barry V. L.; Reed, Michael J.; Packham, Graham</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5441-5450</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">There is considerable interest in the potential use of estrogen derivs. for the treatment and prevention of breast cancer.  We demonstrated previously that the sulfamoylated estrone deriv. 2-methoxyestrone-3-O-sulfamate (2-MeOEMATE) induced G2-M cell cycle arrest and modest levels of apoptosis in breast cancer cells in vitro, whereas the parent estrone deriv., 2-methoxyestrone, did not, 2-MeOEMATE also induced breast tumor regression in vivo in intact rats.  To further explore the significance of sulfamoylation on the anticancer activity of estrone derivs. and to elucidate their mechanism of action, we synthesized two addnl. agents, 2-ethylestrone and 2-ethylestrone-3-O-sulfamate (2-EtEMATE).  2-MeOEMATE and 2-EtEMATE inhibited the growth of a panel of estrogen receptor-neg. and -pos. breast cancer cell lines in vitro, induced mitotic arrest and apoptosis, and suppressed the long-term clonogenic potential of MCF7 and CAL51 breast cancer cells.  In each assay, the sulfamoylated estrone derivs. were > 10-fold more potent than their parent compds.  The sulfamoylated estrone derivs. were also significantly more potent inhibitors of cell growth than the previously studied endogenous estradiol metabolite 2-methoxyestradiol.  2-MeOEMATE and 2-EtEMATE functioned as antimicrotubule agents and inhibited the ability of paclitaxel to promote tubulin assembly in vitro.  Like other antimicrotubule agents, the sulfamoylated estrone derivs. induced BCL-2 and BCL-XL phosphorylation and increased p53 expression.  2-MeOEMATE and 2-EtEMATE are novel antimicrotubule agents that have potent anticancer activity in breast cancer cells in vitro and may be beneficial as anticancer agents in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwuuBiQck6dLVg90H21EOLACvtfcHk0lh4AgA6LMnnfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXns1ehtr8%253D&md5=07ffe177df9adffa388318cc283891ff</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacCarthy-Morrogh%26aufirst%3DL.%26aulast%3DTownsend%26aufirst%3DP.%2BA.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPackham%26aufirst%3DG.%26atitle%3DDifferential%2520effects%2520of%2520estrone%2520and%2520estrone-3-O-sulfamate%2520derivatives%2520on%2520mitotic%2520arrest%252C%2520apoptosis%252C%2520and%2520microtubule%2520assembly%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D5441%26epage%3D5450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholson, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Non-steroidal and steroidal sulfamates: new drugs for cancer therapy</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0303-7207%2800%2900428-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=11165021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsVagsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2001&pages=129-135&author=A.+Purohitauthor=L.+W.+L.+Wooauthor=D.+Barowauthor=H.+A.+M.+Hejazauthor=R.+I.+Nicholsonauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Non-steroidal+and+steroidal+sulfamates%3A+new+drugs+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Non-steroidal and steroidal sulfamates: new drugs for cancer therapy</span></div><div class="casAuthors">Purohit, A.; Woo, L. W. L.; Barrow, D.; Hejaz, H. A. M.; Nicholson, R. I.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">129-135</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The development of inhibitors to block the formation of estrone and 5-androstenediol from sulfated precursors is an important new strategy for the treatment of breast cancer.  In this study a series of tricyclic coumarin sulfamates (665-668 COUMATE) and a tricyclic oxepin sulfamate have been synthesized and tested for their ability to inhibit estrone sulfatase activity (E1-STS).  In addn. the effect of the steroid-based E1-STS inhibitor, 2-methoxyestrone-3-O-sulfamate (2-MeOEMATE) on the morphol. of MDA-MB-231 cells and breast tumor-derived fibroblasts was also examd.  The tricyclic coumarin sulfamates and oxepin sulfamate were potent inhibitors of E1-STS activity with IC50s ranging from 8 to 250 nM.  Of this series 667 COUMATE was the most potent inhibitor (IC50 = 8 nM) and was three-times more potent than estrone-3-O-sulfamate (EMATE, IC50 = 25 nM). 667 COUMATE did not stimulate the growth of MCF-7 breast cancer cells and is therefore devoid of estrogenicity.  In vivo, 667 COUMATE inhibited E1-STS activity in rat liver tissue to a similar extent to that of EMATE. 2-MeOEMATE had a marked effect on the morphol. of MDA-MB-231 cells and breast tumor-derived fibroblasts causing a significant increase in the no. of rounded cells. 667 COUMATE and 2-MeOEMATE therefore offer considerable potential for development for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq88Wp-vfuf57Vg90H21EOLACvtfcHk0lh-oFUe8vuu1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsVagsA%253D%253D&md5=35fea8964370fdbfa57d9186b86a04be</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2FS0303-7207%2800%2900428-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0303-7207%252800%252900428-7%26sid%3Dliteratum%253Aachs%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DBarow%26aufirst%3DD.%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DNicholson%26aufirst%3DR.%2BI.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DNon-steroidal%2520and%2520steroidal%2520sulfamates%253A%2520new%2520drugs%2520for%2520cancer%2520therapy%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2001%26volume%3D171%26spage%3D129%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comninos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solomon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2803%2900045-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=12711018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFWgs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=317-325&author=J.+M.+Dayauthor=S.+P.+Newmanauthor=A.+Comninosauthor=C.+Solomonauthor=A.+Purohitauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=The+effects+of+2-substituted+oestrogen+sulphamates+on+the+growth+of+prostate+and+ovarian+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells</span></div><div class="casAuthors">Day, Joanna M.; Newman, Simon P.; Comninos, Alexander; Solomon, Claire; Purohit, Atul; Leese, Matthew P.; Potter, Barry V. L.; Reed, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">317-325</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The human endogenous metabolite 2-methoxyestradiol (2-MeOE2) has been shown to inhibit the proliferation of breast cancer cells.  The authors have previously shown that sulfamoylation of a series of 2-substituted estrogens greatly enhances their ability to inhibit breast cancer cell proliferation and induce apoptosis.  In this study, the authors have investigated the ability of a no. of 2-substituted estrogens and their sulfamoylated derivs. to inhibit the proliferation of two prostate cancer cell lines, an ovarian cancer cell line and its drug-resistant derivs.  2-Methoxyestrone, 2-ethylestrone and 2-ethylestradiol had little effect on the growth of the cell lines tested (IC50>10 μM).  2-MeOE2 did inhibit the growth of the cells (IC50<10 μM), but to a lesser extent than any of the sulfamoylated derivs. tested (IC50<1.0 μM).  Cells treated with the sulfamoylated derivs. became detached and rounded, displaying a characteristic apoptotic appearance.  FACS anal. revealed induced G2/M cell cycle arrest.  Treatment of cells and subsequent drug removal indicated that the effects of the drugs on the cells were irreversible.  Immunoblot anal. indicated that apoptosis may be induced by phosphorylation of BCL-2.  From these studies, 2-substituted estrogen sulfamates are emerging as a potent new class of drug that may be effective against AR+/AR- prostate and ovarian tumors, and against tumors that are resistant to conventional chemotherapeutic regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgRunccQkZ57Vg90H21EOLACvtfcHk0lh-oFUe8vuu1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFWgs7Y%253D&md5=b052e808207ef9dc7db9ece5b5510a7a</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900045-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900045-1%26sid%3Dliteratum%253Aachs%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DComninos%26aufirst%3DA.%26aulast%3DSolomon%26aufirst%3DC.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520effects%2520of%25202-substituted%2520oestrogen%2520sulphamates%2520on%2520the%2520growth%2520of%2520prostate%2520and%2520ovarian%2520cancer%2520cells%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D84%26spage%3D317%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennie, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2Fijc.20045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=14991574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2cXislCisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=533-540&author=S.+P.+Newmanauthor=M.+P.+Leeseauthor=A.+Purohitauthor=D.+R.+C.+Jamesauthor=C.+E.+Rennieauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Inhibition+of+in+vitro+angiogenesis+by+2-methoxy-+and+2-ethyl-estrogen+sulfamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates</span></div><div class="casAuthors">Newman, Simon P.; Leese, Mathew P.; Purohit, Atul; James, David. R. C.; Rennie, Catherine E.; Potter, Barry V. L.; Reed, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">533-540</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Sulfamoylation of 2-methoxyestrone (2-MeOE1) was shown previously to enhance its potency as an anti-proliferative agent against breast cancer cells.  We have examd. the ability of a series of 2-methoxyestradiol (2-MeOE2) and 2-ethylestradiol (2-EtE2) sulfamates to inhibit angiogenesis in vitro.  2-MeOE2 bis-sulfamate and 2-EtE2 sulfamate were potent inhibitors of human umbilical vein endothelial cell (HUVEC) proliferation with IC50 values of 0.05 μM and 0.01 μM, resp.  A novel co-culture system, in which endothelial cells were cultured in a matrix of human dermal fibroblasts, was also used to assess the anti-angiogenic potential of these drugs.  In this system endothelial cells proliferate and migrate through the culture matrix to form tubule structures.  Whereas 2-MeOE2 (1.0 μM) caused a small redn. in tubule formation, both 2-MeOE2 bis-sulfamate (0.1 μM) and 2-EtE2 sulfamate (0.1 μM) almost completely abolished tubule formation.  2-MeOE2 bis-sulfamate and 2-EtE2 sulfamate both induced BCL-2 phosphorylation, p53 protein expression and apoptosis in HUVECs.  Microarray anal. of a limited no. of genes known to be involved in the angiogenic process did not show any gross changes in cells treated with the 2-substituted estrogens.  The sulfamoylated derivs. of 2-MeOE2 and 2-EtE2 are potent inhibitors of in vitro angiogenesis and both compds. should have therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjobqvR13TBLVg90H21EOLACvtfcHk0lh-oFUe8vuu1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXislCisro%253D&md5=483da21487f348462926eb1b2b11caad</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1002%2Fijc.20045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20045%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DD.%2BR.%2BC.%26aulast%3DRennie%26aufirst%3DC.%2BE.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DInhibition%2520of%2520in%2520vitro%2520angiogenesis%2520by%25202-methoxy-%2520and%25202-ethyl-estrogen%2520sulfamates%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2004%26volume%3D109%26spage%3D533%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Ireson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">932</span><span class="NLM_x">–</span> <span class="NLM_lpage">937</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1038%2Fsj.bjc.6601591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=14970876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2cXht12itbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2004&pages=932-937&author=C.+R.+Iresonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=S.+Pereraauthor=S.+P.+Newmanauthor=D.+Parishauthor=M.+P.+Leeseauthor=A.+C.+Smithauthor=B.+V.+L.+Potterauthor=M.+J.+Reed&title=Pharmacokinetics+and+efficacy+of+2-methoxyoestradiol+and+2-methoxyoestradiol-bis-sulphamate+in+vivo+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents</span></div><div class="casAuthors">Ireson, C. R.; Chander, S. K.; Purohit, A.; Perera, S.; Newman, S. P.; Parish, D.; Leese, M. P.; Smith, A. C.; Potter, B. V. L.; Reed, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">932-937</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">2-Methoxyoestradiol (2-MeOE2) is an endogenous estrogen metabolite that inhibits the proliferation of cancer cells in vitro, and it is also antiangiogenic.  In vivo 2-MeOE2, when administered at relatively high doses, inhibits the growth of tumors derived from breast cancer cells, sarcomas and melanomas.  Sulphamoylated derivs. of 2-MeOE2 are more potent inhibitors of in vitro breast cancer cell growth than 2-MeOE2.  In the present study, the authors have compared the pharmacokinetic profiles and metab. of 2-MeOE2 and its sulfamoylated deriv., 2-methoxyestradiol-bis-sulfamate (2-MeOE2bisMATE), in adult female rats.  Their ability to inhibit tumor growth was compared in nude mice bearing xenografts derived from MDA-MB-435 (estrogen receptor neg.) melanoma cancer cells.  After a single oral 10 mg kg-1 dose of 2-MeOE2bisMATE, significant concns. of this compd. were still detectable at 24 h.  In contrast, no 2-MeOE2 or metabolites were detected in plasma at any time after a 10 mg kg-1 oral dose.  Thus, the bioavailability of 2-MeOE2 is very low, whereas for 2-MeOE2bisMATE it was 85%.  No significant metabolites of 2-MeOE2bisMATE were detected in plasma after oral or i.v. dosing, showing that this drug is resistant to metab.  In the tumor efficacy model, oral administration of 2-MeOE2bisMATE, at 20 mg kg-1 day-1 daily for 28 days, almost completely inhibited tumor growth.  Inhibition of tumor growth was maintained for a further 28 days after the cessation of dosing.  At this dose level, 2-MeOE2 did not inhibit tumor growth.  The resistance to metab. shown by 2-MeOE2bisMATE and its ability to inhibit tumor growth in vivo suggest that this compd. should have considerable potential for development as a novel anticancer drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogMoiaDGhPlLVg90H21EOLACvtfcHk0ljEFy9gIHb2LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXht12itbY%253D&md5=e92f1f7f94f9d2fdb3afad25cc41903d</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6601591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6601591%26sid%3Dliteratum%253Aachs%26aulast%3DIreson%26aufirst%3DC.%2BR.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPerera%26aufirst%3DS.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DParish%26aufirst%3DD.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26atitle%3DPharmacokinetics%2520and%2520efficacy%2520of%25202-methoxyoestradiol%2520and%25202-methoxyoestradiol-bis-sulphamate%2520in%2520vivo%2520in%2520rodents%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2004%26volume%3D90%26spage%3D932%26epage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judde, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lassalle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prevost, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1158%2F1078-0432.CCR-07-1717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18223236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=597-606&author=S.+P.+Newmanauthor=P.+A.+Fosterauthor=C.+Stengelauthor=J.+M.+Dayauthor=Y.+T.+Hoauthor=J.+G.+Juddeauthor=M.+Lassalleauthor=G.+Prevostauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=STX140+is+efficacious+in+vitro+and+in+vivo+in+taxane-resistant+breast+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">STX140 Is Efficacious In vitro and In vivo in Taxane-Resistant Breast Carcinoma Cells</span></div><div class="casAuthors">Newman, Simon P.; Foster, Paul A.; Stengel, Chloe; Day, Joanna M.; Ho, Yaik T.; Judde, Jean-Gabriel; Lassalle, Myriam; Prevost, Gregoire; Leese, Mathew P.; Potter, Barry V. L.; Reed, Michael J.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The aim of these studies was to characterize the action of STX140 in a P-glycoprotein-overexpressing tumor cell line both in vitro and in vivo.  In addn., its efficacy was detd. against xenografts derived from patients who failed docetaxel therapy.  Exptl. Design: The effects of STX140, Taxol, and 2-methoxyestradiol (2-MeOE2) on cell proliferation, cell cycle, and apoptosis were assessed in vitro in drug-resistant cells (MCF-7DOX) and the parental cell line (MCF-7WT).  Mice bearing an MCF-7DOX tumor on one flank and an MCF-7WT tumor on the other flank were used to assess the in vivo efficacy.  Furthermore, the responses to STX140 of three xenografts, derived from drug-resistant patients, were assessed.  RESULTS: In this study, STX140 caused cell cycle arrest, cyclin B1 induction, and subsequent apoptosis of both MCF-7DOX and MCF-7WT cells.  Taxol and 2-MeOE2 were only active in the MCF-7WT parental cell line.  Although both STX140 and Taxol inhibited the growth of xenografts derived from MCF-7WT cells, only STX140 inhibited the growth of tumors derived from MCF-7DOX cells. 2-MeOE2 was ineffective at the dose tested against both tumor types.  Two out of the three newly derived docetaxel-resistant xenografts, including a metastatic triple-neg. tumor, responded to STX140 but not to docetaxel treatment.  CONCLUSIONS: STX140 shows excellent efficacy in both MCF-7WT and MCF-7DOX breast cancer xenograft models, in contrast to Taxol and 2-MeOE2.  The clin. potential of STX140 was further highlighted by the efficacy seen in xenografts recently derived from patients who had failed on taxane therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3lf55ZqF0FLVg90H21EOLACvtfcHk0ljEFy9gIHb2LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKhtrk%253D&md5=8bfc633408bab42c4ccf5eab3d0e68c5</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1717%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DJudde%26aufirst%3DJ.%2BG.%26aulast%3DLassalle%26aufirst%3DM.%26aulast%3DPrevost%26aufirst%3DG.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DSTX140%2520is%2520efficacious%2520in%2520vitro%2520and%2520in%2520vivo%2520in%2520taxane-resistant%2520breast%2520carcinoma%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D597%26epage%3D606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Tagg, S. L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span> </span><span class="NLM_article-title">2-Methoxyoestradiol-3,17-<i>O</i>,<i>O</i>-bis-sulphamate and 2-deoxy-<span class="smallcaps smallerCapital">d</span>-glucose in combination: a potential treatment for breast and prostate cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">1842</span><span class="NLM_x">–</span> <span class="NLM_lpage">1848</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1038%2Fsj.bjc.6604752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18985042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVajtbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=1842-1848&author=S.+L.+C.+Taggauthor=P.+A.+Fosterauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohitauthor=S.+P.+Newman&title=2-Methoxyoestradiol-3%2C17-O%2CO-bis-sulphamate+and+2-deoxy-d-glucose+in+combination%3A+a+potential+treatment+for+breast+and+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer</span></div><div class="casAuthors">Tagg, S. L. C.; Foster, P. A.; Leese, M. P.; Potter, B. V. L.; Reed, M. J.; Purohit, A.; Newman, S. P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1842-1848</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Drug combination therapy is a key strategy to improve treatment efficacy and survival of cancer patients.  In this study the effects of combining 2-methoxyoestradiol-3,17-O,O-bis-sulphamate (STX140), a microtubule disruptor, with 2-deoxy--glucose (2DG) were assessed in MCF-7 (breast) and LNCaP (prostate) xenograft models in vivo.  In mice bearing MCF-7 xenografts, daily p.o. administration of STX140 (5 mg kg-1) resulted in a 46% (P<0.05) redn. of tumor vol.  However, the combination of STX140 (5 mg kg-1 p.o.) and 2DG (2 g kg-1 i.p.) reduced tumor vol. by 76% (P<0.001). 2-Methoxyoestradiol-3,17-O,O-bis-sulphamate also reduced tumor vessel d. 2-Deoxy--glucose alone had no significant effect on tumor vol. or vessel d.  A similar benefit of the combination treatment was obsd. in the LNCaP prostate xenograft model.  In vitro the degree of inhibition of cell proliferation by STX140 was unaffected by oxygen concns.  In contrast, the inhibition of proliferation by 2DG was enhanced under hypoxia by 20 and 25% in MCF-7 and LNCaP cells, resp.  The combination of STX140 and 2DG in LNCaP cells under normoxia or hypoxia inhibited proliferation to a greater extent than either compd. alone.  These results suggest that the antiangiogenic and microtubule disruption activities of STX140 may make tumors more susceptible to inhibition of glycolysis by 2DG.  This is the first study to show the benefit of combining a microtubule disruptor with 2DG in the two most common solid tumors.  British Journal of Cancer (2008) 99, 1842-1848. doi:10.1038/sj.bjc.6604752 www.bjcancer.com Published online 4 Nov. 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG7rOAzcZP97Vg90H21EOLACvtfcHk0ljEFy9gIHb2LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVajtbvO&md5=da1ec76fbe26eea3216818b583af24e1</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604752%26sid%3Dliteratum%253Aachs%26aulast%3DTagg%26aufirst%3DS.%2BL.%2BC.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26atitle%3D2-Methoxyoestradiol-3%252C17-O%252CO-bis-sulphamate%2520and%25202-deoxy-d-glucose%2520in%2520combination%253A%2520a%2520potential%2520treatment%2520for%2520breast%2520and%2520prostate%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D99%26spage%3D1842%26epage%3D1848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Meyer-Losic, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span> </span><span class="NLM_article-title">STX140, but not Paclitaxel, inhibits mammary tumor initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e80305</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e80305&author=F.+Meyer-Losicauthor=S.+P.+Newmanauthor=J.+M.+Dayauthor=M.+J.+Reedauthor=P.+G.+Kasprzykauthor=A.+Purohitauthor=P.+A.+Foster&title=STX140%2C+but+not+Paclitaxel%2C+inhibits+mammary+tumor+initiation+and+progression+in+C3%281%29%2FSV40+T%2Ft-antigen+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer-Losic%26aufirst%3DF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26atitle%3DSTX140%252C%2520but%2520not%2520Paclitaxel%252C%2520inhibits%2520mammary%2520tumor%2520initiation%2520and%2520progression%2520in%2520C3%25281%2529%252FSV40%2520T%252Ft-antigen%2520transgenic%2520mice%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De80305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Raobaikady, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-<i>O</i>-sulphamates</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2Fijc.21066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15880363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVaht7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2005&pages=150-159&author=B.+Raobaikadyauthor=M.+J.+Reedauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=A.+Purohit&title=Inhibition+of+MDA-MB-231+cell+cycle+progression+and+cell+proliferation+by+C-2-substituted+oestradiol+mono-+and+bis-3-O-sulphamates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-O-sulphamates</span></div><div class="casAuthors">Raobaikady, Bindumalini; Reed, Michael J.; Leese, Mathew P.; Potter, Barry V. L.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-159</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A natural metabolite of estradiol (E2), 2-methoxyestradiol (2-MeOE2), exerts both antitumor and antiangiogenic effects.  2-MeOE2 is currently in clin. trials for the treatment of a variety of cancers.  We have previously shown that a no. of sulfamoylated analogs of 2-MeOE2 possess enhanced potency and bioavailability with respect to 2-MeOE2.  In our study, the effects of C-2-substituted E2 derivs., with sulfamoylation at the C-3 and/or C-17 position, on ERα -ve MDA-MB-231 breast cancer cells were evaluated.  Sulfamoylated derivs. were potent inhibitors of cell proliferation, and these effects were irreversible when compared to growth inhibitory effects induced by 2-MeOE2.  Cell cycle anal. suggested that these derivs. caused cells to arrest at the G2-M phase of the cell cycle.  Sulfamoylated analogs suppressed the clonogenic potential of MDA-MB-231 cells and also their growth on Matrigel culture substratum.  Immunofluorescence studies showed fragmented nuclear bodies and an abnormal microtubule cytoskeleton in cells exposed to one of the potent compds., 2-MeOE2-bis-sulfamate.  In addn., these analogs induced phosphorylation of BCL-2, a protein considered to be the guardian of microtubule integrity.  In each of the assays, the sulfamoylated derivs. were at least 10-fold more potent than the parent compd. 2-MeOE2.  In view of the enhanced potencies assocd. with sulfamoylated E2 derivs. in ERα -ve cells, these analogs should hold considerable therapeutic potential for the treatment of hormone-independent breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL0ol5PcTw_7Vg90H21EOLACvtfcHk0lj7fqMpG6U8hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVaht7vF&md5=1c97e2a89074dcabef7283b12b21c890</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1002%2Fijc.21066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.21066%26sid%3Dliteratum%253Aachs%26aulast%3DRaobaikady%26aufirst%3DB.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520MDA-MB-231%2520cell%2520cycle%2520progression%2520and%2520cell%2520proliferation%2520by%2520C-2-substituted%2520oestradiol%2520mono-%2520and%2520bis-3-O-sulphamates%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2005%26volume%3D117%26spage%3D150%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">2-MeOE2<i>bis</i>MATE and 2-EtE2<i>bis</i>MATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-007-9791-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=17957467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVCntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=251-260&author=P.+A.+Fosterauthor=Y.+T.+Hoauthor=S.+P.+Newmanauthor=P.+G.+Kasprzykauthor=M.+P.+Leeseauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=2-MeOE2bisMATE+and+2-EtE2bisMATE+induce+cell+cycle+arrest+and+apoptosis+in+breast+cancer+xenografts+as+shown+by+a+novel+ex+vivo+technique"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique</span></div><div class="casAuthors">Foster, Paul A.; Ho, Yaik T.; Newman, Simon P.; Kasprzyk, Philip G.; Leese, Mathew P.; Potter, Barry V. L.; Reed, Michael J.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-260</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Breast cancer is the leading cause of cancer deaths among women worldwide.  The theory of targeting both cancer cells directly and their blood supply has significant therapeutic potential.  However, to date, there are few clin. successful single agents that meet these criteria. 2-Methoxyestradiol-3,17-O,O-bis-sulfamate (2-MeOE2bisMATE) and 2-ethylestradiol-3,17-O,O-bis-sulfamate (2-EtE2bisMATE) are potent inhibitors of proliferation in a range of cancer cells.  The work presented here demonstrates the potent in vitro and in vivo effects of these compds.  They cause apoptosis via the intrinsic mitochondrial pathway in both MDA-MB-231 breast cancer cells and endothelial cells.  Furthermore, they are potent anti-angiogenic inhibitors in vivo, as shown by their ability to reduce endothelial staining in MDA-MB-231 xenograft tumors.  We have developed a novel, flow cytometry based, ex vivo method which shows in cells recovered from MDA-MB-231 tumors treated with 2-MeOE2bisMATE and 2-EtE2bisMATE an increase in intra-tumoral G2-M arrest and apoptosis.  The degree of apoptosis inversely correlates to tumor vol.  Further in vivo studies reveal that both 2-MeOE2bisMATE and 2-EtE2bisMATE are orally bioavailable and extremely efficacious when compared to clin. tested drugs.  As these compds. are anti-proliferative against breast cancer and endothelial cells they have the potential to be potent, dual acting clin. drugs of the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgbHCFTBrF2bVg90H21EOLACvtfcHk0ligd-UBGRgB9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVCntL0%253D&md5=ea4861632e9bfb78b8c0d4d47e551147</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1007%2Fs10549-007-9791-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-007-9791-5%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DHo%26aufirst%3DY.%2BT.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3D2-MeOE2bisMATE%2520and%25202-EtE2bisMATE%2520induce%2520cell%2520cycle%2520arrest%2520and%2520apoptosis%2520in%2520breast%2520cancer%2520xenografts%2520as%2520shown%2520by%2520a%2520novel%2520ex%2520vivo%2520technique%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2008%26volume%3D111%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Mabjeesh, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escuin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaVallee, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pribluda, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannakakou, P.</span><span> </span><span class="NLM_article-title">2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=363-375&author=N.+J.+Mabjeeshauthor=D.+Escuinauthor=T.+M.+LaValleeauthor=V.+S.+Pribludaauthor=G.+M.+Swartzauthor=M.+S.+Johnsonauthor=M.+T.+Willardauthor=H.+Zhongauthor=J.+W.+Simonsauthor=P.+Giannakakou&title=2ME2+inhibits+tumor+growth+and+angiogenesis+by+disrupting+microtubules+and+dysregulating+HIF"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMabjeesh%26aufirst%3DN.%2BJ.%26aulast%3DEscuin%26aufirst%3DD.%26aulast%3DLaVallee%26aufirst%3DT.%2BM.%26aulast%3DPribluda%26aufirst%3DV.%2BS.%26aulast%3DSwartz%26aufirst%3DG.%2BM.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DWillard%26aufirst%3DM.%2BT.%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DSimons%26aufirst%3DJ.%2BW.%26aulast%3DGiannakakou%26aufirst%3DP.%26atitle%3D2ME2%2520inhibits%2520tumor%2520growth%2520and%2520angiogenesis%2520by%2520disrupting%2520microtubules%2520and%2520dysregulating%2520HIF%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D363%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Semenza, G. L.</span><span> </span><span class="NLM_article-title">Signal transduction to hypoxia-inducible factor 1</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2002&pages=993-998&author=G.+L.+Semenza&title=Signal+transduction+to+hypoxia-inducible+factor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DSignal%2520transduction%2520to%2520hypoxia-inducible%2520factor%25201%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D64%26spage%3D993%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Kopacek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barathova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dequiedt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepelakova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorekova, S.</span><span> </span><span class="NLM_article-title">MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1729</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1729&publication_year=2005&pages=41-49&author=J.+Kopacekauthor=M.+Barathovaauthor=F.+Dequiedtauthor=J.+Sepelakovaauthor=R.+Kettmannauthor=J.+Pastorekauthor=S.+Pastorekova&title=MAPK+pathway+contributes+to+density-+and+hypoxia-induced+expression+of+the+tumor-associated+carbonic+anhydrase+IX"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKopacek%26aufirst%3DJ.%26aulast%3DBarathova%26aufirst%3DM.%26aulast%3DDequiedt%26aufirst%3DF.%26aulast%3DSepelakova%26aufirst%3DJ.%26aulast%3DKettmann%26aufirst%3DR.%26aulast%3DPastorek%26aufirst%3DJ.%26aulast%3DPastorekova%26aufirst%3DS.%26atitle%3DMAPK%2520pathway%2520contributes%2520to%2520density-%2520and%2520hypoxia-induced%2520expression%2520of%2520the%2520tumor-associated%2520carbonic%2520anhydrase%2520IX%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1729%26spage%3D41%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Monti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span> </span><span class="NLM_article-title">Anticancer carbonic anhydrase inhibitors: a patent review (2008–2013)</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1517%2F13543776.2013.798648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23672415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsl2qtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=737-749&author=S.+M.+Montiauthor=C.+T.+Supuranauthor=G.+De+Simone&title=Anticancer+carbonic+anhydrase+inhibitors%3A+a+patent+review+%282008%E2%80%932013%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013)</span></div><div class="casAuthors">Monti, Simona Maria; Supuran, Claudiu T.; De Simone, Giuseppina</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">737-749</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Human carbonic anhydrases (EC 4.2.1.1) IX (hCA IX) and XII (hCA XII) are two tumor-assocd. proteins, being overexpressed in many tumors and involved in crit. processes assocd. with cancer progression and response to therapy.  Both are multi-domain proteins consisting of an extracellular catalytic domain (CA), a transmembrane portion (TM) and an intracytoplasmic (IC) segment.  These domains have peculiar biochem. and physiol. features.  CA IX contains an addnl. proteoglycan-like (PG) domain at the N-terminus which constitutes a unique feature of this enzyme within the CA family.Areas covered: Starting from a brief description of the main mol. and catalytic features of both enzymes, their role in tumor physiol. and their three-dimensional structure, this review describes the main classes of small mol. inhibitors, investigated between 2008 and 2013, able to inhibit these enzymes for both diagnostic and therapeutic applications.Expert opinion: A consistent no. of patents on mols. able to inhibit the catalytic activity of CA IX and CA XII have been recently reported.  Most patents deal with classical sulfonamide derivs., demonstrating that introducing suitable substituents on the inhibitor scaffold, good selectivity can be obtained.  However, the most impressive results are related to compds. contg. novel chemotypes, such as coumarins and thiocumarins.  Thus, it is expected that research in next future will be more dedicated to the development of mols. contg. new chemotypes and a large no. of studies in such field have already been published demonstrating the role of these enzymes in carcinogenesis and metastases formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJBAG0RpDlALVg90H21EOLACvtfcHk0lifjL7x2D6Glg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsl2qtrY%253D&md5=8169a6fa6a70f75654492a326af5a376</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.798648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.798648%26sid%3Dliteratum%253Aachs%26aulast%3DMonti%26aufirst%3DS.%2BM.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26atitle%3DAnticancer%2520carbonic%2520anhydrase%2520inhibitors%253A%2520a%2520patent%2520review%2520%25282008%25E2%2580%25932013%2529%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D737%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Benej, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorkova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorek, J.</span><span> </span><span class="NLM_article-title">Carbonic anhydrase IX: regulation and role in cancer</span> <span class="citation_source-journal">Subcell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2F978-94-007-7359-2_11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=24146381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252Foslekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2014&pages=199-219&author=M.+Benejauthor=S.+Pastorkovaauthor=J.+Pastorek&title=Carbonic+anhydrase+IX%3A+regulation+and+role+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Carbonic anhydrase IX: regulation and role in cancer</span></div><div class="casAuthors">Benej Martin; Pastorekova Silvia; Pastorek Jaromir</div><div class="citationInfo"><span class="NLM_cas:title">Sub-cellular biochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">199-219</span>
        ISSN:<span class="NLM_cas:issn">0306-0225</span>.
    </div><div class="casAbstract">Tumor microenvironment substantially influences the process of tumorigenesis.  In many solid tumors, imbalance between the demand of rapidly proliferating cancer cells and the capabilities of the vascular system generates areas with insufficient oxygen supply.  In response to tumor hypoxia, cancer cells modulate their gene expression pattern to match the requirements of the altered microenvironment.  One of the most significant adaptations to this milieu is the shift towards anaerobic glycolysis to keep up the energy demands.  This oncogenic metabolism is often maintained also in aerobic cells.  Lactic acid, its metabolic end-product, accumulates hand-in-hand with carbon dioxide, leading to acidification of the extracellular environment.  Carbonic anhydrase IX (CA IX) is the most widely expressed gene in response to hypoxia.  Its crucial role in intracellular pH maintenance represents the means by which cancer cells adapt to the toxic conditions of the extracellular milieu.  Furthermore, the activity of CA IX stimulates the migratory pathways of cancer cells and is connected with the increase of the aggressive/invasive phenotype of tumors.  CA IX expression in many types of tumors indicates its relevance as a general marker of tumor hypoxia.  Moreover, its expression is closely related to prognosis of the clinical outcome in several tumor types.  All above mentioned facts support the strong position of CA IX as a potential drug therapy target.  Here, we summarize the state-of-the-art knowledge on its regulation and role in cancer development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTEEmqyE37O0WHOrQ6qeX-mfW6udTcc2eZs4XxNYmKyerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252Foslekuw%253D%253D&md5=5e8c2942814e8fbe7e6c2b70f75b8017</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1007%2F978-94-007-7359-2_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-94-007-7359-2_11%26sid%3Dliteratum%253Aachs%26aulast%3DBenej%26aufirst%3DM.%26aulast%3DPastorkova%26aufirst%3DS.%26aulast%3DPastorek%26aufirst%3DJ.%26atitle%3DCarbonic%2520anhydrase%2520IX%253A%2520regulation%2520and%2520role%2520in%2520cancer%26jtitle%3DSubcell.%2520Biochem.%26date%3D2014%26volume%3D75%26spage%3D199%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span> </span><span class="NLM_article-title">Sulfonamides and their isosteres as carbonic anhydrase inhibitors</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1149</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.4155%2Ffmc.14.68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=25078135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyjurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1149-1165&author=F.+Cartaauthor=C.+T.+Supuranauthor=A.+Scozzafava&title=Sulfonamides+and+their+isosteres+as+carbonic+anhydrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides and their isosters as carbonic anhydrase inhibitors</span></div><div class="casAuthors">Carta, Fabrizio; Supuran, Claudiu T.; Scozzafava, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1149-1165</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Mols. contg. the sulfonamide group (R-SO2NH2) as well as its structurally related isosters, sulfamido (R-NH-SO2NH2) and sulfamato (R-O-SO2NH2), constitute the most important class of inhibitors acting on the metalloenzyme carbonic anhydrase (EC 4.2.1.1).  Despite their presence in the literature, in general the reports lack of a clear and org. overview linking the main structural features of the clin. used inhibitors with the therapeutic aspects.  The current review is intended to highlight the structural basis of the interactions of sulfonamide-like groups within the active site of the carbonic anhydrases and will summarize the clin. use of the most interesting mols. for the treatment of relevant pathologies, such as glaucoma, obesity, cancer and CNS-affecting diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW53ZOzAOKlbVg90H21EOLACvtfcHk0lifjL7x2D6Glg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyjurjM&md5=4f69d9467027c4cafe72e51bdadbbd9d</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.68%26sid%3Dliteratum%253Aachs%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DScozzafava%26aufirst%3DA.%26atitle%3DSulfonamides%2520and%2520their%2520isosteres%2520as%2520carbonic%2520anhydrase%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1149%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Cozier, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiyagarajan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Structures of human carbonic anhydrase II/inhibitor complexes reveal a second binding site for steroidal and nonsteroidal inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3464</span><span class="NLM_x">–</span> <span class="NLM_lpage">3476</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi902178w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFerurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=3464-3476&author=G.+E.+Cozierauthor=M.+P.+Leeseauthor=M.+D.+Lloydauthor=M.+D.+Bakerauthor=N.+Thiyagarajanauthor=K.+R.+Acharyaauthor=B.+V.+L.+Potter&title=Structures+of+human+carbonic+anhydrase+II%2Finhibitor+complexes+reveal+a+second+binding+site+for+steroidal+and+nonsteroidal+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Carbonic Anhydrase II/Inhibitor Complexes Reveal a Second Binding Site for Steroidal and Nonsteroidal Inhibitors,</span></div><div class="casAuthors">Cozier, Gyles E.; Leese, Mathew P.; Lloyd, Matthew D.; Baker, Matthew D.; Thiyagarajan, Nethaji; Acharya, K. Ravi; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3464-3476</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Carbonic anhydrase (CA) catalyzes the reversible hydration of carbon dioxide to hydrogen carbonate, and its role in maintaining pH balance has made it an attractive drug target.  Steroidal sulfamate esters, inhibitors of the cancer drug target steroid sulfatase (STS), are sequestered in vivo by CA II in red blood cells, which may be the origin of their excellent drug properties.  Understanding the structural basis of this is important for drug design.  Structures of CA II complexed with 2-methoxyestradiol 3-O-sulfamate (3), 2-ethylestradiol 3,17-O,O-bis(sulfamate) (4), and 2-methoxyestradiol 17-O-sulfamate (5) are reported to 2.10, 1.85, and 1.64 Å, resp.  Inhibitor 3 interacts with the active site Zn(II) ion through the 3-O-sulfamate, while inhibitors 4 and 5 bind through their 17-O-sulfamate.  Comparison of the IC50 values for CA II inhibition gave resp. values of 56, 662, 2113, 169, 770, and 86 nM for estrone 3-O-sulfamate (1), 2-methoxyestradiol 3,17-O,O-bis(sulfamate) (2), 3, 4, 5, and 5'-((4H-1,2,4-triazol-4-yl)methyl)-3-chloro-2'-cyanobiphenyl-4-yl sulfamate (6), a non-steroidal dual aromatase-sulfatase inhibitor.  Inhibitors 2, 5, and 6 showed binding to a second adjacent site that is capable of binding both steroidal and non-steroidal ligands.  Examn. of both IC50 values and crystal structures suggests that 2-substituents on the steroid nucleus hinder binding via a 3-O-sulfamate, leading to coordination through a 17-O-sulfamate if present.  These results underline the influence of small structural changes on affinity and mode of binding, the degree of flexibility in the design of sulfamate-based inhibitors, and suggest a strategy for inhibitors which interact with both the active site and the second adjacent binding site simultaneously that could be both potent and selective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouImDNqlqiM7Vg90H21EOLACvtfcHk0ljyEP8Eu7Qeew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFerurY%253D&md5=067581896020abe3bb6e49b17063d22f</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fbi902178w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi902178w%26sid%3Dliteratum%253Aachs%26aulast%3DCozier%26aufirst%3DG.%2BE.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DThiyagarajan%26aufirst%3DN.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DStructures%2520of%2520human%2520carbonic%2520anhydrase%2520II%252Finhibitor%2520complexes%2520reveal%2520a%2520second%2520binding%2520site%2520for%2520steroidal%2520and%2520nonsteroidal%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26spage%3D3464%26epage%3D3476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">De Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alterio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">793</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1517%2F17460441.2013.795145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=23627619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpslCnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=793-810&author=G.+De+Simoneauthor=V.+Alterioauthor=C.+T.+Supuran&title=Exploiting+the+hydrophobic+and+hydrophilic+binding+sites+for+designing+carbonic+anhydrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors</span></div><div class="casAuthors">De Simone, Giuseppina; Alterio, Vincenzo; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">793-810</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Carbonic anhydrases (CAs, EC 4.2.1.1) exist as five genetically distinct families (α, β, γ, δ and ζ) in organisms all over the phylogenetic tree.  Due to the ubiquity of such enzymes, the selective inhibition and polypharmacol. of inhibitors is an important aspect of all drug design campaigns.  There are several classes of CA inhibitors (CAIs): i) metal ion binders (sulfonamides and their isosteres [sulfamates/sulfamides], dithiocarbamates, mercaptans and hydroxamates); ii) compds. anchoring to the zinc-coordinated water mol./hydroxide ion (phenols, carboxylates, polyamines, esters and sulfocoumarins) and iii) coumarins and related compds. which apparently bind even further away from the metal ion.  Areas covered: The authors rationalize the drug design strategies of inhibitors belonging to the first two classes, based on recent X-ray crystallog. data.  More precisely, this is achieved by analyzing how the hydrophobic and hydrophilic halves of the enzyme active site interact with inhibitors.  This task has been eased by the recent report of β-CA-like enzymes possessing carbon disulfide and carbonyl sulfide hydrolase activities, resp., allowing the authors to propose a general approach of structure-based drug design of CAIs.  Expert opinion: Although amazing progress has been made in the structure-based drug design of CAIs, this field is still in progress, with many constantly emerging new findings.  Indeed, several new such enzymes were discovered and characterized recently and novel chemotypes were explored for finding compds. with a better inhibition profile.  It is anticipated that this will continue to be one of the main frontiers in the search of pharmacol. relevant enzyme inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolHwWEtsN36rVg90H21EOLACvtfcHk0ljyEP8Eu7Qeew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpslCnsb0%253D&md5=a17278d030023ae0a92e1efd33531e93</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.795145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.795145%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DExploiting%2520the%2520hydrophobic%2520and%2520hydrophilic%2520binding%2520sites%2520for%2520designing%2520carbonic%2520anhydrase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D793%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Tars, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vullo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazaks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lends, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalubovskis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301625s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=293-300&author=K.+Tarsauthor=D.+Vulloauthor=A.+Kazaksauthor=J.+Leitansauthor=A.+Lendsauthor=A.+Grandaneauthor=R.+Zalubovskisauthor=A.+Scozzafavaauthor=C.+T.+Supuran&title=Sulfocoumarins+%281%2C2-benzoxathiine-2%2C2-dioxides%29%3A+a+class+of+potent+and+isoform-selective+inhibitors+of+tumor-associated+carbonic+anhydrases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fjm301625s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301625s%26sid%3Dliteratum%253Aachs%26aulast%3DTars%26aufirst%3DK.%26aulast%3DVullo%26aufirst%3DD.%26aulast%3DKazaks%26aufirst%3DA.%26aulast%3DLeitans%26aufirst%3DJ.%26aulast%3DLends%26aufirst%3DA.%26aulast%3DGrandane%26aufirst%3DA.%26aulast%3DZalubovskis%26aufirst%3DR.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DSulfocoumarins%2520%25281%252C2-benzoxathiine-2%252C2-dioxides%2529%253A%2520a%2520class%2520of%2520potent%2520and%2520isoform-selective%2520inhibitors%2520of%2520tumor-associated%2520carbonic%2520anhydrases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D293%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Alterio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkkila, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scaloni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorekova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span> </span><span class="NLM_article-title">Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">16233</span><span class="NLM_x">–</span> <span class="NLM_lpage">16238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1073%2Fpnas.0908301106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=19805286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Kqt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=16233-16238&author=V.+Alterioauthor=M.+Hilvoauthor=A.+Di+Fioreauthor=C.+T.+Supuranauthor=P.+Panauthor=S.+Parkkilaauthor=A.+Scaloniauthor=J.+Pastorekauthor=S.+Pastorekovaauthor=C.+Pedoneauthor=A.+Scozzafavaauthor=S.+M.+Montiauthor=G.+De+Simone&title=Crystal+structure+of+the+catalytic+domain+of+the+tumor-associated+human+carbonic+anhydrase+IX"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX</span></div><div class="casAuthors">Alterio, Vincenzo; Hilvo, Mika; Di Fiore, Anna; Supuran, Claudiu T.; Pan, Peiwen; Parkkil, Seppo; Scaloni, Andrea; Pastorek, Jaromir; Pastorekova, Silvia; Pedone, Carlo; Scozzafava, Andrea; Monti, Simona Maria; De Simone, Giuseppina</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">16233-16238, S16233/1-S16233/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Carbonic anhydrase (CA) IX is a plasma membrane-assocd. member of the α-CA enzyme family, which is involved in solid tumor acidification.  It is a marker of tumor hypoxia and a prognostic factor in several human cancers.  An aberrant increase in CA IX expression in chronic hypoxia and during development of various carcinomas contributes to tumorigenesis through at least two mechanisms: pH regulation and cell adhesion control.  Here, we report the X-ray structure of the catalytic domain of CA IX in complex with a classical, clin. used sulfonamide inhibitor, acetazolamide.  The structure reveals a typical α-CA fold, which significantly differs from the other CA isoenzymes when the protein quaternary structure is considered.  Thus, two catalytic domains of CA IX assoc. to form a dimer, which is stabilized by the formation of an intermol. disulfide bond.  The active site clefts and the PG domains are located on one face of the dimer, while the C-termini are located on the opposite face to facilitate protein anchoring to the cell membrane.  A correlation between the three-dimensional structure and the physiol. role of the enzyme is suggested, based on the measurement of the pH profile of the catalytic activity for the physiol. reaction, CO2 hydration to bicarbonate and protons.  On the basis of the structural differences obsd. between CA IX and the other membrane-assocd. α-CAs, further prospects for the rational drug design of isoenzyme- specific CA inhibitors are proposed, given that inhibition of this enzyme shows antitumor activity both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw4V_A2HME-7Vg90H21EOLACvtfcHk0lh4cJPQReZA3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Kqt7nL&md5=2c3d3a64d3d4c19a69609c8ae3c9905c</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908301106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908301106%26sid%3Dliteratum%253Aachs%26aulast%3DAlterio%26aufirst%3DV.%26aulast%3DHilvo%26aufirst%3DM.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPan%26aufirst%3DP.%26aulast%3DParkkila%26aufirst%3DS.%26aulast%3DScaloni%26aufirst%3DA.%26aulast%3DPastorek%26aufirst%3DJ.%26aulast%3DPastorekova%26aufirst%3DS.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DMonti%26aufirst%3DS.%2BM.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26atitle%3DCrystal%2520structure%2520of%2520the%2520catalytic%2520domain%2520of%2520the%2520tumor-associated%2520human%2520carbonic%2520anhydrase%2520IX%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D16233%26epage%3D16238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaukroger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Structure–activity relationships of C-17 cyano-substituted estratrienes as anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1295</span><span class="NLM_x">–</span> <span class="NLM_lpage">1308</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701319c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1295-1308&author=M.+P.+Leeseauthor=F.+L.+Jourdanauthor=K.+Gaukrogerauthor=M.+F.+Mahonauthor=S.+P.+Newmanauthor=P.+A.+Fosterauthor=C.+Stengelauthor=S.+Regis-Lydiauthor=E.+Ferrandisauthor=A.+Di+Fioreauthor=G.+De+Simoneauthor=C.+T.+Supuranauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Structure%E2%80%93activity+relationships+of+C-17+cyano-substituted+estratrienes+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fjm701319c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701319c%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%2BL.%26aulast%3DGaukroger%26aufirst%3DK.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520of%2520C-17%2520cyano-substituted%2520estratrienes%2520as%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1295%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Fischer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">D-Ring modified estrone derivatives as novel potent inhibitors of sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1685</span><span class="NLM_x">–</span> <span class="NLM_lpage">1700</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1685-1700&author=D.+S.+Fischerauthor=L.+W.+L.+Wooauthor=M.+F.+Mahonauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=D-Ring+modified+estrone+derivatives+as+novel+potent+inhibitors+of+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DD.%2BS.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DD-Ring%2520modified%2520estrone%2520derivatives%2520as%2520novel%2520potent%2520inhibitors%2520of%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1685%26epage%3D1700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Fischer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Novel D-ring modified steroid derivatives as potent, non-estrogenic, sulfatase inhibitors with in vivo activity</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2FS0960-0760%2803%2900048-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=12711021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFWgsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2003&pages=343-349&author=D.+S.+Fischerauthor=S.+K.+Chanderauthor=L.+W.+L.+Wooauthor=J.+C.+Fentonauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Novel+D-ring+modified+steroid+derivatives+as+potent%2C+non-estrogenic%2C+sulfatase+inhibitors+with+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity</span></div><div class="casAuthors">Fischer, Delphine S.; Chander, Surinder K.; Woo, L. W. Lawrence; Fenton, Janine C.; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">In pursuit of novel steroid sulfatase (STS) inhibitors devoid of estrogenicity, several D-ring modified steroid derivs. were synthesized.  In vitro evaluation of the compds. identified two highly potent inhibitors, 4a and 4b, which were 18 times more active than estrone-3-O-sulfamate (EMATE), both having IC50 values of ∼1 nM.  These 16,17-seco-estra-1,3,5(10)-triene-16,17-imide derivs. were synthesized from estrone, via the intermediate 1, which was easily alkylated, deprotected and sulfamoylated affording the final compds. in high yields.  To assess their biol. profile, the selected inhibitors were tested for their in vivo inhibitory potency and estrogenicity in ovariectomized rats.  After an oral dose of 10 mg/kg per day for 5 days, 4a and 4b were found to inhibit rat liver steroid sulfatase by 99%.  They were also devoid of estrogenic activity in the uterine wt. gain assay, indicating that these two leads have therapeutic potential for the treatment of hormone-dependent breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLCy9SiTYeo7Vg90H21EOLACvtfcHk0lhZImu1jjldUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFWgsL8%253D&md5=2ed568d3179a5f80a1971d208159c139</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2FS0960-0760%2803%2900048-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-0760%252803%252900048-7%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DD.%2BS.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DFenton%26aufirst%3DJ.%2BC.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DNovel%2520D-ring%2520modified%2520steroid%2520derivatives%2520as%2520potent%252C%2520non-estrogenic%252C%2520sulfatase%2520inhibitors%2520with%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D84%26spage%3D343%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharland, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusselle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Anticancer sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2435</span><span class="NLM_x">–</span> <span class="NLM_lpage">2444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1158%2F1535-7163.MCT-08-0195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18723489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWksL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2435-2444&author=L.+W.+L.+Wooauthor=D.+S.+Fischerauthor=C.+M.+Sharlandauthor=M.+Trusselleauthor=P.+A.+Fosterauthor=S.+K.+Chanderauthor=A.+Di+Fioreauthor=C.+T.+Supuranauthor=G.+De+Simoneauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Anticancer+sulfatase+inhibitors%3A+synthesis+of+a+potent+fluorinated+second-generation+agent%2C+in+vitro+and+in+vivo+activities%2C+molecular+modeling%2C+and+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography</span></div><div class="casAuthors">Woo, L. W. Lawrence; Fischer, Delphine S.; Sharland, Christopher M.; Trusselle, Melanie; Foster, Paul A.; Chander, Surinder K.; Di Fiore, Anna; Supuran, Claudiu T.; De Simone, Giuseppina; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2435-2444</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">An improved steroid sulfatase inhibitor was prepd. by replacing the N-Pr group of the second-generation steroid-like inhibitor (2) with a N-3,3,3-trifluoropropyl group to give (10).  This compd. is 5-fold more potent in vitro, completely inhibits rat liver steroid sulfatase activity after a single oral dose of 0.5 mg/kg, and exhibits a significantly longer duration of inhibition over (2).  These biol. properties are attributed to the increased lipophilicity and metabolic stability of (10) rendered by its trifluoropropyl group and also the potential H-bonding between its fluorine atom(s) and Arg98 in the active site of human steroid sulfatase.  Like other sulfamates, (10) is expected to be sequestered, and transported by, erythrocytes in vivo because it inhibits human carbonic anhydrase II (hCAII) potently (IC50, 3 nmol/L).  A congener (4), which possesses a N-(pyridin-3-ylmethyl) substituent, is even more active (IC50, 0.1 nmol/L).  To rationalize this, the hCAII-(4) adduct, obtained by cocrystn., reveals not only the sulfamate group and the backbone of (4) interacting with the catalytic site and the assocd. hydrophobic pocket, resp., but also the potential H-bonding between the N-(pyridin-3-ylmethyl) group and N.vepsiln.2 of Gln136.  Like (2), both (10) and its phenolic precursor (9) are non-estrogenic using a uterine wt. gain assay.  In summary, a highly potent, long-acting, and nonestrogenic steroid sulfatase inhibitor was designed with hCAII inhibitory properties that should pos. influence in vivo behavior.  Compd. (10) and other related inhibitors of this structural class further expand the armory of steroid sulfatase inhibitors against hormone-dependent breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkaOB1KGICwbVg90H21EOLACvtfcHk0lhZImu1jjldUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWksL%252FL&md5=e23509f634bee4e54e9a814825edac86</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0195%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DFischer%26aufirst%3DD.%2BS.%26aulast%3DSharland%26aufirst%3DC.%2BM.%26aulast%3DTrusselle%26aufirst%3DM.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DDi%2BFiore%26aufirst%3DA.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26aulast%3DDe%2BSimone%26aufirst%3DG.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DAnticancer%2520sulfatase%2520inhibitors%253A%2520synthesis%2520of%2520a%2520potent%2520fluorinated%2520second-generation%2520agent%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520activities%252C%2520molecular%2520modeling%252C%2520and%2520protein%2520crystallography%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2435%26epage%3D2444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, M. F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-007-9769-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=17914670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXos1Wnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=129-138&author=P.+A.+Fosterauthor=S.+K.+Chanderauthor=M.+F.+C.+Parsonsauthor=S.+P.+Newmanauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=Efficacy+of+three+potent+steroid+sulfatase+inhibitors%3A+pre-clinical+investigations+for+their+use+in+the+treatment+of+hormone-dependent+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer</span></div><div class="casAuthors">Foster, Paul A.; Chander, Surinder K.; Parsons, Michael F. C.; Newman, Simon P.; Woo, L. W. Lawrence; Potter, Barry V. L.; Reed, Michael J.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-138</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Estrogenic steroids, such as estradiol, are known to play a crucial role in the development and growth of hormone-dependent breast cancer.  Steroid sulfatase (STS) inhibitors that can prevent the biosynthesis of these steroids via the sulfatase pathway offer therapeutic potential.  We show here the in vivo profile, including the efficacy in a xenograft breast cancer model and pharmacokinetics, of three potent STS inhibitors.  MCF-7 cells stably over-expressing STS cDNA (MCF-7STS) were generated.  Ovariectomized, MF-1, female nude mice receiving s.c. injections of estradiol sulfate (E2S) and bearing MCF-7STS xenografts, were orally treated with the STS inhibitors STX64, STX213, and STX1938.  Treatment was administered once weekly at a dose of 1 mg/kg for 35 days during which animals received E2S three times weekly.  Mice were weighed and tumor measurements taken weekly.  Furthermore, the pharmacokinetics for STX213 was detd. in rats.  STX213 and STX1938 exhibited potent STS inhibition in vivo.  However, STX1938 demonstrated a greater duration of activity.  In vehicle treated nude mice receiving E2S, tumor vols. increased by 260% after 35 days compared to day zero.  STX64 (1 mg/kg) failed to reduce tumor growth when given once weekly.  STX213 and STX1938 (once weekly, 1 mg/kg) significantly inhibited (P < 0.05) tumor growth over this same time period.  These compds. completely inhibited liver and tumor STS activity and significantly reduced the levels of plasma E2.  This study indicates that the STS inhibitor, STX213, exhibits excellent efficacy and pharmacokinetics and therefore offers a potentially novel treatment for hormone-dependent breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFBitbQl_2QrVg90H21EOLACvtfcHk0lgKT_9mbFGVMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXos1Wnsb4%253D&md5=3aa214e91484bd890ff106faead5480d</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1007%2Fs10549-007-9769-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-007-9769-3%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DParsons%26aufirst%3DM.%2BF.%2BC.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DEfficacy%2520of%2520three%2520potent%2520steroid%2520sulfatase%2520inhibitors%253A%2520pre-clinical%2520investigations%2520for%2520their%2520use%2520in%2520the%2520treatment%2520of%2520hormone-dependent%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2008%26volume%3D111%26spage%3D129%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">The development of steroid sulphatase inhibitors</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=9-23&author=M.+J.+Reedauthor=A.+Purohitauthor=L.+W.+L.+Wooauthor=B.+V.+L.+Potter&title=The+development+of+steroid+sulphatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DThe%2520development%2520of%2520steroid%2520sulphatase%2520inhibitors%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D1996%26volume%3D3%26spage%3D9%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Hejaz, H. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2759</span><span class="NLM_x">–</span> <span class="NLM_lpage">2772</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2759-2772&author=H.+A.+M.+Hejazauthor=L.+W.+L.+Wooauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Synthesis%2C+in+vitro+and+in+vivo+activity+of+benzophenone-based+inhibitors+of+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHejaz%26aufirst%3DH.%2BA.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520activity%2520of%2520benzophenone-based%2520inhibitors%2520of%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2759%26epage%3D2772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Nussbaumer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winiski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span> </span><span class="NLM_article-title">Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-<i>O</i>-sulfamates: potent inhibitors of human steroid sulfatase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5091</span><span class="NLM_x">–</span> <span class="NLM_lpage">5094</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030926s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5091-5094&author=P.+Nussbaumerauthor=A.+P.+Winiskiauthor=A.+Billich&title=Estrogenic+potential+of+2-alkyl-4-%28thio%29chromenone+6-O-sulfamates%3A+potent+inhibitors+of+human+steroid+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Fjm030926s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030926s%26sid%3Dliteratum%253Aachs%26aulast%3DNussbaumer%26aufirst%3DP.%26aulast%3DWiniski%26aufirst%3DA.%2BP.%26aulast%3DBillich%26aufirst%3DA.%26atitle%3DEstrogenic%2520potential%2520of%25202-alkyl-4-%2528thio%2529chromenone%25206-O-sulfamates%253A%2520potent%2520inhibitors%2520of%2520human%2520steroid%2520sulfatase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5091%26epage%3D5094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Walter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liebl, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Angerer, E.</span><span> </span><span class="NLM_article-title">2-Phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2003.12.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15145451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktVKqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2004&pages=409-420&author=G.+Walterauthor=R.+Lieblauthor=E.+von+Angerer&title=2-Phenylindole+sulfamates%3A+inhibitors+of+steroid+sulfatase+with+antiproliferative+activity+in+MCF-7+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">2-Phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells</span></div><div class="casAuthors">Walter, Georg; Liebl, Renate; von Angerer, Erwin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">409-420</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">: Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A no. of 2-phenylindole sulfamates with lipophilic side chains in 1- or 5-position of the indole were synthesized and evaluated as steroid sulfatase (estrone sulfatase) inhibitors.  Most of the new sulfamates inhibited the enzymic hydrolysis of estrone sulfate in MDA-MB 231 breast cancer cells with IC50 values between 2 nM and 1 μM.  A favorable position for a long side chain is the nitrogen of a carbamoyl group at C-5 of the indole when the Ph ring carries the sulfamate function.  These derivs. inhibit gene activation in estrogen receptor (ER)-pos. MCF-7 breast cancer cells in submicromolar concns. and reduce cell proliferation with IC50 values of ∼1 μM.  All of the potent inhibitors were devoid of estrogenic activity and have the potential for in vivo application as steroid sulfatase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyqKvhr1WfxrVg90H21EOLACvtfcHk0lhbY02wATOC5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktVKqu7o%253D&md5=1477d29f5974d8e63320d69017e409bf</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2003.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2003.12.012%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DG.%26aulast%3DLiebl%26aufirst%3DR.%26aulast%3Dvon%2BAngerer%26aufirst%3DE.%26atitle%3D2-Phenylindole%2520sulfamates%253A%2520inhibitors%2520of%2520steroid%2520sulfatase%2520with%2520antiproliferative%2520activity%2520in%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D88%26spage%3D409%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Nussbaumer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span> </span><span class="NLM_article-title">Nortropinyl-arylsulfonylureas as novel, reversible inhibitors of human steroid sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3673</span><span class="NLM_x">–</span> <span class="NLM_lpage">3677</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3673-3677&author=P.+Nussbaumerauthor=D.+Geylauthor=A.+Horvathauthor=P.+Lehrauthor=B.+Wolffauthor=A.+Billich&title=Nortropinyl-arylsulfonylureas+as+novel%2C+reversible+inhibitors+of+human+steroid+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNussbaumer%26aufirst%3DP.%26aulast%3DGeyl%26aufirst%3DD.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DLehr%26aufirst%3DP.%26aulast%3DWolff%26aufirst%3DB.%26aulast%3DBillich%26aufirst%3DA.%26atitle%3DNortropinyl-arylsulfonylureas%2520as%2520novel%252C%2520reversible%2520inhibitors%2520of%2520human%2520steroid%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3673%26epage%3D3677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Lehr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussbaumer, P.</span><span> </span><span class="NLM_article-title"><i>N</i>-Acyl arylsulfonamides as novel, reversible inhibitors of human steroid sulfatase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1235-1238&author=P.+Lehrauthor=A.+Billichauthor=B.+Wolffauthor=P.+Nussbaumer&title=N-Acyl+arylsulfonamides+as+novel%2C+reversible+inhibitors+of+human+steroid+sulfatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLehr%26aufirst%3DP.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DWolff%26aufirst%3DB.%26aulast%3DNussbaumer%26aufirst%3DP.%26atitle%3DN-Acyl%2520arylsulfonamides%2520as%2520novel%252C%2520reversible%2520inhibitors%2520of%2520human%2520steroid%2520sulfatase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1235%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimberley, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozier, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiyagarajan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Chimeric microtubule disruptors</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2907</span><span class="NLM_x">–</span> <span class="NLM_lpage">2909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=2907-2909&author=M.+P.+Leeseauthor=F.+Jourdanauthor=M.+R.+Kimberleyauthor=G.+E.+Cozierauthor=N.+Thiyagarajanauthor=C.+Stengelauthor=S.+Regis-Lydiauthor=P.+A.+Fosterauthor=S.+P.+Newmanauthor=K.+R.+Acharyaauthor=E.+Ferrandisauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Chimeric+microtubule+disruptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%26aulast%3DKimberley%26aufirst%3DM.%2BR.%26aulast%3DCozier%26aufirst%3DG.%2BE.%26aulast%3DThiyagarajan%26aufirst%3DN.%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DChimeric%2520microtubule%2520disruptors%26jtitle%3DChem.%2520Commun.%26date%3D2010%26volume%3D46%26spage%3D2907%26epage%3D2909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Stengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regis-Lydi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. A.</span><span> </span><span class="NLM_article-title">In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1038%2Fbjc.2014.188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=24960406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVKmt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=300-308&author=C.+Stengelauthor=S.+P.+Newmanauthor=J.+M.+Dayauthor=S.+K.+Chanderauthor=M.+P.+Leeseauthor=E.+Ferrandisauthor=S.+Regis-Lydiauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohitauthor=P.+A.+Foster&title=In+vivo+and+in+vitro+properties+of+STX2484%3A+a+novel+non-steroidal+anti-cancer+compound+active+in+taxane-resistant+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer</span></div><div class="casAuthors">Stengel, C.; Newman, S. P.; Day, J. M.; Chander, S. K.; Jourdan, F. L.; Leese, M. P.; Ferrandis, E.; Regis-Lydi, S.; Potter, B. V. L.; Reed, M. J.; Purohit, A.; Foster, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-308</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: STX2484 is a novel non-steroidal compd. with potent anti-proliferative activity.  These studies aimed to identify STX2484's mechanism of action, in vivo efficacy and activity in taxane-resistant breast cancer models.  Methods: Effects of STX2484 and paclitaxel on proliferation, cell cycle and apoptosis were assessed in vitro in drug-resistant (MCF-7DOX) and non-resistant cells (MCF-7WT).  STX2484 efficacy in βIII tubulin overexpression in MCF-7 cells was also detd.  Anti-angiogenic activity was quantified in vitro by a co-culture model and in vivo using a Matrigel plug assay.  An MDA-MB-231 xenograft model was used to det. STX2484 efficacy in vivo.  Results: STX2484 is a tubulin disruptor, which induces p53 expression, Bcl2 phosphorylation, caspase-3 cleavage, cell cycle arrest and apoptosis.  In addn., STX2484 is a potent anti-angiogenic agent in vitro and in vivo.  In breast cancer xenografts, STX2484 (20 mg kg-1 p.o.) suppressed tumor growth by 84% after 35 days of daily dosing, with limited toxicity.  In contrast to paclitaxel, STX2484 efficacy was unchanged in two clin. relevant drug-resistant models.  Conclusions: STX2484 is an orally bioavailable microtubule-disrupting agent with in vivo anti-angiogenic activity and excellent in vivo efficacy with no apparent toxicity.  Crucially, STX2484 has superior efficacy to paclitaxel in models of clin. drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3uya4N-WEzrVg90H21EOLACvtfcHk0li1NvbF0rdvjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVKmt7nJ&md5=a43451bf87ddc0081c5a953547e5b7c2</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2014.188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2014.188%26sid%3Dliteratum%253Aachs%26aulast%3DStengel%26aufirst%3DC.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DDay%26aufirst%3DJ.%2BM.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DRegis-Lydi%26aufirst%3DS.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DFoster%26aufirst%3DP.%2BA.%26atitle%3DIn%2520vivo%2520and%2520in%2520vitro%2520properties%2520of%2520STX2484%253A%2520a%2520novel%2520non-steroidal%2520anti-cancer%2520compound%2520active%2520in%2520taxane-resistant%2520breast%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2014%26volume%3D111%26spage%3D300%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimberley, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Steroidomimetic tetrahydroisoquinolines for the design of new microtubule disruptors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200232c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=5-9&author=M.+P.+Leeseauthor=F.+Jourdanauthor=W.+Dohleauthor=M.+R.+Kimberleyauthor=M.+P.+Thomasauthor=R.+Baiauthor=E.+Hamelauthor=E.+Ferrandisauthor=B.+V.+L.+Potter&title=Steroidomimetic+tetrahydroisoquinolines+for+the+design+of+new+microtubule+disruptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fml200232c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200232c%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%26aulast%3DDohle%26aufirst%3DW.%26aulast%3DKimberley%26aufirst%3DM.%2BR.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DBai%26aufirst%3DR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSteroidomimetic%2520tetrahydroisoquinolines%2520for%2520the%2520design%2520of%2520new%2520microtubule%2520disruptors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D5%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Tetrahydroisoquinoline-based steroidomimetic and chimeric microtubule disruptors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=85-108&author=M.+P.+Leeseauthor=F.+L.+Jourdanauthor=M.+R.+Majorauthor=W.+Dohleauthor=E.+Hamelauthor=E.+Ferrandisauthor=A.+Fioreauthor=P.+G.+Kasprzykauthor=B.+V.+L.+Potter&title=Tetrahydroisoquinoline-based+steroidomimetic+and+chimeric+microtubule+disruptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%2BL.%26aulast%3DMajor%26aufirst%3DM.%2BR.%26aulast%3DDohle%26aufirst%3DW.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DFiore%26aufirst%3DA.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DTetrahydroisoquinoline-based%2520steroidomimetic%2520and%2520chimeric%2520microtubule%2520disruptors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D85%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Dohle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasprzyk, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis, antitubulin, and antiproliferative SAR of C3/C1-substituted tetrahydroisoquinolines</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=350-370&author=W.+Dohleauthor=M.+P.+Leeseauthor=F.+L.+Jourdanauthor=M.+R.+Majorauthor=R.+Baiauthor=E.+Hamelauthor=E.+Ferrandisauthor=P.+G.+Kasprzykauthor=A.+Fioreauthor=S.+P.+Newmanauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Synthesis%2C+antitubulin%2C+and+antiproliferative+SAR+of+C3%2FC1-substituted+tetrahydroisoquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDohle%26aufirst%3DW.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%2BL.%26aulast%3DMajor%26aufirst%3DM.%2BR.%26aulast%3DBai%26aufirst%3DR.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DKasprzyk%26aufirst%3DP.%2BG.%26aulast%3DFiore%26aufirst%3DA.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%252C%2520antitubulin%252C%2520and%2520antiproliferative%2520SAR%2520of%2520C3%252FC1-substituted%2520tetrahydroisoquinolines%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D350%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Dohle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1783</span><span class="NLM_x">–</span> <span class="NLM_lpage">1793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1783-1793&author=W.+Dohleauthor=M.+P.+Leeseauthor=F.+L.+Jourdanauthor=C.+J.+Chapmanauthor=E.+Hamelauthor=E.+Ferrandisauthor=B.+V.+L.+Potter&title=Optimisation+of+tetrahydroisoquinoline-based+chimeric+microtubule+disruptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDohle%26aufirst%3DW.%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%2BL.%26aulast%3DChapman%26aufirst%3DC.%2BJ.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DOptimisation%2520of%2520tetrahydroisoquinoline-based%2520chimeric%2520microtubule%2520disruptors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D1783%26epage%3D1793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Ouellet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, É.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, D.</span><span> </span><span class="NLM_article-title">In vitro evaluation of a tetrahydroisoquinoline derivative as a steroid sulfatase inhibitor and a selective estrogen receptor modulator</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">103</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=95-103&author=C.+Ouelletauthor=%C3%89.+Ouelletauthor=D.+Poirier&title=In+vitro+evaluation+of+a+tetrahydroisoquinoline+derivative+as+a+steroid+sulfatase+inhibitor+and+a+selective+estrogen+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOuellet%26aufirst%3DC.%26aulast%3DOuellet%26aufirst%3D%25C3%2589.%26aulast%3DPoirier%26aufirst%3DD.%26atitle%3DIn%2520vitro%2520evaluation%2520of%2520a%2520tetrahydroisoquinoline%2520derivative%2520as%2520a%2520steroid%2520sulfatase%2520inhibitor%2520and%2520a%2520selective%2520estrogen%2520receptor%2520modulator%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2014%26volume%3D33%26spage%3D95%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Leese, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jourdan, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrandis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis, anti-tubulin and antiproliferative SAR of steroidomimetic dihydroisoquinolinones</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">798</span><span class="NLM_x">–</span> <span class="NLM_lpage">812</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=798-812&author=M.+P.+Leeseauthor=F.+L.+Jourdanauthor=M.+R.+Majorauthor=W.+Dohleauthor=M.+P.+Thomasauthor=E.+Hamelauthor=E.+Ferrandisauthor=M.+F.+Mahonauthor=S.+P.+Newmanauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Synthesis%2C+anti-tubulin+and+antiproliferative+SAR+of+steroidomimetic+dihydroisoquinolinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeese%26aufirst%3DM.%2BP.%26aulast%3DJourdan%26aufirst%3DF.%2BL.%26aulast%3DMajor%26aufirst%3DM.%2BR.%26aulast%3DDohle%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DFerrandis%26aufirst%3DE.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%252C%2520anti-tubulin%2520and%2520antiproliferative%2520SAR%2520of%2520steroidomimetic%2520dihydroisoquinolinones%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D798%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Chanplakorn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chanplakorn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, M. S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasano, H.</span><span> </span><span class="NLM_article-title">Increased estrogen sulfatase (sulfatase) and 17β-hydroxysteroid dehydrogenase type 1(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-010-0785-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=20151319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjs1ajur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=639-648&author=N.+Chanplakornauthor=P.+Chanplakornauthor=T.+Suzukiauthor=K.+Onoauthor=M.+S.+M.+Chanauthor=Y.+Mikiauthor=S.+Sajiauthor=T.+Uenoauthor=M.+Toiauthor=H.+Sasano&title=Increased+estrogen+sulfatase+%28sulfatase%29+and+17%CE%B2-hydroxysteroid+dehydrogenase+type+1%2817%CE%B2-HSD1%29+following+neoadjuvant+aromatase+inhibitor+therapy+in+breast+cancer+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Increased estrogen sulfatase (STS) and 17β-hydroxysteroid dehydrogenase type 1(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients</span></div><div class="casAuthors">Chanplakorn, Niramol; Chanplakorn, Pongsthorn; Suzuki, Takashi; Ono, Katsuhiko; Chan, Monica S. M.; Miki, Yasuhiro; Saji, Shigetoyo; Ueno, Takayuki; Toi, Masakazu; Sasano, Hironobu</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">639-648</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aromatase inhibitors (AIs) are considered the gold std. for endocrine therapy of estrogen receptor (ER) pos. postmenopausal breast cancer patients.  The therapy may enhance therapeutic response and stabilize disease but resistance and disease progression inevitably occur in the patients.  These are considered at least partly due to an emergence of alternative intratumoral estrogen prodn. pathways.  Therefore, in this study we evaluated effects of exemestane (EXE) upon the enzymes involved in intratumoral estrogen prodn. including estrogen sulfatase (STS), 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1), and estrogen sulfotransferase (EST) and correlated the findings with therapeutic responses including Ki67 labeling index (Ki67). 116 postmenopausal patients with invasive ductal carcinoma, stage II/IIIa, were enrolled in JFMC34-0601 clin. trials between March, 2006 and Jan., 2008.  EXE of 25 mg/day was administered according to the protocol.  Pre- and posttreatment specimens of 49 cases were available for this study.  Status of STS, EST, 17β-HSD1, ER, progesterone receptor (PgR), human epidermal growth factor receptor type 2 (Her2), and Ki67 in pre- and post-specimens were evaluated.  Specimens examd. before the therapy demonstrated following features; ER+ (100%), PgR+ (85.7%), and Her2+ (77.6%).  After treatment, the no. of Ki67, PgR, and ER pos. carcinoma cells demonstrated significant decrement in clin. response (CliR) and pathol. response (PaR) groups.  Significant increment of 17β-HSD1 and STS immunoreactivity was detected in all groups examd. except for STS in PaR.  EST showed significant increment in nonresponsive groups.  Alterations of Ki67 of carcinoma cells before and after therapy were subclassified into three groups according to its degrees.  Significant alterations of intratumoral enzymes, esp. 17β-HSD1 and STS, were correlated with Ki67 redn. after neoadjuvant EXE therapy.  This is the first study demonstrating significant increment of STS and 17β-HSD1 following AI neoadjuvant therapy of postmenopausal ER pos. breast carcinoma patients.  This increment may represent the compensatory response of breast carcinoma tissues to estrogen depletion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDFfZe0ibVgbVg90H21EOLACvtfcHk0liCBDuOO_y9Xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjs1ajur8%253D&md5=cd6132650da598a5526cad54005b393a</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1007%2Fs10549-010-0785-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-010-0785-3%26sid%3Dliteratum%253Aachs%26aulast%3DChanplakorn%26aufirst%3DN.%26aulast%3DChanplakorn%26aufirst%3DP.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DM.%2BS.%2BM.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DSaji%26aufirst%3DS.%26aulast%3DUeno%26aufirst%3DT.%26aulast%3DToi%26aufirst%3DM.%26aulast%3DSasano%26aufirst%3DH.%26atitle%3DIncreased%2520estrogen%2520sulfatase%2520%2528sulfatase%2529%2520and%252017%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%252817%25CE%25B2-HSD1%2529%2520following%2520neoadjuvant%2520aromatase%2520inhibitor%2520therapy%2520in%2520breast%2520cancer%2520patients%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2010%26volume%3D120%26spage%3D639%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">The physicochemical challenges of designing multiple ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4961</span><span class="NLM_x">–</span> <span class="NLM_lpage">4970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFejtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4961-4970&author=R.+Morphyauthor=Z.+Rankovic&title=The+physicochemical+challenges+of+designing+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">The Physicochemical Challenges of Designing Multiple Ligands</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4961-4970</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. designed to bind more than one target can provide a therapeutic benefit relative to highly target-selective ligands.  The physicochem. properties of designed multiple ligands were found to be less druglike than those for preclin. compds. in general.  These properties are controlled by the superfamily to which the targets belong and the lead discovery strategy that was followed.  The properties for peptide G-protein-coupled receptor (GPCR) ligands were the least favorable for oral delivery, whereas transporter, monoamine GPCR, and oxidase ligands were the most druglike.  The lead discovery strategy, framework combination or screening, exerts a profound influence on the property values.  Combining the frameworks from two selective ligands often results in large, complex dual ligands, but druglike ligands can be achieved if the degree of framework overlap is maximized and the size of the selective ligands minimized.  For some target combinations, a screening approach may provide a route to smaller, less complex leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonGHbXyxgv4LVg90H21EOLACvtfcHk0lhvGBRzjd619A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFejtL4%253D&md5=c7a227848516d0aa58ed037a582943fe</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1021%2Fjm0603015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603015%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DThe%2520physicochemical%2520challenges%2520of%2520designing%2520multiple%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4961%26epage%3D4970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Cai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, H.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, C.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, C.</span><span> </span><span class="NLM_article-title">Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-<i>N</i>-hydroxyheptanamide (CUDC-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2000</span><span class="NLM_x">–</span> <span class="NLM_lpage">2009</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901453q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2000-2009&author=X.+Caiauthor=H.-X.+Zhaiauthor=J.+Wangauthor=J.+Forresterauthor=H.+Quauthor=L.+Yinauthor=C.-J.+Laiauthor=R.+Baoauthor=C.+Qian&title=Discovery+of+7-%284-%283-ethynylphenylamino%29-7-methoxyquinazolin-6-yloxy%29-N-hydroxyheptanamide+%28CUDC-101%29+as+a+potent+multi-acting+HDAC%2C+EGFR%2C+and+HER2+inhibitor+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1021%2Fjm901453q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901453q%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DX.%26aulast%3DZhai%26aufirst%3DH.-X.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DForrester%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DL.%26aulast%3DLai%26aufirst%3DC.-J.%26aulast%3DBao%26aufirst%3DR.%26aulast%3DQian%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25207-%25284-%25283-ethynylphenylamino%2529-7-methoxyquinazolin-6-yloxy%2529-N-hydroxyheptanamide%2520%2528CUDC-101%2529%2520as%2520a%2520potent%2520multi-acting%2520HDAC%252C%2520EGFR%252C%2520and%2520HER2%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2000%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Shimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoRusso, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patnaik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beeram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasco, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mays, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laliberte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolcher, A. W.</span><span> </span><span class="NLM_article-title">Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5032</span><span class="NLM_x">–</span> <span class="NLM_lpage">5040</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1158%2F1078-0432.CCR-14-0570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=25107918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12gtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=5032-5040&author=T.+Shimizuauthor=P.+M.+LoRussoauthor=K.+P.+Papadopoulosauthor=A.+Patnaikauthor=M.+Beeramauthor=L.+S.+Smithauthor=D.+W.+Rascoauthor=T.+A.+Maysauthor=G.+Chambersauthor=A.+Maauthor=J.+Wangauthor=R.+Laliberteauthor=M.+Voiauthor=A.+W.+Tolcher&title=Phase+I+first-in-human+study+of+CUDC-101%2C+a+multitargeted+inhibitor+of+HDACs%2C+EGFR%2C+and+HER2+in+patients+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I First-in-Human Study of CUDC-101, a Multitargeted Inhibitor of HDACs, EGFR, and HER2 in Patients with Advanced Solid Tumors</span></div><div class="casAuthors">Shimizu, Toshio; LoRusso, Patricia M.; Papadopoulos, Kyri P.; Patnaik, Amita; Beeram, Muralidhar; Smith, Lon S.; Rasco, Drew W.; Mays, Theresa A.; Chambers, Glenda; Ma, Anna; Wang, Jing; Laliberte, Robert; Voi, Maurizio; Tolcher, Anthony W.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5032-5040</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: This first-in-human phase I study evaluated dose-limiting toxicities (DLT) and defined a phase II recommended dose (RD) for CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 as a 1-h i.v. (i.v.) infusion for 5 consecutive days every 2 wk.  Exptl. Design: Twenty-five patients with advanced solid tumors received escalating doses of CUDC-101 (range, 75-300 mg/m2/day) following a std. 3 + 3 dose escalation design.  Results: The MTD was detd. to be 275 mg/m2.  Common grade 1/2 adverse events included nausea, fatigue, vomiting, dyspnea, pyrexia, and dry skin.  DLTs occurred in 1 patient in the 275-mg/m2 dose cohort (grade 2 serum creatinine elevation, n = 1) and 3 patients in the 300-mg/m2 dose cohort (grade 2 serum creatinine elevation, n = 2; pericarditis, n = 1), all of which were transient and reversible.  CUDC-101 exposure increased linearly with the mean max. concn. (Cmax), clearance (CL), vol. of distribution at steady-state (Vdss), area under curve (AUC), and terminal elimination half-life (t1/2) at the MTD dose of 9.3 mg/L, 51.2 L/h, 39.6 L, 9.95 h·ng/mL and 4.4 h, resp.  Acetylated histone H3 induction was obsd. in posttreatment skin samples from 3 patients in the 275-mg/m2 dose cohort, suggesting adequate systemic exposure and target inhibition.  One patient with gastric cancer had a partial response and 6 patients had stable disease.  Conclusion: CUDC-101 administered by 1-h i.v. infusion for 5 consecutive days every 2 wk was generally well tolerated with preliminary evidence of antitumor activity.  A dose of 275 mg/m2 is recommended for further clin. testing.  Clin Cancer Res; 20(19); 5032-40. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUrKXLHOzT6LVg90H21EOLACvtfcHk0lhVk3xkHzd3iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12gtbzP&md5=62860afa08733980f47047880e11a5ba</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-14-0570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-14-0570%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DLoRusso%26aufirst%3DP.%2BM.%26aulast%3DPapadopoulos%26aufirst%3DK.%2BP.%26aulast%3DPatnaik%26aufirst%3DA.%26aulast%3DBeeram%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DL.%2BS.%26aulast%3DRasco%26aufirst%3DD.%2BW.%26aulast%3DMays%26aufirst%3DT.%2BA.%26aulast%3DChambers%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLaliberte%26aufirst%3DR.%26aulast%3DVoi%26aufirst%3DM.%26aulast%3DTolcher%26aufirst%3DA.%2BW.%26atitle%3DPhase%2520I%2520first-in-human%2520study%2520of%2520CUDC-101%252C%2520a%2520multitargeted%2520inhibitor%2520of%2520HDACs%252C%2520EGFR%252C%2520and%2520HER2%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26spage%3D5032%26epage%3D5040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Okada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoden, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaminami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isomura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shikama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujikura, T.</span><span> </span><span class="NLM_article-title">Studies on aromatase inhibitors. I. Synthesis and biological evaluation of 4-amino-4<i>H</i>-1,2,4-triazole derivatives</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1871</span><span class="NLM_x">–</span> <span class="NLM_lpage">1879</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1996&pages=1871-1879&author=M.+Okadaauthor=T.+Yodenauthor=E.+Kawaminamiauthor=Y.+Shimadaauthor=M.+Kudohauthor=Y.+Isomuraauthor=H.+Shikamaauthor=T.+Fujikura&title=Studies+on+aromatase+inhibitors.+I.+Synthesis+and+biological+evaluation+of+4-amino-4H-1%2C2%2C4-triazole+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DYoden%26aufirst%3DT.%26aulast%3DKawaminami%26aufirst%3DE.%26aulast%3DShimada%26aufirst%3DY.%26aulast%3DKudoh%26aufirst%3DM.%26aulast%3DIsomura%26aufirst%3DY.%26aulast%3DShikama%26aufirst%3DH.%26aulast%3DFujikura%26aufirst%3DT.%26atitle%3DStudies%2520on%2520aromatase%2520inhibitors.%2520I.%2520Synthesis%2520and%2520biological%2520evaluation%2520of%25204-amino-4H-1%252C2%252C4-triazole%2520derivatives%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1996%26volume%3D44%26spage%3D1871%26epage%3D1879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">First dual aromatase–sulfatase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3193</span><span class="NLM_x">–</span> <span class="NLM_lpage">3196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm034033b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3193-3196&author=L.+W.+L.+Wooauthor=O.+B.+Sutcliffeauthor=C.+Bubertauthor=A.+Grassoauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=First+dual+aromatase%E2%80%93sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Fjm034033b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034033b%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DGrasso%26aufirst%3DA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DFirst%2520dual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3193%26epage%3D3196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Dual aromatase–sulfatase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3540</span><span class="NLM_x">–</span> <span class="NLM_lpage">3560</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061462b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3540-3560&author=L.+W.+L.+Wooauthor=C.+Bubertauthor=O.+B.+Sutcliffeauthor=A.+Smithauthor=S.+K.+Chanderauthor=M.+F.+Mahonauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Dual+aromatase%E2%80%93sulfatase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1021%2Fjm061462b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061462b%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DDual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3540%26epage%3D3560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationship studies of derivatives of the dual aromatase-sulfatase inhibitor 4-{[(cyanophenyl)(4<i>H</i>-1,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">799</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=779-799&author=L.+W.+L.+Wooauthor=P.+M.+Woodauthor=C.+Bubertauthor=M.+P.+Thomasauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Synthesis+and+structure%E2%80%93activity+relationship+studies+of+derivatives+of+the+dual+aromatase-sulfatase+inhibitor+4-%7B%5B%28cyanophenyl%29%284H-1%2C2%2C4-triazol-4-yl%29amino%5Dmethyl%7Dphenyl+sulfamate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520derivatives%2520of%2520the%2520dual%2520aromatase-sulfatase%2520inhibitor%25204-%257B%255B%2528cyanophenyl%2529%25284H-1%252C2%252C4-triazol-4-yl%2529amino%255Dmethyl%257Dphenyl%2520sulfamate%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D779%26epage%3D799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">Foster, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span> </span><span class="NLM_article-title">A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6469</span><span class="NLM_x">–</span> <span class="NLM_lpage">6477</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1158%2F1078-0432.CCR-08-1027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18927286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KgtbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=6469-6477&author=P.+A.+Fosterauthor=S.+K.+Chanderauthor=S.+P.+Newmanauthor=L.+W.+L.+Wooauthor=O.+B.+Sutcliffeauthor=C.+Bubertauthor=D.+Zhouauthor=S.+Chenauthor=B.+V.+L.+Potterauthor=M.+J.+Reedauthor=A.+Purohit&title=A+new+therapeutic+strategy+against+hormone-dependent+breast+cancer%3A+the+preclinical+development+of+a+dual+aromatase+and+sulfatase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">A New Therapeutic Strategy against Hormone-Dependent Breast Cancer: The Preclinical Development of a Dual Aromatase and Sulfatase Inhibitor</span></div><div class="casAuthors">Foster, Paul A.; Chander, Surinder K.; Newman, Simon P.; Woo, L. W. Lawrence; Sutcliffe, Oliver B.; Bubert, Christian; Zhou, Dujin; Chen, Shiuan; Potter, Barry V. L.; Reed, Michael J.; Purohit, Atul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6469-6477</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The prodn. of E2 is paramount for the growth of estrogen receptor-pos. breast cancer.  Various strategies have been used, including the use of enzyme inhibitors against either aromatase (AROM) or steroid sulfatase (STS), in an attempt to ablate E2 levels.  Both these enzymes play a crit. role in the formation of estrogenic steroids and their inhibitors are now showing success in the clinic.  Exptl. Design: We show here, in a xenograft nude mouse model, that the inhibition of both enzymes using STX681, a dual AROM and STS inhibitor (DASI), is a potential new therapeutic strategy against HDBC.  MCF-7 cells stably expressing either AROM cDNA (MCF-7AROM) or STS cDNA (MCF-7STS) were generated.  Ovariectomized MF-1 female nude mice receiving s.c. injections of either androstenedione (A4) or E2 sulfate and bearing either MCF-7AROM or MCF-7STS tumors were orally treated with STX64, letrozole, or STX681.  Treatment was administered for 28 days.  Mice were weighed and tumor measurements were taken weekly.  RESULTS: STX64, a potent STS inhibitor, completely blocked MCF-7STS tumor growth but failed to attenuate MCF-7AROM tumor growth.  In contrast, letrozole inhibited MCF-7AROM tumors but had no effect on MCF-7STS tumors.  STX681 completely inhibited the growth of both tumors.  AROM and STS activity was also completely inhibited by STX681, which was accompanied by a significant redn. in plasma E2 levels.  CONCLUSIONS: This study indicates that targeting both the AROM and the STS enzyme with a DASI inhibits HDBC growth and is therefore a potentially novel treatment for this malignancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVzXbjDwCamrVg90H21EOLACvtfcHk0lhFZCvizSiWcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KgtbjJ&md5=a7c09b3cd371bc1de5e74152df1fd511</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1027%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DP.%2BA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DNewman%26aufirst%3DS.%2BP.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPurohit%26aufirst%3DA.%26atitle%3DA%2520new%2520therapeutic%2520strategy%2520against%2520hormone-dependent%2520breast%2520cancer%253A%2520the%2520preclinical%2520development%2520of%2520a%2520dual%2520aromatase%2520and%2520sulfatase%2520inhibitor%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D6469%26epage%3D6477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Synthesis of aromatase inhibitors and dual aromatase sulfatase inhibitors by linking an arylsulfamate motif to 4-(4<i>H</i>-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1708</span><span class="NLM_x">–</span> <span class="NLM_lpage">1730</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1708-1730&author=C.+Bubertauthor=L.+W.+L.+Wooauthor=O.+B.+Sutcliffeauthor=M.+F.+Mahonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Synthesis+of+aromatase+inhibitors+and+dual+aromatase+sulfatase+inhibitors+by+linking+an+arylsulfamate+motif+to+4-%284H-1%2C2%2C4-triazol-4-ylamino%29benzonitrile%3A+SAR%2C+crystal+structures%2C+in+vitro+and+in+vivo+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DSutcliffe%26aufirst%3DO.%2BB.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DSynthesis%2520of%2520aromatase%2520inhibitors%2520and%2520dual%2520aromatase%2520sulfatase%2520inhibitors%2520by%2520linking%2520an%2520arylsulfamate%2520motif%2520to%25204-%25284H-1%252C2%252C4-triazol-4-ylamino%2529benzonitrile%253A%2520SAR%252C%2520crystal%2520structures%252C%2520in%2520vitro%2520and%2520in%2520vivo%2520activities%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D1708%26epage%3D1730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrosse, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Bicyclic derivatives of the potent dual aromatase–sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4<i>H</i>-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1577</span><span class="NLM_x">–</span> <span class="NLM_lpage">1593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1577-1593&author=P.+M.+Woodauthor=L.+W.+L.+Wooauthor=J.-R.+Labrosseauthor=M.+P.+Thomasauthor=M.+F.+Mahonauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Bicyclic+derivatives+of+the+potent+dual+aromatase%E2%80%93sulfatase+inhibitor+2-bromo-4-%7B%5B%284-cyanophenyl%29%284H-1%2C2%2C4-triazol-4-yl%29amino%5Dmethyl%7Dphenylsulfamate%3A+synthesis%2C+SAR%2C+crystal+structure%2C+and+in+vitro+and+in+vivo+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLabrosse%26aufirst%3DJ.-R.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DBicyclic%2520derivatives%2520of%2520the%2520potent%2520dual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitor%25202-bromo-4-%257B%255B%25284-cyanophenyl%2529%25284H-1%252C2%252C4-triazol-4-yl%2529amino%255Dmethyl%257Dphenylsulfamate%253A%2520synthesis%252C%2520SAR%252C%2520crystal%2520structure%252C%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520activities%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1577%26epage%3D1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group">Jackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusselle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Dual aromatase–sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2940</span><span class="NLM_x">–</span> <span class="NLM_lpage">2952</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=2940-2952&author=T.+Jacksonauthor=L.+W.+L.+Wooauthor=M.+N.+Trusselleauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Dual+aromatase%E2%80%93sulfatase+inhibitors+based+on+the+anastrozole+template%3A+synthesis%2C+in+vitro+SAR%2C+molecular+modelling+and+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DT.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DTrusselle%26aufirst%3DM.%2BN.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DDual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitors%2520based%2520on%2520the%2520anastrozole%2520template%253A%2520synthesis%252C%2520in%2520vitro%2520SAR%252C%2520molecular%2520modelling%2520and%2520in%2520vivo%2520activity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2007%26volume%3D5%26spage%3D2940%26epage%3D2952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">A letrozole-based dual aromatase–sulphatase inhibitor with in vivo activity</span> <span class="citation_source-journal">J. Steroid Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.jsbmb.2004.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=15862957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVKksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2005&pages=123-130&author=P.+M.+Woodauthor=L.+W.+L.+Wooauthor=A.+Humphreysauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=A+letrozole-based+dual+aromatase%E2%80%93sulphatase+inhibitor+with+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">A letrozole-based dual aromatase-sulphatase inhibitor with in vivo activity</span></div><div class="casAuthors">Wood, Paul M.; Woo, L. W. Lawrence; Humphreys, Anna; Chander, Surinder K.; Purohit, Atul; Reed, Michael J.; Potter, Barry V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Steroid Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">123-130</span>CODEN:
                <span class="NLM_cas:coden">JSBBEZ</span>;
        ISSN:<span class="NLM_cas:issn">0960-0760</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role of aromatase inhibitors in the treatment of hormone-dependent breast cancer is well established.  However, it is now recognized that steroid sulfatase (STS) inhibitors represent a new form of endocrine therapy.  To explore the potential advantage of dual inhibition by a single agent, we recently developed a series of dual aromatase-sulfatase inhibitors (DASIs) based on the aromatase inhibitor YM511.  We report here a new structural class of DASI obtained by obtained introducing the pharmacophore for STS inhibition, i.e. a phenol sulfamate ester into another established aromatase inhibitor letrozole.  Hence, the bis-sulfamate (I) was synthesized which exhibited IC50 values of 3044 nM for aromatase and >10 μM for STS in JEG-3 cells.  However, at a single oral dose of 10 mg/kg, I inhibited aromatase and rat liver STS by 60% and 88%, resp., 24 h after administration.  A proposed metabolite of I, carbinol (II), was synthesized.  Despite also showing weak STS inhibition in JEG-3 cells, II inhibited rat liver STS activity to the same extent as I at a single oral dose of 10 mg/kg.  Thus, the concept of a letrozole-based DASI has been validated and could be further developed and modified for therapeutic exploitation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo60rSRs5AQELVg90H21EOLACvtfcHk0ljxuy7yiCc17Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVKksrc%253D&md5=90f007c68eeaef39b4ba5dc3fd2157fd</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1016%2Fj.jsbmb.2004.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jsbmb.2004.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DHumphreys%26aufirst%3DA.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DA%2520letrozole-based%2520dual%2520aromatase%25E2%2580%2593sulphatase%2520inhibitor%2520with%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Steroid%2520Biochem.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D94%26spage%3D123%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrosse, J.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusselle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longhi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castiglioni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Chiral aromatase and dual aromatase–sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4226</span><span class="NLM_x">–</span> <span class="NLM_lpage">4238</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800168s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4226-4238&author=P.+M.+Woodauthor=L.+W.+L.+Wooauthor=J.-R.+Labrosseauthor=M.+N.+Trusselleauthor=S.+Abbateauthor=G.+Longhiauthor=E.+Castiglioniauthor=F.+Lebonauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Chiral+aromatase+and+dual+aromatase%E2%80%93sulfatase+inhibitors+from+the+letrozole+template%3A+synthesis%2C+absolute+configuration%2C+and+in+vitro+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Fjm800168s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800168s%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DLabrosse%26aufirst%3DJ.-R.%26aulast%3DTrusselle%26aufirst%3DM.%2BN.%26aulast%3DAbbate%26aufirst%3DS.%26aulast%3DLonghi%26aufirst%3DG.%26aulast%3DCastiglioni%26aufirst%3DE.%26aulast%3DLebon%26aufirst%3DF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DChiral%2520aromatase%2520and%2520dual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitors%2520from%2520the%2520letrozole%2520template%253A%2520synthesis%252C%2520absolute%2520configuration%252C%2520and%2520in%2520vitro%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4226%26epage%3D4238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group">Wood, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Aromatase and dual aromatase–sulfatase inhibitors from the letrozole and vorozole templates</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1438</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1423-1438&author=P.+M.+Woodauthor=L.+W.+L.+Wooauthor=M.+P.+Thomasauthor=M.+F.+Mahonauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Aromatase+and+dual+aromatase%E2%80%93sulfatase+inhibitors+from+the+letrozole+and+vorozole+templates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DP.%2BM.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DThomas%26aufirst%3DM.%2BP.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DAromatase%2520and%2520dual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitors%2520from%2520the%2520letrozole%2520and%2520vorozole%2520templates%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1423%26epage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group">Jackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trusselle, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Non-steroidal aromatase inhibitors based on a biphenyl scaffold: synthesis, in vitro SAR, and molecular modelling</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=603-618&author=T.+Jacksonauthor=L.+W.+L.+Wooauthor=M.+N.+Trusselleauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Non-steroidal+aromatase+inhibitors+based+on+a+biphenyl+scaffold%3A+synthesis%2C+in+vitro+SAR%2C+and+molecular+modelling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DT.%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DTrusselle%26aufirst%3DM.%2BN.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DNon-steroidal%2520aromatase%2520inhibitors%2520based%2520on%2520a%2520biphenyl%2520scaffold%253A%2520synthesis%252C%2520in%2520vitro%2520SAR%252C%2520and%2520molecular%2520modelling%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26spage%3D603%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozier, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acharya, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chander, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Highly potent first examples of dual aromatase–sulfatase inhibitors based on a biphenyl template</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2155</span><span class="NLM_x">–</span> <span class="NLM_lpage">2170</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901705h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2155-2170&author=L.+W.+L.+Wooauthor=T.+Jacksonauthor=A.+Puteyauthor=G.+Cozierauthor=P.+Leonardauthor=K.+R.+Acharyaauthor=S.+K.+Chanderauthor=A.+Purohitauthor=M.+J.+Reedauthor=B.+V.+L.+Potter&title=Highly+potent+first+examples+of+dual+aromatase%E2%80%93sulfatase+inhibitors+based+on+a+biphenyl+template"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1021%2Fjm901705h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901705h%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DJackson%26aufirst%3DT.%26aulast%3DPutey%26aufirst%3DA.%26aulast%3DCozier%26aufirst%3DG.%26aulast%3DLeonard%26aufirst%3DP.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DChander%26aufirst%3DS.%2BK.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DReed%26aufirst%3DM.%2BJ.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DHighly%2520potent%2520first%2520examples%2520of%2520dual%2520aromatase%25E2%2580%2593sulfatase%2520inhibitors%2520based%2520on%2520a%2520biphenyl%2520template%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2155%26epage%3D2170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group">Woo, L. W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purohit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, B. V. L.</span><span> </span><span class="NLM_article-title">Hybrid dual aromatase–steroid sulfatase inhibitors with exquisite picomolar inhibitory activity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">247</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100273k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=243-247&author=L.+W.+L.+Wooauthor=C.+Bubertauthor=A.+Purohitauthor=B.+V.+L.+Potter&title=Hybrid+dual+aromatase%E2%80%93steroid+sulfatase+inhibitors+with+exquisite+picomolar+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1021%2Fml100273k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100273k%26sid%3Dliteratum%253Aachs%26aulast%3DWoo%26aufirst%3DL.%2BW.%2BL.%26aulast%3DBubert%26aufirst%3DC.%26aulast%3DPurohit%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DB.%2BV.%2BL.%26atitle%3DHybrid%2520dual%2520aromatase%25E2%2580%2593steroid%2520sulfatase%2520inhibitors%2520with%2520exquisite%2520picomolar%2520inhibitory%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D243%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group">Rasmussen, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenvang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lykkesfeldt, A. E.</span><span> </span><span class="NLM_article-title">A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer</span> <span class="citation_source-journal">Breast Cancer Res. Treat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs10549-007-9494-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=17268816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1CgtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2007&pages=191-203&author=L.+M.+Rasmussenauthor=N.+T.+Zaveriauthor=J.+Stenvangauthor=R.+H.+Petersauthor=A.+E.+Lykkesfeldt&title=A+novel+dual-target+steroid+sulfatase+inhibitor+and+antiestrogen%3A+SR+16157%2C+a+promising+agent+for+the+therapy+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer</span></div><div class="casAuthors">Rasmussen, Louise M.; Zaveri, Nurulain T.; Stenvang, Jan; Peters, Richard H.; Lykkesfeldt, Anne E.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">191-203</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Endocrine therapy is the ideal treatment choice for estrogen receptor α (ERα)-pos. breast cancer patients.  Principal used therapies target either the ERα e.g. by selective ERα modulators (SERMs) such as tamoxifen or target estrogen biosynthesis with aromatase inhibitors.  Steroid sulfatase (STS) plays a crucial role in formation of compds. with estrogenic properties, converting inactive sulfate-conjugated steroids to active non-conjugated forms.  Steroid sulfates are considered as a reservoir for active steroids due to their prolonged half-life and increased concn. in plasma.  STS is present in several tissues including the breast, and the STS the mRNA level and enzyme activity is significantly increased in ERα-pos. breast tumors.  Inhibition of STS is therefore a new approach for decreasing estrogenic steroids that stimulate breast cancer.  The novel dual-acting compd. SR 16157 is designed as a sulfamate-contg. STS inhibitor that releases a tissue-selective SERM SR 16137.  Use of a dual-target STS inhibitor and SERM represents a new strategy in the treatment of hormone-dependent breast cancer.  In this study, we tested the potential of SR 16157 and SR 16137 on STS activity, cell growth and ERα function in MCF-7 breast cancer cells.  We confirmed that the dual-target compd. SR 16157 exerts STS inhibition and antiestrogenic effects.  SR 16157 was a highly effective growth inhibitor, being 10 times more potent than the antiestrogens SR 16137 and tamoxifen.  Relative to tamoxifen, SR 16137 displays profoundly improved ERα binding affinity and antiestrogenic effects on expression of estrogen-regulated genes.  Thus, the dual-target SR 16157 is possibly a promising new treatment alternative, superior to tamoxifen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUhGswZEecBbVg90H21EOLACvtfcHk0liRXvOuqVVJxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1CgtL7O&md5=da8c8215112ce62e4830ab559845e73c</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1007%2Fs10549-007-9494-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-007-9494-y%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DL.%2BM.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DStenvang%26aufirst%3DJ.%26aulast%3DPeters%26aufirst%3DR.%2BH.%26aulast%3DLykkesfeldt%26aufirst%3DA.%2BE.%26atitle%3DA%2520novel%2520dual-target%2520steroid%2520sulfatase%2520inhibitor%2520and%2520antiestrogen%253A%2520SR%252016157%252C%2520a%2520promising%2520agent%2520for%2520the%2520therapy%2520of%2520breast%2520cancer%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007%26volume%3D106%26spage%3D191%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group">Rausch, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmetz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeValley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaveri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweikart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirsalis, J.</span><span> </span><span class="NLM_article-title">Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1341</span><span class="NLM_x">–</span> <span class="NLM_lpage">1352</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1007%2Fs00280-010-1430-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=20737149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFGhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=1341-1352&author=L.+Rauschauthor=C.+Greenauthor=K.+Steinmetzauthor=S.+LeValleyauthor=P.+Catzauthor=N.+Zaveriauthor=K.+Schweikartauthor=J.+Tomaszewskiauthor=J.+Mirsalis&title=Preclinical+pharmacokinetic%2C+toxicological+and+biomarker+evaluation+of+SR16157%2C+a+novel+dual-acting+steroid+sulfatase+inhibitor+and+selective+estrogen+receptor+modulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacokinetic, toxicological and biomarker evaluation of SR16157, a novel dual-acting steroid sulfatase inhibitor and selective estrogen receptor modulator</span></div><div class="casAuthors">Rausch, Linda; Green, Carol; Steinmetz, Karen; LeValley, Sue; Catz, Paul; Zaveri, Nurulain; Schweikart, Karen; Tomaszewski, Joseph; Mirsalis, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1341-1352</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">SR16157 is a novel dual-acting inhibitor of estrogen action that irreversibly inhibits the estrogen biosynthetic enzyme steroid sulfatase (STS) and releases the selective estrogen receptor modulator SR16137, which blocks the estrogen receptor.  SR16157 is a promising agent for the endocrine therapy of breast cancer.  We conducted preclin. in vivo toxicity evaluations to det. the max.-tolerated dose (MTD), target organ(s) of toxicity, reversibility, dose-limiting toxicity, no observable adverse effect level (NOAEL), and toxicokinetics (TK) and to investigate a potential biomarker for use in SR16157 clin. trials.  SR16157 was administered to female Fischer 344 rats or beagle dogs by oral gavage (po) or capsule.  I.v. groups were included for the detn. of bioavailability.  Endpoints evaluated included clin. observations, body wts., hematol., serum chem., pharmacokinetics, TK, pathol. of tissues, and STS activity in liver, or peripheral blood mononuclear cells (PBMCs).  For rats, the MTD (i.e., the highest dose that did not cause lethality but produced toxicity) was 33 mg/kg/day (198 mg/m2/day), and the NOAEL was <10 mg/kg/day (60 mg/m2/day).  For dogs, the MTD was estd. to exceed 10 mg/kg/day (200 mg/m2/day), and the NOAEL was estd. to be at or above 2.5 mg/kg/day (50 mg/m2/day).  Our studies demonstrate that SR16157 has excellent pharmacokinetic properties and an acceptable toxicol. profile.  Modulation of STS activity in PBMCs appeared to be a possible biomarker for use in future clin. trials of SR16157.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHhmr9Hyw7J7Vg90H21EOLACvtfcHk0ljGAnxh_G486Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFGhsLo%253D&md5=d7d22f7a73ed1b857e27f003cac8449c</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1007%2Fs00280-010-1430-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-010-1430-x%26sid%3Dliteratum%253Aachs%26aulast%3DRausch%26aufirst%3DL.%26aulast%3DGreen%26aufirst%3DC.%26aulast%3DSteinmetz%26aufirst%3DK.%26aulast%3DLeValley%26aufirst%3DS.%26aulast%3DCatz%26aufirst%3DP.%26aulast%3DZaveri%26aufirst%3DN.%26aulast%3DSchweikart%26aufirst%3DK.%26aulast%3DTomaszewski%26aufirst%3DJ.%26aulast%3DMirsalis%26aufirst%3DJ.%26atitle%3DPreclinical%2520pharmacokinetic%252C%2520toxicological%2520and%2520biomarker%2520evaluation%2520of%2520SR16157%252C%2520a%2520novel%2520dual-acting%2520steroid%2520sulfatase%2520inhibitor%2520and%2520selective%2520estrogen%2520receptor%2520modulator%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2011%26volume%3D67%26spage%3D1341%26epage%3D1352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group">Ouellet, É.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltais, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, D.</span><span> </span><span class="NLM_article-title">Investigation of a tetrahydroisoquinoline scaffold as dual-action steroid sulfatase inhibitors generated by parallel solid-phase synthesis</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=681-692&author=%C3%89.+Ouelletauthor=R.+Maltaisauthor=C.+Ouelletauthor=D.+Poirier&title=Investigation+of+a+tetrahydroisoquinoline+scaffold+as+dual-action+steroid+sulfatase+inhibitors+generated+by+parallel+solid-phase+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOuellet%26aufirst%3D%25C3%2589.%26aulast%3DMaltais%26aufirst%3DR.%26aulast%3DOuellet%26aufirst%3DC.%26aulast%3DPoirier%26aufirst%3DD.%26atitle%3DInvestigation%2520of%2520a%2520tetrahydroisoquinoline%2520scaffold%2520as%2520dual-action%2520steroid%2520sulfatase%2520inhibitors%2520generated%2520by%2520parallel%2520solid-phase%2520synthesis%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D681%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group">Hoy, S. M.</span><span> </span><span class="NLM_article-title">Abiraterone acetate: a review of its use in patients with metastatic castration-resistant prostate cancer</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">–</span> <span class="NLM_lpage">2091</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=2077-2091&author=S.+M.+Hoy&title=Abiraterone+acetate%3A+a+review+of+its+use+in+patients+with+metastatic+castration-resistant+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoy%26aufirst%3DS.%2BM.%26atitle%3DAbiraterone%2520acetate%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520patients%2520with%2520metastatic%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DDrugs%26date%3D2013%26volume%3D73%26spage%3D2077%26epage%3D2091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group">Nakanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, I.</span><span> </span><span class="NLM_article-title">Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancers</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2Fbdd.1915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=25156339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWit7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=463-484&author=T.+Nakanishiauthor=I.+Tamai&title=Putative+roles+of+organic+anion+transporting+polypeptides+%28OATPs%29+in+cell+survival+and+progression+of+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancers</span></div><div class="casAuthors">Nakanishi, Takeo; Tamai, Ikumi</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">463-484</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Transporter proteins classified into the solute carrier (SLC) transporter superfamily are essential for the import of nutrients required for cell survival in organisms.  Various SLC transporters are differentially upregulated in cancer cells, and among them, polyspecific org. anion-transporting polypeptides (OATPs) have been proposed to have pathophysiol. significance in cancer.  This review will briefly introduce OATPs and summarize their proposed roles in cancer, focusing particularly on hormone-dependent breast and prostate cancers.  Over the past two decades, compelling evidence has also accumulated that SLC transporters, including OATPs, interact with clin. important anticancer agents and influence their pharmacokinetics, particularly the processes of absorption, elimination and distribution.  Therefore, a better understanding of not only the pathophysiol. roles, but also the pharmacol. effects of OATPs in cancer cells should be helpful in combating human malignant tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpMQcPTkD0TrVg90H21EOLACvtfcHk0ljGAnxh_G486Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWit7nK&md5=50a2231c94b2b7fa529f15537130ca5c</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1002%2Fbdd.1915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.1915%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DT.%26aulast%3DTamai%26aufirst%3DI.%26atitle%3DPutative%2520roles%2520of%2520organic%2520anion%2520transporting%2520polypeptides%2520%2528OATPs%2529%2520in%2520cell%2520survival%2520and%2520progression%2520of%2520human%2520cancers%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2014%26volume%3D35%26spage%3D463%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group">Chura, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomquist, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argenta, P. A.</span><span> </span><span class="NLM_article-title">Estrone sulfatase activity in patients with advanced ovarian cancer</span> <span class="citation_source-journal">Gynecol. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1016%2Fj.ygyno.2008.08.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=18947862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFajsL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2009&pages=205-209&author=J.+C.+Churaauthor=C.+H.+Blomquistauthor=H.+S.+Ryuauthor=P.+A.+Argenta&title=Estrone+sulfatase+activity+in+patients+with+advanced+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Estrone sulfatase activity in patients with advanced ovarian cancer</span></div><div class="casAuthors">Chura, Justin C.; Blomquist, Charles H.; Ryu, Hyung S.; Argenta, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">205-209</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: We sought to identify whether the sulfatase pathway was present in ovarian cancer specimens and then to det. whether a clin. correlation existed between sulfatase activity and survival.  Materials and methods: Enzymic activity was assessed in advanced ovarian cancer specimens via thin layer chromatog. and standardized against total protein.  All enzyme activities are reported in pmol/mg protein/30 min.  Kaplan Meier curves of progression-free and overall survival were constructed to compare outcomes between patients with low sulfatase activity and high sulfatase activity.  Median survival rates were compared using the log-rank test for survival curves.  Differences in proportions between patients with low sulfatase activity vs. high sulfatase activity were compared with the z-test or chi-square anal. as appropriate.  Results: 37 specimens from patients with advanced stage ovarian cancer were analyzed.  Enzymic activity was detected in all specimens except one.  Median progression-free survival was 23.5 mo for patients with low sulfatase activity compared to 6.9 mo for patients with high sulfatase activity (p = 0.008).  Median overall survival favored the low sulfatase group (50.8 vs. 30.6 mo resp.), though statistical difference was not detected (p = 0.16).  No other difference in clin. characteristics between patients with high or low sulfatase activity was detected.  Conclusions: Sulfatase activity is widely present in ovarian cancer specimens.  Increased sulfatase activity is assocd. with worse progression-free survival in patients with advanced stage ovarian cancer.  The sulfatase pathway is a potential therapeutic target in the treatment of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI7edQSbPwpbVg90H21EOLACvtfcHk0liOtk376LiyxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFajsL7J&md5=66e78d0ff1f6e5cc7fd0dc7f5beb4fa4</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.ygyno.2008.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygyno.2008.08.037%26sid%3Dliteratum%253Aachs%26aulast%3DChura%26aufirst%3DJ.%2BC.%26aulast%3DBlomquist%26aufirst%3DC.%2BH.%26aulast%3DRyu%26aufirst%3DH.%2BS.%26aulast%3DArgenta%26aufirst%3DP.%2BA.%26atitle%3DEstrone%2520sulfatase%2520activity%2520in%2520patients%2520with%2520advanced%2520ovarian%2520cancer%26jtitle%3DGynecol.%2520Oncol.%26date%3D2009%26volume%3D112%26spage%3D205%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group">Kang, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.-T.</span><span> </span><span class="NLM_article-title">Synthesis and in vitro evaluation of 2-[<sup>11</sup>C] methoxyestradiol-3,17β-<i>O</i>,<i>O</i>-bissulfamate for in vivo studies of angiogenesis</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1002%2Fjlcr.1930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1OhtrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=783-787&author=C.+M.+Kangauthor=Y.+S.+Choeauthor=K.-H.+Jungauthor=J.+Y.+Choiauthor=K.-H.+Leeauthor=B.-T.+Kim&title=Synthesis+and+in+vitro+evaluation+of+2-%5B11C%5D+methoxyestradiol-3%2C17%CE%B2-O%2CO-bissulfamate+for+in+vivo+studies+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro evaluation of 2-[11C]methoxyestradiol-3,17β-O,O-bissulfamate for in vivo studies of angiogenesis</span></div><div class="casAuthors">Kang, Choong Mo; Choe, Yearn Seong; Jung, Kyung-Ho; Choi, Joon Young; Lee, Kyung-Han; Kim, Byung-Tae</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">783-787</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">In the present study, 2-methoxyestradiol-3,17β-O,O-bis-sulfamate (I), a known angiogenesis inhibitor, was prepd. in a radiolabeled form by 11C-methylation of 2-hydroxyestradiol-3,17β-O,O-bis(N-trityl)sulfamate (II) followed by detritylation.  Synthesis of precursor II required a rather long step because of the presence of two sulfamoyl groups.  The decay-cor. radiochem. yield of [11C]I was 19 ± 2% based on [11C]CH3I, and the specific activity was 34-39 GBq/μmol.  Although I is known to significantly inhibit the proliferation of human umbilical vascular endothelial cells (HUVECs), its radiolabeled form, [11C]I was not avidly taken up by HUVECs, and the uptake increased slightly in a time-dependent manner (156% at 60 min relative to a value of 100% at 5 min).  These results suggest that further studies are warranted to det. the mol. target for [11C]I.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEYxGtx_czmrVg90H21EOLACvtfcHk0liOtk376LiyxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1OhtrjK&md5=f4411f83b6470667d3e77953f81a4367</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.1930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.1930%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DC.%2BM.%26aulast%3DChoe%26aufirst%3DY.%2BS.%26aulast%3DJung%26aufirst%3DK.-H.%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DK.-H.%26aulast%3DKim%26aufirst%3DB.-T.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520evaluation%2520of%25202-%255B11C%255D%2520methoxyestradiol-3%252C17%25CE%25B2-O%252CO-bissulfamate%2520for%2520in%2520vivo%2520studies%2520of%2520angiogenesis%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2011%26volume%3D54%26spage%3D783%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mickens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sledge, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Q.-H.</span><span> </span><span class="NLM_article-title">Design and synthesis of carbon-11-labeled dual aromatase–steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancer</span> <span class="citation_source-journal">Steroids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">896</span><span class="NLM_x">–</span> <span class="NLM_lpage">905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=896-905&author=M.+Wangauthor=J.+Mickensauthor=M.+Gaoauthor=K.+D.+Millerauthor=G.+W.+Sledgeauthor=G.+D.+Hutchinsauthor=Q.-H.+Zheng&title=Design+and+synthesis+of+carbon-11-labeled+dual+aromatase%E2%80%93steroid+sulfatase+inhibitors+as+new+potential+PET+agents+for+imaging+of+aromatase+and+steroid+sulfatase+expression+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DMickens%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DSledge%26aufirst%3DG.%2BW.%26aulast%3DHutchins%26aufirst%3DG.%2BD.%26aulast%3DZheng%26aufirst%3DQ.-H.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520carbon-11-labeled%2520dual%2520aromatase%25E2%2580%2593steroid%2520sulfatase%2520inhibitors%2520as%2520new%2520potential%2520PET%2520agents%2520for%2520imaging%2520of%2520aromatase%2520and%2520steroid%2520sulfatase%2520expression%2520in%2520breast%2520cancer%26jtitle%3DSteroids%26date%3D2009%26volume%3D74%26spage%3D896%26epage%3D905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Q.-H.</span><span> </span><span class="NLM_article-title">Synthesis of a new carbon-11-labelled sulfamate derivative as a potential PET tracer for imaging of breast cancer aromatase and steroid sulfatase expression</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1127</span><span class="NLM_x">–</span> <span class="NLM_lpage">1140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=10.1080%2F00397911003797825" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjs1Wnsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=1127-1140&author=M.+Wangauthor=M.+Gaoauthor=K.+D.+Millerauthor=Q.-H.+Zheng&title=Synthesis+of+a+new+carbon-11-labelled+sulfamate+derivative+as+a+potential+PET+tracer+for+imaging+of+breast+cancer+aromatase+and+steroid+sulfatase+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of a New Carbon-11-Labeled Sulfamate Derivative as a Potential PET Tracer for Imaging of Breast Cancer Aromatase and Steroid Sulfatase Expression</span></div><div class="casAuthors">Wang, Min; Gao, Mingzhang; Miller, Kathy D.; Zheng, Qi-Huang</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1127-1140</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">A carbon-11-labeled sulfamate deriv. was designed and synthesized as a new potential positron-emission-tomog. dual aromatase-steroid sulfatase inhibitor radiotracer for imaging of aromatase and steroid sulfatase expression in breast cancer.  The target tracer 2-chloro-4-(((4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino)methyl)-6-[11C]methoxyphenyl sulfamate ([11C]7) was prepd. from its corresponding precursor 2-chloro-4-(((4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino)methyl)-6-hydroxyphenyl sulfamate (18) with [11C]CH3OTf under basic conditions through the O-[11C]methylation and isolated by the reversed-phase high-performance liq. chromatog. in 40-45% radiochem. yields based on [11C]CO2 and decay cor. to end of bombardment.  The specific activity at end of synthesis was 111-185 GBq/μmol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnX1RtmBoq1rVg90H21EOLACvtfcHk0lgIIvbnUs4DRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjs1Wnsr0%253D&md5=2662ea953464043e70c89a4ea8692f40</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1080%2F00397911003797825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397911003797825%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DZheng%26aufirst%3DQ.-H.%26atitle%3DSynthesis%2520of%2520a%2520new%2520carbon-11-labelled%2520sulfamate%2520derivative%2520as%2520a%2520potential%2520PET%2520tracer%2520for%2520imaging%2520of%2520breast%2520cancer%2520aromatase%2520and%2520steroid%2520sulfatase%2520expression%26jtitle%3DSynth.%2520Commun.%26date%3D2011%26volume%3D41%26spage%3D1127%26epage%3D1140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2X7T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2X7T','PDB','2X7T'); return false;">PDB: 2X7T</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00386&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00386%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-19%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00386" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799620fab543d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
